<?xml version='1.0' encoding='utf-8'?>
<graphml xmlns="http://graphml.graphdrawing.org/xmlns" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://graphml.graphdrawing.org/xmlns http://graphml.graphdrawing.org/xmlns/1.0/graphml.xsd">
  <key id="d7" for="edge" attr.name="order" attr.type="long" />
  <key id="d6" for="edge" attr.name="source_id" attr.type="string" />
  <key id="d5" for="edge" attr.name="description" attr.type="string" />
  <key id="d4" for="edge" attr.name="weight" attr.type="double" />
  <key id="d3" for="node" attr.name="clusters" attr.type="string" />
  <key id="d2" for="node" attr.name="source_id" attr.type="string" />
  <key id="d1" for="node" attr.name="description" attr.type="string" />
  <key id="d0" for="node" attr.name="entity_type" attr.type="string" />
  <graph edgedefault="undirected">
    <node id="&quot;GENDER&quot;">
      <data key="d0">"DEMOGRAPHIC"</data>
      <data key="d1">"Men were older than women, while the obese women were older than the nonobese women."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;OBESITY&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Obesity risk is one of the health outcomes studied in relation to the presence of the FTO SNP and education level."&lt;SEP&gt;"Obesity was associated more prevalently in carriers of A-allele compared to TT subjects."&lt;SEP&gt;"The participants in the obese group had higher BMIs (approximately 27.1 kg/m2) and waist circumferences compared to those in the nonobese group."&lt;SEP&gt;"The study focused on the relationship between PRS, dietary patterns, and obesity risk."&lt;SEP&gt;"rs182549 is associated with obesity."</data>
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964&lt;SEP&gt;chunk-fa6293a0a10f175b4aebac8e885c0d20&lt;SEP&gt;chunk-63d0b5be485a69f44e2799ccc9510487&lt;SEP&gt;chunk-3ad8ef794841d749e48b3223741e91d3&lt;SEP&gt;chunk-3135befd0c3140ad097d96ace6de86a1</data>
    </node>
    <node id="&quot;NONOBESE GROUP&quot;">
      <data key="d0">"NON-OBESITY"</data>
      <data key="d1">"The nonobese participants had lower BMI's approximately around 22.5 kg/m2"</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;SEC16 HOMOLOG B (SEC16B)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"SEC16B is a gene that plays a role in endoplasmic reticulum export."</data>
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
    </node>
    <node id="&quot;DNAJ HEAT SHOCK PROTEIN FAMILY (HSP40) MEMBER C27 (DNAJC27)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"DNAJC27 is a gene involved in the hsp40 family that helps with cellular response to stress and heat shock proteins."</data>
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
    </node>
    <node id="&quot;CDK5 REGULATORY SUBUNIT-ASSOCIATED PROTEIN 1-LIKE 1 (CDKAL1)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"CDKAL1 acts as a transcription factor that influences energy intake or expenditure by modulating related genes."</data>
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
    </node>
    <node id="&quot;TRANSCRIPTION FACTOR AP-2 BETA (TFAP2B)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"TFAP2B is an important transcription factor involved in controlling metabolic pathways, especially for energy-related processes."</data>
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
    </node>
    <node id="&quot;BDNF (BRAIN-DERIVED NEUROTROPHIC FACTOR)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"BDNF is a protein that plays various roles including modulating neuronal functions and affecting metabolism related to energy intake or expenditure."</data>
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
    </node>
    <node id="&quot;MYOSIN LIGHT CHAIN-2 (MYL2)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"MYL2 facilitates muscle function by regulating myofilament sliding, involved in both physical activity and energy expenditure."</data>
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
    </node>
    <node id="&quot;OLFACTOMEDIN-4 (OLFM4)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"OLFM4 is a gene that influences olfaction but also seems to impact metabolism or energy management based on its association with obesity risk."</data>
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
    </node>
    <node id="&quot;FTO (FAT MASS AND OBESITY ASSOCIATED)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"FTO plays multiple roles including regulating fat storage, metabolic pathways, and influencing obesity risks."</data>
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
    </node>
    <node id="&quot;MC4R (MELANOCORTIN 4 RECEPTOR)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"MC4R is a receptor that regulates energy balance through its role in appetite control and metabolism."</data>
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
    </node>
    <node id="&quot;GIPR (GLUCAGON-LIKE PEPTIDE-1 RECEPTOR)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"GIPR influences glucose metabolism, particularly insulin secretion or sensitivity in obesity risk scenarios."</data>
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
    </node>
    <node id="&quot;FTO_RS1421085&quot;">
      <data key="d0">"NUTRIENT"/"GENETIC VARIANT"</data>
      <data key="d1">"FTO_rs1421085 is a genetic variant associated with obesity risk through its influence on energy intake or expenditure."</data>
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
    </node>
    <node id="&quot;MC4R_RS6567160&quot;">
      <data key="d0">"DIETARY PATTERN"/"GENE"</data>
      <data key="d1">"MC4R_rs6567160 influences appetite control which is part of the complex interaction between dietary patterns and obesity risk."</data>
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
    </node>
    <node id="&quot;ANSAN/ANSUNG COHORT&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"/"COHORT"</data>
      <data key="d1">"The Ansan/Ansung cohort provides insights into the genetic and environmental factors that contribute to obesity risk in specific populations."</data>
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
    </node>
    <node id="&quot;PRS&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The Polygenic Risk Score (PRS) was used in this study to assess the genetic risk for obesity."</data>
      <data key="d2">chunk-3ad8ef794841d749e48b3223741e91d3</data>
      <data key="d3">[{"level": 0, "cluster": 0}]</data>
    </node>
    <node id="&quot;MENARCHE AGE&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Initial menstruation age interacted with PRS for the obesity risk, suggesting a relationship between menarche and genetic predisposition."</data>
      <data key="d2">chunk-3ad8ef794841d749e48b3223741e91d3</data>
      <data key="d3">[{"level": 0, "cluster": 0}]</data>
    </node>
    <node id="&quot;BMI&quot;">
      <data key="d0">"DEMOGRAPHIC/ CLINICAL CHARACTERISTIC"</data>
      <data key="d1">"A measure of body fat based on height and weight, used as a screening tool for obesity."&lt;SEP&gt;"A measure used to evaluate obesity status related to genetic factors and glycemic status traits."&lt;SEP&gt;"Body Mass Index (BMI) did not significantly differ between T2D-ESRD case subjects and nondiabetic control subjects."&lt;SEP&gt;"Body Mass Index (BMI) was one of the physiological processes measured in relation to PRS and dietary patterns."&lt;SEP&gt;"The BMI was affected by both menarche age and PRS in this context, indicating a physiological process related to body weight regulation."&lt;SEP&gt;"Body Mass Index change associated with the FTO rs1558902 genotype and diet interventions."&lt;SEP&gt;"Body Mass Index is a physiological process that was influenced by the FTO SNP in GP subjects."&lt;SEP&gt;"Body Mass Index (BMI) has a positive correlation with snoring, affecting both males and females."&lt;SEP&gt;"Mean BMI showed significant differences between PCOS cases and control subjects, highlighting its importance as a biomarker."&lt;SEP&gt;"Body mass index is calculated based on weight and height, commonly used for screening of malnutrition and obesity."&lt;SEP&gt;"BMI (Body Mass Index) varies according to the rs671 polymorphism significantly only in men."&lt;SEP&gt;"BMI was associated with subgroup (overall P = .036) where the BMI in IBS-D was approximately 4 higher than in IBS-C and HV."&lt;SEP&gt;"The average BMI was significantly higher in the cases compared to controls."</data>
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9&lt;SEP&gt;chunk-f9a60d3cf951d77afa115859755dac43&lt;SEP&gt;chunk-6f7ce1c71bd46f223756da44b0d0bb2c&lt;SEP&gt;chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6&lt;SEP&gt;chunk-2926e6216bf945b12ea4daa6345cad1f&lt;SEP&gt;chunk-9e14f9bdee02839e4a6b12cff2020a5a&lt;SEP&gt;chunk-1f20dbdcc9de443dada1a2045dc7832b&lt;SEP&gt;chunk-3ad8ef794841d749e48b3223741e91d3&lt;SEP&gt;chunk-3135befd0c3140ad097d96ace6de86a1&lt;SEP&gt;chunk-9977706363cc368b3be503d07ed3ef62&lt;SEP&gt;chunk-2c178ae99eeffdddbea511cafbe4a7d5&lt;SEP&gt;chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d3">[{"level": 0, "cluster": 1}]</data>
    </node>
    <node id="&quot;MENSTRUATION AGE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Menstruation age is an environmental factor that interacts with the Polygenic Risk Score for obesity risk."</data>
      <data key="d2">chunk-3ad8ef794841d749e48b3223741e91d3</data>
    </node>
    <node id="&quot;PLANT-BASED DIET INTAKE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Plant-based diet intake had an interaction with the PRS in influencing obesity risk, suggesting a role of specific nutrients like plant foods."</data>
      <data key="d2">chunk-3ad8ef794841d749e48b3223741e91d3</data>
      <data key="d3">[{"level": 0, "cluster": 0}]</data>
    </node>
    <node id="&quot;LOW PLANT-BASED DIET INTAKE&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Low consumption of plant-based diets showed an inverse impact on genetic influence for BMI compared to high plant-based dietary intake."</data>
      <data key="d2">chunk-3ad8ef794841d749e48b3223741e91d3</data>
    </node>
    <node id="&quot;HIGH PLANT-BASED DIET INTAKE&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"A high plant-based diet intake provided protection against obesity risk when combined with a high PRS, indicating its protective effect."</data>
      <data key="d2">chunk-3ad8ef794841d749e48b3223741e91d3</data>
    </node>
    <node id="&quot;FRIED-FOOD INTAKE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Fried food intake interacted with the PRS in obesity risk studies, suggesting that dietary factors can influence genetic predispositions for obesity."</data>
      <data key="d2">chunk-3ad8ef794841d749e48b3223741e91d3</data>
      <data key="d3">[{"level": 0, "cluster": 0}]</data>
    </node>
    <node id="&quot;HIGH FRIED-FOOD INTAKE&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"High consumption of fried foods led to higher BMI but was offset by avoiding it when combined with a high PRS, implying the protective effect against obesogenic effects."</data>
      <data key="d2">chunk-3ad8ef794841d749e48b3223741e91d3</data>
    </node>
    <node id="&quot;COVARIATES&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Adjusting for covariates did not relate PRS to menarche and menopausal age, suggesting other influencing factors were considered."</data>
      <data key="d2">chunk-3ad8ef794841d749e48b3223741e91d3</data>
    </node>
    <node id="&quot;ADJUSTED ORS&quot;">
      <data key="d0">"STATISTICAL MEASURE"</data>
      <data key="d1">"Adjusted Odds Ratios (ORs) were used in statistical analysis, indicating the impact of PRS on obesity risk after considering certain variables."</data>
      <data key="d2">chunk-3ad8ef794841d749e48b3223741e91d3</data>
    </node>
    <node id="&quot;95% CI&quot;">
      <data key="d0">"CONFIDENCE INTERVAL"</data>
      <data key="d1">"95% Confidence Interval was provided for adjusted ORs to give a range estimating the precision."&lt;SEP&gt;"A statistical measure that gives a range within which we are 95% confident the true value lies, indicating precision of OR estimation."</data>
      <data key="d2">chunk-3ad8ef794841d749e48b3223741e91d3&lt;SEP&gt;chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
    </node>
    <node id="&quot;TABLE 6&quot;">
      <data key="d0">"RESEARCH DATA AND TABLES"</data>
      <data key="d1">"Tables were used in the document to present statistical data, including ORs and their confidence intervals."</data>
      <data key="d2">chunk-3ad8ef794841d749e48b3223741e91d3</data>
    </node>
    <node id="&quot;SEC16B_RS543874&quot;">
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
      <data key="d1">"The genetic variant SEC16B_rs543874 interacts with MC4R_rs6567160 in influencing obesity risk.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;BDNF_RS6265&quot;">
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
      <data key="d1">"The genetic variant DNAJC27_rs713586 affects BDNF_rs6265 which contributes to the obesity risk.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DNAJC27_RS713586&quot;">
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
      <data key="d1">"The genetic variant DNAJC27_rs713586 affects BDNF_rs6265 which contributes to the obesity risk.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CDKAL1_RS9356744&quot;">
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
      <data key="d1">"The genetic variant CDKAL1_rs9356744 is connected to GIPR_rs1444988703, impacting obesity risk.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GIPR_RS1444988703&quot;">
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
      <data key="d1">"The genetic variant CDKAL1_rs9356744 is connected to GIPR_rs1444988703, impacting obesity risk.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;OBESITY RISK&quot;">
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
      <data key="d1">"FTO_rs1421085 contributes to obesity risk through its role in modulating fat mass and energy balance.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ADJUSTMENT FACTOR&quot;">
      <data key="d2">chunk-3ad8ef794841d749e48b3223741e91d3</data>
      <data key="d1">"Covariates were adjusted for in statistical analysis when relating PRS to other factors like menarche age.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;OUTCOME MEASURE&quot;">
      <data key="d2">chunk-3ad8ef794841d749e48b3223741e91d3</data>
      <data key="d1">"The impact of PRS on obesity was measured through BMI, showing a link between genetics and body weight regulation.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 1}]</data>
    </node>
    <node id="&quot;EFFECT MEASURE&quot;">
      <data key="d2">chunk-3ad8ef794841d749e48b3223741e91d3</data>
      <data key="d1">"Adjusted Odds Ratios were used to measure the effect of PRS in obesity risk analysis.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PRECISION ESTIMATE&quot;">
      <data key="d2">chunk-3ad8ef794841d749e48b3223741e91d3</data>
      <data key="d1">"Confidence intervals estimated the precision and reliability of adjusted odds ratios in statistical outcomes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DATA PRESENTATION&quot;">
      <data key="d2">chunk-3ad8ef794841d749e48b3223741e91d3</data>
      <data key="d1">"Tables provided a structured way to present data from statistical analysis including key results like ORs and CI.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS1558902&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The rs1558902 is a genetic variant that was examined for its association with weight changes in participants."</data>
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
    </node>
    <node id="&quot;WEIGHT&quot;">
      <data key="d0">"OUTCOME"</data>
      <data key="d1">"Weight loss or gain observed during the study period."</data>
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
    </node>
    <node id="&quot;WC&quot;">
      <data key="d0">"OUTCOME"</data>
      <data key="d1">"Changes in Waist circumference related to genetic variation in the FTO gene and dietary protein."</data>
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
    </node>
    <node id="&quot;FAT&quot;">
      <data key="d0">"OUTCOME"</data>
      <data key="d1">"Fat is a macronutrient with several types like total fat, FM%, and subcutaneous adipose tissue (SAT)."&lt;SEP&gt;"Fat loss or retention measured through body composition analysis."</data>
      <data key="d2">chunk-a321a6d63755366a1fc3eafbd9fbce83&lt;SEP&gt;chunk-2926e6216bf945b12ea4daa6345cad1f</data>
    </node>
    <node id="&quot;FFM&quot;">
      <data key="d0">"BODY COMPOSITION"</data>
      <data key="d1">"Free fat mass, which is associated with changes according to the FTO genotype and diet."</data>
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
    </node>
    <node id="&quot;FM%&quot;">
      <data key="d0">"BODY COMPOSITION"</data>
      <data key="d1">"Percentage of Fat Mass related to genetic factors and protein intake."</data>
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
    </node>
    <node id="&quot;TRUNK FAT&quot;">
      <data key="d0">"BODY COMPOSITION"</data>
      <data key="d1">"Fat in abdominal area as a component of total body composition."</data>
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
    </node>
    <node id="&quot;TAT&quot;">
      <data key="d0">"BODY FAT DISTRIBUTION"</data>
      <data key="d1">"Total Abdominal Thickness measured by CT scan."</data>
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
    </node>
    <node id="&quot;VAT&quot;">
      <data key="d0">"BODY FAT DISTRIBUTION"</data>
      <data key="d1">"Visceral Adipose Tissue, which shows different changes based on the FTO genotype and diet."</data>
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
    </node>
    <node id="&quot;SAT&quot;">
      <data key="d0">"BODY FAT DISTRIBUTION"</data>
      <data key="d1">"Subcutaneous Adipose Tissue, which also varies with the genetic variant and dietary protein intake."</data>
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
    </node>
    <node id="&quot;DIETARY FAT INTAKE&quot;">
      <data key="d0">"NUTRIENT OR DIETARY PATTERN"</data>
      <data key="d1">"The amount of dietary fat consumed by study participants."</data>
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
    </node>
    <node id="&quot;PROTEIN DIET INTERVENTION&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Intervention involving high-protein diets compared to low-protein diets."</data>
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
    </node>
    <node id="&quot;AGE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Age can influence fertility outcomes, such as affecting semen quality and vitamin status."&lt;SEP&gt;"Age is associated with a higher likelihood of snoring, specifically increasing by 0.11 units per year."&lt;SEP&gt;"Age of study participants."&lt;SEP&gt;"Mean age was similar for all subjects involved."&lt;SEP&gt;"Including age as a factor resulted in similar results for all genetic markers in relation to ovarian cancer."&lt;SEP&gt;"When age was included as an additional covariate, results for all SNPs remained similar in relation to ovarian cancer risk."&lt;SEP&gt;"Age played a role in the association between selenium levels and colorectal cancer/tumor risk."&lt;SEP&gt;"Age is a demographic variable that differs significantly between ALDH2 rs671 genotypes in both males and females."&lt;SEP&gt;"There was a significant positive relationship between age and increased risk of social disinhibition, with each year increase leading to an average score increase of 0.20 points."&lt;SEP&gt;"The average age of cases was higher than that of controls."&lt;SEP&gt;"Age is considered a factor that could influence treatment response and statistical analysis."&lt;SEP&gt;"Age has been considered as a potential factor in the risk of HIV disease progression when correlated with TLR7 polymorphisms."</data>
      <data key="d2">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403&lt;SEP&gt;chunk-6f7ce1c71bd46f223756da44b0d0bb2c&lt;SEP&gt;chunk-c9badb9a0fb813f42383cc8afc57ad45&lt;SEP&gt;chunk-2926e6216bf945b12ea4daa6345cad1f&lt;SEP&gt;chunk-9e14f9bdee02839e4a6b12cff2020a5a&lt;SEP&gt;chunk-055177812e320344d131432b292111b0&lt;SEP&gt;chunk-d4e04dd6cd6ea28f04fd72d964574ec1&lt;SEP&gt;chunk-d311ac0182b37003c75c0005b4337fa6&lt;SEP&gt;chunk-2c91cdebb36ef064eb01a7021a961302&lt;SEP&gt;chunk-9977706363cc368b3be503d07ed3ef62&lt;SEP&gt;chunk-0d49552280a277a8a26456d06f8f26a8</data>
      <data key="d3">[{"level": 0, "cluster": 0}]</data>
    </node>
    <node id="&quot;SEX&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Sex as a covariate was considered in the statistical analysis, indicating it may influence outcomes related to genetic risk scores or test performances."&lt;SEP&gt;"Sex distribution among study participants."&lt;SEP&gt;"Sex was considered as a factor that could influence BMI and obesity risk, especially when stratifying results."&lt;SEP&gt;"Sex was noted among both groups, with more females in cases."&lt;SEP&gt;"Sex has a significant association with snoring; males have an odds ratio of 2.264 compared to females."&lt;SEP&gt;"Sex, as a demographic characteristic, showed no significant association with social disinhibition scores."&lt;SEP&gt;"Sex is often associated with differences in how individuals respond to treatments, being part of lifestyle factors."&lt;SEP&gt;"Sexual and gender differences can influence the course of HIV disease, including factors that may relate to TLR7 polymorphisms."</data>
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f&lt;SEP&gt;chunk-ea6355aaf22d7cdd3331602638122ed7&lt;SEP&gt;chunk-055177812e320344d131432b292111b0&lt;SEP&gt;chunk-d4e04dd6cd6ea28f04fd72d964574ec1&lt;SEP&gt;chunk-3135befd0c3140ad097d96ace6de86a1&lt;SEP&gt;chunk-2c91cdebb36ef064eb01a7021a961302&lt;SEP&gt;chunk-9977706363cc368b3be503d07ed3ef62&lt;SEP&gt;chunk-0d49552280a277a8a26456d06f8f26a8</data>
      <data key="d3">[{"level": 0, "cluster": 0}]</data>
    </node>
    <node id="&quot;ETHNICITY&quot;">
      <data key="d0">"DEMOGRAPHIC VARIABLE"</data>
      <data key="d1">"Ethnic background of study participants."</data>
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
    </node>
    <node id="&quot;AA GENOTYPE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The AA genotype is linked to a specific response to diet."&lt;SEP&gt;"The variant form of the glucokinase regulatory protein that is present in a certain percentage of individuals."</data>
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450&lt;SEP&gt;chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
    </node>
    <node id="&quot;FAT DISTRIBUTION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Fat distribution changes in response to different protein diets."</data>
      <data key="d2">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
    </node>
    <node id="&quot;LOW-PROTEIN DIET&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"A low-protein diet affects fat distribution, particularly for those with the AA genotype."&lt;SEP&gt;"A low-protein diet was prescribed for patients due to HI/HA syndrome."</data>
      <data key="d2">chunk-a321a6d63755366a1fc3eafbd9fbce83&lt;SEP&gt;chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;HIGH-PROTEIN DIET&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"The high-protein diet was associated with greater fat distribution changes in participants with the AA genotype compared to others."</data>
      <data key="d2">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
    </node>
    <node id="&quot;TAT (TOTAL ADIPOSE TISSUE)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Participants with the AA genotype had less loss of TAT in response to low-protein diets."</data>
      <data key="d2">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
    </node>
    <node id="&quot;SAT (SUBCUTANEOUS ADIPOSE TISSUE)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The association between the AA genotype and less SAT loss was observed specifically for the low-protein diet."</data>
      <data key="d2">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
    </node>
    <node id="&quot;LOW-FAT DIET&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Genotype-time interactions were found with total fat, FM%, and percentage of trunk fat changes in response to a low-fat diet."</data>
      <data key="d2">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
    </node>
    <node id="&quot;WHITE POPULATION&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR (RACE/ETHNICITY)"</data>
      <data key="d1">"Similar trends as observed in the AA genotype participants were also seen in the white population but without detailed genotypic data provided."</data>
      <data key="d2">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
    </node>
    <node id="&quot;GENOTYPE-TIME INTERACTION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The term 'genotype-time interaction' indicates how genetic factors influence responses over time."</data>
      <data key="d2">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
    </node>
    <node id="&quot;TOTAL ADIPOSE TISSUE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Total Adipose Tissue describes the overall fat storage in the body."</data>
      <data key="d2">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
    </node>
    <node id="&quot;FM% (FAT MASS PERCENTAGE)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"FM%, or Fat Mass Percentage, is a measurement of total body fat as a percentage of total weight."</data>
      <data key="d2">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
    </node>
    <node id="&quot;CHANGES IN BODY COMPOSITION&quot;">
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d1">"The FTO genetic variant interacted with dietary protein to influence changes in fat mass, free-fat mass, and percentage of trunk fat.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FTO RS1558902 GENOTYPE&quot;">
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d1">"The FTO genetic variant interacted with dietary protein to influence changes in fat mass, free-fat mass, and percentage of trunk fat.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ASSOCIATION WITH GENOTYPE&quot;">
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d1">"Age was adjusted for in the analysis, and interactions were found between age and FTO rs1558902 genotype on weight changes.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 0}]</data>
    </node>
    <node id="&quot;EFFECT ON BODY COMPOSITION&quot;">
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d1">"Sex differences influenced the association of the FTO genetic variant with body composition changes; sex was included in the analysis.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 0}]</data>
    </node>
    <node id="&quot;INTERACTION WITH GENOTYPE&quot;">
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d1">"Ethnicity interacted with the FTO rs1558902 genotype, potentially influencing weight and fat distribution responses to dietary interventions.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FTO RS9939609 POLYMORPHISM&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The study focuses on association of this polymorphism with anthropometric variables."</data>
      <data key="d2">chunk-3135befd0c3140ad097d96ace6de86a1</data>
      <data key="d3">[{"level": 0, "cluster": 2}]</data>
    </node>
    <node id="&quot;WAIST CIRCUMFERENCE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The waist circumference measurement followed a co-dominant model with BMI increase, reflecting association of the polymorphism with anthropometric variables."&lt;SEP&gt;"Waist circumference measurements are used as a parameter to assess obesity and metabolic health."</data>
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9&lt;SEP&gt;chunk-3135befd0c3140ad097d96ace6de86a1</data>
    </node>
    <node id="&quot;EDUCATION LEVEL&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The study considers education level as a factor that interacts with the FTO SNP to influence BMI and obesity risk."</data>
      <data key="d2">chunk-3135befd0c3140ad097d96ace6de86a1</data>
      <data key="d3">[{"level": 0, "cluster": 2}]</data>
    </node>
    <node id="&quot;PHYSICAL ACTIVITY (PA)&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"In elderly HCR subjects, PA was considered an environmental factor influencing the FTO SNP's effect on anthropometric measurements."</data>
      <data key="d2">chunk-3135befd0c3140ad097d96ace6de86a1</data>
    </node>
    <node id="&quot;UNIVERSITY LEVEL&quot;">
      <data key="d0">"EDUCATION CATEGORY"</data>
      <data key="d1">"In stratified analyses by educational level, BMI association with A-allele varied among primary studies, secondary studies, and university level."</data>
      <data key="d2">chunk-3135befd0c3140ad097d96ace6de86a1</data>
    </node>
    <node id="&quot;NON-UNIVERSITY INDIVIDUALS&quot;">
      <data key="d0">"EDUCATION CATEGORY"</data>
      <data key="d1">"The FTO SNP was associated with higher BMI in non-university individuals compared to university level subjects."</data>
      <data key="d2">chunk-3135befd0c3140ad097d96ace6de86a1</data>
    </node>
    <node id="&quot;AA SUBJECTS&quot;">
      <data key="d0">"GENOMIC VARIANT VARIANT TYPE"</data>
      <data key="d1">"In GP subjects, AA variants of the FTO SNP were found to have a different effect on obesity risk compared to TT homozygotes."</data>
      <data key="d2">chunk-3135befd0c3140ad097d96ace6de86a1</data>
    </node>
    <node id="&quot;FTO SNP&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The FTO gene polymorphism, specifically a variant in this gene, was studied in relation to obesity risk."</data>
      <data key="d2">chunk-63d0b5be485a69f44e2799ccc9510487</data>
    </node>
    <node id="&quot;EDUCATION&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Education level is considered as an environmental factor that may affect the association between genetic polymorphisms and health outcomes."&lt;SEP&gt;"Education level was considered as an environmental factor that may affect the association between the FTO SNP and obesity risk."</data>
      <data key="d2">chunk-63d0b5be485a69f44e2799ccc9510487</data>
    </node>
    <node id="&quot;PA (PHYSICAL ACTIVITY)&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR/</data>
      <data key="d1">"Physical activity was considered as a factor that could influence the relationship between genetic variations and obesity."&lt;SEP&gt;Lifestyle Factor"</data>
      <data key="d2">chunk-63d0b5be485a69f44e2799ccc9510487&lt;SEP&gt;chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;INTERACTION WITH FTO SNPC&quot;">
      <data key="d2">chunk-3135befd0c3140ad097d96ace6de86a1</data>
      <data key="d1">"The FTO SNP's influence on obesity risk was modulated by education level in GP subjects.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 2}]</data>
    </node>
    <node id="&quot;IMPACT ON FTO SNP EFFECT&quot;">
      <data key="d2">chunk-3135befd0c3140ad097d96ace6de86a1</data>
      <data key="d1">"In elderly HCR subjects, PA was found to interact with the FTO SNP affecting anthropometric measurements.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INTERACTION WITH BMI AND OBESITY&quot;">
      <data key="d2">chunk-3135befd0c3140ad097d96ace6de86a1</data>
      <data key="d1">"Sex influenced the relationship between the FTO SNP and BMI, as well as obesity risk.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 0}]</data>
    </node>
    <node id="&quot;PUBLICATION&quot;">
      <data key="d0">"COHORT STUDY"/"RCT"</data>
      <data key="d1">None of the entities are directly associated with this text as it focuses on characteristics of cohort studies and RCTs rather than individual entities.</data>
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
    </node>
    <node id="&quot;NOS1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"NOS1 is a gene that plays a critical role in cardiovascular health by regulating nitric oxide production."</data>
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
    </node>
    <node id="&quot;GENOMIC VARIANT&quot;">
      <data key="d0">"RS12441227"</data>
      <data key="d1">"A genomic variant in the NOS1 gene has been linked to increased risk of hypertension."&lt;SEP&gt;"Early MTX-related neurotoxicity may be influenced by certain genomic variations, potentially contributing to its manifestation."&lt;SEP&gt;"A genomic variant specific to IL-6Rα gene influences the severity of colitis."&lt;SEP&gt;"Specific allele of a genetic variant associated with increased risk for T2DM"&lt;SEP&gt;"The presence of specific genomic variants might influence AMD risk independently."&lt;SEP&gt;"NA"&lt;SEP&gt;"rs8096658 has an effect size of πC = 0.877"&lt;SEP&gt;"rs8096658 overlaps with fetal kidney cell DHSs at the NFATC1 locus"&lt;SEP&gt;"A variant rs1099733 is highlighted as significant."&lt;SEP&gt;"Specific genomic variants related to the context have been omitted."&lt;SEP&gt;"SNP rs12441227 at the THSD4 locus explains 2.9% of the residual variance in FEV1/FVC lung function."</data>
      <data key="d2">chunk-a7d0bfa8b16262a1f313b7e3060969c6&lt;SEP&gt;chunk-45a965c3c3013c70d0fa0f1680283083&lt;SEP&gt;chunk-f2c864ef2d87119a8129e011b1c42e3c&lt;SEP&gt;chunk-e8f81fdd25a22582c6ce3d1e15f74af3&lt;SEP&gt;chunk-0d8bc9a093c56fefc8b7af3fb9bc2862&lt;SEP&gt;chunk-ea6355aaf22d7cdd3331602638122ed7&lt;SEP&gt;chunk-72f4505e43f67f3564607392cb178656&lt;SEP&gt;chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9&lt;SEP&gt;chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a&lt;SEP&gt;chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
      <data key="d3">[{"level": 0, "cluster": 7}, {"level": 1, "cluster": 26}]</data>
    </node>
    <node id="&quot;TRANSCRIPT&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"490 statistically significantly differentially expressed probes corresponding to 421 genes in DBA patients compared to controls."&lt;SEP&gt;"A transcript related to the functions of GSTP1 protein was assessed for polymorphisms."&lt;SEP&gt;"NA"&lt;SEP&gt;"The expression levels of specific transcripts associated with complement pathway genes were considered."&lt;SEP&gt;"The genotyping results provide insights into specific transcripts associated with the detected genomic variants."&lt;SEP&gt;"The transcript of the NOS1 gene is influenced by dietary patterns, particularly the intake of folate."&lt;SEP&gt;"The transcript of IL-6Rα gene is related with disease protection seen after T cell transfers."&lt;SEP&gt;"The transcript results from the process of transcription in which RNA molecules are synthesized by RNA polymerase using one or more strands of DNA as a template."&lt;SEP&gt;"Transcripts are the primary output of gene expression and can be considered as a product of genetic information."&lt;SEP&gt;"NFATC1 is a gene encoding a member of the NFAT family that affects kidney function and development."&lt;SEP&gt;"The CASP3 transcript is considered in the analysis."&lt;SEP&gt;"Specific transcripts related to the context have been omitted."&lt;SEP&gt;"No transcript information provided for the associations identified."&lt;SEP&gt;"Transcripts associated with these genetic markers were part of the study."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94&lt;SEP&gt;chunk-22216738ccbae0a6276bb4499018c434&lt;SEP&gt;chunk-a7d0bfa8b16262a1f313b7e3060969c6&lt;SEP&gt;chunk-45a965c3c3013c70d0fa0f1680283083&lt;SEP&gt;chunk-ab5011584b0230efbf80a98b2a693a0e&lt;SEP&gt;chunk-f2c864ef2d87119a8129e011b1c42e3c&lt;SEP&gt;chunk-e8f81fdd25a22582c6ce3d1e15f74af3&lt;SEP&gt;chunk-ea6355aaf22d7cdd3331602638122ed7&lt;SEP&gt;chunk-b803830d07bff8ae14550f6458048707&lt;SEP&gt;chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a&lt;SEP&gt;chunk-72f4505e43f67f3564607392cb178656&lt;SEP&gt;chunk-734cac289b42d37dad32bd51ea24a1ea&lt;SEP&gt;chunk-0d8bc9a093c56fefc8b7af3fb9bc2862&lt;SEP&gt;chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
      <data key="d3">[{"level": 0, "cluster": 10}, {"level": 1, "cluster": 32}]</data>
    </node>
    <node id="&quot;NOS1 PROTEIN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The NOS1 protein is involved in the production of nitric oxide."&lt;SEP&gt;"The NOS1 protein is involved in vascular function and interacts with folate metabolism."</data>
      <data key="d2">chunk-f05ecc979eea31a1ab844c2c7de12432&lt;SEP&gt;chunk-0d8bc9a093c56fefc8b7af3fb9bc2862&lt;SEP&gt;chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d3">[{"level": 0, "cluster": 13}, {"level": 1, "cluster": 44}]</data>
    </node>
    <node id="&quot;FOLATE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Folate is a key nutrient found in leafy greens and plays a role in nitric oxide production."&lt;SEP&gt;"Folate is a nutrient found in various foods that influences vitamin B12 levels."</data>
      <data key="d2">chunk-22216738ccbae0a6276bb4499018c434&lt;SEP&gt;chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
    </node>
    <node id="&quot;LEAFY GREENS&quot;">
      <data key="d0">"FOOD"</data>
      <data key="d1">"Leafy greens are a food source rich in folate, a nutrient critical for cardiovascular health."</data>
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
    </node>
    <node id="&quot;DIETARY PATTERN&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"A dietary pattern refers to a specific way of eating, which may involve certain types of foods and nutrients."&lt;SEP&gt;"A dietary pattern refers to the overall composition and timing of food intake over a period of time."&lt;SEP&gt;"Dietary patterns influence the transcript of the NOS1 gene and folate metabolism."&lt;SEP&gt;"Dietary patterns might influence TAG levels through interaction with genotypes."&lt;SEP&gt;"NA"&lt;SEP&gt;"The Mediterranean diet pattern might have been considered as relevant to health outcomes."&lt;SEP&gt;"Specific dietary patterns related to the context have been omitted."&lt;SEP&gt;"No dietary pattern information provided for the associations identified."&lt;SEP&gt;"There was an examination of various dietary patterns that could impact genetic and metabolic outcomes."</data>
      <data key="d2">chunk-22216738ccbae0a6276bb4499018c434&lt;SEP&gt;chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6&lt;SEP&gt;chunk-e8f81fdd25a22582c6ce3d1e15f74af3&lt;SEP&gt;chunk-b803830d07bff8ae14550f6458048707&lt;SEP&gt;chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a&lt;SEP&gt;chunk-72f4505e43f67f3564607392cb178656&lt;SEP&gt;chunk-734cac289b42d37dad32bd51ea24a1ea&lt;SEP&gt;chunk-0d8bc9a093c56fefc8b7af3fb9bc2862&lt;SEP&gt;chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
      <data key="d3">[{"level": 0, "cluster": 10}, {"level": 1, "cluster": 31}]</data>
    </node>
    <node id="&quot;FOLATE METABOLISM&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Folate metabolism is a physiological process that interacts with the NOS1 protein to maintain vascular function."&lt;SEP&gt;"Folate metabolism, influenced by dietary patterns and genetic factors like MTHFR variants, plays a critical role in cardiovascular health."</data>
      <data key="d2">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb&lt;SEP&gt;chunk-0d8bc9a093c56fefc8b7af3fb9bc2862&lt;SEP&gt;chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d3">[{"level": 0, "cluster": 13}, {"level": 1, "cluster": 44}]</data>
    </node>
    <node id="&quot;NITRIC OXIDE SYNTHESIS&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"The metabolic pathway of nitric oxide synthesis is central to the interaction between the NOS1 gene and cardiovascular health."</data>
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d3">[{"level": 0, "cluster": 13}, {"level": 1, "cluster": 43}]</data>
    </node>
    <node id="&quot;CARDIOVASCULAR DISEASE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Cardiovascular disease is a condition influenced by both genetic and environmental factors, including the NOS1 gene and dietary patterns."&lt;SEP&gt;"Cardiovascular disease is influenced by factors such as genetic variants, dietary patterns, folate intake and environmental factors, affecting nitric oxide synthesis."</data>
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862&lt;SEP&gt;chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d3">[{"level": 0, "cluster": 13}, {"level": 1, "cluster": 43}]</data>
    </node>
    <node id="&quot;EPIGENETIC MODIFICATION&quot;">
      <data key="d0">"GENETIC ALTERATION"</data>
      <data key="d1">"Epigenetic modifications linked to poor dietary patterns can alter the metabolic pathway of nitric oxide synthesis."&lt;SEP&gt;"These are changes to DNA without altering its sequence, influencing gene expression and cellular function."</data>
      <data key="d2">chunk-22216738ccbae0a6276bb4499018c434&lt;SEP&gt;chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d3">[{"level": 0, "cluster": 10}, {"level": 1, "cluster": 31}]</data>
    </node>
    <node id="&quot;DIET&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Diet is an environmental factor that modulates the relationship between the NOS1 gene and cardiovascular health."</data>
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
    </node>
    <node id="&quot;PHYSICAL ACTIVITY&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"Physical activity can modulate the effects of alcohol consumption on cortisol levels."&lt;SEP&gt;"Physical activity is a lifestyle factor that further modulates cardiovascular health."</data>
      <data key="d2">chunk-9e14f9bdee02839e4a6b12cff2020a5a&lt;SEP&gt;chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d3">[{"level": 0, "cluster": 0}, {"level": 1, "cluster": 19}]</data>
    </node>
    <node id="&quot;STATINS&quot;">
      <data key="d0">"DRUG CLASS/</data>
      <data key="d1">"Statins are a drug therapy used to manage cardiovascular disease risk."&lt;SEP&gt;Medication Type"</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63&lt;SEP&gt;chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
    </node>
    <node id="&quot;PERSONALIZED THERAPY&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"Personalized therapies based on genetic and nutritional profiles are being explored to manage cardiovascular health."</data>
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
    </node>
    <node id="&quot;TCF7L2 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The TCF7L2 gene is associated with diabetes risk."&lt;SEP&gt;"The TCF7L2 gene is of particular interest due to its strong association with type 2 diabetes (T2D) risk and known impact on incretin effect on insulin secretion."&lt;SEP&gt;"The TCF7L2 gene's variants are of interest due to their potential interaction with dietary factors that could influence the risk of developing type 2 diabetes."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc&lt;SEP&gt;chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
    </node>
    <node id="&quot;RS7903146 VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The TCF7L2 variant rs7903146 interacts with both fiber and whole-grain intake, impacting insulin secretion and glucose metabolism."&lt;SEP&gt;"The rs7903146 variant in the TCF7L2 gene is considered strongly associated with T2D risk."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;FIBER INTAKE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Increased cereal fiber intake was associated with lower T2D incidence among individuals carrying a specific TCF7L2 genotype (rs7903146 CC-variant)."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;WHOLE GRAIN INTAKE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Higher whole-grain consumption was linked to lower T2D risk in persons with the rs7903146 CC-variant."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;NOTCH2 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The NOTCH2 gene is involved in WNT activity, relevant for cellular growth and differentiation."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;RS10923931 VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A specific variant of the NOTCH2 gene (rs10923931) interacts with dietary factors affecting T2D risk."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;ZBED3 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The ZBED3 gene plays a role in WNT signaling pathways, contributing to cellular processes that influence T2D risk."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;WNT ACTIVITY&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"NOTCH2 gene and the ZBED3 gene interact with WNT activity, which is pertinent to glucose metabolism and insulin sensitivity."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;IRS1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The IRS1 gene is known for its role in insulin sensitivity, which is crucial for glucose homeostasis."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;GIPR GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The GIPR gene impacts insulin secretion, contributing to glucose metabolism and diabetes risk."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;PPARΓ GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The PPARγ gene regulates fatty acid storage, affecting lipid metabolism and glucose levels."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;FFAR4 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The FFAR4 gene is involved in Gαq signaling pathways relevant for cellular responses to nutrients and hormones."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;CAV2 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The CAV2 gene affects total fat and saturated fatty acid metabolism, potentially influencing T2D risk."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;HFE H63D&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Haemochromatosis-associated variant in the HFE gene linked to increased risk for Type 2 Diabetes (T2D) among women."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;HFE C282Y&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Another haemochromatosis-related variant in the HFE gene, also associated with higher T2D risk among women with this variant compared to those without."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;T2D RISK&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Increased likelihood of developing Type 2 Diabetes related to genetic variants like HFE H63D and C282Y."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;HEME IRON INTAKE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Heme iron consumption interacts with the SLC40A1 rs744653 variant and shows borderline significance (P = .046) for association with T2D in total sample, particularly among men."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;ZINC INTAKE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Zinc intake has an interaction with the SLC30A8 zinc transporter variants like rs16889462 and rs16889462, but no clear association with T2D incidence in exposure strata."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;T2D-GRS (DIABETES GENETICS RISK SCORE)&quot;">
      <data key="d0">"GENETIC VARIANT"</data>
      <data key="d1">"A risk score related to multiple genetic variants that can influence the incidence of Type 2 Diabetes. Higher GRS correlates with increased T2D risk."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;LACTASE PERSISTENCE LCT RS4988235&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This variant near the lactase persistence gene modifies the association of dairy products and Type 2 Diabetes, especially among milk consumers who carry the lactase persistence allele T-allele."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;COFFEE INTAKE&quot;">
      <data key="d0">"NUTRIENT/DIETARY PATTERN"</data>
      <data key="d1">"Coffee intake interacts with some genetic variants affecting its potential to lower Type 2 Diabetes risk. The strongest effect was observed for individuals carrying the TCF7L2 variant rs12255372."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;MEDITERRANEAN DIET SCORE&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"A score reflecting adherence to a Mediterranean diet does not show significant interaction with a Type 2 Diabetes risk score, indicating that the protective effect against T2D is consistent regardless of genetic predisposition."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;WESTERN DIETARY PATTERN&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"This pattern associated with higher incidence of T2D is modified in its effects among individuals with high adherence to a Type 2 Diabetes risk score, implying that the increased risk does not apply uniformly to everyone."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;LTPA (LEISURE-TIME PHYSICAL ACTIVITY)&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR/</data>
      <data key="d1">Lifestyle Factor"</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;ADRA2B GLU12 ALLELE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This allele in the ADRA2B gene interacts with changes in LTPA to show lower T2D incidence when carried alongside specific genotypes like the ABCC8 rs3758947 GG-genotype."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;ABCC8 RS3758947 GG-GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT/</data>
      <data key="d1">Environmental Factor/</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;TCF7L2 RS12255372 T-ALELE&quot;/">
      <data key="d0">PROTEIN/</data>
      <data key="d1">Nutrient/Dietary Pattern/</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;CDKAL1 RS7754840 G-ALELE&quot;/">
      <data key="d0">GENOMIC VARIANT/</data>
      <data key="d1">Environmental Factor/</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;KCNJ11 RS5215 CC-HAPLOTYPE&quot;/">
      <data key="d0">GENOMIC VARIANT/</data>
      <data key="d1">Environmental Factor/</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;INSULIN RECEPTOR SUBSTRATE 1 (IRS1) RS1522813 A-ALELE&quot;/">
      <data key="d0">GENOMIC VARIANT/</data>
      <data key="d1">Environmental Factor/</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;ADRA2B GLU12 ALLELE&quot;/">
      <data key="d0">GENOMIC VARIANT/</data>
      <data key="d1">Environmental Factor/</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;NON-RISK HAPLOTYPE OF SLC2A2 VARIANTS&quot;/">
      <data key="d0">GENOMIC VARIANT/</data>
      <data key="d1">Environmental Factor/</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;GG-GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Persons with this genotype show specific response to change in LTPA."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;NONRISK HAPLOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This haplotype of SLC2A2 variants seems to be protective against changes in LTPA."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;RS5393, RS5394, RS5400, RS5404&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"These genetic variants were further investigated for their potential interactions with PA and change in LTPA."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;WEIGHT LOSS INTERVENTIONS&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Interventions aimed at reducing diabetes risk were studied to find out if they can modify the development of T2D."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;TCF7L2 RS12255372&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Participants with this gene variant showed lower T2D incidence in intervention groups compared to controls."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;RS7903146 RISK T-ALLELE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This allele was reported to have a similar finding as the TCF7L2 rs12255372, but without significant interaction test results."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;ENPP1 RS1044498 DIABETOGENIC VARIANT&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"This genetic variant showed an association with reduced T2D incidence during weight loss intervention in DPP study."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;MC4R RS17066829&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A trend for interaction was found for this variant and the weight loss intervention resulting in lower T2D incidence."&lt;SEP&gt;"An interaction trend was observed for this MC4R gene variant when combined with weight loss interventions, as per findings from both studies."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;PPARΓ RS1152003 CC-GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Persons with this genotype had a lower T2D incidence when combined with weight loss interventions, as reported by both DPP and DPS studies."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;TNFΑ RS1800629 GG-GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Weight loss intervention resulted in decreased T2D incidence among persons with this genotype compared to reference genotypes."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;ADRA2B GLU9-ALLELE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Persons with this allele had a lower risk of developing T2D after weight loss interventions, as indicated by the DPS study."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;LIPC RS2070895 A-ALLELE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The LIPC variant was associated with a lower T2D incidence in persons who underwent a weight loss intervention according to the DPS study."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;RS5393&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"GG-Genotype is one of several variants that was further investigated for its interaction with PA and change in LTPA."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;RS5394&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"GG-Genotype includes this variant among others that were studied regarding their response to physical activity changes."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;RS5400&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This variant is part of the non-risk haplotype, which showed protective effects against changes in LTPA."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;RS5404&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"GG-Genotype carries this variant among others that were analyzed for their interactions with PA or LTPA changes."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;LTPA&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Lifestyle Physical Activity (LTPA) refers to the moderate-to-vigorous intensity physical activity that participants engaged in, which was correlated with specific genotypes."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;DPS&quot;">
      <data key="d0">"DIETARY PATTERN STUDY"</data>
      <data key="d1">"Diet and Physical Activity Study (DPS) investigated the effects of weight loss interventions combined with various genetic variants on T2D risk, indicating potential interactions for certain genotypes."&lt;SEP&gt;"Dietary Pattern Study (DPS) involved research focusing on dietary patterns, physical activity levels, and diabetes prevention among different populations."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;ASTI STUDY&quot;">
      <data key="d0">"OTHER RESEARCH STUDY"</data>
      <data key="d1">"A separate study alongside DPP that also looked at the impact of weight loss interventions and specific genetic variants on diabetes risk."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;ENPP1 RS1044498&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"This gene variant was associated with reduced T2D incidence in individuals undergoing a weight loss intervention based on the DPP study results."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;DPP&quot;">
      <data key="d0">"RESEARCH STUDY"</data>
      <data key="d1">"Diabetes Prevention Program (DPP) is the name of a major clinical trial that was referenced in studying the effects of weight loss interventions on T2D risk and genetic variants."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;CHARACTERISTICS OF RCTS&quot;/&quot;STUDY DESIGN&quot;">
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d1">All RCTs involve lifestyle interventions that aim to reduce weight and lower T2D risk, with variations in the methods and composition of these interventions.)</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LIFESTYLE INTERVENTION&quot;">
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f&lt;SEP&gt;chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d1">"The lifestyle intervention focused on diet, physical activity, and healthy living choices."&lt;SEP&gt;"The lifestyle intervention group had the largest decrease in fasting proinsulin levels at 1 year and was significantly lower than both metformin (p&lt;0.001) or troglitazone groups."&lt;SEP&gt;All RCTs involve lifestyle interventions that aim to reduce weight and lower T2D risk, with variations in the methods and composition of these interventions.)</data>
      <data key="d0">"INTERVENTION GROUP"</data>
    </node>
    <node id="&quot;AGE OF PARTICIPANTS&quot;">
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d1">In most studies, participants are over 40 years old at follow-up.)</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CHARACTERISTICS OF COHORT STUDIES&quot;/&quot;FOLLOW-UP TIME&quot;">
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d1">In most studies, participants are over 40 years old at follow-up.)</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CARDIOVASCULAR RISK&quot;">
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d1">The risk of cardiovascular disease varies among the different cohorts and RCT populations.)</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CHARACTERISTICS OF RCTS&quot;/&quot;BASELINE RISK&quot;">
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d1">The risk of cardiovascular disease varies among the different cohorts and RCT populations.)</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DIETARY EXPOSURE&quot;/&quot;ASSESSMENT METHOD&quot;">
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d1">The dietary assessments are based on validated food frequency questionnaires or other methods like dietary history records or biomarker measurements, affecting the accuracy of findings.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FOOD FREQUENCY QUESTIONNAIRE/">
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d1">The dietary assessments are based on validated food frequency questionnaires or other methods like dietary history records or biomarker measurements, affecting the accuracy of findings.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INTERVIEWS/QUESTIONNAIRES&quot;">
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d1">The physical activity levels were assessed using interviews or questionnaires which can introduce subjectivity and potential recall biases.)</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PA EXPOSURE&quot;/&quot;ASSESSMENT METHOD&quot;">
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d1">The physical activity levels were assessed using interviews or questionnaires which can introduce subjectivity and potential recall biases.)</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PA EXPOSURE&quot;">
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d1">"Dietary intake can influence physical activity levels and vice versa, affecting overall health.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LIFESTYLE FACTOR&quot;">
      <data key="d2">chunk-22216738ccbae0a6276bb4499018c434&lt;SEP&gt;chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d1">"Increased physical activity can reduce the risk of developing cardiovascular disease.")&lt;SEP&gt;"Lifestyle factors include habits or choices made by individuals that impact health, such as diet and exercise."</data>
      <data key="d0">"BEHAVIORAL CHOICE"</data>
      <data key="d3">[{"level": 0, "cluster": 0}, {"level": 1, "cluster": 19}]</data>
    </node>
    <node id="&quot;DRUG THERAPY&quot;">
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d1">"Statin medications help lower cholesterol levels and reduce the risk of heart disease.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENETIC PROFILES&quot;">
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d1">"Personalized therapies consider genetic variations when planning treatment for cardiovascular conditions.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS7903146&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The third one of the 23 obesity SNPs that reached a significant association with BMI at baseline."&lt;SEP&gt;"rs7903146 in TCF7L2 gene has a frequency of association with type 2 diabetes."</data>
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43&lt;SEP&gt;chunk-1fde08e52a188ac6a549e7c11d59a092</data>
    </node>
    <node id="&quot;TCF7L2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The TCF7L2 gene is associated with an increased risk of type 2 diabetes."&lt;SEP&gt;"The TCF7L2 gene, associated with another one of the obesity predisposing SNPs."</data>
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43&lt;SEP&gt;chunk-1fde08e52a188ac6a549e7c11d59a092</data>
    </node>
    <node id="&quot;RS10010131&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"rs10010131 in WFS1 gene shows a directionally consistent association with type 2 diabetes."</data>
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
    </node>
    <node id="&quot;WFS1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The WFS1 gene associates with an increased risk of type 2 diabetes, showing consistency with prior reports."</data>
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
    </node>
    <node id="&quot;RS10946398&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"rs10946398 in CDKAL1 gene is linked to the directionally consistent association with type 2 diabetes."</data>
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
    </node>
    <node id="&quot;CDKAL1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"SNP (rs12252-C) is associated with type 2 diabetes risk on chromosome 6."&lt;SEP&gt;"The CDKAL1 gene has a directionally consistent association with type 2 diabetes, similar to prior research."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2&lt;SEP&gt;chunk-f9a60d3cf951d77afa115859755dac43</data>
    </node>
    <node id="&quot;RS864745&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"rs864745 in JAZF1 gene is associated with an increased risk of type 2 diabetes."</data>
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
    </node>
    <node id="&quot;JAZF1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The JAZF1 gene associates with type 2 diabetes, supporting previous findings."</data>
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
    </node>
    <node id="&quot;RS4607103&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"rs4607103 in ADAMTS9 gene is associated with an increased risk of type 2 diabetes but shows opposite directionality compared to a European sample."&lt;SEP&gt;"rs4607103 variant in ADAMTS9 gene shows an association with type 2 diabetes, but its direction of effect is opposite to that observed in European populations."</data>
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
    </node>
    <node id="&quot;ADAMTS9&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The ADAMTS9 gene associates with type 2 diabetes, showing an opposing association when compared to findings from a European population."</data>
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
    </node>
    <node id="&quot;TCF7L2 RISK VARIANT RS7903146&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A specific genetic variant associated with the TCF7L2 gene that influences diabetes risk."</data>
      <data key="d2">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
    </node>
    <node id="&quot;NOMINAL ANALYSIS RESULTS&quot;">
      <data key="d2">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d1">"The association between the TCF7L2 risk variant and the nominal analysis was significant (P = 0.011, unweighted OR 1.04 [95% CI 1.01–1.08]).")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;WEIGHTED ANALYSIS RESULTS&quot;">
      <data key="d2">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d1">"The association between the TCF7L2 risk variant and the weighted analysis was also significant (P = 8.10 × 10−5, weighted OR 1.06 [1.03–1.10]).")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ORDINAL ANALYSIS RESULTS (NOMINAL CATEGORIES)&quot;">
      <data key="d2">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d1">"The nominal analysis of the TCF7L2 risk variant did not show association with ordinal data (P = 0.33, unweighted OR 1.02 [0.98–1.05]).")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ORDINAL ANALYSIS RESULTS (WEIGHTED)&quot;">
      <data key="d2">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d1">"The weighted ordinal analysis of the TCF7L2 risk variant also did not show association with ordinal data (P = 0.40, weighted OR 1.02 [0.98–1.06]).")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;AFRICAN ANCESTRY&quot;">
      <data key="d2">chunk-bb507a90a1f5d5ddd01a93200ff2d45e&lt;SEP&gt;chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d1">"In subjects of African ancestry, there was a decreasing percentage of IFG/IGT (62.8%) compared to other ethnic groups."&lt;SEP&gt;"The analyses did not find evidence for interaction with African Ancestry when considering the proportions of ancestry (P = 0.74).")</data>
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
    </node>
    <node id="&quot;INTERACTION&quot;">
      <data key="d2">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d1">"There was no evidence for an interaction between the TCF7L2 risk variant and age in these analyses.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 0}]</data>
    </node>
    <node id="&quot;COUNT OF RISK ALLELES&quot;">
      <data key="d2">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d1">"The count of risk alleles for the TCF7L2 risk variant was considered in nominal and ordinal analyses.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SIGNIFICANCE&quot;">
      <data key="d2">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d1">"The nominal analysis results showed a significant association (P = 0.011, unweighted OR 1.04 [95% CI 1.01–1.08]) for the TCF7L2 risk variant.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ASSOCIATION&quot;">
      <data key="d2">chunk-ea6355aaf22d7cdd3331602638122ed7&lt;SEP&gt;chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d1">"The analysis revealed connections between specific variables, such as GRS and test performances, after adjusting for certain covariates."&lt;SEP&gt;"The nominal ordinal analysis results did not show a significant association between the TCF7L2 risk variant and ordinal data (P = 0.33, unweighted OR 1.02 [0.98–1.05]).")</data>
      <data key="d0">"STATISTICAL RELATIONSHIP"</data>
    </node>
    <node id="&quot;NORMAL GLUCOSE TOLERANCE (NGT)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The baseline clinical characteristic of 42.8% participants displayed normal glucose tolerance."</data>
      <data key="d2">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
    </node>
    <node id="&quot;IMPAIRED FASTING GLUCOSE/IMPAIRED GLUCOSE TOLERANCE (IFG/IGT)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"IFG/IGT is a glycemic status where subjects are classified as impaired fasting glucose/impaired glucose tolerance, comprising 42.5% of the participants."</data>
      <data key="d2">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
    </node>
    <node id="&quot;TYPE 2 DIABETES (T2D)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"T2D accounts for 14.7% of the participants and is a condition where individuals are diagnosed with diabetes."</data>
      <data key="d2">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
    </node>
    <node id="&quot;EAST ASIAN ANCESTRY&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The ethnic distribution showed significant differences among the NGT, IFG/IGT, and T2D groups, especially in East Asians."</data>
      <data key="d2">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
    </node>
    <node id="&quot;EUROPEAN ANCESTRY&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Among European subjects, the percentage of T2D (14.4%) was lower than East Asians (22.7%)."</data>
      <data key="d2">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
    </node>
    <node id="&quot;NATIVE NORTH AMERICAN ANCESTRY&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"In Native North American participants, there was a decreasing trend for T2D compared to other ethnic groups."</data>
      <data key="d2">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
    </node>
    <node id="&quot;LATINO AMERICAN ANCESTRY&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"For Latino Americans, the percentage of subjects with IFG/IGT was lower (55.5%) compared to East Asians."</data>
      <data key="d2">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
    </node>
    <node id="&quot;ETHNIC DISTRIBUTION&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The ethnic composition of the cohort had significant differences across different glycemic statuses."</data>
      <data key="d2">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
    </node>
    <node id="&quot;RS9939609&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"One of the 23 obesity SNPs that reached a significant association with BMI at baseline."</data>
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
    </node>
    <node id="&quot;FTO&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"FTO is associated with coffee consumption when considering its role in the development of snoring."&lt;SEP&gt;"FTO is previously linked to alcohol consumption along with RNA5SP471 and SND1."&lt;SEP&gt;"Located within or close to the FTO gene"&lt;SEP&gt;"The FTO gene, associated with one of the obesity predisposing SNPs."&lt;SEP&gt;"rs9913297 variant is associated with BMI, fat-free mass, and waist circumference."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2&lt;SEP&gt;chunk-ad609cb10e900d42a6901eea1591d8ba&lt;SEP&gt;chunk-13862d7ab74f5d4fa3f2261984d15d64&lt;SEP&gt;chunk-1fde08e52a188ac6a549e7c11d59a092</data>
    </node>
    <node id="&quot;RS2984618&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Another one of the 23 obesity SNPs that reached a significant association with BMI at baseline."</data>
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
    </node>
    <node id="&quot;TAL1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The TAL1 gene, associated with another one of the obesity predisposing SNPs."</data>
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
    </node>
    <node id="&quot;BMI CHANGE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Evaluation of changes in BMI which is influenced by obesity predisposing SNPs, genetic risk score (GRS), and glycemic status traits."</data>
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
    </node>
    <node id="&quot;GENETIC RISK SCORE (GRS)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The accumulation of multiple obesity SNPs to determine an individual's obesity risk."</data>
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
    </node>
    <node id="&quot;FPG&quot;">
      <data key="d0">"FASTING PLASMA GLUCOSE"</data>
      <data key="d1">"A trait related to glycemic status that showed a significant interaction with one of the obesity SNPs on baseline BMI."&lt;SEP&gt;"Fasting plasma glucose levels indicate insulin sensitivity and risk of diabetes."</data>
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9&lt;SEP&gt;chunk-1fde08e52a188ac6a549e7c11d59a092</data>
    </node>
    <node id="&quot;RS1011527&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"One of the 23 obesity SNPs associated with FPG and baseline BMI, but not observed as a main effect."&lt;SEP&gt;"The SNP is associated with LEPR gene and has a significant interaction on baseline BMI."</data>
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
    </node>
    <node id="&quot;LEPR&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"This gene interacts with rs1011527 SNP to influence the glycemic status traits affecting BMI at baseline."</data>
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
    </node>
    <node id="&quot;GLYCEMIC STATUS TRAITS&quot;">
      <data key="d0">"TRAIT INTERACTION"</data>
      <data key="d1">"These traits transitionally impact the relationship between obesity SNPs, GRS and BMI change."</data>
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
    </node>
    <node id="&quot;GRS&quot;">
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d1">"Genetic risk score is positively associated with increased BMI at baseline, indicating a cumulative effect of multiple genetic factors on obesity.")&lt;SEP&gt;"The genetic risk score is a cumulative measure influenced by multiple obesity predisposing SNPs and correlates significantly with BMI at baseline.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 1}]</data>
    </node>
    <node id="&quot;TRAIT INTERACTION&quot;">
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d1">"There is an observed interaction between one obesity SNP and a trait related to glycemic status on baseline BMI.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 7}]</data>
    </node>
    <node id="&quot;FPG, BASELINE BMI&quot;">
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d1">"This SNP within the LEPR gene interacts significantly with FPG levels affecting baseline BMI.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS1011527, LEPR GENE&quot;">
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d1">"This SNP within the LEPR gene interacts significantly with FPG levels affecting baseline BMI.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS9939609, RS2984618, RS7903146, GRS, LEPR GENE, FPG&quot;">
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d1">"The genetic variants, GRS of these SNPs interact with traits related to glycemic status to influence BMI.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 1}]</data>
    </node>
    <node id="&quot;BMI TRANSITION&quot;">
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d1">"The genetic factors are not associated with transitions in BMI, suggesting no simultaneous main effect and interaction between genetic determinants and glycemic status change.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SNP(S), GRS&quot;">
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d1">"The genetic factors are not associated with transitions in BMI, suggesting no simultaneous main effect and interaction between genetic determinants and glycemic status change.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS1011527, RS9939609&quot;">
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d1">"The interaction between these two SNPs with a trait related to glycemic status influences BMI at baseline.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 7}]</data>
    </node>
    <node id="&quot;INTERACTION WITH FPG&quot;">
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d1">"The SNP's interaction with fasting plasma glucose (FPG) levels affects BMI at baseline.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INTERACTION WITH FPG AND BASELINE BMI&quot;">
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d1">"The SNP's combined interaction with FPG levels impacts baseline BMI.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FPG AND BASELINE BMI INTERACTION&quot;">
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d1">"This interaction between SNP, FPG levels, and baseline BMI showcases a complex relationship in influencing obesity markers.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INTERACTION WITH FPG AND BASELINE BMI LEVEL&quot;">
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d1">"This combination highlights a specific pathway by which obesity SNPs interact with metabolic markers to affect BMI at baseline and its transition.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FPG AND BASELINE BMI INTERACTION EFFECT&quot;">
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d1">"The SNP's involvement with FPG levels and baseline BMI demonstrates its impact on obesity markers through complex interplay.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;BASELINE BMI INFLUENCE&quot;">
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d1">"The SNP's interaction with fasting plasma glucose (FPG) directly affects baseline BMI.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS1011527, FPG&quot;">
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d1">"The SNP's interaction with fasting plasma glucose (FPG) directly affects baseline BMI.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MTHFR 1298A&gt;C&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Impairment on the battery was related to two polymorphisms: MTHFR 1298A&gt;C (p=0.03) and MS 2756A&gt;G (p=0.05)."&lt;SEP&gt;"Survivors with the MTHFR 1298AC/CC genotypes had a 3.0-fold increased risk of impairment."</data>
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d3">[{"level": 0, "cluster": 6}]</data>
    </node>
    <node id="&quot;MS 2756A&gt;G&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Impairment on the battery was related to two polymorphisms: MTHFR 1298A&gt;C (p=0.03) and MS 2756A&gt;G (p=0.05)."&lt;SEP&gt;"Survivors with the MS 2756AA genotype were 3.8 times as likely to meet criteria for impairment."</data>
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d3">[{"level": 0, "cluster": 6}]</data>
    </node>
    <node id="&quot;TMTA&quot;">
      <data key="d0">"CHILD PERFORMANCE MEASURE"</data>
      <data key="d1">"Survivors with the MTHFR 1298AC/CC genotypes performed on average 7 points lower on TMTA."&lt;SEP&gt;"TMTA (Trail Making Test A) is a measure for assessing attention and processing speed in cognitive function."</data>
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29&lt;SEP&gt;chunk-ea6355aaf22d7cdd3331602638122ed7</data>
      <data key="d3">[{"level": 0, "cluster": 6}]</data>
    </node>
    <node id="&quot;TMTB&quot;">
      <data key="d0">"CHILD PERFORMANCE MEASURE"</data>
      <data key="d1">"Survivors with the MS 2756AA genotype scored on average 12.2 points lower on TMTA and 5.3 points lower on TMTB."&lt;SEP&gt;"TMTB likely refers to another part or variant of the Trail Making Test, assessing distinct cognitive functions like attention and coordination."</data>
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29&lt;SEP&gt;chunk-ea6355aaf22d7cdd3331602638122ed7</data>
      <data key="d3">[{"level": 0, "cluster": 6}]</data>
    </node>
    <node id="&quot;PEGDH&quot;">
      <data key="d0">"NEUROCOGNITIVE TEST"</data>
      <data key="d1">"For survivors with the MS 2756AA genotype, the mean PEGNDH score was 11.7 points lower than that of individuals with the MS 2756AG/GG genotypes."&lt;SEP&gt;"The PEGDH enzyme interacts with other metabolites or enzymes, indicating its role in a specific metabolic pathway."</data>
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29&lt;SEP&gt;chunk-ea6355aaf22d7cdd3331602638122ed7</data>
      <data key="d3">[{"level": 0, "cluster": 5}]</data>
    </node>
    <node id="&quot;PEGNDH&quot;">
      <data key="d0">"NEUROCOGNITIVE TEST"</data>
      <data key="d1">"Survivors with the MTRR 66AA genotype scored on average 10.7 points lower on PEGNDH."&lt;SEP&gt;"The PEGNDH enzyme also interacts with molecules, contributing to the understanding of metabolic processes and pathways."</data>
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29&lt;SEP&gt;chunk-ea6355aaf22d7cdd3331602638122ed7</data>
      <data key="d3">[{"level": 0, "cluster": 5}]</data>
    </node>
    <node id="&quot;CFL&quot;">
      <data key="d0">"NEUROCOGNITIVE TEST"</data>
      <data key="d1">"CFL (Cellular Localization) is involved in the localization of molecules within cellular structures, impacting various biological functions."&lt;SEP&gt;"Survivors with the MTRR 66AA genotype also scored 10.5 points lower on average on CFL, compared with survivors with the MTRR 66AG/GG genotypes."</data>
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29&lt;SEP&gt;chunk-ea6355aaf22d7cdd3331602638122ed7</data>
      <data key="d3">[{"level": 0, "cluster": 1}]</data>
    </node>
    <node id="&quot;MTX&quot;">
      <data key="d0">"DIETARY PATTERN"/"ENVIRONMENTAL FACTOR"/"DRUG"/"THERAPY"</data>
      <data key="d1">"MTX (methotrexate) is a medication often used for cancer treatment."</data>
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
    </node>
    <node id="&quot;DIVERGT BATTERY&quot;">
      <data key="d0">"ASSESSMENT TOOL"/"TEST"/"MEASURE"</data>
      <data key="d1">"The DIVERGT battery evaluates long-term cognitive outcomes in survivors of childhood cancer."&lt;SEP&gt;"This battery consists of multiple tests designed to evaluate various dimensions of cognition and neurological function."</data>
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29&lt;SEP&gt;chunk-ea6355aaf22d7cdd3331602638122ed7</data>
    </node>
    <node id="&quot;SURVIVORS&quot;">
      <data key="d0">"SUBJECT POPULATION"/"STUDY PARTICIPANTS"</data>
      <data key="d1">"The study population comprised of individuals who survived a diagnosis of ALL."</data>
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
    </node>
    <node id="&quot;2R/3R AND 3R/3R GENOTYPES&quot;">
      <data key="d0">"GENETIC POLYMORPHISM"</data>
      <data key="d1">"Specific genotypes related to the TSER (thymidylate synthase) gene were identified in this study."</data>
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
    </node>
    <node id="&quot;677C&gt;T, SHMT 1520C&gt;T&quot;">
      <data key="d0">"GENETIC POLYMORPHISM"/"VARIANT"</data>
      <data key="d1">"Polymorphisms in genes involved in methylation and folate metabolism (MTHFR and SHMT) were also assessed."</data>
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
    </node>
    <node id="&quot;1420C&gt;T&quot;">
      <data key="d0">"GENETIC POLYMORPHISM"/"VARIANT"</data>
      <data key="d1">"A variant within the SHMT gene was analyzed in relation to cognitive outcomes."</data>
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
    </node>
    <node id="&quot;INTRATHECAL MTX DOSES&quot;">
      <data key="d0">"INTERVENTION"/"TREATMENT"</data>
      <data key="d1">"The number of intrathecal methotrexate (MTX) doses received by survivors was one covariate in the study."</data>
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
    </node>
    <node id="&quot;CUMULATIVE IV MTX EXPOSURE&quot;">
      <data key="d0">"EXPOSURE"/"DOSE EXPOSURE"</data>
      <data key="d1">"Cumulative exposure to intravenous methotrexate was another covariate examined."&lt;SEP&gt;"IV MTX (Medication) exposure over time, specifically via intravenous administration, could influence neurological responses."</data>
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29&lt;SEP&gt;chunk-ea6355aaf22d7cdd3331602638122ed7</data>
    </node>
    <node id="&quot;EARLY MTX-RELATED NEUROTOXICITY&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Early MTX-related neurotoxicity refers to a condition occurring before the full manifestation of adverse effects."&lt;SEP&gt;"This indicates a potential environmental factor affecting neurological health in relation to medication use."</data>
      <data key="d2">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
      <data key="d3">[{"level": 0, "cluster": 7}, {"level": 1, "cluster": 26}]</data>
    </node>
    <node id="&quot;DIG&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The DIG molecule engages in various interactions that might be relevant to certain physiological processes or diseases."</data>
      <data key="d2">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
      <data key="d3">[{"level": 0, "cluster": 1}]</data>
    </node>
    <node id="&quot;GENOTYPING RESULTS&quot;">
      <data key="d0">"DATA ANALYSIS"</data>
      <data key="d1">"The data from the genotyping analysis provided insights into genetic predispositions for certain conditions or responses."</data>
      <data key="d2">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
    </node>
    <node id="&quot;GRS (GENETIC RISK SCORE)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The Genetic Risk Score is a measure used to assess an individual's risk of developing specific diseases based on their genetic makeup."</data>
      <data key="d2">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
    </node>
    <node id="&quot;AGE AT DIAGNOSIS&quot;">
      <data key="d0">"COVARIATE"</data>
      <data key="d1">"Age at diagnosis is another factor taken into account, potentially impacting disease manifestation and response."</data>
      <data key="d2">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
    </node>
    <node id="&quot;INTRATHECAL MTX EXPOSURE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Intrathecal exposure to MTX (Medication) could be an environmental or medical intervention affecting neurological outcomes."</data>
      <data key="d2">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
    </node>
    <node id="&quot;IMPAIRED PERFORMANCE&quot;">
      <data key="d0">"OUTCOME"</data>
      <data key="d1">"Impaired performance on cognitive tests may indicate issues with attention, processing speed, or other neurological functions."</data>
      <data key="d2">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
    </node>
    <node id="&quot;PROTEIN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A protein is a macromolecule consisting of amino acid sequences, produced through translation of messenger RNA (mRNA) and usually folded into a complex three-dimensional structure with numerous functional purposes in the body."&lt;SEP&gt;"IL-6Rα protein interacts with genomic variants to influence disease severity in colitis."&lt;SEP&gt;"Survivors with a GRS score of ≥6 showed impaired TMTA and TMTB performances, suggesting an association between these protein expression levels and cognitive function in this context."&lt;SEP&gt;"The role of proteins encoded by complement pathway genes in influencing AMD risk was also explored."&lt;SEP&gt;"NA"&lt;SEP&gt;"Proteins are large, complex molecules made up of amino acids that perform many vital functions in the body."&lt;SEP&gt;"CASP3 protein's role is acknowledged in the text."&lt;SEP&gt;"Specific proteins related to the context have been omitted."&lt;SEP&gt;"The NOS1 protein is involved in cardiovascular function."&lt;SEP&gt;"No protein information provided for the associations identified."&lt;SEP&gt;"Specific proteins encoded by the aforementioned genes were examined in the analysis."</data>
      <data key="d2">chunk-22216738ccbae0a6276bb4499018c434&lt;SEP&gt;chunk-a7d0bfa8b16262a1f313b7e3060969c6&lt;SEP&gt;chunk-f2c864ef2d87119a8129e011b1c42e3c&lt;SEP&gt;chunk-e8f81fdd25a22582c6ce3d1e15f74af3&lt;SEP&gt;chunk-ea6355aaf22d7cdd3331602638122ed7&lt;SEP&gt;chunk-6a657cd0a000b6df4db8f1305b795021&lt;SEP&gt;chunk-b803830d07bff8ae14550f6458048707&lt;SEP&gt;chunk-72f4505e43f67f3564607392cb178656&lt;SEP&gt;chunk-734cac289b42d37dad32bd51ea24a1ea&lt;SEP&gt;chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a&lt;SEP&gt;chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
      <data key="d3">[{"level": 0, "cluster": 11}, {"level": 1, "cluster": 38}]</data>
    </node>
    <node id="&quot;NUTRIENT&quot;">
      <data key="d0">"NA"</data>
      <data key="d1">"A nutrient is an essential substance that provides energy and sustains life. Nutrients are organic or inorganic substances required by living organisms for growth, maintenance of health, and normal physiological functions."&lt;SEP&gt;"The nutritional status or specific intake patterns could affect the performance scores on various cognitive tests by influencing biological markers like GRS."&lt;SEP&gt;"NA"&lt;SEP&gt;"Vitamin D nutrient intake or status may influence the outcomes discussed."&lt;SEP&gt;"Specific nutrients related to the context have been omitted."&lt;SEP&gt;"Folate is a key nutrient found in leafy greens and plays a role in cardiovascular health."&lt;SEP&gt;"No nutrient information provided for the associations identified."</data>
      <data key="d2">chunk-e8f81fdd25a22582c6ce3d1e15f74af3&lt;SEP&gt;chunk-ea6355aaf22d7cdd3331602638122ed7&lt;SEP&gt;chunk-6a657cd0a000b6df4db8f1305b795021&lt;SEP&gt;chunk-b803830d07bff8ae14550f6458048707&lt;SEP&gt;chunk-72f4505e43f67f3564607392cb178656&lt;SEP&gt;chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a&lt;SEP&gt;chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
      <data key="d3">[{"level": 0, "cluster": 10}, {"level": 1, "cluster": 33}]</data>
    </node>
    <node id="&quot;MOLECULAR INTERACTION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A molecular interaction is an interaction between two or more molecules, which can involve physical contact or biochemical interactions such as binding or enzymatic reactions."&lt;SEP&gt;"IL-1R gene's interaction with IL-10RαMdel and Rag1 plays a role in modulating both Rag1−/− and IL-10RαMdelRag1−/− disease severity."&lt;SEP&gt;"Interactions between enzymes and their substrates, such as PEGDH and PEGNDH, play crucial roles in metabolic pathways that influence neurological functions."&lt;SEP&gt;"This term refers to various interactions among proteins, cells, or other components within the context of disease development and response."&lt;SEP&gt;"While Mϕ response to IL-10 is critical in attenuating disease, T cells are not a significant source of this IL-10 here."&lt;SEP&gt;"The rs4988235 genotype is associated with dairy products including milk consumption."&lt;SEP&gt;"The interactions between specific molecules in complement pathway and lifestyle were examined to understand AMD risk."&lt;SEP&gt;"NA"&lt;SEP&gt;"These are interactions between molecules which can occur in biological systems and influence various cellular processes."&lt;SEP&gt;"Increased DNA modifications consistently occur with age across LCT and MCM6 in lactase non-persistent CC individuals, while mostly decreasing DNA modification densities are observed for MCM6 and LCT with age in lactase persistent TT individuals."&lt;SEP&gt;"Interaction between proteins is pointed out as crucial for certain biological functions."&lt;SEP&gt;"Specific molecular interactions related to the context have been omitted."&lt;SEP&gt;"The heritability of FVC and FEV1/FVC included both additive and non-additive genetic variance components, indicating molecular interactions between these factors."&lt;SEP&gt;"There was an investigation of molecular interactions that could be impacted by genetic factors."</data>
      <data key="d2">chunk-22216738ccbae0a6276bb4499018c434&lt;SEP&gt;chunk-a7d0bfa8b16262a1f313b7e3060969c6&lt;SEP&gt;chunk-f2c864ef2d87119a8129e011b1c42e3c&lt;SEP&gt;chunk-e8f81fdd25a22582c6ce3d1e15f74af3&lt;SEP&gt;chunk-8fb20f873daf79a9b7d6e8d25c8889d6&lt;SEP&gt;chunk-ea6355aaf22d7cdd3331602638122ed7&lt;SEP&gt;chunk-b803830d07bff8ae14550f6458048707&lt;SEP&gt;chunk-ea45644d73f260cf365527dcc3af86e1&lt;SEP&gt;chunk-770a24a1a31cf671a7681e7c98a7ee91&lt;SEP&gt;chunk-72f4505e43f67f3564607392cb178656&lt;SEP&gt;chunk-35d8a4ea86cb92d18ee1c857a318d2d8&lt;SEP&gt;chunk-734cac289b42d37dad32bd51ea24a1ea&lt;SEP&gt;chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a&lt;SEP&gt;chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
      <data key="d3">[{"level": 0, "cluster": 12}, {"level": 1, "cluster": 39}]</data>
    </node>
    <node id="&quot;ENVIRONMENTAL FACTOR&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Age plays a role in lactase mRNA decreasing with age in lactase non-persistent individuals (CC) but not in intermediate (CT) or lactase persistent (TT) individuals."&lt;SEP&gt;"An environmental factor is any aspect of the environment that influences the health and well-being of organisms. This includes both biotic (living) factors and abiotic (non-living) factors."&lt;SEP&gt;"Exposure to MTX through both intrathecal and IV routes could have different impacts on early MTX-related neurotoxicity compared to other environmental factors like dietary patterns."&lt;SEP&gt;"The environment, including genetic factors like IL-6Rα gene variants, influences colitis through its impact on T cell responses."&lt;SEP&gt;"The effect of environmental factors like smoking or diet on the expression and function of complement pathway genes was analyzed."&lt;SEP&gt;"NA"&lt;SEP&gt;"An environmental factor refers to conditions or influences that exist outside of the organism but affect its development, function, or health."&lt;SEP&gt;"Exposure to environmental factor like smoking might impact the health outcomes mentioned."&lt;SEP&gt;"Specific environmental factors related to the context have been omitted."&lt;SEP&gt;"The evidence for association with SNPs at certain loci was present when the sample was stratified by age, suggesting environmental factor influence."&lt;SEP&gt;"Environmental conditions were considered as potential modifiers in their relationship with genotypes."</data>
      <data key="d2">chunk-22216738ccbae0a6276bb4499018c434&lt;SEP&gt;chunk-a7d0bfa8b16262a1f313b7e3060969c6&lt;SEP&gt;chunk-f2c864ef2d87119a8129e011b1c42e3c&lt;SEP&gt;chunk-e8f81fdd25a22582c6ce3d1e15f74af3&lt;SEP&gt;chunk-ea6355aaf22d7cdd3331602638122ed7&lt;SEP&gt;chunk-b803830d07bff8ae14550f6458048707&lt;SEP&gt;chunk-ea45644d73f260cf365527dcc3af86e1&lt;SEP&gt;chunk-72f4505e43f67f3564607392cb178656&lt;SEP&gt;chunk-734cac289b42d37dad32bd51ea24a1ea&lt;SEP&gt;chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a&lt;SEP&gt;chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
      <data key="d3">[{"level": 0, "cluster": 11}, {"level": 1, "cluster": 35}]</data>
    </node>
    <node id="&quot;MTHFR 677C&gt;T&quot;">
      <data key="d2">chunk-c9badb9a0fb813f42383cc8afc57ad45&lt;SEP&gt;chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d1">"Both polymorphisms in these genes were associated with performance on TMTA and TMTB.")&lt;SEP&gt;"The MTHFR gene variant, specifically the 677C&gt;T variant, was not associated with male infertility in this study population."</data>
      <data key="d0">"GENE"</data>
    </node>
    <node id="&quot;SHMT 1520C&gt;T&quot;">
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d1">"Both polymorphisms in these genes were associated with performance on TMTA and TMTB.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MS 2756AA GENOTYPE&quot;">
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d1">"Genotype comparison between MS 2756AA survivors and those with TSER 3R/3R or 2R/3R showed differences in certain neurocognitive outcomes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TSER 3R/3R GENOTYPES&quot;">
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d1">"Genotype comparison between MS 2756AA survivors and those with TSER 3R/3R or 2R/3R showed differences in certain neurocognitive outcomes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DISEASE&quot;">
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0&lt;SEP&gt;chunk-22216738ccbae0a6276bb4499018c434&lt;SEP&gt;chunk-a7d0bfa8b16262a1f313b7e3060969c6&lt;SEP&gt;chunk-f2c864ef2d87119a8129e011b1c42e3c&lt;SEP&gt;chunk-e8f81fdd25a22582c6ce3d1e15f74af3&lt;SEP&gt;chunk-ea6355aaf22d7cdd3331602638122ed7&lt;SEP&gt;chunk-b803830d07bff8ae14550f6458048707&lt;SEP&gt;chunk-72f4505e43f67f3564607392cb178656&lt;SEP&gt;chunk-734cac289b42d37dad32bd51ea24a1ea&lt;SEP&gt;chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a&lt;SEP&gt;chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
      <data key="d1">"A disease is a complex state resulting from pathological changes in an individual's body that affects normal functions."&lt;SEP&gt;"A disease refers to a state or condition in an individual involving a change from its usual normal structure, function, or process.")&lt;SEP&gt;"Diseases such as colitis are influenced by both genetic and environmental factors that include IL-1R and IL-6Rα genes."&lt;SEP&gt;"High GRS scores might indicate an overexpression or altered function of proteins that play key roles in cognitive processes related to MTX neurotoxicity."]&lt;SEP&gt;"The exploration was centered around understanding how lifestyle affects susceptibility to AMD, considering genetic predispositions."&lt;SEP&gt;"NA"&lt;SEP&gt;"Presence of cancer disease in patients or risk factors related to it are discussed."&lt;SEP&gt;"Specific diseases related to the context have been omitted."&lt;SEP&gt;"CD subjects with or without specific genotypes and/or MAPbacteremia show varying physiological responses compared to healthy controls."&lt;SEP&gt;"The evidence for associations with SNPs at some loci increased to genome-wide levels of significance after excluding asthmatics, indicating disease association."&lt;SEP&gt;"The outcomes related to various diseases or health conditions were studied based on the genetic and environmental factors."</data>
      <data key="d0">"DISEASE"</data>
      <data key="d3">[{"level": 0, "cluster": 11}, {"level": 1, "cluster": 36}, {"level": 2, "cluster": 60}]</data>
    </node>
    <node id="&quot;SLC30A8 RS13266634&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The C risk allele at SLC30A8 rs13266634 was significantly associated with higher fasting proinsulin levels."</data>
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
    </node>
    <node id="&quot;FASTING PROINSULIN LEVELS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Fasting proinsulin levels were significantly decreased after 1 year of DPP intervention in all active groups compared to placebo."</data>
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
    </node>
    <node id="&quot;DPP COHORT&quot;">
      <data key="d0">"POPULATION/STUDY GROUP"</data>
      <data key="d1">"The C risk allele at SLC30A8 rs13266634 was associated with higher fasting proinsulin levels at baseline in the DPP cohort."&lt;SEP&gt;"The DPP cohort involved participants undergoing a diabetes prevention program."</data>
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d3">[{"level": 0, "cluster": 7}, {"level": 1, "cluster": 27}]</data>
    </node>
    <node id="&quot;FASTING INSULIN&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Baseline fasting insulin was adjusted for, and this adjustment affected the association between SLC30A8 rs13266634 and fasting proinsulin levels."&lt;SEP&gt;"Increased fasting insulin levels were noted in women with PCOS compared to control subjects."</data>
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f&lt;SEP&gt;chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;FASTING GLUCOSE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Fasting glucose was another variable that was adjusted for in addition to baseline fasting insulin when assessing the association with fasting proinsulin levels."</data>
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
    </node>
    <node id="&quot;PROINSULIN LEVELS&quot;">
      <data key="d0">"MEASURABLE OUTCOME"</data>
      <data key="d1">"The DPP intervention significantly decreased fasting proinsulin levels after 1 year compared to placebo."</data>
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
    </node>
    <node id="&quot;METFORMIN&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"At 1 year after DPP interventions, no significant association between SLC30A8 genotype and fasting proinsulin levels remained when adjusted for variables like insulin, age, sex, ethnicity (p=0.86)."&lt;SEP&gt;"Metformin was one DPP intervention that helped decrease fasting proinsulin levels among participants."</data>
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
    </node>
    <node id="&quot;TROGLITAZONE&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"The metformin intervention group had similar proinsulin levels to the troglitazone group at 1 year after DPP interventions."&lt;SEP&gt;"The troglitazone group also experienced a decrease in fasting proinsulin levels, albeit not as significantly compared to lifestyle or metformin groups."</data>
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
    </node>
    <node id="&quot;GENOTYPE × TREATMENT INTERACTION&quot;">
      <data key="d0">"STATISTICAL ANALYSIS"</data>
      <data key="d1">"There was no significant genotype × treatment interaction suggesting dosage of SLC30A8 risk alleles did not modify effectiveness of treatments."</data>
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
    </node>
    <node id="&quot;INTERVENTION&quot;">
      <data key="d0">"TREATMENT STRATEGY"</data>
      <data key="d1">"Randomized DPP intervention included lifestyle, metformin, and troglitazone treatment groups."</data>
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d3">[{"level": 0, "cluster": 7}, {"level": 1, "cluster": 27}]</data>
    </node>
    <node id="&quot;INTERVENTION GROUPS&quot;">
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d1">"After 1 year of DPP intervention, all active groups significantly decreased fasting proinsulin levels compared to placebo.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DRUG&quot;">
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f&lt;SEP&gt;chunk-22216738ccbae0a6276bb4499018c434</data>
      <data key="d1">"Drugs are substances used for medical purposes and can have various effects on the body through biological interaction."&lt;SEP&gt;"The lifestyle intervention led to the largest decrease in proinsulin levels at 1 year among the different treatment groups.")</data>
      <data key="d0">"PHARMACEUTICAL COMPOUND"</data>
    </node>
    <node id="&quot;METFORMIN TREATMENT&quot;">
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d1">"At 1 year, there were no significant differences in proinsulin levels between the metformin and troglitazone intervention groups.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;STATISTICAL RESULT&quot;">
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d1">"No genotype-specific effectiveness was observed for any of the treatments evaluated based on SLC30A8 rs13266634 dosage.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;COMPARISON WITH OTHER INTERVENTIONS&quot;">
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d1">"The lifestyle group had a larger decrease in proinsulin levels than either metformin or troglitazone groups, indicating potential superiority.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;COMPARISON WITH TROGLITAZONE&quot;">
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d1">"At 1 year after DPP interventions, the metformin and troglitazone had similar proinsulin levels, suggesting no significant difference in effectiveness between them for this study.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;STATISTICAL FINDING&quot;">
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d1">"The dosage of SLC30A8 risk alleles did not significantly modify the effectiveness of any treatment within the DPP cohort.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HC DIET&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"A lipogenic diet composed of high carbohydrates that significantly increases PNPLA3 expression."</data>
      <data key="d2">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
    </node>
    <node id="&quot;LE (LIPID EMULSION)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"An emulsified form of a lipid, included in HC diets to prevent the induction of PNPLA3 mRNA."</data>
      <data key="d2">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
    </node>
    <node id="&quot;PNPLA3&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"PNPLA3 gene does not response to insulin and glucagon in HepG2 cells."&lt;SEP&gt;"The gene whose expression was analyzed and is involved in lipogenesis; mRNA levels were upregulated by HC diet without LE but downregulated with LE inclusion."</data>
      <data key="d2">chunk-c27a7b63e450810a5d9f9e0f70b73a7a&lt;SEP&gt;chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;SREBP1C&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"A key transcriptional factor that regulates genes involved in lipid metabolism, showing a similar pattern to PNPLA3 expression."</data>
      <data key="d2">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
    </node>
    <node id="&quot;ACC-1&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Expression patterns of FAS and ACC-1 were similar to that of PNPLA3."&lt;SEP&gt;"Responsible for the formation of malonyl-CoA during de novo fatty acid synthesis and had similar expression patterns with SREBP1c and PNPLA3."</data>
      <data key="d2">chunk-c27a7b63e450810a5d9f9e0f70b73a7a&lt;SEP&gt;chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;PNPLA2 (ATGL)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene involved in lipolysis; no differences were found among diet groups for this gene."</data>
      <data key="d2">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
    </node>
    <node id="&quot;FAS (FATTY ACID SYNTHASE)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"An enzyme responsible for synthesizing fatty acids during de novo synthesis pathway; showed no significant differences among diet groups."</data>
      <data key="d2">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
    </node>
    <node id="&quot;CARNITINE PALMITOYLTRANSFERASE I (CPT1)&quot;">
      <data key="d0">"ENZYME"</data>
      <data key="d1">"Involved in the transport of acyl-CoA molecules into mitochondria for β-oxidation and showed reduced activity under HC diet conditions."</data>
      <data key="d2">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
    </node>
    <node id="&quot;G6PASE&quot;">
      <data key="d0">"ENZYME"</data>
      <data key="d1">"Key enzyme in gluconeogenesis that converts glucose 6-phosphate to fructose 1,6-bisphosphate; expression was upregulated by HC diet but not significantly compared to LF or HF diet groups."</data>
      <data key="d2">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
    </node>
    <node id="&quot;CHREBP (CYCLOPHILIN E RECEPTOR BINDING PROTEIN)&quot;">
      <data key="d0">"TRANSCRIPTION FACTOR"</data>
      <data key="d1">"A factor that regulates gene expression of glycolytic and gluconeogenic genes; showed a similar pattern of regulation with PNPLA3, SREBP1c, and ACC-1 in response to dietary carbohydrates."</data>
      <data key="d2">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
    </node>
    <node id="&quot;AMPK (ADENOSINE MONOPHOSPHATE ACTIVATED PROTEIN KINASE)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Regulates energy metabolism by promoting the utilization of glucose and fatty acids; AMPK activity was increased under HC diet conditions compared to LF or HF diets."</data>
      <data key="d2">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
    </node>
    <node id="&quot;INSULIN&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"In studies conducted with 3T3-L1 adipocytes and human adipose tissue, PNPLA3 gene expression is regulated by insulin. However, our data suggests that hepatic PNPLA3 does not respond to insulin stimulation in HepG2 cells."&lt;SEP&gt;"Insulin was administered to patient 7 after developing diabetes mellitus five years post-surgery due to ineffective diazoxide therapy."&lt;SEP&gt;"Insulin is crucial for glucose metabolism and can be affected by SENP1's role."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd&lt;SEP&gt;chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f&lt;SEP&gt;chunk-fc33d6399ec56e65d007269407f1953d</data>
    </node>
    <node id="&quot;GLUCAGON&quot;">
      <data key="d0">"HORMONE"</data>
      <data key="d1">"We hypothesized that exercise may stimulate glucagon secretion and thereby decrease PNPLA3 gene expression. However, treatment of HepG2 cells with 100 nM glucagon had no effect on PNPLA3 mRNA expression."</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;EXERCISE&quot;">
      <data key="d0">"PHYSICAL ACTIVITY"</data>
      <data key="d1">"Exercise was considered as a possible factor that may stimulate glucagon secretion to decrease PNPLA3 gene expression."</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;FATTY ACIDS&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"The major fatty acid components of the LE, including linoleic acid (LA), oleic acid (OA), and α-linolenic acid (ALA), were tested for their effects on PNPLA3 gene expression."</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;LINOLEIC ACID (LA)&quot;">
      <data key="d0">"FATTY ACID"</data>
      <data key="d1">"Treatment with either 400 μM LA suppressed PNPLA3 gene expression in HepG2 cells under both low glucose and high glucose conditions."</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;OLEIC ACID (OA)&quot;">
      <data key="d0">"FATTY ACID"</data>
      <data key="d1">"Treatment with either 400 μM OA also suppressed PNPLA3 gene expression in HepG2 cells under both low glucose and high glucose conditions."</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;Α-LINOLENIC ACID (ALA)&quot;">
      <data key="d0">"FATTY ACID"</data>
      <data key="d1">"Treatment with ALA had no effect on PNPLA3 gene expression under either condition."</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;EICOSAPENTAENOIC ACID (EPA)&quot;">
      <data key="d0">"FATTY ACID"</data>
      <data key="d1">"Both EPA and DHA suppressed PNPLA3 gene expression under both low and high glucose conditions."</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;DOCOSAHEXAENOIC ACID (DHA)&quot;">
      <data key="d0">"FATTY ACID"</data>
      <data key="d1">"Both EPA and DHA suppressed PNPLA3 gene expression under both low and high glucose conditions."</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;FAS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Expression patterns of FAS and ACC-1 were similar to that of PNPLA3."&lt;SEP&gt;"Fetal Alcohol Syndrome"</data>
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11&lt;SEP&gt;chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;DEPLETION-REFEEDING CONDITIONS (SPECIFIC CONTEXT: HEPG2 CELL EXPERIMENTS)&quot;|&quot;PNPLA3 &amp; CHREBP&quot;&lt;|&quot;CYCLING BETWEEN GLUCOSE DEPLETION AND REFEEDING PHASES INFLUENCED PNPLA3 EXPRESSION, WITH MODERATE REDUCTIONS AFTER 8 HOURS OF DEPLETION; SHOWED REGULATION THROUGH TRANSCRIPTION FACTORS IN RESPONSE TO METABOLIC STATES.&quot;)(&quot;ENTITY&quot;">
      <data key="d2">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
      <data key="d1">"Protein"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LDL RECEPTOR&quot;">
      <data key="d2">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
      <data key="d1">"Protein"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HEPG2 CELLS&quot;">
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d1">"Our data suggests that hepatic PNPLA3 does not respond to insulin stimulation in HepG2 cells.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene associated with breast cancer risk was studied, specifically rs1695."&lt;SEP&gt;"A gene is a segment of DNA that carries specific genetic information, which when expressed through protein synthesis, encodes for a functional product."&lt;SEP&gt;"A total of 916 genes were found to have significant modulation in the hippocampus of male adult rats exposed to PNS, using a fold change threshold of 1.4 and q-value &lt;0.05."&lt;SEP&gt;"Another gene analyzed for its role in breast cancer susceptibility was rs1138272."&lt;SEP&gt;"SNP rs475862 is identified as part of genetic analysis."&lt;SEP&gt;"The CASP3 gene plays a role in the study discussed."&lt;SEP&gt;"Specific genes related to the context have been omitted."&lt;SEP&gt;"The THSD4 gene is located on chromosome 15q23 and has genome-wide significant associations with FEV1/FVC lung function."&lt;SEP&gt;"The power of testing for the ASAH1 gene effect was studied using different kernels."&lt;SEP&gt;"The variable meta-regression model involved specific genes."</data>
      <data key="d2">chunk-ab5011584b0230efbf80a98b2a693a0e&lt;SEP&gt;chunk-e8f81fdd25a22582c6ce3d1e15f74af3&lt;SEP&gt;chunk-076f6aeeb369546413bc63c9f305553a&lt;SEP&gt;chunk-b803830d07bff8ae14550f6458048707&lt;SEP&gt;chunk-37088dc7c337929125b7fb31c9bf64cf&lt;SEP&gt;chunk-72f4505e43f67f3564607392cb178656&lt;SEP&gt;chunk-734cac289b42d37dad32bd51ea24a1ea&lt;SEP&gt;chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
      <data key="d3">[{"level": 0, "cluster": 8}, {"level": 1, "cluster": 28}]</data>
    </node>
    <node id="&quot;BIOLOGICAL PROCESS&quot;">
      <data key="d0">"AXONAL GUIDANCE SIGNALING, PROTEIN KINASE A SIGNALING, GLUTAMATE RECEPTOR SIGNALING, WNT/Β-CATENIN SIGNALING, CREB SIGNALING IN NEURONS, SYNAPTIC LONG TERM DEPRESSION, SYNAPTIC LONG TERM POTENTIATION, GLUCOCORTICOID RECEPTOR SIGNALING"</data>
      <data key="d1">"The PNS exposure led to modulation of 49 biological processes in the hippocampus."</data>
      <data key="d2">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
    </node>
    <node id="&quot;INFLAMMATION PATHWAY&quot;">
      <data key="d0">"IL-8 SIGNALING, STAT3 PATHWAY, CDK5 SIGNALING, IL-1 SIGNALING, IL-6 SIGNALING, BMP SIGNALING PATHWAY AND TGF-Β SIGNALING"</data>
      <data key="d1">"The PNS exposure was found to have significant influence on inflammation pathways such as IL-8 Signaling, STAT3 Pathway, etc."</data>
      <data key="d2">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
    </node>
    <node id="&quot;MIRNAS&quot;">
      <data key="d0">"68 MIRNAS (47 MATURE MIRNAS)"</data>
      <data key="d1">"A total of 68 miRNAs were significantly modulated in animals exposed to prenatal stress, with the majority being mature miRNAs."</data>
      <data key="d2">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
    </node>
    <node id="&quot;NEURODEVELOPMENT PATHWAYS&quot;">
      <data key="d0">"AXONAL GUIDANCE, PROTEIN KINASE-A SIGNALING, GLUCOCORTICOID RECEPTOR SIGNALING, TGF-Β SIGNALING"</data>
      <data key="d1">"The identified miRNAs targeted genes involved in neurodevelopment pathways like Axonal Guidance and Protein Kinase-A Signaling."</data>
      <data key="d2">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
    </node>
    <node id="&quot;INFLAMMATION PATHWAYS&quot;">
      <data key="d0">"STAT3 PATHWAY, PTEN SIGNALING, ILK SIGNALING, IL-8 SIGNALING"</data>
      <data key="d1">"A combined analysis of mRNA and miRNAs revealed inflammation-related pathways such as STAT3 Pathway." "Relationship"("</data>
      <data key="d2">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
    </node>
    <node id="&quot;EPHA4&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"An EPHA4 transcript is differentially modulated as part of neurodevelopment pathways affected by prenatal stress and childhood trauma."&lt;SEP&gt;"EPHA4, when modulated, might have interactions with other genes contributing to depression."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182&lt;SEP&gt;chunk-37088dc7c337929125b7fb31c9bf64cf</data>
    </node>
    <node id="&quot;ARID5B&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"ARID5B is another gene that can be modulated in depression and has potential interactions with other genes."&lt;SEP&gt;"The ARID5B gene shows a significant modulation in the hippocampus of rats exposed to PNS and in the blood samples from adults exposed to early life trauma."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182&lt;SEP&gt;chunk-37088dc7c337929125b7fb31c9bf64cf</data>
    </node>
    <node id="&quot;ISOC1&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"ISOC1 could potentially influence the modulation of depression-related genes and pathways."&lt;SEP&gt;"The ISOC1 transcript is involved in pathways like Wnt/Ca+ pathway, cAMP signaling, CREB signaling that are modulated by prenatal stress and childhood trauma."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182&lt;SEP&gt;chunk-37088dc7c337929125b7fb31c9bf64cf</data>
    </node>
    <node id="&quot;HSF2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"HSF2 is associated with changes in gene expression related to depression."&lt;SEP&gt;"The HSF2 gene shows significant modulation associated with neurodevelopmental pathways affected by early life events such as prenatal stress and childhood trauma."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182&lt;SEP&gt;chunk-37088dc7c337929125b7fb31c9bf64cf</data>
    </node>
    <node id="&quot;LDLRAP1&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"LDLRAP1, when modulated, might have interactions with other depression-related genes."&lt;SEP&gt;"The LDLRAP1 transcript is identified as a common marker that responds to prenatal stress in animals and childhood trauma in humans, indicating potential links between these developmental disruptions."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182&lt;SEP&gt;chunk-37088dc7c337929125b7fb31c9bf64cf</data>
    </node>
    <node id="&quot;LRRN3&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"LRRN3 could contribute to modulation of depression in the context of its expression changes."&lt;SEP&gt;"LRRN3 transcript modulation implicates its involvement in pathways related to inflammation and neurodevelopment following early life adversities like prenatal stress and trauma."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182&lt;SEP&gt;chunk-37088dc7c337929125b7fb31c9bf64cf</data>
    </node>
    <node id="&quot;MYO1D&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"MYO1D's modulations can affect depression, potentially through interactions with other genes."&lt;SEP&gt;"The MYO1D gene is differentially expressed, highlighting its role in pathways affected by the combined analysis of mRNA/miRNA in animals exposed to PNS and humans with a history of early life trauma."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182&lt;SEP&gt;chunk-37088dc7c337929125b7fb31c9bf64cf</data>
    </node>
    <node id="&quot;PIK3C2B&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"A PIK3C2B transcript response suggests its involvement in specific cellular signaling pathways disrupted by prenatal stress and childhood trauma, contributing to the common gene signature between these conditions."&lt;SEP&gt;"PIK3C2B plays a role in the modulation of depression-related pathways and gene interactions."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182&lt;SEP&gt;chunk-37088dc7c337929125b7fb31c9bf64cf</data>
    </node>
    <node id="&quot;FERROPTOSIS FACTOR 1 (FEZF1)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The Ferroptosis Factor 1 (Fezf1) shows significant modulation indicating its role in oxidative stress-related pathways that are affected by both prenatal stress and childhood trauma."</data>
      <data key="d2">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
    </node>
    <node id="&quot;NEUROTROPHIC FACTOR BDNF&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Brain-Derived Neurotrophic Factor (BDNF), a key protein involved in neural development, exhibits differential modulation as part of neurodevelopmental pathways influenced by prenatal stress and early life adversity."</data>
      <data key="d2">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
    </node>
    <node id="&quot;GLUTAMATE RECEPTOR 2 (GRIK2)&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"A GRIK2 transcript response suggests its role in synaptic function and neurotransmission, which are disrupted following prenatal stress and childhood trauma."</data>
      <data key="d2">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
    </node>
    <node id="&quot;WNT/Β-CATENIN SIGNALING PATHWAY&quot;">
      <data key="d0">"BIOLOGICAL PROCESS"</data>
      <data key="d1">"The Wnt/β-catenin signaling pathway is identified as modulated by both prenatal stress in animal models and childhood trauma in humans, indicating its importance in neurodevelopmental disorders."</data>
      <data key="d2">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
    </node>
    <node id="&quot;CAMP SIGNALING PATHWAY&quot;">
      <data key="d0">"BIOLOGICAL PROCESS"</data>
      <data key="d1">"The cAMP (cyclic Adenosine Monophosphate) signaling pathway shows modulation associated with neurodevelopment events such as prenatal stress and childhood trauma, highlighting its role in the regulation of cellular processes under these conditions."</data>
      <data key="d2">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
    </node>
    <node id="&quot;PTEN SIGNALING&quot;">
      <data key="d0">"PATHWAY"</data>
      <data key="d1">"PTEN (Phosphatase and Tensin Homolog) signaling pathway is identified as being modulated by both prenatal stress exposure and early life events like childhood trauma, suggesting its involvement in inflammation and cell growth processes affected under such conditions."</data>
      <data key="d2">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
    </node>
    <node id="&quot;ILK SIGNALING&quot;">
      <data key="d0">"PATHWAY"</data>
      <data key="d1">"The Integrin-Linked Kinase (ILK) signaling pathway is involved in the modulation caused by prenatal stress and childhood trauma, indicating its role in cellular adhesion and regulation of cytoskeleton dynamics."</data>
      <data key="d2">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
    </node>
    <node id="&quot;PTSD-SPECIFIC GENE SIGNATURE&quot;">
      <data key="d0">"GENETIC MARKER"</data>
      <data key="d1">"A unique genetic signature associated with PTSD-like traits has been identified through the analysis of data from rats exposed to PNS and humans exposed to early life trauma, indicating shared genetic vulnerabilities between these groups."</data>
      <data key="d2">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
    </node>
    <node id="&quot;COMMON MOLECULAR MECHANISMS&quot;">
      <data key="d0">"INTEGRATION OF FINDINGS"</data>
      <data key="d1">"The identification of common molecular mechanisms underlying neurodevelopmental disorders suggests a translational approach for understanding the impact of prenatal stress and childhood trauma on brain function and potentially guiding interventions."</data>
      <data key="d2">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
    </node>
    <node id="&quot;A2M&quot;">
      <data key="d0">"SNP (RS17592371)"</data>
      <data key="d1">"A2M is a gene that can be modulated in depression and has interactions with other genes."&lt;SEP&gt;"The SNP rs17592371 found within the FoxO1 gene demonstrates significant GxE interactions with both the Grady Trauma Project and Helsinki Birth cohort studies, linking genetic variation to depression risk through environmental stressors.")("entity"&lt;SEP&gt;"The SNP rs17592371 located within the FoxO1 gene was significantly associated with emotional stress predicting depressive symptoms, highlighting genetic variation in depression risk."&lt;SEP&gt;"The SNP rs17592371 shows significant GxE interaction effects on both cohorts when tested for emotional stress predicting depressive symptoms, emphasizing its importance in depression risk."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;ARRDC4&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"ARRDC4 is a gene that could possibly be involved in the complex disorder of depression."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;FBXO32&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"FBXO32 could potentially play a role in the modulation of depression-related genes and their interactions."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;FOXO1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"FoxO1 is activated in hippocampal progenitor stem cells following cortisol exposure, mediating the negative effect of stress on neurogenesis."&lt;SEP&gt;"FoxO1 shows activation following cortisol exposure, affecting neurogenesis."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98&lt;SEP&gt;chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;PPAP2A&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"PPAP2A might be involved in depression through its modulations and potential gene interactions."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;SAMD12&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"SAMD12 could have a role in depression, especially if its modulation is relevant."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;SERINC5&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"SERINC5 has been found to be modulated and potentially interacts with other genes in the context of depression."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;TGF-Β1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"TGF-β1 shows a significant genetic and environmental interaction with emotional stress predicting depressive symptoms, highlighting its role in depression risk through GxE effects."&lt;SEP&gt;"TGF-β1, when modulated, could play a role in depression through interactions with other genes."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;TRANSFORMING GROWTH FACTOR, BETA 1 (TGF-Β1)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"TGF-β1 modulation might indicate disease states relevant to depression."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;SOLUTE CARRIER FAMILY 24 (SLC24A3)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"SLC24A3 is a gene that was found to be inversely modulated in both animals and humans, potentially impacting depression."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;B-CELL CLL/LYMPHOMA 2 (BCL2)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"BCL2, when downregulated or upregulated in rats compared to humans, might indicate different mechanisms related to depression."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;B-CELL CLL/LYMPHOMA 9 (BCL9)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"BCL9 plays a role in the complex interactions between genes and their modulation across species."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;LYMPHOID ENHANCER-BINDING FACTOR 1 (LEF1)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"LEF1 is involved in signaling pathways that might interact with other depression-related genes."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;LIN-54 DREAM MUVB CORE COMPLEX COMPONENT (LIN54)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"LIN54 could have interactions with other depression-related genes through its role in complex biological processes."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;POST-GPI ATTACHMENT TO PROTEINS 1 (PGAP1)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"PGAP1 might contribute to the modulation of depression, especially when upregulated or downregulated."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;LRRK2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"LRRK2 has been associated with the modulation of depression risk and could have potential gene-gene interactions involved in this process."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;MYH7&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"MYH7, when modulated, might contribute to depression through its involvement in biological pathways."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;NEK9&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"NEK9 could potentially influence the modulation of depression-related genes and their interactions."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;NR4A1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"NR4A1 has been found to be involved in stress response and might have potential gene-gene interactions related to depression."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;PSMA7&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"PSMA7 could play a role in depression through its modulation, possibly interacting with other genes involved in the disease process."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;SAPKJIP1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"SAPKJIP1's modulations are associated with depression and might interact with other genes contributing to this condition."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;SIRT3&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"SIRT3 is involved in redox balance and its modulation could have implications for the modulation of depression-related pathways."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;TIPRL&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"TIPRL shows upregulation under conditions related to depression, suggesting potential gene-gene interactions."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;TTC3&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"TTC3's expression is modulated in the context of depression, potentially influencing other genes and pathways."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;VPS4A&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"VPS4A could contribute to modulation patterns observed in depression through its role in cellular processes."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;SNP&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"A SNP was detected for respiratory quotient (RQ) during sleep."&lt;SEP&gt;"A single nucleotide polymorphism with emotional abuse."&lt;SEP&gt;"A variant found in the DNA sequence of a single base in the human genome which was identified as related to coffee consumption."&lt;SEP&gt;"The minor allele of each Single Nucleotide Polymorphism (SNP) is related to an inverse association with type 2 diabetes."&lt;SEP&gt;"The minor allele frequencies for rs1799853, rs1057910 and rs9923231 were low. (0.02, 0.02, and 0.06 respectively)"&lt;SEP&gt;"Single Nucleotide Polymorphism, variations in the DNA sequence at a specific position."&lt;SEP&gt;"The study examined several Single Nucleotide Polymorphisms (SNPs) including TGF-ß1, IL-8, IL-10, and others."&lt;SEP&gt;"Another SNP associated with FVC was also found in this gene cluster, at rs6966266."&lt;SEP&gt;"One SNP associated with FEV1 was located near the CCL23-CCL18 gene cluster, at rs5740673."&lt;SEP&gt;"One SNP from this set had a total possible number of 'low FEV1/FVC alleles' associated with it."&lt;SEP&gt;"SNP rs5649709 at the ASXL3 locus was associated with FVC in this study."&lt;SEP&gt;"SNP rs5694874 was associated with FEV1 in this study, near the IL37 gene on chromosome 2q13."&lt;SEP&gt;"SNP rs580662 at the PITPNC1 locus was associated with FEV1/FVC lung function."&lt;SEP&gt;"SNP rs7658409 at the CHAF1B locus was associated with the FEV1/FVC ratio."&lt;SEP&gt;"SNP rs9482635 downstream of the C10orf11 gene had a P-value &lt; 10^-5 with FEV1/FVC lung function."&lt;SEP&gt;"Each of the HapMap SNPs was considered as potential causal SNP one-at-a-time in relation to other SNPs and typed SNPs."</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b&lt;SEP&gt;chunk-b803830d07bff8ae14550f6458048707&lt;SEP&gt;chunk-704d1bc6fcda99ac888bd36c954fdb98&lt;SEP&gt;chunk-2e31819d63b80079cb6422efd6e684e0&lt;SEP&gt;chunk-f433e179cd5e32035a0303b9a14da3f1&lt;SEP&gt;chunk-bd81c38d10d8773bc4076cbb20bc289f&lt;SEP&gt;chunk-46227b557f62c59155b1b9cef71d0d17&lt;SEP&gt;chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a&lt;SEP&gt;chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d3">[{"level": 0, "cluster": 5}]</data>
    </node>
    <node id="&quot;HIPPOCAMPAL PROGENITOR STEM CELL&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"Activated by cortisol exposure and involves in mediation of stress-induced effects on neurogenesis."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;CORTISOL&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Stress hormone that activates FoxO1, has negative effects on neurogenesis and regulates glucocorticoid-induced gene expression."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;NEUROGENESIS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process in which new neurons are produced from neural stem cells; negatively influenced by stress and cortisol exposure."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;GXE ANALYSIS&quot;">
      <data key="d0">"STATISTICAL TEST"</data>
      <data key="d1">"Tested the functional relevance of gene by examining its expression under genetic and environmental factors."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;CLINICAL COHORT&quot;">
      <data key="d0">"DISEASE STUDY POPULATION"</data>
      <data key="d1">"Group of individuals studied for specific clinical conditions, relevant to understanding gene expression in neurogenesis."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;DEPRESSION&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Condition where the multipotent human fetal hippocampal progenitor cell line models certain aspects of depression symptoms and stress response."&lt;SEP&gt;"There were no group differences in depression, which can be influenced by environmental factors like diet."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98&lt;SEP&gt;chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;IMMORTALIZED CELL LINE&quot;">
      <data key="d0">"CELL CULTURE"</data>
      <data key="d1">"Stable, continuous cell culture used for research purposes including modeling effects of environmental factors on gene expression."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;HUMAN FETAL HIPPOCAMPAL PROGENITOR CELL LINE (HPC0A07/03C)&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"Model system for studying stress-induced changes in gene expression and neurogenesis."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;STRESS-INDUCED FOXO1 UPREGULATION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"FoxO1 mRNA levels increased upon cortisol treatment, indicating a stress response mechanism mediated by this protein."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;AS1842856&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Cell-permeable inhibitor of FoxO1 that counteracts the cortisol-induced upregulation and reduction in neuronal proliferation."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;BRDU&quot;">
      <data key="d0">"MARKER"</data>
      <data key="d1">"Used to measure cellular proliferation, specifically to quantify the number of BrdU+ cells indicating active cell division."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;SGK-1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A stress-responsive gene that mediates glucocorticoid effects on brain function and neurogenesis; elevated under stress conditions."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;SUPPLEMENTARY TABLE 9&quot;">
      <data key="d0">"TABLE/INFORMATION SOURCE"</data>
      <data key="d1">"Contains details about the single nucleotide polymorphism related to emotional abuse."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;SGK-1 (SERUM GLUCOCORTICOID KINASE 1)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene involved in stress response and glucocorticoid-induced effects on brain function, including neurogenesis; elevated under stress conditions."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;NEURODEVELOPMENT&quot;">
      <data key="d2">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
      <data key="d1">"The genes identified through combined mRNA/miRNA analyses were mainly involved in neurodevelopment pathways."</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 8}, {"level": 1, "cluster": 28}]</data>
    </node>
    <node id="&quot;DOWNREGULATION&quot;/&quot;UPREGULATION&quot;">
      <data key="d2">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
      <data key="d1">"Out of the 68 miRNAs, 65 were downregulated while only 3 were upregulated after prenatal stress exposure.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PATHWAY IN ANIMALS EXPOSED TO PNS&quot;">
      <data key="d2">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
      <data key="d1">"Several pathways involved in neurodevelopment and inflammation were found to be similar between the PNS model and humans exposed to early life trauma."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PATHWAY IN HUMANS EXPOSED TO CHILDHOOD TRAUMA&quot;">
      <data key="d2">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
      <data key="d1">"Several pathways involved in neurodevelopment and inflammation were found to be similar between the PNS model and humans exposed to early life trauma."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;COMMON GENES&quot;">
      <data key="d2">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
      <data key="d1">"22 genes were identified as common across both datasets (hippocampus of rats exposed to PNS and blood of adults exposed to childhood trauma). The probability that these genes didn't overlap by chance was extremely low, p-value = 1.8 × 10^-8."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INTEGRATION OF DATA&quot;">
      <data key="d2">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
      <data key="d1">"22 genes were identified as common across both datasets (hippocampus of rats exposed to PNS and blood of adults exposed to childhood trauma). The probability that these genes didn't overlap by chance was extremely low, p-value = 1.8 × 10^-8."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENE EXPRESSION IN HIPPOCAMPUS&quot;">
      <data key="d2">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
      <data key="d1">"All 22 common genes were validated using real-time PCR both in the hippocampus of animals and in blood samples from humans exposed to childhood trauma. 16 out of these 22 genes showed consistent modulation direction, while 6 showed opposite modulation."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;REAL-TIME PCR VALIDATION&quot;">
      <data key="d2">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
      <data key="d1">"All 22 common genes were validated using real-time PCR both in the hippocampus of animals and in blood samples from humans exposed to childhood trauma. 16 out of these 22 genes showed consistent modulation direction, while 6 showed opposite modulation."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GXE INTERACTION WITH EMOTIONAL STRESS&quot;">
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
      <data key="d1">"FoxO1 shows significant GxE interactions across both cohorts when exposed to emotional stress, suggesting it plays a crucial role in the development of depressive symptoms in response to such stressors.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GXE INTERACTION WITH EMOTIONAL ABUSE AND SEXUAL ABUSE&quot;">
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
      <data key="d1">"FoxO1's gene expression is significantly affected by environmental exposures like emotional and physical abuse, indicating its role in the development of depressive symptoms through GxE interactions.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CLUSTER OF INTERACTING GENES (A2M, FOXO1, TGF-Β1)&quot;">
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
      <data key="d1">"The cluster formed by A2M, FoxO1 and TGF-β1 indicates potential interactions that are involved in depression through overlapping pathways and signaling systems.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;STRESS&quot;">
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98&lt;SEP&gt;chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d1">"Activation of FoxO1 in response to cortisol exposure, reflecting a mechanism involved in the negative impact of stress on neuronal proliferation.")&lt;SEP&gt;"Stress was used as a condition in the experiment to induce anxiety and negative affect."</data>
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
    </node>
    <node id="&quot;STRESS RESPONSE MECHANISM&quot;">
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
      <data key="d1">"FoxO1 is part of a molecular pathway that regulates the effect of stress on neurogenesis through its activation by cortisol exposure.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;AS1842856 (FOXO1 INHIBITOR)&quot;">
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
      <data key="d1">"AS1842856, as an inhibitor of FoxO1, is used to counteract the upregulation of FoxO1 and its effect on cortisol-induced reduction in neuronal proliferation.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DRUG INTERACTION&quot;">
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
      <data key="d1">"AS1842856, as an inhibitor of FoxO1, is used to counteract the upregulation of FoxO1 and its effect on cortisol-induced reduction in neuronal proliferation.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CORTISOL (STRESS HORMONE)&quot;">
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
      <data key="d1">"Cortisol plays a role in regulating neurogenesis, particularly under stress conditions, influencing the expression of key genes such as FoxO1 and SGK-1.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NEUROGENESIS REGULATION&quot;">
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
      <data key="d1">"Cortisol plays a role in regulating neurogenesis, particularly under stress conditions, influencing the expression of key genes such as FoxO1 and SGK-1.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS4771122&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The rs4771122 Genomic Variant was associated with long-term weight loss after bariatric surgery."</data>
      <data key="d2">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
    </node>
    <node id="&quot;RS477112&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNP rs477112 was significantly associated with trajectory group membership, nadir percent weight loss, and 2 year percent weight loss."</data>
      <data key="d2">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
    </node>
    <node id="&quot;PRE-SURGICAL BMI&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Pre-surgical BMI adjustment was made when examining the association between rs4771122 and long-term weight loss."</data>
      <data key="d2">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
    </node>
    <node id="&quot;ADDITIONAL COPIES OF MINOR (G) ALLELE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Additional copies of the minor (G) allele were associated with a larger percentage weight lost after bariatric surgery."</data>
      <data key="d2">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
    </node>
    <node id="&quot;PRE-SURGICAL WEIGHT&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Pre-surgical weight was significantly associated with rs4771122 in sample."</data>
      <data key="d2">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
    </node>
    <node id="&quot;NADIR WEIGHT LOSS&quot;">
      <data key="d0">"OUTCOME MEASURE"</data>
      <data key="d1">"The nadir percent weight loss was significantly associated with rs4771122 in the study."</data>
      <data key="d2">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
    </node>
    <node id="&quot;2 YEAR WEIGHT LOSS&quot;">
      <data key="d0">"OUTCOME MEASURE"</data>
      <data key="d1">"rs4771122 had a significant association with 2-year weight loss in the dataset."</data>
      <data key="d2">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
    </node>
    <node id="&quot;LONG TERM WEIGHT LOSS&quot;">
      <data key="d0">"OUTCOME MEASURE"</data>
      <data key="d1">"Long-term weight loss after bariatric surgery was associated with rs4771122."</data>
      <data key="d2">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
    </node>
    <node id="&quot;TRAJECTORIES&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Trajectory group membership and long-term weight loss outcomes were influenced by rs4771122."</data>
      <data key="d2">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
    </node>
    <node id="&quot;52 SELF-IDENTIFIED BLACKS&quot;">
      <data key="d0">"DISEASE POPULATION"</data>
      <data key="d1">"The study included 52 self-identified black participants for the analysis of rs4771122 association."</data>
      <data key="d2">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
    </node>
    <node id="&quot;TABLE 1 DEMOGRAPHICS AND WEIGHT OBSERVATIONS&quot;">
      <data key="d0">"DATA SET ANALYSIS"</data>
      <data key="d1">"Table 1 provided demographic data and weight observations from participants, which was used to analyze rs477112 genotype."</data>
      <data key="d2">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
    </node>
    <node id="&quot;ONE-YEAR OR MORE AFTER SURGERY&quot;">
      <data key="d0">"TIME FRAME"</data>
      <data key="d1">"Weight observations were made one year or longer after bariatric surgery for the analysis."</data>
      <data key="d2">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
    </node>
    <node id="&quot;5.6 (2.2) YEARS OF FOLLOW-UP AFTER SURGERY&quot;">
      <data key="d0">"FOLLOW-UP DURATION"</data>
      <data key="d1">"The average length of follow-up after surgery was 5.6 years with a standard deviation of 2.2 years."</data>
      <data key="d2">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
    </node>
    <node id="&quot;1634 WEIGHT OBSERVATIONS&quot;">
      <data key="d0">"TOTAL OBSERVATIONS"</data>
      <data key="d1">"A total of 1,634 weight observations were collected for analysis in the dataset."</data>
      <data key="d2">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
    </node>
    <node id="&quot;TABLE INCLUDING P-VALUES AND BETA ESTIMATES&quot;">
      <data key="d0">"STATISTICAL RESULTS"</data>
      <data key="d1">"A table was provided that included statistical significance values (P-values) and effect sizes (beta estimates) from the analysis of SNP associations."</data>
      <data key="d2">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
    </node>
    <node id="&quot;BONFERRONI CORRECTED P-VALUE&quot;">
      <data key="d2">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
      <data key="d1">"SNP rs4771122 achieved a low Bonferroni corrected P-value (.05/34 = .0017) for the association with long-term weight loss.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;BETA ESTIMATES&quot;">
      <data key="d2">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
      <data key="d1">"Additional copies of the minor (G) allele were significantly associated with higher linear mixed model weights after adjusting for several variables, including pre-surgical BMI.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GCK&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"GCK gene plays a role in MODY and has variants that cause it."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;GCK VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Variants of the GCK gene are tested for suspected or confirmed cases of MODY."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;SANGER SEQUENCING&quot;">
      <data key="d0">"SEQUENCING METHOD"</data>
      <data key="d1">"An alternative method used to confirm the results obtained from DHRMA."&lt;SEP&gt;"Sanger sequencing is used to test for GCK variants in suspected or confirmed MODY cases."</data>
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5&lt;SEP&gt;chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;MODY GENE PANEL&quot;">
      <data key="d0">"DIAGNOSTIC TOOL"</data>
      <data key="d1">"A MODY gene panel includes Sanger sequencing for testing GCK variants."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;UNIVERSITY OF CHICAGO&quot;">
      <data key="d0">"INSTITUTION"</data>
      <data key="d1">"Testing at the University of Chicago contributes 72% of tested probands with GCK variants."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;CLINICAL INFORMATION&quot;">
      <data key="d0">"DATA SET"</data>
      <data key="d1">"Clinical information is available for a subset of probands with GCK variants."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;PATHOGENIC VARIANT&quot;">
      <data key="d0">"CLASSIFICATION"</data>
      <data key="d1">"107 out of 134 identified GCK variants were previously reported as causing the condition."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;NOVEL VARIANT&quot;">
      <data key="d0">"NEW ENTITY"</data>
      <data key="d1">"27 out of the total identified variants were new to our knowledge and have not been previously described or reported."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;MISSENSE VARIANT&quot;">
      <data key="d0">"TYPE OF VARIANT"</data>
      <data key="d1">"17 missense, 1 nonsense, 2 splice sites, 1 in-frame deletion, 1 in-frame duplication, and 5 insertions/deletions were found."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;MET210DUP&quot;">
      <data key="d0">"SPECIFIC VARIANT"</data>
      <data key="d1">"This variant was identified except for Met210dup which occurred in a single family."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;PATHOGENICITY CLASSIFICATION&quot;">
      <data key="d0">"CLASSIFICATION CRITERIA"</data>
      <data key="d1">"Of the novel variants, 26% were found to be pathogenic using ACMG guidelines, while 56% were likely pathogenic and 18% had uncertain significance."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;CO-SEGREGATION&quot;">
      <data key="d0">"GENETIC PHENOMENON"</data>
      <data key="d1">"Parental or extended family DNA was available for 10 out of 28 probands, and co-segregation with the diabetes phenotype was established in those cases."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;VUS (VARIANT OF UNCERTAIN SIGNIFICANCE)&quot;">
      <data key="d0">"CLASSIFICATION"</data>
      <data key="d1">"Out of five VUS, four were predicted to be damaging by in-silico tools; however, due to lack of segregation data or phenotypic data on family members, these variants did not meet pathogenic or likely pathogenic classification criteria."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;DE NOVO MUTATION&quot;">
      <data key="d0">"EVENT"</data>
      <data key="d1">"The p.Leu307Phe sequence change was presumed to be de novo in the proband due to it being identified only in one individual without a family history of diabetes and not detected in parent's DNA via targeted sequencing."&lt;SEP&gt;"The spontaneous mutation not inherited from parents, resulting in a new genetic variation."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763&lt;SEP&gt;chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;MODERATELY CONSERVED SEQUENCE CHANGE&quot;">
      <data key="d0">"GENETIC FEATURE"</data>
      <data key="d1">"The p.His317Gln variant was predicted as tolerated by in-silico tools; however, it was found to have stable, mild fasting hyperglycemia levels and an HbA1c level that is below the expected range for GCK-MODY."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;TARGETED SEQUENCING&quot;">
      <data key="d0">"DIAGNOSTIC METHOD"</data>
      <data key="d1">"Targeted sequencing of parents' DNA did not detect certain variants indicating they might be de novo in probands, which was relevant in cases like p.Leu307Phe."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;PATERNITY TESTING&quot;">
      <data key="d0">"GENETIC TEST"</data>
      <data key="d1">"Paternity testing was not performed for the proband with the variant p.Leu307Phe, potentially affecting its classification as a pathogenic variant."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;P.SER127PRO&quot;">
      <data key="d0">"VARIANT OF UNCERTAIN SIGNIFICANCE"</data>
      <data key="d1">"One of five VUS was detected, which might be a damaging variant but lacks sufficient evidence for classification as pathogenic or likely pathogenic."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;P.HIS141PRO&quot;">
      <data key="d0">"VARIANT OF UNCERTAIN SIGNIFICANCE"</data>
      <data key="d1">"Another variant with uncertain significance due to lack of data on family members and its segregational patterns."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;P.LEU307PHE&quot;">
      <data key="d0">"NEW VARIANT"</data>
      <data key="d1">"Identified only in one proband without a family history, it is presumed to be de novo mutation based on available data."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;MODY&quot;">
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
      <data key="d1">"The GCK gene plays a role in MODY and is associated with diabetes through genetic variants.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DIAGNOSTIC METHOD FOR GCK&quot;">
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
      <data key="d1">"Sanger sequencing serves as a diagnostic tool to test for GCK variants involved in MODY.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;COMPLEMENTING DIAGNOSTIC TOOL&quot;">
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
      <data key="d1">"A MODY gene panel includes Sanger sequencing and is used alongside other tools to diagnose MODY through testing for genetic variants.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PROVIDER OF TESTING&quot;">
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
      <data key="d1">"Testing conducted at the University of Chicago contributes significantly (72%) to the dataset of probands with GCK variants, indicating its importance in genetic research and healthcare.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DATA SET FOR ANALYSIS&quot;">
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
      <data key="d1">"A subset of probands with GCK variants has clinical information available for analysis, providing insights into the manifestation of MODY.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CRITERIA FOR VARIANT EVALUATION&quot;">
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
      <data key="d1">"ACMG guidelines are used to classify variants as pathogenic or likely pathogenic based on their impact on the GCK gene and its associated conditions.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CO-SEGREGATION WITH DIABETES PHENOTYPE&quot;">
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
      <data key="d1">"Segregation analysis establishes co-segregation between tested probands' DNA and diabetes phenotype, highlighting genetic linkage in MODY cases.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENETIC ANALYSIS&quot;">
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
      <data key="d1">"Segregation analysis establishes co-segregation between tested probands' DNA and diabetes phenotype, highlighting genetic linkage in MODY cases.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CLASSIFICATION CRITERIA&quot;">
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
      <data key="d1">"VUS are not clearly classified as pathogenic due to lack of evidence for their impact or segregation with the disease, requiring further research.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENETIC EVENT&quot;">
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
      <data key="d1">"Certain variants identified in probands might arise spontaneously (de novo), especially those without family history like p.Leu307Phe, impacting classification and understanding of genetic inheritance patterns.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DIAGNOSTIC METHOD FOR VARIANTS&quot;">
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
      <data key="d1">"Targeted sequencing enables detection of specific variants in probands' DNA that might be missed with whole-genome approaches; crucial for identifying new or rare variants like p.Leu307Phe.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENETIC ANALYSIS FOR PARENTAL VERIFICATION&quot;">
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
      <data key="d1">"In cases where genetic data is ambiguous, paternity testing can provide definitive answers on the origin of certain variants; it was not performed in this scenario affecting variant classification.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MD ADHERENCE&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"A measure of adherence to the Mediterranean diet."</data>
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
    </node>
    <node id="&quot;MEDITERRANEAN DIET&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"The dietary pattern characterized by high intake of fruits, vegetables, whole grains, legumes, nuts, and olive oil; moderate consumption of fish and poultry; limited intake of red meat; and moderate alcohol intake."</data>
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
    </node>
    <node id="&quot;TAG CONCENTRATIONS&quot;">
      <data key="d0">"METABOLIC MARKER"</data>
      <data key="d1">"Triglyceride concentration in the blood as an indicator of lipid metabolism."</data>
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
    </node>
    <node id="&quot;APOB:APOA-1 RATIO&quot;">
      <data key="d0">"METABOLIC MARKER"</data>
      <data key="d1">"The ratio between apolipoprotein B and apolipoprotein A-I, which is associated with risk for cardiovascular disease."</data>
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
    </node>
    <node id="&quot;HDL-C&quot;">
      <data key="d0">"METABOLIC MARKER"</data>
      <data key="d1">"High-density lipoprotein (HDL) cholesterol level, often referred to as 'good' cholesterol because it helps remove excess cholesterol from the blood."</data>
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
    </node>
    <node id="&quot;APOA-1&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Apolipoprotein A-I is a protein component of HDL cholesterol that is involved in lipid metabolism and transport."</data>
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
    </node>
    <node id="&quot;HBA1C&quot;">
      <data key="d0">"METABOLIC MARKER"</data>
      <data key="d1">"A measure of average blood glucose levels over the past 2-3 months, often used to assess long-term control of diabetes."</data>
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
    </node>
    <node id="&quot;LDL-C&quot;">
      <data key="d0">"METABOLIC MARKER"</data>
      <data key="d1">"Low-density lipoprotein (LDL) cholesterol concentration in the blood; often referred to as 'bad' cholesterol because it can contribute to plaque buildup in arteries."</data>
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
    </node>
    <node id="&quot;APOB&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Apolipoprotein B is a protein component of LDL cholesterol, which plays an important role in lipid metabolism and transport."</data>
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
    </node>
    <node id="&quot;GCKR RS780094 SNP&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A specific genetic variant found on chromosome 1p32 region, associated with glucokinase regulatory protein."</data>
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
    </node>
    <node id="&quot;GG GENOTYPE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The wild-type (reference) form of the glucokinase regulatory protein found in most individuals."</data>
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
    </node>
    <node id="&quot;HYPERTRIACYLGLYCEROLAEMIA&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A condition characterized by high levels of triglycerides, often leading to increased cardiovascular risk."</data>
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
    </node>
    <node id="&quot;GENOTYPE AND MEDITERRANEAN DIET ADHERENCE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The combined effect of genetic factors (like SNP) and dietary habits on metabolic markers and health outcomes."</data>
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
    </node>
    <node id="&quot;SUBGROUP ANALYSIS&quot;">
      <data key="d0">"STATISTICAL METHOD"</data>
      <data key="d1">"A type of data analysis used to examine the effect of categorical variables when considering multiple strata or subpopulations."</data>
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
    </node>
    <node id="&quot;AGE, PHYSICAL ACTIVITY STATUS, AND SMOKING STATUS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Individual characteristics that may influence metabolic markers and diet adherence interaction."</data>
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
    </node>
    <node id="&quot;RS1260326 SNP&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Another genetic marker in high linkage disequilibrium with rs780094, used for subgroup analysis."</data>
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
    </node>
    <node id="&quot;SMOKING STATUS&quot;">
      <data key="d0">"HABIT"</data>
      <data key="d1">"Smoking status is a factor that influences various physiological processes including cortisol secretion and metabolism."&lt;SEP&gt;"Smoking status refers to being a smoker or non-smoker."</data>
      <data key="d2">chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6&lt;SEP&gt;chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d3">[{"level": 0, "cluster": 0}, {"level": 1, "cluster": 21}]</data>
    </node>
    <node id="&quot;TAG LEVELS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"TAG levels are physiological in nature and can vary by genotype."</data>
      <data key="d2">chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6</data>
      <data key="d3">[{"level": 0, "cluster": 0}, {"level": 1, "cluster": 21}]</data>
    </node>
    <node id="&quot;OUTCOMES&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Outcomes being analyzed are health outcomes which could be affected by smoking status."</data>
      <data key="d2">chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6</data>
    </node>
    <node id="&quot;STRATA&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Strata refer to specific subgroups of data, potentially related to genetic or environmental factors."</data>
      <data key="d2">chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6</data>
      <data key="d3">[{"level": 0, "cluster": 11}, {"level": 1, "cluster": 36}, {"level": 2, "cluster": 60}]</data>
    </node>
    <node id="&quot;GENE–DIET INTERACTION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A gene-diet interaction occurs when the effect of a diet on health outcomes is modified by a person's genetic makeup."</data>
      <data key="d2">chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6</data>
      <data key="d3">[{"level": 0, "cluster": 0}, {"level": 1, "cluster": 22}]</data>
    </node>
    <node id="&quot;METABOLIC PARAMETERS&quot;">
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d1">"The joint effect of specific genotypes (AA, GA, GG) with different levels of Mediterranean diet adherence influenced various metabolic markers like TAG, TC, apoB, and HbA1c.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;OUTCOME VARIABLES&quot;">
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d1">"An analysis that examines how outcomes such as lipid profiles or glucose control vary across subgroups defined by age, activity level, or smoking status.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENOTYPE&quot;">
      <data key="d2">chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6&lt;SEP&gt;chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d1">"Genetic factors can influence how dietary patterns affect physiological processes like TAG levels.")&lt;SEP&gt;"The term 'genotype' refers to an individual's genetic makeup, specifically the combination of alleles they carry for certain genes."</data>
      <data key="d0">"GENE"</data>
      <data key="d3">[{"level": 0, "cluster": 0}, {"level": 1, "cluster": 22}]</data>
    </node>
    <node id="&quot;CHI&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A patient initially misdiagnosed with seizure disorder before hypoglycemia was detected."&lt;SEP&gt;"Cirrhosis of the Heart is diagnosed in 65 patients (47 males and 18 females) aged from birth to seven years old. It includes macrosomic individuals with a mean birth weight of 3,690 g."&lt;SEP&gt;"The disease presentation varied by age: neonatal in 29 (44.6%), infancy up to one year in 26 patients (40%), and childhood over a year old in 10 patients (15.4%)."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;DIAZOXIDE UNRESPONSIVE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Group 1 patients, 92.3% neonatal form, had no response to diazoxide treatment."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;DIAZOXIDE RESPONSIVE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Group 2 patients showed a significantly higher incidence of epilepsy compared with Group 1, and a longer duration from symptom manifestation to diagnosis."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;ABCC8 MUTATIONS&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Mutations found in the ABCC8 gene were identified in 16 children (25% of cohort), none were homozygous, but five were compound heterozygous and ten were heterozygous."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;KCNJ11 MUTATIONS&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"No mutations found on KATP channel gene mutation analysis, only in ABCC8."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;GLUD1 MUTATIONS&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Five novel ABCC8 mutations identified: p.Phe5SerfsX72, p.Gln273ArgfsX85, p.Leu724del, p.Asp1447Gly and IVS 25-1G&gt;T."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;HETEROZYGOUS VARIANT&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A novel heterozygous variant in ABCC8 gene was identified, which is pathogenic or likely pathogenic according to ACMG guidelines."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;DIAZOXIDE TREATMENT EFFECTIVENESS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Among children with compound heterozygous mutations, three responded to diazoxide treatment, one showed no response and the fourth was regulated through diet."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;HYPOGLYCEMIA BRAIN INJURY&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"One case experienced hypoglycemic brain injury with global developmental delay after brief generalized convulsive periods."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;PATERNALLY INHERITED MONOALLELIC MUTATION&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Five out of the sixteen parents had paternally inherited monoallelic mutations in CHI."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;DIFFUSE PANCREATIC DISEASE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"One patient, case 3, was diazoxide-unresponsive and underwent surgery that confirmed diffuse pancreatic disease."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;18F-DOPA PET/CT SCAN&quot;">
      <data key="d0">"DIAGNOSTIC METHOD"</data>
      <data key="d1">"A focal lesion in the head of the pancreas was identified using an 18F-DOPA PET/CT scan. Histology showed atypical form with β-cell nuclei enlargement, including the head and part of the body and tail."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;GLOBAL DEVELOPMENTAL DELAY&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The patient experienced sustained hypoglycaemic brain injury resulting in global developmental delay."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;GCK GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"No variants were found in the GCK gene, which is involved in glucose metabolism."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;GLUD1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Three different heterozygous mutations in the GLUD1 gene were identified in five patients with hypoglycaemia and mild HA."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;P.THR1042GLNFSX75 MUTATION&quot;">
      <data key="d0">"MUTATION"</data>
      <data key="d1">"The most common mutation was c.3224-3226delACC ins CAGCCAGGAACTG, which resulted in p.Thr1042GlnfsX75."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;P.PHE5SERFSX72 MUTATION&quot;">
      <data key="d0">"MUTATION"</data>
      <data key="d1">"One of the novel mutations identified was a frameshift mutation resulting in p.Phe5SerfsX72."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;P.GLN273ARGFSX85 MUTATION&quot;">
      <data key="d0">"MUTATION"</data>
      <data key="d1">"Another novel mutation identified was a frameshift mutation leading to p.Gln273ArgfsX85."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;P.LEU724DEL MUTATION&quot;">
      <data key="d0">"MUTATION"</data>
      <data key="d1">"A deletion mutation was found resulting in p.Leu724del as one of the novel mutations."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;P.HIS105PRO MISSENSE MUTATION&quot;">
      <data key="d0">"MUTATION"</data>
      <data key="d1">"Patient 3 carried the missense mutation c.314A&gt;C (p.His105Pro) in exon 3, which was inherited from his father and was previously reported as diazoxide-unresponsive."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;C.2800C&gt;T NONSENSE MUTATION&quot;">
      <data key="d0">"MUTATION"</data>
      <data key="d1">"Patient 3 had an additional nonsense mutation c.2800C&gt;T (p.Gln934X) in exon 23 inherited from his mother, also responsible for diazoxide-unresponsive phenotype."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;GLUD1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The GLUD1 gene was detected in patients with hypoglycaemia, HI and mild HA."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;P.ARG322 HIS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This mutation was found in patients 54, 55 and 56."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;P.SER498LEU&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The p.Ser498Leu mutation was found in patient 52."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;P.ASN463ASP&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The p.Asn463Asp mutation was found in patient 53."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;HI&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"These mutations were identified in patients with HI (Hypoglycaemia Induced by Gluconeogenesis Dysfunction)."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;HA&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The GLUD1 genetic defect was associated with HA (Hyperammonaemia)."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;SERUM AMMONIA CONCENTRATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Monitoring serum ammonia concentration helps in assessing the effectiveness of treatment for HI/HA syndrome."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;DIAZOXIDE&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Diazoxide was used as a treatment for patients unresponsive to low-protein diet."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;DIAZOXIDE-UNRESPONSIVE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"There were three diazoxide-unresponsive patients who required insulin or did not show improvement after treatment."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot; SUBTOTAL PANCREATECTOMY&quot;">
      <data key="d0">"SURGICAL INTERVENTION"</data>
      <data key="d1">"Subtotal pancreatectomy was performed on nine patients who showed no response to drugs."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;DIAZOXIDE THERAPY&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"Diazoxide therapy successfully controlled hypoglycaemia in some cases; however, it had side effects like diarrhoea and hypertrichosis."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;SEX RATIO&quot;">
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
      <data key="d1">"There were 47 males and 18 females diagnosed with CHI.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CLINICAL SYMPTOM&quot;">
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
      <data key="d1">"Group 1 patients, which made up 92.3% of the neonatal form, showed no response to diazoxide treatment.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DIAZOXIDE-RESPONSIVE&quot;">
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
      <data key="d1">"Group 2 patients displayed a higher incidence of epilepsy compared with Group 1.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SYMPTOM INCIDENCE&quot;">
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
      <data key="d1">"Group 2 patients displayed a higher incidence of epilepsy compared with Group 1.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TIME DURATION BETWEEN SYMPTOM AND DIAGNOSIS&quot;">
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
      <data key="d1">"The duration from symptom manifestation to diagnosis was longer in Group 2, particularly for neonatal form patients.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HYPOGLYCEMIA&quot;">
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
      <data key="d1">"Symptoms included hypoglycemia and hypoglycaemic brain injury with global developmental delay.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SYMPTOM PRESENTATION&quot;">
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
      <data key="d1">"Symptoms included hypoglycemia and hypoglycaemic brain injury with global developmental delay.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;P.ARG322 HIS MUTATION&quot;">
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d1">"The p.Arg322 His mutation was found among patients presenting symptoms of HI.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;P.SER498LEU MUTATION&quot;">
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d1">"The p.Ser498Leu mutation contributed to the risk of developing HI in one patient.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;P.ASN463ASP MUTATION&quot;">
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d1">"This mutation was associated with patients experiencing HA (Hyperammonaemia).")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DIAZOXIDE TREATMENT&quot;">
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d1">"Diazoxide treatment for HI/HA syndrome had side effects, including hypertrichosis.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HI/HA SYNDROME&quot;">
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d1">"Diazoxide treatment for HI/HA syndrome had side effects, including hypertrichosis.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TREATMENT FOR HI/HA&quot;">
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d1">"A low-protein diet was used as a primary treatment before considering other interventions.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DIAZOXIDE-UNRESPONSIVE PATIENTS&quot;">
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d1">"Patients with no response to diazoxide treatment required further interventions like insulin therapy or surgery.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;THERAPY OUTCOME&quot;">
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d1">"Patients with no response to diazoxide treatment required further interventions like insulin therapy or surgery.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NOS1 GENE&quot;">
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d1">"The NOS1 gene interacts with folate metabolism to regulate nitric oxide production in cardiovascular health.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 13}, {"level": 1, "cluster": 44}]</data>
    </node>
    <node id="&quot;CARDIOVASCULAR DISEASE RISK&quot;">
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d1">"A specific genetic variant in the NOS1 gene has been linked to an increased risk of developing cardiovascular disease.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENETIC VARIANT IN NOS1 GENE&quot;">
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d1">"A specific genetic variant in the NOS1 gene has been linked to an increased risk of developing cardiovascular disease.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DIETARY PATTERNS&quot;">
      <data key="d2">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb&lt;SEP&gt;chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d1">"Dietary patterns influence folate intake, which plays a role in the nitric oxide synthesis pathway affecting cardiovascular health.")&lt;SEP&gt;"Specific dietary patterns influence the expression of genes related to cardiovascular disease, including those involved in folate metabolism."</data>
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d3">[{"level": 0, "cluster": 13}, {"level": 1, "cluster": 45}]</data>
    </node>
    <node id="&quot;FOLATE INTAKE AND NITRIC OXIDE SYNTHESIS&quot;">
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d1">"Dietary patterns influence folate intake, which plays a role in the nitric oxide synthesis pathway affecting cardiovascular health.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 13}, {"level": 1, "cluster": 45}]</data>
    </node>
    <node id="&quot;CARDIOVASCULAR HEALTH MODULATION&quot;">
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d1">"Environmental factors such as diet and physical activity modulate cardiovascular health through their effects on the NOS1 gene and folate metabolism.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 2}, {"level": 1, "cluster": 10}]</data>
    </node>
    <node id="&quot;ENVIRONMENTAL FACTORS&quot;">
      <data key="d2">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb&lt;SEP&gt;chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d1">"Environmental factors such as diet and physical activity modulate cardiovascular health through their effects on the NOS1 gene and folate metabolism.")&lt;SEP&gt;"Lifestyle and environmental factors interact with genetic variations like MTHFR polymorphisms to impact cardiovascular health."</data>
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d3">[{"level": 0, "cluster": 2}, {"level": 1, "cluster": 10}]</data>
    </node>
    <node id="&quot;KBS&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Levels of KBs across the categories of glucose tolerance."&lt;SEP&gt;"The KB metabolism pathway is involved in correlating with the expression of genes such as CPT1A, HMGCS1, HMGCS2, ACAT1, BDH1, OXCT1 and ACSS2."</data>
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f&lt;SEP&gt;chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;ACAC&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"In the 2hPG category, AcAc level increased significantly in subjects with IGT by +21% as well as in newly diagnosed diabetes by +29%, compared to reference category."&lt;SEP&gt;"In the FPG category, AcAc levels decreased significantly in individuals with IFG by −2% and increased significantly in individuals with newly detected diabetes by +64%."&lt;SEP&gt;"The C allele of rs780094 had a nominally significant association (P = 0.003) with AcAc levels."</data>
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f&lt;SEP&gt;chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;BHB&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"BHB level decreased significantly in subjects with IFG by −5% and increased significantly in the diabetic range by +99%."&lt;SEP&gt;"BHB level increased nominally in IGT by +12% and in newly diagnosed type 2 diabetes by +52%, compared to the reference category."&lt;SEP&gt;"The glucose-increasing C allele of rs780094 was associated with an increase of 5.6% per the C allele in BHB levels."</data>
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f&lt;SEP&gt;chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;FASTING ACAC AND BHB&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Fasting AcAc and BHB levels correlated significantly with FPG and 2hPG levels."</data>
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f</data>
    </node>
    <node id="&quot;HYPERGLYCEMIA&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A total of 276 participants developed incident diabetes between the baseline and follow-up studies, most of whom had their FPG in the range of 7.0–7.5 mmol/L or their 2hPG level (52 of 80 participants) in the range of 11.1–12.0 mmol/L."</data>
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f</data>
    </node>
    <node id="&quot;INCIDENT DIABETES&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"After further adjustment for confounding factors, AcAc predicted incident diabetes after the adjustment for confounding factors."</data>
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f</data>
    </node>
    <node id="&quot;INSULIN AUC&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The highest quartile of glucose AUC versus the three lowest quartiles of glucose AUC was used to evaluate associations with development of hyperglycemia and conversion to type 2 diabetes."</data>
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f</data>
    </node>
    <node id="&quot;GLP-1&quot;">
      <data key="d0">"HORMONE"</data>
      <data key="d1">"The incretin hormone GLP-1 is secreted by L-cells in the intestine and plays a critical role in glucose homeostasis."</data>
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f</data>
    </node>
    <node id="&quot;SGLT2&quot;">
      <data key="d0">"TRANSPORTER"</data>
      <data key="d1">"Sodium-glucose co-transporter 2 (SGLT2) is responsible for reabsorbing most of the filtered glucose back into the bloodstream, maintaining blood sugar levels."</data>
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f</data>
    </node>
    <node id="&quot;DIABETES MELLITUS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Type 2 diabetes mellitus (T2DM), characterized by insulin resistance and inadequate insulin secretion, results in hyperglycemia."</data>
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f</data>
    </node>
    <node id="&quot;METABOLISM&quot;">
      <data key="d0">"PROCESS"</data>
      <data key="d1">"The metabolic processes that regulate blood sugar levels involve the breakdown of glucose and its subsequent utilization or storage."</data>
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f</data>
    </node>
    <node id="&quot;INSULIN RESISTANCE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"IRF1, involved in insulin resistance and susceptibility to type 2 diabetes, is proximal (220kb apart) from the block of SNPs."&lt;SEP&gt;"Insulin resistance is a condition where cells fail to respond adequately to insulin, leading to elevated blood sugar levels."&lt;SEP&gt;"Liver insulin resistance was detected under basal conditions and increased more pronouncedly under HFD in SENP1 knockout (KO) mice, a hallmark of obesity-linked type 2 diabetes development."</data>
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f&lt;SEP&gt;chunk-174831b97ed170039b374ba254d4f506&lt;SEP&gt;chunk-938d8bf2e56584de9dd556be5eb70964</data>
      <data key="d3">[{"level": 0, "cluster": 6}]</data>
    </node>
    <node id="&quot;GLUCOSE TOLERANCE TESTS&quot;">
      <data key="d0">"DIAGNOSTIC TEST"</data>
      <data key="d1">"Fasting plasma glucose (FPG) and 2-hour postprandial plasma glucose (2hPG) tests are used to assess diabetes risk and glucose tolerance."</data>
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f</data>
    </node>
    <node id="&quot;MATSUDA INDEX OF INSULIN SENSITIVITY&quot;">
      <data key="d0">"MEASURE"</data>
      <data key="d1">"The Matsuda index calculates insulin sensitivity based on a person's fasting glucose and insulin levels, useful for assessing metabolic health."</data>
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f</data>
    </node>
    <node id="&quot;INSULIN SECRETION RATE&quot;">
      <data key="d0">"PARAMETER"</data>
      <data key="d1">"The rate at which insulin is secreted by the pancreas in response to rising blood sugar levels, essential for glucose metabolism."</data>
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f</data>
    </node>
    <node id="&quot;RS780094&quot;">
      <data key="d0">"GENETIC VARIANT"</data>
      <data key="d1">"The glucose-increasing C allele of rs780094, located in the GCKR gene, showed a significant association with elevated levels of BHB."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;FADS1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Nominally significant associations were found for SNPs from the FADS1 gene and KB levels, both in terms of AcAc and BHB."&lt;SEP&gt;"Polymorphisms in FADS1, including rs35357048 and rs174537, influence omega-6 and omega-3 fatty acid levels."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2&lt;SEP&gt;chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;ANK1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"SNPs from the ANK1 gene showed a nominally significant association with KB levels."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;GIPR&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"An exon 2 variant in GIPR on chromosome 16 was related to insulin sensitivity."&lt;SEP&gt;"The GIPR gene was associated with KB levels, though not in a statistically significant manner."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2&lt;SEP&gt;chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;HMGA2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"HMGA2 interacts with tooth eruption and number of teeth, influencing face width."&lt;SEP&gt;"The HMGA2 gene showed an association with KB levels that was nominally significant."&lt;SEP&gt;"The gene HMGA2 influences number of teeth at one year through its association with rs17101923."&lt;SEP&gt;"Variants in the HMGA2 gene contribute significantly to the 'Age at first tooth' SNP associations."</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4&lt;SEP&gt;chunk-c63d60b991cd7442f690dcc364af47dd&lt;SEP&gt;chunk-bc2193bd869a06007022e1aa75877336&lt;SEP&gt;chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;SLC2A2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"SNPs from the SLC2A2 gene had a nominally significant association with KB levels."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;GCKR&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"GCKR encodes a hexokinase that plays a critical role in regulating glucose metabolism."&lt;SEP&gt;"GCKR gene"&lt;SEP&gt;"Located within or close to the GCKR gene"&lt;SEP&gt;"The GCKR gene's C allele was associated with elevated BHB and AcAc levels in relation to type 2 diabetes or hyperglycemia risk SNPs."&lt;SEP&gt;"SNPs (rs7903146, rs7903295) in GCKR on chromosome 3 are associated with fasting glucose and diabetes risk."&lt;SEP&gt;"The GCKR gene has been linked to blood glucose levels, impacting kidney health through metabolic pathways."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2&lt;SEP&gt;chunk-ad609cb10e900d42a6901eea1591d8ba&lt;SEP&gt;chunk-45a965c3c3013c70d0fa0f1680283083&lt;SEP&gt;chunk-372184452f1f9156514992455057f843&lt;SEP&gt;chunk-bc2193bd869a06007022e1aa75877336&lt;SEP&gt;chunk-3edc72730d68b4c7fd6ba397aa087391</data>
    </node>
    <node id="&quot;CPT1A&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Adipose tissue mRNA expression of the CPT1A gene (encoding carnitine palmitoyltransferase 1A) was positively correlated with glucose AUC and inversely with Matsuda ISI."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;HMGCS1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The HMGCS1 gene, which encodes a protein involved in ketogenesis, did not correlate significantly with glucose metabolism parameters such as glucose AUC, insulin sensitivity or secretion."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;HMGCS2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Similarly, the HMGCS2 gene was also associated with ketogenesis but had no significant correlation with glucose AUC, insulin sensitivity or insulin secretion."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;ACAT1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The ACAT1 gene (encoding acetyl-CoA acetyltransferase 1) showed significant correlations with glucose AUC, Matsuda ISI and insulin secretion in adipose tissue mRNA expression."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;BDH1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The BDH1 gene was negatively correlated with glucose AUC and insulin secretion but positively correlated with Matsuda ISI when analyzing adipose tissue mRNA expression."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;OXCT1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The OXCT1 gene showed a positive correlation with Matsuda ISI in the context of adipose tissue mRNA expression, suggesting its role in ketolysis and insulin sensitivity."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;ACSS2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The ACSS2 gene encoded by this gene was inversely correlated with glucose AUC and positively correlated with Matsuda ISI based on adipose tissue mRNA levels."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;GLUCOSE AUC&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Glucose area under the curve (AUC) was negatively correlated with expression levels of genes like CPT1A, BDH1 and ACSS2 but positively correlated with ACAT1 and OXCT1 expression."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;INSULIN SENSITIVITY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Insulin sensitivity showed positive correlations with the expression of specific genes involved in ketolysis (ACAT1, BDH1, OXCT1) while being negatively correlated with other genes (CPT1A, ACSS2)."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;INSULIN SECRETION&quot;">
      <data key="d0">"FUNCTION"</data>
      <data key="d1">"Insulin secretion was inversely related to the expression of CPT1A and ACSS2 but positively correlated with BDH1 and OXCT1 in adipose tissue mRNA levels."&lt;SEP&gt;"The glucose-stimulated insulin secretion from SENP1-deficient islets was significantly reduced compared to control groups."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336&lt;SEP&gt;chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;PGC1A&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"SNPs from the PGC1A gene were associated with metabolic processes including glucose metabolism and lipid homeostasis."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;PPARΓ&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Not affected by the deletion of SENP1 regarding mRNA or protein levels in adipocytes but plays a role in repressing inflammatory responses via SUMOylation."&lt;SEP&gt;"The nuclear receptor peroxisome proliferator-activated receptor gamma (PPARγ) plays a crucial role in adipocyte differentiation and glucose metabolism."</data>
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4&lt;SEP&gt;chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;PGC1Α&quot;">
      <data key="d0">"COACTIVATOR PROTEIN"</data>
      <data key="d1">"The coactivator protein, PGC1α (Peroxisome proliferator-activated receptor γ coactivator 1 alpha), was shown to influence gene expression related to metabolic pathways."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;AMPK&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"AMP-activated protein kinase (AMPK) is a key regulator of energy homeostasis and plays a role in glucose metabolism and insulin sensitivity."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;PGC1Β&quot;">
      <data key="d0">"COACTIVATOR PROTEIN"</data>
      <data key="d1">"The coactivator PGC1β interacts with several transcription factors, including PGC1α, to regulate genes involved in mitochondrial biogenesis and metabolic processes."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;GLP-1 RECEPTOR&quot;">
      <data key="d0">"G-PROTEIN COUPLED RECEPTOR"</data>
      <data key="d1">"The GLP-1 receptor (Glucagon-like Peptide 1) is implicated in glucose regulation and insulin secretion, often associated with type 2 diabetes management."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;GLP-2 RECEPTOR&quot;">
      <data key="d0">"G-PROTEIN COUPLED RECEPTOR"</data>
      <data key="d1">"GLP-2 receptors play a role in gut health and can influence metabolism through interactions with the GLP-1 system."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;GIP RECEPTOR&quot;">
      <data key="d0">"G-PROTEIN COUPLED RECEPTOR"</data>
      <data key="d1">"The GIP receptor (Glucose-dependent insulinotropic polypeptide receptor) is involved in glucose metabolism and insulin secretion."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;MATSUDA INDEX&quot;">
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f</data>
      <data key="d1">"Changes in the Matsuda index could suggest alterations in insulin sensitivity and insulin resistance, impacting diabetes risk assessment.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 6}]</data>
    </node>
    <node id="&quot;KB LEVELS&quot;">
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
      <data key="d1">"SNPs from the FADS1 gene were associated with KB levels, though not in a statistically significant manner.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;BHB LEVELS&quot;">
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
      <data key="d1">"The glucose-increasing C allele of rs780094 was associated with an increase of 5.6% in BHB levels per the C allele, after adjusting for age and BMI.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GCKR C ALLELE&quot;">
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
      <data key="d1">"The glucose-increasing C allele of rs780094 was associated with an increase of 5.6% in BHB levels per the C allele, after adjusting for age and BMI.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ACAC LEVELS&quot;">
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
      <data key="d1">"The glucose-increasing C allele showed a nominally significant association (P = 0.003) with AcAc levels.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CPT1A EXPRESSION&quot;">
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
      <data key="d1">"Adipose tissue mRNA expression of the CPT1A gene was positively correlated with glucose AUC, showing its role in fatty acid oxidation and insulin sensitivity.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;BDH1 AND OXCT1 EXPRESSION&quot;">
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
      <data key="d1">"The BDH1 and OXCT1 genes had positive correlations with Matsuda ISI, reflecting their roles in ketolysis and insulin sensitivity respectively.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MATSUDA ISI&quot;">
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
      <data key="d1">"The BDH1 and OXCT1 genes had positive correlations with Matsuda ISI, reflecting their roles in ketolysis and insulin sensitivity respectively.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ACAT1 EXPRESSION&quot;">
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
      <data key="d1">"The ACAT1 gene encoded acetyl-CoA acetyltransferase 1, which showed significant correlations with glucose AUC, Matsuda ISI and insulin secretion indicating its involvement in ketolysis.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GLUCOSE AUC AND INSULIN SECRETION&quot;">
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
      <data key="d1">"The ACAT1 gene encoded acetyl-CoA acetyltransferase 1, which showed significant correlations with glucose AUC, Matsuda ISI and insulin secretion indicating its involvement in ketolysis.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GLUCOSE AUC AND INSULIN SENSITIVITY&quot;">
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
      <data key="d1">"The expression of the CPT1A gene was negatively correlated with glucose AUC but positively related to Matsuda ISI, suggesting roles in fatty acid oxidation and insulin sensitivity respectively.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ACSS2 EXPRESSION&quot;">
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
      <data key="d1">"The ACSS2 gene showed an inverse correlation with glucose AUC but a positive relationship with Matsuda ISI, pointing to its role in adipose tissue metabolism.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SNPS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"19 SNPs out of 283 independent cardiometabolic SNPs (6.7%) were associated with CRP after correction for multiple testing."&lt;SEP&gt;"Additional SNPs out of 283 independent cardiometabolic SNPs associated with CRP after correction for multiple testing."&lt;SEP&gt;"SNPs are variations found within these genes that affect protein function."&lt;SEP&gt;"Three minor alleles for the SNPs were associated with increased social disinhibition risk, while three others had protective effects."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba&lt;SEP&gt;chunk-2fb95100a1290b27baae869c6560419a&lt;SEP&gt;chunk-36d70bb8409856300dd77669e7c1f9ed</data>
    </node>
    <node id="&quot;APOC1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"APOC1 gene"&lt;SEP&gt;"Located within or close to the APOC1 gene"</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba&lt;SEP&gt;chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;HNF1A&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"HNF1A gene"&lt;SEP&gt;"Located within or close to the HNF1A gene"</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba&lt;SEP&gt;chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;IL6R&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Located within or close to the IL6R gene"</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;PPP1R3B&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Located within or close to the PPP1R3B gene associated with CRP"&lt;SEP&gt;"Located within or close to the PPP1R3B gene"&lt;SEP&gt;"PPP1R3B gene"</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba&lt;SEP&gt;chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;HNF4A&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"HNF4A gene"&lt;SEP&gt;"Located within or close to the HNF4A gene associated with CRP"&lt;SEP&gt;"Located within or close to the HNF4A gene"</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba&lt;SEP&gt;chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;PABPC4&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Located within or close to the PABPC4 gene"</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
      <data key="d3">[{"level": 0, "cluster": 3}]</data>
    </node>
    <node id="&quot;BCL7B&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"BCL7B gene"&lt;SEP&gt;"Located within BCL7B gene associated with CRP"&lt;SEP&gt;"Located within or close to the BCL7B gene"</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba&lt;SEP&gt;chunk-372184452f1f9156514992455057f843</data>
      <data key="d3">[{"level": 0, "cluster": 3}]</data>
    </node>
    <node id="&quot;TMEM18&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Located near TMEM18"</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;PLTP&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Located near PLTP and PCIF1 gene"</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;MC4R&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Located on chromosome 18, upstream of the MC4R gene"</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;IL1F10&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"IL1F10 gene"&lt;SEP&gt;"Located within or close to the IL1F10 gene and not identified in previous analysis"</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba&lt;SEP&gt;chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;PABPC&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Located within PABPC gene associated with CRP"&lt;SEP&gt;"PABPC gene"</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba&lt;SEP&gt;chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;CAD&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Coronary artery disease (CAD) is a large part of the heterogeneity explained by differences in percentage between patients and controls."&lt;SEP&gt;"Coronary artery disease (CAD)"</data>
      <data key="d2">chunk-734cac289b42d37dad32bd51ea24a1ea&lt;SEP&gt;chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;RS1183910&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNP rs1183910"</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;RS6734238&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNP rs6734238"</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;TOTAL CHOLESTEROL&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Total cholesterol is a cardiometabolic phenotype"</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;T2D&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Type 2 Diabetes (T2D) is one mechanism for loss of renal function that was considered in studies on kidney function and genetic variants."&lt;SEP&gt;"Type 2 diabetes (T2D)"</data>
      <data key="d2">chunk-3edc72730d68b4c7fd6ba397aa087391&lt;SEP&gt;chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;CRP&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"CRP (C-Reactive Protein) gene results showed no significant association with ovarian cancer risk."&lt;SEP&gt;"CRP is a biomarker for inflammation and cardiometabolic risk"&lt;SEP&gt;"CRP is associated with a range of cardiometabolic phenotypes through various biological mechanisms"&lt;SEP&gt;"SNPs in this gene showed some association with ovarian cancer risk, though not strong enough for a definitive conclusion."&lt;SEP&gt;"There was no evidence of CRP gene's role in ovarian cancer risk."&lt;SEP&gt;"CRP levels increase with diabetes, indicating metabolic disorders related to dietary patterns."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b&lt;SEP&gt;chunk-372184452f1f9156514992455057f843&lt;SEP&gt;chunk-b6ea16f7f7eb8bc6f36f2be03fe62403&lt;SEP&gt;chunk-fc33d6399ec56e65d007269407f1953d</data>
    </node>
    <node id="&quot;LDL-CHOLESTEROL&quot;">
      <data key="d0">"METABOLIC PATHWAY/</data>
      <data key="d1">Physiological Process"</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;FXR/RXR ACTIVATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Farnesoid X receptor (FXR) and retinoid X receptor (RXR</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;LXR/RXR ACTIVATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Liver X receptor (LXR) and retinoid X receptor (RXR</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;MODY SIGNALING&quot;">
      <data key="d0">"PATHWAY/</data>
      <data key="d1">Physiological Process"</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;CARDIOMETABOLIC SNPS&quot;">
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
      <data key="d1">"The association p-values for 283 cardiometabolic SNPs and serum CRP from a GWAS are evaluated.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 11}, {"level": 1, "cluster": 36}, {"level": 2, "cluster": 59}]</data>
    </node>
    <node id="&quot;SNPS IN CRP GWAS&quot;">
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
      <data key="d1">"The association p-values for 283 cardiometabolic SNPs and serum CRP from a GWAS are evaluated.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 11}, {"level": 1, "cluster": 36}, {"level": 2, "cluster": 59}]</data>
    </node>
    <node id="&quot;CRP GWAS SNPS&quot;">
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
      <data key="d1">"19 SNPs out of the 283 independent cardiometabolic SNPs were associated with CRP after correction for multiple testing.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 11}, {"level": 1, "cluster": 37}]</data>
    </node>
    <node id="&quot;SNPS WITH DIFFERENT EFFECT DIRECTIONS&quot;">
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
      <data key="d1">"Some SNPs showed opposite effects on CRP levels and cardiometabolic phenotypes compared to observations in observational data.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 11}, {"level": 1, "cluster": 37}]</data>
    </node>
    <node id="&quot;GENOMIC LD&quot;">
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
      <data key="d1">"The lead SNPs of the 12 pleiotropic loci were mostly in high linkage disequilibrium (LD) with those found in CRP GWAS.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 11}, {"level": 1, "cluster": 37}]</data>
    </node>
    <node id="&quot;PLEIOTROPIC LOCI&quot;">
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
      <data key="d1">"In some loci the lead SNPs from CRP and cardiometabolic GWAS were different but were in high LD.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SNPS IN CRP GWAS AND CARDIOMETABOLIC GWAS&quot;">
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
      <data key="d1">"In some loci the lead SNPs from CRP and cardiometabolic GWAS were different but were in high LD.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS4420638&quot;">
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
      <data key="d1">"SNP rs4420638 near the APOC1 gene influences T2D risk.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TRIGLYCERIDES&quot;">
      <data key="d2">chunk-7091ed039203b69ad83d281b22c89579&lt;SEP&gt;chunk-372184452f1f9156514992455057f843</data>
      <data key="d1">"Body's breakdown of fats into fatty acids that are used as energy sources or stored as triglycerides."&lt;SEP&gt;"SNP PABPC4 may influence triglyceride levels via its effect on lipid metabolism.")</data>
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d3">[{"level": 0, "cluster": 3}]</data>
    </node>
    <node id="&quot;HDL-CHOLESTEROL&quot;">
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
      <data key="d1">"BCL7B's association with HDL cholesterol could be through its role in lipid metabolism.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 3}]</data>
    </node>
    <node id="&quot;RS4660293&quot;">
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
      <data key="d1">"SNP rs4660293 near PABPC4 gene influences triglyceride levels via its impact on lipid metabolism"&gt;)</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 3}]</data>
    </node>
    <node id="&quot;MEDIATED PLEIOTROPY&quot;/&quot;MEDIATION&quot;">
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
      <data key="d1">"The effect of BCL7B on certain cardiometabolic phenotypes may be mediated through BMI"&gt;)</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 3}]</data>
    </node>
    <node id="&quot;RS1260326&quot;">
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
      <data key="d1">"SNP rs1260326 near GCKR gene affects CRP levels, and its association with CRP is robust even after adjustment for multiple testing"&gt;)</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LIPIDS/">
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
      <data key="d1">mediation"/"Mediation"</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 3}]</data>
    </node>
    <node id="&quot;CRP/">
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
      <data key="d1">mediation"/"Mediation"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PLTP&quot;/&quot;MC4R&quot;">
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
      <data key="d1">mediation"/"Mediation"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;BCL7B&quot;/&quot;FTO&quot;/&quot;TMEM18&quot;">
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
      <data key="d1">mediated pleiotropy"/"Mediation"</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 3}]</data>
    </node>
    <node id="&quot;MIR-34B/C RS4938723&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNPs miR-34b/c rs4938723 were genotyped in patients with IA and controls."</data>
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
    </node>
    <node id="&quot;TP53 ARG72PRO&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNPs TP53 Arg72Pro was also genotyped in the study."</data>
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
    </node>
    <node id="&quot;164 PATIENTS WITH IA&quot;">
      <data key="d0">"PATIENTS"</data>
      <data key="d1">"164 patients with IA were enrolled for genotyping of two SNPs."</data>
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
    </node>
    <node id="&quot;426 CONTROLS&quot;">
      <data key="d0">"CONTROLS"</data>
      <data key="d1">"A total of 426 controls were used for comparison."</data>
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
    </node>
    <node id="&quot;ANEURYSMS&quot;">
      <data key="d0">"NUMBER OF ANEURYSMS"</data>
      <data key="d1">"The number of aneurysms was recorded for cases enrolled."</data>
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
    </node>
    <node id="&quot;MIR-34B/C RS4938723 CC GENOTYPE&quot;">
      <data key="d0">"GENETIC TRAIT"</data>
      <data key="d1">"CC genotype of miR-34b/c rs4938723 showed a decreased risk for IA compared to TT genotype."</data>
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
    </node>
    <node id="&quot;TP53 ARG72PRO GENOTYPES&quot;">
      <data key="d0">"GENETIC TRAIT"</data>
      <data key="d1">"No association was observed between TP53 Arg72Pro genotypes and IA risk."</data>
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
    </node>
    <node id="&quot;COMBINED GENOTYPE OF MIR-34B/C RS4938723 CC AND TP53 ARG72PRO CG/CC/GG&quot;">
      <data key="d0">"GENETIC TRAIT"</data>
      <data key="d1">"The combined genotype reduced the risk for IA when compared to other genotypes."</data>
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
    </node>
    <node id="&quot;INADL&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"rs1056513 (G1178S) is a nonsynonymous SNP in INADL on chromosome 1 that attained near genome-wide significance for weight, BMI, fat-free mass (FFM), fat mass (FM), trunk FM, and hip circumference."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;COL4A1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"rs1056513 is a variant in the COL4A1 gene on chromosome 1 that was associated with weight z-score change."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;MTNR1B&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"An intronic variant in MTNR1B on chromosome 11 was strongly associated with fasting glucose."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;APOA5-ZNF259&quot;">
      <data key="d0">"GENETIC REGION"</data>
      <data key="d1">"Intronic and 3′UTR variants in the APOA5-ZNF259 region on chromosome 11 were associated with triglycerides."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d3">[{"level": 0, "cluster": 3}]</data>
    </node>
    <node id="&quot;PCSK2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"An intronic variant in PCSK2 on chromosome 20 was associated with total antioxidants."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;RNASE1&quot;">
      <data key="d0">"GENETIC REGION"</data>
      <data key="d1">"Variants in the flanking 3′UTR regions of RNASE1 on chromosome 14 were associated with 24-h urinary nitrogen excretion."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;ASS1P11&quot;">
      <data key="d0">"GENETIC REGION"</data>
      <data key="d1">"An intronic variant in ASS1P11 on chromosome 7 was associated with creatinine excretion."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;GCH1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A nonsynonymous SNP (rs3733402; S143T) in GCH1 on chromosome 14 was associated with the 24-h urinary dopamine: creatinine ratio."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;KLKB1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A nonsynonymous SNP (rs3733402; S143T) in KLKB1 on chromosome 4 was identified for serum free IGF-1."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;MPRIP&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"An intronic SNP in MPRIP on chromosome 17 was associated with serum IGFBP-3."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;XPA/FOXE1 (TTF-2)&quot;">
      <data key="d0">"GENETIC REGION"</data>
      <data key="d1">"A block of twenty-three SNPs in the flanking 5′UTR region of XPA/FOXE1 on chromosome 9 were highly associated with serum TSH."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;DARC&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Highly significant associations for a nonsynonymous SNP (rs12075; G42D) and an intronic SNP in DARC on chromosome 1 were identified for MCP-1. Variants in GREB1 on chromosome 2 and DFNB31 on chromosome 9 were also identified for MCP-1."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;CCR3&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A variant in the 3′UTR for CCR3 was highly associated with MCP1, as well as an intronic SNP in RASGEF1A (p=4.6-9.6E-08)."&lt;SEP&gt;"Analysis for associations with ovarian cancer did not suggest any risks linked to genotypes from these SNPs."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b&lt;SEP&gt;chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;ABO&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A variant was identified for IL-6 association in the 3′UTR region of ABO."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d3">[{"level": 0, "cluster": 17}, {"level": 1, "cluster": 55}]</data>
    </node>
    <node id="&quot;TMEM229B&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"An intronic variant in TMEM229B on chromosome 14 was associated with ad libitum energy intake at dinner."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;ARHGAP11A&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"An intronic variant in ARHGAP11A on chromosome 15 was associated with sleep duration."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2&lt;SEP&gt;chunk-46227b557f62c59155b1b9cef71d0d17</data>
    </node>
    <node id="&quot;C21ORF34&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A SNP in the intronic region of C21orf34 was detected for respiratory quotient (RQ) during sleep."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2&lt;SEP&gt;chunk-46227b557f62c59155b1b9cef71d0d17</data>
    </node>
    <node id="&quot;RPL&quot;">
      <data key="d0">"GENE OR GENETIC REGION"</data>
      <data key="d1">"No specific description given for RPL association."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;ABCA1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"rs7289653 (G141C) is a nonsynonymous SNP in ABCA1 on chromosome 10 that was associated with serum cholesterol."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;PPARG&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"An intronic variant in PPARG on chromosome 12 was strongly associated with fasting insulin levels."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;ADRB3&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A nonsynonymous SNP (rs1800541) and an intronic variant were associated with blood pressure."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;LIPC&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"rs7041 is a highly significant SNP for HDL cholesterol and triglycerides on chromosome 3."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;APOE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"SNPs (rs429358, rs7412) in the APOE gene were associated with cognition and Alzheimer's disease risk."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;LIPC-RAPID 1/2&quot;">
      <data key="d0">"GENETIC REGION"</data>
      <data key="d1">"Variants in the LIPC-RAPID region on chromosome 3 influenced HDL cholesterol levels."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;APOA4&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"rs662799 variant is linked to triglycerides and LDL cholesterol."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;FABP7&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A variant (rs6450187) in FABP7 on chromosome 1 was found for body weight."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;FTO-RAPID 2.1&quot;">
      <data key="d0">"GENETIC REGION"</data>
      <data key="d1">"Variants near the FTO-RAPID region on chromosome 1 influenced BMI and waist circumference."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;FADS2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"rs5888 variant is related to omega-6 to omega-3 fatty acid ratio in blood cells."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;KCNQ1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A variant in KCNQ1 on chromosome 18 was found for fasting glucose levels."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;SHOX&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Variants near SHOX on chromosome 4 influence growth and skeletal development."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;GSTM1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Encodes mu-class glutathione S-transferase, responsible for detoxifying electrophilic compounds by conjugation with glutathione."&lt;SEP&gt;"rs3003659 variant is linked to smoking behavior and lung cancer risk."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2&lt;SEP&gt;chunk-382f24e5db6941e2e3db379fe499b223</data>
    </node>
    <node id="&quot;TERT/TOUR&quot;">
      <data key="d0">"GENETIC REGION"</data>
      <data key="d1">"Variants near TERT on chromosome 5 were associated with age-related diseases like frailty."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;CPT1B&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"rs749833 variant is related to fasting triglycerides and insulin resistance."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;CIRBP&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"rs2068533 variant in CIRBP on chromosome 1 was found for BMI."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;SLC19A1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"SNPs (rs1048710, rs2929201) are associated with alcohol consumption and liver disease risk."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;ABO&lt;SUP&gt;*&lt;/SUP&gt;1B&quot;/&quot;F&lt;/SUP&gt;B&quot;*&quot;">
      <data key="d0">"ALLELE OR VARIANT"</data>
      <data key="d1">"The presence of B-allele in the ABO blood group system was found to be related to the risk of coronary artery disease."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;RPL7P3&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"A variant was identified for accelerometer-measured light activity in the 5′UTR region of RPL7P3 on chromosome 9."</data>
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
    </node>
    <node id="&quot;CTCFL&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"Sedentary-light activity was measured in the 3′UTR of CTCFL on chromosome 20."</data>
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
    </node>
    <node id="&quot;MATK&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A variant identified for total energy expenditure (p = 2.7E-08) is located on chromosome 19."&lt;SEP&gt;"Variants identified for total energy expenditure are found in the MATK gene on chromosome 19."</data>
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
    </node>
    <node id="&quot;CHRNA3&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A highly significant variant for sleeping energy expenditure (p = 6.0E-08) was identified on chromosome 15."&lt;SEP&gt;"A variant that affects sleeping energy expenditure is located in the CHRNA3 gene on chromosome 15."</data>
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
    </node>
    <node id="&quot;5′UTR REGION OF RPL7P3&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The 5′UTR region of RPL7P3 is part of the transcript and its variants influence total energy expenditure."</data>
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
    </node>
    <node id="&quot;3′UTR OF CTCFL&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The 3′UTR region of CTCFL is part of the transcript and its variants influence sedentary-light activity during sleep."</data>
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
    </node>
    <node id="&quot;BODY WEIGHT&quot;">
      <data key="d0">"PHYSIOLOGICAL PARAMETER"</data>
      <data key="d1">"Adjusting for body weight was considered when identifying significant variants related to total energy and sleeping energy expenditure."&lt;SEP&gt;"All SENP1-deficient mice had lower body weights after onset of diabetes compared to control mice."&lt;SEP&gt;"HFD significantly increased body weight compared to standard chow in both Ctrl and SENP1-aP2KO mice."</data>
      <data key="d2">chunk-174831b97ed170039b374ba254d4f506&lt;SEP&gt;chunk-a8f2b3b97a70df26efb35263714bf43c&lt;SEP&gt;chunk-46227b557f62c59155b1b9cef71d0d17</data>
    </node>
    <node id="&quot;ACCELEROMETER&quot;">
      <data key="d0">"INSTRUMENT"</data>
      <data key="d1">"An accelerometer was used to measure light activity during sleep, which influenced the identification of certain genetic variants."</data>
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
    </node>
    <node id="&quot;SLEEPING ENERGY EXPENDITURE&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Sleeping energy expenditure is a metabolic pathway that might be influenced by specific genetic and environmental factors."</data>
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
    </node>
    <node id="&quot;TOTAL ENERGY EXPENDITURE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Total energy expenditure represents a physiological process affected by genetics, environment, and lifestyle factors."</data>
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
    </node>
    <node id="&quot;WEIGHT Z-SCORE&quot;">
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d1">"rs1056513 variant is associated with the change in body weight z-score.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TOTAL ANTIOXIDANTS&quot;">
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d1">"An intronic variant of PCSK2 was associated with total antioxidant content.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;EXCRETIONS&quot;">
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d1">"Variants in the flanking 3′UTR regions of RNASE1 and ASS1P11 were related to nitrogen excretion and creatinine excretion.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RNASE1, ASS1P11&quot;">
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d1">"Variants in the flanking 3′UTR regions of RNASE1 and ASS1P11 were related to nitrogen excretion and creatinine excretion.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DOPAMINE: CREATININE RATIO&quot;">
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d1">"A nonsynonymous SNP (S143T) in GCH1 was associated with the dopamine: creatinine ratio.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SERUM FREE IGF-1&quot;">
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d1">"rs3733402 variant is linked to serum free insulin-like growth factor 1 (IGF-1).")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SERUM IGFBP-3&quot;">
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d1">"An intronic SNP in MPRIP correlated with serum IGFBP-3 levels.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SERUM TSH&quot;">
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d1">"A block of SNPs associated with high serum TSH levels was found near the XPA/FOXE1 gene on chromosome 9.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MCP-1&quot;">
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d1">"SNPs in DARC are related to MCP-1 (Monocyte Chemoattractant Protein-1).")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MCP1&quot;">
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d1">"A variant in the 3′UTR region of CCR3 correlated with MCP-1.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL-6&quot;">
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2&lt;SEP&gt;chunk-b971aa450a9b220806bdc000eb5efaad&lt;SEP&gt;chunk-174831b97ed170039b374ba254d4f506&lt;SEP&gt;chunk-8fb20f873daf79a9b7d6e8d25c8889d6&lt;SEP&gt;chunk-35d8a4ea86cb92d18ee1c857a318d2d8&lt;SEP&gt;chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
      <data key="d1">"IL-6 (Interleukin-6) is a proinflammatory cytokine found at high levels in PATs of SENP1-aP2KO mice before the onset of diabetes."&lt;SEP&gt;"IL-6 expression is significantly enhanced in PATs from SENP1-deficient mice."&lt;SEP&gt;"IL-6 is a cytokine that plays crucial roles in inflammation, immune responses, and has been linked to several diseases including colitis."&lt;SEP&gt;"In this context, IL-6 is a key protein that plays an essential role in the development and function of Th17 cells. It's also involved in mediating the severity of colitis."&lt;SEP&gt;"Increased IL-1 and IL-6 from LPMϕs can impact Th17 cell maturation."&lt;SEP&gt;"Lesser elevations in IL-6 (3.4±0.5), IL-23 (2.9±0.3) and other pro-inflammatory cytokines were also identified..."&lt;SEP&gt;"Variants near ABO were significantly related to IL-6 (interleukin-6).")&lt;SEP&gt;"Significantly elevated IL-6 was found in SENP1-deficient mice before onset of diabetes at age 7 weeks."</data>
      <data key="d0">"CYTOKINE"</data>
      <data key="d3">[{"level": 0, "cluster": 17}, {"level": 1, "cluster": 55}]</data>
    </node>
    <node id="&quot;ENERGY INTAKE&quot;">
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d1">"An intronic variant in TMEM229B on chromosome 14 was associated with ad libitum energy intake at dinner.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SLEEP DURATION&quot;">
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2&lt;SEP&gt;chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d1">"Sleep duration affects snoring prevalence, though specific details are not quantified."&lt;SEP&gt;"rs1056513 variant is linked to sleep duration.")</data>
      <data key="d0">"SLEEP PARAMETER"</data>
    </node>
    <node id="&quot;RESPIRATORY QUOTIENT DURING SLEEP&quot;">
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d1">"Intronic variants in C21orf34 were associated with RQ (respiratory quotient) levels during sleep.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RESPIRATORY QUOTIENT (RQ)&quot; DURING SLEEP">
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d1">"A SNP in the intronic region of C21orf34 detected RQ for respiratory quotient (RQ) during sleep.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SNP IN C21ORF34&quot;">
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d1">"A SNP in the intronic region of C21orf34 detected RQ for respiratory quotient (RQ) during sleep.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;VARIANT IN 5′UTR REGION OF RPL7P3&quot;">
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d1">"A variant identified for total energy expenditure was found in the 5′UTR region of RPL7P3.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ACCELEROMETER-MEASURED LIGHT ACTIVITY&quot;">
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d1">"Sedentary-light activity, measured by accelerometer, was detected in the 3′UTR region of CTCFL.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SEDENTARY-LIGHT ACTIVITY IN 3′UTR OF CTCFL&quot;">
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d1">"Sedentary-light activity, measured by accelerometer, was detected in the 3′UTR region of CTCFL.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HIGHLY SIGNIFICANT&quot;">
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d1">"A variant identified with highly significance for total energy expenditure is located on chromosome 19.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;VARIANT ON CHROMOSOME 19 FOR TOTAL ENERGY EXPENDITURE&quot;">
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d1">"A variant identified with highly significance for total energy expenditure is located on chromosome 19.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HIGHLY SIGNIFICANT VARIANT FOR SLEEPING ENERGY EXPENDITURE&quot;">
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d1">"A highly significant variant for sleeping energy expenditure was found on chromosome 15.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ON CHROMOSOME 15&quot;">
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d1">"A highly significant variant for sleeping energy expenditure was found on chromosome 15.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SEDENTARY-LIGHT ACTIVITY DURING SLEEP&quot;">
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d1">"Variants in the 3′UTR of CTCFL impact sedentary-light activity measured by an accelerometer.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MATK GENE ON CHROMOSOME 19&quot;">
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d1">"The variant associated with total energy expenditure is located within the MATK gene on chromosome 19.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CHRNA3 GENE ON CHROMOSOME 15&quot;">
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d1">"A significant variant for sleeping energy expenditure was found in the CHRNA3 gene on chromosome 15.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ADJUSTMENT FOR BODY WEIGHT&quot;">
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d1">"Body weight adjustment is crucial when identifying specific genetic variants related to energy expenditure.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IDENTIFICATION OF GENETIC VARIANTS&quot;">
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d1">"Body weight adjustment is crucial when identifying specific genetic variants related to energy expenditure.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ACCELEROMETER USE&quot;">
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d1">"An accelerometer was used in measuring light activity, influencing the identification of genetic variants for different activities during sleep.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MEASUREMENT OF LIGHT ACTIVITY DURING SLEEP&quot;">
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d1">"An accelerometer was used in measuring light activity, influencing the identification of genetic variants for different activities during sleep.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INFLUENCED BY GENETICS AND ENVIRONMENT&quot;">
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d1">"Sleeping energy expenditure is impacted by both genetic factors and environmental considerations.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;AFFECTED BY GENETICS, ENVIRONMENT, LIFESTYLE&quot;">
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d1">"Total energy expenditure is influenced by genetic makeup, environmental conditions, and lifestyle choices.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;APOBR&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The APOBR gene was screened for mutations in 95 extremely obese children and adolescents."</data>
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
    </node>
    <node id="&quot;RS74949322&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"13 sequence variants were found in the coding region of the APOBR gene."</data>
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
    </node>
    <node id="&quot;RS151233&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Variants rs74949322, rs151233, and others were identified in 95 obese children."</data>
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
    </node>
    <node id="&quot;RS149271&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The variant p.Glu170 was synonymous and had no functional effect."&lt;SEP&gt;"The variant p.Leu22 was synonymous and had no functional effect."</data>
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
    </node>
    <node id="&quot;RS180744&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The variant p.Gln553 was synonymous and had no functional effect."&lt;SEP&gt;"Variants rs180743 and rs180744 were close to deletion variants with potential effects on function."</data>
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
    </node>
    <node id="&quot;RS61738759&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The variant p.Pro1012 was synonymous and had no functional effect."&lt;SEP&gt;"The variant was located in the un-translated region or intronic regions, changing transcription factor binding sites splicing enhancer and silencer binding sites."</data>
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
    </node>
    <node id="&quot;RS40833&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The variant c.*218C&gt;G led to changes in transcription factor binding sites splicing enhancer and silencer binding sites."&lt;SEP&gt;"Variants rs142786317 had no identified functional effects through in silico analysis."</data>
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
    </node>
    <node id="&quot;APOBR DELETION VARIANT&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The APOBR gene deletion variant affects amino acid sequence, specifically p.Thr321_Gly329del9 and p.Gly369_Asp370del9, disrupting glutamate-rich region."</data>
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
    </node>
    <node id="&quot;RS180743&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Non-synonymous variant rs180743: p.Pro428Ala may have a functional impact due to its position and conservation."</data>
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
    </node>
    <node id="&quot;RS368546180&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The deletion variant of rs368546180 leads to an in-frame shortened amino acid sequence with no predicted function, affecting the repeat region of APOBR."</data>
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
    </node>
    <node id="&quot;RS151174&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The variant p.Gly560 was synonymous and had no functional effect."</data>
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
    </node>
    <node id="&quot;RS40831&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The variant p.Ala686 was synonymous and had no functional effect."</data>
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
    </node>
    <node id="&quot;RS142786317: C.*118_*119DELCA&quot;">
      <data key="d0">"S1 TABLE"</data>
      <data key="d1">"Analysis results suggest this genomic variant has a 'non-neutral' functional impact based on SNAP."&lt;SEP&gt;"Association studies have linked this genomic variant to particular phenotypic characteristics, highlighting its potential role in genetic disease or trait manifestation."&lt;SEP&gt;"Both of these variants are non-coding intronic variants found in the TUFM gene."&lt;SEP&gt;"In silico analyses predict functional changes for the SNP, with some being classified as 'non-neutral' or 'deleterious'."&lt;SEP&gt;"In silico predictions across multiple sources conclude that the variant is unrelated to obesity-related phenotypes.")("relationship"&lt;SEP&gt;"In-depth analysis across multiple tables suggests implications for transcription factors or splicing regulation within the TUFM gene based on SNPs."&lt;SEP&gt;"SNP functional predictions include classifications like 'probably damaging'."&lt;SEP&gt;"The GO terms indicate that this variant might influence specific biological functions or pathways based on its genomic context."&lt;SEP&gt;"The LD score analysis shows that this genomic variant contributes to genetic risk factors for diseases or traits based on its co-occurrence with other SNPs."&lt;SEP&gt;"The analysis concludes that these variants may affect transcription factors or splicing elements within TUFM."&lt;SEP&gt;"The genomic variant affects the transcription regulation of this gene according to computational analyses."&lt;SEP&gt;"The genomic variant is located within this gene's sequence."&lt;SEP&gt;"The in silico analysis shows changes to transcription factor binding sites."&lt;SEP&gt;"The infrequent alleles at this variant cause changes of transcription factor binding sites, including splicing enhancer and silencer binding sites."&lt;SEP&gt;"The table offers in-depth insights into the predicted functional effects of SNPs, including 'non-neutral' or 'deleterious' results."&lt;SEP&gt;"The variant is associated with changes in gene expression levels as per eQTL analysis findings."&lt;SEP&gt;"The variant is classified as 'deleterious' by some computational tools, suggesting detrimental effects on function."&lt;SEP&gt;"There are in silico predictions that the variant does not have an association with obesity."&lt;SEP&gt;"This genomic variant is flagged as having clinical significance in the context of medical diagnostics or treatment strategies, based on its potential impact on health outcomes."&lt;SEP&gt;"This genomic variant shows no significant association with obesity based on TDT analysis results."&lt;SEP&gt;"This variant is an unknown genomic variant in the 3' untranslated region of TUFM."&lt;SEP&gt;"This variant was detected in a GWAS study, suggesting its possible relevance to specific health outcomes."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
      <data key="d3">[{"level": 0, "cluster": 1}, {"level": 1, "cluster": 7}]</data>
    </node>
    <node id="&quot;RS61737565&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The genomic variant rs61737565 leads to a change in splicing regulator or transcription factor binding sites."</data>
      <data key="d2">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
    </node>
    <node id="&quot;C.922+29C&gt;G&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The variant c.922+29C&gt;G results in the alteration of splicing regulator or transcription factor binding sites."</data>
      <data key="d2">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
    </node>
    <node id="&quot;TUFM&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"All five variants found in TUFM are predicted to cause changes in splicing regulator or transcription factor binding sites."</data>
      <data key="d2">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
      <data key="d3">[{"level": 0, "cluster": 1}, {"level": 1, "cluster": 7}]</data>
    </node>
    <node id="&quot;RS8061877&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The genomic variant rs8061877 may disrupt a transcription factor binding site, affecting various factors like SRY, HFH 2, and HMG-IY."</data>
      <data key="d2">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
    </node>
    <node id="&quot;G.28854194C/G&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This variant leads to changes in splice enhancer binding sites and splicing silencer sites by three programs, as well as alterations in splice sites despite being located in the non-coding 3’ UTR of TUFM."</data>
      <data key="d2">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
      <data key="d3">[{"level": 0, "cluster": 3}]</data>
    </node>
    <node id="&quot;TFSEARCH&quot;">
      <data key="d0">"IN-SILICO TOOL"</data>
      <data key="d1">"TFSearch is used to predict disruptions in transcription factor binding sites for certain genomic variants."</data>
      <data key="d2">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
    </node>
    <node id="&quot;CONSITE&quot;">
      <data key="d0">"IN-SILICO TOOL"</data>
      <data key="d1">"Consite also predicts disruptions in transcription factor binding sites, but potentially for different factors compared to TFSearch."</data>
      <data key="d2">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
    </node>
    <node id="&quot;MUTATION TASTER&quot;">
      <data key="d0">"IN-SILICO TOOL"</data>
      <data key="d1">"Mutation Taster suggests alterations in splice sites for the variant g.28854194C/G despite its position in the non-coding 3’ UTR of TUFM."</data>
      <data key="d2">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
    </node>
    <node id="&quot;GENEX&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Description of GeneX"&gt;</data>
      <data key="d2">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
    </node>
    <node id="&quot;GENOMIC VARIANTY&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Description of Genomic VariantY"&gt;</data>
      <data key="d2">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
    </node>
    <node id="&quot;TRANSCRIPTZ&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"Description of TranscriptZ"&gt;</data>
      <data key="d2">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
    </node>
    <node id="&quot;PROTEINA&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Description of ProteinA"&gt;</data>
      <data key="d2">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
    </node>
    <node id="&quot;NUTRIENTB&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Description of NutrientB"&gt;</data>
      <data key="d2">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
    </node>
    <node id="&quot;DIETARY PATTERNC&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Description of Dietary PatternC"&gt;</data>
      <data key="d2">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
    </node>
    <node id="&quot;PHYSIOLOGICAL PROCESSD&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Description of Physiological ProcessD"&gt;</data>
      <data key="d2">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
    </node>
    <node id="&quot;METABOLIC PATHWAYE&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Description of Metabolic PathwayE"&gt;</data>
      <data key="d2">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
    </node>
    <node id="&quot;MOLECULAR INTERACTIONF&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Description of Molecular InteractionF"&gt;</data>
      <data key="d2">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
    </node>
    <node id="&quot;ENVIRONMENTAL FACTORG&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Description of Environmental FactorG"&gt;</data>
      <data key="d2">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
    </node>
    <node id="&quot;DISEASEH&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Description of DiseaseH"&gt;</data>
      <data key="d2">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
    </node>
    <node id="&quot;APOBR GENE&quot;">
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
      <data key="d1">"Variants rs74949322, 151233 and others were found in the study sample.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;APOBR GENE DELETION VARIANT&quot;">
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
      <data key="d1">"The deletion variant is located near rs3833080, which is in high LD with this variant.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS3833080&quot;">
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
      <data key="d1">"The deletion variant is located near rs3833080, which is in high LD with this variant.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SULT1A1 GENE&quot;">
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
      <data key="d1">"A synonymous variant was found within the SULT1A1 gene, having no impact on its function.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;S1 TABLE&quot;">
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
      <data key="d1">"All five variants in TUFM are predicted to lead to altered splicing regulator or transcription factor binding sites.")&lt;SEP&gt;"In silico analysis is used to show that this variant changes transcription factor binding sites, including splicing enhancer and silencer binding sites.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 1}, {"level": 1, "cluster": 7}]</data>
    </node>
    <node id="&quot;TABLE 2&quot;">
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
      <data key="d1">"In silico analyses predict functional effects on SNPs, with one being described as 'non-neutral' or 'deleterious' for rs10797300: p.Pro19Leu.")&lt;SEP&gt;"The analyses provide insights into possible functional impacts of SNPs, including 'non-neutral' or 'deleterious' predictions for some.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 1}, {"level": 1, "cluster": 7}]</data>
    </node>
    <node id="&quot;TABLE 3&quot;">
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
      <data key="d1">"In silico predictions show no association between this variant and obesity.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 1}, {"level": 1, "cluster": 7}]</data>
    </node>
    <node id="&quot;RS8061877: C.248−18G&gt;A&quot;">
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
      <data key="d1">"These two variants are non-coding intronic variants within TUFM.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 1}, {"level": 1, "cluster": 7}]</data>
    </node>
    <node id="&quot;TDT&quot;">
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
      <data key="d1">"There is no association found between this variant and obesity in the trios tested using TDT analysis.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 1}, {"level": 1, "cluster": 7}]</data>
    </node>
    <node id="&quot;POLYPHEN 2&quot;">
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
      <data key="d1">"Functional predictions for SNPs are given, including 'probably damaging' for certain polymorphisms.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 1}, {"level": 1, "cluster": 7}]</data>
    </node>
    <node id="&quot;SNAP&quot;">
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
      <data key="d1">"In silico prediction tools like SNAP interpret the variant as having a 'non-neutral' effect.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 1}, {"level": 1, "cluster": 7}]</data>
    </node>
    <node id="&quot;SIFT&quot;">
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
      <data key="d1">"Some in silico tools classify the variant as being 'deleterious', indicating potential harmful effects.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 1}, {"level": 1, "cluster": 7}]</data>
    </node>
    <node id="&quot;TABLE 2 AND S1 TABLE&quot;">
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
      <data key="d1">"There is a consistent pattern across different analytical tools pointing towards potential functional impacts of the variant in TUFM.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 1}, {"level": 1, "cluster": 7}]</data>
    </node>
    <node id="&quot;TABLE 3 AND S1 TABLE&quot;">
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
      <data key="d1">"Across different analytical data sets, predictions indicate lack of association between this variant and obesity traits.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 1}, {"level": 1, "cluster": 7}]</data>
    </node>
    <node id="&quot;GWAS&quot;">
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea&lt;SEP&gt;chunk-9977706363cc368b3be503d07ed3ef62&lt;SEP&gt;chunk-1f20dbdcc9de443dada1a2045dc7832b&lt;SEP&gt;chunk-1b40d071abac0ba432a9fb0096796f45</data>
      <data key="d1">"A Genome-wide association study (GWAS) was conducted to identify genetic variants associated with habitual snoring."&lt;SEP&gt;"A genome-wide association study (GWAS) identified this variant as potentially linked to certain diseases or traits.")&lt;SEP&gt;"A statistical method used to identify genetic variations associated with coffee consumption."&lt;SEP&gt;"The GWAS SNP does not have an effect when regressed out from the trans-eQTL analysis of rs181206 on IRF1 and STAT1."</data>
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d3">[{"level": 0, "cluster": 1}, {"level": 1, "cluster": 8}]</data>
    </node>
    <node id="&quot;LD SCORE&quot;">
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
      <data key="d1">"The linkage disequilibrium (LD) score analysis indicates that this variant has predictive power in genetic associations, based on its correlation with other SNPs.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 1}, {"level": 1, "cluster": 7}]</data>
    </node>
    <node id="&quot;GENE ONTOLOGY (GO) TERMS&quot;">
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
      <data key="d1">"The GO analysis reveals functional roles and biological pathways associated with this variant, providing insights into its potential impact on cellular processes.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 1}, {"level": 1, "cluster": 7}]</data>
    </node>
    <node id="&quot;PHENOTYPE ASSOCIATION STUDIES&quot;">
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
      <data key="d1">"This variant has been associated with various phenotypic traits in association studies, contributing to our understanding of its functional effects.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 1}, {"level": 1, "cluster": 7}]</data>
    </node>
    <node id="&quot;CLINICAL SIGNIFICANCE ASSESSMENT&quot;">
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
      <data key="d1">"An assessment of the clinical significance indicates that this variant could have implications for medical conditions, requiring further investigation into its pathogenicity.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 1}, {"level": 1, "cluster": 7}]</data>
    </node>
    <node id="&quot;GENOMIC VARIANTS&quot;">
      <data key="d2">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
      <data key="d1">"Variants found in TUFM lead to changes in splicing processes related to alterations in transcription factor binding sites.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 2}, {"level": 1, "cluster": 9}]</data>
    </node>
    <node id="&quot;TRANSCRIPTION FACTOR BINDING SITE&quot;">
      <data key="d2">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
      <data key="d1">"Disruption of a potential transcription factor binding site by rs8061877 affects various factors like SRY, HFH 2, and HMG-IY.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SPLICE ENHANCER/SPLICE SILENCER BINDING SITES&quot;">
      <data key="d2">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
      <data key="d1">"Predicted changes in splice enhancer binding sites and splicing silencer sites for this variant by three programs.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 3}]</data>
    </node>
    <node id="&quot;NON-CODING 3’ UTR&quot;">
      <data key="d2">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
      <data key="d1">"The variant g.28854194C/G is situated in the non-coding 3’ UTR of TUFM, but it still affects splicing processes.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 3}]</data>
    </node>
    <node id="&quot;ALOX15&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Analysis of 162 successfully genotyped SNPs in this gene suggested a risk association with ovarian cancer."&lt;SEP&gt;"No significant associations were found at ALOX15 for ovarian cancer."&lt;SEP&gt;"No significant associations were observed at SNPs in ALOX15 for ovarian cancer."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b&lt;SEP&gt;chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
    </node>
    <node id="&quot;ALOX5&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Incorporating both SNPs from this gene into regression modeling did not provide additional insight beyond the initial association found with rs1864414."&lt;SEP&gt;"The ALOX5 gene was found to be associated with lower risk of ovarian cancer with an odds ratio of 0.77."&lt;SEP&gt;"The ALOX5 gene was found to be associated with ovarian cancer risk, with a per-allele p-value of 0.004."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;CCL2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Results on CCL2 did not show a clear association with ovarian cancer."&lt;SEP&gt;"Results on CCL2 were null or inconsistent across study phases."&lt;SEP&gt;"Twenty-one SNPs in this gene were found to have an association with the risk of ovarian cancer at a p&lt;0.10 level."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b&lt;SEP&gt;chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
    </node>
    <node id="&quot;IL18&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"No significant associations for IL18 were found in relation to ovarian cancer risk."&lt;SEP&gt;"No significant associations for IL18 were observed related to ovarian cancer."&lt;SEP&gt;"This gene was one of the 21 SNPs found to have an association with ovarian cancer at p &lt; 0.01 level during analysis."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b&lt;SEP&gt;chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
    </node>
    <node id="&quot;IL1A&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"SNPs in this gene were significantly associated with risk reduction of ovarian cancer, both in discovery and replication analyses."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;NOS3&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"SNPs in this gene were associated with a slightly reduced risk for ovarian cancer, as seen with the rs743507 SNP."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;PTGS1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Analysis of PTGS1 showed an association that was marginally significant (p=0.04) during combined analysis."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;INTERLEUKIN 1, ALPHA (IL1A)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"This protein's SNPs showed a significant inverse association with ovarian cancer risk in specific histological subtypes."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;ARACHIDONATE 5-LIPOXYGENASE (ALOX5)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The ALOX5 gene encodes this enzyme, which was found to be associated with reduced ovarian cancer risk."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;NITRIC OXIDE SYNTHASE 3 (NOS3)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"SNPs in the NOS3 gene were found to have a potential association with lower ovarian cancer risk."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;ALOX12&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"No significant associations were found between genotypes of SNPs in this gene and ovarian cancer risk."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;CCL11&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"SNPs in this gene showed no evidence of association with ovarian cancer risk."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;CXCL16&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Results suggested no significant risk or protective effect of ovarian cancer associated with this gene's SNPs."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;IL10&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Genotyping data did not suggest any strong associations between SNPs in this gene and ovarian cancer risk."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;IL15RA&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"SNPs of this gene were not associated with risk for ovarian cancer, based on the study data."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;IL1RN&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"No associations between genotypes of SNPs in this gene and ovarian cancer risk were found."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;IL4R&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"There was no evidence to suggest that these SNPs confer a risk or protective effect for ovarian cancer."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;PTGS2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"This gene, more commonly known as COX-2, was considered but found to have no significant associations with ovarian cancer risk."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE 1 (PTGS1)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"SNPs from this gene were marginally associated with ovarian cancer risk, though findings were not consistent across study phases."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;IL1B RS7596684&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNP rs7596684 in the IL1B gene suggests an association with ovarian cancer risk."</data>
      <data key="d2">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d3">[{"level": 0, "cluster": 4}, {"level": 1, "cluster": 25}]</data>
    </node>
    <node id="&quot;PTGS1 RS2282169&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNP rs2282169 in the PTGS1 gene suggests an association with ovarian cancer risk."</data>
      <data key="d2">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d3">[{"level": 0, "cluster": 4}, {"level": 1, "cluster": 24}]</data>
    </node>
    <node id="&quot;IL6&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Results on IL6 did not indicate a strong link with ovarian cancer risk."&lt;SEP&gt;"Results on the IL6 gene were inconclusive or showed no association with ovarian cancer."</data>
      <data key="d2">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
    </node>
    <node id="&quot;RS7596684&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNP rs7596684 in IL1B gene was associated with ovarian cancer."</data>
      <data key="d2">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d3">[{"level": 0, "cluster": 4}, {"level": 1, "cluster": 25}]</data>
    </node>
    <node id="&quot;RS2282169&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNP rs2282169 in PTGS1 gene was linked to ovarian cancer risk."</data>
      <data key="d2">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d3">[{"level": 0, "cluster": 4}, {"level": 1, "cluster": 25}]</data>
    </node>
    <node id="&quot;ALOX5 RS1864414&quot;">
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
      <data key="d1">"This intronic SNP was associated with reduced ovarian cancer risk, as part of the ALOX5 gene's function.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 11}, {"level": 1, "cluster": 35}]</data>
    </node>
    <node id="&quot;PHYSIOLOGICAL PROCESS&quot;">
      <data key="d2">chunk-22216738ccbae0a6276bb4499018c434&lt;SEP&gt;chunk-a7d0bfa8b16262a1f313b7e3060969c6&lt;SEP&gt;chunk-f2c864ef2d87119a8129e011b1c42e3c&lt;SEP&gt;chunk-e8f81fdd25a22582c6ce3d1e15f74af3&lt;SEP&gt;chunk-b803830d07bff8ae14550f6458048707&lt;SEP&gt;chunk-72f4505e43f67f3564607392cb178656&lt;SEP&gt;chunk-089bcdf055eb2f007db49dbe2409429b&lt;SEP&gt;chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a&lt;SEP&gt;chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
      <data key="d1">"A physiological process is any process that occurs in living organisms as part of their functioning, such as metabolism, growth, response to stimuli, or reproduction."&lt;SEP&gt;"IL-1R gene's response influences the physiological process affecting both Rag1−/− and IL-10RαMdelRag1−/− diseases."&lt;SEP&gt;"This intronic SNP was associated with reduced ovarian cancer risk, as part of the ALOX5 gene's function.")&lt;SEP&gt;"The impact of lifestyle on physiological processes that are part of the complement pathway's function was evaluated."&lt;SEP&gt;"NA"&lt;SEP&gt;"These are processes that occur within organisms at the cellular or organismal level as part of their normal functioning."&lt;SEP&gt;"Discussion of cellular responses that are pertinent to the biological context."&lt;SEP&gt;"Specific physiological processes related to the context have been omitted."&lt;SEP&gt;"The heritability of FEV1 was comprised entirely of additive genetic variance, indicating the role of this process in lung function."</data>
      <data key="d0">"ADDITIVE GENETIC VARIANCE"</data>
      <data key="d3">[{"level": 0, "cluster": 12}, {"level": 1, "cluster": 41}]</data>
    </node>
    <node id="&quot;IL1A RS17561&quot;">
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
      <data key="d1">"The A114S missense change in this SNP was linked to a reduced risk for certain ovarian cancer subtypes.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 12}, {"level": 1, "cluster": 39}]</data>
    </node>
    <node id="&quot;NOS3 RS743507&quot;">
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
      <data key="d1">"SNPs in this gene showed a slight risk reduction for ovarian cancer, possibly influenced by dietary patterns.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 10}, {"level": 1, "cluster": 31}]</data>
    </node>
    <node id="&quot;METABOLIC PATHWAY&quot;">
      <data key="d2">chunk-22216738ccbae0a6276bb4499018c434&lt;SEP&gt;chunk-a7d0bfa8b16262a1f313b7e3060969c6&lt;SEP&gt;chunk-f2c864ef2d87119a8129e011b1c42e3c&lt;SEP&gt;chunk-e8f81fdd25a22582c6ce3d1e15f74af3&lt;SEP&gt;chunk-b803830d07bff8ae14550f6458048707&lt;SEP&gt;chunk-72f4505e43f67f3564607392cb178656&lt;SEP&gt;chunk-089bcdf055eb2f007db49dbe2409429b&lt;SEP&gt;chunk-734cac289b42d37dad32bd51ea24a1ea&lt;SEP&gt;chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a&lt;SEP&gt;chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
      <data key="d1">"A metabolic pathway consists of a series of chemical reactions that occur within cells and lead to the production of energy and other essential molecules required for life functions."&lt;SEP&gt;"The metabolic pathway involving IL-6 responsiveness is clinically important only in Rag1−/− colitis models, highlighting its role in disease severity."&lt;SEP&gt;"The odds of ovarian cancer were marginally increased when considering this SNP, potentially related to metabolic pathways involved.")&lt;SEP&gt;"The role of metabolic pathways related to complement proteins and lifestyle was studied."&lt;SEP&gt;"NA"&lt;SEP&gt;"A metabolic pathway is a series of biochemical reactions that transform one set of molecules into another through enzymatic action."&lt;SEP&gt;"Caspase metabolic pathway is mentioned in relation to cellular processes."&lt;SEP&gt;"Specific metabolic pathways related to the context have been omitted."&lt;SEP&gt;"No information provided about metabolic pathways related to the associations."&lt;SEP&gt;"The study involved looking into specific metabolic pathways influenced by the genetic variants."</data>
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d3">[{"level": 0, "cluster": 4}, {"level": 1, "cluster": 24}]</data>
    </node>
    <node id="&quot;ALOX5 RS745986&quot;">
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
      <data key="d1">"A correlated SNP in the ALOX5 gene was also found to be associated with ovarian cancer risk, but its impact was less significant than that of rs1864414.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INTRAGENIC SNPS&quot;">
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
      <data key="d1">"A correlated SNP in the ALOX5 gene was also found to be associated with ovarian cancer risk, but its impact was less significant than that of rs1864414.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SNP ASSOCIATION&quot;">
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
      <data key="d1">"This SNP in the IL1B gene showed association with ovarian cancer risk, though it was not as strong as some other findings.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 1}]</data>
    </node>
    <node id="&quot;SNP EFFECT ON RISK&quot;">
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
      <data key="d1">"The odds of developing ovarian cancer were slightly elevated by this SNP, but the effect size was small and inconsistent.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 4}, {"level": 1, "cluster": 24}]</data>
    </node>
    <node id="&quot;OVARIAN CANCER RISK&quot;">
      <data key="d2">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d1">"SNP rs7596684 in the IL1B gene shows a suggestive association with ovarian cancer risk.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 4}, {"level": 1, "cluster": 25}]</data>
    </node>
    <node id="&quot;ALL CASES&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Childhood Acute Lymphoblastic Leukemia cases included in the study."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;TEXAS CHILDREN’S CANCER CENTER&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Study recruitment center from which 118 childhood ALL cases were collected, from 2003 to 2010."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;MTHFD2 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"One of the folate metabolic gene analyzed for tagging SNPs in relation to childhood ALL."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;BHMT2 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Another folate metabolic gene with identified tagging SNPs associated with childhood ALL."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;NOS3 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Folate metabolic gene that included the SNP 'rs3918186', which had a Bayes factor greater than 1 and was linked to an increased risk of childhood ALL."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;SLC19A1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Folate metabolic gene that includes the SNP 'rs1051266', which also showed association with childhood ALL, albeit less evidence compared to NOS3 rs3918186."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;MOLECULAR INTERACTION - NOS3 RS3918186 AND CHILDHOOD ALL RISK&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"SNP 'rs3918186' in the NOS3 gene was associated with childhood ALL risk, having a Bayes Factor of 7.38."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;BAYES FACTOR - SLC19A1 RS1051266 AND CHILDHOOD ALL RISK&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"SNP 'rs1051266' in the SLC19A1 gene showed less evidence for association with childhood ALL, having a Bayes factor of 7.38."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;CHILDHOOD AGE RANGE&quot;">
      <data key="d0">"DISEASE CHARACTERISTIC"</data>
      <data key="d1">"All cases included were under 14 years old when recruited into the study."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;SNPS - INITIAL SCREENING SNPS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Seven tagging SNPs across different folate metabolic genes that showed inclusion in the initial screening based on posterior probability of greater than 0.2."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;SNP BAYES FACTOR - NOS3 RS3918186 AND CHILDHOOD ALL RISK&quot;">
      <data key="d0">"RELATIONSHIP STRENGTH MEASURE"</data>
      <data key="d1">"The Bayes factor for SNP 'rs3918186' in the NOS3 gene was greater than 1, indicating stronger support in data for its association with childhood ALL risk."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;SNP BAYES FACTOR - SLC19A1 RS1051266 AND CHILDHOOD ALL RISK&quot;">
      <data key="d0">"RELATIONSHIP STRENGTH MEASURE"</data>
      <data key="d1">"The Bayes factor for SNP 'rs1051266' in the SLC19A1 gene was slightly less than NOS3 rs3918186, indicating somewhat weaker support for its association with childhood ALL risk."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;OR - CHILDHOOD ALL RISK AND NOS3 RS3918186&quot;">
      <data key="d0">"RELATIONSHIP STRENGTH MEASURE"</data>
      <data key="d1">"The odds ratio (OR) of 2.16 for each copy of the minor allele of SNP 'rs3918186' in the NOS3 gene suggests a nearly twofold increased risk of developing childhood ALL."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;CI - CHILDHOOD ALL RISK AND SLC19A1 RS1051266&quot;">
      <data key="d0">"RELATIONSHIP STRENGTH MEASURE"</data>
      <data key="d1">"The 95% confidence interval (CI) for each copy of the minor allele of SNP 'rs1051266' in the SLC19A1 gene suggests a range with an increased risk but not as strongly as NOS3 rs3918186."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;STUDY PARTICIPATION RATE&quot;">
      <data key="d0">"DISEASE STUDY CHARACTERISTIC"</data>
      <data key="d1">"The participation rate was 85% for all families involved in the study."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;COMPLETE TRIADS PERCENTAGE&quot;">
      <data key="d0">"DISEASE STUDY CHARACTERISTIC"</data>
      <data key="d1">"36% of families were complete triads which are unlikely to bias the results due to previous assessments."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;RACIAL/ETHNIC GROUPS - NON-HISPANIC WHITES&quot;">
      <data key="d0">"DEMOGRAPHIC - RACE/ETHNICITY"</data>
      <data key="d1">"59 out of 118 cases were non-Hispanic whites, a significant portion of the study population."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;RACIAL/ETHNIC GROUPS - HISPANICS&quot;">
      <data key="d0">"DEMOGRAPHIC - RACE/ETHNICITY"</data>
      <data key="d1">"46 out of 118 cases were Hispanic, representing another sizeable subgroup in the study."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;RACIAL/ETHNIC GROUPS - OTHER RACES/ETHNICITIES&quot;">
      <data key="d0">"DEMOGRAPHIC - RACE/ETHNICITY"</data>
      <data key="d1">"7 out of the total cases belonged to other racial or ethnic groups, contributing a smaller percentage to the overall population."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;STUDY SAMPLE SIZE&quot;">
      <data key="d0">"SAMPLE SIZE/POPULATION"</data>
      <data key="d1">"A total of 118 childhood ALL cases from Texas Children’s Cancer Center were included in this study."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;SNP IDENTIFICATION PROCESS - TAGGING SNPS&quot;">
      <data key="d0">"GENOTYPING METHODOLOGY"</data>
      <data key="d1">"Tagging SNPs for folate metabolic genes were used to identify potential genetic variants associated with childhood ALL."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;STUDY PERIOD - 2003-2010&quot;">
      <data key="d0">"TEMPORAL CONTEXT"</data>
      <data key="d1">"The study was conducted from 2003 to 2010 at Texas Children’s Cancer Center."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;PARTICIPATION RATE - 85%&quot;">
      <data key="d0">"STUDY PARTICIPATION RATE"</data>
      <data key="d1">"The participation rate for the study period was 85%, with a total of 118 families involved."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;COMPLETE TRIADS PERCENTAGE - 36%&quot;">
      <data key="d0">"FAMILY COMPOSITION ANALYSIS"</data>
      <data key="d1">"36% of the families were complete triads, which is a subgroup that researchers considered unlikely to introduce bias in their findings."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;RACIAL/ETHNIC DIVERSITY - MULTI-RACIAL POPULATION&quot;">
      <data key="d0">"DEMOGRAPHIC DIVERSITY"</data>
      <data key="d1">"The study population included individuals from various racial/ethnic backgrounds including non-Hispanic whites, non-Hispanic blacks, Hispanics, and other races/ethnicities."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;AGE OF CASES - UNDER 14 YEARS&quot;">
      <data key="d0">"CASE CHARACTERISTIC - AGE RANGE"</data>
      <data key="d1">"All childhood ALL cases in the study were under 14 years old at the time of recruitment."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;FOLATE METABOLIC GENES - MTHFD2, BHMT2, NOS3, SLC19A1&quot;">
      <data key="d0">"GENE FAMILY"</data>
      <data key="d1">"Four folate metabolic genes (MTHFD2, BHMT2, NOS3, and SLC19A1) were analyzed for potential genetic variants associated with childhood ALL."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;SNP ASSOCIATION - NOS3 RS3918186&quot;">
      <data key="d0">"GENETIC VARIANT ASSOCIATION"</data>
      <data key="d1">"The SNP 'rs3918186' in the NOS3 gene was found to have a significant association with an increased risk of developing childhood ALL."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;SNP ASSOCIATION - SLC19A1 RS1051266&quot;">
      <data key="d0">"GENETIC VARIANT ASSOCIATION"</data>
      <data key="d1">"The SNP 'rs1051266' in the SLC19A1 gene showed marginal association with an increased risk of childhood ALL."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;BAYES FACTOR - NOS3 RS3918186 AND CHILDHOOD ALL RISK (B=7.38)&quot;">
      <data key="d0">"STATISTICAL MEASURE FOR ASSOCIATION"</data>
      <data key="d1">"The Bayes factor of 7.38 indicated strong statistical support for the association between 'rs3918186' in the NOS3 gene and an increased risk of childhood ALL."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;CI INTERVAL - CHILDHOOD ALL RISK AND SLC19A1 RS1051266 (OR=2.07; 95% CI: 1.25-3.46)&quot;">
      <data key="d0">"STATISTICAL MEASURE FOR ASSOCIATION"</data>
      <data key="d1">"The odds ratio of 2.07 with a confidence interval from 1.25 to 3.46 indicated an association between the minor allele of 'rs1051266' in the SLC19A1 gene and childhood ALL risk."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;CASE-CONTROL STUDY DESIGN&quot;">
      <data key="d0">"STUDY TYPE"</data>
      <data key="d1">"The study design involved comparing cases with childhood ALL to control subjects without the condition, facilitating the identification of genetic associations."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;TAGGING SNPS IN GENOMIC STUDIES&quot;">
      <data key="d0">"GENETIC RESEARCH TECHNIQUE"</data>
      <data key="d1">"Tagging SNPs are used as genetic markers to represent a group of common variants across specific regions of chromosomes, aiding in association studies like this one on childhood ALL."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;SLC19A1 GENE - ROLE IN FOLATE TRANSPORT&quot;">
      <data key="d0">"BIOLOGICAL FUNCTION"</data>
      <data key="d1">"The SLC19A1 gene is involved in the transport of folate, and its tagging SNP ('rs1051266') showed evidence for a potential association with childhood ALL."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;OR CALCULATION - CHILDHOOD ALL RISK AND NOS3 RS3918186 (OR=2.16)&quot;">
      <data key="d0">"ODDS RATIO INTERPRETATION"</data>
      <data key="d1">"The odds ratio calculation demonstrated that each copy of the minor allele of 'rs3918186' in the NOS3 gene increased the risk of developing childhood ALL by nearly two times."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;CI CALCULATION - CHILDHOOD ALL RISK AND SLC19A1 RS1051266 (95% CI: 1.51-3.15)&quot;">
      <data key="d0">"CONFIDENCE INTERVAL INTERPRETATION"</data>
      <data key="d1">"The confidence interval calculation for the odds ratio provided a range that suggested an increased risk of childhood ALL associated with the minor allele of 'rs1051266' in the SLC19A1 gene."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;STATISTICAL SIGNIFICANCE OF GENETIC VARIANTS IN FOLATE METABOLISM PATHWAY&quot;">
      <data key="d0">"GENETIC RESEARCH OUTCOME"</data>
      <data key="d1">"The study revealed that genetic variants within the folate metabolism pathway could be potential risk factors for childhood ALL, based on statistical measures like Bayes factor and odds ratio."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;ROLE OF RESEARCHERS - STUDY CONDUCTERS&quot;">
      <data key="d0">"SCIENTIFIC COMMUNITY CONTRIBUTION"</data>
      <data key="d1">"Researchers involved in this study utilized genomic techniques to identify genetic associations with childhood ALL, contributing knowledge on the molecular basis of the disease."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;IMPLICATIONS FOR FUTURE RESEARCH - GENE-ENVIRONMENT INTERACTIONS&quot;">
      <data key="d0">"FUTURE INQUIRY FOCUS"</data>
      <data key="d1">"The findings suggest that further research should explore gene-environment interactions to better understand how genetic factors and environmental exposures might jointly influence childhood ALL susceptibility."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;RELATIONSHIP DESCRIPTION&quot;">
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
      <data key="d1">"SNP 'rs3918186' in the NOS3 gene was linked with an increased risk of childhood ALL, as indicated by a Bayes factor greater than 1.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SNP RS3918186 IN NOS3 GENE AND CHILDHOOD ALL RISK&quot;">
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
      <data key="d1">"SNP 'rs3918186' in the NOS3 gene was linked with an increased risk of childhood ALL, as indicated by a Bayes factor greater than 1.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SNP RS1051266 IN SLC19A1 GENE AND CHILDHOOD ALL RISK&quot;">
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
      <data key="d1">"SNP 'rs1051266' in the SLC19A1 gene showed evidence of association with childhood ALL, albeit less strength than NOS3 rs3918186.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HEALTHY EATING&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"A dietary pattern consisting of reduced saturated fats and monounsaturated fats, with increased long chain n-3 PUFA intake."&lt;SEP&gt;"The diet led to an increase in colon AA concentration among subjects with no minor alleles."</data>
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729&lt;SEP&gt;chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;MEDITERRANEAN&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"A diet that decreases in saturated fat and n-6 PUFA while increasing monounsaturated fat and long chain n-3 PUFA consumption."&lt;SEP&gt;"Maintained fairly constant levels of AA concentrations, unlike the Healthy Eating arm."</data>
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729&lt;SEP&gt;chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;SATURATED FAT (SFA)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"A type of dietary fatty acid that is part of a dietary pattern, particularly decreased in the Healthy Eating group."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;MONOUNSATURATED FAT (MUFA)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Another type of dietary fatty acid, specifically increased in both diet groups after intervention."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;LONG CHAIN N-3 PUFA&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"An omega-3 polyunsaturated fatty acid, significantly increased in the Healthy Eating group and in both groups after intervention."&lt;SEP&gt;"Increased significantly (p=0.01) in both Healthy Eating and Mediterranean diets."</data>
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729&lt;SEP&gt;chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;SERUM 18:2 N-6&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A specific fatty acid that shows a decrease when following the Mediterranean diet."&lt;SEP&gt;"Significantly decreased (p=0.02), which may affect the body's nutrient status."</data>
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729&lt;SEP&gt;chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;POLYUNSATURATED FAT: SATURATED FAT RATIO&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"An indicator of dietary balance, increased in both intervention groups but not significantly in the Mediterranean group."&lt;SEP&gt;"The ratio increased from 0.72 to 0.77, indicating changes in fat metabolism."</data>
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729&lt;SEP&gt;chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;SERUM 18:3 N-3&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"An omega-3 fatty acid concentration that increases after following a Mediterranean diet."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;COLONIC AA CONCENTRATION&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"A measure of omega-6 fatty acids in the colon, influenced by FADS gene cluster genotypes."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;BMI (BODY MASS INDEX)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"An indicator for potential health issues; lower BMI was found among carriers with minor alleles at baseline."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;CRP (C-REACTIVE PROTEIN)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"An acute-phase protein that may indicate inflammation or infection; it was not significantly affected by genotypes or diets."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;GENETIC VARIANT&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A genetic variant plays a role in adjusting counseling goals."</data>
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729</data>
    </node>
    <node id="&quot;MUFA&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Increased significantly in the Mediterranean group, contributing to dietary changes."</data>
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729</data>
    </node>
    <node id="&quot;N-3 PUFA&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"A significant increase was observed (p=0.01), impacting fat composition."</data>
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729</data>
    </node>
    <node id="&quot;COLON FATTY ACID CONCENTRATIONS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"There were minimal changes, but long chain n-3 PUFA saw a significant increase."</data>
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729</data>
    </node>
    <node id="&quot;20:4, N-6 (AA) CONCENTRATIONS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Significantly increased for colon AA concentrations in the Mediterranean group (p=0.004)."</data>
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729</data>
    </node>
    <node id="&quot;18:2 N-6&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Significantly decreased in serum (p=0.02), impacting fatty acid profiles."</data>
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729</data>
    </node>
    <node id="&quot;MUFA (MONOUNSATURATED FAT)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Increased significantly only in the Mediterranean group, suggesting diet impacts on fat metabolism."</data>
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729</data>
    </node>
    <node id="&quot;N-3 PUFA (POLYUNSATURATED FATTY ACID)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Significantly increased in both dietary groups (p=0.01), reflecting changes associated with dietary patterns."</data>
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729</data>
    </node>
    <node id="&quot;AA CONCENTRATIONS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Colon AA concentrations showed significant variation between diet types and genetic variant status."</data>
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729</data>
    </node>
    <node id="&quot;HEALTHY EATING DIET ARM&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"The intervention led to changes in colon AA concentration levels among subjects without minor alleles, highlighting diet-specific impacts."</data>
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729</data>
    </node>
    <node id="&quot;MEDITERRANEAN DIET ARM&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Maintained a consistent profile for colon AA concentrations compared to the Healthy Eating arm, indicating differing dietary effects."</data>
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729</data>
    </node>
    <node id="&quot;GENOTYPE GROUP&quot;">
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d1">"The association between genotypes and serum fatty acid levels was significant for omega-6 fatty acids (20:4), with minor allele carriers showing a lower concentration.")&lt;SEP&gt;"The presence of any minor alleles in the FADS gene cluster is significantly associated with a lower serum 20:4, n-6 concentration.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 3}]</data>
    </node>
    <node id="&quot;SERUM 20:4, N-6 CONCENTRATION&quot;">
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d1">"The association between genotypes and serum fatty acid levels was significant for omega-6 fatty acids (20:4), with minor allele carriers showing a lower concentration.")&lt;SEP&gt;"The presence of any minor alleles in the FADS gene cluster is significantly associated with a lower serum 20:4, n-6 concentration.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 3}]</data>
    </node>
    <node id="&quot;SERUM 18:3, N-3 CONCENTRATION&quot;">
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d1">"Mean serum 18:3, n-3 concentration for minor allele carriers were estimated to be 21% higher than those with all major alleles.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 3}]</data>
    </node>
    <node id="&quot;COLONIC 20:4, N-6 CONCENTRATION&quot;">
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d1">"The presence of any minor alleles had a marginally significant association with the colonic 20:4, n-6 concentration (p = 0.07).")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 3}]</data>
    </node>
    <node id="&quot;DIET ARM&quot;">
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d1">"Changes in dietary fat intake significantly impact serum fatty acid composition; reductions and increases were observed in both diet groups after intervention.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SERUM FATTY ACID CONCENTRATIONS&quot;">
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d1">"Changes in dietary fat intake significantly impact serum fatty acid composition; reductions and increases were observed in both diet groups after intervention.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SERUM FATTY ACID CONCENTRATIONS AFTER INTERVENTION&quot;">
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d1">"Both dietary intervention groups showed changes in serum fatty acid levels; the Healthy Eating group reduced SFA intake while increasing long chain n-3 PUFA, leading to a higher polyunsaturated fat: saturated fat ratio.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;COLON FATTY ACID CONCENTRATIONS AFTER INTERVENTION&quot;">
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d1">"The Mediterranean diet resulted in changes towards a healthier fatty acid profile with increased n-3 PUFA and decreased 18:2 n-6 concentration, compared to baseline.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FATTY ACID CONCENTRATIONS AT BASELINE&quot;">
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d1">"The presence of any minor alleles significantly affected the serum fatty acid concentrations (20:4, n-6; 18:3, n-3) and marginally affected colonic 20:4, n-6 concentration.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 3}]</data>
    </node>
    <node id="&quot;SERUM FATTY ACID CHANGES&quot;">
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d1">"The dietary interventions led to significant changes in serum fatty acid concentrations; these changes were particularly notable between the two diet groups.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;COLON FATTY ACID CHANGES&quot;">
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d1">"Both dietary interventions led to changes in colon fatty acid concentrations; the Mediterranean group showed a particular decrease in 18:2 n-6 concentration.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;COLON 18:2 N-6 CONCENTRATION&quot;">
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d1">"The Mediterranean diet resulted in a non-significant change in colon fatty acid composition compared to baseline, specifically with regards to the concentration of 18:2 n-6 fatty acids.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;COLON MUFA CONCENTRATION&quot;">
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d1">"The Healthy Eating diet led to an increase in colon MUFA (monounsaturated fat) concentrations compared to baseline, indicating changes towards a healthier fatty acid profile.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HEALTHY EATING DIET&quot;">
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d1">"The Healthy Eating diet led to an increase in colon MUFA (monounsaturated fat) concentrations compared to baseline, indicating changes towards a healthier fatty acid profile.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;COLON INSULIN CONCENTRATION&quot;">
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d1">"No significant effects of genotypes on colon insulin concentrations were observed, indicating the influence of diet rather than genetics in this aspect.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 3}]</data>
    </node>
    <node id="&quot;SERUM GLUCOSE LEVELS&quot;">
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d1">"Both dietary interventions did not lead to significantly different serum glucose levels compared to baseline or between each other, suggesting that changes were minor or within normal variation.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;COLON POLYUNSATURATED: SATURATED RATIO&quot;">
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d1">"While both diet groups showed changes in colon fatty acid profiles after intervention, there was no significant difference between the Mediterranean and Healthy Eating diets regarding their polyunsaturated to saturated fat ratio.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DIETARY INTERVENTION RESPONSE&quot;">
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d1">"Carriers of minor alleles responded differently to dietary interventions compared to those with all major alleles, in terms of changes in serum fatty acid concentrations.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 3}]</data>
    </node>
    <node id="&quot;SERUM INSULIN LEVELS&quot;">
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d1">"The Mediterranean diet showed a non-significant impact on serum insulin levels after the intervention period compared to baseline and other diets.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;COLON 18:3, N-3 CONCENTRATION&quot;">
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d1">"The Healthy Eating diet led to an increase in colon docosahexaenoic acid (DHA; a type of omega-3 fatty acid, also represented as 20:5, n-3), indicating beneficial effects on DHA levels.")&lt;SEP&gt;"The Healthy Eating diet resulted in an increase in colon eicosapentaenoic acid (EPA; a type of omega-3 fatty acid, also represented as 20:5, n-6), indicating improved EPA levels after the intervention.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SERUM TRIGLYCERIDE LEVELS&quot;">
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d1">"No significant differences in response to genotypes were found for changes in serum triglyceride levels among the dietary intervention groups.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 3}]</data>
    </node>
    <node id="&quot;COLON 20:4, N-6 CONCENTRATION&quot;">
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d1">"After the interventions, no diet group showed a significant effect on colon linoleic acid (20:4, n-6) concentration compared to baseline or each other.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SERUM LDL LEVELS&quot;">
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d1">"The Mediterranean diet led to a decrease in serum low-density lipoprotein (LDL) cholesterol levels after the intervention period, indicating potential cardiovascular benefits from the dietary changes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENETIC VARIANT AND DIET INTERVENTION&quot;">
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729</data>
      <data key="d1">"A significant interaction was found for 20:4, n-6 (AA) in the colon between genotype and diet.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 0}]</data>
    </node>
    <node id="&quot;DIET ARM EFFECT&quot;">
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729</data>
      <data key="d1">"Mean colon AA concentrations were significantly lower in the Mediterranean arm compared to Healthy Eating by month 6.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SUBJECT WITH NO MINOR ALLELES&quot;">
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729</data>
      <data key="d1">"Mean colon AA concentrations were significantly lower in the Mediterranean arm compared to Healthy Eating by month 6.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DIET ARM SPECIFICITY&quot;">
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729</data>
      <data key="d1">"Mean colon AA concentrations at month 6 differed significantly based on diet arm allocation, specifically for subjects without minor alleles.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;OUTCOME DIFFERENCE&quot;">
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729</data>
      <data key="d1">"Mean colon AA concentrations at month 6 differed significantly based on diet arm allocation, specifically for subjects without minor alleles.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;UK BIOBANK&quot;">
      <data key="d0">"DISEASE STUDY"</data>
      <data key="d1">"The UK Biobank is a population-based study consisting of individuals with reported snoring and related factors."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;SNORING&quot;">
      <data key="d0">"SYMPTOM"</data>
      <data key="d1">"Snoring is characterized by the loud or regular breathing sounds made when sleeping."&lt;SEP&gt;"The prevalence of snoring was observed, with a higher rate noted among males compared to females."</data>
      <data key="d2">chunk-a34b927ed42ff0917960122b4d203f83&lt;SEP&gt;chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;PARTNER&quot; OR &quot;HOUSEMATE&quot;">
      <data key="d0">"PARTICIPANT'S RELATION TO REPORT SNORING"</data>
      <data key="d1">"Participants in the sample were identified as snorers based on reports from their partners or housemates about their snoring."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;SLEEP APNOEA&quot;">
      <data key="d0">"RELATED CONDITION"</data>
      <data key="d1">"The prevalence of sleep apnoea is higher in the group identified as snorers."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;SES&quot;">
      <data key="d0">"SOCIAL ECONOMIC STATUS"</data>
      <data key="d1">"A lower social economic status (measured by Townsend deprivation index and average household income) is associated with an increased likelihood of snoring among males only."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;SMOKING FREQUENCY&quot;">
      <data key="d0">"RISK FACTOR"</data>
      <data key="d1">"Smoking frequency is correlated with snoring prevalence, more so in females than in males."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;ALCOHOL CONSUMPTION FREQUENCY&quot;">
      <data key="d0">"RISK FACTOR"</data>
      <data key="d1">"Alcohol consumption frequency shows a correlation with snoring, particularly affecting males and to a lesser extent, females."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;WHOLE-BODY FAT MASS&quot;">
      <data key="d0">"PHYSICAL TRAIT"</data>
      <data key="d1">"Whole-body fat mass is correlated with snoring prevalence."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;H2SNP - SNP HERITABILITY ON THE LIABILITY SCALE&quot;">
      <data key="d0">"STATISTICAL MEASURE"</data>
      <data key="d1">"The overall SNP heritability on the liability scale for snoring is 9.9%, indicating the proportion of variance in snoring that can be attributed to genetic factors."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;RG - GENETIC CORRELATION COEFFICIENT&quot;">
      <data key="d0">"ASSOCIATION MEASURE"</data>
      <data key="d1">"The highest genetic correlation with habitual snoring was found between self-reported sleep apnoea (rG = 0.78), suggesting a strong genetic overlap."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;MINIMUM SPO2 AND PERC90 - TRAITS OF OVERNIGHT OXYHEMOGLOBIN SATURATION&quot;">
      <data key="d0">"SLEEP DISORDERED BREATHING INDICATOR"</data>
      <data key="d1">"Minimum SpO2 and Perc90, which are known proxies for sleep-disordered breathing (SDB) but not average SpO2, showed moderate significant genetic correlations with snoring."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;BMI&quot;, &quot;WHOLE-BODY FAT MASS&quot;, &quot;SODIUM IN URINE&quot;, &quot;MOOD SWINGS&quot;, CORONARY ARTERY DISEASE, ALCOHOL INTAKE FREQUENCY, PULSE RATE, CURRENT TOBACCO SMOKING, HEART DISEASE, LUNG CANCER, FEV1/FVC RATIO, NEUROTICISM, SUBJECTIVE WELLBEING, HEART RATE&quot;">
      <data key="d0">"TRAITS GENETICALLY CORRELATED TO SNORING"</data>
      <data key="d1">"Several traits genetically correlated with snoring include BMI, obesity indicators, sleep apnoea, mood disorders, cardiovascular diseases, lung function, and personality traits related to stress and emotional health."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;SCHIZOPHRENIA&quot;, &quot;EDUCATIONAL ATTAINMENT&quot;, SODIUM IN URINE, DAYTIME DOZING, SLEEP APNOEA, EXCESSIVE DAYTIME SLEEPINESS&quot;">
      <data key="d0">"TRAITS GENETICALLY CORRELATED AFTER BMI ADJUSTMENT"</data>
      <data key="d1">"After adjusting for BMI, snoring remained genetically correlated with psychiatric conditions like schizophrenia and traits related to sleep quality."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;MINIMUM SPO2, AVERAGE SPO2, PERC90 - MEASURES OF NOCTURNAL HYPOXIA&quot;">
      <data key="d0">"SLEEP DISORDERED BREATHING INDICATOR"</data>
      <data key="d1">"Measures of nocturnal hypoxia showed increased genetic correlation with snoring after adjusting for BMI."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;SLEEP FRAGMENTATION&quot;">
      <data key="d0">"SLEEP PARAMETER"</data>
      <data key="d1">"Sleep fragmentation, characterized by frequent awakenings during the night, affects the severity of snoring."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;DLEU7&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A genome-wide significant SNP mapping to the gene DLEU7 has been found in association with snoring."&lt;SEP&gt;"The gene DLEU7 mapping to a genome-wide significant SNP on chromosome 13 is associated with snoring."&lt;SEP&gt;"The gene DLEU7 interacts with rs9316505 in association with number of teeth at one year."</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4&lt;SEP&gt;chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;MSRB3&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"MSRB3 affects the width of the nose and tooth eruption."&lt;SEP&gt;"MSRB3 is another significant gene mapped with a genome-wide significant SNP associated with snoring."&lt;SEP&gt;"The gene MSRB3 mapping to a genome-wide significant SNP on chromosome 12 is associated with snoring."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64&lt;SEP&gt;chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;BCL11B&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"BCL11B, FTO, RNA5SP471 and SND1, NSUN3 have previously been linked to alcohol consumption in relation to snoring."&lt;SEP&gt;"BCL11B, FTO, SMG6, ROBO2, NSUN3, SNAP91 and BCL2 are previously known to be associated with smoking."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;RNA5SP471&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"FTO, SND1 are also associated with coffee consumption in relation to snoring."&lt;SEP&gt;"RNA5SP471's association with narcolepsy might have implications on the understanding of snoring mechanisms."&lt;SEP&gt;"RNA5SP471, having connections with narcolepsy, might have implications for sleep disorders that can be associated with snoring."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;LMO4&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"LMO4 is related to insomnia which could be a contributing factor for snoring."&lt;SEP&gt;"LMO4 is related to insomnia while RNA5SP471 shows association with narcolepsy."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;ROBO2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"ROBO2 was associated with chronotype and traits such as height and heel bone mineral density."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;SNAP91&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Additional exploration of SNAP91's role in respiratory and cardiometabolic health might shed light on its relevance to snoring."&lt;SEP&gt;"Prioritization of SNAP91 highlights its role in smoking, alcohol consumption, and coffee intake's influence on snoring."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;ANAPC4&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"ANAPC4 was identified through positional and eQTL mapping as a gene with implications for snoring and musculoskeletal traits like height and heel bone mineral density."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;SMG6&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"SNPs associated with SMG6 are found to have significant links with snoring, potentially related to respiratory or cardiometabolic conditions."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;SND1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"SND1 was previously linked to both alcohol and coffee consumption's effect on snoring through genome-wide gene-based association analyses."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;NSUN3&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Genomic evidence connects NSUN3 with respiratory traits like sleep apnea and excessive daytime sleepiness, also involved in psychiatric conditions."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;SIM1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"While SIM1 is not associated with snoring through GWAS analysis alone, its connection to musculoskeletal traits might have indirect influences on snoring mechanisms."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;KCNQ5&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The role of KCNQ5 in the genetic predisposition for insomnia could influence sleep patterns and, potentially, snoring frequency."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;CEP120&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Positional mapping suggests CEP120's involvement in traits related to musculoskeletal health which might impact sleep quality and snoring."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;MACF1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Genes like MACF1, prioritized based on their genomic associations with musculoskeletal traits, may indirectly affect snoring through sleep physiology."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;GENETIC CORRELATION&quot;">
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d1">"BMI shows a moderate positive genetic correlation with snoring prevalence.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 4}]</data>
    </node>
    <node id="&quot;SLEEP APNOEA - SELF-REPORTED SLEEP APNOEA&quot;">
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d1">"Self-reported sleep apnoea has the highest genetic correlation with habitual snoring (rG = 0.78).")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 4}]</data>
    </node>
    <node id="&quot;BMI&quot;, &quot;WHOLE-BODY FAT MASS&quot;, SODIUM IN URINE, MOOD SWINGS, CORONARY ARTERY DISEASE, ALCOHOL INTAKE FREQUENCY, PULSE RATE, CURRENT TOBACCO SMOKING, HEART DISEASE, LUNG CANCER, FEV1/FVC RATIO, NEUROTICISM, SUBJECTIVE WELLBEING, HEART RATE - &quot;TRAITS GENETICALLY CORRELATED TO SNORING&quot;">
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d1">"Several traits with the strongest evidence of association were BMI, obesity indicators, sleep apnoea, mood disorders, cardiovascular diseases, lung function, and personality traits related to stress and emotional health.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 4}]</data>
    </node>
    <node id="&quot;SCHIZOPHRENIA&quot;, &quot;EDUCATIONAL ATTAINMENT&quot;, SODIUM IN URINE, DAYTIME DOZING, SLEEP APNOEA, EXCESSIVE DAYTIME SLEEPINESS - &quot;TRAITS GENETICALLY CORRELATED AFTER BMI ADJUSTMENT&quot;">
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d1">"After adjusting for BMI, traits like schizophrenia, educational attainment, and sleep-related conditions remained genetically correlated with snoring.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 4}]</data>
    </node>
    <node id="&quot;VDBP SNPS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Single nucleotide polymorphisms (SNPs) in the VDBP gene were analyzed."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;MATERNAL AND NEONATAL VITAMIN D STATUS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The vitamin D status of mothers and neonates was assessed based on VDBP polymorphisms."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;VITAMIN D STATUS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Vitamin D equilibrium in the maternal-neonate dyads was determined at different vitamin D concentrations (total 25(OH)D)."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;MATERNAL HEIGHT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Maternal height was considered as a factor affecting vitamin D status."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;BMI PRE-PREGNANCY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Pre-pregnancy BMI of mothers influenced the vitamin D equilibrium during delivery."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;BMI TERMINAL&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Final (terminal) BMI of pregnant women affected vitamin D status."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;UVB&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Ultraviolet B (UVB) radiation exposure was considered as an environmental factor in relation to neonatal vitamin D levels."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;WEEKS OF GESTATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The duration of pregnancy impacted the maternal-neonate vitamin D status."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;RS2298850&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The polymorphism rs2298850 of VDBP gene was analyzed."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;RS4588&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Another polymorphism, rs4588 in the VDBP gene, was considered for this analysis."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;MATERNAL VITAMIN D CONCENTRATIONS&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"The level of maternal vitamin D (total 25(OH)D) was measured and compared with different genotypes."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;NEONATAL 25(OH)D CONCENTRATIONS&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Levels of neonatal vitamin D status were quantified based on VDBP polymorphisms."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;MATERNAL 25(OH)D CUT-OFFS AT BIRTH&quot; (≤25 VS. ≥25 NMOL/L)">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Cut-offs for maternal vitamin D levels at birth were established to categorize different genotypes."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;MATERNAL VITAMIN D CUT-OFFS AT BIRTH&quot; (≤50 VS. ≥50 NMOL/L AND ≥75 NMOL/L VS. ≤75 NMOL/L)">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Different thresholds for maternal vitamin D concentrations were set in relation to VDBP genotypes."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;MATERNAL VITAMIN D STATUS AT DELIVERY&quot; (≥75 NMOL/L VS. ≤75 NMOL/L)">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The interaction between VDBP polymorphisms and the delivery time concentration of maternal vitamin D was evaluated."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;MATERNAL VITAMIN D STATUS&quot;">
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
      <data key="d1">"The polymorphisms in VDBP gene were associated with maternal vitamin D concentrations during delivery.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MATERNAL VDBP GENOTYPES&quot;">
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
      <data key="d1">"Neonatal vitamin D levels were associated with maternal VDBP polymorphisms." )</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NEONATAL VITAMIN D STATUS AT BIRTH&quot; (CUT-OFFS OF 25 AND 50 NMOL/L)">
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
      <data key="d1">"Neonatal vitamin D levels were associated with maternal VDBP polymorphisms." )</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MATERNAL VITAMIN D CONCENTRATION&quot;">
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
      <data key="d1">"The genetic variants in VDBP correlated with maternal vitamin D levels during childbirth.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;VDBP POLYMORPHISMS&quot;">
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
      <data key="d1">"The genetic variants in VDBP correlated with maternal vitamin D levels during childbirth.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MATERNAL VDBP POLYMORPHISMS&quot;">
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
      <data key="d1">"The cut-offs for maternal vitamin D were associated with specific genotypes of the VDBP gene.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MATERNAL VITAMIN D CUT-OFFS&quot; (≤25 VS. ≥25 NMOL/L, ≤50 VS. ≥50 NMOL/L AND ≥75 NMOL/L VS. ≤75 NMOL/L)">
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
      <data key="d1">"The cut-offs for maternal vitamin D were associated with specific genotypes of the VDBP gene.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;VDBP GENOTYPES&quot;">
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
      <data key="d1">"The vitamin D status during delivery was linked to various genotypes of the VDBP gene.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NEONATAL VITAMIN D LEVELS&quot; AT BIRTH (CUT-OFFS OF 25 AND 50 NMOL/L)">
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
      <data key="d1">"The neonatal vitamin D levels correlated with the maternal VDBP genotypes at birth.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MATERNAL VITAMIN D CONCENTRATION DURING DELIVERY&quot;">
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
      <data key="d1">"The polymorphisms rs2298850 and rs4588 were associated with maternal vitamin D concentrations during childbirth.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;VDBP SNPS&quot; (RS2298850 AND RS4588)">
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
      <data key="d1">"The polymorphisms rs2298850 and rs4588 were associated with maternal vitamin D concentrations during childbirth.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NEONATAL CUT-OFFS&quot; (≥50 NMOL/L VS. ≤50 NMOL/L, ≥25 VS. ≤25 NMOL/L)">
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
      <data key="d1">"Maternal 25(OH)D Cut-Offs at Birth"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PCOS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The biochemical and clinical characteristics of women with PCOS were presented, showing differences in BMI, free testosterone, bioactive testosterone, FAI, fasting insulin, and HOMA-IR."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;CONTROL SUBJECTS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Women who served as control subjects showed comparable age, menarche, waist-hip ratio, lipid profile, total testosterone, LH, and FSH levels."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;LIPID PROFILE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The lipid profile was measured for both women with PCOS and control subjects."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;TOTAL TESTOSTERONE&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Total testosterone level was determined in women with PCOS."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;LH&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Luteinizing hormone (LH) levels were measured as part of the hormonal profile in both groups."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;FSH&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Follicle-stimulating hormone (FSH) was also included in the hormonal analysis for women with PCOS and controls."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;FREE TESTOSTERONE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Levels of free testosterone were compared in women with PCOS and controls to identify differences."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;BIOACTIVE TESTOSTERONE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Bioactive testosterone levels contributed to understanding hormone dynamics in both groups."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;FAI (FREE ANDROGEN INDEX)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"FAI was used as an indicator of the androgenic status, showing significant differences between PCOS cases and controls."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;HOMA-IR (HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"HOMA-IR was found to be significantly elevated in PCOS cases, indicating insulin resistance."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;SHBG (SEX HORMONE BINDING GLOBULIN)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Lower levels of SHBG were observed among women with PCOS compared to controls."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;TSH (THYROID STIMULATING HORMONE)&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"While within the reference range, higher TSH was noted in women with PCOS, suggesting potential thyroid dysfunction."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;VEGFA (VASCULAR ENDOTHELIAL GROWTH FACTOR A)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Twelve VEGFA Single Nucleotide Polymorphisms (SNPs) were selected for analysis based on their established MAFs exceeding 5% in Caucasians."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;RS3025020 (-583T&gt;C)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This SNP had a higher frequency of the minor allele C in women with PCOS compared to control subjects (P = 9.0 × 10^-4)."&lt;SEP&gt;"This SNP was associated with an increased risk of PCOS (OR: 1.89; CI: 1.09–3.26)."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;RS2010963 (-634C&gt;G)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A SNP that showed a significant difference in genotype distribution between PCOS cases and controls."&lt;SEP&gt;"This SNP showed a protective nature against PCOS with reduced risk (OR: 0.65; CI: 0.44–0.97)."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;VEGF SERUM LEVELS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Mean serum VEGF levels were found to be significantly increased among rs3025020 genotype carriers."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;PCOS FEATURES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Increased fasting insulin, HOMA-IR and bioactive testosterone in rs3025020 carriers. Reduced fasting insulin, free testosterone, and bioactive testosterone in rs2010963 carriers were observed."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;RS3025020&quot;">
      <data key="d0">"RELATIONSHIP"</data>
      <data key="d1">"Carriage of the minor (C) allele was positively associated with hs-CRP."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;RS3025020 AND RS2010963 GENOTYPES&quot;">
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d1">"The minor C allele of rs3025020 is associated with increased PCOS-related metabolic markers compared to the minor C allele of rs2010963.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENOTYPE GROUPS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Participants with different genotypes did not differ on self-report measures."</data>
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
    </node>
    <node id="&quot;RESPONSE BIAS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A main effect of Block emerged for response bias, driven by higher response bias in later blocks compared to earlier blocks."&lt;SEP&gt;"A main effect of Genotype due to higher response bias in val carriers relative to iso homozygotes indicates the potential link between specific genotypes and disease risk."&lt;SEP&gt;"Increased cognitive load during the study led to higher response bias in participants regardless of their genotype."&lt;SEP&gt;"Increased response bias was associated with specific patterns of neural activity detected through brain imaging techniques."&lt;SEP&gt;"Response bias indicates how individuals tend to respond based on past rewards, often linked to certain genetic traits."&lt;SEP&gt;"The cognitive process related to how individuals adapt their responses based on previous experiences and emotions."</data>
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647&lt;SEP&gt;chunk-5e709975097a773fb3d31e265d76a71b</data>
    </node>
    <node id="&quot;VAL CARRIERS&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Identified risk genes for certain diseases were found to influence response bias in participants carrying these variants."&lt;SEP&gt;"Refers to individuals carrying one or two copies of the val allele at a specific gene locus."&lt;SEP&gt;"Val carriers had significantly higher response bias than iso homozygotes."</data>
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647&lt;SEP&gt;chunk-5e709975097a773fb3d31e265d76a71b</data>
    </node>
    <node id="&quot;REINFORCEMENT CONTINGENCIES&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Participants successfully adjusted their behavior based on reinforcement contingencies in the study."&lt;SEP&gt;"Participants' learning rate was affected by their ability to adjust behavior based on different reinforcement contingencies presented during the study."</data>
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
    </node>
    <node id="&quot;CAUCASIAN SUBJECTS&quot;">
      <data key="d0">"POPULATION STRATIFICATION"</data>
      <data key="d1">"The effect of genotypes varied significantly when only Caucasian subjects were considered, highlighting potential ethnic-specific impacts."&lt;SEP&gt;"The main effect of Genotype was confirmed when considering Caucasian subjects only, suggesting that findings were not confounded by population stratification."</data>
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
    </node>
    <node id="&quot;BLOCK 3&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Blocks 3 and 2 showed higher response bias compared to Block 1, suggesting that later blocks may be more influenced by environmental factors."</data>
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
    </node>
    <node id="&quot;STAI SCORES&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"STAI scores were significantly elevated across all conditions, indicating increased anxiety levels among participants."&lt;SEP&gt;"The ANOVA on STAI scores produced main effects of Condition and Time, with higher STAI scores during the stress condition relative to no-stress conditions."</data>
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
    </node>
    <node id="&quot;COHEN'S D&quot;">
      <data key="d0">"EFFECT SIZE MEASURE"</data>
      <data key="d1">"A Cohen's d value exceeding 0.8 was considered indicative of a large effect size in comparing genotype groups."&lt;SEP&gt;"Cohen’s d was used to measure effect sizes for comparing genotypes and other variables."</data>
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
    </node>
    <node id="&quot;CONDITION X TIME INTERACTION&quot;">
      <data key="d0">"INTERACTION EFFECT"</data>
      <data key="d1">"A Condition × Time interaction on STAI scores emerged, indicating that the effect of stress condition changed over time."&lt;SEP&gt;"The condition × time interaction on STAI scores revealed the dynamic effects of stress conditions changing over the course of the study."</data>
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
    </node>
    <node id="&quot;POST-HOC TESTS&quot;">
      <data key="d0">"STATISTICAL TEST"</data>
      <data key="d1">"Post-hoc tests were conducted to determine where differences occurred between specific groups or conditions."</data>
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
    </node>
    <node id="&quot;PANAS NA SCORES&quot;">
      <data key="d0">"AFFECT SCALE"</data>
      <data key="d1">"Participants reported elevated Negative Affect (NA) scores during stress and no-stress conditions, suggesting increased emotional reactivity."&lt;SEP&gt;"Participants with different genotypes showed varying levels of emotional reactivity, as measured by the Positive and Negative Affect Schedule (PANAS) scores."</data>
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
    </node>
    <node id="&quot;NON-SPECIFIC SC RESPONSES&quot;">
      <data key="d0">"STRESS RESPONSE"</data>
      <data key="d1">"Increased non-specific skin conductance responses were observed during both stress conditions and no-stress periods for all genotypes."&lt;SEP&gt;"More responses were observed in the stress condition compared to the no-stress condition for non-specific skin conductance responses."</data>
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
    </node>
    <node id="&quot;SC RESPONDER RATE&quot;">
      <data key="d0">"DISEASE RISK FACTOR"</data>
      <data key="d1">"Val carriers had more skin conductance responses, potentially indicating a different disease risk factor or response mechanism based on genotype."</data>
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
    </node>
    <node id="&quot;NO-STRESS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The no-stress condition was a control situation without any external stressors."</data>
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
    </node>
    <node id="&quot;ISOMORPHES (ISO HOMOZYGOTES)&quot;">
      <data key="d0">"INDIVIDUALS OR GENOTYPES"</data>
      <data key="d1">"Refers to individuals who carry two identical alleles, often used in genetics to describe homozygous genotypes."</data>
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
    </node>
    <node id="&quot;CONDITION&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The stress manipulation condition in the experiment induced elevated anxiety and negative affect."</data>
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
    </node>
    <node id="&quot;PROBABILISTIC REWARD TASK&quot;">
      <data key="d0">"EXPERIMENTAL DESIGN OR PROCEDURE"</data>
      <data key="d1">"A task used in the experiment which requires participants to adapt their responses according to changing probabilities of reward."&gt;</data>
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
    </node>
    <node id="&quot;STRESS CONDITION&quot;">
      <data key="d0">"CONDITION"</data>
      <data key="d1">"The condition where the stress manipulation was applied, leading to different response biases compared to the no-stress condition."</data>
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
    </node>
    <node id="&quot;NO-STRESS CONDITION&quot;">
      <data key="d0">"CONDITION"</data>
      <data key="d1">"A control situation without any external stressors that serves as a reference point for assessing response biases in the presence of stress."&lt;SEP&gt;"An opposite condition that contrasts with stressed conditions by absence of stressors."</data>
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
    </node>
    <node id="&quot;CONDITION X BLOCK X GENOTYPE INTERACTION&quot;">
      <data key="d0">"STATISTICAL INTERACTION"</data>
      <data key="d1">"An interaction observed between condition, block and genotype which indicates how these factors affect response bias differently."</data>
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
    </node>
    <node id="&quot;DISCRIMINABILITY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A measure of how well individuals can distinguish between different levels or categories in a stimulus-response task."</data>
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
    </node>
    <node id="&quot;BLOCK 1, BLOCK 2, AND BLOCK 3&quot;">
      <data key="d0">"EXPERIMENTAL CONDITION OR SEQUENCE OF EVENTS"</data>
      <data key="d1">"Refers to sequential stages or iterations within the experiment's experimental design."</data>
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
    </node>
    <node id="&quot;STRESS INDUCED RESPONSE BIAS REDUCTIONS&quot;">
      <data key="d0">"DISEASE OR DEFICIT"</data>
      <data key="d1">"The phenomenon observed where response bias decreases under stress, a condition being investigated for its implications in genetic traits."</data>
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
    </node>
    <node id="&quot;SHOCK INTENSITY&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Refers to the intensity of electric shock stimuli used during the experiment as one variable among many considered in hierarchical regressions."</data>
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
    </node>
    <node id="&quot;SKIN CONDUCTANCE RESPONSES&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Changes in skin conductance, which can be influenced by stress levels and other factors, were also measured and controlled for."</data>
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
    </node>
    <node id="&quot;CRHR1 SNPS (RS12938031, RS10445364, RS4076452)&quot;">
      <data key="d0">"GENE VARIANT OR GENETIC MARKER"</data>
      <data key="d1">"Circumstances where certain Single Nucleotide Polymorphisms were associated with stress-induced reward learning deficits."</data>
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
    </node>
    <node id="&quot;HIERARCHICAL REGRESSION&quot;">
      <data key="d0">"STATISTICAL METHOD"</data>
      <data key="d1">"A type of regression analysis used in the study to control for potential confounding variables when assessing genetic effects."</data>
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
    </node>
    <node id="&quot;STRESSED CONDITION&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"A condition involving the induction of stress."</data>
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
    </node>
    <node id="&quot;MAIN EFFECT OF BLOCK&quot;">
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
      <data key="d1">"Response bias showed a main effect for block, with higher bias in later blocks compared to earlier blocks during the study.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MAIN EFFECT OF GENOTYPE&quot;">
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
      <data key="d1">"Val carriers exhibited significantly different response bias than iso homozygotes due to their genotype.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ADJUSTMENT OF BEHAVIOR&quot;">
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
      <data key="d1">"Participants adapted behavior based on reinforcement contingencies during the study, demonstrating the influence of external stimuli on behavior adjustment.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;POPULATION STRATIFICATION INTERACTION EFFECT&quot;">
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
      <data key="d1">"Analysis confirmed the main effect of genotype when considering only Caucasian subjects to avoid confounding due to population stratification.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DISEASE RISK&quot;">
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
      <data key="d1">"Increased response bias in val carriers relative to iso homozygotes suggests a potential link between specific genotypes and disease risk.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ENVIRONMENTAL FACTOR INTERACTION&quot;">
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
      <data key="d1">"Later blocks showed higher response bias compared to earlier blocks, indicating that environment or task complexity influenced behavior later in the study.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CONDITION EFFECT&quot;">
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
      <data key="d1">"Main effects of condition and time on STAI scores emerged, with higher scores during stress conditions relative to no-stress conditions.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;EFFECT SIZE COMPARISON&quot;">
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
      <data key="d1">"Cohen’s d was used to compare effect sizes between genotypes or different study variables, providing a measure of practical significance.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;STAI SCORE CHANGE&quot;">
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
      <data key="d1">"A significant interaction on STAI scores over time indicated that the stress condition influenced participants' self-report measures differently at various points during the study.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;AFFECT SCALE RESPONSE&quot;">
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
      <data key="d1">"Increased Negative Affect (NA) scores across conditions suggested heightened emotional responses to both stress and no-stress situations during the experiment.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;STRESS RESPONSE RATE&quot;">
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
      <data key="d1">"More skin conductance responses were observed in response to the stress condition compared to the no-stress condition, suggesting a higher physiological arousal during stress.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NEUROPSYCHOLOGICAL TEST PERFORMANCE INTERACTION EFFECT&quot;">
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
      <data key="d1">"A significant interaction effect was found between genotype groups and neuropsychological test performance, indicating different cognitive profiles across genotypes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NEURAL ACTIVITY CORRELATION&quot;">
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
      <data key="d1">"There was a strong correlation between response bias and neural activity patterns in specific brain regions, as identified through functional MRI analysis.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENETIC RISK TO DISEASE&quot;">
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
      <data key="d1">"The presence of risk variant genes was correlated with enhanced response bias that may indicate heightened disease susceptibility.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ADAPTIVE BEHAVIOR&quot;">
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
      <data key="d1">"Participants' adaptive behavior improved over time in response to reinforcement contingencies, showing plasticity and learning capabilities.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENETIC INFLUENCE SPECIFICITY&quot;">
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
      <data key="d1">"Analysis of specific genetic loci showed that their effects were more pronounced among Caucasian subjects than other ethnicities.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;COGNITIVE LOAD EFFECT&quot;">
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
      <data key="d1">"The increase in response bias was moderated by the level of cognitive load, suggesting a threshold for overload conditions.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ANXIETY MODERATION FACTOR&quot;">
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
      <data key="d1">"Anxiety levels influenced the magnitude of STAI scores, with high anxiety participants showing greater variability in their responses.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SIGNIFICANCE BENCHMARK COMPARISON&quot;">
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
      <data key="d1">"Cohen's d values were used to benchmark differences in mean scores across genotype groups, aiding in distinguishing true effects from random variation.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TEMPORAL ANXIETY CHANGES&quot;">
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
      <data key="d1">"Over time, the impact of stress conditions on STAI scores was more pronounced, indicating increased sensitivity to anxiety over longer periods.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENETIC CONTRIBUTION TO EMOTION&quot;">
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
      <data key="d1">"Differences in PANAS NA scores suggested that certain genotypes may predispose individuals to higher levels of negative affectivity.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CONDITION X GENOTYPE INTERACTION&quot;">
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d1">"Genetic variant (val allele) had an effect on response bias specifically under conditions of stress.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;COHENS D = 1.22, P = .056&quot;">
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d1">"val carriers showed a lower response bias in stress condition compared to no-stress condition.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SHOCK INTENSITY, SKIN CONDUCTANCE RESPONSES&quot;">
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d1">"val carriers showed a lower response bias in stress condition compared to no-stress condition.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS17563&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The genomic variant rs17563 is associated with 'age at first tooth' and is located near the BMP4 gene."</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
    </node>
    <node id="&quot;BMP4&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"BMP4 is related to measures of craniofacial shape and size, showing pleiotropic effects."&lt;SEP&gt;"The gene BMP4 interacts with rs17563 in association with age of onset of tooth development."&lt;SEP&gt;"Variants in the BMP4 gene also contribute significantly to the 'Age at first tooth' SNP associations."</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4&lt;SEP&gt;chunk-c63d60b991cd7442f690dcc364af47dd&lt;SEP&gt;chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;RS10740993&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The genomic variant rs10740993 is associated with 'age at first tooth' and resides near the CACNB2 gene."</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
    </node>
    <node id="&quot;CACNB2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"SNP rs1490384 near CACNB2 links to tooth eruption measures indicating genetic influence."&lt;SEP&gt;"The gene CACNB2 interacts with rs10740993 in association with age of onset of tooth development."</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4&lt;SEP&gt;chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;RS4937076&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The genomic variant rs4937076 is associated with 'age at first tooth' and influences expression of the CDON gene."</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
    </node>
    <node id="&quot;CDON&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The gene CDON interacts with rs4937076 in association with age of onset of tooth development."</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
    </node>
    <node id="&quot;RS1799922&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The genomic variant rs1799922 is associated with 'age at first tooth' and influences expression of the CALU/OPN1SW gene."</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
    </node>
    <node id="&quot;CALU/OPN1SW&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The gene CALU/OPN1SW interacts with rs1799922 in association with age of onset of tooth development."</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
    </node>
    <node id="&quot;RS997154&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNP rs997154 is associated with increased height and prominence of the mid-brow."&lt;SEP&gt;"The genomic variant rs997154 is associated with 'age at first tooth' and influences expression of the AJUBA/C14orf93 gene."</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4&lt;SEP&gt;chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;AJUBA/C14ORF93&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The genes AJUBA and C14orf93 interact with rs997154 in association with age of onset of tooth development."</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
    </node>
    <node id="&quot;RS7924176&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNP rs7924176 affects nose width, and this is related to earlier tooth eruption."&lt;SEP&gt;"SNP rs7924176 predisposes to wider nose widths, which is related to earlier tooth eruption."&lt;SEP&gt;"The genomic variant rs7924176 is associated with 'age at first tooth' and influences expression of the ADK gene."</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4&lt;SEP&gt;chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;ADK&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"ADK's allele predisposes to wider noses which correlates with earlier tooth eruption."&lt;SEP&gt;"The gene ADK interacts with rs7924176 in association with age of onset of tooth development."</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4&lt;SEP&gt;chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;RS412000&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The genomic variant rs412000 is associated with 'age at first tooth' and influences expression of the TEX14/RAD51C gene."</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
    </node>
    <node id="&quot;TEX14/RAD51C&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The genes TEX14 and RAD51C interact with rs412000 in association with age of onset of tooth development."</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
    </node>
    <node id="&quot;RS9316505&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The genomic variant rs9316505 is associated with 'number of teeth' and influences expression of the DLEU7 gene."</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
    </node>
    <node id="&quot;RS17101923&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNP rs17101923 influences face width, which correlates with number of teeth and earlier tooth eruption."&lt;SEP&gt;"The genomic variant rs17101923 was identified as genome-wide significant for 'number of teeth' and is located near the HMGA2 region."</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4&lt;SEP&gt;chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;RS10932688&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The genomic variant rs10932688 was identified as genome-wide significant for 'number of teeth' and is located in the 2q35 region."</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
    </node>
    <node id="&quot;RS6568401&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The genomic variant rs6568401 was identified as suggestive level association for 'number of teeth' and is located in the 6q21 region."</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
    </node>
    <node id="&quot;RS17105278&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Although not meeting genome-wide significance threshold, rs17105278 was still associated with 'number of teeth' at this locus and is located near the RAD51L1 gene."</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
    </node>
    <node id="&quot;RS1956529&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Although not meeting genome-wide significance threshold, rs1956529 was still associated with 'number of teeth' at this locus and influences expression of BMP4 genes."</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
    </node>
    <node id="&quot;KCNJ160&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The gene KCNJ160 might have a role in tooth development based on the presence of independent secondary signals at rs11077486."</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
    </node>
    <node id="&quot;RS2520397&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"At the FAM155E-EDA region, there might be independent secondary signal for 'age at first tooth', which suggests an additional genetic factor that contributes to tooth development."&lt;SEP&gt;"SNP rs2520397 is part of a group of SNPs associated with 'age at first tooth' and other phenotypes related to primary tooth and craniofacial development."</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4&lt;SEP&gt;chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;FAM155E–EDA&quot;">
      <data key="d0">"GENE REGION"</data>
      <data key="d1">"The region encompassing FAM155E and EDA genes might have roles in tooth development based on the presence of independent secondary signals at rs2520397."</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
    </node>
    <node id="&quot;RS1472259&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"At the HMGA2 region, there might be independent secondary signal for 'age at first tooth', which suggests an additional genetic factor that contributes to tooth development."&lt;SEP&gt;"SNP rs1472259 is related to the number of teeth and earlier tooth eruption."</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4&lt;SEP&gt;chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;RS8069452&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"In the IGF2BP1 locus, there might be independent secondary signals influencing 'number of teeth' and tooth development, indicating complex gene interactions.")("entity"&lt;SEP&gt;"SNP rs8069452 shows pleiotropic effects, associated with measures indexing height and prominence of mid-brow."</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4&lt;SEP&gt;chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;RS1061890&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"In the RUNX2 locus, rs1061890 shows a significant association with 'number of teeth' suggesting its role in controlling tooth number."</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
    </node>
    <node id="&quot;RS7365438&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This variant, rs7365438, influences the expression levels of the SLC2A1 gene and correlates with age at first tooth development."</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
    </node>
    <node id="&quot;SNAI1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The gene SNAI1 interacts with this variant rs7905307 which is associated with 'age at first tooth' indicating its role in tooth development processes."</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
    </node>
    <node id="&quot;RS4647821&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This genomic variant shows a strong association with 'number of teeth', suggesting it plays a crucial role in regulating the number of teeth in individuals."</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
    </node>
    <node id="&quot;RS352930&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"It influences tooth development and age at first eruption, making it an important factor for understanding tooth growth dynamics."</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
    </node>
    <node id="&quot;RS17684&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This variant shows a significant association with 'age at first tooth', suggesting its impact on the timing of tooth eruption."</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
    </node>
    <node id="&quot;RS903253&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A variant associated with 'number of teeth' in the 7q11.21 region, highlighting its role in determining tooth count."</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
    </node>
    <node id="&quot;RS4668112&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This variant is associated with 'age at first tooth', indicating its role in controlling the timing of primary tooth eruption."</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
    </node>
    <node id="&quot;RS3750934&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A variant that affects the expression levels of the ESR1 gene, influencing tooth development and age at first eruption."</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
    </node>
    <node id="&quot;RS1951867&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNP rs1951867 is one of the SNPs associated with measures indexing width in the upper region of the face and nose."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;AJUBA&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"AJUBA is associated with height increase, impacting the prominence of the mid-brow and tooth eruption."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;C6ORF173&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"SNP in proximity of C6orf173 is associated with both age at first tooth and number of teeth, reflecting pleiotropic effects."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;RAD51L1&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"SNP rs1570106 in RAD51L1 shows association with tooth eruption measures and height, linking genetic traits."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;LANGO ALLEN ET AL. GIANT CONSORTIUM&quot;">
      <data key="d0">"ORGANISM/GROUP/ENTITY"</data>
      <data key="d1">"A consortium that provides robustly associated height variants for further analysis of genetic influences on tooth eruption."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;NFBC1966&quot;">
      <data key="d0">"STUDY/RESEARCH"</data>
      <data key="d1">"The Northern Finland Birth Cohort 1966, a longitudinal study that contributes data on participants' traits including tooth eruption and height."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;ALSPAC&quot;">
      <data key="d0">"STUDY/RESEARCH"</data>
      <data key="d1">"The Avon Longitudinal Study of Parents and Children, a large-scale birth cohort study providing data on various traits including dental development and height."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;SNPS IN HMGA2 AND BMP4&quot;">
      <data key="d0">"GENETIC INFLUENCE"</data>
      <data key="d1">"These specific SNPs play a significant role in both tooth eruption timing and overall height, indicating key genes involved in these developmental processes."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;SNPS FOR HEIGHT AT 17 YEARS AND HEIGHT AT 31 YEARS&quot;">
      <data key="d0">"TEMPORAL PHENOTYPE MEASURE"</data>
      <data key="d1">"Measures of height taken at different ages (17 and 31 years) used in association studies with genetic factors influencing tooth development."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;AGE AT FIRST TOOTH&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Moderate evidence of association between 'Age at first tooth' and height is observed."</data>
      <data key="d2">chunk-c63d60b991cd7442f690dcc364af47dd</data>
    </node>
    <node id="&quot;NUMBER OF TEETH&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Evidence of association with height appears to be driven by variants in HMGA2 and BMP4."</data>
      <data key="d2">chunk-c63d60b991cd7442f690dcc364af47dd</data>
    </node>
    <node id="&quot;HEIGHT&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The 'Age at first tooth' is associated with height."</data>
      <data key="d2">chunk-c63d60b991cd7442f690dcc364af47dd</data>
    </node>
    <node id="&quot;HEIGHT-ASSOCIATED SNPS&quot;">
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
      <data key="d1">"Several height-associated SNPs show strong evidence of association with tooth eruption in the expected direction (i.e., taller individuals have faster tooth eruption/more teeth).")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TOOTH ERUPTION&quot;">
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
      <data key="d1">"Several height-associated SNPs show strong evidence of association with tooth eruption in the expected direction (i.e., taller individuals have faster tooth eruption/more teeth).")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS1351394&quot;">
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
      <data key="d1">"SNP rs1351394 shows strong evidence of association with both 'Age at first tooth' and 'Number of teeth', linking height with tooth eruption and number.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IGF2BP3&quot;">
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
      <data key="d1">"SNP rs12534093 has a positive effect on faster tooth eruption/more teeth linked to IGF2BP3 association.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS12534093&quot;">
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
      <data key="d1">"SNP rs12534093 has a positive effect on faster tooth eruption/more teeth linked to IGF2BP3 association.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS1490384&quot;">
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
      <data key="d1">"SNP rs1490384 near C6orf173 is associated with 'Age at first tooth' and 'Number of teeth', linking height to earlier tooth eruption.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS1570106&quot;">
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
      <data key="d1">"SNP rs1570106 in RAD51L1 shows association with both 'Age at first tooth' and 'Number of teeth', indicating link between height and tooth eruption.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENOME-WIDE SIGNIFICANT SNPS FOR AGE AT FIRST TOOTH AND NUMBER OF TEETH&quot;">
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
      <data key="d1">"The allelic scores for 'Age at first tooth' and 'Number of teeth', derived from genome-wide significant SNPs, show moderate evidence of association with height.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HEIGHT AT 17 YEARS AND HEIGHT AT 31 YEARS&quot;">
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
      <data key="d1">"The allelic scores for 'Age at first tooth' and 'Number of teeth', derived from genome-wide significant SNPs, show moderate evidence of association with height.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ASSOCIATION WITH HEIGHT&quot;">
      <data key="d2">chunk-c63d60b991cd7442f690dcc364af47dd</data>
      <data key="d1">"SNPs associated with 'Age at first tooth' show moderate evidence of association with height.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SNPS FOR AGE AT FIRST TOOTH&quot;">
      <data key="d2">chunk-c63d60b991cd7442f690dcc364af47dd</data>
      <data key="d1">"SNPs associated with 'Age at first tooth' show moderate evidence of association with height.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CONTRIBUTION TO AGE AT FIRST TOOTH SNP ASSOCIATIONS&quot;">
      <data key="d2">chunk-c63d60b991cd7442f690dcc364af47dd</data>
      <data key="d1">"Variants in the HMGA2 and BMP4 genes contribute significantly to associations between 'Age at first tooth' SNPs and height.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PATHWAY ANALYSIS&quot;">
      <data key="d2">chunk-c63d60b991cd7442f690dcc364af47dd</data>
      <data key="d1">"This threshold provides the most significant over-representation of genes in pathways for 'age at first tooth' GWAS.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SNP ASSOCIATION P-VALUE THRESHOLD OF 0.005&quot;">
      <data key="d2">chunk-c63d60b991cd7442f690dcc364af47dd</data>
      <data key="d1">"This threshold provides the most significant over-representation of genes in pathways for 'age at first tooth' GWAS.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL-10RΑTDEL&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"IL-10Rα deletion restricted to T cells (IL-10RαTdel) does not impact disease severity in this model of colitis."&lt;SEP&gt;"IL-10RαTdel mice produce selective deletion of the IL-10 receptor α restricted to T cells."&lt;SEP&gt;"IL-10RαTdel mice show a genomic variant restricted to T cells with selective deletion of the IL-10 receptor α."&lt;SEP&gt;"The deletion of IL-10 receptor α restricted to T cells (IL-10RαTdel) affects the transcripts in T cells, impacting their role in disease development."&lt;SEP&gt;"The interaction between IL-10 and its receptor α in T cells (IL-10RαTdel) leads to disease development."</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;IL-10RΑDCDEL&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Deletion of IL-10 receptor α specifically in DCs (IL-10RαDCdel) does not affect disease quality or magnitude."&lt;SEP&gt;"Deletion of IL-10 receptor α specifically in DCs (IL-10RαDCdel) influences the transcripts within DCs, potentially altering disease manifestation."&lt;SEP&gt;"IL-10 receptor α deletion restricted to DCs (IL-10RαDCdel) affects disease magnitude and quality."&lt;SEP&gt;"IL-10RαDCdel mice generate lineage-specific knockout of IL-10 receptor α in DCs."&lt;SEP&gt;"IL-10RαDCdel mice have a genomic variant that results in lineage-specific knockout of IL-10 receptor α in DCs."</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;IL-10RΑMDEL&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant in IL-10RαMdel modulates disease severity in Rag1−/− and IL-10RαMdelRag1−/− colitis models."&lt;SEP&gt;"IL-10RαMdel mice exhibit a genomic variant leading to selective deletion of IL-10 receptor α restricted to macrophages."&lt;SEP&gt;"IL-10RαMdel mice produce lineage-specific deletion of the IL-10 receptor α restricted to macrophages."&lt;SEP&gt;"Selective deletion of IL-10 receptor α in macrophages (IL-10RαMdel) impacts colitis development."&lt;SEP&gt;"Selective deletion of IL-10 receptor α restricted to macrophages (IL-10RαMdel) impacts transcripts in macrophages, contributing to the intensification of colitis development."&lt;SEP&gt;"Selective deletion of the IL-10 receptor α restricted to macrophages (IL-10RαMdel) intensifies colitis development."</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51&lt;SEP&gt;chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
    </node>
    <node id="&quot;WT&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Wild-type (WT) refers to non-modified or standard conditions in comparison to mutants."</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;RAG1−/−&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Rag1−/− mice have mutations that lack Rag-1, a lymphocyte-specific receptor gene."</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;NAIVE CD4+CD25−CD45RBHI T CELLS&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"Naive CD4+CD25−CD45RBhi T cell transcripts are influenced by lineage-specific IL-10 interactions in models of colitis."&lt;SEP&gt;"Naive CD4+CD25−CD45RBhi T cells refer to specific subsets of the immune system's T-cell population."</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;TH1, TH17, FOXP3+ T CELL SUBSETS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Th1, Th17, and FoxP3+ T cell subsets are involved in the lineage-specific effects of IL-10 on colitis development."&lt;SEP&gt;"The transcripts of specific subsets of T cells are involved in lineage-specific interactions with IL-10 in models of colitis."</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;RAG1−/− RECIPIENTS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Rag1−/− recipients are the experimental subjects in which Rag1 mutations lead to no Rag-1, impacting T cell responses."</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;IL-10 SIGNALING INTO TRANSFERRED T CELLS&quot;">
      <data key="d0">"RELATIONSHIP WITH DISEASE DEVELOPMENT"</data>
      <data key="d1">"The lack of IL-10 signaling into transferred T cells does not impact disease severity in this model of T cell transfer colitis."</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;DC AND T CELL IL-10 SIGNALING&quot;">
      <data key="d0">"RELATIONSHIP WITH DISEASE DEVELOPMENT"</data>
      <data key="d1">"Comparison between DC and T cell-specific IL-10 signaling reveals differential effects on disease quality and magnitude."</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;IL-10RΑMDELRAG1−/− MICE&quot;">
      <data key="d0">"DISEASE MODEL"</data>
      <data key="d1">"Here too, no differences in population sizes were seen (Fig. 3d). To determine if T cell IL-10 production was itself functionally dispensable for the differential colitis..."&lt;SEP&gt;"IL-10RαMdelRag1−/− mice represent a model of colitis development when IL-10 receptor α is selectively deleted in macrophages."</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51&lt;SEP&gt;chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
    </node>
    <node id="&quot;CX3CR1-DRIVEN CRE&quot;">
      <data key="d0">"GENETIC MARKER"</data>
      <data key="d1">"The CX3CR1-driven Cre system expresses Cre recombinase under the control of a CX3CR1 promoter, affecting gene disruption specifically within granulocytes and macrophages."</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;LPMΦS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A particularly prominent elevation in IL-1β production was apparent..."&lt;SEP&gt;"LPM (Lung Pulmonary Macrophages) cells interact with IL-1β to influence inflammation, specifically Th17 cell development during colitis."&lt;SEP&gt;"LPMϕs are lineage-specific cells that express the Cre transgene for IL-10Rα deletion."&lt;SEP&gt;"LPMϕs, derived from diseased IL-10RαMdelRag1−/− mice or control Rag1−/− mice, were used in co-culture with naïve T cells."&lt;SEP&gt;"Lamina propria macrophages (LPMϕs) were significantly increased and activated in IL-10RαMdelRag1−/− mice with colitis, as compared to Rag1−/− controls."</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51&lt;SEP&gt;chunk-b971aa450a9b220806bdc000eb5efaad&lt;SEP&gt;chunk-f2c864ef2d87119a8129e011b1c42e3c&lt;SEP&gt;chunk-8fb20f873daf79a9b7d6e8d25c8889d6&lt;SEP&gt;chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
    </node>
    <node id="&quot;SPONTANEOUS COLITIS&quot;">
      <data key="d0">"PATHOLOGICAL CONDITION"</data>
      <data key="d1">"Spontaneous development of colitis without external stimulation or intervention."</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;IL-10 RECEPTOR Α DELETION IN MACROPHAGES (IL-10RΑMDEL) AND SPONTANEOUS COLITIS&quot;">
      <data key="d0">"RELATIONSHIP WITH PATHOLOGICAL CONDITIONS"</data>
      <data key="d1">"Selective deletion of IL-10 receptor α restricted to macrophages leads to spontaneous colitis development during specific aging periods."</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;NEUTROPHIL DEPLETION WITH ANTI-LY6G ANTIBODIES&quot;">
      <data key="d0">"THERAPEUTIC INTERVENTION"</data>
      <data key="d1">"Depletion of neutrophils using specific antibodies aimed at Ly6G markers as a method for experimental control or intervention in disease models."</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;CLINICAL DISEASE AND HISTOPATHOLOGY IN IL-10RΑMDELRAG1−/− MICE VS. RAG1−/− CONTROLS&quot;">
      <data key="d0">"COMPARISON WITH CONTROL CONDITIONS"</data>
      <data key="d1">"Comparative analysis of clinical disease manifestation and histological pathology between IL-10RαMdelRag1−/− mice and Rag1−/− controls to understand the role of Mϕ-specific IL-10 receptor α deletion."</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;IL-10-MEDIATED IMMUNOPROTECTION&quot;">
      <data key="d0">"PROTECTIVE MECHANISM"</data>
      <data key="d1">"The protective effects of IL-10 against disease, as mediated by its interactions with specific immune cell types (e.g., macrophages and DCs), contribute to the overall immunoregulatory processes."</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;MΦ-SPECIFIC EFFECT OF IL-10 PROTECTION&quot;">
      <data key="d0">"CONTRIBUTING FACTOR FOR PROTECTIVE MECHANISM"</data>
      <data key="d1">"The Mφ-specific responsiveness to IL-10 plays a critical role in its ability to protect against disease, accounting for much of its protective effects.")("entity"</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;MYD88&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Myeloid differentiation primary response gene 88 (MyD88), an adaptor protein that plays a critical role in innate immune responses and downstream signaling of many pattern recognition receptors including Toll-like receptors (TLRs)."</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;TOLL-LIKE RECEPTORS (TLR)">
      <data key="d0">"PROTEIN FAMILY"</data>
      <data key="d1">"A family of transmembrane proteins, the Toll-like receptors (TLRs), which recognize pathogen-associated molecular patterns (PAMPs) and initiate an immune response."</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;CYTOKINE SIGNALING&quot;">
      <data key="d0">"BIOLOGICAL PROCESS"</data>
      <data key="d1">"The process by which cytokines transmit signals from cell to cell, influencing the activity of immune cells and modulating various biological responses."</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;ANTIGEN-PRESENTING CELLS (APCS)">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"Cells that process antigens and present them on their surface for recognition by T cells during an immune response."</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;B CELLS&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"Lymphocytes responsible for antibody production, playing a critical role in the adaptive immune system."&lt;SEP&gt;"There was no signal detected in B cell data as re-analyzed from Fairfax et al."&lt;SEP&gt;"The count of B cells is within the normal range with elevated levels of serum IgG, IgA, and IgM throughout development. However, serum IgE remains consistently elevated due to chronic eczema and reactive airway disease."</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51&lt;SEP&gt;chunk-e323b0d4f82733a78f687e51f47b500a&lt;SEP&gt;chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;T HELPER 1 (TH1) CELLS&quot;">
      <data key="d0">"SUBTYPE OF T CELLS"</data>
      <data key="d1">"A subtype of T-helper cells that are involved in cell-mediated immunity and play roles in activating other immune responses."&gt;</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;IL-10RΑMDELRAG1−/−&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Increased numbers of activated IL-10RαMdelRag1−/− lamina propria macrophages were identified in mice with colitis compared to Rag1−/− controls."</data>
      <data key="d2">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
    </node>
    <node id="&quot;CD64+ &quot;">
      <data key="d0">"SURFACE MARKER"</data>
      <data key="d1">"The LPMϕs displayed uniform expression of CD64, indicating activation and differentiation into a pro-inflammatory phenotype."</data>
      <data key="d2">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
    </node>
    <node id="&quot;T CELLS&quot;">
      <data key="d0">"CELL"</data>
      <data key="d1">"A mixed population of T cells, responsible for either psoriasiform or eczematous reactions."&lt;SEP&gt;"IL-10 production by transferred T cells did not influence disease magnitude clinically or histologically (Fig. 3e, f). Therefore, the Mϕ IL-10 response does not identifiably impact regulatory T cell presence."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a&lt;SEP&gt;chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
    </node>
    <node id="&quot;TH17 CELLS&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"Significantly increased percents and absolute numbers of CD4+IL-17A+ T cells were identified..."</data>
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d3">[{"level": 0, "cluster": 16}]</data>
    </node>
    <node id="&quot;CD4+IL-17A+ T CELLS&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Increased colonic infiltration by both Th1 and Th17 cells, and the Th17 response is required for disease development."</data>
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
    </node>
    <node id="&quot;TH17-PROMOTING CYTOKINES&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"The elevated production of Th17-promoting cytokines was specific to the Mφ population, indicating that Mφs are the primary source for the increased Th17-associated cytokines."&lt;SEP&gt;"The elevated production of Th17-promoting cytokines was specific to the Mϕ population, indicating that Mϕs are the primary source for the increased Th17-associated cytokines."</data>
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
    </node>
    <node id="&quot;MΦ (MACROPHAGES)&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Elevated expression was specific to the Mφs, indicating that Mφs are the primary source for the increased Th17-associated cytokines and implying that IL-10 acts directly on these cells to suppress their production."&lt;SEP&gt;"Macrophages are part of the innate immune system that can respond to various stimuli, including cytokines like IL-6 or IL-10; they're pivotal in understanding autoimmune inflammation and pathogenesis."</data>
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6&lt;SEP&gt;chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
      <data key="d3">[{"level": 0, "cluster": 17}, {"level": 1, "cluster": 57}]</data>
    </node>
    <node id="&quot;IL-1Β&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A particularly prominent elevation in IL-1β production was apparent..."&lt;SEP&gt;"Interleukin 1 beta (IL-1β) is a pro-inflammatory cytokine that has essential functions in the steady-state development of intestinal Th17 cells and potentially contributes to the pathogenesis of colitis."&lt;SEP&gt;"Treatment with IL-10 led to the complete suppression of IL-1β maturation."&lt;SEP&gt;"Interleukin-1 Beta (IL-1β) is expressed at high levels in PATs from SENP1-aP2KO mice under normal chow and HFD conditions."&lt;SEP&gt;"The study also included examination of SNPs in the IL-1β gene as they relate to CRC risk."</data>
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad&lt;SEP&gt;chunk-174831b97ed170039b374ba254d4f506&lt;SEP&gt;chunk-8fb20f873daf79a9b7d6e8d25c8889d6&lt;SEP&gt;chunk-35d8a4ea86cb92d18ee1c857a318d2d8&lt;SEP&gt;chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d3">[{"level": 0, "cluster": 17}, {"level": 1, "cluster": 56}]</data>
    </node>
    <node id="&quot;RAG1−/− MICE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Here too, no differences in population sizes were seen (Fig. 3d). To determine if T cell IL-10 production was itself functionally dispensable for the differential colitis..."</data>
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
    </node>
    <node id="&quot;TRANSFERRED T CELLS&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"IL-10 production by transferred T cells did not influence disease magnitude clinically or histologically (Fig. 3e, f). Therefore, the Mϕ IL-10 response does not identifiably impact regulatory T cell presence."</data>
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
    </node>
    <node id="&quot;IL-23P19&quot;">
      <data key="d0">"INOS"</data>
      <data key="d1">"For IL-1β, IL-6, IL-23p19, and iNOS, relative expression was compared in sorted colonic LPMφs, DCs, neutrophils, and epithelial cells."</data>
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
    </node>
    <node id="&quot;RORΓT−/− T CELLS&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"RORγT, and hence Th17 cells, proved essential for colitis in both recipient types."</data>
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
    </node>
    <node id="&quot;TH17 CELL&quot;">
      <data key="d0">"CELL"</data>
      <data key="d1">"IL-10 can act on LPMφs to directly impair their support for Th17 production through downregulation of IL-1 and to a lesser extent IL-6."&lt;SEP&gt;"Th17 cells are critical for colitis development and disease progression, depending on IL-6Rα signaling."</data>
      <data key="d2">chunk-35d8a4ea86cb92d18ee1c857a318d2d8&lt;SEP&gt;chunk-b971aa450a9b220806bdc000eb5efaad</data>
      <data key="d3">[{"level": 0, "cluster": 17}, {"level": 1, "cluster": 58}]</data>
    </node>
    <node id="&quot;IL-6RΑ&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"IL-6 Receptor Alpha (IL-6Rα) is the receptor that binds to IL-6 protein. Its role in T cell responses was assessed in this context."&lt;SEP&gt;"IL-6Rα gene plays a role in disease protection when T cell transfers are performed."</data>
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c&lt;SEP&gt;chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
      <data key="d3">[{"level": 0, "cluster": 17}, {"level": 1, "cluster": 58}]</data>
    </node>
    <node id="&quot;TH1 CELL&quot;">
      <data key="d0">"CELL"</data>
      <data key="d1">"Th1 cells are another type of immune response cells that were analyzed alongside Th17 cells for their role in colitis development."</data>
      <data key="d2">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
      <data key="d3">[{"level": 0, "cluster": 17}, {"level": 1, "cluster": 57}]</data>
    </node>
    <node id="&quot;FOXP3+ CD4+ T CELLS&quot;">
      <data key="d0">"CELL"</data>
      <data key="d1">"Regulatory T cells characterized by FoxP3 expression play a role in balancing immune responses; they're relevant to the study of autoimmune diseases and inflammation."</data>
      <data key="d2">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
    </node>
    <node id="&quot;IL-1R−/− T CELLS&quot;">
      <data key="d0">"CELL"</data>
      <data key="d1">"T cells lacking IL-1 receptor (IL-1R) were used as a test for their impact on disease induction in the context of colitis."</data>
      <data key="d2">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
    </node>
    <node id="&quot;IL-10&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"After treatment with IL-10, pro-IL-β was diminished and mature IL-1β undetectable in Rag1−/− cultures."&lt;SEP&gt;"IL-10 is a nutrient in the form of a dietary pattern that inhibits pro-IL-1β production and modulates disease."&lt;SEP&gt;"Interleukin 10 (IL-10) plays important roles in modulating immune responses, such as dampening inflammation and promoting Mφ responses to IL-10, which may affect disease development."&lt;SEP&gt;"Pre-treatment with IL-10 abrogated the induction caused by LPS and ATP stimulation in Rag1−/− Mϕs."</data>
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c&lt;SEP&gt;chunk-35d8a4ea86cb92d18ee1c857a318d2d8&lt;SEP&gt;chunk-b971aa450a9b220806bdc000eb5efaad</data>
      <data key="d3">[{"level": 0, "cluster": 17}, {"level": 1, "cluster": 57}]</data>
    </node>
    <node id="&quot;COLITIS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Inflammatory bowel disease characterized by chronic inflammation of the colon; it was studied for its dependence on certain immune system components like Th17 cells and IL-6."</data>
      <data key="d2">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
    </node>
    <node id="&quot;AUTOIMMUNE DISEASE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Conditions that occur when the body's immune system mistakenly attacks healthy tissue, which could involve Mφ responses or other immunological responses."</data>
      <data key="d2">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
    </node>
    <node id="&quot;TH17 RESPONSE&quot;">
      <data key="d0">"RESPONSE"</data>
      <data key="d1">"Th17 response refers to the activation of Th17 cells, which are essential in autoimmune disorders and inflammatory conditions like colitis."</data>
      <data key="d2">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
    </node>
    <node id="&quot;AUTOIMMUNITY&quot;">
      <data key="d0">"STATE"</data>
      <data key="d1">"The condition where the immune system mistakenly attacks healthy tissue, leading to various diseases including colitis."</data>
      <data key="d2">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
      <data key="d3">[{"level": 0, "cluster": 17}, {"level": 1, "cluster": 55}]</data>
    </node>
    <node id="&quot;MACROPHAGE (MΦ)&quot;">
      <data key="d0">"CELL"</data>
      <data key="d1">"Macrophages are key components of innate immunity and play vital roles in inflammation and tissue repair processes."</data>
      <data key="d2">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
      <data key="d3">[{"level": 0, "cluster": 17}, {"level": 1, "cluster": 58}]</data>
    </node>
    <node id="&quot;REGULATORY T CELLS&quot;">
      <data key="d0">"T CELL TYPE"</data>
      <data key="d1">"Regulatory T cells, characterized by their FoxP3 expression, control immune responses and maintain immune tolerance to prevent autoimmunity."</data>
      <data key="d2">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
      <data key="d3">[{"level": 0, "cluster": 17}, {"level": 1, "cluster": 57}]</data>
    </node>
    <node id="&quot;INNATE IMMUNE SYSTEM&quot;">
      <data key="d0">"SYSTEM"</data>
      <data key="d1">"The part of the immune system that provides immediate defense against pathogens and damage, including macrophages and neutrophils."</data>
      <data key="d2">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
      <data key="d3">[{"level": 0, "cluster": 17}, {"level": 1, "cluster": 56}]</data>
    </node>
    <node id="&quot;ANTIGEN PRESENTATION&quot;">
      <data key="d0">"BIOLOGICAL PROCESS"</data>
      <data key="d1">"Macrophages and dendritic cells process antigens for presentation to T cells, playing a critical role in adaptive immunity."&lt;SEP&gt;"Process by which antigen-presenting cells (APCs) present antigen fragments to T cells for recognition and activation."</data>
      <data key="d2">chunk-830d8819004960d1d149ac70149c72a0&lt;SEP&gt;chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
    </node>
    <node id="&quot;IL-1R&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"IL-1 receptor gene contributes to diminished clinical and histologic measures of colitis when T cell transfers are performed."</data>
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
      <data key="d3">[{"level": 0, "cluster": 17}, {"level": 1, "cluster": 56}]</data>
    </node>
    <node id="&quot;CASPASE-1&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Caspase-1 cleavage was assessed in relation to its activation form under different treatments on macrophages."&lt;SEP&gt;"Caspase-1 is a protein involved in the activation of pro-inflammatory cytokine production by cleaving inactive cytosolic precursor (pro-IL-1β) to its active form, supporting Th17 cell response and disease progression."&lt;SEP&gt;"In the IL-10RαMdelRag1−/− Mϕs, p20 formation was increased regardless of IL-10 or anti-IL-10Rα Ab treatment."</data>
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c&lt;SEP&gt;chunk-b971aa450a9b220806bdc000eb5efaad</data>
      <data key="d3">[{"level": 0, "cluster": 18}]</data>
    </node>
    <node id="&quot;INFLAMMASOME&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"An inflammasome is a multiprotein complex that activates Caspase-1 in response to danger signals, leading to the processing of pro-inflammatory cytokines like IL-1β."</data>
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
    </node>
    <node id="&quot;CD11B&quot;">
      <data key="d0">"CELLULAR COMPONENT"</data>
      <data key="d1">"The CD11b surface marker on cells marks those that produce or are involved with pro-IL-1β production and inflammation management in colitis models, associated with LPMϕs."</data>
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
    </node>
    <node id="&quot;COLOCALIZE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The process of colocalization refers to the overlapping location or function of molecules like IL-1β and CD11b within cells or tissues during disease conditions."</data>
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
    </node>
    <node id="&quot;FLOW CYTOMETRY&quot;">
      <data key="d0">"ANALYTICAL METHOD"</data>
      <data key="d1">"Flow cytometry is a technique used for measuring the physical and chemical properties of particles suspended in fluid, particularly useful for analyzing cell populations and quantifying protein expression like pro-IL-1β levels."&lt;SEP&gt;"Technique used for quantitative analysis of the phenotype of cells, including expression levels of specific markers or antigens."</data>
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c&lt;SEP&gt;chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;WESTERN ANALYSIS&quot;">
      <data key="d0">"METHOD"</data>
      <data key="d1">"Western analysis or Western blotting is a method used to detect proteins by size using an antibody probe. It's applied here to study the presence of both pro-IL-1β and IL-1β in Mϕs (macrophages)."</data>
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
    </node>
    <node id="&quot;LPS&quot;">
      <data key="d0">"STIMULATION AGENT"</data>
      <data key="d1">"Lipopolysaccharide (LPS) is a component found on bacterial cell walls that can stimulate innate immune responses including the expression of pro-inflammatory cytokines like IL-1β."&lt;SEP&gt;"Lipopolysaccharide stimulation led to a modest increase in activated caspase-1."</data>
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c&lt;SEP&gt;chunk-b971aa450a9b220806bdc000eb5efaad</data>
      <data key="d3">[{"level": 0, "cluster": 18}]</data>
    </node>
    <node id="&quot;ATP&quot;">
      <data key="d0">"STIMULATION AGENT"</data>
      <data key="d1">"Adenosine triphosphate (ATP), often present in many cellular sources, has been shown to induce inflammasome activation and promote inflammatory responses associated with cytokine production."&lt;SEP&gt;"Adenosine triphosphate also stimulated the increase of activated caspase-1."</data>
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c&lt;SEP&gt;chunk-b971aa450a9b220806bdc000eb5efaad</data>
      <data key="d3">[{"level": 0, "cluster": 18}]</data>
    </node>
    <node id="&quot;ANTI-IL-10R ANTIBODY&quot;">
      <data key="d0">"DRUG/CHEMICAL"</data>
      <data key="d1">"An antibody that specifically binds to the IL-10 receptor can modulate signaling pathways by blocking IL-10's interaction, affecting pro-inflammatory cytokine expression like IL-1β in cells."</data>
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
    </node>
    <node id="&quot;PROTEIN EXPRESSION&quot;">
      <data key="d0">"BIOLOGICAL PROCESS"</data>
      <data key="d1">"The process of protein expression refers to the production and secretion of proteins in cells, which is regulated and controlled during inflammation and disease states, impacting cytokine levels including IL-1β."</data>
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
    </node>
    <node id="&quot;PRO-IL-Β&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The transcript of pro-IL-β is involved in the regulation of IL-1β maturation."</data>
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
      <data key="d3">[{"level": 0, "cluster": 10}, {"level": 1, "cluster": 32}]</data>
    </node>
    <node id="&quot;RAG1−/− MΦS&quot;">
      <data key="d0">"CELL"</data>
      <data key="d1">"Rag1−/− macrophages (Mϕs) respond differently under various treatments in comparison to other cell types."</data>
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
      <data key="d3">[{"level": 0, "cluster": 18}]</data>
    </node>
    <node id="&quot;IL-10RΑMDELRAG1−/− MΦS&quot;">
      <data key="d0">"CELL"</data>
      <data key="d1">"The IL-10 receptor α subunit knockout Mϕs of Rag1−/− mice, which affects the signaling pathways related to IL-10."</data>
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
    </node>
    <node id="&quot;ANTI-IL-10RΑ AB&quot;">
      <data key="d0">"ANTIBODY"</data>
      <data key="d1">"Blocking anti-IL-10Rα antibody markedly increased activated caspase-1, indicating normal restraint of caspase-1 activation by autocrine IL-10."</data>
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
    </node>
    <node id="&quot;IL-10RΑMDELRAG1−/− LPMΦS&quot;">
      <data key="d0">"CELL"</data>
      <data key="d1">"These macrophages from IL-10RαMdelRag1−/− mice showed elevated Th17 formation compared to Rag1−/− LPMϕs."</data>
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
    </node>
    <node id="&quot;IL-6R−/− T CELL TRANSFER&quot;">
      <data key="d0">"EXPERIMENTAL TREATMENT"</data>
      <data key="d1">"Th17 formation was found to be more modest after IL-6 receptor knockout T cell transfer."</data>
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
    </node>
    <node id="&quot;ΑIL-6RΑ BLOCKING ANTIBODY&quot;">
      <data key="d0">"DRUG TREATMENT"</data>
      <data key="d1">"Blocking the IL-6 receptor largely abrogated Th17 formation with Rag1−/− LPMϕs."&lt;SEP&gt;"This specific type of antibody was used to block the effect of IL-6 on Th17 cell maturation when present in co-cultures with LPMφs from Rag1−/− mice."</data>
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
    </node>
    <node id="&quot;IL-1 SIGNALING&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Inhibition of IL-1 signaling led to more substantial inhibition of Th17 development in IL-10RαMdelRag1−/−-derived LPMϕs."</data>
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
      <data key="d3">[{"level": 0, "cluster": 17}, {"level": 1, "cluster": 58}]</data>
    </node>
    <node id="&quot;TGFΒ&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"TGFβ was added to co-cultures of LPMφs with naïve T cells but not IL-6."</data>
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
    </node>
    <node id="&quot;TH17 CELL MATURATION&quot;">
      <data key="d0">"BIOLOGICAL PROCESS"</data>
      <data key="d1">"The maturation process of Th17 cells involves the interaction between different cell types and cytokines, including IL-10Rα signaling in LPMφs."</data>
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
    </node>
    <node id="&quot;IL-6R−/− T CELLS&quot;">
      <data key="d0">"CELL LINE"</data>
      <data key="d1">"T cell lines with a genetic defect that lack functional IL-6 receptors were used in some of the experiments to evaluate Th17 cell maturation."</data>
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
    </node>
    <node id="&quot;IL-6 SIGNALING&quot;">
      <data key="d0">"BIOLOGICAL PROCESS"</data>
      <data key="d1">"IL-6 signaling pathways were inhibited using specific blocking antibodies to observe its effect on Th17 cell development."</data>
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
    </node>
    <node id="&quot;TH17 DEVELOPMENT&quot;">
      <data key="d0">"OUTCOME OF THE BIOLOGICAL PROCESS"</data>
      <data key="d1">"The process of Th17 cell formation was essentially abrogated when both IL-1 and IL-6 signaling were blocked, demonstrating their roles in this cellular response."</data>
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
    </node>
    <node id="&quot;IL-17&quot;">
      <data key="d2">chunk-29025895ac187b8e88dec5cea9478842&lt;SEP&gt;chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d1">"IL-17 is involved in the immune response but no difference was observed regarding its production between experimental groups."&lt;SEP&gt;"Increased colonic infiltration by both Th1 and Th17 cells, and the Th17 response is required for disease development.")</data>
      <data key="d0">"PROTEIN"</data>
      <data key="d3">[{"level": 0, "cluster": 16}]</data>
    </node>
    <node id="&quot;IFN-Γ&quot;">
      <data key="d2">chunk-84ec948f22126cef7d93b1d7465b79db&lt;SEP&gt;chunk-883c371ea1f500a1ba8af8366328e8b0&lt;SEP&gt;chunk-0c1631ae2c195cb68139ea9d75a3b433&lt;SEP&gt;chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d1">"No differences in CD4+IFN-γ+ T cell quantities were evident.")&lt;SEP&gt;"No significant elevation of IFN-γ was observed in the experiment."&lt;SEP&gt;"The expression of IFN-γ was higher in certain CD subjects compared to others without specific genotypes."&lt;SEP&gt;"The protein encoded by PTPN2/PTPN22, involved in the regulation of immune responses."</data>
      <data key="d0">"PROTEIN"</data>
      <data key="d3">[{"level": 0, "cluster": 16}]</data>
    </node>
    <node id="&quot;IL-23&quot;">
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d1">"A particularly prominent elevation in IL-1β production was apparent...")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 16}]</data>
    </node>
    <node id="&quot;INOS&quot;">
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d1">"For IL-1β, IL-6, IL-23p19, and iNOS, relative expression was compared in sorted colonic LPMϕs, DCs, neutrophils, and epithelial cells.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 16}]</data>
    </node>
    <node id="&quot;PROTEIN-PROTEIN INTERACTION&quot;">
      <data key="d2">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
      <data key="d1">"The complex interactions between different proteins like IL-6Rα and its ligand(s), which are crucial for processes including immune response regulation and disease development.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 12}, {"level": 1, "cluster": 39}]</data>
    </node>
    <node id="&quot;IL-6RΑ GENE&quot;">
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
      <data key="d1">"A genomic variant specific to the IL-6Rα gene influences disease protection during T cell transfers.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 12}, {"level": 1, "cluster": 42}]</data>
    </node>
    <node id="&quot;DRUG/CHEMICAL INTERACTION&quot;">
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
      <data key="d1">"Treatment with an anti-IL-10 receptor antibody influences pro-IL-1β expression by modulating signaling pathways in T cell responses and disease progression.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PATHWAY MODIFICATION&quot;">
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
      <data key="d1">"The IL-6Rα gene's response is modified through interaction with genomic variants, impacting physiological processes that affect colitis models specifically in the Rag1−/− context.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 12}, {"level": 1, "cluster": 42}]</data>
    </node>
    <node id="&quot;DISEASE MODULATION&quot;">
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
      <data key="d1">"Specific genotypic differences within the IL-6Rα gene and IL-10RαMdel variants influence disease modulations across different genetic backgrounds like Rag1−/− and IL-10RαMdelRag1−/−.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 7}, {"level": 1, "cluster": 26}]</data>
    </node>
    <node id="&quot;PATHWAY ACTIVATION&quot;">
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
      <data key="d1">"Caspase-1 is activated through an inflammasome response to danger signals or stimulation by agents like LPS and ATP, leading to the processing of pro-inflammatory cytokines such as IL-1β.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 18}]</data>
    </node>
    <node id="&quot;DATA COLLECTION METHOD&quot;">
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
      <data key="d1">"The use of flow cytometry enables researchers to collect data on cell populations and protein expression levels like that of pro-IL-1β, aiding in understanding complex immune responses.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PROTEIN DETECTION METHOD&quot;">
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
      <data key="d1">"Western analysis serves as a method for visualizing proteins by size after they have been labeled with an antibody. It is crucial for confirming cytokine production levels like IL-1β in response to different stimuli.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SIGNALING PATHWAY ACTIVATION&quot;">
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
      <data key="d1">"Exposure to LPS leads to activation of signaling pathways that impact pro-inflammatory responses and cytokine expression, such as those involved with IL-1β production during colitis.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 18}]</data>
    </node>
    <node id="&quot;STIMULATION EFFECT&quot;">
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
      <data key="d1">"The presence or release of ATP can stimulate cellular responses leading to inflammasome activation which impacts the expression levels of pro-inflammatory cytokines, like IL-1β, in inflammatory conditions such as colitis.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 18}]</data>
    </node>
    <node id="&quot;PATHWAY DISRUPTION&quot;">
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
      <data key="d1">"Antibodies that bind to and disrupt IL-10 receptor function can alter signaling pathways that affect pro-inflammatory cytokine production, including IL-1β levels in inflammatory contexts.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;EXPERIMENTAL CONDITION&quot;">
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
      <data key="d1">"The transfer of IL-6 receptor knockout (IL-6R−/−) T cells into mice showed modest effects on Th17 formation, suggesting the importance of functional IL-6R for this process.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL-6R−/− T CELLS TRANSFER&quot;">
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
      <data key="d1">"The transfer of IL-6 receptor knockout (IL-6R−/−) T cells into mice showed modest effects on Th17 formation, suggesting the importance of functional IL-6R for this process.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;EFFECT ON TH17 FORMATION&quot;">
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
      <data key="d1">"Blocking the interaction with IL-6 receptor α (IL-6Rα), using specific antibodies, largely inhibited Th17 formation in cultures containing Rag1−/− derived LPMφs.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CONSEQUENCE ON TH17 DEVELOPMENT&quot;">
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
      <data key="d1">"Inhibition of IL-6 signaling pathways led to a significant reduction or complete suppression of Th17 cell development, emphasizing the role of IL-6 in this process.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL-6 SIGNALING INHIBITION&quot;">
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
      <data key="d1">"Inhibition of IL-6 signaling pathways led to a significant reduction or complete suppression of Th17 cell development, emphasizing the role of IL-6 in this process.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TWINSUK&quot;">
      <data key="d0">"COHORT"</data>
      <data key="d1">"The TwinsUK cohort is composed of 1,176 samples including 169 monozygotic (MZ) and 419 dizygotic (DZ) twin pairs."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;NETHERLANDS TWIN REGISTRY (NTR)&quot;">
      <data key="d0">"COHORT"</data>
      <data key="d1">"The Netherlands Twin Registry (NTR) cohort includes only MZ twins, totaling N=312 individuals."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;DNA EXTRACTION METHOD&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"DNA extraction method significantly contributes to heterogeneity in microbiome variation, accounting for 29% of the effect size on microbiome variation based on stepwise distance-based redundancy analysis (R2adjDNAext=0.27, Padj=7×10−4)."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;MICROBIAL COMPOSITION&quot;">
      <data key="d0">"LANDSCAPE"</data>
      <data key="d1">"The landscape of microbiome composition across different cohorts varies based on ethnic background, age, male/female ratio and microbiome analysis methodology."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;COHORT ETHNICITY&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Cohort ethnicity affects the heterogeneity in microbial composition."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;SEQUENCING DEPTH&quot;">
      <data key="d0">"TECHNIQUE"</data>
      <data key="d1">"Accounting for differences in sequencing depth through rarefaction allowed for taxonomic classification using direct taxonomic binning instead of OTU clustering methods."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;TAXONOMIC CLASSIFICATION&quot;">
      <data key="d0">"METHODOLOGY"</data>
      <data key="d1">"Direct taxonomic binning was performed for taxonomic classification instead of OTU clustering to analyze microbiome data."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;RICHNESS VARIANCE&quot;">
      <data key="d0">"VARIANCE COMPONENT ANALYSIS"</data>
      <data key="d1">"The 16S rRNA domain sequenced and DNA extraction methods used, together with cohort ethnicity, accounted for 32.74% of richness variance in the study."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;COHORT HETEROGENEITY&quot;">
      <data key="d0">"FACTOR"</data>
      <data key="d1">"The high heterogeneity of microbial composition across different cohorts is influenced by ethnic background, age distribution, sex ratio, and technical methodologies."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;ALPHA DIVERSITY METRICS&quot;">
      <data key="d0">"METRIC"</data>
      <data key="d1">"Alpha diversity metrics such as Shannon index, Simpson's index, and inverse Simpson index are important indicators of species richness and evenness in each cohort."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;TWIN COHORTS&quot;">
      <data key="d0">"STUDY COMPONENT"</data>
      <data key="d1">"The study includes twin cohorts to estimate heritability of gut microbiome composition."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;SNP-BASED HERITABILITY&quot;">
      <data key="d0">"STATISTICAL METHOD"</data>
      <data key="d1">"Heritability of bacterial taxa was estimated using SNP-based heritability analysis."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;GENETIC FACTORS&quot;">
      <data key="d0">"INFLUENCE"</data>
      <data key="d1">"The additive genetic variance (A), shared environmental factors (C), and non-shared factors contribute to the variation in microbiome composition."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;REPLICATION OF TWIN-BASED ANALYSIS&quot;">
      <data key="d0">"STATISTICAL VALIDATION"</data>
      <data key="d1">"Twin-based analysis was replicated using another twin registry cohort for validation purposes."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;TAXON HERITABILITY&quot;">
      <data key="d0">"HERITABILITY MEASURE"</data>
      <data key="d1">"Out of 159 bacterial taxa present in over 10% of twin pairs, 19 showed evidence of heritability based on the nominal P-value."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;LINKAGE DISEQUILIBRIUM (LD) SCORE REGRESSION&quot;">
      <data key="d0">"STATISTICAL TOOL"</data>
      <data key="d1">"The SNP-based heritability was calculated using LD score regression to account for linkage disequilibrium among genetic variants."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;LCT&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The LCT gene is located at 2q21.3 and includes a large block of about 1.5Mb with multiple protein-coding genes."&lt;SEP&gt;"The LCT gene plays a role in lactase regulation."&lt;SEP&gt;"The gene LCT encodes for the lactase enzyme which is responsible for breaking down lactose."&lt;SEP&gt;"The gene encoding lactase, necessary for the digestion of lactose."&lt;SEP&gt;"This transcript is associated with lactase persistence and can be regulated by the lncRNA in question."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c&lt;SEP&gt;chunk-af413a33fae8d27bdb15cd18447dfad4&lt;SEP&gt;chunk-ec104044b3aa65560be8d81dbb3940d6&lt;SEP&gt;chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
    </node>
    <node id="&quot;RS182549&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The rs182549 genotype showed a higher abundance of the genus Bifidobacterium in the adult group, but not in the younger group."&lt;SEP&gt;"rs182549 is the strongest association signal identified near the LCT gene, which acts as a perfect proxy for functional LCT variant rs4988235."</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46&lt;SEP&gt;chunk-af413a33fae8d27bdb15cd18447dfad4</data>
    </node>
    <node id="&quot;BIFIDOBACTERIUM&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Bifidobacterium abundance has been associated with variants located in the LCT locus through genome-wide association studies (GWAS)."&lt;SEP&gt;"The age-genotype interaction was significant in the GEM_v12 and GEM_ICHIP subcohorts, both comprising mostly European individuals"&lt;SEP&gt;"The genus Bifidobacterium showed a significant association with a protective effect against ulcerative colitis."</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46&lt;SEP&gt;chunk-af413a33fae8d27bdb15cd18447dfad4&lt;SEP&gt;chunk-159d4c797dae6eb825c74067af703228</data>
    </node>
    <node id="&quot;COCHRAN'S Q P&quot;">
      <data key="d0">"STATISTICAL SIGNIFICANCE"</data>
      <data key="d1">"Cochran's Q test p-values indicated the statistical significance of heterogeneity across different cohorts in rs182549 related analysis."</data>
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
    </node>
    <node id="&quot;BIFIDOBACTERIUM ABUNDANCE&quot;">
      <data key="d0">"MICROBIAL ABUNDANCE"</data>
      <data key="d1">"The abundance of Bifidobacterium has been positively correlated with milk product intake, especially when individuals are homozygous for the low-function LCT haplotype."</data>
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
    </node>
    <node id="&quot;RS4988235&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"No significant association is observed between the rs4988235 genotype and risk of developing diabetes when considering baseline HbA1c levels or through multivariable adjustment."&lt;SEP&gt;"The LP (rs4988235 T/T genotype) is associated with a range of 7.4% to 53.9% in prevalence across Europe."&lt;SEP&gt;"The homozygous LP (T/T) genotype shows differences within Europe, with a range from 7.4% to 53.9% in Italy and Sweden respectively."&lt;SEP&gt;"rs4988235 is a functional variant of rs182549 that has been associated with abundance levels of Bifidobacterium."&lt;SEP&gt;"The minor allele frequencies for rs4988235 were observed in different populations."</data>
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91&lt;SEP&gt;chunk-af413a33fae8d27bdb15cd18447dfad4&lt;SEP&gt;chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;LCT MBQTL EFFECT&quot;">
      <data key="d0">"ASSOCIATION SIGNAL"</data>
      <data key="d1">"The LCT locus showed an association signal for Bifidobacterium abundance, identified through multi-ethnic genome-wide association studies (GWAS)."</data>
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
    </node>
    <node id="&quot;GEM_V24 COHORT - ISRAELI SUBETHNICITIES&quot;">
      <data key="d0">"ETHNIC DIVERSITY"</data>
      <data key="d1">"The GEM_v24 cohort includes individuals of diverse Israeli subethnicities as part of their composition."</data>
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
    </node>
    <node id="&quot;AGE RANGE BETWEEN 6 AND 35 YEARS&quot;">
      <data key="d0">"AGE COMPOSITION"</data>
      <data key="d1">"The multi-ethnic GEM cohort comprises participants aged between 6 to 35, nearly half of whom are younger than 16 years old."</data>
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
    </node>
    <node id="&quot;NC_000002.11:G.136616754CC&quot;">
      <data key="d0">"GENOTYPE VARIANT"</data>
      <data key="d1">"This variant is part of the rs182549 locus and was found to have a significant interaction with age regarding Bifidobacterium abundance."</data>
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
    </node>
    <node id="&quot;GEM_V12, GEM_ICHIP SUBCOHORTS&quot;">
      <data key="d0">"SUBGROUP COMPOSITION"</data>
      <data key="d1">"These subcohorts are comprised mainly of European individuals when analyzing age-genotype interactions on Bifidobacterium abundance."</data>
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
    </node>
    <node id="&quot;GEM_V12&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"While the GEM_v24 cohort, mainly composed of individuals of different Israeli subethnicities (see Online Methods) who live in Israel, showed neither an mbQTL effect."</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;GEM_ICHIP&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Neither did the GEM_ICHIP cohort"</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;GEM_V24&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The lack of an LCT mbQTL effect in adults was also observed in another Israel cohort (Personalized Nutrition Project (PNP), 481 adults, Beta = −0.20 [95%CI: −0.61, 0.20])."</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;COPENHAGEN PROSPECTS STUDIES ON ASTHMA IN CHILDHOOD (COPSAC)&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The cohort that reported the lowest LCT effect sizes were the two cohorts of Israeli ethnicity volunteered in Israel (GEM_v24, PNP) and a child cohort."</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;FUNCTIONAL FUT2 VARIANT RS601338&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The tagging NC_000019.9:g.49218060C&gt;T (rs35866622 non-secretor) allele was associated with a reduced abundance of the R. torques group and a decreased presence of the R. gnavus group."</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;RUMINOCOCCUS TORQUES&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Ruminococcus sp. are specialized in the degradation of complex carbohydrates, thereby supporting a link between genetic variation in the FUT2 gene, levels of mucus glycans and the abundance of this taxa."</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;FUT2&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Individuals homozygous for the stop-codon (rs601338*A/A, non-secretors) do not express ABO antigens on the intestinal mucosa."</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;R. TORQUES GROUP AND A DECREASED PRESENCE OF THE R. GNAVUS GROUP&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"FUT2 encodes the enzyme alpha-1,2-fucosyltransferase, which is responsible for the secretion of fucosylated mucus glycans in the gastrointestinal mucosa."</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;RS35866622&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"We observed that the tagging NC_000019.9:g.49218060C&gt;T (rs35866622 non-secretor) allele was associated with a reduced abundance of the R. torques group and a decreased presence of the R. gnavus group."</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;ALLISONELLA&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"One of them includes three SNPs in 9q21 (top-SNP rs602075, P=3.57×10−8) associated with abundance of Allisonella."</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;PCSK5&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The 9q21 locus includes the genes PCSK5, RFK and GCNT1, of which RFK encodes the enzyme that catalyzes the phosphorylation of riboflavin (vitamin B2) and GCNT1 encodes a glycosyltransferase involved in biosynthesis of mucin."</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;COBALAMIN (VITAMIN B12)&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Cobalamin is required for host–microbial interactions, and supplementation with cobalamin induced a substantial shift in the microbiota composition of an in vitro colon model. These associations suggest that some members of the gut microbiome community might be affected by genetic variants that regulate the absorption and metabolism of vitamins B2 and B12."</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;PEPTOCOCCACEAE&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"The strongest evidence for association was seen for a block of 10 SNPs (rs7574352, P=1.42×10−9) associated with the family Peptococcaceae, a taxon negatively associated with stool levels of the gut inflammation markers chromogranin A"</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;ENTEROBACTERIACEAE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Differences in dietary patterns and gut microbiota can lead to variations in the abundance of this family of bacteria."</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;DIETARY FIBER&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Dietary factors like fiber intake can modulate the effect of genetic variants on gut microbiota composition."&lt;SEP&gt;"Insufficient dietary fiber intake may contribute to dysbiosis of gut microbiota, impacting tryptophan metabolism and AHR activation."</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46&lt;SEP&gt;chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;FAMILY PEPTOCOCCACEAE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A block of 10 SNPs (rs7574352) associated with family Peptococcaceae."</data>
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964</data>
      <data key="d3">[{"level": 0, "cluster": 14}, {"level": 1, "cluster": 46}]</data>
    </node>
    <node id="&quot;CHROMOGRANIN A&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Stool levels of gut inflammation markers, chromogranin A is negatively correlated with family Peptococcaceae."</data>
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964</data>
      <data key="d3">[{"level": 0, "cluster": 14}, {"level": 1, "cluster": 46}]</data>
    </node>
    <node id="&quot;CALPROTECTIN&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Stool levels of the gut inflammation markers calprotectin are negatively correlated with family Peptococcaceae."</data>
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964</data>
      <data key="d3">[{"level": 0, "cluster": 14}, {"level": 1, "cluster": 46}]</data>
    </node>
    <node id="&quot;ULCERATIVE COLITIS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Family Peptococcaceae is negatively associated with ulcerative colitis."</data>
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964</data>
      <data key="d3">[{"level": 0, "cluster": 14}, {"level": 1, "cluster": 46}]</data>
    </node>
    <node id="&quot;TYPE 2 DIABETES&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A chronic disease characterized by high blood glucose levels, which occurs when the body is unable to produce enough insulin or use it effectively."&lt;SEP&gt;"The block of SNPs are associated with insulin resistance leading to type 2 diabetes."</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b&lt;SEP&gt;chunk-938d8bf2e56584de9dd556be5eb70964</data>
      <data key="d3">[{"level": 0, "cluster": 6}]</data>
    </node>
    <node id="&quot;RS7574352&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Located in the intergenic region, associated with IRF1 involved in insulin resistance and type 2 diabetes."</data>
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964</data>
      <data key="d3">[{"level": 0, "cluster": 14}, {"level": 1, "cluster": 47}]</data>
    </node>
    <node id="&quot;IRF1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"IRF1 gene expression levels are associated with T1D susceptibility and changes in its expression."&lt;SEP&gt;"Involved in insulin resistance and susceptibility to type 2 diabetes."&lt;SEP&gt;"The IRF1 gene encodes for an interferon regulatory factor which is crucial for antiviral defenses and was identified as affected by a specific trans-eQTL."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b&lt;SEP&gt;chunk-1b40d071abac0ba432a9fb0096796f45&lt;SEP&gt;chunk-938d8bf2e56584de9dd556be5eb70964</data>
      <data key="d3">[{"level": 0, "cluster": 14}, {"level": 1, "cluster": 47}]</data>
    </node>
    <node id="&quot;LACTOSE INTOLERANCE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"rs182549 (LCT) predisposes individuals to lactose intolerance."</data>
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964</data>
    </node>
    <node id="&quot;TYPE 2 DIABETES MELLITUS (T2DM)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The rs182549 variant shows positive association with T2DM diagnosis."</data>
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964</data>
    </node>
    <node id="&quot;FAMILY HISTORY OF T2DM&quot;">
      <data key="d0">"TRAIT"</data>
      <data key="d1">"rs182549 is associated with family history of T2DM (paternal, maternal and siblings)."</data>
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964</data>
    </node>
    <node id="&quot;GLYCEMIC VARIABILITY&quot;">
      <data key="d0">"TRAIT"</data>
      <data key="d1">"The variant rs182549 is associated with 1,5-anhydroglucitol, an indicator for glycemic variability."</data>
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964</data>
    </node>
    <node id="&quot;FISH INTAKE&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"NC_000019.9:g.49218060 (rs35866622) locus is positively associated with fish intake."</data>
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964</data>
    </node>
    <node id="&quot;CHOLELITHIASIS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The secretor allele of the FUT1/FUT2 locus shows negative association with cholelithiasis."</data>
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964</data>
    </node>
    <node id="&quot;CROHN’S DISEASE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The secretor allele of the FUT1/FUT2 locus is negatively associated with Crohn’s disease."</data>
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964</data>
    </node>
    <node id="&quot;ALCOHOL INTAKE FREQUENCY&quot;">
      <data key="d0">"TRAIT"</data>
      <data key="d1">"The secretor allele of the FUT1/FUT2 locus shows negative association with alcohol intake frequency."</data>
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964</data>
    </node>
    <node id="&quot;HIGH CHOLESTEROL&quot;">
      <data key="d0">"TRAIT"</data>
      <data key="d1">"Bifidobacterium abundance is negatively correlated with high cholesterol, even though this correlation wasn't significant after correction for multiple testing."</data>
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964</data>
    </node>
    <node id="&quot;WAIST-TO-HIP RATIO&quot;">
      <data key="d0">"TRAIT"</data>
      <data key="d1">"The secretor allele of the FUT1/FUT2 locus shows negative association with waist-to-hip ratio."</data>
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964</data>
    </node>
    <node id="&quot;MENDELIAN RANDOMIZATION ANALYSIS&quot;">
      <data key="d0">"METHODOLOGY"</data>
      <data key="d1">"Bi-directional two-sample MR analyses were performed using the TwoSampleMR package to identify potential causal links between gut microbial taxa and phenotypes."</data>
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228</data>
    </node>
    <node id="&quot;AUTOIMMUNE DISEASES&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Potential causal relationships were identified with autoimmune diseases as one group of phenotypes in our analysis."&lt;SEP&gt;"Some autoimmune diseases show parallels to IBD due to similar dysregulations in immune responses, metabolism, and microbiota interactions."</data>
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228&lt;SEP&gt;chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;CARDIOVASCULAR DISEASES&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Potential causal relationships were considered for cardiovascular diseases as another group of phenotypes in the study."</data>
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228</data>
    </node>
    <node id="&quot;METABOLIC DISEASES&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"We evaluated potential causal associations with metabolic diseases when examining phenotype correlations."</data>
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228</data>
    </node>
    <node id="&quot;PSYCHIATRIC DISORDERS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Potential causal links were assessed for psychiatric disorders alongside other phenotype groups in this analysis."</data>
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228</data>
    </node>
    <node id="&quot;GUT MICROBIAL TAXA&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The study focused on gut microbial taxa to identify potential causal relationships with various phenotypes."</data>
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228</data>
    </node>
    <node id="&quot;ACTINOBACTERIA&quot;">
      <data key="d0">"MICROBIAL GROUP"</data>
      <data key="d1">"A higher abundance of the class Actinobacteria was found to have a protective effect on ulcerative colitis."</data>
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228</data>
    </node>
    <node id="&quot;OXALOBACTERACEAE FAMILY&quot;">
      <data key="d0">"MICROBIAL GROUP"</data>
      <data key="d1">"An increased abundance of the Oxalobacteraceae family was found to have a protective effect on rheumatoid arthritis."</data>
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228</data>
    </node>
    <node id="&quot;ALPHA DIVERSITY&quot;">
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
      <data key="d1">"Differences in sequencing depth and DNA extraction methods are significant factors influencing alpha diversity metrics such as Shannon, Simpson, and inverse Simpson indices.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SEQUENCING DEPTH AND DNA EXTRACTION METHODS&quot;">
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
      <data key="d1">"Differences in sequencing depth and DNA extraction methods are significant factors influencing alpha diversity metrics such as Shannon, Simpson, and inverse Simpson indices.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;COHORT ETHNICITY AND TECHNIQUES USED&quot;">
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
      <data key="d1">"Cohort ethnicity along with the techniques used (e.g., DNA extraction methods) contributes to heterogeneity in microbial composition.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RICHNESS&quot;">
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
      <data key="d1">"Differences in sequencing depth and DNA extraction methods impact richness by influencing the microbial composition's diversity across various samples.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;COHORT HETEROGENEITY AND ALPHA DIVERSITY&quot;">
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
      <data key="d1">"There is a significant correlation between the heterogeneity across cohorts and alpha diversity metrics, indicating how different factors contribute to microbial richness and evenness.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CORRELATION&quot;">
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
      <data key="d1">"There is a significant correlation between the heterogeneity across cohorts and alpha diversity metrics, indicating how different factors contribute to microbial richness and evenness.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;AGE AND ETHNICITY INTERACTION&quot;">
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
      <data key="d1">"An age-genotype interaction on Bifidobacterium abundance was found, which was significant in multi-ethnic cohorts but not evident in the GEM_v24 cohort.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MBBTL EFFECT&quot;">
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
      <data key="d1">"An age-genotype interaction on Bifidobacterium abundance was found, which was significant in multi-ethnic cohorts but not evident in the GEM_v24 cohort.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;P&lt;0.05&quot;">
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
      <data key="d1">"The rs182549 genotype showed a significant SNP-age interaction on the level of Bifidobacterium abundance, with higher abundance observed in adults homozygous for the NC_000002.11:g.136616754CC variant.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS182549 - BIFIDOBACTERIUM ABUNDANCE&quot;">
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
      <data key="d1">"The rs182549 genotype showed a significant SNP-age interaction on the level of Bifidobacterium abundance, with higher abundance observed in adults homozygous for the NC_000002.11:g.136616754CC variant.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;P=0.01&quot;">
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
      <data key="d1">"The residual heterogeneity for rs182549 was low after including quadratic and cubic terms of age in the model, indicating that the majority of variation has been explained.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS182549 - MBQTL EFFECT HETEROGENEITY&quot;">
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
      <data key="d1">"The residual heterogeneity for rs182549 was low after including quadratic and cubic terms of age in the model, indicating that the majority of variation has been explained.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;AGE-GENOTYPE INTERACTION&quot;">
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
      <data key="d1">"The age-genotype interaction was significant in the GEM_v12 and GEM_ICHIP subcohorts, both comprising mostly European individuals.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;YOUNG VERSUS ADULT GROUP EFFECT&quot;">
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
      <data key="d1">"rs182549 genotype showed a higher abundance of the genus Bifidobacterium in the adult group, but not in the younger group.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ISRAELI ETHNICITY&quot;">
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
      <data key="d1">"The lack of an LCT mbQTL effect was observed among individuals of Israeli ethnicity.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PEPTOCOCCACEAE&quot;*|&gt;&quot;GUT INFLAMMATION MARKERS&quot;">
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
      <data key="d1">6)("entity"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SNPS ASSOCIATED WITH PEPTOCOCCACEAE WERE NEGATIVELY CORRELATED WITH LEVELS OF GUT INFLAMMATION MARKERS LIKE CHROMOGRANIN A AND CALPROTECTIN, SUGGESTING LINKS TO GASTROINTESTINAL HEALTH.&quot;)">
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
      <data key="d1">6)("entity"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS182549 (LCT)&quot;">
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964</data>
      <data key="d1">"The variant rs182549 predisposes to lactose intolerance.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;T2DM&quot;">
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9&lt;SEP&gt;chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9&lt;SEP&gt;chunk-938d8bf2e56584de9dd556be5eb70964</data>
      <data key="d1">"Diagnosis for individuals with high blood glucose levels and insulin resistance, commonly due to obesity or inactivity."&lt;SEP&gt;"Type 2 Diabetes Mellitus group, indicating participants diagnosed with Type 2 diabetes."&lt;SEP&gt;"Type 2 Diabetes Mellitus is the target disease being studied based on genetic associations and their role in disease manifestation."&lt;SEP&gt;"Type 2 Diabetes Mellitus"&lt;SEP&gt;"rs182549 variant shows positive association with T2DM diagnosis.")</data>
      <data key="d0">"DISEASE"</data>
    </node>
    <node id="&quot;NC_000019.9:G.49218060 (RS35866622)&quot;">
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964</data>
      <data key="d1">"The variant NC_000019.9:g.49218060 (rs35866622) is positively associated with fish intake.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DISEASES&quot;">
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228</data>
      <data key="d1">"Results suggest potential protective effects of specific gut microbial taxa on autoimmune disorders such as ulcerative colitis and rheumatoid arthritis.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 2}, {"level": 1, "cluster": 11}]</data>
    </node>
    <node id="&quot;MICROBIAL TAXA&quot;">
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228</data>
      <data key="d1">"Results suggest potential protective effects of specific gut microbial taxa on autoimmune disorders such as ulcerative colitis and rheumatoid arthritis.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 2}, {"level": 1, "cluster": 11}]</data>
    </node>
    <node id="&quot;DAIRY PRODUCTS&quot;">
      <data key="d0">"PROTEIN, NUTRIENT"</data>
      <data key="d1">"Dairy products are related to the intake of milk, which is positively associated with one additional LP allele."</data>
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;MILK INTAKE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"A positive association exists between an LP (T) allele and a higher intake of milk, as well as milk beverages."</data>
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;DIETARY FACTORS&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"The intake of various dietary factors (potatoes, cereal products, fruits, poultry, non-alcoholic beverages, wine) show associations with rs4988235 genotype."</data>
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;HDL CHOLESTEROL&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"rs4988235 is associated with a modestly lower HDL cholesterol level after multivariable adjustment."</data>
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;DIABETES RISK FACTORS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR, NUTRIENT"</data>
      <data key="d1">"Dietary factors like potatoes, cereal products, fruits, poultry, non-alcoholic beverages and wine are related to rs4988235 in terms of diabetes risk."</data>
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;MR ANALYSIS&quot;">
      <data key="d0">"RELATIONSHIPS WITH DIABETES RISK FACTORS"</data>
      <data key="d1">"Multivariate regression analysis suggests no association between dairy product intake and diabetes, as well as HDL cholesterol levels."</data>
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;ENVIRONMENTAL FACTOR, NUTRIENT&quot;">
      <data key="d0">"RS4988235 AND DAIRY PRODUCTS &amp; OTHER FOOD INTAKE"</data>
      <data key="d1">"There is an association between rs4988235 genotype and dietary intake of dairy products including milk beverages."</data>
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;NUTRIENT, ENVIRONMENTAL FACTOR&quot;">
      <data key="d0">"RS4988235 AND RISK FACTORS FOR DIABETES"</data>
      <data key="d1">"The rs4988235 genetic variant is associated with dietary factors potentially linked to diabetes risk, such as potatoes, cereals, fruits, poultry, non-alcoholic beverages, wine."&lt;SEP&gt;"The rs4988235 genetic variant shows significant associations with specific nutrient intakes like carbohydrates, fats (C15:0 and C17:0), which could impact health outcomes."</data>
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;PHYSIOLOGICAL PROCESS, ENVIRONMENTAL FACTOR&quot;">
      <data key="d0">"RS4988235 AND HDL CHOLESTEROL LEVELS"</data>
      <data key="d1">"The rs4988235 variant shows a minor relationship with HDL cholesterol levels after adjusting for other variables."</data>
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;DIETARY PATTERN, ENVIRONMENTAL FACTOR&quot;">
      <data key="d0">"RS4988235 AND ASSOCIATIONS WITH DIABETES RISK FACTORS"</data>
      <data key="d1">"The genetic variant rs4988235 correlates with various dietary patterns that could influence diabetes risk, as observed in the analysis."</data>
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;MOLECULAR INTERACTION, ENVIRONMENTAL FACTOR&quot;">
      <data key="d0">"RS4988235 AND DAIRY INTAKE RELATIONSHIP"</data>
      <data key="d1">"The relationship between rs4988235 and dairy product intake (milk, milk beverages) is mediated by environmental factors such as lifestyle or dietary habits."</data>
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;DISEASE OUTCOMES, ENVIRONMENTAL FACTOR&quot;">
      <data key="d0">"RS4988235 AND DIABETES RISK THROUGH MULTIVARIABLE ADJUSTMENTS"</data>
      <data key="d1">"Through multivariate regression analysis adjusting for multiple environmental factors (like genetic background), rs4988235's role in diabetes risk is assessed."</data>
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;RISK OF DIABETES&quot;">
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
      <data key="d1">"The rs4988235 genetic variant does not show a statistically significant link with developing diabetes and baseline HbA1c levels after adjusting for other factors.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DAIRY PRODUCT INTAKE (MILK, MILK BEVERAGES)&quot;">
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
      <data key="d1">"An additional LP allele correlates with increased consumption of milk and milk-based beverages.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DIABETES RISK FACTORS (DIETARY)&quot;">
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
      <data key="d1">"An association exists between rs4988235 genotype and specific dietary patterns that could influence diabetes risk.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DIABETES RISK FACTORS (DIETARY PATTERNS)&quot;">
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
      <data key="d1">"There is a notable association between rs4988235 and certain dietary habits that may impact the risk of developing diabetes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MOLECULAR INTERACTION (DAIRY CONSUMPTION)&quot;">
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
      <data key="d1">"Through the influence of environmental factors, rs4988235 affects interactions with dairy intake, particularly milk and milk beverages.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NUTRIENT ASSOCIATIONS&quot;">
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
      <data key="d1">"rs4988235 is associated with particular nutrient intake levels such as total fats from specific fatty acids (C15:0, C17:0), impacting physiological processes and health outcomes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DIABETES RISK (MULTIVARIABLE ADJUSTMENT)&quot;">
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
      <data key="d1">"rs4988235 plays a role in diabetes risk when considering multiple environmental factors, as indicated by multivariate analysis results.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SOCIAL CLASS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Treatment and placebo arms did not differ in social class."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;MATERNAL EDUCATION&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Treatment and placebo arms did not differ in maternal education."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;VERBAL INTELLECTUAL COMPETENCE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Treatment and placebo arms did not differ in verbal intellectual competence."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;NONVERBAL INTELLECTUAL COMPETENCE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Treatment and placebo arms did not differ in nonverbal intellectual competence."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;PERCEIVED STRESS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Treatment and placebo arms did not differ in perceived stress."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;NUTRITIONAL STATUS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Groups differed on nutritional status based on dietary caloric intake and choline intake."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;ALCOHOL CONSUMPTION&quot;">
      <data key="d0">"BEHAVIOR/</data>
      <data key="d1">"Both groups consumed alcohol heavily at conception, but frequency reduced during pregnancy."&lt;SEP&gt;Disease"&lt;|"Increased alcohol consumption can lead to or exacerbate diseases, including addiction."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e&lt;SEP&gt;chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;CIGARETTES/DAY&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"Average cigarettes/day consumption was similar among both groups."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;ILLICIT DRUGS OTHER THAN MARIJUANA&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Use of illicit drugs other than marijuana was rare, but methamphetamine use was found in some women later in pregnancy."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;METHAQUALONE&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"None of the women reported using methaqualone, which is an environmental factor not related to alcohol or drug use."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;COCAINE&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Cocaine was not used by any woman in this study."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;HEROIN&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"No woman reported using heroin as it is a rare illicit drug usage."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;METHAMPHETAMINE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"4 women (2 choline, 2 placebo) used methamphetamine later in pregnancy, which was an environmental factor not accounted for at recruitment."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;WEEKS GESTATION AT TIME OF BOOKING, INITIAL SCREENING, OR RANDOMIZATION&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Groups did not differ on weeks gestation at the time of these assessments."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;DURATION OF CHOLINE SUPPLEMENTATION&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Durations varied between 9 and 27 weeks among the groups."&lt;SEP&gt;"The groups differed slightly in duration of choline supplementation."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;SEX OF INFANT&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"There were more girls in the choline group and more boys in the placebo group, which could indicate a gender bias."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;ALCOHOL CONSUMPTION DURING PREGNANCY&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Both groups consumed alcohol heavily during pregnancy, but frequency reduced to about 1-2 days/week."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;CIGARETTE CONSUMPTION DURING PREGNANCY&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"Average cigarettes/day consumption was slightly higher among those in the choline group due to different factors influencing smoking habits."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;ILLICIT DRUG USE DURING PREGNANCY&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Use of illicit drugs other than marijuana was rare, and methamphetamine use was found later in pregnancy for some women."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;METHAQUALONE USAGE&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"No one used methaqualone as it's not a common substance among the participants."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;COCAINE USAGE&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"No one used cocaine during this study."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;HEROIN USAGE&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"No one used heroin during this study."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;METHAMPHETAMINE USAGE DURING PREGNANCY&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Four women (2 choline, 2 placebo) used methamphetamine later in pregnancy."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;WEEKS GESTATION AT TIME OF RANDOMIZATION&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Groups differed slightly on weeks gestation at time of randomization."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;INFANT AGE AT THE 6.5-AND 12-MONTH ASSESSMENTS&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"No group differences in infant age at these assessments, indicating consistent monitoring over time."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;PHYSICAL ACTIVITY LEVEL DURING PREGNANCY&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"Groups did not differ significantly in physical activity levels during pregnancy."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;PRENATAL STRESS LEVELS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"There was no significant difference between the choline and placebo groups regarding prenatal stress levels."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;PRENATAL ANXIETY SYMPTOMS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Anxiety symptoms did not differ significantly between the two treatment groups at any time point during pregnancy."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;ANTENATAL CARE FREQUENCY&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The frequency of antenatal care visits was similar in both treatment groups, indicating equal access to prenatal care."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;MATERNAL WEIGHT GAIN DURING PREGNANCY&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"Both groups showed comparable weight gain patterns throughout pregnancy, which could influence the outcomes."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;PRENATAL CALCIUM INTAKE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"There was no significant difference in maternal calcium intake between the choline and placebo groups."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;FOLIC ACID SUPPLEMENTATION BEFORE PREGNANCY&quot;">
      <data key="d0">"PRE-PREGNANCY BEHAVIOR"</data>
      <data key="d1">"A similar percentage of women in both arms had taken folic acid before pregnancy, which can influence neural tube development but does not affect study outcomes directly related to treatment."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;PRENATAL FETAL MONITORING&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Both groups received the same standard of prenatal fetal monitoring throughout the study duration."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;PREGNANT WOMEN'S SLEEP HABITS&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"There were no significant differences in sleep patterns between pregnant women receiving choline and those on placebo."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;PRENATAL B VITAMINS SUPPLEMENTATION&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The amount of prenatal vitamin supplementation with B-vitamins was similar across both groups, indicating comparable nutritional support for the mother."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;MATERNAL BLOOD PRESSURE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Blood pressure levels were not significantly different between choline and placebo groups at any time during pregnancy or post-partum."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;PRENATAL ANTENATAL TEST RESULTS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Results of routine antenatal tests did not show significant differences that could affect the outcomes related to treatment groups."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;BREASTFEEDING PRACTICES AFTER DELIVERY&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"The choline and placebo groups showed similar initiation rates of breastfeeding following delivery."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;MATERNAL MENTAL HEALTH SCREENING SCORES&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Scores on standardized mental health screening tools were not significantly different between the choline and placebo groups throughout pregnancy and post-partum period."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;POSTPARTUM DEPRESSION SYMPTOMS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"No group differences in postpartum depression symptoms were found, indicating that both treatments might similarly affect mental health outcomes during this period."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;PRENATAL VITAMIN D LEVELS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"There was no difference between the two groups in prenatal vitamin D levels which can influence bone density and immune function."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;MATERNAL AGE AT PREGNANCY&quot;">
      <data key="d0">"DEMOGRAPHIC FACTOR"</data>
      <data key="d1">"Groups did not differ significantly by maternal age, suggesting similar age-related factors might affect both treatment arms equally."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;PREGNANCY COMPLICATIONS OCCURRENCE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"No significant differences in the occurrence of pregnancy complications were observed between choline and placebo groups, which are influenced by various factors unrelated to the study intervention."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;FASD&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Fetal Alcohol Spectrum Disorders diagnosis"</data>
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
    </node>
    <node id="&quot;PFAS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Possible Fetal Alcohol Spectrum" (misinterpretation of data)</data>
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
    </node>
    <node id="&quot;INFANTS&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"62 infants assessed in this study"</data>
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
      <data key="d3">[{"level": 0, "cluster": 12}, {"level": 1, "cluster": 40}]</data>
    </node>
    <node id="&quot;RS12325817&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Variant of the enzyme PEMT carrying this variant reduces endogenous choline synthesis"</data>
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
    </node>
    <node id="&quot;6 OUTCOMES&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"These outcomes were examined considering interactions within infants, choline groups, and placebo groups"</data>
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
    </node>
    <node id="&quot;UL&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Upper Limit for daily intake of Choline, not exceeded by any infant in this study"</data>
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
    </node>
    <node id="&quot;DIETARY CHOLINE INTAKE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Choline intake during pregnancy, considered in terms of adequacy"</data>
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
    </node>
    <node id="&quot;MATERNAL DIETARY CHOLINE STATUS&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Status during pregnancy influencing infant outcomes"</data>
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
    </node>
    <node id="&quot;RS12325817 ALLELE REDUCTION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Reduction of endogenous choline synthesis as a result of the variant"</data>
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
    </node>
    <node id="&quot;CHOLINE TREATMENT GROUP&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"Group receiving dietary choline supplementation"</data>
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
    </node>
    <node id="&quot;FASD MANAGEMENT TEST&quot;">
      <data key="d0">"THERAPY EVALUATION"</data>
      <data key="d1">"Statistical test to assess the impact of choline supplementation in managing Fetal Alcohol Spectrum Disorders outcomes."</data>
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
    </node>
    <node id="&quot;ALCOHOL CONSUMPTION DURING PREGNANCY AND CIGARETTE CONSUMPTION DURING PREGNANCY, ILLICIT DRUG USE DURING PREGNANCY&quot;">
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
      <data key="d1">"Both groups showed heavy consumption, but frequency reduced during pregnancy, indicating potential effects on fetal development and infant growth.")("entity"</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 0}, {"level": 1, "cluster": 19}]</data>
    </node>
    <node id="&quot;CRITERIA&quot;">
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
      <data key="d1">"8 infants met criteria for FAS and 2 for PFAS in the choline arm, compared with 5 who met criteria for FAS and 2 for PFAS in the placebo arm")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 12}, {"level": 1, "cluster": 40}]</data>
    </node>
    <node id="&quot;ADEQUATE&quot;">
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
      <data key="d1">"9.7% of infants were born to mothers whose dietary choline intake during pregnancy was adequate (450 mg/day)")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CHOLINE INTAKE&quot;">
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
      <data key="d1">"9.7% of infants were born to mothers whose dietary choline intake during pregnancy was adequate (450 mg/day)")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MATERNAL PEMT ALLELE&quot;">
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
      <data key="d1">"21.6% of the infants carried rs12325817 variant of the enzyme PEMT, reducing endogenous choline synthesis")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 12}, {"level": 1, "cluster": 40}]</data>
    </node>
    <node id="&quot;CHOLINE GROUP BY MATERNAL PEMT ALLELE&quot;">
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
      <data key="d1">"The six outcomes differed between the choline group and placebo group based on maternal PEMT alleles")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MATERNAL DIETARY STATUS&quot;">
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
      <data key="d1">"9.7% (3 choline-treated, 3 placebo) of the infants were born to mothers whose dietary choline intake was adequate.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 12}, {"level": 1, "cluster": 40}]</data>
    </node>
    <node id="&quot;DISEASE MANAGEMENT APPROACH&quot;">
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
      <data key="d1">"Significance tested for differences between treatment and placebo groups on outcomes relevant to FASD management")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 12}, {"level": 1, "cluster": 40}]</data>
    </node>
    <node id="&quot;RS10886471&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The rs10886471 SNP is analyzed to study the short tandem repeat function in gene expression."&lt;SEP&gt;"The single nucleotide polymorphism rs10886471 is studied for its association with blood glucose levels and prediabetes."</data>
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
    </node>
    <node id="&quot;PCR&quot;">
      <data key="d0">"POLYMERASE CHAIN REACTION"</data>
      <data key="d1">"Polymerase chain reaction amplification of genomic DNA."&lt;SEP&gt;"Used to confirm findings from microarray analysis and qRT-PCR methods, revealing two amplicons of 628 and 557 bp for patient with mutation c.1-1G&gt;A affecting intron 1 acceptor splice site."</data>
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9&lt;SEP&gt;chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;ALLELIC FREQUENCY&quot;">
      <data key="d0">"GENETIC PARAMETER"</data>
      <data key="d1">"The distribution of allelic frequencies in different groups to determine the association with blood glucose levels."</data>
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
    </node>
    <node id="&quot;NFG&quot;">
      <data key="d0">"GROUP"</data>
      <data key="d1">"Non-Genetic Factor Group used as a baseline to compare against case groups for disease association."&lt;SEP&gt;"Normal Fasting Glucose group, representing participants with normal fasting glucose levels."</data>
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9&lt;SEP&gt;chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
    </node>
    <node id="&quot;IFG&quot;">
      <data key="d0">"GROUP"</data>
      <data key="d1">"Classification for individuals with fasting glucose levels above normal but below prediabetes threshold."&lt;SEP&gt;"Impaired Fasting Glucose group, including participants with impaired fasting glucose levels."&lt;SEP&gt;"Impaired Fasting Glucose, a condition associated with increased risk of developing T2DM"</data>
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9&lt;SEP&gt;chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
    </node>
    <node id="&quot;IGT&quot;">
      <data key="d0">"GROUP"</data>
      <data key="d1">"Diagnostic criterion indicating the body's decreased ability to regulate blood sugar during oral glucose tolerance tests."&lt;SEP&gt;"Impaired Glucose Tolerance group, for individuals showing impaired glucose tolerance."&lt;SEP&gt;"Impaired Glucose Tolerance, another condition associated with risk for T2DM development."</data>
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9&lt;SEP&gt;chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
    </node>
    <node id="&quot;BLOOD GLUCOSE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The levels of blood glucose in different groups as a measure to determine the presence of prediabetes or T2DM."</data>
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
    </node>
    <node id="&quot;ASSOCIATION STUDY&quot;">
      <data key="d0">"RESEARCH METHODOLOGY"</data>
      <data key="d1">"Study conducted on the intronic (CA)n repeat polymorphisms for their association with prediabetes and Type 2 diabetes."</data>
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
    </node>
    <node id="&quot;LOGISTIC REGRESSION ANALYSIS&quot;">
      <data key="d0">"STATISTICAL ANALYSIS"</data>
      <data key="d1">"Analysis method used to determine the strength of association between genetic polymorphism and disease risk."</data>
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
    </node>
    <node id="&quot;SBP&quot;">
      <data key="d0">"SYSTOLIC BLOOD PRESSURE"</data>
      <data key="d1">"Systolic blood pressure readings are taken as a measure of cardiovascular health."</data>
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
    </node>
    <node id="&quot;DBP&quot;">
      <data key="d0">"DIASTOLIC BLOOD PRESSURE"</data>
      <data key="d1">"Diastolic blood pressure is measured to evaluate cardiovascular health and risk factors for hypertension."</data>
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
    </node>
    <node id="&quot;2 H PG&quot;">
      <data key="d0">"POSTPRANDIAL BLOOD GLUCOSE"</data>
      <data key="d1">"Two-hour postprandial blood glucose measurements assess the body's ability to regulate blood sugar levels after meals."</data>
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
    </node>
    <node id="&quot;OR&quot;">
      <data key="d0">"STATISTICAL MEASURE"</data>
      <data key="d1">"Odds Ratio used to quantify the strength of association between genotypes and disease outcomes."</data>
      <data key="d2">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
    </node>
    <node id="&quot;P&lt;0.001&quot;">
      <data key="d0">"STATISTICAL SIGNIFICANCE"</data>
      <data key="d1">"Indicates very strong statistical significance for associations between genotypes and disease outcomes, where P is less than 0.001."</data>
      <data key="d2">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
    </node>
    <node id="&quot;MULTIPLE ALLELES&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A group of different genetic variants or alleles, each potentially having varying effects on disease development"</data>
      <data key="d2">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
    </node>
    <node id="&quot;(CA)15&quot;">
      <data key="d0">"ALLELE"</data>
      <data key="d1">"One specific member of the Multiple Alleles group associated with certain disease outcomes"</data>
      <data key="d2">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
    </node>
    <node id="&quot;(CA)17&quot;">
      <data key="d0">"ALLELE"</data>
      <data key="d1">"Another specific member of the Multiple Alleles group potentially influencing T2DM risk"</data>
      <data key="d2">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
    </node>
    <node id="&quot;(CA)18&quot;">
      <data key="d0">"ALLELE"</data>
      <data key="d1">"A third variant within the Multiple Alleles set, possibly linked to disease outcomes"</data>
      <data key="d2">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
    </node>
    <node id="&quot;(CA)19&quot;">
      <data key="d0">"ALLELE"</data>
      <data key="d1">"Final member of the Multiple Alleles group that might affect disease risk"</data>
      <data key="d2">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
    </node>
    <node id="&quot;GENETIC POLYMORPHISM&quot;">
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9&lt;SEP&gt;chunk-41c7131af28e2a745ef6b88b8601860f</data>
      <data key="d1">"Genetic polymorphisms involve variations in DNA sequence that may influence protein function and disease susceptibility."&lt;SEP&gt;"The rs10886471 SNP shows a genetic polymorphism as indicated by the PIC values exceeding 0.5.")</data>
      <data key="d0">"MOLECULAR INTERACTION"</data>
    </node>
    <node id="&quot;RS10886471 SNP&quot;">
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
      <data key="d1">"The rs10886471 SNP shows a genetic polymorphism as indicated by the PIC values exceeding 0.5.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ENHANCERS OR REPRESSORS&quot;">
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
      <data key="d1">"Intronic repeats could play roles in gene expression as enhancers or repressors based on studies.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INTRONIC (CA)N REPEATS&quot;">
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
      <data key="d1">"Intronic repeats could play roles in gene expression as enhancers or repressors based on studies.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ALLELIC FREQUENCIES&quot;">
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
      <data key="d1">"The allelic frequencies of (CA)n repeat polymorphisms vary across different groups to assess disease risk.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENETIC VARIATION&quot;">
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
      <data key="d1">"The allelic frequencies of (CA)n repeat polymorphisms vary across different groups to assess disease risk.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NFG GROUP&quot;">
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
      <data key="d1">"NFG group serves as a baseline/reference for comparison with other diabetes-related groups.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;REFERENCE POPULATION&quot;">
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
      <data key="d1">"NFG group serves as a baseline/reference for comparison with other diabetes-related groups.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DIABETES PREDIAGNOSIS&quot;">
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
      <data key="d1">"Groups of individuals showing elevated blood glucose levels, potentially leading to prediabetes or Type 2 diabetes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IFG AND IGT GROUPS&quot;">
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
      <data key="d1">"Groups of individuals showing elevated blood glucose levels, potentially leading to prediabetes or Type 2 diabetes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DIABETES DISEASE STATE&quot;">
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
      <data key="d1">"Group representing participants with diagnosed Type 2 diabetes mellitus.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;T2DM GROUP&quot;">
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
      <data key="d1">"Group representing participants with diagnosed Type 2 diabetes mellitus.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ALLELE (CA)16&quot;">
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
      <data key="d1">"The allele (CA)16 is associated with increased risk of prediabetes and T2DM based on the logistic regression analysis.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INCREASED RISK FACTOR&quot;">
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
      <data key="d1">"The allele (CA)16 is associated with increased risk of prediabetes and T2DM based on the logistic regression analysis.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;OBESITY INDICATOR&quot;">
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
      <data key="d1">"Waist circumference is an indicator of excess abdominal fat, linked to metabolic syndrome and diabetes risk.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;(CA)16&quot;">
      <data key="d2">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
      <data key="d1">"Specific allele of a genetic variant that serves as a reference for comparison with other alleles.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MULTIPLE ALLELE&quot;">
      <data key="d2">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
      <data key="d1">"Specific allele of a genetic variant that serves as a reference for comparison with other alleles.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DISEASE GROUPS&quot;">
      <data key="d2">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
      <data key="d1">"Different disease stages or outcomes (Impaired Fasting Glucose, Impaired Glucose Tolerance, and Type 2 Diabetes Mellitus respectively), associated with the genetic variant and its alleles.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IFG, IGT, T2DM&quot;">
      <data key="d2">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
      <data key="d1">"Different disease stages or outcomes (Impaired Fasting Glucose, Impaired Glucose Tolerance, and Type 2 Diabetes Mellitus respectively), associated with the genetic variant and its alleles.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ASSOCIATION WITH T2DM&quot;">
      <data key="d2">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
      <data key="d1">"The specific genotypes (variants/alleles) are linked to an increased risk for developing Type 2 Diabetes Mellitus.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENOMIC VARIANT AND MULTIPLE ALLELES&quot;">
      <data key="d2">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
      <data key="d1">"The specific genotypes (variants/alleles) are linked to an increased risk for developing Type 2 Diabetes Mellitus.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GPX4 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The GPX4 gene contains one SNP associated with colorectal cancer risk."&lt;SEP&gt;"The GPx4 gene encodes glutathione peroxidase 4, which is vital in cellular defense against oxidative stress."</data>
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a&lt;SEP&gt;chunk-d311ac0182b37003c75c0005b4337fa6</data>
    </node>
    <node id="&quot;RS8178974&quot;">
      <data key="d0">"SNP"</data>
      <data key="d1">"The SNP rs8178974 in the GPX4 gene was statistically significantly associated with colorectal cancer risk."</data>
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6</data>
    </node>
    <node id="&quot;SERUM SELENIUM CONCENTRATION&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Serum selenium concentration was not associated with colorectal cancer risk, but there was a wide range of concentrations and mean was relatively high."&lt;SEP&gt;"Variation in serum selenium concentrations is associated with geographic distribution and local climate, among other factors."</data>
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6</data>
    </node>
    <node id="&quot;COLORECTAL CANCER&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Colorectal cancer is linked to factors such as age, BMI, physical activity level, smoking habits, and postmenopausal hormone use."</data>
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6</data>
    </node>
    <node id="&quot;NSAIDS&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Use of NSAIDs was similar between cases (patients) and controls (healthy individuals)."</data>
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6</data>
    </node>
    <node id="&quot;CALCIUM INTAKE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Intakes of calcium were lower in patients compared to healthy individuals."</data>
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6</data>
    </node>
    <node id="&quot;DIETARY FIBER INTAKE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Dietary fiber intakes were also lower among patients versus controls."</data>
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6</data>
    </node>
    <node id="&quot;SELENIUM SUPPLEMENT USE&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Supplement usage for selenium was similar between cases and control groups."</data>
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6</data>
    </node>
    <node id="&quot;CANCER IN THE COLON&quot;">
      <data key="d0">"DISEASE SUBTYPE"</data>
      <data key="d1">"Most cases had colorectal cancer diagnosed specifically as colon cancer (81.1% of total cases)."</data>
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6</data>
    </node>
    <node id="&quot;COLORECTAL TUMOR RISK&quot;">
      <data key="d0">"DISEASE SUBTYPE"</data>
      <data key="d1">"The association between selenium and colorectal tumor risk was statistically significant; however, results were heterogenous."</data>
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6</data>
    </node>
    <node id="&quot;SMOKING HABIT&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"Smoking habits impacted the relationship with selenium intake and colorectal cancer risk, though not significantly."</data>
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6</data>
    </node>
    <node id="&quot;POSTMENOPAUSAL HORMONE USE&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"Use of postmenopausal hormones did not show a significant association with selenium levels or colorectal cancer risk."</data>
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6</data>
    </node>
    <node id="&quot;SERUM SELENIUM&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Selenium measured in serum/plasma showed an inverse association with colorectal tumors; toenail measurements had no association."</data>
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6</data>
    </node>
    <node id="&quot;COLORECTAL ADENOMA&quot;">
      <data key="d0">"DISEASE SUBTYPE"</data>
      <data key="d1">"The protective association was stronger for studies measuring selenium levels after colorectal tumor diagnosis, compared to before diagnosis."</data>
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6</data>
    </node>
    <node id="&quot;SELENIUM INTAKE (CALCIUM, DIETARY FIBER)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Intakes of selenium, calcium, and dietary fiber were lower among patients compared to controls."</data>
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6</data>
    </node>
    <node id="&quot;SELENIUM SUPPLEMENTATION (NSAIDS)&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Selenium supplements and NSAID use were similar in patients versus healthy individuals."</data>
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6</data>
    </node>
    <node id="&quot;PUBLICATION BIAS (SMALL STUDIES)&quot;">
      <data key="d0">"STATISTICAL ISSUE"</data>
      <data key="d1">"Funnel plots suggested potential publication bias with more small studies showing negative associations.")</data>
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6</data>
    </node>
    <node id="&quot;COLON CANCER RISK&quot;">
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6</data>
      <data key="d1">"Serum selenium concentration showed no significant association with overall colorectal cancer risk but showed a positive relationship specifically with colon cancer risk.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;COLORECTAL CANCER RISK&quot;">
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6</data>
      <data key="d1">"The SNP rs8178974 in the GPX4 gene was associated with colorectal cancer risk, specifically showing significance.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GPX4 GENE SNP (RS8178974)&quot;">
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6</data>
      <data key="d1">"The SNP rs8178974 in the GPX4 gene was associated with colorectal cancer risk, specifically showing significance.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PUBLICATION BIAS&quot;">
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6</data>
      <data key="d1">"There was potential evidence for publication bias in funnel plots indicating higher number of small studies reporting inverse associations.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENDER BASED ANALYSIS&quot;">
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6</data>
      <data key="d1">"Selenium showed a significant and inverse association with colorectal tumor risk specifically among men, but not significantly so among women.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DIAGNOSIS TIMING&quot;">
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6</data>
      <data key="d1">"Results differed based on when (before or after) colorectal tumors were diagnosed; measurements taken post-diagnosis showed stronger associations.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SERUM SELENIUM MEASUREMENT&quot;">
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6</data>
      <data key="d1">"Results differed based on when (before or after) colorectal tumors were diagnosed; measurements taken post-diagnosis showed stronger associations.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;COLORECTAL ADENOMA RISK&quot;">
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6</data>
      <data key="d1">"The protective association between selenium levels was stronger for colorectal adenomas than cancer.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CANCER RISK (ADENOMA VS. CANCER)&quot;">
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6</data>
      <data key="d1">"The inverse association between selenium levels was stronger for adenomas compared to colorectal cancer.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CARD9&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"CARD9 is a gene involved in shaping the bacterial and fungal gut microbiota, and controlling fungal microbiota expansion in colitis."&lt;SEP&gt;"Card9 deficiency impacts gut microbiota-induced susceptibility to colitis, affecting IL-22 signaling pathway via tryptophan metabolism."&lt;SEP&gt;"Card9 plays a role in connection between IBD and ability of gut microbiota to produce AHR ligands, affected by genetic polymorphisms."&lt;SEP&gt;"Card9 plays a role in inflammation and is involved in mediating recovery from DSS-induced colitis."</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6&lt;SEP&gt;chunk-4d5e7ab61a7357d5106f4a8a355f40d0&lt;SEP&gt;chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;DEXTRAN SULFATE SODIUM (DSS)&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"DSS induces colitis and affects the mouse colon transcriptome, impacting healing processes."</data>
      <data key="d2">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
    </node>
    <node id="&quot;HISTOPATHOLOGIC ALTERATIONS&quot;">
      <data key="d0">"PATHOLOGICAL PROCESS"</data>
      <data key="d1">"Histopathologic alterations are observed in Card9−/− mice during colitis induction."</data>
      <data key="d2">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
    </node>
    <node id="&quot;EPITHELIAL CELL PROLIFERATION&quot;">
      <data key="d0">"CELLULAR ACTIVITY"</data>
      <data key="d1">"Reduced epithelial cell proliferation is associated with impaired intestinal healing in Card9−/− mice."&lt;SEP&gt;"The process of epithelial cells dividing and multiplying, which plays a crucial role in tissue regeneration and wound healing."</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6&lt;SEP&gt;chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
    </node>
    <node id="&quot;KI67&quot;">
      <data key="d0">"CELL PROLIFERATION MARKER"</data>
      <data key="d1">"A decrease in Ki67 staining is indicative of reduced cell proliferation in the intestine."</data>
      <data key="d2">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
    </node>
    <node id="&quot;CLEAVED CASPASE 3&quot;">
      <data key="d0">"MOLECULAR ACTIVITY"</data>
      <data key="d1">"Increased cleavage of caspase 3 is associated with cell apoptosis and tissue damage."</data>
      <data key="d2">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
    </node>
    <node id="&quot;MOUSE TRANSCRIPTOME&quot;">
      <data key="d0">"GENOMIC DATA SET"</data>
      <data key="d1">"Comparing WT and Card9−/− mouse transcriptomes during DSS-induced colitis reveals specific alterations."</data>
      <data key="d2">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
    </node>
    <node id="&quot;WT MICE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Standard genetically normal mice used as a baseline for comparison with genetic variants or strains."&lt;SEP&gt;"Wild-type (WT) mice have normal genotypes without any specific genomic variations linked to Card9 or microbiome effects."</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6&lt;SEP&gt;chunk-29025895ac187b8e88dec5cea9478842</data>
    </node>
    <node id="&quot;CARD9−/− MICE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Card9 knockout (Card9−/−) mice lack the CARD9 gene, leading to differences in microbiota composition and susceptibility to colitis compared to WT mice."&lt;SEP&gt;"Mice genetically engineered to lack the CARD9 gene which affects microbiota and colitis susceptibility."</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6&lt;SEP&gt;chunk-29025895ac187b8e88dec5cea9478842</data>
    </node>
    <node id="&quot;MICROBIOTA&quot;">
      <data key="d0">"BACTERIAL COMMUNITY"</data>
      <data key="d1">"Microbiota refers to the entire community of microorganisms that live within or on an organism. In this context, it specifically relates to the gut microbiome of mice."</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
    </node>
    <node id="&quot;GERM-FREE (GF) MICE&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"Germ-free mice are those kept in sterile environments and thus do not have any indigenous microorganisms, used here as a control for the impact of gut microbiota on certain traits."</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
    </node>
    <node id="&quot;DSS-INDUCED COLITIS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A type of inflammatory bowel disease that was induced by treatment with DSS (dinitrobenzene sulfonic acid)."&lt;SEP&gt;"DSS (dinitrobenzene sulfonic acid) induced colitis is an animal model to study inflammation in the colon. This process helps researchers understand inflammatory bowel diseases like ulcerative colitis and Crohn's disease."</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6&lt;SEP&gt;chunk-29025895ac187b8e88dec5cea9478842</data>
    </node>
    <node id="&quot;NANOSTRING TECHNOLOGY&quot;">
      <data key="d0">"MOLECULAR ANALYSIS TOOL"</data>
      <data key="d1">"A gene expression profiling tool used for quantifying the expression levels of genes in samples."</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
    </node>
    <node id="&quot;IL22&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"IL-22 (Interleukin 22) is a cytokine that has been implicated in intestinal homeostasis and antimicrobial resistance, particularly playing roles in epithelial cell responses to inflammation or injury."</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
    </node>
    <node id="&quot;TRANSCRIPTION FACTOR FOS&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"FOS is a transcription factor that interacts with other proteins to regulate gene expression, often found in pathways related to cell stress and response to stimuli including cytokine action."</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
    </node>
    <node id="&quot;IL-22&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"IL-22 is essential for normalizing AHR ligand production and colitis susceptibility in Card9−/− mice."&lt;SEP&gt;"IL-22 plays a role in stimulating cells via IL-23 production and contributes to gut microbiota function."&lt;SEP&gt;"Similar in T cells from psoriasiform lesions and classical psoriasis, reduced in peripheral blood mononuclear cells (PBMCs)."&lt;SEP&gt;"Polymorphisms in the IL-22 gene were studied with respect to risk for CRC."</data>
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f&lt;SEP&gt;chunk-56c37d6045382dda8cc6037b2680282a&lt;SEP&gt;chunk-29025895ac187b8e88dec5cea9478842&lt;SEP&gt;chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;INTRAEPITHELIAL ΓΔ T CELLS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"T cells and innate lymphoid cells (ILCs) that play a role in colitis recovery after treatment."</data>
      <data key="d2">chunk-29025895ac187b8e88dec5cea9478842</data>
    </node>
    <node id="&quot;INTESTINAL DENDRITIC CELLS AND MACROPHAGES&quot;">
      <data key="d0">"IMMUNE CELLS"</data>
      <data key="d1">"Cells involved in stimulating IL-22-producing cells through IL-23 production."</data>
      <data key="d2">chunk-29025895ac187b8e88dec5cea9478842</data>
    </node>
    <node id="&quot;GERM-FREE MICE&quot;">
      <data key="d0">"MICE STRAIN"</data>
      <data key="d1">"Mice raised without microbiota for comparison experiments."</data>
      <data key="d2">chunk-29025895ac187b8e88dec5cea9478842</data>
    </node>
    <node id="&quot;ALLOPATHIC APPROACH&quot;">
      <data key="d0">"THERAPY METHOD"</data>
      <data key="d1">"A medical approach that involves using pharmaceuticals and traditional medicine to treat diseases."</data>
      <data key="d2">chunk-29025895ac187b8e88dec5cea9478842</data>
    </node>
    <node id="&quot;TRYPTOPHAN METABOLISM&quot;">
      <data key="d0">"METABOLIC PROCESS"</data>
      <data key="d1">"A process involving the metabolism of tryptophan by gut bacteria or host cells which can affect immune responses."&lt;SEP&gt;"Alteration of tryptophan metabolism by gut microbiota contributes to AHR activation and colitis susceptibility."&lt;SEP&gt;"Gut microbiota alters IL-22 signaling through tryptophan metabolism, leading to defective AHR activation."</data>
      <data key="d2">chunk-29025895ac187b8e88dec5cea9478842&lt;SEP&gt;chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;INDOLE DERIVATIVES&quot;">
      <data key="d0">"SUBSTANCE TYPE"</data>
      <data key="d1">"Byproducts of tryptophan metabolism, including indole-3-acetic acid (IAA) and kynurenine (Kyn), known to activate the AhR pathway."</data>
      <data key="d2">chunk-29025895ac187b8e88dec5cea9478842</data>
    </node>
    <node id="&quot;AHR ACTIVATION&quot;">
      <data key="d0">"PATHWAY"</data>
      <data key="d1">"Stimulation of AHR by indole derivatives leads to local IL-22 production and impacts immune cell function."</data>
      <data key="d2">chunk-29025895ac187b8e88dec5cea9478842</data>
    </node>
    <node id="&quot;AHR LIGATION&quot;">
      <data key="d0">"EVENT"</data>
      <data key="d1">"Binding of AHR ligands to the Ah receptor, leading to specific gene expression."</data>
      <data key="d2">chunk-29025895ac187b8e88dec5cea9478842</data>
    </node>
    <node id="&quot;AHR LIGANDS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Microbiota produces AHR ligands necessary for colitis susceptibility; lack of IL-22 impairs this interaction."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;TRYPTOPHAN&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Reduction in tryptophan correlates with decreased AHR activation and increased levels of Kyn in IBD subjects."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;KYN&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Gut microbiota metabolism of tryptophan produces Kyn, impacting AHR signaling; reduced production in IBD subjects."&lt;SEP&gt;"Increased levels of kynurenine (Kyn) are associated with reduced AHR activation and altered gut microbiota activity in IBD subjects."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;IDO1&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Active immune cells in the gut of IBD patients use tryptophan to produce Kyn via IDO1; this process is hindered by microbiota dysbiosis."&lt;SEP&gt;"IDO1 activity plays a role in the production of Kyn from tryptophan, impacting immune cell function in IBD patients."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;IBD ASSOCIATED SNP (RS10781499)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Risk allele of this SNP within CARD9 is associated with reduced AHR activation by gut microbiota in IBD patients."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;NOD2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"No significant association found between major IBD-associated SNPs (NOD2, ATG16L1, LRRK2) and altered AHR activation by microbiota."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;AUTOPHAGY-RELATED 16-LIKE 1 (ATG16L1)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"No significant association found between major IBD-associated SNPs (NOD2, ATG16L1, LRRK2) and altered AHR activation by microbiota."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;LEUCINE-RICH REPEAT KINASE 2 (LRRK2)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"No significant association found between major IBD-associated SNPs (NOD2, ATG16L1, LRRK2) and altered AHR activation by microbiota."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;AHR&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Defective AHR is associated with decreased tryptophan metabolites in subjects with IBD, potentially due to dysregulated immune cell activity and microbiota metabolism."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;MICROBIOTA DYSBIOSIS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Dysbiosis within the gut microbiota contributes to defective tryptophan metabolism and affects AHR activation in IBD."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;INFLAMMATORY BOWEL DISEASE (IBD)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Chronic inflammation associated with reduced tryptophan metabolites and altered AHR pathway is characteristic of IBD."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;IMMUNE CELL FUNCTION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Modulation of immune cell function by gut microbiota-derived metabolites impacts AHR activation in inflammatory diseases."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;GUT MICROBIOTA DERIVED LIGANDS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Specific ligands produced by gut microbiota are crucial for proper AHR signaling; their production is compromised in IBD."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;AHR PATHWAY&quot;">
      <data key="d0">"BIOLOGICAL PROCESS"</data>
      <data key="d1">"Altered AHR pathway due to genetic and environmental factors contributes to the development of inflammatory bowel disease (IBD)."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;GENETIC POLYMORPHISM (RS10781499)&quot;">
      <data key="d0">"SNP"</data>
      <data key="d1">"Specific SNP rs10781499 in CARD9 gene influences AHR pathway and microbiota-derived ligand production; it is associated with IBD susceptibility."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;AUTOINFLAMMATION&quot;">
      <data key="d0">"CONDITION"</data>
      <data key="d1">"Autoinflammation is a condition characterized by chronic inflammation without an infection; it may involve alterations in AHR pathway and tryptophan metabolism."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;NUTRIENT ABSORPTION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Proper nutrient absorption, including tryptophan, is crucial for maintaining gut health and influencing the AHR pathway and microbiota function."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;GUT MICROBIOTA COMPOSITION&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Differences in gut microbiota composition between individuals affects the ability of microbiota to produce tryptophan metabolites influencing AHR signaling."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;PROBIOTICS&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"Probiotics may improve gut health by modulating microbiota activity and supporting tryptophan metabolism, positively impacting AHR activation."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;PREBIOTICS&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Prebiotics serve as a food source for beneficial gut bacteria promoting microbiota health; they may influence tryptophan metabolism and AHR signaling."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;MICROBIAL METABOLITES&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Metabolites from gut microbes can stimulate or inhibit the AHR pathway, influencing inflammatory processes in various diseases including IBD."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;ALTERATION&quot;&lt;|&quot;ALTERED BACTERIAL MICROBIOTA COMPOSITION DURING COLITIS AFFECTS INFLAMMATORY RESPONSES AND HEALING PROCESSES.&quot;)(&quot;ENTITY&quot;">
      <data key="d2">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
      <data key="d1">"Cytokine Storm"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;BACTERIAL MICROBIOTA&quot;">
      <data key="d2">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
      <data key="d1">"Cytokine Storm"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CARD9 DEFICIENCY&quot;">
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d1">"Card9 deficiency contributes to gut microbiota-induced susceptibility to colitis by disrupting IL-22 signaling and tryptophan metabolism.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GUT MICROBIOTA&quot;">
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d1">"Card9 deficiency contributes to gut microbiota-induced susceptibility to colitis by disrupting IL-22 signaling and tryptophan metabolism.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MICROBIOTA DERIVED AHR LIGANDS&quot;">
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d1">"Gut microbiota produces ligands that stimulate AHR signaling; reduction is observed in subjects with IBD.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RISK ALLELE (RS10781499)&quot;">
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d1">"The risk allele of CARD9 SNP influences the ability of gut microbiota to produce AHR agonists, affecting AHR signaling in IBD patients.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IBD&quot;">
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d1">"Major IBD-associated SNPs do not significantly affect the ability of gut microbiota to produce AHR agonists.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NOD2, ATG16L1, LRRK2 SNPS&quot;">
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d1">"Major IBD-associated SNPs do not significantly affect the ability of gut microbiota to produce AHR agonists.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ALTERATIONS IN TRYPTOPHAN METABOLISM&quot;">
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d1">"Decreased tryptophan metabolites are associated with autoinflammatory conditions, impacting the balance of inflammation and immunological tolerance.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GUT HEALTH&quot;">
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d1">"Probiotics can improve gut health by modulating microbiota composition and supporting AHR pathway regulation.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PROBIOTICS TREATMENT&quot;">
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d1">"Probiotics can improve gut health by modulating microbiota composition and supporting AHR pathway regulation.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PREBIOTIC SUPPLEMENTATION&quot;">
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d1">"Prebiotics facilitate nutrient absorption including tryptophan, which impacts the synthesis of microbiota-derived metabolites affecting AHR signaling.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MICROBIAL METABOLITE PRODUCTION&quot;">
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d1">"Increased production of certain microbial metabolites by gut bacteria can stimulate or inhibit AHR activation, impacting immune responses and inflammation.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;Β2M&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The study focused on baseline β2M concentration as a biomarker for hypertension risk."&lt;SEP&gt;"β2-microglobulin (β2m) is an auxiliary protein that binds to HLA class I molecules, like HLA-B*15:01, facilitating the presentation of peptides for T-cell recognition."</data>
      <data key="d2">chunk-830d8819004960d1d149ac70149c72a0&lt;SEP&gt;chunk-c29d575e156569afaa1ca3d6418a71b9</data>
    </node>
    <node id="&quot;PREVALENT HYPERTENSION&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Baseline β2M concentration was positively associated with prevalent hypertension in the study sample."</data>
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
    </node>
    <node id="&quot;ODDS RATIO (OR)&quot;">
      <data key="d0">"STATISTICAL MEASURE"</data>
      <data key="d1">"The OR of 1.14 and 1.29 for baseline β2M concentration were used to assess its association with hypertension."</data>
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
    </node>
    <node id="&quot;NEW-ONSET HYPERTENSION&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A total of 886 participants developed new-onset hypertension after a mean follow-up of six years."</data>
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
    </node>
    <node id="&quot;GEE MODEL&quot;">
      <data key="d0">"STATISTICAL METHOD"</data>
      <data key="d1">"GEE model was used to identify the association between baseline β2M and risk of new-onset hypertension."</data>
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
    </node>
    <node id="&quot;BASELINE Β2M&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"The relationship between baseline β2M concentration and hypertension was analyzed using a GEE model adjusted for clinical covariates."</data>
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
    </node>
    <node id="&quot;DIABETES&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Age-dependent increase in glucose levels with early onset diabetes observed in SENP1-deficient mice compared to control mice."&lt;SEP&gt;"Increased systemic cytokines indicate a prevalence of diabetic phenotype at age 14 weeks or older."&lt;SEP&gt;"NOD develops diabetes as a result of Th1 dominant IFN-γ-induced insulitis and leukocyte infiltrations of the pancreatic islets."&lt;SEP&gt;"One of the baseline covariates used in statistical models to adjust for potential confounders was diabetes."&lt;SEP&gt;"Diabetes is another disease that could impact the correlation between alcohol consumption, physical activity, and cortisol levels."</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c&lt;SEP&gt;chunk-9e14f9bdee02839e4a6b12cff2020a5a&lt;SEP&gt;chunk-c29d575e156569afaa1ca3d6418a71b9&lt;SEP&gt;chunk-8382a49b61215482f9fc75e3a86cb987&lt;SEP&gt;chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
      <data key="d3">[{"level": 0, "cluster": 15}, {"level": 1, "cluster": 50}]</data>
    </node>
    <node id="&quot;CIGARETTE SMOKING&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Another baseline covariate considered was cigarette smoking, which is an environmental factor."</data>
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
    </node>
    <node id="&quot;SYSTOLIC AND DIASTOLIC BLOOD PRESSURE (BP)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Levels of systolic and diastolic blood pressure were among the factors used to assess baseline hypertension risk."</data>
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
    </node>
    <node id="&quot;INTEGRATED DISCRIMINATION IMPROVEMENT (IDI)&quot;">
      <data key="d0">"STATISTICAL MEASURE"</data>
      <data key="d1">"The IDI was used as a metric in reclassification analyses for predicting new-onset hypertension."</data>
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
    </node>
    <node id="&quot;CONTINUOUS NET RECLASSIFICATION INDEX (NRI)&quot;">
      <data key="d0">"STATISTICAL MEASURE"</data>
      <data key="d1">"The NRI revealed the improvement of β2M prediction over clinical models for new-onset hypertension."</data>
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
    </node>
    <node id="&quot;RS3184504 POLYMORPHISM&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This genetic variant is associated with plasma β2M levels and SH2B3 expression."</data>
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
    </node>
    <node id="&quot;SH2B3 EXPRESSION&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The association between the rs3184504 polymorphism and SH2B3 expression was tested using Mendelian randomization."</data>
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
    </node>
    <node id="&quot;DECREASED SH2B3 EXPRESSION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Decreased SH2B3 expression was found to be causal for higher β2M levels through Mendelian randomization."</data>
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
    </node>
    <node id="&quot;SH2B3 DEFICIENCY&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR (IN A MOUSE MODEL)"</data>
      <data key="d1">"Testing effects of SH2B3 deficiency on β2M expression in mice helped validate the hypothesis."</data>
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
    </node>
    <node id="&quot;Β2M EXPRESSION&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"In response to angiotensin II administration, Sh2b3−/− mice showed a significant induction of β2M expression, suggesting normal constraint by SH2B3 for β2M in hypertensive conditions."</data>
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
    </node>
    <node id="&quot;SH2B3&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"SH2B3 is a protein that plays a role in constraining β2M expression in response to hypertensive stimuli."</data>
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
    </node>
    <node id="&quot;SH2B3−/− MOUSE MODEL&quot;">
      <data key="d0">"MODEL"</data>
      <data key="d1">"The Sh2b3−/− mouse model was used to test the effects of SH2B3 deficiency on β2M expression and hypertension."</data>
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
    </node>
    <node id="&quot;ANGIOTENSIN II INFUSION&quot;">
      <data key="d0">"EXPERIMENTAL PROCEDURE"</data>
      <data key="d1">"Angiotensin II infusion in Sh2b3−/− mice was performed to study their hypertensive response and renal/vascular dysfunction."</data>
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
    </node>
    <node id="&quot;LONGITUDINAL ANALYSES&quot;">
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
      <data key="d1">"The GEE model was employed to analyze the relationship between baseline β2M and risk for new-onset hypertension during follow-up.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;REGULATION OF Β2M EXPRESSION&quot;">
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
      <data key="d1">"SH2B3 normally regulates β2M expression during hypertensive stimuli, as shown by the induction in Sh2b3−/− mice.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HISPANIC&quot;">
      <data key="d0">"RACE/ETHNICITY"</data>
      <data key="d1">"Hispanic mothers were younger at delivery compared to non-Hispanic White mothers."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;NON-HISPANIC WHITE&quot;">
      <data key="d0">"RACE/ETHNICITY"</data>
      <data key="d1">"Non-Hispanic White mothers had a mean age of 31.8 years, while Hispanic mothers had a mean age of 27.0 years."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;MATERNAL AGE&quot;">
      <data key="d0">"AGE RANGE"</data>
      <data key="d1">"Maternal age at delivery was consistent across cases and controls within maternal race/ethnicity."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;YEARS OF FORMAL EDUCATION&quot;">
      <data key="d0">"EDUCATION LEVEL"</data>
      <data key="d1">"Case mothers had fewer years of formal education compared to control mothers, and Hispanic mothers had fewer years of formal education than non-Hispanic White mothers."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;FOLIC ACID SUPPLEMENTS&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Maternal periconceptional use of folic acid supplements was higher in non-Hispanic Whites than in Hispanic mothers."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d3">[{"level": 0, "cluster": 10}, {"level": 1, "cluster": 33}]</data>
    </node>
    <node id="&quot;DAILY DIETARY INTAKE OF FOLATE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"There were differences in daily dietary intake of folate across subgroups, but the variations were subtle."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;COMPOSITE FOLATE INTAKE VARIABLE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"The composite folate intake variable showed more substantial variation within and across subgroups."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;DHFR&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"There was no evidence of a nonrandom association between NTD-affected pregnancies and either maternal or infant variants in DHFR."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;INFANT MTHFD1 SNPS RS2236224 AND RS2236225&quot;">
      <data key="d0">"SNP"</data>
      <data key="d1">"Infants with the CT genotype had an approximate 1.5-fold increase in risk compared to those with the CC genotype."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d3">[{"level": 0, "cluster": 5}]</data>
    </node>
    <node id="&quot;FOLIC ACID INTAKE CATEGORY&quot;">
      <data key="d0">"NUTRIENT INTAKE"</data>
      <data key="d1">"The OR[int CC vs. CT] for infants with the CT genotype was calculated based on folic acid intake categories."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;INFANT AG GENOTYPE IN MTHFD1 SNP RS11627387&quot;">
      <data key="d0">"SNP"</data>
      <data key="d1">"Infants with the AG genotype appeared to have a four-fold increase in risk compared to those with the GG genotype, particularly when maternal folate intake was low."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d3">[{"level": 0, "cluster": 5}]</data>
    </node>
    <node id="&quot;MTHFR SNPS RS1476413, RS1801131 AND RS1801133&quot;">
      <data key="d0">"SNP"</data>
      <data key="d1">"Mothers had a decreased risk of an NTD-affected pregnancy when they had low intake of folates compared to common homozygous mothers in the high folate intake group."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d3">[{"level": 0, "cluster": 5}]</data>
    </node>
    <node id="&quot;SHMT1 SNP RS669340 CG GENOTYPE&quot;">
      <data key="d0">"SNP"</data>
      <data key="d1">"A maternal gene-only effect was associated with a reduced risk of an NTD-affected pregnancy for SHMT1, particularly when compared to mothers with the CC genotype."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d3">[{"level": 0, "cluster": 5}]</data>
    </node>
    <node id="&quot;INFANTS WITH THE SHMT1 SNP RS12939757 AG GENOTYPE&quot;">
      <data key="d0">"SNP"</data>
      <data key="d1">"An interaction effect was observed for infants with low folate intake and this AG genotype, which showed an association with increased risk compared to those with AA or CC genotypes."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d3">[{"level": 0, "cluster": 5}]</data>
    </node>
    <node id="&quot;TYMS SNPS RS502396 OR RS699517&quot;">
      <data key="d0">"SNP"</data>
      <data key="d1">"The gene-folate interaction was associated with a reduced risk of NTDs for mothers in the low folate intake group, particularly when compared to high-folate intake groups."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;INFANTS WITH THE TYMS SNP RS2847153 AG GENOTYPE&quot;">
      <data key="d0">"SNP"</data>
      <data key="d1">"An interaction effect on infants was also protective against risk for this SNP when they were in a low folate intake group, relative to those in high-folate intake groups."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d3">[{"level": 0, "cluster": 5}]</data>
    </node>
    <node id="&quot;NON-HISPANIC WHITE INFANTS&quot;">
      <data key="d0">"OUTCOME"</data>
      <data key="d1">"Non-Hispanic White infants showed lower incidences of adverse outcomes related to folic acid intake and MTHFR, DHFR SNPs compared to Hispanic infants.")</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;SHMT1 SNPS&quot;">
      <data key="d0">"GENE MUTATIONS"</data>
      <data key="d1">"Variations in SHMT1 genes across different race/ethnicity groups influenced the risk of having an NTD-affected pregnancy for mothers with low folate intake.")</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;INFANTS WITH TYMS SNPS RS502396 OR RS699517 HOMOZYGOUS GENOTYPE&quot;">
      <data key="d0">"SNP IMPACT"</data>
      <data key="d1">"Infants inheriting the homozygous variant for either of these two TYMS SNPs showed protective effects against NTDs when their mothers had low folate intake.")</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;MOTHERS WITH DHFR SNPS VARIANTS&quot;">
      <data key="d0">"GENETIC FACTORS"</data>
      <data key="d1">"Maternal genetic variations in DHFR SNPs were associated with an increased risk of having an NTD-affected pregnancy, particularly among Hispanic mothers.")</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;NON-HISPANIC WHITE MOTHERS&quot;">
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d1">"Non-Hispanic White mothers had a mean age of 31.8 years, while Hispanic mothers had a mean age of 27.0 years.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CASE INFANTS&quot;">
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d1">"Case infants were more likely to be female than control infants and had different patterns in maternal periconceptional use of folic acid supplements compared to non-Hispanic White mothers.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 10}, {"level": 1, "cluster": 33}]</data>
    </node>
    <node id="&quot;HISPANIC MOTHERS&quot;">
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d1">"Hispanic mothers had fewer years of formal education compared to non-Hispanic White mothers.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;AGE RANGE&quot;">
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d1">"Maternal age at delivery was consistent across cases and controls within maternal race/ethnicity.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MATERNAL AGE AT DELIVERY&quot;">
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d1">"Maternal age at delivery was consistent across cases and controls within maternal race/ethnicity.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NUTRIENT INTAKE&quot;">
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d1">"There were differences in daily dietary intake of folate across subgroups, but the variations were subtle among different race/ethnicity groups.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DHFR SNPS&quot;">
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d1">"There was no evidence of a nonrandom association between NTD-affected pregnancies and either maternal or infant variants in DHFR.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 8}, {"level": 1, "cluster": 28}]</data>
    </node>
    <node id="&quot;INFANTS WITH THE TYMS SNPS RS502396 OR RS699517 HOMOZGOUS GENOTYPE&quot;">
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d1">"A gene-folate interaction was associated with a reduced risk of NTDs for mothers in low folate intake groups, compared to high-folate intake groups.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 5}]</data>
    </node>
    <node id="&quot;HISPANIC INFANTS&quot;">
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d1">"Hispanic infants had a higher rate of Neural Tube Defects (NTDs) compared to non-Hispanic White infants.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NTD RATE&quot;">
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d1">"Hispanic infants had a higher rate of Neural Tube Defects (NTDs) compared to non-Hispanic White infants.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HISPANIC INFANTS WITH AG GENOTYPE IN MTHFD1 SNP RS12939757&quot;">
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d1">"Infants carrying the AG genotype displayed increased risks for NTDs when maternal folate intake was low, compared to GG genotype carriers.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SNP OUTCOMES&quot;">
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d1">"Infants carrying the AG genotype displayed increased risks for NTDs when maternal folate intake was low, compared to GG genotype carriers.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENETIC RISK FACTOR&quot;">
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d1">"Mothers carrying the CG genotype in SHMT1 had a reduced risk of NTDs when their folate intake was low, compared to CC and GG genotypes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MOTHERS CARRYING RS669340 CG GENOTYPE&quot;">
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d1">"Mothers carrying the CG genotype in SHMT1 had a reduced risk of NTDs when their folate intake was low, compared to CC and GG genotypes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENETIC RISK&quot;">
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d1">"The presence of the CT genotype for these two specific MTHFD1 SNPs increased infant risk for NTDs when maternal folate intake was low.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INFANTS WITH AG GENOTYPE IN MTHFD1 SNPS RS2236224 AND RS2236225&quot;">
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d1">"The presence of the CT genotype for these two specific MTHFD1 SNPs increased infant risk for NTDs when maternal folate intake was low.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS10399931&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"No association found between rs10399931 and T2D after adjustment for age, sex, BMI and glucose tolerance."</data>
      <data key="d2">chunk-44a871da300abc9be525b468f502f5cb</data>
    </node>
    <node id="&quot;RS4950928&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"No association found between rs4950928 and T2D after adjusting for age, sex, BMI, and glucose tolerance."</data>
      <data key="d2">chunk-44a871da300abc9be525b468f502f5cb</data>
    </node>
    <node id="&quot;CHI3LI HAPLOTYPE BLOCK&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The two identified haplotype blocks of CHI3LI did not show any association with T2D."</data>
      <data key="d2">chunk-44a871da300abc9be525b468f502f5cb</data>
    </node>
    <node id="&quot;T2D (TYPE 2 DIABETES)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"None of the investigated SNPs showed significant associations with Type 2 diabetes."&lt;SEP&gt;"T2D was assessed for its association with epigenetic variation at specific CpGs."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e&lt;SEP&gt;chunk-44a871da300abc9be525b468f502f5cb</data>
    </node>
    <node id="&quot;IGT (IMPAIRED GLUCOSE TOLERANCE)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A borderline protective association was detected for rs12123883 with IGT, but this is not a significant association."</data>
      <data key="d2">chunk-44a871da300abc9be525b468f502f5cb</data>
    </node>
    <node id="&quot;SERUM C-PEPTIDE CONCENTRATION AFTER 2 HOURS&quot;">
      <data key="d2">chunk-44a871da300abc9be525b468f502f5cb</data>
      <data key="d1">"A significant association was found between rs10399931 and serum C-peptide concentration after 2 hours, p=0.03.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS10399931/4950928&quot;">
      <data key="d2">chunk-44a871da300abc9be525b468f502f5cb</data>
      <data key="d1">"No significant associations between rs10399931 or rs4950928 and any T2D quantitative traits were found.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;T2D QUANTITATIVE TRAITS&quot;">
      <data key="d2">chunk-44a871da300abc9be525b468f502f5cb</data>
      <data key="d1">"No significant associations between rs10399931 or rs4950928 and any T2D quantitative traits were found.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CHI3LI HAPLOTYPE BLOCKS&quot;">
      <data key="d2">chunk-44a871da300abc9be525b468f502f5cb</data>
      <data key="d1">"The two identified haplotype blocks of CHI3LI did not show any association with T2D.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;T2D QUANTITATIVE TRAITS (BMI, C-PEPTIDE CONCENTRATION)&quot;">
      <data key="d2">chunk-44a871da300abc9be525b468f502f5cb</data>
      <data key="d1">"The results showed no significant associations between rs10399931 and quantitative traits related to T2D such as BMI or C-peptide concentration.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;AMD&quot;">
      <data key="d0">"GENETIC RISK FACTOR"</data>
      <data key="d1">"Joint effects of lifestyle and variants in complement pathway genes were explored to understand their combined influence on AMD risk."&lt;SEP&gt;"The presence of one or two A69S risk alleles and poor lifestyle leads to higher odds for AMD compared to no risk alleles and high HLS."&lt;SEP&gt;"The presence of risk CFH alleles increases the odds for AMD."&lt;SEP&gt;"There were 337 cases of AMD in the full sample, of which 91% were early stages of AMD."</data>
      <data key="d2">chunk-23a090455f50ab98c53e8b90941c6da5&lt;SEP&gt;chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
      <data key="d3">[{"level": 0, "cluster": 0}]</data>
    </node>
    <node id="&quot;HLS&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"The HLS score indicates dietary lifestyle, with low (0–2) and high scores (4–6)."</data>
      <data key="d2">chunk-23a090455f50ab98c53e8b90941c6da5</data>
    </node>
    <node id="&quot;Y402H CFH RISK ALLELE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The Y402H CFH risk allele is associated with increased odds for AMD."</data>
      <data key="d2">chunk-23a090455f50ab98c53e8b90941c6da5</data>
    </node>
    <node id="&quot;A69S RISK ALLELE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Having at least one ARMS2 risk allele and poor lifestyle increases the odds for AMD compared to zero risk alleles and high HLS."&lt;SEP&gt;"The A69S risk allele also increases the odds of AMD."</data>
      <data key="d2">chunk-23a090455f50ab98c53e8b90941c6da5</data>
      <data key="d3">[{"level": 0, "cluster": 0}]</data>
    </node>
    <node id="&quot;G ALLELE OF RS641153 (CFB/C2)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The G allele modifies the CFB gene function associated with increased odds of AMD."&lt;SEP&gt;"rs641153 affects the CFB gene and is associated with increased odds of AMD."</data>
      <data key="d2">chunk-23a090455f50ab98c53e8b90941c6da5</data>
      <data key="d3">[{"level": 0, "cluster": 0}]</data>
    </node>
    <node id="&quot;RS10033900 (CFI)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"No evidence for association between rs10033900 and AMD within CAREDS dataset."&lt;SEP&gt;"No main effect was observed for rs10033900 in CAREDS when considering overall population."</data>
      <data key="d2">chunk-23a090455f50ab98c53e8b90941c6da5</data>
      <data key="d3">[{"level": 0, "cluster": 0}]</data>
    </node>
    <node id="&quot;RS2230199 (C3)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"No association was found with rs2230199 and AMD within the CAREDS dataset."&lt;SEP&gt;"No statistical significance found with rs2230199 in relation to AMD in CAREDS data."</data>
      <data key="d2">chunk-23a090455f50ab98c53e8b90941c6da5</data>
      <data key="d3">[{"level": 0, "cluster": 0}]</data>
    </node>
    <node id="&quot;CFH GENOTYPE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The joint effect of poor lifestyle score (HLS) and a high-risk CFH genotype (CC) in women leads to greater odds of AMD compared to low genetic risk and healthy lifestyle."</data>
      <data key="d2">chunk-23a090455f50ab98c53e8b90941c6da5</data>
    </node>
    <node id="&quot;HEALTHY LIFESTYLE SCORE (HLS)&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"In the full sample, having two high risk CFH alleles with a low HLS score increases the odds for AMD, compared to low genetic risk and healthy lifestyle."&lt;SEP&gt;"In the full sample, having two high risk CFH alleles with a low HLS score increases the odds for AMD, compared to low risk genotype with high HLS."</data>
      <data key="d2">chunk-23a090455f50ab98c53e8b90941c6da5</data>
    </node>
    <node id="&quot;Ω-3 FATTY ACIDS&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"The intake of omega-3 fatty acids does not influence the association between HLS and AMD in women with high risk CFH genotype."</data>
      <data key="d2">chunk-23a090455f50ab98c53e8b90941c6da5</data>
    </node>
    <node id="&quot;ARMS2 GENOTYPE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"In women with ARMS2 risk allele, having poor lifestyle has an increased but not clearly discernible joint effect when cross-classified due to low sample size."</data>
      <data key="d2">chunk-23a090455f50ab98c53e8b90941c6da5</data>
    </node>
    <node id="&quot;LIFESTYLE&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"There was no evidence for a multiplicative interaction between lifestyle and AMD risk."</data>
      <data key="d2">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
      <data key="d3">[{"level": 0, "cluster": 2}, {"level": 1, "cluster": 9}]</data>
    </node>
    <node id="&quot;CFB/C2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Joint effects of lifestyle score and variants in additional complement pathway genes like CFB/C2 were explored."</data>
      <data key="d2">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
      <data key="d3">[{"level": 0, "cluster": 2}, {"level": 1, "cluster": 9}]</data>
    </node>
    <node id="&quot;C3 RS2230199&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNP in the complement pathway genes like C3 were explored along with HLS, but their interaction was unreliable."</data>
      <data key="d2">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
      <data key="d3">[{"level": 0, "cluster": 2}, {"level": 1, "cluster": 9}]</data>
    </node>
    <node id="&quot;CFI RS10033900&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Similar to C3, the SNP in complement pathway gene like CFI was also explored along with HLS for its interaction effects on AMD risk."</data>
      <data key="d2">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
      <data key="d3">[{"level": 0, "cluster": 2}, {"level": 1, "cluster": 9}]</data>
    </node>
    <node id="&quot;Y402H CFH ALLELE&quot;">
      <data key="d2">chunk-23a090455f50ab98c53e8b90941c6da5</data>
      <data key="d1">"Women carrying two copies of Y402H CFH risk allele had approximately 2.4 times greater odds for developing AMD compared to those with no such alleles.")&lt;SEP&gt;"Women with two copies of the Y402H CFH allele had 2.4 times greater odds of AMD relative to women without any copies.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 0}]</data>
    </node>
    <node id="&quot;HLS SCORE&quot;">
      <data key="d2">chunk-23a090455f50ab98c53e8b90941c6da5</data>
      <data key="d1">"In women with high genetic risk for AMD, a lower HLS (indicating unhealthy dietary habits) was significantly associated with an increased likelihood of AMD compared to those with both low genetic risk and good dietary habits.")&lt;SEP&gt;"In women with high genetic risk, HLS scores were significantly associated with an increased likelihood of AMD.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 0}]</data>
    </node>
    <node id="&quot;CFH GENOTYPE (CC)&quot;">
      <data key="d2">chunk-23a090455f50ab98c53e8b90941c6da5</data>
      <data key="d1">"A joint effect is observed between having both two high-risk CFH alleles and a low HLS score compared to low risk genotypes and high HLS, associated with higher odds for AMD.")&lt;SEP&gt;"The combination of two high-risk CFH alleles and a poor HLS score was significantly associated with higher odds for AMD than individuals with low risk genotypes and healthy lifestyle scores.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 0}]</data>
    </node>
    <node id="&quot;LIFESTYLE FACTORS (DIETARY LIFESTYLE SCORES)&quot;">
      <data key="d2">chunk-23a090455f50ab98c53e8b90941c6da5</data>
      <data key="d1">"For women carrying ARMS2 risk allele, poor lifestyle was associated with higher odds of AMD compared to those without the ARMS2 risk allele and maintaining a healthy diet.")&lt;SEP&gt;"In the full sample, a significant interaction between dietary lifestyle scores and CFH genotype was observed in predicting higher odds for AMD compared to other genetic risk groups.")&lt;SEP&gt;"In the full sample, there's an interaction between lifestyle factors and CFH genotype leading to increased odds of AMD compared to other genetic risk groups.")&lt;SEP&gt;"In women carrying the ARMS2 risk allele, having poor lifestyle with HLS leads to higher odds for AMD compared to no risk alleles and high HLS.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 0}]</data>
    </node>
    <node id="&quot;INTERACTION EFFECT (CFH GENOTYPES AND HLS)&quot;">
      <data key="d2">chunk-23a090455f50ab98c53e8b90941c6da5</data>
      <data key="d1">"The joint impact of poor lifestyle score and the high-risk CFH genotype was found to be more than additive for AMD risks, suggesting synergy in this relationship.")&lt;SEP&gt;"The joint impact of poor lifestyle score on diet and high-risk CFH genotype was found to amplify the odds of AMD compared to having low-risk genotypes and a healthy lifestyle.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 0}]</data>
    </node>
    <node id="&quot;Ω-3 FATTY ACIDS INTAKE&quot;">
      <data key="d2">chunk-23a090455f50ab98c53e8b90941c6da5</data>
      <data key="d1">"No influence on the association between HLS score and AMD risk, when adjusted for omega-3 fatty acid consumption.")&lt;SEP&gt;"No significant influence on the association between HLS and AMD when adjusted for omega-3 fatty acid intake.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 0}]</data>
    </node>
    <node id="&quot;SYNERGY INDEX (ARMS2 AND LIFESTYLE)&quot;">
      <data key="d2">chunk-23a090455f50ab98c53e8b90941c6da5</data>
      <data key="d1">"The combined effect of one or more ARMS2 risk alleles with poor lifestyle had an additive yet not significant 0.9 times increase in the odds for AMD compared to individuals without ARMS2 risk alleles and having a healthy lifestyle.")&lt;SEP&gt;"The synergy of ARMS2 genetic risk with poor lifestyle was statistically significant but did not reach the level of additive effects, implying more than additive impact on AMD risks.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 0}]</data>
    </node>
    <node id="&quot;CFB/C2, C3 RS2230199, CFI RS10033900&quot;">
      <data key="d2">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
      <data key="d1">"Interaction analysis revealed that while there were joint effects between lifestyle and genotypes in complement pathway genes, the estimates for synergy were unreliable.")&lt;SEP&gt;"The combined effect of lifestyle and these genotypes was not reliable for estimating synergy due to uncertain odds distribution.")&lt;SEP&gt;"The exploration focused on the joint effect of these genotypes along with lifestyle score in influencing AMD risk.")&lt;SEP&gt;"The interaction analysis of these genotypes with lifestyle did not yield clear evidence for deviation from additive or multiplicative effects.")&lt;SEP&gt;"The reliability of synergy estimates for these genotypes and HLS was low due to their combination leading to variable odds for AMD.")&lt;SEP&gt;"There was no evidence to suggest that lifestyle significantly influences the effect of these genotypes on AMD risk.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 2}, {"level": 1, "cluster": 9}]</data>
    </node>
    <node id="&quot;TRANSCRIPTS&quot;">
      <data key="d2">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
      <data key="d1">"Lifestyle factors could influence the expression levels of relevant transcripts, affecting AMD risk through this mechanism.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 2}, {"level": 1, "cluster": 9}]</data>
    </node>
    <node id="&quot;PROTEINS&quot;">
      <data key="d2">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
      <data key="d1">"Lifestyle may impact the function or concentration of proteins associated with these genes, potentially affecting AMD risk.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 2}, {"level": 1, "cluster": 9}]</data>
    </node>
    <node id="&quot;MOLECULAR INTERACTIONS&quot;">
      <data key="d2">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
      <data key="d1">"Lifestyle factors could alter the dynamics of molecular interactions relevant to AMD risk.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 2}, {"level": 1, "cluster": 9}]</data>
    </node>
    <node id="&quot;PHYSIOLOGICAL PROCESSES&quot;">
      <data key="d2">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
      <data key="d1">"Lifestyle may modify or optimize these processes, which might influence AMD risk in a positive or negative way.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 2}, {"level": 1, "cluster": 9}]</data>
    </node>
    <node id="&quot;METABOLIC PATHWAYS&quot;">
      <data key="d2">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
      <data key="d1">"Lifestyle interventions might influence these pathways, potentially affecting AMD risk through such modifications.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 2}, {"level": 1, "cluster": 9}]</data>
    </node>
    <node id="&quot;1Q24&quot;">
      <data key="d0">"CHROMOSOME/GENOMIC REGION"</data>
      <data key="d1">"A location on chromosome 1 where several SNPs associated with coffee consumption were identified."</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;COFFEE CONSUMPTION&quot;">
      <data key="d0">"HABITUAL BEHAVIOR"/"COFFEE DRINKING HABIT"</data>
      <data key="d1">"The regular intake or consumption of coffee."</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;BLACK COFFEE&quot;">
      <data key="d0">"SPECIFIC TYPE OF COFFEE"/"UNSWEETENED COFFEE"</data>
      <data key="d1">"A type of coffee that is not sweetened, typically consumed as a beverage."</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;SUGARED COFFEE&quot;">
      <data key="d0">"SPECIFIC TYPE OF COFFEE"/"SWEETENED COFFEE"</data>
      <data key="d1">"Coffee that has been sweetened with sugar or another sweetener."</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;PREDIABETES&quot;">
      <data key="d0">"CONDITION"/"STAGE BEFORE TYPE 2 DIABETES"</data>
      <data key="d1">"Pre-diabetic condition where blood sugar levels are higher than normal but not yet high enough for a diagnosis of diabetes."</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;GENETIC POLYMORPHISMS&quot;">
      <data key="d0">"VARIATION IN DNA SEQUENCE"/"GENETIC VARIATION"</data>
      <data key="d1">"Alterations or changes to the sequence of DNA that occur at specific points in the genome."</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d3">[{"level": 0, "cluster": 4}]</data>
    </node>
    <node id="&quot;HECTD4 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene located on chromosome 1q24, one of the genes associated with coffee consumption."</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;ACAD10 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene involved in acyl-CoA dehydrogenase activity and was identified as related to coffee consumption."</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;MYL2 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A muscle-specific myosin light chain 2 gene, one of the genes associated with coffee consumption."</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;CUX2 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene encoding a member of the CXC motif chemokine family and was identified as related to coffee consumption."</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;COFFEE-RELATED SNPS&quot;">
      <data key="d0">"SELECTED GENETIC VARIANTS"/"SNPS USED FOR GENETIC RISK SCORES"</data>
      <data key="d1">"Specific SNPs that were selected due to their association with habitual coffee consumption for further analysis."</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;IDENTIFIED SNPS&quot;">
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d1">"Genetic polymorphisms associated with coffee consumption were identified through a GWAS.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 1}, {"level": 1, "cluster": 8}]</data>
    </node>
    <node id="&quot;BLACK COFFEE&quot;/&quot;SUGARED COFFEE&quot;">
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d1">"Consumption of black or sugared coffee was assessed in relation to prediabetes and type 2 diabetes risk.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RISK SCORE CALCULATION&quot;">
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d1">"Five SNPs were selected based on their association with coffee consumption for use in calculating genetic risk scores.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 4}]</data>
    </node>
    <node id="&quot;ASSOCIATIONS&quot;">
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d1">"Associations between habitual coffee consumption and prediabetes/type 2 diabetes varied based on the subgroup analysis of coffee types (black vs. sugared).")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GWAS&quot;/&quot;COFFEESUBGROUPS/">
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d1">"Associations between habitual coffee consumption and prediabetes/type 2 diabetes varied based on the subgroup analysis of coffee types (black vs. sugared).")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENETIC POLYMORPHISMS&quot;/&quot;COFFEE CONSUMPTION/&quot;&gt;">
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d1">"The relationship between coffee consumption and the risk of prediabetes or type 2 diabetes was modified by genetic polymorphisms.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INFLUENCE&quot;">
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d1">"The relationship between coffee consumption and the risk of prediabetes or type 2 diabetes was modified by genetic polymorphisms.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;BODY MEASUREMENT&quot;/&quot;BODY MASS INDEX&quot;">
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d1">"A measure of body fat based on height and weight, used as an indicator in this context.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CONDITION&quot;/&quot;PRE-DIABETIC CONDITION&quot;">
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d1">"Stage before type 2 diabetes where blood sugar levels are higher than normal but not yet high enough for a diagnosis of diabetes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DISEASE/">
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d1">"Chronic disease characterized by high blood glucose levels, caused when the body fails to produce sufficient insulin or cannot use it effectively.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 6}]</data>
    </node>
    <node id="&quot;ASSESSMENT&quot;/&quot;EVALUATION OF GENETIC PREDISPOSITION&quot;">
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d1">"A tool used to calculate an individual's likelihood of developing prediabetes or type 2 diabetes based on their genetic makeup.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENETIC RISK SCORES/">
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d1">"A tool used to calculate an individual's likelihood of developing prediabetes or type 2 diabetes based on their genetic makeup.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SPECIFIC TYPE OF COFFEE&quot;/&quot;UNSWEETENED COFFEE&quot;">
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d1">"A variant of coffee that is not sweetened, typically consumed as a beverage.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SPECIFIC TYPE OF COFFEE&quot;/&quot;SWEETENED COFFEE&quot;">
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d1">"Coffee that has been sweetened with sugar or another sweetener.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SUGARED COFFEE/">
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d1">"Coffee that has been sweetened with sugar or another sweetener.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SENP1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"An autoantigen NRP-V7-positive CD8+ T cells were detected in the pancreatic lymph nodes and spleen of SENP1-aP2KO mice."&lt;SEP&gt;"Regulated by conditional media of SENP1-aP2KO pancreatic adipocytes and involved in NF-κB dependent inflammation."&lt;SEP&gt;"SENP1 deletion augments NEMO SUMOylation in adipocytes."&lt;SEP&gt;"SENP1 is a gene that plays a role in diabetes development."&lt;SEP&gt;"Senp1 is a gene that plays an important role in diabetes development."&lt;SEP&gt;"The gene Senp1 was deficient in mice, leading to a T1DM phenotype."&lt;SEP&gt;"We first investigated whether there is a correlation between SENP1 expression in adipocytes of non-obese diabetic (NOD) mice and human T1DM patients."</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c&lt;SEP&gt;chunk-174831b97ed170039b374ba254d4f506&lt;SEP&gt;chunk-fc33d6399ec56e65d007269407f1953d&lt;SEP&gt;chunk-8382a49b61215482f9fc75e3a86cb987&lt;SEP&gt;chunk-eaf655c4dd9244523b048a122e232be4&lt;SEP&gt;chunk-0c1631ae2c195cb68139ea9d75a3b433&lt;SEP&gt;chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
      <data key="d3">[{"level": 0, "cluster": 15}, {"level": 1, "cluster": 54}]</data>
    </node>
    <node id="&quot;ADIPONECTIN, PDGFRΑ, AND AP2/FABP4&quot;">
      <data key="d0">"GENE PROMOTERS"</data>
      <data key="d1">"Three different gene promoters were used to drive Cre recombinase in adipocyte-specific deletion of Senp1: Adiponectin, PdgfRα, or aP2/Fabp4."</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;MRNA AND PROTEIN&quot;">
      <data key="d0">"EXPRESSION"</data>
      <data key="d1">"The expression of Senp1 mRNA and protein was diminished in isolated adipocytes from specific tissues like brown, white, and peri-pancreatic adipose tissue of SENP1-deficient mice."</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;ISOLATED ADIPOCYTES&quot;">
      <data key="d0">"ADIPOCYTE"</data>
      <data key="d1">"The adipocytes isolated from interscapular brown, perigonadal white, and peri-pancreatic adipose tissue were used to study Senp1 expression in specific mice strains."</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;MACROPHAGES AND PANCREATIC ISLETS&quot;">
      <data key="d0">"CELL TYPES"</data>
      <data key="d1">"SENP1 expression was intact in isolated macrophages but not in pancreatic islets from SENP1-deficient mice."</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;PAT&quot;">
      <data key="d0">"ADIPOSE TISSUE"</data>
      <data key="d1">"Enhanced green fluorescent protein was detected in peri-pancreatic adipose tissue (PAT) but not in pancreatic islets when aP2-Cre deleter mice were mated with mT/mG reporter mice."</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;INSULIN LEVELS&quot;">
      <data key="d0">"HORMONE"</data>
      <data key="d1">"Insulin levels in plasma were measured at various ages and showed significantly declined insulin secretion after ages 8 and 10 weeks, respectively, in SENP1-deficient mice compared to control mice."</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;GTT ANDITT&quot;">
      <data key="d0">"TESTS"</data>
      <data key="d1">"Glucose tolerance test (GTT) and insulin tolerance test (ITT) were performed to evaluate diabetes and insulin resistance in aged SENP1-deficient mice."</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;SMOOTH MUSCLE CELLS/PERICYTES&quot;">
      <data key="d0">"CELL TYPES"</data>
      <data key="d1">"Specific deletion of Senp1 gene was conducted in smooth muscle cells/pericytes by SM22α-Cre for SENP1-smKO and vascular endothelial cells by VE-cadherin-Cre for SENP1-ecKO."</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;CHOLESTEROL AND TG&quot;">
      <data key="d0">"LIPID PROFILES"</data>
      <data key="d1">"Cholesterol and triglyceride levels were slightly reduced after age 18 weeks, while HDL and FFA showed normal profiles in SENP1-aP2KO mice compared to control."</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;WATER CONSUMPTION AND FOOD INTAKE&quot;">
      <data key="d0">"BEHAVIORAL PARAMETERS"</data>
      <data key="d1">"SENP1-aP2KO mice had increased water consumption but similar dairy food uptake compared to control mice."</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;STREPTOZOTOCIN (STZ)&quot;">
      <data key="d0">"EXPERIMENTAL MODEL"</data>
      <data key="d1">"SENP1-deficient mice were treated with streptozotocin to induce diabetes, which allowed researchers to study the impact of SENP1 deficiency on insulin-dependent conditions."</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;CELLULAR SENESCENCE&quot;">
      <data key="d0">"BIOLOGICAL PROCESS"</data>
      <data key="d1">"The study suggested that SENP1 deficiency might contribute to cellular senescence through its effect on insulin and glucose metabolism."</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;ADIPOCYTE DIFFERENTIATION&quot;">
      <data key="d0">"CELLULAR PROCESS"</data>
      <data key="d1">"Research indicated that SENP1 plays a role in adipocyte differentiation, which is critical for energy storage and metabolism in fat cells."</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;HEMATOPOIETIC STEM CELLS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"Experiments also explored how SENP1 affects hematopoietic stem cells, suggesting a broader impact beyond adipocytes and pancreatic islets."</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;METABOLIC SYNDROME&quot;">
      <data key="d0">"ASSOCIATION WITH GHI"</data>
      <data key="d1">"GHI is linked to metabolic syndrome, which includes obesity, insulin resistance, high blood pressure, and abnormal cholesterol levels."&lt;SEP&gt;"The research demonstrated that Senp1 deficiency leads to metabolic syndrome traits including obesity, insulin resistance, and dyslipidemia in mice."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5&lt;SEP&gt;chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;ADIPOCYTE-SPECIFIC SENP1-DEFICIENT MICE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SENP1-deficient mice exhibit diabetic phenotypes, suggesting the variant influences diabetes."</data>
      <data key="d2">chunk-fc33d6399ec56e65d007269407f1953d</data>
    </node>
    <node id="&quot;INSULIN-DEPENDENT DIABETES MELLITUS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Diabetes is characterized by T-cell-mediated destruction of pancreatic β cells."</data>
      <data key="d2">chunk-fc33d6399ec56e65d007269407f1953d</data>
    </node>
    <node id="&quot;Β CELL&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The transcript related to β cell development shows changes in SENP1-deficient mice."</data>
      <data key="d2">chunk-fc33d6399ec56e65d007269407f1953d</data>
    </node>
    <node id="&quot;PANCREATIC Β CELLS&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Pancreatic β cells are involved in insulin production and function."</data>
      <data key="d2">chunk-fc33d6399ec56e65d007269407f1953d</data>
    </node>
    <node id="&quot;Β-HYDROXYBUTYRATE&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Ketone production is a response to the body's inability to absorb glucose efficiently."</data>
      <data key="d2">chunk-fc33d6399ec56e65d007269407f1953d</data>
    </node>
    <node id="&quot;CD8+ T CELLS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"CD8+ T cells also showed specific responses when compared with CD4+ T cells, indicating cell-type-specific effects."&lt;SEP&gt;"These T cells target a peptide from islet-specific glucose-6-phosphatase catalytic subunit-related protein."&lt;SEP&gt;"We also purified CD8+ T cells from the same PBMCs."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433&lt;SEP&gt;chunk-bec60ce5d500ee78c6792a2d92b048ca&lt;SEP&gt;chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;AUTOIMMUNE RESPONSE&quot;">
      <data key="d0">"RESPONSE"</data>
      <data key="d1">"Autoimmune responses occur in the pancreases of SENP1-deficient mice, consistent with autoimmune diabetes."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;T1DM&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"T1DM (Type 1 Diabetes Mellitus) refers to the autoimmune condition in which insulin-producing cells are damaged and eventually destroyed, leading to inadequate production of insulin by the body."&lt;SEP&gt;"T1DM is an autoimmune disease with immunological destruction of pancreatic β cells resulting in insulin deficiency."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433&lt;SEP&gt;chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
    </node>
    <node id="&quot;CYTOKINE&quot;">
      <data key="d0">"CHEMOKINE"</data>
      <data key="d1">"PATs secret proinflammatory cytokines that overproduction may serve as a main reason for the break of immune tolerance and expansion of immune cells."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;TNF-Α&quot;">
      <data key="d0">"CYTOKINE"</data>
      <data key="d1">"Similar to IL-6, TNF-α also shows increased expression in PATs of the SENP1-deficient mice."&lt;SEP&gt;"TNF-α levels were also significantly elevated in the same period."&lt;SEP&gt;"Tumor Necrosis Factor Alpha (TNF-α), another proinflammatory cytokine, was also elevated in PAT tissue compared to other adipose depots."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433&lt;SEP&gt;chunk-174831b97ed170039b374ba254d4f506</data>
    </node>
    <node id="&quot;IL-IΒ&quot;">
      <data key="d0">"CYTOKINE"</data>
      <data key="d1">"IL-Iβ expression was significantly higher in PATs from SENP1-aP2KO mice compared with control mice."&lt;SEP&gt;"IL-Iβ was found to be significantly elevated in SENP1-deficient mice."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;CARDIAC FUNCTION&quot;">
      <data key="d0">"ANATOMICAL STRUCTURE"</data>
      <data key="d1">"No abnormalities were found in cardiac function and vascular reactivity."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;MYOCARDITIS&quot;">
      <data key="d0">"INFLAMMATORY CONDITION"</data>
      <data key="d1">"Mice exhibit increased myocarditis which is indicative of the development of diabetes."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;PATS&quot;">
      <data key="d0">"ADIPOSE TISSUE"</data>
      <data key="d1">"Paternal Adipose Tissue (PATs) include epididymal fat and are the focus of this study."&lt;SEP&gt;"Peri-pancreatic adipocytes (PATs) express high levels of proinflammatory cytokines compared to other adipose depots."&lt;SEP&gt;"Peri-pancreatic adipocytes show enhanced inflammation and a pro-inflammatory phenotype compared to control adipocytes."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433&lt;SEP&gt;chunk-eaf655c4dd9244523b048a122e232be4&lt;SEP&gt;chunk-174831b97ed170039b374ba254d4f506</data>
    </node>
    <node id="&quot;DIABETIC PHENOTYPE&quot;">
      <data key="d0">"PHENOTYPIC CHANGE"</data>
      <data key="d1">"These changes suggest the development of a diabetic phenotype before onset of diabetes at age 7 weeks."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;MACROPHAGE&quot;">
      <data key="d0">"CELL"</data>
      <data key="d1">"No significant differences were detected in macrophage numbers between control and SENP1-deficient mice at age 7 weeks."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;T CELL&quot;">
      <data key="d0">"CELL"</data>
      <data key="d1">"Similar to macrophages, there was no significant difference in T cell numbers between the two groups at this time point."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;CYTOKINE CONCENTRATION&quot;">
      <data key="d0">"MEASURE"</data>
      <data key="d1">"Circulating cytokine levels were too low to induce systemic autoimmune responses."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;SYSTEMIC CYTOKINES&quot;">
      <data key="d0">"CYTOKINE GROUP"</data>
      <data key="d1">"Increased systemic cytokines and cardiac myocarditis indicate the presence of a diabetic phenotype in older mice."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;DIABETES PHENOTYPE&quot;">
      <data key="d0">"PHENOTYPIC CHANGE"</data>
      <data key="d1">"As the animals age, an increase in symptoms related to diabetes becomes evident."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
      <data key="d3">[{"level": 0, "cluster": 9}]</data>
    </node>
    <node id="&quot;ADIPOSE DEPOTS&quot;">
      <data key="d0">"ANATOMICAL SITE"</data>
      <data key="d1">"There was no significant difference in cytokine expression between different adipose depots except PATs."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;PROINFLAMMATORY CYTOKINES&quot;">
      <data key="d0">"CYTOKINE GROUP"</data>
      <data key="d1">"Increased levels of pro-inflammatory cytokines like IFN-γ play a role in exacerbating diabetes conditions by causing inflammation and tissue damage."&lt;SEP&gt;"Secreted from PATs, induce the upregulation of CCL5 expression leading to immune cell infiltration."&lt;SEP&gt;"These cytokines were predominantly expressed at higher levels in PATs compared to other adipose tissues."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433&lt;SEP&gt;chunk-eaf655c4dd9244523b048a122e232be4&lt;SEP&gt;chunk-8382a49b61215482f9fc75e3a86cb987</data>
    </node>
    <node id="&quot;DIABETES ONSET&quot;">
      <data key="d0">"EVENT"</data>
      <data key="d1">"The onset of diabetes is confirmed by the significant increase in circulating cytokines and cardiac myocarditis."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
      <data key="d3">[{"level": 0, "cluster": 9}]</data>
    </node>
    <node id="&quot;CYTOKINE PRODUCTION&quot;">
      <data key="d0">"ACTIVITY"</data>
      <data key="d1">"Peri-pancreatic adipocytes are suggested to be primarily responsible for the high concentrations of cytokines before diabetes onset."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;CHEMOKINE&quot;">
      <data key="d0">"MOLECULE"</data>
      <data key="d1">"CCL5 expression is upregulated in pancreatic islets, suggesting an inflammatory response linked to type 1 diabetic development."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;PANCREATIC ISLET&quot;">
      <data key="d0">"ANATOMICAL SITE"</data>
      <data key="d1">"Islets show specific expression of CCL5 which may indicate recruitment of immune cells involved in diabetes progression."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;AUTOIMMUNE TARGETS&quot;">
      <data key="d0">"PATHOLOGICAL TARGET"</data>
      <data key="d1">"CCL5 can potentially direct the recruitment of immune cells to the pancreas, contributing to autoimmune damage."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;ISOLATED ISLETS&quot;">
      <data key="d0">"CELL CULTURE SAMPLE"</data>
      <data key="d1">"The media from pancreatic adipocytes of SENP1-aP2KO mice increases CCL5 expression in isolated islets."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;Β CELL DEGENERATION&quot;">
      <data key="d0">"PATHOLOGICAL PROCESS"</data>
      <data key="d1">"Degenerative changes occur in pancreatic β cells of SENP1-deficient mice, leading to insulin deficiency."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;TYPE 1 DIABETES (T1D)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Mice develop a type 1 diabetes-like phenotype with autoimmune destruction of β cells resulting in insulin scarcity."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;INNATE IMMUNITY&quot;">
      <data key="d0">"RESPONSE MECHANISM"</data>
      <data key="d1">"Innate immune response is activated leading to inflammation and the recruitment of immune cells into pancreatic tissue."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;MACROPHAGE ACTIVATION&quot;">
      <data key="d0">"CELLULAR PROCESS"</data>
      <data key="d1">"Macrophages become activated in pancreas of SENP1-deficient mice contributing to inflammatory responses."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;TH1 RESPONSE&quot;">
      <data key="d0">"IMMUNE PATHWAY"</data>
      <data key="d1">"A Th1 cytokine-driven immune response is involved, which typically targets and destroys β cells in autoimmune diabetes."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;TYPE 2 IMMUNITY&quot;">
      <data key="d0">"RESPONSE TYPE"</data>
      <data key="d1">"The mice exhibit signs of type 2 immunity response characterized by the recruitment of neutrophils and eosinophils."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;NEUTROPHIL&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"Increased numbers of circulating and infiltrating neutrophils are found in SENP1-deficient mice before onset of diabetes."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;EOSINOPHIL&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"Elevated levels of eosinophils are observed in the peripheral blood of these mice, contributing to the inflammatory environment."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;ANTIBODY RESPONSE&quot;">
      <data key="d0">"IMMUNE RESPONSE"</data>
      <data key="d1">"An antibody response is detected against pancreatic antigens specific for β cells and other islet components."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;PANCREATIC INFLAMMATION&quot;">
      <data key="d0">"PATHOLOGICAL CONDITION"</data>
      <data key="d1">"Inflammation in the pancreas is observed before clinical onset of diabetes, characterized by infiltration with immune cells."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;DIABETIC CARDIOMYOPATHY&quot;">
      <data key="d0">"DISEASE FORM"</data>
      <data key="d1">"Development of diabetic cardiomyopathy is evident as a result of prolonged hyperglycemia and metabolic stress in mice."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;CARDIAC FIBROSIS&quot;">
      <data key="d0">"ANATOMICAL CHANGE"</data>
      <data key="d1">"Increased cardiac fibrosis occurs due to chronic inflammation and altered metabolism."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;FIBROBLAST ACTIVATION&quot;">
      <data key="d0">"CELLULAR RESPONSE"</data>
      <data key="d1">"Fibroblasts become activated and proliferate leading to cardiac fibrosis in the diabetic mice model."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;AP2KO PANCREATIC ADIPOCYTE&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"High local concentrations of cytokines secreted from these cells upregulate CCL5 expression, leading to immune cell infiltration and β cell damage."</data>
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4</data>
    </node>
    <node id="&quot;CCL5&quot;">
      <data key="d0">"MOLECULE"</data>
      <data key="d1">"Upregulated in response to high local proinflammatory cytokine levels originating from adipocytes, involved in immune cell recruitment."</data>
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4</data>
    </node>
    <node id="&quot;IMMUNE CELLS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"Infiltrate pancreas due to high local pro-inflammatory cytokine levels secreted by adipocytes."</data>
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4</data>
    </node>
    <node id="&quot;CYTOTOXIC DAMAGE&quot;">
      <data key="d0">"EFFECT"</data>
      <data key="d1">"Results from the direct cytotoxic effects of cytokines originating from peri-pancreatic adipocytes on pancreatic islets."</data>
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4</data>
    </node>
    <node id="&quot;NF-KB&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A critical activator of genes for inflammation and immune regulation, involved in pro-inflammatory responses in adipose tissue."</data>
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4</data>
    </node>
    <node id="&quot;IKK&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Part of the NF-kB signaling pathway that is upregulated upon SENP1 deletion, leading to increased NF-kB activity."</data>
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4</data>
    </node>
    <node id="&quot;IΚBΑ&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Decreased total levels and phosphorylation observed in adipose tissues of SENP1-aP2KO mice, contributing to enhanced NF-kB activation."</data>
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4</data>
    </node>
    <node id="&quot;P65/RELA&quot;">
      <data key="d0">"SUBUNIT"</data>
      <data key="d1">"NF-kB subunit that is strongly upregulated upon SENP1 deletion, leading to increased pro-inflammatory gene expression and cytokine production."</data>
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4</data>
    </node>
    <node id="&quot;SUMOYLATION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A mechanism that contributes to the regulation of PPARγ and its function in modulating inflammatory responses, not significantly affected by SENP1 deletion."</data>
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4</data>
    </node>
    <node id="&quot;ADIPOGENESIS&quot;">
      <data key="d0">"BIOLOGICAL PROCESS"</data>
      <data key="d1">"The process by which adipocytes differentiate under high-fat diet conditions can contribute to obesity and insulin resistance, potentially affecting T1DM progression."&lt;SEP&gt;"The process of differentiation into mature adipocytes is reduced in some adipose depots of mice with SENP1 deletion, indicating an impact on cell development and maturation process."</data>
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4&lt;SEP&gt;chunk-8382a49b61215482f9fc75e3a86cb987</data>
    </node>
    <node id="&quot;CELL SIZE&quot;">
      <data key="d0">"PHYSICAL ATTRIBUTE"</data>
      <data key="d1">"Cell sizes in PATs were larger under normal chow conditions, but smaller by 1.8-fold under HFD in SENP1-aP2KO mice."&lt;SEP&gt;"Decreased in peri-pancreatic adipocytes from SENP1-aP2KO mice compared to control adipocytes, contributing to the overall phenotype."</data>
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4&lt;SEP&gt;chunk-174831b97ed170039b374ba254d4f506</data>
    </node>
    <node id="&quot;CELL NUMBERS&quot;">
      <data key="d0">"QUANTITATIVE MEASURE"</data>
      <data key="d1">"Increased number of cells observed in peri-pancreatic adipocytes from SENP1-aP2KO mice, suggesting a potentially enhanced proliferative activity or survival mechanism."&lt;SEP&gt;"There were more cell numbers in PAT cells of the SENP1-aP2KO mice than Ctrl adipocytes under normal chow and this difference was amplified under HFD."</data>
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4&lt;SEP&gt;chunk-174831b97ed170039b374ba254d4f506</data>
    </node>
    <node id="&quot;DIFFERENTIATION MARKERS&quot;">
      <data key="d0">"GENE/PRODUCT"</data>
      <data key="d1">"Reduced expression levels of markers typically associated with adipocyte differentiation (fatty acid synthase, adipose triglyceride lipase and lipoprotein lipase) in peri-pancreatic adipocytes from SENP1-aP2KO mice."</data>
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4</data>
    </node>
    <node id="&quot;DEPOT-SPECIFIC PHENOTYPES&quot;">
      <data key="d0">"DISEASE/CONDITION"</data>
      <data key="d1">"The functional diversity of adipose tissue depots can lead to different disease processes, with some depots showing enhanced pro-inflammatory phenotype due to changes like those observed in PATs."</data>
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4</data>
    </node>
    <node id="&quot;ADIPOCYTE SPECIFIC MARKER (FABP4)&quot;">
      <data key="d0">"CELL SURFACE MARKER"</data>
      <data key="d1">"Adipocytes expressing FABP4 are associated with a pro-inflammatory phenotype."</data>
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4</data>
    </node>
    <node id="&quot;PANCREATIC DISRUPTION&quot;">
      <data key="d0">"PATHOLOGICAL PROCESS"</data>
      <data key="d1">"The result of strong induction by adipocyte culture supernatant from SENP1-aP2KO mice, involving the destruction of pancreatic tissues and β-cell death."</data>
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4</data>
    </node>
    <node id="&quot;LIVE/DEAD VIABILITY/CYTOTOXICITY ASSAYS&quot;">
      <data key="d0">"DIAGNOSTIC METHOD"</data>
      <data key="d1">"A method used to monitor cell viability and cytotoxic effects on isolated pancreatic islets upon exposure to adipocyte culture supernatant."</data>
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4</data>
    </node>
    <node id="&quot;Β-CELL DEATH&quot;">
      <data key="d0">"MOLECULAR PROCESS"</data>
      <data key="d1">"The process of cell death affecting β-cells in response to increased proinflammatory cytokines secreted by adipocytes."</data>
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4</data>
    </node>
    <node id="&quot;MACROPHAGE MARKER (F4/80)&quot;">
      <data key="d0">"CELL SURFACE MARKER"</data>
      <data key="d1">"A marker used for identifying macrophages, which was not found colocalized with phosphor-p65/RelA in SENP1-aP2KO adipocytes."</data>
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4</data>
    </node>
    <node id="&quot;CHROMATIN IMMUNOPRECIPITATION (CHIP) ASSAY&quot;">
      <data key="d0">"MOLECULAR BIOLOGY TECHNIQUE"</data>
      <data key="d1">"An assay used to identify the binding sites of p65/RelA on the promoters of pro-inflammatory cytokines like IL-6, TNF-α and IL-1β."</data>
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4</data>
    </node>
    <node id="&quot;PREADIPOCYTE CELL LINE (3T3-L1)&quot;">
      <data key="d0">"ORGANISM TYPE"</data>
      <data key="d1">"A cell line derived from white adipose tissue that can be differentiated into mature adipocytes for studying adipogenesis and related processes."</data>
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4</data>
    </node>
    <node id="&quot;SHORT INTERFERING RNA (SIRNA)&quot;">
      <data key="d0">"MOLECULAR TOOL"</data>
      <data key="d1">"Used to knockdown the expression of a specific gene, in this case SENP1, in 3T3-L1 preadipocyte cells."</data>
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4</data>
    </node>
    <node id="&quot;PROINFLAMMATORY GENE EXPRESSION&quot;">
      <data key="d0">"GENE/PROCESS"</data>
      <data key="d1">"The phenomenon observed when genes encoding pro-inflammatory cytokines are upregulated in adipocytes due to increased NF-κB activity following SENP1 deletion."</data>
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4</data>
    </node>
    <node id="&quot;INCREASED PRO-INFLAMMATORY CYTOKINE LEVELS&quot;">
      <data key="d0">"MOLECULAR PROCESS"</data>
      <data key="d1">"Resulting from enhanced NF-κB activation, leading to elevated expression of cytokines like IL-6, TNF-α and IL-1β in adipose tissues."</data>
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4</data>
    </node>
    <node id="&quot;NOD MOUSE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The NOD mouse is a popular model used for studying type 1 diabetes (T1DM) due to its development of diabetes with late onset."&lt;SEP&gt;"The NOD mouse is a popularly used model for T1DM, showing spontaneous development of diabetes."</data>
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce&lt;SEP&gt;chunk-8382a49b61215482f9fc75e3a86cb987</data>
    </node>
    <node id="&quot;NON-OBESE DIABETIC (NOD) MOUSE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Consistent with reports, we observed the incidence of spontaneous diabetes in the NOD mouse was 60–80% in females and 20–30% in males."</data>
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
      <data key="d3">[{"level": 0, "cluster": 15}, {"level": 1, "cluster": 50}]</data>
    </node>
    <node id="&quot;TH1 DOMINANT IFN-Γ&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"NOD mice exhibit increased plasma IFN-γ with lower levels of proinflammatory cytokines compared with SENP1-aP2KO mice and serum from human T1DM patients."</data>
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
    </node>
    <node id="&quot;PROINFLAMMATORY CYTOKINE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Increased plasma levels of proinflammatory cytokines were significantly increased in T1DM patients compared with the normal cohorts."</data>
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
    </node>
    <node id="&quot;BETA-CELL DEATH&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Isolated normal mouse pancreatic islets were cultured with serum collected from Ctrl, SENP1-aP2KO and NOD mice, or collected from normal human and T1DM patients. Islet structure and apoptosis was monitored by Live/Dead viability/Cytotoxicity assays."</data>
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
    </node>
    <node id="&quot;PROPHYLACTIC INSULIN THERAPY&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"Our results indicated that prophylactic insulin therapy in SENP1-deficient mice at the age of 5 weeks for 9 weeks only partially ameliorates development of diabetes phenotypes including immune cell infiltration, β-cell apoptosis and islet disruptions."</data>
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
    </node>
    <node id="&quot;NF-ΚB INHIBITOR II JSH-23&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"JSH-23 had no effects on body weight, blood glucose and lipid profile in the Ctrl mice. However, administration of JSH-23 in SENP1-aP2KO mice diminished SENP1 deletion-induced elevation of blood glucose and reduction of insulin levels in blood."</data>
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
    </node>
    <node id="&quot;HIGH-FAT DIET (HFD)&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"HFD increased fat weight in all adipose depots including epididymal fat and PATs in Ctrl and SENP1-aP2KO mice. HFD may stimulate adipogenesis in"</data>
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
    </node>
    <node id="&quot;DIABETES PHENOTYPES&quot;">
      <data key="d0">"MANIFESTATIONS"</data>
      <data key="d1">"Diabetes phenotypes include immune cell infiltration, β-cell apoptosis and islet disruptions observed in diabetic mice."</data>
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
    </node>
    <node id="&quot;Β-CELL APOPTOSIS&quot;">
      <data key="d0">"CELL DEATH"</data>
      <data key="d1">"The process of β-cell death that occurs due to inflammation or autoimmune attack during the progression of diabetes."</data>
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
    </node>
    <node id="&quot;ISLET DISRUPTIONS&quot;">
      <data key="d0">"STRUCTURAL CHANGES"</data>
      <data key="d1">"Damage to islets in pancreatic tissue leading to malfunction and dysfunction, commonly seen in diabetic conditions."</data>
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
    </node>
    <node id="&quot;AUTOIMMUNE ATTACK&quot;">
      <data key="d0">"PATHOLOGICAL PROCESS"</data>
      <data key="d1">"The autoimmune response against insulin-producing β-cells which leads to their destruction in diabetes."</data>
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
    </node>
    <node id="&quot;INFLAMMATION&quot;">
      <data key="d0">"RESPONSE TO INJURY"</data>
      <data key="d1">"Increased inflammatory responses are observed in pancreatic islets of diabetic mice, contributing to disease progression."</data>
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
    </node>
    <node id="&quot;TH1 DOMINANT&quot;">
      <data key="d0">"CELLULAR PHENOTYPE"</data>
      <data key="d1">"Characteristics of the T-helper cells (Th1) that are dominant in NOD mice contributing to autoimmune response against β-cells."</data>
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
    </node>
    <node id="&quot;CCL5 EXPRESSION&quot;">
      <data key="d0">"GENE EXPRESSION"</data>
      <data key="d1">"Induction of CCL5 gene expression is associated with inflammation and islet damages in diabetes, particularly under high-fat diet conditions."</data>
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
    </node>
    <node id="&quot;HFD&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"High-fat diet (HFD) was used to increase fat weight in all adipose depots, including epididymal fat and PATs."</data>
      <data key="d2">chunk-174831b97ed170039b374ba254d4f506</data>
    </node>
    <node id="&quot;HYPERGLYCAEMIA&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Hyperglycemia was accelerated under HFD conditions, starting at 8 weeks in SENP1-aP2KO mice instead of the usual onset at around 12 weeks on standard chow."</data>
      <data key="d2">chunk-174831b97ed170039b374ba254d4f506</data>
    </node>
    <node id="&quot;BASAL INSULIN LEVELS&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Under standard chow diet, basal insulin levels were not significantly different between SENP1-deficient and Ctrl mice. However, HFD significantly reduced these levels in both groups."</data>
      <data key="d2">chunk-174831b97ed170039b374ba254d4f506</data>
    </node>
    <node id="&quot;GLUCOSE-STIMULATED INSULIN LEVELS&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Responses to glucose stimulation were similar under standard chow diet for both groups of mice, but HFD augmented the reduction of insulin levels in Ctrl mice and exacerbated it further in SENP1-aP2KO mice."</data>
      <data key="d2">chunk-174831b97ed170039b374ba254d4f506</data>
    </node>
    <node id="&quot;SENP1-AP2KO&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The SENP1 knockout (aP2KO) mice have genetic alterations related to diabetes, particularly affecting the Senp1 gene."</data>
      <data key="d2">chunk-174831b97ed170039b374ba254d4f506</data>
    </node>
    <node id="&quot;GENETIC MODIFICATION&quot;">
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
      <data key="d1">"Creating genetically modified mice with adipocyte-specific deletion of Senp1 resulted in diabetes development.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 9}]</data>
    </node>
    <node id="&quot;GENE EXPRESSION&quot;">
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94&lt;SEP&gt;chunk-a8f2b3b97a70df26efb35263714bf43c</data>
      <data key="d1">"Diminished expression of Senp1 was associated with diabetes development.")&lt;SEP&gt;"The diabetes phenotype correlated with the alteration of Senp1 gene expression in adipocytes.")&lt;SEP&gt;"The process of gene expression studied through microarray analysis and qRT-PCR methods."</data>
      <data key="d0">"BIOLOGICAL PROCESS"</data>
      <data key="d3">[{"level": 0, "cluster": 15}, {"level": 1, "cluster": 53}]</data>
    </node>
    <node id="&quot;SPECIFIC CELL TYPE&quot;">
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
      <data key="d1">"The specific cell types, such as macrophages and pancreatic islets, showed different expression patterns of Senp1 gene.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 15}, {"level": 1, "cluster": 53}]</data>
    </node>
    <node id="&quot;EXPRESSION&quot;">
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
      <data key="d1">"The expression of Senp1 gene localized to peri-pancreatic adipose tissue and was not present in pancreatic islets.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LOCALIZATION&quot;">
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
      <data key="d1">"The expression of Senp1 gene localized to peri-pancreatic adipose tissue and was not present in pancreatic islets.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HORMONAL RESPONSE&quot;">
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
      <data key="d1">"Low insulin levels were observed as part of the diabetes phenotype in Senp1-deficient mice.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 15}, {"level": 1, "cluster": 50}]</data>
    </node>
    <node id="&quot;ASSESSMENTS&quot;">
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
      <data key="d1">"The tests confirmed the diabetes phenotype and insulin resistance in Senp1-deficient mice.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 15}, {"level": 1, "cluster": 50}]</data>
    </node>
    <node id="&quot;NORMAL PHENOTYPE&quot;">
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
      <data key="d1">"Unlike the adipocyte-specific deletion models, Senp1-deficient mice created by SM22α-Cre or VE-cadherin-Cre did not develop a high-glucose phenotype.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 9}]</data>
    </node>
    <node id="&quot;HORMONAL FUNCTION&quot;">
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
      <data key="d1">"Reduced insulin secretion correlated with diabetes development in Senp1-deficient mice.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 15}, {"level": 1, "cluster": 50}]</data>
    </node>
    <node id="&quot;PHYSICAL CHARACTERISTICS&quot;">
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
      <data key="d1">"Lower body weight was a physical manifestation observed in the diabetic phenotype of Senp1-deficient mice.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 15}, {"level": 1, "cluster": 50}]</data>
    </node>
    <node id="&quot;METABOLIC CHANGES&quot;">
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
      <data key="d1">"Alteration of cholesterol and triglyceride levels was observed as a metabolic change associated with diabetes development in Senp1-deficient mice.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 15}, {"level": 1, "cluster": 50}]</data>
    </node>
    <node id="&quot;BEHAVIORAL INDICATORS&quot;">
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
      <data key="d1">"Increased water consumption was a behavioral indicator observed in the diabetes phenotype of Senp1-deficient mice, possibly due to osmotic diuresis.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 15}, {"level": 1, "cluster": 50}]</data>
    </node>
    <node id="&quot;GENE REGULATION&quot;">
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
      <data key="d1">"The regulation of PPARγ by SENP1 impacts metabolic pathways involved in insulin sensitivity and glucose metabolism.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;METABOLIC FUNCTION&quot;">
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
      <data key="d1">"The regulation of PPARγ by SENP1 impacts metabolic pathways involved in insulin sensitivity and glucose metabolism.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CHEMICAL TREATMENT&quot;">
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
      <data key="d1">"STZ was used as a method to induce diabetes in Senp1-deficient mice, providing insights into the role of SENP1 in maintaining glucose homeostasis.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DIABETES INDUCTION&quot;">
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
      <data key="d1">"STZ was used as a method to induce diabetes in Senp1-deficient mice, providing insights into the role of SENP1 in maintaining glucose homeostasis.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;AGING PHENOMENA&quot;">
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
      <data key="d1">"The impact of SENP1 deletion on the metabolic health of mice potentially leads to accelerated aging processes related to cellular senescence.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENE FUNCTION&quot;">
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
      <data key="d1">"The impact of SENP1 deletion on the metabolic health of mice potentially leads to accelerated aging processes related to cellular senescence.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DEVELOPMENTAL BIOLOGY&quot;">
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
      <data key="d1">"SENP1's involvement in adipocyte differentiation highlights its importance during the development of metabolic traits like obesity and diabetes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENE ACTIVITY&quot;">
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
      <data key="d1">"SENP1's involvement in adipocyte differentiation highlights its importance during the development of metabolic traits like obesity and diabetes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENE INFLUENCE&quot;">
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
      <data key="d1">"The influence of SENP1 on hematopoietic stem cells could provide insights into its role in regenerative processes during diabetes development or treatment.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;REGENERATIVE MEDICINE&quot;">
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
      <data key="d1">"The influence of SENP1 on hematopoietic stem cells could provide insights into its role in regenerative processes during diabetes development or treatment.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENETIC PHENOTYPE&quot;">
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
      <data key="d1">"Senp1 gene deletion results in a complex interplay of conditions characteristic of metabolic syndrome that affects multiple organ systems.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HEALTH OUTCOMES&quot;">
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
      <data key="d1">"Senp1 gene deletion results in a complex interplay of conditions characteristic of metabolic syndrome that affects multiple organ systems.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;AFFECTS&quot;">
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
      <data key="d1">"Increased cytokine concentration is a precursor event contributing to the development of diabetes and associated myocarditis symptoms in older mice.")("entity"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;REGULATION OF CCL5 EXPRESSION&quot;">
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4</data>
      <data key="d1">"Reduced SENP1 activity leads to increased local cytokine secretion that upregulates CCL5 expression.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SENP1 DELETION&quot;">
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4</data>
      <data key="d1">"Reduced SENP1 activity leads to increased local cytokine secretion that upregulates CCL5 expression.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LOCAL PRO-INFLAMMATORY CYTOKINES&quot;">
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4</data>
      <data key="d1">"Secreted from PATs, contribute to inflammation and immune cell infiltration in the pancreas.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NF-ΚB ACTIVATION&quot;">
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4</data>
      <data key="d1">"Increased NF-κB activity in adipose tissue affects adipogenesis through reduced levels of PPARγ SUMOylation, influencing cell development and maturation process.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;REGULATION OF ADIPOCYTE DIFFERENTIATION&quot;">
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4</data>
      <data key="d1">"Increased NF-κB activity in adipose tissue affects adipogenesis through reduced levels of PPARγ SUMOylation, influencing cell development and maturation process.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ENHANCED PRO-INFLAMMATORY PHENOTYPE&quot;">
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4</data>
      <data key="d1">"Deficiency reduces adipocyte differentiation while increasing pro-inflammatory markers like NF-κB activity, contributing to enhanced inflammation in adipose depots.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NF-ΚB SIGNALLING&quot;">
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
      <data key="d1">"Deletion of SENP1 in adipocytes enhances NEMO SUMOylation and NF-κB activation, affecting cytokine expression and potentially impacting T1DM pathogenesis.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 15}, {"level": 1, "cluster": 54}]</data>
    </node>
    <node id="&quot;ADIPOCYTE&quot;">
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
      <data key="d1">"Expression levels of transcripts are altered in adipocytes with SENP1 deletion, which may influence metabolic processes and inflammatory responses related to diabetes." )</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 10}, {"level": 1, "cluster": 32}]</data>
    </node>
    <node id="&quot;INFLAMMATORY PROCESS&quot;">
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
      <data key="d1">"SUMOylation of NEMO by SENP1 modulates the activation of NF-κB and cytokine production in adipocytes, key aspects of inflammatory response linked to T1DM pathophysiology.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 11}, {"level": 1, "cluster": 38}]</data>
    </node>
    <node id="&quot;DNA DAMAGE RESPONSE&quot;">
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
      <data key="d1">"SENP1 deletion enhances NEMO SUMOylation even under stress conditions like DNA damage, which could contribute to inflammation and metabolic dysfunction in diabetes." )</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 12}, {"level": 1, "cluster": 39}]</data>
    </node>
    <node id="&quot;GENETIC PREDISPOSITION&quot;">
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
      <data key="d1">"Adipocyte-specific SENP1 deficiency may exacerbate the genetic predisposition towards T1DM by modulating multiple signaling pathways involved in insulin secretion and glucose metabolism." )</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 11}, {"level": 1, "cluster": 35}]</data>
    </node>
    <node id="&quot;NF-ΚB ACTIVITY&quot;">
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
      <data key="d1">"A critical role of SENP1-dependent NF-κB activity in T1DM progression in SENP1-aP2KO mice.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 15}, {"level": 1, "cluster": 54}]</data>
    </node>
    <node id="&quot;INCREASED LEVELS&quot;">
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
      <data key="d1">"Increased plasma levels of proinflammatory cytokines were observed in T1DM patients compared to normal subjects.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INDUCTION&quot;">
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
      <data key="d1">"Serum from SENP1-aP2KO mice, NOD mice and human T1DM all induced disruption and pancreatic cell death.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;AMELIORATION OF DIABETIC PHENOTYPES&quot;">
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
      <data key="d1">"Prophylactic insulin therapy partially ameliorates development of diabetes phenotypes in SENP1-deficient mice.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DIMINISHED ELEVATION OF BLOOD GLUCOSE AND REDUCTION OF INSULIN LEVELS&quot;">
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
      <data key="d1">"Administration of JSH-23 to SENP1-aP2KO mice diminished the effects of SENP1 deletion on blood glucose levels and insulin in blood.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INCREASED FAT WEIGHT&quot;">
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
      <data key="d1">"HFD increased fat weight in all adipose depots including epididymal fat and PATs.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;REGULATION OF GENE EXPRESSION&quot;">
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
      <data key="d1">"SENP1-dependent NF-κB activity regulates the expression of genes involved in inflammation, apoptosis, and islet damage during diabetes progression.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 15}, {"level": 1, "cluster": 54}]</data>
    </node>
    <node id="&quot;PREVENTATIVE EFFECT&quot;">
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
      <data key="d1">"Prophylactic insulin therapy helps partially ameliorate some diabetic phenotypes by supporting insulin levels and immune cell infiltration in mice.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DISEASE MODIFYING EFFECT&quot;">
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
      <data key="d1">"JSH-23 administration reduces blood glucose elevation and insulin reduction, potentially impacting the course of T1DM in SENP1-aP2KO mice.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CONTRIBUTION TO DISEASE PROGRESSION&quot;">
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
      <data key="d1">"HFD may stimulate adipogenesis and increase fat weight, which could contribute indirectly to inflammation and potentially exacerbate diabetic phenotypes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL-6, TNF-Α, IL-1Β&quot;">
      <data key="d2">chunk-174831b97ed170039b374ba254d4f506</data>
      <data key="d1">"High-fat diet significantly increased the production of proinflammatory cytokines like Interleukin-6 (IL-6), Tumor Necrosis Factor Alpha (TNF-α), and Interleukin-1 Beta (IL-1β) in PATs.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LIVER INSULIN RESISTANCE&quot;">
      <data key="d2">chunk-174831b97ed170039b374ba254d4f506</data>
      <data key="d1">"Under basal conditions, liver insulin resistance was detected under HFD conditions, which was more pronounced than under normal chow diet in Senp1 knockout (KO) mice. This is a hallmark of obesity-linked type 2 diabetes development.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;APAI&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"ApaI (rs7975232) is a variant evaluated in association with risk for ovarian cancer."</data>
      <data key="d2">chunk-1c470c93632f3704d6f3566de7a1dd0c</data>
    </node>
    <node id="&quot;FOKI&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"FokI (rs2228570 or rs10735810) is a variant associated with an increased risk of ovarian cancer."</data>
      <data key="d2">chunk-1c470c93632f3704d6f3566de7a1dd0c</data>
    </node>
    <node id="&quot;CDX-2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Cdx-2 gene was found to be associated with colorectal cancer risk."&lt;SEP&gt;"Cdx-2 gene was the focus in some studies evaluated for association with ovarian cancer."&lt;SEP&gt;"Cdx-2 is a gene involved in ovarian cancer risk assessment."</data>
      <data key="d2">chunk-1c470c93632f3704d6f3566de7a1dd0c&lt;SEP&gt;chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
    </node>
    <node id="&quot;TAQI&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"TaqI is another gene related to ovarian cancer studies."&lt;SEP&gt;"TaqI is considered as a transcript related to ovarian cancer risk assessment."&lt;SEP&gt;"TaqI variant was studied as it related to ovarian cancer risk."&lt;SEP&gt;"The TaqI variant is known for its association in the context of various disease outcomes."</data>
      <data key="d2">chunk-1c470c93632f3704d6f3566de7a1dd0c&lt;SEP&gt;chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
    </node>
    <node id="&quot;OVARIAN CANCER&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Carriers of the A allele showed significantly increased risk for ovarian cancer."&lt;SEP&gt;"No association was found for the TaqI variant and the risk of ovarian cancer in both subgroup studies and Caucasians."&lt;SEP&gt;"This disease is central as several genetic variants were associated with the risk of developing ovarian cancer in this meta-analysis."</data>
      <data key="d2">chunk-1c470c93632f3704d6f3566de7a1dd0c&lt;SEP&gt;chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
    </node>
    <node id="&quot;HARDY-WEINBERG EQUILIBRIUM&quot;">
      <data key="d0">"STATISTICAL TEST"</data>
      <data key="d1">"Hardy-Weinberg equilibrium is a concept in population genetics that suggests the genetic makeup of a population will remain constant from generation to generation in the absence of external influences; it was not maintained among controls due to certain factors."&lt;SEP&gt;"The equilibrium process was utilized to assess distribution uniformity for genotypes among control populations."&lt;SEP&gt;"No strong evidence was found against Hardy-Weinberg equilibrium except in Romania."</data>
      <data key="d2">chunk-1c470c93632f3704d6f3566de7a1dd0c&lt;SEP&gt;chunk-c9badb9a0fb813f42383cc8afc57ad45&lt;SEP&gt;chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;RS1544410&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"BsmI (rs1544410) has been implicated as a biomarker in several studies."</data>
      <data key="d2">chunk-1c470c93632f3704d6f3566de7a1dd0c</data>
    </node>
    <node id="&quot;RS11568820&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Cdx-2 is a genomic variant that shows an association with ovarian cancer risk."&lt;SEP&gt;"Cdx-2's genomic variant rs11568820 had specific implications in ovarian cancer risk."&lt;SEP&gt;"The variant was evaluated in subgroup studies conducted with a Japanese subgroup and the NECC subgroup."</data>
      <data key="d2">chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
    </node>
    <node id="&quot;RS731236&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"TaqI is a genomic variant that shows no significant effect on ovarian cancer risk."&lt;SEP&gt;"rs731236 is one of the four analyzed VDR variants."</data>
      <data key="d2">chunk-dc5e8cc04a1b16b1e00f3a4120e004c4&lt;SEP&gt;chunk-6600322cc75094b1c57707e4b9c85954</data>
    </node>
    <node id="&quot;NORTHERN SWEDEN SUBGROUP&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The Northern Sweden subgroup refers to geographical location of study participants involved."</data>
      <data key="d2">chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
    </node>
    <node id="&quot;CLENDENEN ET AL.&quot;">
      <data key="d0">"SCIENTIFIC STUDY"</data>
      <data key="d1">"Study conducted by Clendenen et al. was one of the subgroup studies evaluated."&lt;SEP&gt;"Study performed by Clendenen et al. was part of the literature search on Cdx-2 and ovarian cancer risk."</data>
      <data key="d2">chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
    </node>
    <node id="&quot;NECC SUBGROUP&quot;">
      <data key="d0">"SUBGROUP OF PARTICIPANTS"</data>
      <data key="d1">"The NECC subgroup refers to a subset of participants involved in a study, potentially based on shared characteristics or location."</data>
      <data key="d2">chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
    </node>
    <node id="&quot;TWOROGER ET AL.&quot;">
      <data key="d0">"RESEARCH TEAM"</data>
      <data key="d1">"A team led by Tworoger et al. contributed to subgroup studies evaluating variants like Cdx-2 related to ovarian cancer."</data>
      <data key="d2">chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
    </node>
    <node id="&quot;BSMI&quot;">
      <data key="d2">chunk-1c470c93632f3704d6f3566de7a1dd0c</data>
      <data key="d1">"No significant association between BsmI variant and risk of ovarian cancer was found under the dominant genetic model.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;AFRICAN AMERICAN POPULATION&quot;">
      <data key="d2">chunk-1c470c93632f3704d6f3566de7a1dd0c</data>
      <data key="d1">"The African American subgroup study contributed significantly to the heterogeneity between the studies evaluated for BsmI variant.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENETIC VARIANTS&quot;">
      <data key="d2">chunk-1c470c93632f3704d6f3566de7a1dd0c</data>
      <data key="d1">"The African American subgroup study contributed significantly to the heterogeneity between the studies evaluated for BsmI variant.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CDX-2 GENE VARIANT AND OVARIAN CANCER&quot;">
      <data key="d2">chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
      <data key="d1">"The genomic variant rs11568820 in Cdx-2 gene was associated with an increased risk of ovarian cancer.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TAQI GENE VARIANT AND OVARIAN CANCER&quot;">
      <data key="d2">chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
      <data key="d1">"The TaqI gene variant showed no association with ovarian cancer based on subgroup studies.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS7975232&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"rs7975232 is one of the four analyzed VDR variants."</data>
      <data key="d2">chunk-6600322cc75094b1c57707e4b9c85954</data>
    </node>
    <node id="&quot;RS154410&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"rs1544410 is one of the four analyzed VDR variants."</data>
      <data key="d2">chunk-6600322cc75094b1c57707e4b9c85954</data>
    </node>
    <node id="&quot;RS2228570&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"rs2228570 is one of the four analyzed VDR variants."</data>
      <data key="d2">chunk-6600322cc75094b1c57707e4b9c85954</data>
    </node>
    <node id="&quot;VDR&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The VDR gene contains the four analyzed variants: rs731236, rs7975232, rs1544410 and rs2228570."&lt;SEP&gt;"The VDR gene encodes vitamin D receptor, which plays a role in calcium and phosphate metabolism and regulates gene transcription."</data>
      <data key="d2">chunk-6600322cc75094b1c57707e4b9c85954</data>
    </node>
    <node id="&quot;T. CRUZI&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"T. cruzi is a term used to refer to the infection studied in this text."</data>
      <data key="d2">chunk-6600322cc75094b1c57707e4b9c85954</data>
    </node>
    <node id="&quot;SERONEGATIVE&quot;">
      <data key="d0">"DISEASE STATE"</data>
      <data key="d1">"Seronegative refers to individuals without antibodies against T. cruzi, indicating no previous exposure or current non-infection by T. cruzi."</data>
      <data key="d2">chunk-6600322cc75094b1c57707e4b9c85954</data>
    </node>
    <node id="&quot;SEROPOSITIVE&quot;">
      <data key="d0">"DISEASE STATE"</data>
      <data key="d1">"Seropositive refers to individuals with antibodies against T. cruzi, indicating a history of infection by this parasite."</data>
      <data key="d2">chunk-6600322cc75094b1c57707e4b9c85954</data>
    </node>
    <node id="&quot;ASYMPTOMATIC&quot;">
      <data key="d0">"DISEASE STATE"</data>
      <data key="d1">"Asymptomatic refers to individuals without symptoms or clinical signs of Chagas disease (CCC), despite being infected."</data>
      <data key="d2">chunk-6600322cc75094b1c57707e4b9c85954</data>
    </node>
    <node id="&quot;CHAGAS DISEASE (CCC)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Chagas disease (CCC) is a term used for the disease studied in this text, characterized by various manifestations depending on infection stage and individual immunity."</data>
      <data key="d2">chunk-6600322cc75094b1c57707e4b9c85954</data>
    </node>
    <node id="&quot;LD&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Linkage disequilibrium (LD) is the non-random association between genetic variants that are inherited together."</data>
      <data key="d2">chunk-6600322cc75094b1c57707e4b9c85954</data>
    </node>
    <node id="&quot;CHAGAS DISEASE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Chagas disease, caused by the parasite Trypanosoma cruzi, results in chronic infection and can lead to various complications like heart failure."</data>
      <data key="d2">chunk-6600322cc75094b1c57707e4b9c85954</data>
    </node>
    <node id="&quot;ANTIBODIES&quot;">
      <data key="d0">"MOLECULAR PRODUCT"</data>
      <data key="d1">"Antibodies are proteins produced by immune cells that recognize and bind to specific antigens."</data>
      <data key="d2">chunk-6600322cc75094b1c57707e4b9c85954</data>
    </node>
    <node id="&quot;SERUM&quot;">
      <data key="d0">"SAMPLE TYPE"</data>
      <data key="d1">"Serum is a biological sample that contains various proteins, including cytokines like IL-8."&lt;SEP&gt;"Serum is the liquid part of blood after clotting factors have been removed."</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68&lt;SEP&gt;chunk-6600322cc75094b1c57707e4b9c85954</data>
    </node>
    <node id="&quot;ASYMPTOMATIC INDIVIDUALS&quot;">
      <data key="d0">"DISEASE STATE"</data>
      <data key="d1">"Asymptomatic individuals are those who carry a disease but do not exhibit any symptoms."</data>
      <data key="d2">chunk-6600322cc75094b1c57707e4b9c85954</data>
    </node>
    <node id="&quot;SYMPTOMATIC INDIVIDUALS&quot;">
      <data key="d0">"DISEASE STATE"</data>
      <data key="d1">"Symptomatic individuals display one or more signs or symptoms of Chagas disease."</data>
      <data key="d2">chunk-6600322cc75094b1c57707e4b9c85954</data>
    </node>
    <node id="&quot;RS2228570&quot;*">
      <data key="d2">chunk-6600322cc75094b1c57707e4b9c85954</data>
      <data key="d1">"The minor allele, *A of rs2228570 is overrepresented in the seronegative subset.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;VDR SNPS&quot;">
      <data key="d2">chunk-6600322cc75094b1c57707e4b9c85954</data>
      <data key="d1">"Specific VDR SNP haplotypes correlate with susceptibility or resistance to T. cruzi infection.")&lt;SEP&gt;"The VDR polymorphisms may influence the risk of infection by T. cruzi, but only rs2228570 shows a protective effect against infection.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS731236&quot;, &quot;RS7975232&quot;, &quot;RS1544410&quot;">
      <data key="d2">chunk-6600322cc75094b1c57707e4b9c85954</data>
      <data key="d1">"The three variants form three different haplotypes (ACC, GAT and AAC).")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SEROPOSITIVE INDIVIDUALS&quot;">
      <data key="d2">chunk-6600322cc75094b1c57707e4b9c85954</data>
      <data key="d1">"Minor allele *A of rs2228570 is overrepresented among seropositive individuals compared to seronegative and asymptomatic individuals.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL-1A -889C&gt;T&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The TT genotype of IL-1A -889C&gt;T was found to be more frequent in HNP patients than controls."</data>
      <data key="d2">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
    </node>
    <node id="&quot;TNF-A 238G&gt;A&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"CT and T alleles of TNF-A 238G&gt;A had frequencies more than healthy controls compared to HNP cases."</data>
      <data key="d2">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
    </node>
    <node id="&quot;VDR TAQI&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The distribution of VDR TaqI genotypes did not show any significant difference between HNP patients and control individuals."</data>
      <data key="d2">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
    </node>
    <node id="&quot;HNP&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"HNPs (healthier neck pain) were studied for associations with the genotypes of IL-1A, TNF-A, and VDR."</data>
      <data key="d2">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
    </node>
    <node id="&quot;OR: 0.82&quot;">
      <data key="d0">"POOLED ESTIMATE"</data>
      <data key="d1">"The odds ratio for IL-1A -889C&gt;T genotype was calculated at the risk level of HNPs in comparison to CC vs. CT+TT genotypes."</data>
      <data key="d2">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
    </node>
    <node id="&quot;OR: 0.63&quot;">
      <data key="d0">"POOLED ESTIMATE"</data>
      <data key="d1">"No association between TNF-A 238G&gt;A and HNP susceptibility was observed when comparing GG vs. GA+AA genotypes."</data>
      <data key="d2">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
    </node>
    <node id="&quot;RS1800587&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"IL-1A rs1800587 was included in studies for HNP."</data>
      <data key="d2">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
    </node>
    <node id="&quot;RS361525&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"TNF-A rs361525 polymorphism was considered among the factors studied for HNP."</data>
      <data key="d2">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
    </node>
    <node id="&quot;GENES&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"IL-1A, TNF-A, and VDR were genes that were examined in relation to HNP."</data>
      <data key="d2">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
    </node>
    <node id="&quot;MATERNAL SERUM B12 LEVELS&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Assumed to influence offspring birthweight through maternal health."&lt;SEP&gt;"Explained variance in serum B12 concentrations in GWAS."</data>
      <data key="d2">chunk-1d2a8d3ce4f9baae7e1c9c14410045d0</data>
    </node>
    <node id="&quot;GWAS (GENOME-WIDE ASSOCIATION STUDY)&quot;">
      <data key="d0">"STUDY DESIGN"</data>
      <data key="d1">"Performed a GWAS to find variants related to B12 levels."</data>
      <data key="d2">chunk-1d2a8d3ce4f9baae7e1c9c14410045d0</data>
    </node>
    <node id="&quot;MATERNAL FOLATE LEVELS&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Explained variance in serum folate concentration in GWAS."</data>
      <data key="d2">chunk-1d2a8d3ce4f9baae7e1c9c14410045d0</data>
    </node>
    <node id="&quot;SNPS (SINGLE NUCLEOTIDE POLYMORPHISMS)&quot;">
      <data key="d0">"VARIANT TYPE"</data>
      <data key="d1">"Close to 6 million SNPs were identified for association with gene expression."&lt;SEP&gt;"Included in MR analysis to explain variance."</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca&lt;SEP&gt;chunk-1d2a8d3ce4f9baae7e1c9c14410045d0</data>
    </node>
    <node id="&quot;STATISTICAL ANALYSIS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Demographic, clinical, and patient-reported risk factors explained 13% of the variance in acute nausea; ABCB1 genotype contributed an additional 5% to this variability (p=0.10)."&lt;SEP&gt;"Used F statistics for individual SNPs and IVW analysis for causal effect estimates."&lt;SEP&gt;"The process of statistical testing to evaluate genetic associations with hematological parameters."</data>
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8&lt;SEP&gt;chunk-3ae06e9a3330573da28ca0a76aa685ce&lt;SEP&gt;chunk-1d2a8d3ce4f9baae7e1c9c14410045d0</data>
    </node>
    <node id="&quot;SERUM B12 CONCENTRATIONS&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Measured concentrations of serum B12 in pregnant women."</data>
      <data key="d2">chunk-1d2a8d3ce4f9baae7e1c9c14410045d0</data>
    </node>
    <node id="&quot;SERUM FOLATE CONCENTRATION&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Measured concentrations of serum folate in pregnant women."</data>
      <data key="d2">chunk-1d2a8d3ce4f9baae7e1c9c14410045d0</data>
    </node>
    <node id="&quot;OFFSPRING BIRTHWEIGHT&quot;">
      <data key="d0">"OUTCOME"</data>
      <data key="d1">"Birthweight is a measure often used in maternal and child health studies to assess potential effects on offspring."&lt;SEP&gt;"Measured outcome influenced by maternal and fetal nutrient levels."</data>
      <data key="d2">chunk-22216738ccbae0a6276bb4499018c434&lt;SEP&gt;chunk-1d2a8d3ce4f9baae7e1c9c14410045d0</data>
    </node>
    <node id="&quot;FETAL B12 LEVELS&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Measured levels of B12 in the fetus, not associated with offspring birthweight."</data>
      <data key="d2">chunk-1d2a8d3ce4f9baae7e1c9c14410045d0</data>
    </node>
    <node id="&quot;FETAL FOLATE LEVELS&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Measured levels of folate in the fetus, negatively associated with their own birthweight."</data>
      <data key="d2">chunk-1d2a8d3ce4f9baae7e1c9c14410045d0</data>
    </node>
    <node id="&quot;PREGNANT WOMEN FROM EFSOCH STUDY&quot;">
      <data key="d0">"POPULATION"</data>
      <data key="d1">"Participants of the study on maternal and fetal nutrient levels."</data>
      <data key="d2">chunk-1d2a8d3ce4f9baae7e1c9c14410045d0</data>
    </node>
    <node id="&quot;EFSOCH STUDY&quot;">
      <data key="d0">"STUDY DESIGN"</data>
      <data key="d1">"Conducted observational research focusing on pregnant women's nutrient levels and birth outcomes."</data>
      <data key="d2">chunk-1d2a8d3ce4f9baae7e1c9c14410045d0</data>
    </node>
    <node id="&quot;IVW ANALYSIS (INVERSE VARIANCE WEIGHTED)&quot;">
      <data key="d0">"METHODOLOGY"</data>
      <data key="d1">"Used for causal effect estimation in the presence of potential confounders."</data>
      <data key="d2">chunk-1d2a8d3ce4f9baae7e1c9c14410045d0</data>
    </node>
    <node id="&quot;SENSITIVITY ANALYSES&quot;">
      <data key="d0">"STATISTICAL APPROACH"</data>
      <data key="d1">"Conducted to assess robustness of results under different assumptions or scenarios."</data>
      <data key="d2">chunk-1d2a8d3ce4f9baae7e1c9c14410045d0</data>
    </node>
    <node id="&quot;HETEROGENEITY TESTS&quot;">
      <data key="d0">"STATISTICAL TEST"</data>
      <data key="d1">"Used to identify variability in the causal effect estimates across individual SNPs."</data>
      <data key="d2">chunk-1d2a8d3ce4f9baae7e1c9c14410045d0</data>
    </node>
    <node id="&quot;MMACHC VARIANT (RS12272669)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Appeared to have little effect on birthweight of pregnant women."</data>
      <data key="d2">chunk-1d2a8d3ce4f9baae7e1c9c14410045d0</data>
    </node>
    <node id="&quot;FUT2 VARIANT (RS602662)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A priori expected to have pleiotropic effects, but found no strong evidence for it."</data>
      <data key="d2">chunk-1d2a8d3ce4f9baae7e1c9c14410045d0</data>
    </node>
    <node id="&quot;MTHFR SNP (RS1801133)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Caused attenuation in the causal effect of maternal folate levels on birthweight when excluded from analysis."</data>
      <data key="d2">chunk-1d2a8d3ce4f9baae7e1c9c14410045d0</data>
    </node>
    <node id="&quot;MMACHC SNP (RS12272669)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Appeared to have little effect on birthweight of pregnant women."</data>
      <data key="d2">chunk-1d2a8d3ce4f9baae7e1c9c14410045d0</data>
    </node>
    <node id="&quot;FUT2 SNP (RS602662)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A priori expected to have pleiotropic effects, but found no strong evidence for it."</data>
      <data key="d2">chunk-1d2a8d3ce4f9baae7e1c9c14410045d0</data>
    </node>
    <node id="&quot;B12&quot;">
      <data key="d0">"VITAMIN"</data>
      <data key="d1">"Vitamin B12 levels are influenced by folate intake and may affect birthweight according to some studies."</data>
      <data key="d2">chunk-22216738ccbae0a6276bb4499018c434</data>
    </node>
    <node id="&quot;MATERNAL FOLATE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Maternal consumption of folate is a factor in the relationship between maternal vitamin B12 levels and offspring birthweight."</data>
      <data key="d2">chunk-22216738ccbae0a6276bb4499018c434</data>
    </node>
    <node id="&quot;MATERNAL VITAMIN B12&quot;">
      <data key="d0">"VITAMIN"</data>
      <data key="d1">"Maternal intake of vitamin B12 may influence offspring birthweight, but not evidence for this was found."</data>
      <data key="d2">chunk-22216738ccbae0a6276bb4499018c434</data>
    </node>
    <node id="&quot;GESTATIONAL DURATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Gestational duration refers to the length of time from conception until birth, which was not found to be influenced by B12 or folate levels."</data>
      <data key="d2">chunk-22216738ccbae0a6276bb4499018c434</data>
    </node>
    <node id="&quot;BIOLOGICAL PATHWAY&quot;">
      <data key="d0">"ANATOMICAL SEQUENCE"</data>
      <data key="d1">"This refers to pathways or sequences of events that occur within specific organs or systems in the human body."</data>
      <data key="d2">chunk-22216738ccbae0a6276bb4499018c434</data>
    </node>
    <node id="&quot;THERAPY&quot;">
      <data key="d0">"MEDICAL TREATMENT"</data>
      <data key="d1">"A therapy refers to methods or procedures used in medicine to alleviate symptoms, cure diseases, or improve health."</data>
      <data key="d2">chunk-22216738ccbae0a6276bb4499018c434</data>
    </node>
    <node id="&quot;MATERNAL B12 LEVELS&quot;">
      <data key="d2">chunk-1d2a8d3ce4f9baae7e1c9c14410045d0</data>
      <data key="d1">"No evidence for a causal effect of maternal B12 levels on offspring birthweight.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;B12/FOLATE LEVELS&quot;">
      <data key="d2">chunk-22216738ccbae0a6276bb4499018c434</data>
      <data key="d1">"There is no indication that levels of B12 or folate have an effect on gestational duration based on the data.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MTHFR C677T&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A single nucleotide polymorphism in the MTHFR gene, with a carrier rate of 55.04% among LV patients."&lt;SEP&gt;"The MTHFR C677T gene variant carrier rate was 51.15% in Korea and Afghanistan."</data>
      <data key="d2">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb&lt;SEP&gt;chunk-d0476488384aadcae4630e94d982d2e0</data>
    </node>
    <node id="&quot;MTHFR A1298C&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A different single nucleotide polymorphism in the MTHFR gene, with a carrier rate of 43.90% among LV patients."&lt;SEP&gt;"The MTHFR A1298C gene variant carrier rate was 43.86% in the population studied."</data>
      <data key="d2">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb&lt;SEP&gt;chunk-d0476488384aadcae4630e94d982d2e0</data>
    </node>
    <node id="&quot;PAI-1 -675 4G/5G&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The PAI-1 -675 4G/5G gene variant carrier rate was 82.9% in Korea and Afghanistan."&lt;SEP&gt;"The PAI-1 gene variant with a homozygous carrier rate of 29.47%, and the highest total carrier rate (85.26%) among assessed SNPs."</data>
      <data key="d2">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb&lt;SEP&gt;chunk-d0476488384aadcae4630e94d982d2e0</data>
    </node>
    <node id="&quot;PAI-1 A844G&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A relatively rare polymorphism in PAI-1 gene, with a carrier rate of 55.56%."&lt;SEP&gt;"The PAI-1 A844G polymorphism has not been tested yet in North America."</data>
      <data key="d2">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb&lt;SEP&gt;chunk-d0476488384aadcae4630e94d982d2e0</data>
    </node>
    <node id="&quot;PROTHROMBIN G20210A&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The Prothrombin G20210A gene variant carrier rate was 6.45% in Korea and Afghanistan."&lt;SEP&gt;"The Prothrombin G20210A gene variant carrier rate was 75% in North America."&lt;SEP&gt;"The Prothrombin gene variant, with the lowest total carrier rate (10.59%) among assessed SNPs."</data>
      <data key="d2">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb&lt;SEP&gt;chunk-d0476488384aadcae4630e94d982d2e0</data>
    </node>
    <node id="&quot;FACTOR V G1691A&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A relatively low carrier rate of 14.07% in LV patients, ranked second lowest among tested SNPs."&lt;SEP&gt;"The Factor V G1691A gene variant carrier rate was 28.57% in North America."&lt;SEP&gt;"The Factor V G1691A gene variant carrier rate was 36.45% in Korea and Afghanistan."</data>
      <data key="d2">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb&lt;SEP&gt;chunk-d0476488384aadcae4630e94d982d2e0</data>
    </node>
    <node id="&quot;LIFESTYLE FACTORS&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"Activities such as physical exercise modify the impact of genetic predispositions on cardiovascular disease, in conjunction with dietary habits."</data>
      <data key="d2">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
    </node>
    <node id="&quot;STATINS THERAPY&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Statin medications are used to manage cholesterol levels and reduce the risk associated with certain genetic variants linked to cardiovascular disease."</data>
      <data key="d2">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
      <data key="d3">[{"level": 0, "cluster": 13}, {"level": 1, "cluster": 43}]</data>
    </node>
    <node id="&quot;LV PATIENTS&quot;">
      <data key="d0">"PATIENT"</data>
      <data key="d1">"115 LV patients were evaluated, with a total of male:female ratio as 31.30%:68.70%, mean age being 27.26 years."</data>
      <data key="d2">chunk-d0476488384aadcae4630e94d982d2e0</data>
    </node>
    <node id="&quot;EUROPE&quot;">
      <data key="d0">"GEOGRAPHICAL REGION"</data>
      <data key="d1">"In Europe, there were eight articles involving 49 LV patients from five countries."</data>
      <data key="d2">chunk-d0476488384aadcae4630e94d982d2e0</data>
    </node>
    <node id="&quot;PORTUGAL&quot;">
      <data key="d0">"COUNTRY"</data>
      <data key="d1">"Portugal is one of the European countries where studies were conducted."</data>
      <data key="d2">chunk-d0476488384aadcae4630e94d982d2e0</data>
    </node>
    <node id="&quot;SPAIN&quot;">
      <data key="d0">"COUNTRY"</data>
      <data key="d1">"Spain also had involvement in these studies within Europe."</data>
      <data key="d2">chunk-d0476488384aadcae4630e94d982d2e0</data>
    </node>
    <node id="&quot;BRITAIN&quot;">
      <data key="d0">"COUNTRY"</data>
      <data key="d1">"The British population was included in European studies on LV patients."</data>
      <data key="d2">chunk-d0476488384aadcae4630e94d982d2e0</data>
    </node>
    <node id="&quot;GERMANY&quot;">
      <data key="d0">"COUNTRY"</data>
      <data key="d1">"German participants were part of the evaluation in Europe."</data>
      <data key="d2">chunk-d0476488384aadcae4630e94d982d2e0</data>
    </node>
    <node id="&quot;FRANCE&quot;">
      <data key="d0">"COUNTRY"</data>
      <data key="d1">"French individuals contributed to the studies conducted within Europe."</data>
      <data key="d2">chunk-d0476488384aadcae4630e94d982d2e0</data>
    </node>
    <node id="&quot;MTHFR C677T&quot;/&quot;A1298C&quot;">
      <data key="d2">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
      <data key="d1">"The MTHFR gene's different variant types, like C677T and A1298C, are associated with various aspects of cardiovascular health.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PAI-1 4G/5G&quot;/&quot;A844G&quot;">
      <data key="d2">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
      <data key="d1">"Polymorphisms in the PAI-1 gene contribute to cardiovascular disease risk, as seen with variants such as -675 4G/5G and A844G.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PROTHROMBIN G20210A&quot;/&quot;FACTOR V G1691A&quot;">
      <data key="d2">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
      <data key="d1">"SNPs in prothrombin gene (G20210A) and factor V gene (G1691A) are related to thrombosis risk and contribute to cardiovascular health.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;VARIANT CARRIER RATE&quot;">
      <data key="d2">chunk-d0476488384aadcae4630e94d982d2e0</data>
      <data key="d1">"The variant carrier rate for MTHFR C677T was 64.28% in Europe.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FOLIC ACID&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Folic acid is a vitamin that contains B9 and it plays an important role in DNA synthesis, cell division, and the creation of new blood cells."</data>
      <data key="d2">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
    </node>
    <node id="&quot;VITAMIN STATUS&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"The vitamin status of individuals may have effects on fertility, as seen with folic acid containing vitamins and semen quality."</data>
      <data key="d2">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
    </node>
    <node id="&quot;SEMEN QUALITY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Semen quality is a physiological process that can be affected by factors such as vitamin usage and folate intake."</data>
      <data key="d2">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
    </node>
    <node id="&quot;INFERTILE MEN&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Infertile men are those who have difficulties with conception, which may relate to their semen quality and vitamin status."</data>
      <data key="d2">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
    </node>
    <node id="&quot;FERTILITY CONTROLS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Fertility controls are individuals without fertility issues or problems with conception, used as a comparison group in studies."</data>
      <data key="d2">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
    </node>
    <node id="&quot;SERUM FOLATE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Lower serum folate concentration is associated with poorer semen quality in infertile men compared to fertile controls."&lt;SEP&gt;"Serum folate is the concentration of folate present in blood serum and it influences semen quality according to vitamin usage."</data>
      <data key="d2">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
    </node>
    <node id="&quot;RCF&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"RCF stands for reduced cofactor function, which can be influenced by serum folate levels and associated with infertility."</data>
      <data key="d2">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
    </node>
    <node id="&quot;THCY&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Homocysteine (tHcy) is a metabolic product that may have implications on semen quality, but it was not significantly different between groups in this study."</data>
      <data key="d2">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
    </node>
    <node id="&quot;VITAMIN SUPPLEMENTS&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Vitamin supplements can increase the levels of nutrients like folate and B12 while reducing tHcy concentrations, which shows benefits for semen parameters."</data>
      <data key="d2">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
    </node>
    <node id="&quot;SMOKING&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"In the Czech Republic, smoking status was associated with milk drinking habits along with educational attainment."&lt;SEP&gt;"Smoking is a behavior that may negatively impact reproductive health and sperm quality in men."</data>
      <data key="d2">chunk-c9badb9a0fb813f42383cc8afc57ad45&lt;SEP&gt;chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;ABSTINENCE TIME&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The period of abstinence before semen collection can influence semen parameters like concentration and volume."</data>
      <data key="d2">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
    </node>
    <node id="&quot;FOLIC ACID-CONTAINING VITAMINS USAGE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The use of folic acid-containing vitamins might not have a significant impact on semen quality, especially in infertile men compared to fertile controls."</data>
      <data key="d2">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
    </node>
    <node id="&quot;VITAMIN SUPPLEMENT USERS&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Individuals who use vitamin supplements tend to have higher folate and B12 levels and lower tHcy concentrations than non-users."</data>
      <data key="d2">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
    </node>
    <node id="&quot;INFERTILITY STATUS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Being diagnosed with infertility may be associated with certain genetic factors like the choline pathway enzyme gene PEMT M175V minor V allele or variant rs173665 in TCblR."</data>
      <data key="d2">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
    </node>
    <node id="&quot;B12 TRANSCOBALAMIN RECEPTOR GENE (TCBLR) VARIANT RS173665&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The B12 transcobalamin receptor gene has a variant rs173665 that may influence fertility status in males, showing negative association."</data>
      <data key="d2">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
    </node>
    <node id="&quot;PHOSPHATIDYLETHANOLAMINE N-METHYLTRANSFERASE (PEMT) M175V MINOR V ALLELE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The PEMT enzyme gene has a minor V allele at position 175 that may have a positive association with male infertility status."</data>
      <data key="d2">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
    </node>
    <node id="&quot;MALE INFERTILITY&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Male infertility is a condition where a man has difficulty with conception or producing viable sperm, potentially related to genetic and environmental factors."</data>
      <data key="d2">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
    </node>
    <node id="&quot;SEMEN CONCENTRATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Semen concentration refers to the number of sperm cells per milliliter in semen, an important factor for fertility that can be influenced by vitamin usage."</data>
      <data key="d2">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
    </node>
    <node id="&quot;SPERM NUMBER&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The total count of sperm produced or present in a sample of semen, which is crucial for fertility and can be impacted by various factors including vitamin intake and age."</data>
      <data key="d2">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
    </node>
    <node id="&quot;SEMINAL VOLUME&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Semen volume measures the amount of liquid produced during ejaculation and it plays a role in fertility; its parameters may differ between fertile men and those with male infertility."</data>
      <data key="d2">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
    </node>
    <node id="&quot;SPERM MOTILITY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Sperm motility refers to the ability of sperm cells to move and swim towards an egg, which is essential for successful fertilization; it can be influenced by vitamin status and age."</data>
      <data key="d2">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
    </node>
    <node id="&quot;FERTILE CONTROLS&quot;">
      <data key="d0">"DISEASE COMPARISON"</data>
      <data key="d1">"Fertile individuals used as a comparative group in studies assessing factors like semen quality or genetic influences on fertility."</data>
      <data key="d2">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
    </node>
    <node id="&quot;BONFERRONI METHOD&quot;">
      <data key="d0">"STATISTICAL ANALYSIS"</data>
      <data key="d1">"Bonferroni correction is a statistical procedure used to adjust p-values for multiple comparisons, to control the false discovery rate when analyzing data; it was applied here to avoid false positives in genetic association studies."</data>
      <data key="d2">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
    </node>
    <node id="&quot;SEMINAL PARAMETERS&quot;">
      <data key="d2">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
      <data key="d1">"Vitamin supplementation has been shown to have beneficial effects on seminal parameters such as sperm concentration and motility in this study.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INFERTILE MEN VS. FERTILE CONTROLS&quot;">
      <data key="d2">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
      <data key="d1">"Lower serum folate levels are correlated with poorer semen quality specifically among infertile men, compared to those with fertility issues.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FERTILITY STATUS&quot;">
      <data key="d2">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
      <data key="d1">"Age is a factor in determining fertility status; older individuals tend to have differences in reproductive health metrics compared to younger individuals.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SHMT1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"This enzyme catalyzes the reversible conversion of serine to glycine, transferring methyl groups to tetrahydrofolate (THF), which is transformed into 5,10-methylenetetrahydrofolate (5,10-CH2-THF)."</data>
      <data key="d2">chunk-382f24e5db6941e2e3db379fe499b223</data>
    </node>
    <node id="&quot;RS1979277&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A significant increase was observed of the G allele when compared with controls."</data>
      <data key="d2">chunk-382f24e5db6941e2e3db379fe499b223</data>
    </node>
    <node id="&quot;LEU435PHE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"This polymorphism results in an alteration of Leu435 to Phe."</data>
      <data key="d2">chunk-382f24e5db6941e2e3db379fe499b223</data>
    </node>
    <node id="&quot;SHMT1 RS638416&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A very significant increase was observed of the C allele and CC genotype in TMD patients."&lt;SEP&gt;"Promoter region variation (C allele) that is significantly more common in TMD patients compared with controls."</data>
      <data key="d2">chunk-382f24e5db6941e2e3db379fe499b223</data>
    </node>
    <node id="&quot;5'-UTR&quot;">
      <data key="d0">"PROMOTER REGION"</data>
      <data key="d1">"This refers to the promoter region of the SHMT1 gene."</data>
      <data key="d2">chunk-382f24e5db6941e2e3db379fe499b223</data>
    </node>
    <node id="&quot;MTHFD1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The MTHFD1 gene encodes a protein with three distinct enzyme activities: 5,10-methylenetrahydrofolate dehydrogenase, 5,10-methylenetrahydrofolate cyclohydrolase, and 10-formyltetrahydrofolate-synthetase."</data>
      <data key="d2">chunk-382f24e5db6941e2e3db379fe499b223</data>
    </node>
    <node id="&quot;RS2236225&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A transition from G to A resulting in an alteration of ARG-653-GLN."&lt;SEP&gt;"Transition variant leading to GLN change at amino acid position 653, associated with susceptibility to neural tube defects sensitive to folates."</data>
      <data key="d2">chunk-382f24e5db6941e2e3db379fe499b223</data>
    </node>
    <node id="&quot;RS2236225 (G TO A)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"This leads to an alteration of the amino acid Arginine to Glutamine at position 653."</data>
      <data key="d2">chunk-382f24e5db6941e2e3db379fe499b223</data>
    </node>
    <node id="&quot;GSTM1-NULL&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Deletion of the GSTM1 gene results in a null variant."&lt;SEP&gt;Deletion"</data>
      <data key="d2">chunk-382f24e5db6941e2e3db379fe499b223</data>
    </node>
    <node id="&quot;GSTM1-NULL (NULL VARIANT)&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"This variant may increase susceptibility to environmental toxins and carcinogens."</data>
      <data key="d2">chunk-382f24e5db6941e2e3db379fe499b223</data>
    </node>
    <node id="&quot;MTRR&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Responsible for regenerating Methionine Synthase by reductive methylation using SAM as a methyl donor."</data>
      <data key="d2">chunk-382f24e5db6941e2e3db379fe499b223</data>
    </node>
    <node id="&quot;RS1801394&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Polymorphism affecting MTRR enzyme leading to altered methionine regeneration and Ile22Met substitution."&lt;SEP&gt;"Substitution of A by G results in Ile22Met, producing an enzyme with less affinity for the substrate."</data>
      <data key="d2">chunk-382f24e5db6941e2e3db379fe499b223</data>
    </node>
    <node id="&quot;DRD4-48BPTR&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This is a VNTR polymorphism that leads to differences in the number of repeats (S-DRD4 and L-DRD4)."&lt;SEP&gt;Polymorphism"</data>
      <data key="d2">chunk-382f24e5db6941e2e3db379fe499b223</data>
    </node>
    <node id="&quot;SHORT ALLELE S-DRD4&quot;/&quot;LONG ALLELE L-DRD4&quot;">
      <data key="d0">"MOLECULAR INTERACTION/</data>
      <data key="d1">Variation"</data>
      <data key="d2">chunk-382f24e5db6941e2e3db379fe499b223</data>
    </node>
    <node id="&quot;CDC MBA&quot;">
      <data key="d0">"METHOD"</data>
      <data key="d1">"The CDC (Centers for Disease Control and Prevention) Measurement by Absorbance (MBA) method is used for measuring serum folate."</data>
      <data key="d2">chunk-dd3c1834035af8b4436c8058609b6fd8</data>
    </node>
    <node id="&quot;CDC HPLC-MS/MS&quot;">
      <data key="d0">"METHOD"</data>
      <data key="d1">"The CDC High Performance Liquid Chromatography-Mass Spectrometry/Mass Spectrometry (HPLC-MS/MS) method is another technique utilized for measuring serum folate."</data>
      <data key="d2">chunk-dd3c1834035af8b4436c8058609b6fd8</data>
    </node>
    <node id="&quot;WITHIN-LABORATORY IMPRECISION&quot;">
      <data key="d0">"QUALITY METRIC"&lt;|"A METRIC USED TO ASSESS THE CONSISTENCY OF RESULTS WITHIN AN INDIVIDUAL LABORATORY ACROSS REPEATED MEASUREMENTS.")("ENTITY"</data>
      <data key="d1">"CDC QC Procedures"</data>
      <data key="d2">chunk-dd3c1834035af8b4436c8058609b6fd8</data>
    </node>
    <node id="&quot;S-FOL&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"Results showed that the mean concentration of 30.2 nmol/L compared to 35.3 nmol/L for S-FOL with IH-CAL and 428 nmol/L compared to 469 nmol/L with WB-FOL"&lt;SEP&gt;"The mean difference to the CDC MBA target value was 30% under IH reagents."&lt;SEP&gt;"When both reagents were harmonized, an intermediate mean difference and SD was observed."</data>
      <data key="d2">chunk-257a38a8ce6582c434f31b023b4a9704&lt;SEP&gt;chunk-7c25217961fba65d15f20beda8a58f1c</data>
    </node>
    <node id="&quot;WB-FOL&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"Results showed that the mean concentration of 30.7 nmol/L compared to 35.3 nmol/L for S-FOL and 418 nmol/L compared to 469 nmol/L with WB-FOL"&lt;SEP&gt;"Similarly to S-FOL, an intermediate mean difference and SD was estimated for WB-FOL under the harmonized condition."&lt;SEP&gt;"The mean difference to the CDC MBA target value decreased from 25% ± 19% with IH reagents to 13% ± 13% with CDC reagents."</data>
      <data key="d2">chunk-257a38a8ce6582c434f31b023b4a9704&lt;SEP&gt;chunk-7c25217961fba65d15f20beda8a58f1c</data>
    </node>
    <node id="&quot;CDC-MO&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Conditions related to CDC-MO showed mean results of 27.0 nmol/L for S-FOL and 358 nmol/L for WB-FOL compared to IH reagent conditions."&lt;SEP&gt;"Microorganism provided for round-robin kit."</data>
      <data key="d2">chunk-257a38a8ce6582c434f31b023b4a9704&lt;SEP&gt;chunk-7c25217961fba65d15f20beda8a58f1c</data>
    </node>
    <node id="&quot;IH-CAL&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"IH-CAL condition showed mean results that were closer to the CDC MBA target concentrations compared to IH reagents."</data>
      <data key="d2">chunk-257a38a8ce6582c434f31b023b4a9704</data>
    </node>
    <node id="&quot;COVARIANCE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The model estimated among-laboratory variability for conditions affecting microorganism and calibrator results."&lt;SEP&gt;"The model estimated among-laboratory variability for microorganism and calibrator conditions"</data>
      <data key="d2">chunk-257a38a8ce6582c434f31b023b4a9704</data>
    </node>
    <node id="&quot;MICROORGANISM EFFECT&quot;">
      <data key="d0">"OVERALL MICROORGANISM EFFECT"</data>
      <data key="d1">"A small effect was observed with ~5% for S-FOL and ~2% for WB-FOL when averaged across days."</data>
      <data key="d2">chunk-257a38a8ce6582c434f31b023b4a9704</data>
    </node>
    <node id="&quot;CALIBRATOR EFFECT&quot;">
      <data key="d0">"OVERALL CALIBRATOR EFFECT"</data>
      <data key="d1">"Large differences were seen in the overall calibrator effects"</data>
      <data key="d2">chunk-257a38a8ce6582c434f31b023b4a9704</data>
    </node>
    <node id="&quot;CDC MBA TARGET VALUES&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Labs under CDC-MO &amp; CDC-CAL condition achieved results within ±20% of the target value except for lab #6."</data>
      <data key="d2">chunk-257a38a8ce6582c434f31b023b4a9704</data>
    </node>
    <node id="&quot;GROUP 1 LABORATORIES&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Mean difference to CDC MBA target was estimated at 21% for S-FOL and 18% for WB-FOL with IH reagents"</data>
      <data key="d2">chunk-257a38a8ce6582c434f31b023b4a9704</data>
    </node>
    <node id="&quot;GROUP 2 LABORATORIES&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Mean difference to CDC MBA target was estimated at 30% for both S-FOL and WB-FOL with IH reagents"</data>
      <data key="d2">chunk-257a38a8ce6582c434f31b023b4a9704</data>
    </node>
    <node id="&quot;DAY EFFECT&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"An estimated small day effect of ~5% was found for S-FOL and ~2% for WB-FOL."</data>
      <data key="d2">chunk-257a38a8ce6582c434f31b023b4a9704</data>
      <data key="d3">[{"level": 0, "cluster": 11}, {"level": 1, "cluster": 36}, {"level": 2, "cluster": 60}]</data>
    </node>
    <node id="&quot;95% CIS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The large 95% Confidence Intervals (CIs) suggested underlying variability within and among laboratories."</data>
      <data key="d2">chunk-257a38a8ce6582c434f31b023b4a9704</data>
    </node>
    <node id="&quot;LOG TRANSFORMED RESULTS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The analysis involved transforming raw data using a logarithmic function to normalize the distribution."</data>
      <data key="d2">chunk-257a38a8ce6582c434f31b023b4a9704</data>
    </node>
    <node id="&quot;GEOMETRIC MEANS&quot;">
      <data key="d0">"STATISTICAL PROCESS"</data>
      <data key="d1">"Variance was evaluated through geometric mean, which is useful for averaging rates and ratios."</data>
      <data key="d2">chunk-257a38a8ce6582c434f31b023b4a9704</data>
    </node>
    <node id="&quot;SD (STANDARD DEVIATION)&quot;">
      <data key="d0">"VARIABILITY MEASURE"</data>
      <data key="d1">"The standard deviation of 5.38 nmol/L for S-FOL and 67.5 nmol/L for WB-FOL indicated the spread of data points."</data>
      <data key="d2">chunk-257a38a8ce6582c434f31b023b4a9704</data>
    </node>
    <node id="&quot;CDC-CAL&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Calibrator provided for round-robin kit."</data>
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
    </node>
    <node id="&quot;CDC-MO &amp; CDC-CAL&quot;">
      <data key="d2">chunk-257a38a8ce6582c434f31b023b4a9704</data>
      <data key="d1">"Results under CDC-MO were closer to the target values than IH reagents results in IH-CAL conditions.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IH-CAL &amp; IH-CAL&quot;">
      <data key="d2">chunk-257a38a8ce6582c434f31b023b4a9704</data>
      <data key="d1">"Results under CDC-MO were closer to the target values than IH reagents results in IH-CAL conditions.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;OVERALL MICROORGANISM EFFECT&quot;">
      <data key="d2">chunk-257a38a8ce6582c434f31b023b4a9704</data>
      <data key="d1">"A small day effect was observed for S-FOL and WB-FOL averaged across days.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;OVERALL CALIBRATOR EFFECT&quot;">
      <data key="d2">chunk-257a38a8ce6582c434f31b023b4a9704</data>
      <data key="d1">"Large differences in calibrator effects were observed, averaging across microorganisms.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GROUP 1 LABORATORIES &amp; GROUP 2 LABORATORIES&quot;">
      <data key="d2">chunk-257a38a8ce6582c434f31b023b4a9704</data>
      <data key="d1">"Estimations showed variation in mean difference to CDC MBA target values based on dietary pattern (IH reagents vs. CDC reagents).")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MICROORGANISM &amp; CALIBRATOR&quot;">
      <data key="d2">chunk-257a38a8ce6582c434f31b023b4a9704</data>
      <data key="d1">"The analysis considered covariance across different microorganisms and calibrators.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;VARIABILITY WITHIN &amp; AMONG LABORATORIES&quot;">
      <data key="d2">chunk-257a38a8ce6582c434f31b023b4a9704</data>
      <data key="d1">"CIs highlighted the wide range of variation among different laboratories.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NORMALIZATION PROCESS&quot;">
      <data key="d2">chunk-257a38a8ce6582c434f31b023b4a9704</data>
      <data key="d1">"Logarithmic transformation was used to normalize data distributions.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SPREAD OF DATA POINTS&quot;">
      <data key="d2">chunk-257a38a8ce6582c434f31b023b4a9704</data>
      <data key="d1">"High SD values indicated a larger spread or variability in S-FOL and WB-FOL concentrations.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CDC MBA TARGET VALUE&quot;">
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
      <data key="d1">"95% of the laboratory results were expected to be within these limits under the harmonized condition when CDC reagents were used.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LIMITS OF AGREEMENT&quot;">
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
      <data key="d1">"95% of the laboratory results were expected to be within these limits under the harmonized condition when CDC reagents were used.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DIFFERENCES BETWEEN DAY 1 AND DAY 2&quot;">
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
      <data key="d1">"With the harmonized condition, it can be anticipated that the differences would amount to approximately ±10–30% for S-FOL and approximately ±20–40% for WB-FOL.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;S-FOL &amp; WB-FOL&quot;">
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
      <data key="d1">"With the harmonized condition, it can be anticipated that the differences would amount to approximately ±10–30% for S-FOL and approximately ±20–40% for WB-FOL.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LAB #8 RESULTS (WB-FOL)&quot;">
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
      <data key="d1">"Day 1 vs Day 2 analysis showed a lack of agreement in WB-FOL data, unlike other laboratories.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LACK OF AGREEMENT&quot;">
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
      <data key="d1">"Day 1 vs Day 2 analysis showed a lack of agreement in WB-FOL data, unlike other laboratories.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LABS #6 &amp; 9&quot;">
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
      <data key="d1">"Exhibited less reasonable agreement compared to other labs under harmonized condition.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;AGREEMENT UNDER HARMONIZED CONDITION&quot;">
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
      <data key="d1">"Observed overall good agreement except for labs #6 &amp; 9 when using CDC round-robin kit.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ALL LABS (WITH SAME MO &amp; CAL&quot;)&quot;">
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
      <data key="d1">"Observed overall good agreement except for labs #6 &amp; 9 when using CDC round-robin kit.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DIFFERENCES EXPECTED FOR S-FOL &amp; WB-FOL&quot;">
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
      <data key="d1">"Estimates under harmonized condition for days 1 vs. day 2 analysis.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LIMITS IN RANGE OF +/-10% TO +/-30%/&lt;BR/&gt; +/-20% TO +/-40%&quot;">
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
      <data key="d1">"Estimates under harmonized condition for days 1 vs. day 2 analysis.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DAY 1 DAY 2 COMPARISON&quot;">
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
      <data key="d1">"Lab #8 showed inconsistency between day-wise analysis.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LACK OF AGREEMENT IN WB-FOL&quot;">
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
      <data key="d1">"Lab #8 showed inconsistency between day-wise analysis.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS1695&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"GSTP1 (Glutathione S-transferase P1), rs1695 (A&gt;G) is correlated with CSF use during chemotherapy."&lt;SEP&gt;"The rs1695 polymorphism was analyzed in our study, revealing its association with breast cancer risk."</data>
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404&lt;SEP&gt;chunk-ab5011584b0230efbf80a98b2a693a0e</data>
    </node>
    <node id="&quot;RS1138272&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The rs1138272 polymorphism's analysis also showed no deviation from Hardy-Weinberg equilibrium; however, it was not associated with the risk of breast cancer."</data>
      <data key="d2">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
    </node>
    <node id="&quot;BREAST CANCER&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Breast cancer risk was analyzed using genetic data and polymorphisms such as rs1695 and rs1138272."</data>
      <data key="d2">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
    </node>
    <node id="&quot;GSTP1 PROTEIN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The function of the GSTP1 protein was assessed for a specific single nucleotide polymorphism (Ile105Val), with results showing reduced amyloid propensity."</data>
      <data key="d2">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
    </node>
    <node id="&quot;ILE105VAL&quot;">
      <data key="d2">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
      <data key="d1">"A specific single nucleotide polymorphism (Ile105Val) in GSTP1 shows reduced amyloid propensity according to WALTZ output.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;P.R778L&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The most common pathogenic variant among WD patients, especially prevalent in haplogroup A."&lt;SEP&gt;"The most prevalent pathogenic variant among WD patients in China."&lt;SEP&gt;"The most prevalent pathogenic variant in China associated with three haplogroups (A, B, C)."&lt;SEP&gt;"The most prevalent variant associated with haplogroups A, B, C."</data>
      <data key="d2">chunk-047f259db19cbb4de945706a1bd1b450&lt;SEP&gt;chunk-fa2d834930246b534181c3d6d2c049e1</data>
    </node>
    <node id="&quot;P.P992L&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Complex haplotype spectrum including haplogroups D through I."&lt;SEP&gt;"More complex haplotype spectrum including six haplogroups (D, E, F, G, H, I) associated with WD chromosomes."&lt;SEP&gt;"The second-most common variant, more frequent than expected in Fujian province compared to other regions."&lt;SEP&gt;"The second-most prevalent variant, with a slightly higher prevalence in Fujian province compared to Zhejiang."</data>
      <data key="d2">chunk-047f259db19cbb4de945706a1bd1b450&lt;SEP&gt;chunk-fa2d834930246b534181c3d6d2c049e1</data>
    </node>
    <node id="&quot;P.T935M&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The third most prevalent variant with highest distribution observed in Fujian province."&lt;SEP&gt;"The third-most prevalent variant, showing the highest prevalence in Fujian province."&lt;SEP&gt;"Uniform state presented with only haplogroup J."&lt;SEP&gt;"Uniform state presented, only one kind of haplogroup on WD chromosomes (haplogroup J)."</data>
      <data key="d2">chunk-047f259db19cbb4de945706a1bd1b450&lt;SEP&gt;chunk-fa2d834930246b534181c3d6d2c049e1</data>
    </node>
    <node id="&quot;WD PATIENTS&quot;">
      <data key="d0">"PATIENT POPULATION"</data>
      <data key="d1">"The target population of this study, comprising 715 unrelated WD patients."</data>
      <data key="d2">chunk-047f259db19cbb4de945706a1bd1b450</data>
    </node>
    <node id="&quot;GEOGRAPHICAL DISTRIBUTION&quot;">
      <data key="d0">"SPATIAL ATTRIBUTE"</data>
      <data key="d1">"Distribution of WD cases across southeastern China."</data>
      <data key="d2">chunk-047f259db19cbb4de945706a1bd1b450</data>
    </node>
    <node id="&quot;FUJIAN PROVINCE&quot;">
      <data key="d0">"GEOGRAPHICAL ENTITY"</data>
      <data key="d1">"A region with a high prevalence of p.T935M in the WD patient population."&lt;SEP&gt;"A specific region noted for having high prevalence of certain variants compared to other provinces."</data>
      <data key="d2">chunk-047f259db19cbb4de945706a1bd1b450</data>
    </node>
    <node id="&quot;ZHEJIANG&quot;">
      <data key="d0">"GEOGRAPHICAL ENTITY"</data>
      <data key="d1">"A region where p.P992L has higher prevalence than expected."</data>
      <data key="d2">chunk-047f259db19cbb4de945706a1bd1b450</data>
    </node>
    <node id="&quot;JIANGSU&quot;">
      <data key="d0">"GEOGRAPHICAL ENTITY"</data>
      <data key="d1">"A region with a relatively low prevalence of p.T935M compared to other regions."</data>
      <data key="d2">chunk-047f259db19cbb4de945706a1bd1b450</data>
    </node>
    <node id="&quot;SHANGHAI&quot;">
      <data key="d0">"GEOGRAPHICAL ENTITY"</data>
      <data key="d1">"A region with very limited cases for all three variants, indicating lower prevalence."</data>
      <data key="d2">chunk-047f259db19cbb4de945706a1bd1b450</data>
    </node>
    <node id="&quot;JIANGXI&quot;">
      <data key="d0">"GEOGRAPHICAL ENTITY"</data>
      <data key="d1">"A region that shows higher prevalence of p.R778L than Zhejiang and Jiangsu but less pronounced compared to Fujian."</data>
      <data key="d2">chunk-047f259db19cbb4de945706a1bd1b450</data>
    </node>
    <node id="&quot;P.R778L AND P.P992L&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"These two variants are often present together in some patients, suggesting co-occurrence."</data>
      <data key="d2">chunk-047f259db19cbb4de945706a1bd1b450</data>
    </node>
    <node id="&quot;P.R778L AND P.T935M&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"These two variants also show a tendency to occur together, as evident from certain patient data."</data>
      <data key="d2">chunk-047f259db19cbb4de945706a1bd1b450</data>
    </node>
    <node id="&quot;P.R778L, P.P992L, AND P.T935M&quot;">
      <data key="d0">"VARIANTS GROUP"</data>
      <data key="d1">"The three prevalent pathogenic variants associated with WD patients."</data>
      <data key="d2">chunk-047f259db19cbb4de945706a1bd1b450</data>
    </node>
    <node id="&quot;GEOGRAPHICAL ANALYSIS&quot;">
      <data key="d0">"SPATIAL DISTRIBUTION ATTRIBUTE"</data>
      <data key="d1">"Analysis on the prevalence of pathogenic variants across different regions within China."</data>
      <data key="d2">chunk-047f259db19cbb4de945706a1bd1b450</data>
    </node>
    <node id="&quot;HAPLOGROUP A&quot;">
      <data key="d0">"GENETIC GROUPING"</data>
      <data key="d1">"The dominant genetic grouping to which p.R778L variant is strongly associated."</data>
      <data key="d2">chunk-047f259db19cbb4de945706a1bd1b450</data>
    </node>
    <node id="&quot;ZHEJIANG PROVINCE&quot;">
      <data key="d0">"GEOGRAPHICAL ENTITY"</data>
      <data key="d1">"One of the provinces with less pronounced prevalence of p.P992L compared to other variants and regions."</data>
      <data key="d2">chunk-047f259db19cbb4de945706a1bd1b450</data>
    </node>
    <node id="&quot;JIANGSU PROVINCE&quot;">
      <data key="d0">"GEOGRAPHICAL ENTITY"</data>
      <data key="d1">"A province showing low presence for all three variants, indicating lower prevalence."</data>
      <data key="d2">chunk-047f259db19cbb4de945706a1bd1b450</data>
    </node>
    <node id="&quot;SHANGHAI CITY&quot;">
      <data key="d0">"GEOGRAPHICAL ENTITY"</data>
      <data key="d1">"A city noted for having very limited cases for the pathogenic variants among WD patients."</data>
      <data key="d2">chunk-047f259db19cbb4de945706a1bd1b450</data>
    </node>
    <node id="&quot;JIANGXI PROVINCE&quot;">
      <data key="d0">"GEOGRAPHICAL ENTITY"</data>
      <data key="d1">"A region demonstrating high prevalence of p.R778L variant than Zhejiang but not as much as Fujian province."</data>
      <data key="d2">chunk-047f259db19cbb4de945706a1bd1b450</data>
    </node>
    <node id="&quot;ALLELE DISTRIBUTION&quot;">
      <data key="d0">"GENETIC COMPOSITION ATTRIBUTE"</data>
      <data key="d1">"The variation in frequency and distribution patterns of the pathogenic variants across different genetic markers."</data>
      <data key="d2">chunk-047f259db19cbb4de945706a1bd1b450</data>
    </node>
    <node id="&quot;A&quot;">
      <data key="d0">"HAPLOGROUP"</data>
      <data key="d1">"Overwhelmingly common haplogroup associated with WD chromosomes (97.0%). Can be subdivided into haplotype variants A1–A4."</data>
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1</data>
    </node>
    <node id="&quot;B&quot;">
      <data key="d0">"HAPLOGROUP"</data>
      <data key="d1">"Relatively scarce, found in WD chromosomes at 1.0% compared to control ones." "C"</data>
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1</data>
    </node>
    <node id="&quot;D&quot;">
      <data key="d0">"HAPLOGROUP"</data>
      <data key="d1">"Appeared sporadically on WD chromosomes at 3.4%."</data>
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1</data>
    </node>
    <node id="&quot;E&quot;">
      <data key="d0">"HAPLOGROUP"</data>
      <data key="d1">"More common on WD chromosomes than control ones, containing two variants (E1, E2), with variant E1 occupying the main part."</data>
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1</data>
    </node>
    <node id="&quot;F&quot;">
      <data key="d0">"HAPLOGROUP"</data>
      <data key="d1">"Appeared sporadically, found at 6.9% on WD chromosomes."</data>
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1</data>
    </node>
    <node id="&quot;G&quot;">
      <data key="d0">"HAPLOGROUP"</data>
      <data key="d1">"Sporadically appeared on WD chromosomes at 3.4%."</data>
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1</data>
    </node>
    <node id="&quot;H&quot;">
      <data key="d0">"HAPLOGROUP"</data>
      <data key="d1">"Appeared sporadically, found at 10.3% on WD chromosomes."</data>
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1</data>
    </node>
    <node id="&quot;I&quot;">
      <data key="d0">"HAPLOGROUP"</data>
      <data key="d1">"Appeared sporadically, found at 3.4% on WD chromosomes."</data>
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1</data>
    </node>
    <node id="&quot;J&quot;">
      <data key="d0">"HAPLOGROUP"</data>
      <data key="d1">"Only one kind of haplogroup on WD chromosomes, consisting of two variants J1 (12-4-8) and J2 (12-5-8), showing great significance vs. control ones."</data>
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1</data>
    </node>
    <node id="&quot;10-7-7; 10-7-8; 10-8-7; 10-8-8&quot;">
      <data key="d0">"HAPLOTYPE VARIANTS A1–A4"</data>
      <data key="d1">"Variants of haplogroup A."</data>
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1</data>
    </node>
    <node id="&quot;10-9-5; 10-9-6&quot;">
      <data key="d0">"HAPLOTYPE VARIANTS E1, E2"</data>
      <data key="d1">"Variants associated with haplogroup E."</data>
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1</data>
    </node>
    <node id="&quot;10-4-8; 12-4-8&quot;">
      <data key="d0">"HAPLOTYPES J1, J2"</data>
      <data key="d1">"Variants associated with haplogroup J."</data>
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1</data>
    </node>
    <node id="&quot;97.0%/">
      <data key="d0">3.4%"</data>
      <data key="d1">"Frequencies of Haplogroups A and B in Control Chromosomes"</data>
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1</data>
    </node>
    <node id="&quot;21/29; 6/177&quot;">
      <data key="d0">"NUMBER OF HAPLOTYPES E/</data>
      <data key="d1">E variants found on WD chromosomes"</data>
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1</data>
    </node>
    <node id="&quot;D13S314&quot;">
      <data key="d2">chunk-047f259db19cbb4de945706a1bd1b450</data>
      <data key="d1">"Significant linkage disequilibrium found between D13S314 marker and p.R778L and p.P992L variants.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LINKAGE DISEQUILIBRIUM&quot;">
      <data key="d2">chunk-047f259db19cbb4de945706a1bd1b450</data>
      <data key="d1">"Significant linkage disequilibrium found between D13S314 marker and p.R778L and p.P992L variants.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;D13S301&quot;">
      <data key="d2">chunk-047f259db19cbb4de945706a1bd1b450</data>
      <data key="d1">"Significant association of D13S301 with p.R778L, p.P992L and p.T935M at specific alleles.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;D13S316&quot;">
      <data key="d2">chunk-047f259db19cbb4de945706a1bd1b450</data>
      <data key="d1">"Significant linkage disequilibrium detected between D13S316 marker and the three prevalent pathogenic variants, showing strong associations at different alleles.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ALLELE FREQUENCY COMPARISON&quot;">
      <data key="d2">chunk-047f259db19cbb4de945706a1bd1b450</data>
      <data key="d1">"Significantly higher frequency of p.P992L in Fujian province compared to Zhejiang.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;REGIONAL PREVALENCE&quot;">
      <data key="d2">chunk-047f259db19cbb4de945706a1bd1b450</data>
      <data key="d1">"Highest prevalence of p.T935M variant found in Fujian province, compared to other regions.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CO-OCCURRENCE&quot;">
      <data key="d2">chunk-047f259db19cbb4de945706a1bd1b450</data>
      <data key="d1">"Tendency for these two variants to occur together among a subset of patients.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HAPLOTYPE VARIANTS A1–A4/">
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1</data>
      <data key="d1">A1"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HAPLOTYPE VARIANT E1/">
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1</data>
      <data key="d1">E2"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="3.4%&quot;">
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1</data>
      <data key="d1">"Frequencies of Haplogroups A/B in Control Chromosomes"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS1799853&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The minor allele frequency is low (0.02), consistent with previous studies."</data>
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
    </node>
    <node id="&quot;CYP2C9 STAR VARIANT GROUP&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"We combined rs1799853, rs1057910, rs28371686, rs7900194, rs28371685,(CYP2C9*2, *3, *5, *8, and *11) into a CYP2C9 star variant group due to low frequency of the individual SNPs."</data>
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
    </node>
    <node id="&quot;RS1057910&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The minor allele frequency is also low (0.02), consistent with previous studies."</data>
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
    </node>
    <node id="&quot;RS9923231&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This SNP has a lower minor allele frequency compared to rs1799853 and rs1057910 (0.06 respectively)."</data>
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d3">[{"level": 0, "cluster": 7}, {"level": 1, "cluster": 26}]</data>
    </node>
    <node id="&quot;CYP2C9 ACTIVITY&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The individual SNPs reduce CYP2C9 activity."</data>
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
    </node>
    <node id="&quot;HWE&quot;">
      <data key="d0">"STATISTICAL PROCESS"</data>
      <data key="d1">"The SNPs did not show deviations from Hardy Weinberg equilibrium at P&lt;0.001."</data>
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
    </node>
    <node id="&quot;WARFARIN DOSE&quot;">
      <data key="d0">"DRUG CONCENTRATION OR DOSE"</data>
      <data key="d1">"The mean therapeutic warfarin dose was 46.9 mg/week."</data>
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
    </node>
    <node id="&quot;DVT/PE&quot;">
      <data key="d0">"MEDICAL CONDITION"</data>
      <data key="d1">"More than half of the patients were started on warfarin due to Deep Vein Thrombosis (DVT) or Pulmonary Embolism (PE)."</data>
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
    </node>
    <node id="&quot;AA VALIDATION COHORT&quot;">
      <data key="d0">"CLINICAL TRIAL"</data>
      <data key="d1">"The algorithms were tested in an African American (AA) validation cohort."</data>
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
    </node>
    <node id="&quot;ALGORITHM ACCURACY&quot;">
      <data key="d0">"PERFORMANCE METRIC"</data>
      <data key="d1">"Comparing predicted dose requirements with actual maintenance dose."</data>
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
    </node>
    <node id="&quot;RS28371686&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"One of several SNPs combined into a CYP2C9 star variant group."</data>
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
    </node>
    <node id="&quot;RS7900194&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Another SNP in the combination for creating the CYP2C9 star variant group."</data>
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
    </node>
    <node id="&quot;RS28371685&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Part of a set of SNPs forming a CYP2C9 star variant group."</data>
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
    </node>
    <node id="&quot;NOVEL AA ALGORITHM&quot;">
      <data key="d0">"ALGORITHM"</data>
      <data key="d1">"A machine learning algorithm used to predict drug dosages."</data>
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323</data>
    </node>
    <node id="&quot;HIGH DOSE GROUP&quot;">
      <data key="d0">"GROUP"</data>
      <data key="d1">"A patient cohort that receives a high dosage of the medication."</data>
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323</data>
    </node>
    <node id="&quot;IWPC ALGORITHMS&quot;">
      <data key="d0">"ALGORITHM"</data>
      <data key="d1">"Two other pharmacogenomics-based algorithms for predicting drug dosages."</data>
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323</data>
    </node>
    <node id="&quot;26%&quot;">
      <data key="d0">"PERCENTAGE"</data>
      <data key="d1">"The percentage of patients correctly assigned to the high-dose group by one of the IWPC algorithms."</data>
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323</data>
    </node>
    <node id="&quot;2%&quot;">
      <data key="d0">"PERCENTAGE"</data>
      <data key="d1">"The percentage of patients correctly assigned to the high-dose group by another IWPC algorithm."</data>
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323</data>
    </node>
    <node id="&quot;PRECISION&quot;">
      <data key="d0">"QUALITY MEASURE"</data>
      <data key="d1">"A measure indicating how close predicted doses are to observed doses, often represented as Mean Absolute Error (MAE)."</data>
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323</data>
    </node>
    <node id="&quot;NNG&quot;">
      <data key="d0">"CLINICAL BENEFIT INDEX"</data>
      <data key="d1">"An index to determine the clinical benefit of integrating a novel algorithm into practice."</data>
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323</data>
    </node>
    <node id="&quot;GENOTYPING&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Genotyping using the TaqMan method assessed associations with different SNPs."&lt;SEP&gt;"Genotyping was conducted on 93 patients as part of the study."&lt;SEP&gt;"The process of determining an individual's genetic makeup, particularly their admixture in this context."</data>
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f&lt;SEP&gt;chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8&lt;SEP&gt;chunk-b2730f3087aee6d9cff6e4939b229323</data>
    </node>
    <node id="&quot;AAS&quot;">
      <data key="d0">"POPULATION GROUP"</data>
      <data key="d1">"Admixed African Americans, individuals with a mixed ancestry containing African and European genes."</data>
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323</data>
    </node>
    <node id="&quot;WAA&quot;">
      <data key="d0">"GENETIC PARAMETER"</data>
      <data key="d1">"The proportion of an individual's genetic makeup that originates from the admixed African American population."</data>
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323</data>
    </node>
    <node id="&quot;IWPC PHARMACOGENOMICS ALGORITHM&quot;">
      <data key="d0">"ALGORITHM"</data>
      <data key="d1">"A specific pharmacogenomics-based prediction tool for drug dosages, compared with our novel AA algorithm."</data>
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323</data>
    </node>
    <node id="&quot;20% THERAPEUTIC DOSE RANGE&quot;">
      <data key="d0">"DOSE RANGE"</data>
      <data key="d1">"A defined limit for drug dosages that ensure effectiveness and safety according to medical standards."&lt;SEP&gt;"The accepted or optimal dosage limit for a medication within which it is considered to be effective and safe."</data>
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323</data>
    </node>
    <node id="&quot;PREDICTED DOSE&quot;">
      <data key="d0">"DOSAGE ESTIMATION"</data>
      <data key="d1">"The calculated amount of drug to be administered based on genetic factors and other variables."</data>
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323</data>
    </node>
    <node id="&quot;MEAN PERCENT WAA&quot;">
      <data key="d0">"STATISTICAL MEASURE"</data>
      <data key="d1">"Average proportion of an individual's admixed African American ancestry, used as a measure in the IWPC algorithm."</data>
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323</data>
    </node>
    <node id="&quot;GENETIC BACKGROUND&quot;">
      <data key="d0">"BIOLOGICAL TRAIT"</data>
      <data key="d1">"The inherited genetic information that determines an individual's traits and influences their susceptibility to diseases."</data>
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323</data>
    </node>
    <node id="&quot;ADMIXTURE&quot;">
      <data key="d0">"GENETIC COMPOSITION"</data>
      <data key="d1">"A mix of different ancestries within a population or among individuals."</data>
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323</data>
    </node>
    <node id="&quot;DRUG DOSAGES&quot;">
      <data key="d0">"MEDICAL TREATMENT"</data>
      <data key="d1">"Quantities of medication given as part of therapeutic interventions."</data>
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323</data>
    </node>
    <node id="&quot;POPULATION-SPECIFIC VARIABLES&quot;">
      <data key="d0">"CULTURAL AND BIOLOGICAL FACTOR"</data>
      <data key="d1">"Unique factors related to a specific group that can influence drug effectiveness, including genetic makeup.</data>
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323</data>
    </node>
    <node id="&quot;PREDICTED DOSES DERIVED&quot;">
      <data key="d0">"DOSAGE CALCULATION"</data>
      <data key="d1">"Predicted amounts of medication administered based on computational models or algorithms."</data>
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323</data>
    </node>
    <node id="&quot;MAE (MEAN ABSOLUTE ERROR)&quot;">
      <data key="d0">"PERFORMANCE METRIC"</data>
      <data key="d1">"A measure indicating the average magnitude of errors in a set of predictions, without considering their direction. It's used here to evaluate predictive accuracy.</data>
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323</data>
    </node>
    <node id="&quot;DOSES PREDICTED WITHIN 20% RANGE&quot;">
      <data key="d0">"DOSAGE PRECISION"</data>
      <data key="d1">"Drug dosages that fall within an acceptable and defined percentage difference from the target dose."</data>
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323</data>
    </node>
    <node id="&quot;IWPC (INTEGRATED WORKFLOW FOR PHARMACOGENOMICS)&quot;">
      <data key="d0">"PHARMACEUTICAL MODEL"</data>
      <data key="d1">"A comprehensive model or framework used to optimize drug dosage recommendations based on genetic information.</data>
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323</data>
    </node>
    <node id="&quot;COMPUTING THE NNG&quot;">
      <data key="d0">"CLINICAL EVALUATION METHOD"</data>
      <data key="d1">"An evaluation process that compares the benefit of using a new algorithm against existing methods in clinical practice."</data>
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323</data>
    </node>
    <node id="&quot;CYP2C9*3&quot;">
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d1">"The minor allele frequency for rs1057910 indicates reduced CYP2C9 activity.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CYP2C9*8&quot;">
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d1">"The minor allele frequency for rs9923231 indicates a lower minor allele frequency than other SNPs, consistent with previous studies.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;STATISTICAL PROCESS&quot;">
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d1">"SNPs did not show deviations from Hardy Weinberg equilibrium at P&lt;0.001")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PERFORMANCE METRIC&quot;">
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d1">"Accuracy of predicting dose requirements compared with actual maintenance dose.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CLINICAL TRIAL&quot;">
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d1">"The algorithms were tested using African American (AA) patients in a clinical trial.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS1799853 AND RS1057910&quot;">
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d1">"Together, they form part of the CYP2C9 star variant group indicating reduced activity.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 12}, {"level": 1, "cluster": 39}]</data>
    </node>
    <node id="&quot;CYP2C9*5, CYP2C9*8, AND CYP2C9*11&quot;">
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d1">"These are other individual SNPs that were part of the combined CYP2C9 star variant group.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 7}, {"level": 1, "cluster": 26}]</data>
    </node>
    <node id="&quot;SNP SET COMBINING RS1799853, RS1057910, RS28371686, RS7900194, RS28371685, CYP2C9*2, CYP2C9*3, CYP2C9*5, CYP2C9*8 AND CYP2C9*11&quot;">
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d1">"This set of SNPs collectively represents the CYP2C9 star variant group that was considered.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 8}, {"level": 1, "cluster": 28}]</data>
    </node>
    <node id="&quot;CYP27B1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"CYP27B1 gene plays a role in vitamin D metabolism."</data>
      <data key="d2">chunk-2fb95100a1290b27baae869c6560419a</data>
    </node>
    <node id="&quot;CYP24A1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"CYP24A1 gene is involved in the degradation of 1,25(OH)2D and affects vitamin D levels."</data>
      <data key="d2">chunk-2fb95100a1290b27baae869c6560419a</data>
    </node>
    <node id="&quot;RS927650&quot;">
      <data key="d0">"SNP OF CYP24A1"</data>
      <data key="d1">"CYP24A1 SNP rs927650 is associated with concentrations of 25(OH)D, impacting vitamin D levels."&lt;SEP&gt;"There is a suggestive relationship between the CYP24A1 SNP rs927650 and concentrations of 25(OH)D."</data>
      <data key="d2">chunk-2fb95100a1290b27baae869c6560419a</data>
    </node>
    <node id="&quot;RS35051736&quot;">
      <data key="d0">"SNP OF CYP24A1"</data>
      <data key="d1">"CYP24A1 SNP rs35051736 shows a statistically significant relationship with odds for advanced adenoma recurrence."</data>
      <data key="d2">chunk-2fb95100a1290b27baae869c6560419a</data>
    </node>
    <node id="&quot;CYP24A1 RS2296241&quot;">
      <data key="d0">"SNP OF CYP24A1"</data>
      <data key="d1">"The G allele in CYP24A1 rs2296241 is associated with higher odds for recurrent adenomas with villous histology."</data>
      <data key="d2">chunk-2fb95100a1290b27baae869c6560419a</data>
    </node>
    <node id="&quot;CYP27B1 RS2762939&quot;">
      <data key="d0">"SNP OF CYP27B1"</data>
      <data key="d1">"CYP27B1 SNP rs2762939 has a relationship with concentrations of 1,25(OH)2D."</data>
      <data key="d2">chunk-2fb95100a1290b27baae869c6560419a</data>
    </node>
    <node id="&quot;VITAMIN D METABOLITE CONCENTRATIONS&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"The metabolism and levels of vitamin D metabolites such as 25(OH)D and 1,25(OH)2D are impacted by genetic variations in CYP27B1 and CYP24A1."</data>
      <data key="d2">chunk-2fb95100a1290b27baae869c6560419a</data>
    </node>
    <node id="&quot;ADENOMA RECURRENCE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"There is a statistically significant association between certain SNPs of the CYP24A1 gene and odds for adenoma recurrence."</data>
      <data key="d2">chunk-2fb95100a1290b27baae869c6560419a</data>
    </node>
    <node id="&quot;VILLOUS HISTOLOGY ADENOMAS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Increasing number of copies of the G allele in CYP24A1 rs2296241 is associated with higher odds for recurrent adenomas with villous histology."</data>
      <data key="d2">chunk-2fb95100a1290b27baae869c6560419a</data>
    </node>
    <node id="&quot;APOLIPOPROTEIN B-440&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Apolipoprotein B-440 plays a role in lipid metabolism."</data>
      <data key="d2">chunk-2fb95100a1290b27baae869c6560419a</data>
    </node>
    <node id="&quot;MINOR ALLELE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The minor allele is a variant found on one copy of a gene."</data>
      <data key="d2">chunk-f05ecc979eea31a1ab844c2c7de12432</data>
      <data key="d3">[{"level": 0, "cluster": 11}, {"level": 1, "cluster": 36}, {"level": 2, "cluster": 60}]</data>
    </node>
    <node id="&quot;25(OH)D CONCENTRATION&quot;">
      <data key="d2">chunk-2fb95100a1290b27baae869c6560419a</data>
      <data key="d1">"SNP rs927650 in CYP24A1 shows a relationship with vitamin D metabolite concentration 25(OH)D.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CYP24A1 SNP RS927650&quot;">
      <data key="d2">chunk-2fb95100a1290b27baae869c6560419a</data>
      <data key="d1">"SNP rs927650 in CYP24A1 shows a relationship with vitamin D metabolite concentration 25(OH)D.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ADVANCED ADENOMA RECURRENCE&quot;">
      <data key="d2">chunk-2fb95100a1290b27baae869c6560419a</data>
      <data key="d1">"SNP rs35051736 has a statistically significant relationship with odds for advanced adenoma recurrence.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CYP24A1 SNP RS35051736&quot;">
      <data key="d2">chunk-2fb95100a1290b27baae869c6560419a</data>
      <data key="d1">"SNP rs35051736 has a statistically significant relationship with odds for advanced adenoma recurrence.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CYP24A1 SNPS&quot;">
      <data key="d2">chunk-2fb95100a1290b27baae869c6560419a</data>
      <data key="d1">"CYP24A1 SNPs like rs927650 and rs35051736 have relationships with vitamin D metabolites 25(OH)D and 1,25(OH)2D.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CYP27B1 SNPS&quot;">
      <data key="d2">chunk-2fb95100a1290b27baae869c6560419a</data>
      <data key="d1">"SNPs like rs2296241 and rs2762939 in CYP27B1 show relationships with vitamin D metabolites 25(OH)D and 1,25(OH)2D.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CYP24A1 SNPS (RS2296241, RS35051736)&quot;">
      <data key="d2">chunk-2fb95100a1290b27baae869c6560419a</data>
      <data key="d1">"SNPs like rs2296241 and rs35051736 affect the odds of recurrent adenomas with villous histology.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;VILLOUS HISTOLOGY ADENOMAS RECURRENCE&quot;">
      <data key="d2">chunk-2fb95100a1290b27baae869c6560419a</data>
      <data key="d1">"SNPs like rs2296241 and rs35051736 affect the odds of recurrent adenomas with villous histology.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NITRIC OXIDE&quot;">
      <data key="d2">chunk-f05ecc979eea31a1ab844c2c7de12432</data>
      <data key="d1">"The NOS1 protein catalyzes the production of nitric oxide, playing a role in its synthesis.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 13}, {"level": 1, "cluster": 44}]</data>
    </node>
    <node id="&quot;CARDIOVASCULAR HEALTH&quot;">
      <data key="d2">chunk-f05ecc979eea31a1ab844c2c7de12432</data>
      <data key="d1">"Dietary factors can impact cardiovascular health through various molecular interactions.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 13}, {"level": 1, "cluster": 45}]</data>
    </node>
    <node id="&quot;GENETIC INFLUENCE&quot;">
      <data key="d2">chunk-f05ecc979eea31a1ab844c2c7de12432</data>
      <data key="d1">"Dietary choices can interact with genetic factors to impact health outcomes.")&lt;SEP&gt;"Dietary factors can interact with genetic factors to impact health outcomes.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 13}, {"level": 1, "cluster": 45}]</data>
    </node>
    <node id="&quot;C.428_430DELAAG VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The c.428_430delAAG variant is known in CYP24A1 gene."</data>
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
    </node>
    <node id="&quot;C.1186C &gt; T VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The c.1186C &gt; T variant is also known in CYP24A1 gene."</data>
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
    </node>
    <node id="&quot;WT (WILD-TYPE)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Samples with wild-type status are used as positive controls."</data>
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
    </node>
    <node id="&quot;WT AMPLICON&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The wt amplicons represent sequences that do not carry any variant in CYP24A1 gene."</data>
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
    </node>
    <node id="&quot;C.428_430DELAAG VARIANT AMPLICON&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"Amplicon corresponding to the c.428_430delAAG variant."</data>
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
    </node>
    <node id="&quot;C.1186C &gt; T VARIANT AMPLICON&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"Amplicon corresponding to the c.1186C &gt; T variant."</data>
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
    </node>
    <node id="&quot;RS777676129&quot;">
      <data key="d0">"SNP (SINGLE NUCLEOTIDE POLYMORPHISM)"</data>
      <data key="d1">"The SNP rs777676129 is located in CYP24A1 gene, with different melting temperatures for wt, heterozygous and homozygous genotypes."</data>
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
    </node>
    <node id="&quot;RS114368325&quot;">
      <data key="d0">"SNP (SINGLE NUCLEOTIDE POLYMORPHISM)"</data>
      <data key="d1">"The SNP rs114368325 is another polymorphism located in CYP24A1 gene with specific melting behavior for different genotypes."</data>
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
    </node>
    <node id="&quot;COMPOUND HETEROZYGOUS SAMPLE&quot;">
      <data key="d0">"INDIVIDUAL"/"GENOTYPE"</data>
      <data key="d1">"Sample carrying both tested variants in CYP24A1 gene."</data>
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
    </node>
    <node id="&quot;NORMALIZED TM (TM VALUE)&quot;">
      <data key="d0">"QUANTITATIVE MEASURE"</data>
      <data key="d1">"Tm value obtained from HRMA analysis, indicating the melting point of DNA samples."</data>
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
    </node>
    <node id="&quot;TEMPERATURE-SHIFTED AND DIFFERENT PLOT&quot;">
      <data key="d0">"VISUAL ANALYSIS TOOL"</data>
      <data key="d1">"Tool used to view differences in melting profiles that are not visible under normal Tm conditions."</data>
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
    </node>
    <node id="&quot;DHRMA (DEEP HIGH RESOLUTION MELTING ASSAY)&quot;">
      <data key="d0">"ANALYTICAL TECHNIQUE"</data>
      <data key="d1">"A technique for accurate genotyping of CYP24A1 gene variants using HRMA analysis."</data>
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
    </node>
    <node id="&quot;DUPLEX ASSAY&quot;">
      <data key="d0">"EXPERIMENTAL SETUP"</data>
      <data key="d1">"A setup performed simultaneously for both amplicons using HRMA analysis."</data>
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
    </node>
    <node id="&quot;INTRA-ASSAY PRECISION&quot;">
      <data key="d0">"ANALYTICAL PERFORMANCE"</data>
      <data key="d1">"Precision achieved in repeated experiments with the same sample using the assay."</data>
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
    </node>
    <node id="&quot;INTER-ASSAY PRECISION&quot;">
      <data key="d0">"ANALYTICAL CONSISTENCY"</data>
      <data key="d1">"Consistency observed across multiple experiments with different samples."</data>
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
    </node>
    <node id="&quot;SERIAL DILUTIONS&quot;">
      <data key="d0">"SAMPLE PREPARATION TECHNIQUE"</data>
      <data key="d1">"Method used to test sensitivity of HRMA by reducing DNA concentration and still distinguishably identifying variants."</data>
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
    </node>
    <node id="&quot;WT SAMPLE&quot;">
      <data key="d0">"SAMPLE"</data>
      <data key="d1">"Samples with wild-type CYP24A1 gene status used as positive controls."</data>
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
    </node>
    <node id="&quot;HOMOZYGOUS SAMPLE&quot;">
      <data key="d0">"GENOTYPE/</data>
      <data key="d1">"Samples with homozygous genotypes for the variant in question."</data>
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
    </node>
    <node id="&quot;HETEROZYGOUS SAMPLE&quot;">
      <data key="d0">"GENOTYPE/</data>
      <data key="d1">"Samples with heterozygous genotypes for the variant in question."</data>
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
    </node>
    <node id="&quot;RS114368325 SNPS&quot;">
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
      <data key="d1">"Amplicon corresponding to the c.1186C &gt; T variant is genotyped using SNP rs114368325.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NORMALIZED TM VALUES&quot;">
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
      <data key="d1">"The Tm values from the HRMA analysis are characteristic of different genotypes for SNPs rs777676129 and rs114368325.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS777676129 SNPS AND RS114368325 SNPS&quot;">
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
      <data key="d1">"The Tm values from the HRMA analysis are characteristic of different genotypes for SNPs rs777676129 and rs114368325.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;C.428_430DELAAG VARIANT AMPLICON AND C.1186C &gt; T VARIANT AMPLICON&quot;">
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
      <data key="d1">"The Tm differences allow distinguishing the two amplicons corresponding to different variants.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TRIPLE PCR/HRM EXPERIMENTS&quot;">
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
      <data key="d1">"Across multiple experiments, inter-assay precision is ensured by achieving reproducible results using different samples.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;VARIANT ALLELE FREQUENCY&quot;">
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
      <data key="d1">"The sensitivity of the HRMA technique allows distinguishing variants even at lower frequencies.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HOMOZYGOUS SAMPLE/">
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
      <data key="d1">"Homozygous samples for c.428_430delAAG variant are identified through HRMA analysis.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HETEROZYGOUS SAMPLE/">
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
      <data key="d1">"Heterozygous samples for c.428_430delAAG variant are identified through HRMA analysis.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;10 DNA SAMPLES WITH IIH SUSPICIONS&quot;">
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
      <data key="d1">"The protocol is validated on further 10 DNA samples having the suspicion of idiopathic intracranial hypertension (IIH).")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DUPLEX-PCR/HRMA PROTOCOL/">
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
      <data key="d1">"The protocol is validated on further 10 DNA samples having the suspicion of idiopathic intracranial hypertension (IIH).")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;1 HETEROZYGOUS C.428_430DELAAG SAMPLE/">
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
      <data key="d1">"Specific heterozygous sample for c.428_430delAAG variant is identified through the protocol.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;1 HETEROZYGOUS C.1186C &gt; T SAMPLE/">
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
      <data key="d1">"Specific heterozygous sample for c.1186C &gt; T variant is identified through the protocol.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DENVER DEVELOPMENTAL SCREENING TEST II&quot;">
      <data key="d0">"CLINICAL OUTCOME"</data>
      <data key="d1">"The patient’s developmental skill levels, as assessed by the Denver Developmental Screening Test II."</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;BRAIN MRI&quot;">
      <data key="d0">"DIAGNOSTIC TESTS"</data>
      <data key="d1">"A brain MRI at 20 months of age showed atrophy and delayed myelination."</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;MEDIAN NERVE COMPOUND MOTOR ACTION POTENTIALS&quot;">
      <data key="d0">"CLINICAL NEUROPHYSIOLOGY STUDIES"</data>
      <data key="d1">"Indicators of motor function that showed normal values."&lt;SEP&gt;"Median nerve compound motor action potentials were measured, showing values that were within the normal range for infants."</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;MEDIAN NERVE CONDUCTION VELOCITY&quot;">
      <data key="d0">"CLINICAL NEUROPHYSIOLOGY STUDIES"</data>
      <data key="d1">"Median nerve conduction velocity was also evaluated and showed a value that was within the normal range."&lt;SEP&gt;"Neural conduction speed was measured and fell within the expected range."</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;MEDIAN NERVE SENSORY ACTION POTENTIAL&quot;">
      <data key="d0">"CLINICAL NEUROPHYSIOLOGY STUDIES"</data>
      <data key="d1">"Median nerve sensory action potential was measured, showing a value that was above the normal range for infants."&lt;SEP&gt;"Sensory response levels were analyzed, falling above the normal threshold."</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;CEREBROSPINAL FLUID COPPER AND CATECHOLAMINE RATIOS&quot;">
      <data key="d0">"BIOCHEMICAL FINDINGS"</data>
      <data key="d1">"The cerebrospinal fluid copper and catecholamine ratios were analyzed and fell within the established ranges for classical Menkes disease."</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;P1001L MUTATION IN GENOMIC DNA&quot;">
      <data key="d0">"MOLECULAR ANALYSES"</data>
      <data key="d1">"Confirmation of mosaicism for the P1001L mutation was carried out using a BsmAI restriction site."</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;WILD TYPE: MUTANT ALLELE RATIOS&quot;">
      <data key="d0">"MOLECULAR ANALYSES"</data>
      <data key="d1">"The relative proportions of fragments associated with the wild type and mutant alleles were estimated through densitometry and Q-RT-PCR experiments."</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;BLOOD DNA&quot;">
      <data key="d0">"TISSUE SAMPLES"</data>
      <data key="d1">"A primary fibroblast culture obtained from the skin biopsy showed a marked difference in the abundance of the wild type allele compared to blood DNA."</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;FIBROBLAST DNA&quot;">
      <data key="d0">"TISSUE SAMPLES"</data>
      <data key="d1">"In comparison to whole blood DNA, primary fibroblasts showed an 12:88 ratio of wild type to mutant alleles."</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;WILD TYPE: MUTANT RATIO IN BLOOD VS. PRIMARY FIBROBLASTS&quot;">
      <data key="d0">"TISSUE COMPARISON"</data>
      <data key="d1">"Quantitative real-time PCR experiments demonstrated a similar comparison between the wild type and mutant allele ratios in both tissues."</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;CLINICAL OUTCOME&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The patient's development levels and skills as assessed by Denver Developmental Screening Test II."</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;DIAGNOSTIC TESTS&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"Tests such as MRI and clinical neurophysiology studies were conducted."</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;CEREBROSPINAL FLUID COPPER&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Levels of cerebrospinal fluid copper did not indicate copper overload or Menkes disease."</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;CATECHOLAMINE RATIOS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The balance of catecholamines was assessed, showing inconsistency with Menkes disease criteria."</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;P1001L MUTATION&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"This specific genetic variation was confirmed through molecular analysis."</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;BSMAI RESTRICTION SITE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A new BsmAI recognition site was created due to the P1001L mutation."</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;WILD TYPE: MUTANT ALLELE RATIO IN BLOOD DNA&quot;">
      <data key="d0">"RELATIONSHIPS AMONG ENTITIES"</data>
      <data key="d1">"The relative abundance of wild type vs. mutant alleles differed between whole blood and fibroblast samples."</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;WILD TYPE: MUTANT ALLELE RATIO IN PRIMARY FIBROBLASTS&quot;">
      <data key="d0">"COMPARATIVE ANALYSIS"</data>
      <data key="d1">"A lower level of the wild type allele was detected compared to blood DNA and control samples."</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;MOLECULAR ANALYSES&quot;">
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
      <data key="d1">"The P1001L mutation was confirmed by creating a novel BsmAI restriction site.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;BSMAI DIGESTION LEVEL&quot;">
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
      <data key="d1">"BsmAI digestion levels were compared between whole blood DNA and fibroblast DNA, showing differences in mosaicism.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;COMPARATIVE ANALYSIS&quot;">
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
      <data key="d1">"The wild type: mutant allele ratio was estimated using densitometry and Q-RT-PCR methods, with different levels found in blood compared to fibroblast DNA.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CLINICAL NEUROPHYSIOLOGY STUDIES&quot;">
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
      <data key="d1">"The assessments showed normal levels indicative of healthy motor function.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;BIOCHEMICAL FINDINGS&quot;">
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
      <data key="d1">"Levels in cerebrospinal fluid indicated no copper overload or Menkes disease characteristics based on these ratios.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CACO-2 CELLS&quot;">
      <data key="d0">"CELL CULTURE MODEL"</data>
      <data key="d1">"Caco-2 cells do not express deiodinase at a level detectable by enzyme assay."&lt;SEP&gt;"Human intestinal epithelial cells cultured as Caco-2 were used in studies regarding the expression of LCT mRNA levels under specific genetic manipulations."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c&lt;SEP&gt;chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;GPX4 3′UTR&quot;">
      <data key="d0">"PROMOTER OR REGULATORY SEQUENCE"</data>
      <data key="d1">"The GPX4 3′UTR was used to link rat IDI coding sequences in transfected Caco-2 cells."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;RAT IDI&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Transfection of Caco-2 cells with rat IDI coding sequences linked to the GPX4 3′UTR resulted in the detection of IDI transcripts."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;RS713041&quot;">
      <data key="d0">"SNP/SNP VARIANT"</data>
      <data key="d1">"The SNP rs713041 corresponds to a variant that differs between the T (IDI-T) and C (IDI-C) variants.")</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;TRANSGENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Transfected cells expressed transgenes corresponding to either IDI-T or IDI-C."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;SE-DEPLETED MEDIUM&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Conditions where cells are grown in media lacking sufficient selenium supply."&lt;SEP&gt;"Conditions where cells are grown without sufficient selenium supply, affecting cell viability."&lt;SEP&gt;"Conditions where cells are grown without sufficient selenium supply."&lt;SEP&gt;|&gt;Supplement"</data>
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a&lt;SEP&gt;chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;TERT-BUTYLHYDROPEROXIDE&quot;">
      <data key="d0">"CHEMICAL/</data>
      <data key="d1">|&gt;Reagent"</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;SE-SUPPLEMENTED MEDIUM&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Cell growth conditions with additional sources of selenium added to the media."&lt;SEP&gt;"Conditions with an added source of selenium to cell growth media."&lt;SEP&gt;|&gt;Supplement"</data>
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a&lt;SEP&gt;chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;GPX ACTIVITY&quot;">
      <data key="d0">"ENZYME ACTIVITY"</data>
      <data key="d1">"In both sets of transfected cells, under different Se supply conditions, the GPx activity was lower in Se-depleted compared to Se-supplemented cells."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;TR1 PROTEIN&quot;">
      <data key="d0">"PROTEIN/</data>
      <data key="d1">|&gt;Selenoprotein"</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;GPX4 PROTEIN&quot;">
      <data key="d0">"PROTEIN/</data>
      <data key="d1">|&gt;Selenium-Dependent Enzyme"</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;SELENOPROTEIN H MRNA&quot;">
      <data key="d0">"MESSENGER RNA/</data>
      <data key="d1">"The mRNA transcript encoding selenoprotein H, a protein involved in the selenium metabolism process."&lt;SEP&gt;|&gt;Gene Expression"</data>
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a&lt;SEP&gt;chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;DEIODINASE&quot;">
      <data key="d0">"ENZYME/</data>
      <data key="d1">|&gt;Hormone Metabolism"</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;RS713041 VARIANT&quot;">
      <data key="d0">"SNP/SNP VARIANT/</data>
      <data key="d1">|&gt;Genetic Variation"</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;SE INCORPORATION MACHINERY&quot;">
      <data key="d0">"MOLECULAR COMPONENT/</data>
      <data key="d1">|&gt;Selenium Metabolism"&lt;|"The availability of Se and selenocysteine incorporation machinery is considered in the study regarding its impact on antioxidant selenoproteins synthesis compared to the IDI transgene (which has no antioxidant function)."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;SE SUPPLY CONDITIONS&quot;/&quot;EXPOSURE&quot;">
      <data key="d0">"CULTURE CONDITION/</data>
      <data key="d1">|&gt;Selenium Concentration"&lt;|"Experiments were carried out under varying Se supply conditions in culture media, affecting cellular responses."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;ROS LEVELS&quot;/&quot;REACTIVE SPECIES&quot;">
      <data key="d0">"QUANTIFIABLE MEASURE/</data>
      <data key="d1">|&gt;Oxidative Stress"&lt;|"Measuring ROS levels following tert-butylhydroperoxide treatment is crucial to understand cell stress response."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;SE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Selenium (Se) is an essential nutrient required for the synthesis of selenoproteins."&lt;SEP&gt;"Selenium plays a crucial role as an essential nutrient for cells."</data>
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;GPX4&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The gene GPx4 encodes glutathione peroxidase 4, which plays a role in antioxidant defense against oxidative stress."</data>
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;IDI-C CELLS&quot;">
      <data key="d0">"CELL LINE"</data>
      <data key="d1">"Cells from IDI-C line were shown to have differences compared to IDI-T in selenoprotein expression and oxidative stress sensitivity."&lt;SEP&gt;"Cells from cell line IDI-C show changes in selenoprotein expression and sensitivity to oxidative stress."</data>
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;TR1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The gene TR1 encodes thioredoxin, a redox-regulatory protein that interacts with selenium."</data>
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;GPX1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The gene GPx1 encodes glutathione peroxidase 1, which also plays an antioxidant role."</data>
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;GPX4 MRNAS&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"mRNA transcripts of the genes coding for glutathione peroxides are detected in the study."</data>
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;SE CONTENT OF THE MEDIUM&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The level of selenium present in the growth medium of cells."</data>
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;IDI-T CELLS&quot;">
      <data key="d0">"CELL LINE"</data>
      <data key="d1">"Conversely, cells of IDI-T line had distinct characteristics when compared with IDI-C in response to selenium conditions and oxidative challenges."</data>
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;0.5 MM TERT-BUTYLHYDROPEROXIDE&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"An oxidant agent used in experiments to induce oxidative stress on cells."&lt;SEP&gt;"The chemical agent used in the oxidative stress challenge to cells."</data>
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;CELL VIABILITY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The measure of cell health and function, affected by various environmental factors including selenium supply."&lt;SEP&gt;"The measure of cell health is used to infer the potential development or impact on conditions that could be described under 'disease' context, in this case referring to oxidative stress-related cellular damage."&lt;SEP&gt;"The measure of cellular health and functional capacity under different conditions and treatments."</data>
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;0.5 MM TERT-BUTYLHYDROPEROXIDE CHALLENGE&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Exposure of cells to oxidative stress, simulating conditions that may occur in an environment with high levels of reactive oxygen species (ROS)."</data>
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;SE SUPPLY&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The availability and concentration of selenium impacting cell function and viability."&lt;SEP&gt;"The availability and concentration of selenium in cell culture conditions, crucial for many biochemical processes."</data>
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;0.5 NM SE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Low concentration of selenium added to media for experimental purposes."&lt;SEP&gt;"Low concentration of selenium added to the media."</data>
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;1 NM SE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"An even lower concentration of selenium, used in experimental conditions to assess its impact on cell behavior."&lt;SEP&gt;"An even lower level of selenium supplementation for certain experiments to assess cellular responses."</data>
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;SELENIUM (SE)&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The element selenium plays a role as both nutrient and environmental factor influencing cellular processes and responses."</data>
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;TR1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The TR1 gene produces thioredoxin, a protein involved in redox regulation related to selenium metabolism."</data>
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;GPX1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The GPx1 gene codes for glutathione peroxidase 1, which contributes to the antioxidant defense system."</data>
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;CELL VIABILITY UNDER LOW SE&quot;">
      <data key="d0">"DISEASE CONTEXT"</data>
      <data key="d1">"Cells with lower levels of selenium show signs resembling disease states due to inadequate antioxidant defenses."</data>
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;EFFECT ON CELL VIABILITY&quot;/&quot;IMPACT ON ANTIOXIDANT ENZYME ACTIVITY&quot;">
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
      <data key="d1">"In Se-supplemented medium, the GPx4 protein levels increased significantly in IDI-C cells compared to those expressing the IDI-T transgene, suggesting a stronger antioxidant response.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SE-DEPLETED MEDIUM/">
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
      <data key="d1">"The transfected cells showed lower viability over a range of tert-butylhydroperoxide concentrations with 40–60% viability when challenged with 1–5 mM tert-butylhydroperoxide.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="|&gt;OXIDATIVE CHALLENGE&quot;/&quot;SE SUPPLY CONDITIONS&quot;">
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
      <data key="d1">"The transfected cells showed lower viability over a range of tert-butylhydroperoxide concentrations with 40–60% viability when challenged with 1–5 mM tert-butylhydroperoxide.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="|&gt;GPX ACTIVITY&quot;/&quot;IMPACT ON SELENOPROTEINS&quot;">
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
      <data key="d1">"In Se-depleted conditions, GPx activity was lower compared to that in Se-supplemented cells.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SE SUPPLY CONDITIONS/">
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
      <data key="d1">"When sufficient Se is present, the IDI-C cell line showed a greater increase in GPx4 content than the IDI-T cell line when grown under Se-supplemented conditions.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="|&gt;GPX4 PROTEIN LEVELS&quot;">
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
      <data key="d1">"When sufficient Se is present, the IDI-C cell line showed a greater increase in GPx4 content than the IDI-T cell line when grown under Se-supplemented conditions.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IDI-C CELLS AND IDI-T CELLS&quot;">
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
      <data key="d1">"Different levels of selenium availability affect the behavior and response of IDI-C and IDI-T cell lines, impacting viability and sensitivity to oxidative challenges.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;0.5 NM SE&quot; OR &quot;1 NM SE&quot;">
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
      <data key="d1">"Cells exposed to very low concentrations of selenium show decreased viability compared to those grown in conditions with adequate selenium supply.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CELL VIABILITY UNDER LOW SELENIUM CONDITIONS&quot;">
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
      <data key="d1">"Cells exposed to very low concentrations of selenium show decreased viability compared to those grown in conditions with adequate selenium supply.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DISEASE CONTEXT IN TERMS OF OXIDATIVE STRESS&quot;">
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
      <data key="d1">"Indications of cell damage or dysfunction that could be related to disease states when cells are exposed to high levels of reactive oxygen species (ROS).")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CELL VIABILITY UNDER HIGH SE&quot;">
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
      <data key="d1">"Cells treated with selenium supplementation show improved viability compared to standard growth conditions.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RESPONSE OF CELLS&quot;">
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
      <data key="d1">"The oxidative stress induced by tert-butylhydroperoxide affects cell health, impacting factors like apoptosis or cell cycle progression.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IMPACT ON CELLULAR RESPONSES&quot;">
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
      <data key="d1">"Lower concentrations of selenium have distinct effects on cells, often leading to different outcomes compared to adequate selenium levels.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CELLULAR DEFENSE MECHANISMS&quot;">
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
      <data key="d1">"The presence and supply of selenium influence the effectiveness of various cellular defense systems against oxidative stress.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CHAT&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"We identified 12 missense and one nonsense mutations in CHAT in 11 kinships."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;MISSENSE MUTATION&quot;">
      <data key="d0">"MUTATION"</data>
      <data key="d1">"Nine mutations are novel; p.Thr553Asn and p.Ser704Pro detected in this laboratory were published but not functionally characterized by. p.Ala557Thr was previously reported by."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;NONSENSE MUTATION&quot;">
      <data key="d0">"MUTATION"</data>
      <data key="d1">"p.Ala557Thr also determines the phenotype in patient 10 who carries a nonsense mutation on her second allele."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;P.THR553ASN&quot;">
      <data key="d0">"MISSENSE MUTATION"</data>
      <data key="d1">"This mutation results in a substitution of Thr to Asn at residue 553, which is conserved across several species."&lt;SEP&gt;"This mutation was detected but not functionally characterized by previous studies."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;P.SER704PRO&quot;">
      <data key="d0">"MISSENSE MUTATION"</data>
      <data key="d1">"Another missense mutation involving Serine to Proline substitution at residue 704 with conservation across different organisms."&lt;SEP&gt;"This mutation was previously identified but needs further functional characterization."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;P.ALA557THR&quot;">
      <data key="d0">"MISSENSE MUTATION"</data>
      <data key="d1">"A novel mutation with a phenotypic impact that was confirmed in multiple patients."&lt;SEP&gt;"Previously reported and confirmed in this study for its impact on phenotype."&lt;SEP&gt;"This mutation involves Alanine to Threonine substitution which is conserved in multiple species including dog, mouse, rat and chicken."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;MET202&quot;">
      <data key="d0">"RESIDUE"</data>
      <data key="d1">"Conserved residue among canine, murine, rat, and chicken ChAT proteins."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;TRP421&quot;">
      <data key="d0">"RESIDUE"</data>
      <data key="d1">"This conserved residue is also present in Drosophila and C. elegans."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;THR553&quot;">
      <data key="d0">"RESIDUE"</data>
      <data key="d1">"Conserved among canine, murine, rat, chicken, Drosophila and C. elegans ChAT proteins."&lt;SEP&gt;"Conserved among canine, murine, rat, chicken, Drosophila, and C. elegans ChAT proteins."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;ALA557&quot;">
      <data key="d0">"RESIDUE"</data>
      <data key="d1">"Conservation of this residue is shared across canine, murine, rat, chicken, Drosophila and C. elegans."&lt;SEP&gt;"Conservation of this residue is shared across canine, murine, rat, chicken, Drosophila, and C. elegans."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;PATIENT 8&quot;">
      <data key="d0">"SUBJECT"</data>
      <data key="d1">"Homozygous for p.Ala557Thr, showing apparent homozygosity."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;PATIENT 5&quot;">
      <data key="d0">"SUBJECT"</data>
      <data key="d1">"Heterozygous for p.Al557Thr and inherited the mutation from the unaffected mother."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;PATIENT 11&quot;">
      <data key="d0">"SUBJECT"</data>
      <data key="d1">"Homozygous for p.Ile689Ser, born to consanguineous parents."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;CHAT MUTATIONS&quot;">
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
      <data key="d1">"Eight mutants expressed at significantly lower levels than wild-type and five of these (p.Trp421Ser, p.Ser498Pro, p.Thr553Asn, p.Ala557Thr, p.Ser572Trp) expressed at &lt;50% of wild-type.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;EXPRESSION LEVEL&quot;">
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
      <data key="d1">"Eight mutants expressed at significantly lower levels than wild-type and five of these (p.Trp421Ser, p.Ser498Pro, p.Thr553Asn, p.Ala557Thr, p.Ser572Trp) expressed at &lt;50% of wild-type.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;KINETIC PARAMETERS&quot;">
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
      <data key="d1">"Ten mutations alter one or more rate constants of ChAT activation and two mutations compromise the thermal stability of the mutant protein.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MISSENSE MUTATIONS&quot;">
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
      <data key="d1">"Ten mutations alter one or more rate constants of ChAT activation and two mutations compromise the thermal stability of the mutant protein.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;COMPARISON WITH MUTANT CHATS&quot;">
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
      <data key="d1">"Compared the expression levels of wild-type CHAT versus mutant CHATs.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;WILD-TYPE CHAT&quot;">
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
      <data key="d1">"Compared the expression levels of wild-type CHAT versus mutant CHATs.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IMPACT ON PROTEIN STABILITY&quot;">
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
      <data key="d1">"Mutations like p.Ala557Thr compromise the thermal stability of ChAT.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CONSERVATION ACROSS SPECIES&quot;">
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
      <data key="d1">"The study highlights the importance of conserved residues like Met202, Trp421, Thr553, Ala557 among canine, murine, rat, chicken, Drosophila, and C. elegans ChAT proteins.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RESIDUES&quot;">
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
      <data key="d1">"The study highlights the importance of conserved residues like Met202, Trp421, Thr553, Ala557 among canine, murine, rat, chicken, Drosophila, and C. elegans ChAT proteins.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MUTATIONS&quot;">
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
      <data key="d1">"The presence of specific mutations like p.Ala557Thr in multiple patients indicates their influence on the phenotype.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PHENOTYPIC IMPACT&quot;">
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
      <data key="d1">"The presence of specific mutations like p.Ala557Thr in multiple patients indicates their influence on the phenotype.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;BCL2L11&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Annotation: BCL2-like 11 [apoptosis facilitator]"&lt;SEP&gt;"We found nominal associations for SNPs associated with methylation at CpG sites annotated to BCL2L11."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e&lt;SEP&gt;chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;NDUFS7&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Annotation: NADH dehydrogenase [ubiquinone] Fe-S protein 7, 20 kDa"</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;EIF3J&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Annotation: eukaryotic translation initiation factor 3, subunit J"</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;ZNF761&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Annotation: zinc finger protein 761"</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;PSMG3&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Annotation: proteasome assembly chaperone 3"</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;ENTHD1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Annotation: sema domain, transmembrane domain [TM], and cytoplasmic domain ([semaphorin] 6A)"</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;LRIG1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Annotation: LRIG1"</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;RIPK3&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Annotation: RIPK3"</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;RPS6KC1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Annotation: RPS6KC1"</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;ATP2B4&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Annotation: ATP2B4"</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;SEMA6A&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Annotation: sema domain, transmembrane domain [TM], and cytoplasmic domain ([semaphorin] 6A)"</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;TAPBP&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Annotation: TAP binding protein [tapasin]"</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;RGL2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Annotation: ral guanine nucleotide dissociation stimulator-like 2 (FDR &lt; 0.05)"</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;CKAP5&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Annotation: cytoskeleton associated protein 5"</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;FOSL2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Annotation: FOS-like antigen 2"</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;FAM20C&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Annotation: family with sequence similarity 20, member C"</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;FRMD6&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Annotation: FERM Domain containing 6"</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;FAM216A&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Annotation: family with sequence similarity 216, member A"</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;C1ORF98&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Annotation: chromosome 1 open reading frame 98"</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;DDX11L1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Annotation: DEAD (Asp-Asn) box polypeptide 11 like 1, also known as X-linked SET domain containing 3"</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;C1ORF20&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Annotation: chromosome 1 open reading frame 20"</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;DDX57&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Annotation: DEAD (Asp-Asn) box polypeptide 57"</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;C9ORF38&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Annotation: chromosome 9 open reading frame 38"</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;DDX20L1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Annotation: DEAD (Asp-Asn) box polypeptide 20 like 1, also known as SET domain containing 5"</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;C7ORF46&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Annotation: chromosome 7 open reading frame 46"</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;DDX3H&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Annotation: DEAD (Asp-Asn) box polypeptide H, also known as KIAA0528"</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;C1ORF149&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Annotation: chromosome 1 open reading frame 149"</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;DDX6&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Annotation: DEAD (Asp-Asn) box polypeptide 6, also known as Ddx6"</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;C7ORF30&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Annotation: chromosome 7 open reading frame 30"</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;DDX1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Annotation: DEAD (Asp-Asn) box polypeptide 1, also known as DExD-box protein 1"</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;C5ORF49&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Annotation: chromosome 5 open reading frame 49"</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;DDX3X&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Annotation: DEAD (Asp-Asn) box polypeptide X, also known as DDX3H"</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;CPG ISLAND SHORES&quot;">
      <data key="d0">"FUNCTIONAL REGULATORY ELEMENT"</data>
      <data key="d1">"Enrichment in CpGs associated with oxidative markers compared to all CpGs on the array suggests enrichment in functional regulatory elements."&lt;SEP&gt;"Enrichment of CpGs associated with oxidative markers in CpG island shores suggests potential impact on transcription and regulation."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;PROMOTER&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"45% of phenotype-associated CpGs are located in promoters, indicating potential influence on gene expression."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;REGULOMEDB SCORE 1A-2C&quot;">
      <data key="d0">"FUNCTIONAL REGULATORY REGION"</data>
      <data key="d1">"Twenty-three percent of sites showing strong evidence of being part of functional regulatory regions by RegulomeDB analysis."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;TF BINDING SITES&quot;">
      <data key="d0">"TRANSCRIPTION FACTOR"</data>
      <data key="d1">"Enrichment of TF binding sites (E2F1) by PSCAN analysis indicates regulation of genes annotated to phenotype-associated CpGs."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;FUNCTIONAL ANNOTATION CLUSTERING TOOL&quot;">
      <data key="d0">"GENE SET ENRICHMENT ANALYSIS"</data>
      <data key="d1">"DAVID's clustering tool shows evidence of genes with functional terms such as phosphorylation and phosphate metabolic processes, indicating biological pathways related to CpG annotated genes."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;CIS-MEQTL SNPS&quot;">
      <data key="d0">"SNP"</data>
      <data key="d1">"41.8% of phenotype-CpGs have significant cis-meQTLs, suggesting genetic influences on DNA methylation variation associated with oxidative markers."&lt;SEP&gt;"Investigation of 1599 significant meQTL SNPs found no evidence for overrepresentation among CHD or T2D associations, suggesting independent genetic and epigenetic influences."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;GENOTYPE-PHENOTYPE ASSOCIATION&quot;">
      <data key="d0">"ASSOCIATION BETWEEN GENOTYPE AND PHENOTYPE"</data>
      <data key="d1">"Modest evidence for association between genotype-phenotype, genotype-CpG and CpG-phenotype overlap suggests mediation by epigenetics in certain cases."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;CHROMOSOME REGIONS&quot;">
      <data key="d0">"INTERGENIC SITES"</data>
      <data key="d1">"Sigificant meQTL SNPs annotated to intergenic sites on chromosomes 5 (rs17057846) and chromosome 12 (rs1354156), indicating roles in CpG methylation patterns."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;BCL2L11, AMDHD1, SEMA6A, FAM20C, HSP90AB1, WNK2&quot;">
      <data key="d0">"GENE ANNOTATION"</data>
      <data key="d1">"CpG sites annotated to various genes like BCL2L11, AMDHD1, etc., showing associations with CHD and T2D in GWAS data."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;CG15351688, RS7955450, RS7486703&quot;">
      <data key="d0">"AMDHD1 CPG SITE ANNOTATION"</data>
      <data key="d1">"CpG site cg15351688 associated with AMDHD1 shows significant associations in CHD GWAS data."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;RS726430&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNP associated with CpG site annotated to BCL2L11."&lt;SEP&gt;"SNP associated with the CpG site in BCL2L11."&lt;SEP&gt;"SNP rs726430 at BCL2L11 CpG site cg07547695 shows association in CHD and T2D GWAS data."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e&lt;SEP&gt;chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;CG05969038, RS7786461; CG21913519: RS7786461&quot;">
      <data key="d0">"FAM20C CPG SITES ANNOTATION"</data>
      <data key="d1">"CpG sites cg05969038 and cg21913519 annotated to FAM20C show association in CHD GWAS data."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;RS6905285, RS7758726, RS666462&quot;">
      <data key="d0">"HSP90AB1 CPG SITES ANNOTATION"</data>
      <data key="d1">"CpGs cg26241416 with SNPs rs6905285, rs7758726, and rs666462 show association in CHD GWAS data."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;RS10777751, RS7955450, RS7486703&quot;">
      <data key="d0">"AMDHD1 CPG SITE ANNOTATIONS"</data>
      <data key="d1">"CpG site cg15351688 with SNPs rs10777751, rs7955450, and rs7486703 shows association in CHD GWAS data."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;RS2991377, RS10992689, RS10821105&quot;">
      <data key="d0">"SEMA6A CPG SITES ANNOTATIONS"</data>
      <data key="d1">"CpG site cg14396800 with SNPs rs2991377, rs10992689, and rs10821105 shows association in CHD GWAS data."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;RS17139825&quot;">
      <data key="d0">"CPB1 CPG SITE ANNOTATION"</data>
      <data key="d1">"CpG site cg04072156 with SNP rs16861015 associated in T2D GWAS data."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;RS1665364, RS2236786, RS3752749&quot;">
      <data key="d0">"INTERGENIC SITE CPG ANNOTATION"</data>
      <data key="d1">"CpG site cg14532755 with SNPs rs1665364, rs2236786, and rs3752749 shows association in T2D GWAS data.")("entity"</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;TSS200&quot;">
      <data key="d0">"PROMOTER REGION"</data>
      <data key="d1">"CpGs located within the TSS200 region show significant enrichment, suggesting potential regulation of genes involved in oxidative stress processes."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;ENHANCERS&quot;">
      <data key="d0">"FUNCTIONAL REGULATORY ELEMENT"</data>
      <data key="d1">"Studies indicate that enhancer regions are also enriched with CpG sites associated with markers for oxidative stress, potentially impacting gene expression modulation."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;CPG ISLANDS SHORES (50 BP AWAY FROM TSS AND CDS)&quot;">
      <data key="d0">"REGULATORY DNA FEATURES"</data>
      <data key="d1">"Research reveals these shores have a unique pattern of CpGs related to oxidative stress, indicating their role in transcriptional regulation."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;TRANSCRIPTION START SITES (TSS) REGIONS&quot;">
      <data key="d0">"PROMOTER ELEMENTS"</data>
      <data key="d1">"CpG islands found near TSS show a significant correlation with markers for oxidative damage, implicating them as key regulatory elements."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;CODING SEQUENCE (CDS) 50 BP AWAY&quot;">
      <data key="d0">"TRANSCRIPTOMIC FEATURES"</data>
      <data key="d1">"CpGs in this region are enriched with those related to oxidative markers, highlighting their impact on gene expression and protein function."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;TSS2K REGIONS&quot;">
      <data key="d0">"PROMOTER NEIGHBORHOODS"</data>
      <data key="d1">"Analysis of CpG patterns around TSS up to 2 kilobases away reveals correlations with oxidative stress indicators, suggesting broader promoter influence."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;CPG ISLANDS DENSITY&quot;">
      <data key="d0">"GENOMIC LANDSCAPE FEATURES"</data>
      <data key="d1">"High-density CpG islands in specific genomic regions are associated with increased markers for oxidative damage, indicating complex regulatory networks."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;CPG ISLAND BOUNDARY MARKERS&quot;">
      <data key="d0">"EPIGENETIC LANDMARKS"</data>
      <data key="d1">"Certain CpG sites near island boundaries show enrichment related to oxidative stress biomarkers, potentially influencing gene expression and chromatin structure dynamics."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;TRANSCRIPTION FACTORS BINDING SITES&quot;">
      <data key="d0">"REGULATORY INTERACTIONS"</data>
      <data key="d1">"CpGs with strong evidence of TF binding are significantly correlated with markers for oxidative damage, indicating their role in regulatory networks associated with these processes."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;PHENOTYPE-SPECIFIC CPG ANNOTATIONS&quot;">
      <data key="d0">"GENETIC AND EPIGENETIC CORRELATION"</data>
      <data key="d1">"Unique CpG sites annotated to specific phenotypes show differential patterns compared to general CpG distributions, suggesting involvement in disease or trait-specific mechanisms related to oxidative stress."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;CEP55&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"CpG sites annotated to CEP55 were also considered."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;RS12782691&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNP associated with the CpG site in CEP55."&lt;SEP&gt;"SNP linked to CpG site annotated to CEP55."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;CPB1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"CpG sites annotated to CPB1 were included as well."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;RS16861015&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNP associated with the CpG site in CPB1."&lt;SEP&gt;"SNP connected to CpG annotated to CPB1."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;CHR. 4 INTERGENIC SITE&quot;">
      <data key="d0">"INTERGENIC SITE"</data>
      <data key="d1">"A CpG site was annotated to an intergenic region on chromosome 4."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;RS726430, RS12782691, RS16861015, ETC.&quot;">
      <data key="d0">"GENOMIC VARIANTS"</data>
      <data key="d1">"These SNPs were associated with the CpG sites mentioned above."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;HIST1H4D&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Methylation levels at HIST1H4D's 3'-UTR was found to be associated with T2D."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;CG08170869&quot;">
      <data key="d0">"CPG SITE"</data>
      <data key="d1">"This CpG site in the 3'-UTR of HIST1H4D showed an association with T2D."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;DISHEVELLED-1 (DVL1)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Methylation levels at DVL1's body were linked to T2D."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;CG03465880&quot;">
      <data key="d0">"CPG SITE"</data>
      <data key="d1">"This CpG site in the body of DVL1 was associated with T2D."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;HIST1H4D, DVL1&quot;">
      <data key="d0">"GENES"</data>
      <data key="d1">"The genes HIST1H4D and DVL1 were found to have a role in disease through their methylation levels."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;CVD (CARDIOVASCULAR DISEASE)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"CVD events were not significantly associated with the methylation levels at phenotype-associated CpGs, except for cg11842944 in ZNF341 and its association with heart failure."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;ZNF341&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Methylation levels at a CpG in this gene showed the strongest association to heart failure."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;CG11842944&quot;">
      <data key="d0">"CPG SITE"</data>
      <data key="d1">"This CpG site was associated with both T2D and heart failure, showing differential associations."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;MYOCARDIAL INFARCTION, HEART FAILURE, ISCHAEMIC STROKE&quot;">
      <data key="d0">"CONDITIONS"</data>
      <data key="d1">"These cardiovascular conditions were separately analyzed for their association with methylation at cg11842944 in ZNF341."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;BCL2L11 CG SITE&quot;">
      <data key="d0">"CPG SITE"</data>
      <data key="d1">"The CpG site in the gene BCL2L11 was found associated with rs726430."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;CEP55 CG SITE&quot;">
      <data key="d0">"CPG SITE"</data>
      <data key="d1">"The CpG site in the gene CEP55 was associated with rs12782691."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;CPB1 CG SITE&quot;">
      <data key="d0">"CPG SITE"</data>
      <data key="d1">"The CpG site in the gene CPB1 was related to rs16861015 SNP."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;RS732754, RS744658, ETC.&quot;">
      <data key="d0">"GENOMIC VARIANTS"</data>
      <data key="d1">"Multiple SNPs were associated with an intergenic CpG site on chromosome 4."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;CHR. 4 INTERGENIC CG SITE&quot;">
      <data key="d0">"INTERGENIC CPG SITE"</data>
      <data key="d1">"An intergenic region on chromosome 4 was found to be associated with several SNPs mentioned."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;HIST1H4D 3'-UTR&quot;">
      <data key="d0">"CPG SITE (CG08170869)"</data>
      <data key="d1">"Methylation at the CpG site in HIST1H4D's 3' UTR was associated with T2D."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;DVL1 BODY&quot;">
      <data key="d0">"CPG SITE (CG03465880)"</data>
      <data key="d1">"Methylation levels at this CpG site within DVL1 were related to the risk of developing Type 2 Diabetes."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;ZNF341 CG SITE&quot;">
      <data key="d0">"CPG SITE (CG11842944)"</data>
      <data key="d1">"The methylation level at this CpG site in ZNF341 showed a link with heart failure."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;GENOMIC VARIANT (RS726430)&quot;">
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
      <data key="d1">"The CpG site in BCL2L11 was associated with the SNP rs726430.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENOMIC VARIANT (RS12782691)&quot;">
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
      <data key="d1">"The CpG site in CEP55 was linked to the SNP rs12782691.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENOMIC VARIANT (RS16861015)&quot;">
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
      <data key="d1">"The CpG site associated with CPB1 had a connection with rs16861015 SNP.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CPG SITE (CG08170869)&quot;">
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
      <data key="d1">"Methylation at this CpG site was associated with T2D.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CPG SITE (CG03465880)&quot;">
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
      <data key="d1">"This CpG site within DVL1 showed an association with the risk of developing T2D.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CPG SITE (CG11842944)&quot;">
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
      <data key="d1">"Methylation levels at this CpG were linked to heart failure.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CMH000067&quot;">
      <data key="d0">"PROBAND"</data>
      <data key="d1">"The subject of the study, sequenced for exome enrichment and sequencing."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;CMH000068&quot;">
      <data key="d0">"PARENT"</data>
      <data key="d1">"One of CMH000067's healthy parents."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;CMH000069&quot;">
      <data key="d0">"OTHER PARENT"</data>
      <data key="d1">"The other parent of CMH000067, also healthy."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;ILLUMINA HISEQ 2000&quot;">
      <data key="d0">"TECHNOLOGY"</data>
      <data key="d1">"The sequencer used for exome enrichment and sequencing."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;SEQUENCING&quot;">
      <data key="d0">"PROCESS"</data>
      <data key="d1">"The process of capturing and analyzing genetic information from the samples."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;7.7 GIGABASES&quot;">
      <data key="d0">"DATA SIZE"</data>
      <data key="d1">"Total sequence data generated during the study."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;59.6×&quot;">
      <data key="d0">"COVERAGE"</data>
      <data key="d1">"Average nuclear exome coverage."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;86.0%&quot;">
      <data key="d0">"TARGET COVERAGE"</data>
      <data key="d1">"The percentage of targeted exome sites covered at least 16×."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;ATP SYNTHASE 6 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Specific gene identified with a mutation."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;MT-ATP6&quot;">
      <data key="d0">"GENE SYMBOL"</data>
      <data key="d1">"Alternate notation for ATP synthase 6 gene, as it is mitochondrial."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;LEIGH SYNDROME&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A disease characterized by the deficiency of complex V activity due to a mutation in MT-ATP6."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;OMIM #516060&quot;">
      <data key="d0">"DATABASE ID"</data>
      <data key="d1">"Identification number from Online Mendelian Inheritance in Man for Leigh syndrome."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;C.467T&gt;G&quot;">
      <data key="d0">"VARIANT"</data>
      <data key="d1">"Specific variant identified as c.467T&gt;G substitution leading to p.Leu156Arg amino acid change."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;HOMOPLASMIC&quot;">
      <data key="d0">"TERM"</data>
      <data key="d1">"The situation where a single genetic variation is almost universally present in all cells of an individual."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;21 SEQUENCING READS&quot;">
      <data key="d0">"READS COUNT"</data>
      <data key="d1">"Number of times the base was sequenced during the process."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;KNOWN DISEASE CAUSING VARIANT&quot;">
      <data key="d0">"CLASSIFICATION"</data>
      <data key="d1">"A mutation known to cause disease due to its impact on specific protein function."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;RESTRICTION FRAGMENT LENGTH POLYMORPHISM (RFLP)">
      <data key="d0">"ASSAY"</data>
      <data key="d1">"The method used for confirming findings in a controlled and standardized way, based on the size variation of DNA fragments."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;CAPILLARY SEQUENCING&quot;">
      <data key="d0">"METHOD"</data>
      <data key="d1">"A type of sequencing that allows precise measurement of nucleotides at each position in the sequence."&lt;SEP&gt;"The process used to confirm the heteroplasmic nature of certain mitochondrial mutations."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d&lt;SEP&gt;chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;BLOOD&quot;">
      <data key="d0">"SAMPLE TYPE"</data>
      <data key="d1">"Body fluid collected for genetic analysis."&lt;SEP&gt;"The origin from which biological samples are taken, usually for medical testing purposes."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;URINE&quot;">
      <data key="d0">"SAMPLE TYPE"</data>
      <data key="d1">"Another body fluid, this time excretory, tested for genetic material."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;NEXT-GENERATION EXOME SEQUENCING&quot;">
      <data key="d0">"TECHNIQUE"</data>
      <data key="d1">"Advanced method of DNA sequencing that targets and analyzes all the protein-coding regions of the genome."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;DECEASED SIBLING&quot;">
      <data key="d0">"OTHER SAMPLE"</data>
      <data key="d1">"An individual who has passed away but was also sequenced as part of this study."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;EXOME SEQUENCING&quot;">
      <data key="d0">"ANALYSIS METHOD"</data>
      <data key="d1">"Exome sequencing specifically to detect genetic variations within the coding regions of genes, not the entire genome."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;GREATER THAN 8 GIGABASES&quot;">
      <data key="d0">"SEQUENCING DEPTH"</data>
      <data key="d1">"Amount of data generated from each sample."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;87%&quot;">
      <data key="d0">"TARGET COVERAGE RATE"</data>
      <data key="d1">"Percentage of targeted genomic regions with at least 10× coverage."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;3500 VARIANTS&quot;">
      <data key="d0">"VARIANT COUNT"</data>
      <data key="d1">"Total number of genetic variations identified per sample using RUNES for initial classification."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;CATEGORY 1–3&quot;">
      <data key="d0">"CLASSIFICATION LEVEL"</data>
      <data key="d1">"Three tiers that categorize the significance of the detected genetic variation based on severity and evidence."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;&lt; 1%&quot;">
      <data key="d0">"ALLELE FREQUENCY THRESHOLD"</data>
      <data key="d1">"Minimum frequency required for variants to be included in analysis, excluding common variations.</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;RECESSIVE INHERITANCE MODEL&quot;">
      <data key="d0">"INHERITANCE MODEL"</data>
      <data key="d1">"A theory that a genetic trait requires two copies of the variant (one from each parent) to manifest."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;HOMOZYGOUS VARIANTS&quot;">
      <data key="d0">"VARIANT TYPE"</data>
      <data key="d1">"Variants present on both alleles for the same gene, indicating inheritance of the same mutation from both parents."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;TWO OR MORE VARIANTS INHERITED ON DIFFERENT ALLELES&quot;">
      <data key="d0">"INHERITANCE PATTERN"</data>
      <data key="d1">"Individuals having at least two genetic variations spread across their chromosomes from both parents."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;18 GENES&quot;">
      <data key="d0">"GENE SET"</data>
      <data key="d1">"Collection of genes selected for further investigation due to shared pathogenic mutations among affected siblings."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;NDUFV1&quot;">
      <data key="d0">"DISEASE-ASSOCIATED GENE"</data>
      <data key="d1">"Specific gene identified as associated with mitochondrial diseases, particularly relevant here in relation to complex I dysfunction.</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;COMPOUND HETEROZYGOTES&quot;">
      <data key="d0">"GENETIC STATE"</data>
      <data key="d1">"Condition where individuals carry different mutations on each copy of the same gene, often seen in cases requiring a recessive mode of inheritance.</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;C.736G&gt;A&quot;">
      <data key="d0">"VARIANT IN NDUFV1 GENE"</data>
      <data key="d1">"Specific substitution found within the NDUFV1 gene sequence leading to p.Glu246Lys amino acid change."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;P.GLU246LYS&quot;">
      <data key="d0">"AMINO ACID CHANGE"</data>
      <data key="d1">"The resulting amino acid sequence after a mutation occurs, here affecting Glutamic acid to Lysine at position 246 of the protein sequence."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;C.349G&gt;A&quot;">
      <data key="d0">"SECOND NDUFV1 VARIANT"</data>
      <data key="d1">"Another variant in the same gene leading to p.Ala117Thr amino acid change."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;P.ALA117THR&quot;">
      <data key="d0">"AMINO ACID CHANGE (NDUFV1)"</data>
      <data key="d1">"The outcome of the mutation at position 349, affecting Alanine to Threonine at position 117 of NDUFV1 protein sequence."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;MISSENSE VARIANTS&quot;">
      <data key="d0">"VARIANT TYPE (GENETIC MUTATIONS)"</data>
      <data key="d1">"Variants that alter one or more amino acids in a protein due to mutations but not altering the reading frame, often associated with disease.("entity"</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;MUTATION SCREENING BY NEXT-GENERATION SEQUENCING&quot;">
      <data key="d0">"METHOD"</data>
      <data key="d1">"A method used to identify genetic mutations using advanced sequencing technologies."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;MITOCHONDRIAL COMPLEX V ACTIVITY&quot;">
      <data key="d0">"FUNCTION"</data>
      <data key="d1">"The enzymatic activity responsible for the final steps of oxidative phosphorylation in mitochondria."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;LEIGH SYNDROME WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT&quot;">
      <data key="d0">"SPECIFIC FORM"</data>
      <data key="d1">"A variant form of Leigh syndrome characterized by additional neurological symptoms involving the brainstem and spinal cord."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;MITOCHONDRIAL DNA HAPLOGROUP&quot;">
      <data key="d0">"POPULATION GENETICS"</data>
      <data key="d1">"A genetic lineage traced through maternal lineage, specifically in mitochondrial DNA studies."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;MUTATION RATE ESTIMATION&quot;">
      <data key="d0">"STATISTICAL METHOD"</data>
      <data key="d1">"The process of estimating how often specific mutations occur within a population or an individual over time."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;WHOLE GENOME SEQUENCING&quot;">
      <data key="d0">"COMPREHENSIVE ANALYSIS"</data>
      <data key="d1">"A complete analysis method that sequences the entire human genome to identify all types of genetic variations."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;FAMILY HISTORY OF LEIGH SYNDROME&quot;">
      <data key="d0">"CLINICAL HISTORY"</data>
      <data key="d1">"The medical history within a family that includes instances or risk for developing a disease like Leigh syndrome."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;EXONIC SPLICING VARIATION (ESV)">
      <data key="d0">"GENETIC VARIATION TYPE"</data>
      <data key="d1">"A type of genetic variant affecting the splicing process in pre-mRNA, leading to altered gene function."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;CLINICAL PRESENTATION VARIABILITY&quot;">
      <data key="d0">"CLINICAL OBSERVATION"</data>
      <data key="d1">"The range of symptoms and signs that individuals with the same underlying condition may exhibit during clinical evaluation."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;NEUROMUSCULAR DISEASE&quot;">
      <data key="d0">"DISEASE CATEGORY"</data>
      <data key="d1">"A group of disorders affecting the nervous system and muscles, including Leigh syndrome."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;MITOCHONDRIAL RNA POLYMERASE&quot;">
      <data key="d0">"MOLECULAR COMPONENT"</data>
      <data key="d1">"The enzyme responsible for synthesizing mitochondrial RNA from DNA templates in mitochondria."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;COMPLEX I ACTIVITY DEFECT&quot;">
      <data key="d0">"PATHOLOGICAL FEATURE"</data>
      <data key="d1">"A condition where the initial step of oxidative phosphorylation is impaired, as seen in some cases of Leigh syndrome."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;DE NOVO MUTATION RATE ESTIMATION&quot;">
      <data key="d0">"SPECIFIC MUTATION ESTIMATION"</data>
      <data key="d1">"The process to estimate how often new mutations occur without parental contribution during an individual's development."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;MITOCHONDRIAL BIOGENESIS&quot;">
      <data key="d0">"BIOLOGICAL PROCESS"</data>
      <data key="d1">"A cellular process by which mitochondria are produced and maintained in sufficient quantity for metabolic demands."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;RESPIRATORY CHAIN&quot;">
      <data key="d0">"BIOCHEMICAL PATHWAY"</data>
      <data key="d1">"The series of enzyme-catalyzed reactions that produce ATP from adenosine diphosphate (ADP) using oxygen as the final electron acceptor."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;MITOCHONDRIAL DYSFUNCTION&quot;">
      <data key="d0">"PATHOPHYSIOLOGICAL CONDITION"</data>
      <data key="d1">"A condition characterized by impaired function of mitochondria, affecting cellular energy production and other essential processes."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;MITOCHONDRIAL INHERITANCE PATTERN&quot;">
      <data key="d0">"INHERITANCE PATTERN"</data>
      <data key="d1">"The way in which mitochondrial DNA traits are passed from mother to offspring, differing from nuclear DNA inheritance."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;MATERNAL TRANSMISSION&quot;">
      <data key="d0">"SPECIFIC MODE OF INHERITANCE"</data>
      <data key="d1">"A type of genetic trait or disease that is transmitted directly from the mother to her offspring without involving the father's contribution."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;ACID LONG PROTEIN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The protein functions to release electrons from NADH via complex 1 of the electron transport chain."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;NADH&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"NADH is part of a protein that binds FMN and iron–sulfur clusters for proper functioning of complex I."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;FMN&quot;">
      <data key="d0">"VITAMIN"</data>
      <data key="d1">"FMN, also known as flavin mononucleotide (FMN), binds to proteins in the electron transport chain."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;IRON–SULFUR CLUSTER&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Iron–sulfur clusters are part of several enzymes and play a role in the protein's function."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;GLUTAMIC ACID (GLU)&quot;">
      <data key="d0">"AMINO ACID"</data>
      <data key="d1">"Glu246Lys mutation occurs in the FMN binding site which could potentially impact NADH binding."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Some identified variants are categorized as 1–3 by RUNES, which may be associated with disease causing mutations."&lt;SEP&gt;"Variants were found through sequencing of DNA from peripheral blood cells."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;NUCLEAR EXOME&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"The nuclear exome was enriched and sequenced to identify genetic variants."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;MEAN TARGET NUCLEAR EXOME COVERAGE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The mean target nuclear exome coverage of 71.9× indicates the thoroughness of sequencing."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;MTDNA&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Nuclear and mtDNA variants were found through enrichment for the nuclear exome."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;SERINE (SER)&quot;">
      <data key="d0">"AMINO ACID"</data>
      <data key="d1">"The mutation Ser146Asn is caused by c.437G&gt;A in the COQ2 gene."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;COENZYME Q2 HOMOLOG, PRENYLTRANSFERASE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"COQ2 mutations have been reported to cause coenzyme Q10 deficiency (OMIM #609825)."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;C.437G&gt;A&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The mutation c.437G&gt;A changes serine (Ser) to aspartic acid (Asp) at position 146."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;ARGININE (ARG)&quot;">
      <data key="d0">"AMINO ACID"</data>
      <data key="d1">"Mutation Arg387X causes a premature stop codon following the change from arginine to a stop codon."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;MT-ND1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The variant found in MT-ND1 is novel and implies ~22% heteroplasmy in peripheral blood."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;3754C&gt;A&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This variant was confirmed through subsequent capillary sequencing."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;LEBER OPTIC ATROPHY&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Mutations in MT-ND1 can cause Leber optic atrophy (OMIM #535000)."&lt;SEP&gt;"Mutations in MT-ND1 can lead to Leber optic atrophy (OMIM #535000)."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;MITOCHONDRIAL COMPLEX I DEFICIENCY&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Mutations in MT-ND1 are linked to mitochondrial complex I deficiency (OMIM #252010)."&lt;SEP&gt;"Mutations in MT-ND1 can lead to mitochondrial complex I deficiency (OMIM #252010)."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;MELAS SYNDROME&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Mutations in MT-ND1 can also result in MELAS syndrome (OMIM #540000)."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;COMPLEX 1 OF ELECTRON TRANSPORT CHAIN&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The acid long protein functions as part of complex 1, which aids in electron transfer."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;ELECTRON TRANSPORT CHAIN&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process by which the electron is released from NADH to ubiquinone."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;UBIQUINONE&quot;">
      <data key="d0">"VITAMIN"</data>
      <data key="d1">"Ubiquinone plays a role in electron transfer within complex 1."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;C.437G&gt;A (SER146ASN) MUTATION&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Previously reported disease-causing mutations include c.437G&gt;A changing serine to aspartic acid at position 146 in the COQ2 gene."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;C.1159C&gt;T (ARG387X) MUTATION&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A second variant changes arginine at amino acid position 387 to a premature stop codon through c.1159C&gt;T."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;COENZYME Q10 DEFICIENCY&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"COQ2 mutations are associated with coenzyme Q10 deficiency (OMIM #609825)."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;DIDEOXYNUCLEOTIDE PEAKS&quot;">
      <data key="d0">"QUANTITATIVE MEASURE"</data>
      <data key="d1">"Indicators used in capillary sequencing for estimating variant frequencies."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;HETEROPLASMY&quot;">
      <data key="d0">"GENETIC PHENOMENON"</data>
      <data key="d1">"The presence of multiple variants within a single individual, as observed with the MT-ND1 gene variant."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;FUNCTIONING&quot;">
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
      <data key="d1">"NADH is a key component in the electron transport chain.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;BINDING&quot;">
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
      <data key="d1">"FMN binds to proteins like iron–sulfur clusters for proper functioning.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PROTEIN FUNCTION&quot;">
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
      <data key="d1">"Iron–sulfur clusters are part of several enzymes, including the protein mentioned.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GLU246LYS MUTATION&quot;">
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
      <data key="d1">"The mutation could impact NADH binding to proteins.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MUTATION&quot;">
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
      <data key="d1">"Mutation changes serine (Ser) to aspartic acid (Asp) at position 146 in COQ2 gene.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;C.1159C&gt;T&quot;">
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
      <data key="d1">"Mutation causes arginine (Arg) change to a premature stop codon at amino acid position 387.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;OPRM1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Results revealed significant genotype group differences across drinking variables, specifically AUDIT score, number of drinking days, and drinks per drinking day in the past 30 days."&lt;SEP&gt;"The intronic region of the opioid receptor gene OPRM1 contained genomic variant rs1998220, which was related to social disinhibition."&lt;SEP&gt;"rs1998220 in the intronic region of OPRM1 showed associations with social disinhibition."</data>
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544&lt;SEP&gt;chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;AUDIT SCORE&quot;">
      <data key="d0">"DRINKING VARIABLE"</data>
      <data key="d1">"The AUDIT score was used to measure alcohol consumption among participants grouped by their OPRM1 genotype."</data>
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d3">[{"level": 0, "cluster": 8}, {"level": 1, "cluster": 28}]</data>
    </node>
    <node id="&quot;NUMBER OF DRINKING DAYS&quot;">
      <data key="d0">"DRINKING VARIABLE"</data>
      <data key="d1">"Number of days when drinking occurred varied significantly across different OPRM1 genotypes."</data>
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d3">[{"level": 0, "cluster": 8}, {"level": 1, "cluster": 28}]</data>
    </node>
    <node id="&quot;DRINKS PER DRINKING DAY&quot;">
      <data key="d0">"BEHAVIORAL METRIC"</data>
      <data key="d1">"The number of drinks consumed on a drinking day was measured for alcohol-dependent individuals."&lt;SEP&gt;"The quantity of alcohol consumed on drinking days differed among participants based on their OPRM1 genotype."</data>
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544&lt;SEP&gt;chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
      <data key="d3">[{"level": 0, "cluster": 8}, {"level": 1, "cluster": 29}]</data>
    </node>
    <node id="&quot;ALDH2&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR/</data>
      <data key="d1">Dietary Pattern"/&gt;"Analyses controlled for ALDH2 (rs671) and ADH1B (rs1229984) markers to validate main results."</data>
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d3">[{"level": 0, "cluster": 8}, {"level": 1, "cluster": 28}]</data>
    </node>
    <node id="&quot;ADH1B&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR/</data>
      <data key="d1">Dietary Pattern"/&gt;"Analyses controlled for ADH1B marker to further validate the results related to OPRM1 genotype and alcohol effects."</data>
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d3">[{"level": 0, "cluster": 8}, {"level": 1, "cluster": 28}]</data>
    </node>
    <node id="&quot;MEDICATION&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR/</data>
      <data key="d1">Dietary Pattern"/&gt;"Medications (naltrexone and placebo) were tested for their effects on alcohol craving, sedation, or stimulation along with OPRM1 genotypes."</data>
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d3">[{"level": 0, "cluster": 8}, {"level": 1, "cluster": 28}]</data>
    </node>
    <node id="&quot;MEDICATION × GENOTYPE INTERACTION&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR/</data>
      <data key="d1">Dietary Pattern"/&gt;"The combination of specific medication and OPRM1 genotype influenced the outcomes related to alcohol craving, sedation or stimulation."</data>
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d3">[{"level": 0, "cluster": 8}, {"level": 1, "cluster": 28}]</data>
    </node>
    <node id="&quot;BRAC&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR/</data>
      <data key="d1">Dietary Pattern"/&gt;"Blood Alcohol Concentration (BrAC) was controlled to examine the effect of alcohol craving, sedation or stimulation."</data>
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d3">[{"level": 0, "cluster": 8}, {"level": 1, "cluster": 28}]</data>
    </node>
    <node id="&quot;ALDH2 GENOTYPE&quot;">
      <data key="d0">"GENETIC FACTOR"</data>
      <data key="d1">"ALDH2 genotype is a genetic factor that was found to have significant covariates in the analysis."</data>
      <data key="d2">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
    </node>
    <node id="&quot;BASELINE STIMULATION VALUES&quot;">
      <data key="d0">"PHYSIOLOGICAL MEASUREMENT"</data>
      <data key="d1">"Baseline stimulation values were identified as significant covariates."</data>
      <data key="d2">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
    </node>
    <node id="&quot;NICOTINE SMOKING STATUS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Smoking status, considered as an environmental factor, was not a significant moderator of the effects in any analysis."</data>
      <data key="d2">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
      <data key="d3">[{"level": 0, "cluster": 8}, {"level": 1, "cluster": 28}]</data>
    </node>
    <node id="&quot;ASP40 CARRIER&quot;">
      <data key="d0">"GENOTYPE"</data>
      <data key="d1">"Asp40 carrier was one genotype group that showed significantly fewer drinks consumption compared to Asn40 homozygotes."</data>
      <data key="d2">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
    </node>
    <node id="&quot;ASN40 HOMOZYGOTE&quot;">
      <data key="d0">"GENOTYPE"</data>
      <data key="d1">"Asn40 homozygotes were another genotype group in the study."</data>
      <data key="d2">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
    </node>
    <node id="&quot;NICOTINE&quot;">
      <data key="d0">"DRUG"/"SUBSTANCE"</data>
      <data key="d1">"Nicotine was considered as one of the environmental factors that did not significantly moderate the effects of medication or genotype."</data>
      <data key="d2">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
    </node>
    <node id="&quot;OPRM1 GENOTYPE&quot;">
      <data key="d0">"GENETIC FACTOR"</data>
      <data key="d1">"When OPRM1 genotype was treated as a three-level variable, it did not significantly alter the previously reported pharmacogenetic results."</data>
      <data key="d2">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
    </node>
    <node id="&quot;MEDICATION × GENOTYPE × BRAC INTERACTION&quot;">
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d1">"The combined effect of medications, OPRM1 genotypes, and BrAC in influencing alcohol-induced subjective responses was analyzed.")&lt;SEP&gt;"The complex interactions between medications, OPRM1 gene variants, and BrAC influenced evaluations related to alcohol-induced sedative responses.")&lt;SEP&gt;"The complex interactions between medications, OPRM1 gene variants, and BrAC levels influenced evaluations related to alcohol cravings.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 8}, {"level": 1, "cluster": 28}]</data>
    </node>
    <node id="&quot;CIGARETTE SMOKING STATUS&quot;">
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d1">"The impact of OPRM1 genotype in conjunction with medication influenced alcohol-induced responses was assessed by considering current cigarette smoking status.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 8}, {"level": 1, "cluster": 28}]</data>
    </node>
    <node id="&quot;NALTREXONE&quot;">
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d1">"The influence of OPRM1 gene variations and naltrexone were studied to understand their mutual impact on alcohol effects.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 8}, {"level": 1, "cluster": 28}]</data>
    </node>
    <node id="&quot;PLACEBO&quot;">
      <data key="d2">chunk-0c7ab28db433187759e760725a105836&lt;SEP&gt;chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d1">"A control substance given to the comparison group in the study."&lt;SEP&gt;"The role of the OPRM1 gene on alcohol responses under placebo conditions was analyzed during studies employing various medications.")</data>
      <data key="d0">"DRUG"</data>
      <data key="d3">[{"level": 0, "cluster": 8}, {"level": 1, "cluster": 30}]</data>
    </node>
    <node id="&quot;ALCOHOL CRAVING&quot;">
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d1">"The impact of the OPRM1 gene on alcohol craving was evaluated in relation to medication types and BrAC levels.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 8}, {"level": 1, "cluster": 28}]</data>
    </node>
    <node id="&quot;ALCOHOL-INDUCED SEDATION&quot;">
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d1">"The OPRM1 gene's effect on alcohol-induced sedation was compared across different medication types and BrAC levels.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 8}, {"level": 1, "cluster": 28}]</data>
    </node>
    <node id="&quot;ALCOHOL-INDUCED STIMULATION/">
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d1">"The OPRM1 gene's effect on alcohol-induced stimulant responses was studied considering different medication types and BrAC levels.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 8}, {"level": 1, "cluster": 28}]</data>
    </node>
    <node id="&quot;MEDICATION × GENOTYPE INTERACTION/">
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d1">Stimulation"/&gt;"The combined effects of various medications with OPRM1 gene variations on assessing alcohol-induced stimulant responses were explored.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 8}, {"level": 1, "cluster": 28}]</data>
    </node>
    <node id="&quot;MEDICATION × GENOTYPE × BRAC INTERACTION/">
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d1">Stimulation"/&gt;"The complex interactions between medications, OPRM1 gene variants, and BrAC influenced evaluations related to alcohol-induced stimulant responses.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 8}, {"level": 1, "cluster": 28}]</data>
    </node>
    <node id="&quot;GENE/">
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d1">"The Asn40 homozygote group, when administered the placebo, demonstrated unique responses to alcohol-induced stimulation.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="ASN40 HOMOZYGOTES&quot;">
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d1">"The Asn40 homozygote group, when administered the placebo, demonstrated unique responses to alcohol-induced stimulation.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="MEDICATION × GENOTYPE INTERACTION/">
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d1">"Environmental Factors"/&gt;"Medications' combined effects with OPRM1 gene variants on alcohol-induced responses were considered when looking at external factors.")&lt;SEP&gt;"Environmental Factors"/&gt;"The combined effect of certain medications with OPRM1 gene variants played a key role in evaluating alcohol responses while considering environmental influences.")&lt;SEP&gt;"Environmental Factors"/&gt;"The combined effect of certain medications with OPRM1 gene variants significantly influenced evaluations of alcohol responses while taking into account external influences.")&lt;SEP&gt;"Environmental Factors"/&gt;"The combined impact of certain medications with OPRM1 gene variants played a key role in evaluating alcohol responses while considering environmental influences.")&lt;SEP&gt;"Environmental Factors"/&gt;"The combined influence of certain medications with OPRM1 gene variants played an important role in evaluating alcohol responses while taking into account environmental influences.")&lt;SEP&gt;"Environmental Factors"/&gt;"The combined influence of certain medications with OPRM1 gene variants significantly shaped evaluations of alcohol responses while taking into account environmental influences.")&lt;SEP&gt;"Environmental Factors"/&gt;"The combined influence of medications with OPRM1 gene variants shaped the analysis of alcohol responses when considering external factors.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="BRAC × MEDICATION × GENOTYPE INTERACTION/">
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d1">"Environmental Factors"/&gt;"The combined effect of BrAC levels with different medications and OPRM1 gene variants influenced assessments related to alcohol responses when examining environmental influences.")&lt;SEP&gt;"Environmental Factors"/&gt;"The combined effect of differing BrAC levels with specific medications and OPRM1 gene variants significantly influenced evaluations of alcohol responses while considering environmental influences.")&lt;SEP&gt;"Environmental Factors"/&gt;"The combined effect of differing BrAC levels with specific medications and OPRM1 gene variants was crucial for assessing alcohol responses while considering environmental influences.")&lt;SEP&gt;"Environmental Factors"/&gt;"The combined effect of varying BrAC levels with specific medications and OPRM1 gene variants significantly influenced evaluations of alcohol responses while considering environmental influences.")&lt;SEP&gt;"Environmental Factors"/&gt;"The combined influence of varying BrAC levels with specific medications and OPRM1 gene variants significantly influenced evaluations of alcohol responses while considering environmental influences.")&lt;SEP&gt;"Environmental Factors"/&gt;"The combined influence of varying BrAC levels with specific medications and OPRM1 gene variants was pivotal in assessing alcohol responses while considering environmental influences.")&lt;SEP&gt;"Environmental Factors"/&gt;"The intricate relationship among BrAC levels, various medications, and OPRM1 gene variants influenced evaluations related to alcohol responses.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="ASN40 HOMOZYGOTES + PLACEBO GROUP/">
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d1">"Stimulation"/&gt;"The Asn40 homozygote group, when receiving the placebo, showed distinct responses related to alcohol-induced stimulation compared to others.")&lt;SEP&gt;"Stimulation"/&gt;"The effect of being an Asn40 homozygote with exposure to the placebo led to differentiated responses in alcohol-induced stimulation when compared to others.")&lt;SEP&gt;"Stimulation"/&gt;"The effect of being an Asn40 homozygote, when exposed to a placebo condition, led to differentiated responses in alcohol-induced stimulation relative to others.")&lt;SEP&gt;"Stimulation"/&gt;"The effect of being an Asn40 homozygote, when exposed to a placebo condition, led to distinctive responses in alcohol-induced stimulation relative to others.")&lt;SEP&gt;"Stimulation"/&gt;"The influence of being an Asn40 homozygote, when exposed to a placebo condition, led to distinctive responses in alcohol-induced stimulation relative to others.")&lt;SEP&gt;"Stimulation"/&gt;"The influence of being an Asn40 homozygote, when in the placebo condition, led to distinctive alcohol-induced stimulation responses relative to others.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LATENCY TO FIRST DRINK&quot;">
      <data key="d2">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
      <data key="d1">"There was a significant main effect of ALDH2 genotype on latency to first drink, with Asn40 homozygotes having shorter latencies.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENETIC FACTOR&quot;">
      <data key="d2">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
      <data key="d1">"The analysis found no significant medication × genotype interaction regarding the effects on alcohol self-administration or latency to first drink consumption.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MEDICATION EFFECTS&quot;">
      <data key="d2">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
      <data key="d1">"The analysis found no significant medication × genotype interaction regarding the effects on alcohol self-administration or latency to first drink consumption.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PHARMACOGENETIC RESULTS&quot;">
      <data key="d2">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
      <data key="d1">"Treatments of OPRM1 genotype as a three-level variable did not significantly affect the reported pharmacogenetic outcomes related to alcohol self-administration and latency to drink.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ALDH2 RS671 GENOTYPES&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The ALDH2 rs671 genotypes are variants present in the human genome that influence alcohol metabolism."</data>
      <data key="d2">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d3">[{"level": 0, "cluster": 0}, {"level": 1, "cluster": 21}]</data>
    </node>
    <node id="&quot;DAILY DRINKS&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Daily drinks refer to the amount of alcohol consumed per day, classified based on ALDH2 rs671 genotypes."</data>
      <data key="d2">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d3">[{"level": 0, "cluster": 0}, {"level": 1, "cluster": 21}]</data>
    </node>
    <node id="&quot;CORTISOL LEVELS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Cortisol levels are a measure of the body's stress hormone that varies according to ALDH2 rs671 genotypes and sex."</data>
      <data key="d2">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d3">[{"level": 0, "cluster": 0}, {"level": 1, "cluster": 21}]</data>
    </node>
    <node id="&quot;HYPERTENSION&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Hypertension is a condition that affects blood pressure and can influence cortisol levels when considered as a confounding factor."&lt;SEP&gt;"Hypertension, or high blood pressure, can lead to serious health issues if not managed."</data>
      <data key="d2">chunk-9e14f9bdee02839e4a6b12cff2020a5a&lt;SEP&gt;chunk-41c7131af28e2a745ef6b88b8601860f</data>
      <data key="d3">[{"level": 0, "cluster": 0}, {"level": 1, "cluster": 20}]</data>
    </node>
    <node id="&quot;EDUCATION STATUS&quot;">
      <data key="d0">"SOCIOECONOMIC FACTOR"</data>
      <data key="d1">"Education status can influence lifestyle factors like physical activity and smoking, impacting cortisol levels in both men and women."</data>
      <data key="d2">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d3">[{"level": 0, "cluster": 0}, {"level": 1, "cluster": 19}]</data>
    </node>
    <node id="&quot;RS671 POLYMORPHISM&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The rs671 polymorphism is a single nucleotide variation found within the ALDH2 gene which influences alcohol metabolism."</data>
      <data key="d2">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d3">[{"level": 0, "cluster": 0}, {"level": 1, "cluster": 21}]</data>
    </node>
    <node id="&quot;MR (MENDELIAN RANDOMIZATION)&quot;">
      <data key="d0">"STATISTICAL METHOD"</data>
      <data key="d1">"Mendelian randomization is a technique used to infer causality between an exposure and an outcome by using genetic variants as instrumental variables, as applied in Table 4 for alcohol consumption and cortisol levels."</data>
      <data key="d2">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
    </node>
    <node id="&quot;GENOTYPES&quot;">
      <data key="d2">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d1">"ALDH2 genotypes are associated with age differences in both males and females.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS671 GENOTYPES&quot;">
      <data key="d2">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d1">"Genotypes associated with the rs671 variant may result in age differences among genotypic groups.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ASSOCIATION BETWEEN ALCOHOL CONSUMPTION AND BLOOD CORTISOL LEVEL&quot;">
      <data key="d2">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d1">"The MR technique was used to assess potential causal links between genetically predicted alcohol intake levels and changes in blood cortisol levels.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HUA&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Hyperuricemia, characterized by elevated uric acid levels in the blood."&lt;SEP&gt;"The prevalence of Hyperuricemia (HUA) was 14.71% in the study population, with 151 HUA cases and 1055 controls."</data>
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd&lt;SEP&gt;chunk-7091ed039203b69ad83d281b22c89579</data>
    </node>
    <node id="&quot;SLC22A12 RS893006&quot;">
      <data key="d0">"SNP"&lt;|"THE DISTRIBUTION OF SLC22A12 RS893006 WAS NOT SIGNIFICANTLY ASSOCIATED WITH HYPERURICEMIA (HUA) IN BOTH MALES AND FEMALES.")</data>
      <data key="d1">"The G allele of SLC22A12 rs893006 is a genetic variant that contributes to the generation of a genetic risk score for sUA levels."&lt;SEP&gt;14</data>
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd&lt;SEP&gt;chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00</data>
    </node>
    <node id="&quot;SLC2A9 RS3733951&quot;">
      <data key="d0">"GENETIC VARIANT"</data>
      <data key="d1">"The C allele of SLC2A9 rs3733951 is a genetic variant that affects sUA levels."</data>
      <data key="d2">chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00</data>
    </node>
    <node id="&quot;ABCG2 RS2231142&quot;">
      <data key="d0">"GENETIC VARIANT"</data>
      <data key="d1">"The T allele of ABCG2 rs2231142 influences the risk of Hyperuricemia (HUA) with or without cardiovascular risk factors."</data>
      <data key="d2">chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00</data>
    </node>
    <node id="&quot;SUA LEVEL&quot;">
      <data key="d0">"METABOLIC PATHWAY"/"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Serum uric acid (sUA) level is affected by genetic variants and can be influenced by cardiovascular risk factors."&lt;SEP&gt;"Uric acid production regulation in the body, related to cardiovascular disease risk."</data>
      <data key="d2">chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00&lt;SEP&gt;chunk-7091ed039203b69ad83d281b22c89579</data>
    </node>
    <node id="&quot;CARDIOVASCULAR RISK FACTOR&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"/"LIFESTYLE FACTOR"</data>
      <data key="d1">"Factors such as obesity, hypertension, high triglyceride levels, low HDL cholesterol levels, etc., are cardiovascular risk factors that influence the association between genetic variants and HUA risk/sUA levels."</data>
      <data key="d2">chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00</data>
    </node>
    <node id="&quot;SUA&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Cardiovascular disease risk factor associated with uric acid levels."</data>
      <data key="d2">chunk-7091ed039203b69ad83d281b22c89579</data>
    </node>
    <node id="&quot;RS2231142 T ALLELE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A specific genomic variant identified with the rs2231142 tag."</data>
      <data key="d2">chunk-7091ed039203b69ad83d281b22c89579</data>
    </node>
    <node id="&quot;HEMATOCRIT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A blood test that measures the percentage of red blood cells in whole blood."</data>
      <data key="d2">chunk-7091ed039203b69ad83d281b22c89579</data>
    </node>
    <node id="&quot;CHOLESTEROL&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"The process by which the body produces cholesterol, essential for cell membranes and hormone synthesis."</data>
      <data key="d2">chunk-7091ed039203b69ad83d281b22c89579</data>
      <data key="d3">[{"level": 0, "cluster": 2}]</data>
    </node>
    <node id="&quot;RS2231142 T ALLELE CARRIERS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Individuals who carry the T variant at the rs2231142 locus, impacting uric acid metabolism and cardiovascular disease risk."</data>
      <data key="d2">chunk-7091ed039203b69ad83d281b22c89579</data>
      <data key="d3">[{"level": 0, "cluster": 5}]</data>
    </node>
    <node id="&quot;TG&quot;">
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd&lt;SEP&gt;chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
      <data key="d1">"Increased triglyceride levels can lead to lipemia retinalis, abdominal pain and gastrointestinal hemorrhage."&lt;SEP&gt;"Increased triglyceride levels were observed in the HUA group.")</data>
      <data key="d0">"NUTRIENT"</data>
    </node>
    <node id="&quot;LDL&quot;">
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd</data>
      <data key="d1">"Participants with Hyperuricemia showed higher LDL levels than those without.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HYPERTENSIVE PATIENTS&quot;">
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd</data>
      <data key="d1">"A higher percentage of hypertensive patients were identified among those with Hyperuricemia (HUA).")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DIURETICS&quot;">
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd</data>
      <data key="d1">"The usage ratio of diuretics was not significantly different between the HUA cases and controls.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FBG&quot;">
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd</data>
      <data key="d1">"No significant difference in Fasting Blood Glucose (FBG) levels was observed between HUA cases and controls.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ABC&quot;">
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd</data>
      <data key="d1">"The study found that HUA cases showed a significant association with the risk alleles of ABC-related genes, as well as an increased sUA level and HUA risk.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENETIC VARIANT/">
      <data key="d2">chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00</data>
      <data key="d1">Genetic Risk Score"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SLC2A9 RS3733951&quot;/&quot;ABCG2 RS2231142&quot;/&quot;SLC22A12 RS893006&quot;">
      <data key="d2">chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00</data>
      <data key="d1">Genetic Risk Score"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SUA LEVEL&quot;/&quot;SLC2A9 RS3733951&quot;/&quot;ABCG2 RS2231142/">
      <data key="d2">chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00</data>
      <data key="d1">"Metabolic Pathway/</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="SLC22A12 RS893006&quot;">
      <data key="d2">chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00</data>
      <data key="d1">"Metabolic Pathway/</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="ENVIRONMENTAL FACTOR&quot;/&quot;CARDIOVASCULAR RISK FACTOR&quot;">
      <data key="d2">chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00</data>
      <data key="d1">"Environmental Factor"/"Lifestyle Factor/&lt;SEP&gt;"Environmental Factor/</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="ENVIRONMENTAL FACTOR&quot;/&quot;CARDIOVASCULAR RISK FACTOR/">
      <data key="d2">chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00</data>
      <data key="d1">sUA level/</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;METABOLIC PATHWAY/">
      <data key="d2">chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00</data>
      <data key="d1">Physiological Process"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SUA LEVEL&quot;/&quot;RS13206634&quot;">
      <data key="d2">chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00</data>
      <data key="d1">Physiological Process"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SUA LEVEL&quot;/&quot;RS7509837&quot;">
      <data key="d2">chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00</data>
      <data key="d1">Physiological Process/</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CARDIOVASCULAR RISK FACTORS&quot;">
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5&lt;SEP&gt;chunk-7091ed039203b69ad83d281b22c89579</data>
      <data key="d1">"Carriers of the rs2231142 T allele are associated with cardiovascular risk factors, including sUA levels and HUA risk.")&lt;SEP&gt;"GHI increases the risk of developing cardiovascular diseases later in life, partly due to insulin resistance and other metabolic abnormalities."</data>
      <data key="d0">"LINKED TO GHI"</data>
    </node>
    <node id="&quot;LRP2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The LRP2 gene is associated with kidney function and has been identified in trans-ethnic meta-analysis."</data>
      <data key="d2">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
    </node>
    <node id="&quot;NFATC1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"NFATC1 plays a central role in inducible gene transcription during immune response and is a downstream target of the transplant immunosuppression drug cyclosporine A."&lt;SEP&gt;"The NFATC1 gene was discovered in a recently published meta-analysis of European ancestry GWASs."&lt;SEP&gt;"The mRNA expression of Nfatc1 was significantly reduced during high-salt exposure and tended to decrease in CKD models."</data>
      <data key="d2">chunk-3edc72730d68b4c7fd6ba397aa087391&lt;SEP&gt;chunk-45a965c3c3013c70d0fa0f1680283083&lt;SEP&gt;chunk-5ac437b050552f5db2abf19f1bf897cf</data>
    </node>
    <node id="&quot;EGFR&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"eGFR (estimated glomerular filtration rate) is an important indicator for kidney function and has been studied across ancestry groups."</data>
      <data key="d2">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
    </node>
    <node id="&quot;ESRD&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"End-stage renal disease (ESRD) is a condition defined by eGFR &lt; 60 mL/min/1.73 m2, or the occurrence of ESRD."</data>
      <data key="d2">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
    </node>
    <node id="&quot;T1D&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"T1D (Type 1 Diabetes) is associated with the region containing rs181206 and changes in expression of IRF1 and STAT1."&lt;SEP&gt;"The identified GWAS SNPs were associated with T1D, highlighting their role in disease susceptibility."&lt;SEP&gt;"Type 1 Diabetes (T1D), another condition associated with diabetic nephropathy, was also considered in studies related to kidney function and genetic variants."</data>
      <data key="d2">chunk-3edc72730d68b4c7fd6ba397aa087391&lt;SEP&gt;chunk-5b68770e1b446d6cba0d4e1ecabf497b&lt;SEP&gt;chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;PDILT-UMOD&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The PDILT-UMOD gene has been reported as driving association signals for CKD and shows homogeneous effects on eGFR across diverse populations."</data>
      <data key="d2">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
    </node>
    <node id="&quot;HFE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The HFE gene, involved in iron metabolism and related to kidney function."</data>
      <data key="d2">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
    </node>
    <node id="&quot;SLC34A1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The SLC34A1 gene is associated with phosphate reabsorption in the kidney."</data>
      <data key="d2">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
    </node>
    <node id="&quot;DCDC5-MPPED2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"DCDC5 and MPPED2 are interacting proteins involved in the regulation of cell motility and adhesion."&lt;SEP&gt;"The DCDC5-MPPED2 gene is implicated in retinal development and function, but its role in kidney function requires further investigation."</data>
      <data key="d2">chunk-3edc72730d68b4c7fd6ba397aa087391&lt;SEP&gt;chunk-45a965c3c3013c70d0fa0f1680283083</data>
    </node>
    <node id="&quot;NUTRIENT X&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Nutrient X plays a role in various physiological processes that influence kidney health."</data>
      <data key="d2">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
    </node>
    <node id="&quot;DIETARY PATTERN Y&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Dietary pattern Y has been associated with improved kidney function or increased risk, depending on its components."</data>
      <data key="d2">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
    </node>
    <node id="&quot;RGS14&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"RGS14 encodes a member of the regulator of G protein signaling family, which modulates downstream effects of Gα subunits and has unknown function in kidneys."&lt;SEP&gt;"The mRNA expression of Rgs14 was decreased by about 75% during high-salt exposure and approached statistical significance in the CKD model."</data>
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083&lt;SEP&gt;chunk-5ac437b050552f5db2abf19f1bf897cf</data>
    </node>
    <node id="&quot;DHSS&quot;">
      <data key="d0">"REGULATORY CHROMATIN STATE"</data>
      <data key="d1">"The lead SNPs at certain loci overlap with annotated regulatory chromatin states in specific cells."</data>
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
    </node>
    <node id="&quot;CHIP-SEQ BINDING SITES&quot;">
      <data key="d0">"TRANSCRIPTION FACTOR BINDING SITES"</data>
      <data key="d1">"Significant effects on posterior probability of driving association signals are observed for variants near ChIP-seq binding sites, notably for HDAC8"</data>
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
    </node>
    <node id="&quot;HDAC8&quot;">
      <data key="d0">"HISTONE DEACETYLASE"</data>
      <data key="d1">"HDACs play a role in kidney function and development."</data>
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
    </node>
    <node id="&quot;HISTONE DEACETYLASE INHIBITORS&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"The potential use of histone deacetylase inhibitors as treatments for kidney disease"</data>
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
    </node>
    <node id="&quot;PIP5K1B&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"PIP5K1B is a phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2) kinase that catalyzes the production of PtdIns(4,5)P2."</data>
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
    </node>
    <node id="&quot;DHSS IN RPTECS AND HRCES&quot;">
      <data key="d0">"REGULATORY CHROMATIN STATES"</data>
      <data key="d1">"DHSs refer to regions of deoxyribonucleoprotein (DNAP) in chromatin that are accessible for transcription factors binding."</data>
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
    </node>
    <node id="&quot;CHIP-SEQ BINDING SITES FOR HDAC8&quot;">
      <data key="d0">"TRANSCRIPTION FACTOR BINDING SITES"</data>
      <data key="d1">"These sites represent the locations on the DNA where specific transcription factors bind and regulate gene expression."</data>
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
    </node>
    <node id="&quot;LOCOD06164&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"loco mutants with locod06164/+ exhibit improved survival on NaCl-supplemented food."</data>
      <data key="d2">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
    </node>
    <node id="&quot;LOCOEY-P283/">
      <data key="d0">"GENE"</data>
      <data key="d1">"loco mutants with locoEY-P283/+ show enhanced survival on NaCl-supplemented food compared to controls."</data>
      <data key="d2">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
    </node>
    <node id="&quot;Y1W1&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"There is minimal mortality for all genotypes on non-NaCl-supplemented food during the tested time period, indicating similar viability."</data>
      <data key="d2">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
    </node>
    <node id="&quot;129S6 MOUSE STRAIN&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"This strain is salt-sensitive and prone to glomerulosclerosis when subjected to high-salt diets."</data>
      <data key="d2">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
    </node>
    <node id="&quot;HIGH-SALT DIET&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR/</data>
      <data key="d1">"High salt intake leads to a decrease in both Nfatc1 and Rgs14 mRNA expression."</data>
      <data key="d2">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
    </node>
    <node id="&quot;CKD (CHRONIC KIDNEY DISEASE)">
      <data key="d0">"DISEASE/</data>
      <data key="d1">"The expression of Nfatc1 and Rgs14 were altered during CKD development, with Nfatc1 showing significant reduction."</data>
      <data key="d2">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
    </node>
    <node id="&quot;CKD&quot;">
      <data key="d2">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
      <data key="d1">"The eGFR decreasing allele is associated with increased risk of CKD in individuals.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;KIDNEY FUNCTION&quot;">
      <data key="d2">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
      <data key="d1">"Type 2 Diabetes impacts kidney function through mechanisms such as diabetic nephropathy, influencing eGFR.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SNP Z&quot;">
      <data key="d2">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
      <data key="d1">"The SNP Z is significantly associated with a decrease in eGFR and an increased risk of kidney disease.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HFE GENE&quot;">
      <data key="d2">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
      <data key="d1">"Variants in the HFE gene affect iron metabolism, which can impact kidney health through oxidative stress and inflammation.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IRON METABOLISM&quot;">
      <data key="d2">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
      <data key="d1">"Variants in the HFE gene affect iron metabolism, which can impact kidney health through oxidative stress and inflammation.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PHOSPHATE REABSORPTION&quot;">
      <data key="d2">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
      <data key="d1">"Mutations or variations in SLC34A1 may alter phosphate reabsorption, impacting kidney function.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RETINAL DEVELOPMENT&quot;">
      <data key="d2">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
      <data key="d1">"While primarily associated with vision, changes in DCDC5-MPPED2 may indirectly influence kidney health via shared signaling pathways or genetic networks.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RISK OR PROTECTION&quot;">
      <data key="d2">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
      <data key="d1">"The dietary pattern Y may provide protective benefits against kidney disease through specific nutrients and antioxidants.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LEAD SNPS&quot;">
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
      <data key="d1">"lead SNPs at certain loci contribute significantly to the posterior probability of driving association signals.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;POSTERIOR PROBABILITY&quot;">
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
      <data key="d1">"lead SNPs at certain loci contribute significantly to the posterior probability of driving association signals.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NFATC1 GENOMIC VARIANT&quot;">
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
      <data key="d1">"Ancestral orthologs for both genes are present in Drosophila melanogaster")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RGS14 GENOMIC VARIANT&quot;">
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
      <data key="d1">"Ancestral orthologs for both genes are present in Drosophila melanogaster")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ASSOCIATION SIGNALS&quot;">
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
      <data key="d1">"Variants mapping to non-coding sequence at these loci account for more than 99.4% of the probability of driving eGFR association.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;KIDNEY DHSS&quot;">
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
      <data key="d1">"Variants mapping to non-coding sequence at these loci account for more than 99.4% of the probability of driving eGFR association.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SIGNIFICANT EFFECTS&quot;">
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
      <data key="d1">"There are significant effects on posterior probability for variants near HDAC8 binding sites")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;POTENTIAL TREATMENT&quot;">
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
      <data key="d1">"The potential use of histone deacetylase inhibitors as treatments for kidney disease")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;REGULATORY CHROMATIN STATE IN RPTECS&quot;&amp;&quot;HRCES&quot;">
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
      <data key="d1">"The lead SNPs at NFATC1 locus overlaps with DHSs in renal proximal tubular epithelial cells (RPTECs) and renal cortical epithelial cells (HRCEs)")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LONGEVITY &amp; STRESS RESISTANCE&quot;">
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
      <data key="d1">"Reduction in expression of the RGS14 ortholog loco results in longer lifespan and stress resistance")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CAMPYLOBACTER&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"In this study, 975 culture-confirmed Campylobacter infections were reported, with some infected by quinolone-resistant isolates."</data>
      <data key="d2">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
    </node>
    <node id="&quot;QUINOLONE-RESISTANT CASES&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"study identified 12 quinolone-resistant cases that were domestically acquired."</data>
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9</data>
    </node>
    <node id="&quot;DOMESTICALLY ACQUIRED INFECTIONS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"An unmatched subanalysis on domestically acquired infections (quinolone-resistant versus quinolone-sensitive) was performed."&lt;SEP&gt;"Infections treated with fluoroquinolones before specimen collection were excluded."</data>
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9</data>
      <data key="d3">[{"level": 0, "cluster": 10}, {"level": 1, "cluster": 34}]</data>
    </node>
    <node id="&quot;ANTIMICROBIAL DRUGS&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"We found information on antimicrobial drugs received by 122 of 126 patients."</data>
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9</data>
    </node>
    <node id="&quot;CAMPYLOBACTERIOSIS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Forty patients (32.8%) were treated with antimicrobial agents for their campylobacteriosis; of these, 33 patients (27%) received a fluoroquinolone, 6 patients (4.9%) received a macrolide, and 1 patient (1%) received both a fluoroquinolone and a macrolide for the C. jejuni infection."</data>
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9</data>
    </node>
    <node id="&quot;RETAIL FOOD PRODUCTS&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"The human isolates were included in a database and compared with 180 Campylobacter isolates obtained from retail food products (chicken [n = 139], turkey [n = 39], and pork [n = 2])."</data>
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9</data>
    </node>
    <node id="&quot;BROILER CHICKENS&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Of the human isolates, most (63%) were from Danish-bred food animals; the remaining were from imported food from France, Italy, or the United Kingdom."</data>
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9</data>
    </node>
    <node id="&quot;FLUOROQUINOLONE-RESISTANT ISOLATES&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A subanalysis of resistance status by origin of 139 retail chicken products (domestic versus imported) showed that 7 (8.0%) of 87 C. jejuni isolates and three (60%) of five C. coli isolates from domestic raised chicken products were resistant to nalidixic acid."</data>
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9</data>
    </node>
    <node id="&quot;NALIDIXIC ACID RESISTANCE&quot;">
      <data key="d0">"PHENOTYPE"</data>
      <data key="d1">"Of isolates from imported chicken products, 5 (14.7%) (3 isolates from France and 2 isolates from the United Kingdom) of 34 C. jejuni isolates and 1 (10%) (from France) of 10 C. coli isolates were resistant to nalidixic acid."</data>
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9</data>
    </node>
    <node id="&quot;ERYTHROMYCIN RESISTANCE&quot;">
      <data key="d0">"PHENOTYPE"</data>
      <data key="d1">"Of the isolates from chicken products, two isolates (one C. jejuni and one C. coli) from domestic chicken products were resistant to both antimicrobial agents. A subanalysis of resistance status by origin showed that 7 (8.0%) of 87 C. jejuni isolates and three (60%) of five C. coli isolates from domestic raised chicken products were resistant to nalidixic acid."</data>
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9</data>
    </node>
    <node id="&quot;ANTIMICROBIAL DRUG TREATMENT&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"We found information on antimicrobial drugs received by 122 of 126 patients."</data>
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9</data>
    </node>
    <node id="&quot;CAMPYLOBACTER JEJUNI&quot;">
      <data key="d0">"SPECIES"</data>
      <data key="d1">"A type of bacteria known for causing campylobacteriosis."</data>
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9</data>
    </node>
    <node id="&quot;CAMPYLOBACTER COLI&quot;">
      <data key="d0">"SPECIES"</data>
      <data key="d1">"Another type of bacteria related to Campylobacter jejuni that can cause similar infections."</data>
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9</data>
    </node>
    <node id="&quot;QUINOLONE RESISTANCE&quot;">
      <data key="d2">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
      <data key="d1">"Foreign travel was associated with a higher proportion of quinolone-resistant Campylobacter infections compared to domestic infections.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TRAVEL&quot;">
      <data key="d2">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
      <data key="d1">"Foreign travel was associated with a higher proportion of quinolone-resistant Campylobacter infections compared to domestic infections.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;C. COLI&quot;">
      <data key="d2">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
      <data key="d1">"Of the three erythromycin-resistant isolates, two were also quinolone-resistant and originated from travelers returning to Denmark from Spain and Portugal.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DESTINATION&quot;">
      <data key="d2">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
      <data key="d1">"Travel to certain regions like southern Europe and Southeast Asia was significantly associated with high prevalence of quinolone-resistant Campylobacter infections.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;C. JEJUNI&quot;">
      <data key="d2">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
      <data key="d1">"The mean duration of illness was longer for patients infected by quinolone-resistant C. jejuni compared to those infected by quinolone-sensitive strains.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DURATION OF ILLNESS&quot;">
      <data key="d2">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
      <data key="d1">"The mean duration of illness was longer for patients infected by quinolone-resistant C. jejuni compared to those infected by quinolone-sensitive strains.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FOREIGN TRAVEL&quot;">
      <data key="d2">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
      <data key="d1">"Foreign travel, especially to specific destinations like Spain and Portugal, significantly increased the risk of acquiring a quinolone-resistant Campylobacter infection.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;QUINOLONE SENSITIVITY/RESISTANCE&quot;">
      <data key="d2">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
      <data key="d1">"C. jejuni infections did not differ in severity when comparing resistant to sensitive strains, but there was a difference in the mean duration of illness.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TRAVEL DESTINATIONS&quot;">
      <data key="d2">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
      <data key="d1">"Certain destinations like southern Europe and Southeast Asia were associated with higher proportions of quinolone-resistant Campylobacter infections than others.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SWIMMING&quot;">
      <data key="d2">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
      <data key="d1">"Swimming was identified as an independent risk factor for acquiring a quinolone-resistant C. jejuni infection, though the exact mechanism is unclear.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FRESH POULTRY&quot;">
      <data key="d2">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
      <data key="d1">"Eating fresh poultry other than chicken and turkey was associated with an increased risk of quinolone-resistant infections.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;C. COLI STRAINS&quot;">
      <data key="d2">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
      <data key="d1">"The RiboGroups of C. coli isolates play a role in identifying the different susceptibilities to quinolones among the strains.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;QUINOLONE SUSCEPTIBILITY&quot;">
      <data key="d2">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
      <data key="d1">"The RiboGroups of C. coli isolates play a role in identifying the different susceptibilities to quinolones among the strains.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;C. JEJUNI STRAINS&quot;">
      <data key="d2">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
      <data key="d1">"The serotypes of C. jejuni isolates can influence their sensitivity patterns against quinolones.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;C. JEJUNI STRAIN CO-INFECTION&quot;">
      <data key="d2">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
      <data key="d1">"A patient was found to have two C. jejuni strains with identical serotype and RiboGroup, but different susceptibility patterns towards quinolones due to a Thr-86 to Ala-86 mutation in gyrA.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;QUINOLONE-RESISTANT ISOLATES&quot;">
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9</data>
      <data key="d1">"Quinolone-resistant isolates showed decreased susceptibility to fluoroquinolones compared to primary model, but sample size was lower resulting in increased confidence intervals.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FOOD ISOLATES&quot;">
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9</data>
      <data key="d1">"The origin of food isolates was traced back to various sources including Danish-bred food animals, imported foods from France, Italy, and the United Kingdom.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ORIGIN&quot;">
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9</data>
      <data key="d1">"The origin of food isolates was traced back to various sources including Danish-bred food animals, imported foods from France, Italy, and the United Kingdom.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TREATMENT&quot;">
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9</data>
      <data key="d1">"Patients with domestically acquired campylobacteriosis were more likely to receive antimicrobial treatment compared to those with travel-related infections.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 10}, {"level": 1, "cluster": 34}]</data>
    </node>
    <node id="&quot;RETAIL FOOD PRODUCTS AND BROILER CHICKENS&quot;">
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9</data>
      <data key="d1">"Human isolates of Campylobacter bacteria were compared with isolates obtained from retail food products (chicken, turkey, pork), chicken fecal samples, and broiler chickens.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SOURCE&quot;">
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9</data>
      <data key="d1">"Human isolates of Campylobacter bacteria were compared with isolates obtained from retail food products (chicken, turkey, pork), chicken fecal samples, and broiler chickens.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS9534511&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Minor allele of rs9534511 was associated with an increase in social disinhibition score by 0.32 points (95% CI: 0.14-0.50, P &lt; 0.001)."&lt;SEP&gt;"The Gencall score of less than 95% for rs9534511 on HTR2A was indicative of a potential association with social disinhibition."</data>
      <data key="d2">chunk-36d70bb8409856300dd77669e7c1f9ed&lt;SEP&gt;chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;RS4938056&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Minor allele of rs4938056 was associated with an increase in social disinhibition score."&lt;SEP&gt;"The genomic variant rs4938056 on HTR3B had a Gencall score below 95%, which was related to social disinhibition risk."</data>
      <data key="d2">chunk-36d70bb8409856300dd77669e7c1f9ed&lt;SEP&gt;chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;RS1998220&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Minor allele of rs1998220 was associated with an increase in social disinhibition score by 0.19 points (95% CI: 0.06-0.32, P = 0.003)."&lt;SEP&gt;"The intronic region of the opioid receptor gene OPRM1 contained the genomic variant rs1998220, which showed associations with social disinhibition."</data>
      <data key="d2">chunk-36d70bb8409856300dd77669e7c1f9ed&lt;SEP&gt;chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;RS1003921&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Minor allele of rs1003921 was associated with a decrease (negative effect) in social disinhibition score by -0.64 points (95% CI: -1.13 to -0.15, P = 0.011)."&lt;SEP&gt;"Residing in an intronic region of KCNC1, the genomic variant rs1003921 was related to social disinhibition risk."</data>
      <data key="d2">chunk-36d70bb8409856300dd77669e7c1f9ed&lt;SEP&gt;chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;RS16116&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Minor allele of rs16116 was associated with a decrease (negative effect) in social disinhibition score by -0.29 points (95% CI: -0.48 to -0.09, P = 0.004)."&lt;SEP&gt;"The intergenic region downstream of NPY contained the genomic variant rs16116 and showed an association with increased social disinhibition scores."</data>
      <data key="d2">chunk-36d70bb8409856300dd77669e7c1f9ed&lt;SEP&gt;chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;RS16870286&quot;">
      <data key="d0">"SNP"</data>
      <data key="d1">"Minor allele of rs16870286 was associated with a protective effect against social disinhibition."&lt;SEP&gt;"Minor allele of rs16870286 was associated with a protective effect."&lt;SEP&gt;"The genomic variant rs16870286 was part of LINC00518, which codes for an uncharacterized protein and showed associations with social disinhibition."</data>
      <data key="d2">chunk-36d70bb8409856300dd77669e7c1f9ed&lt;SEP&gt;chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;HTR2A&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"SNP rs9534511 on the HTR2A gene pathway was significant in the final multivariable model associated with social disinhibition."&lt;SEP&gt;"rs9534511 on HTR2A showed significant association with social disinhibition."</data>
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;HTR3B&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Genomic variant rs4938056 on HTR3B was related to increased risk of social disinhibition."&lt;SEP&gt;"Genomic variant rs4938056 on the HTR3B gene pathway showed a potential association with increased risk of social disinhibition."</data>
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;KCNC1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Intronic genomic variant rs1003921 on KCNC1 gene showed associations with increased risk of social disinhibition."&lt;SEP&gt;"The genomic variant rs1003921 on KCNC1 was associated with increased risk of social disinhibition."</data>
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;NPY&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The intergenic region downstream of NPY contained the genomic variant rs16116, which was associated with social disinhibition scores."</data>
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;LINC00518&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The genomic variant rs16870286 was part of LINC00518 gene, coding for an uncharacterized protein, which showed associations with increased risk of social disinhibition."&lt;SEP&gt;"The genomic variant rs16870286 was part of LINC00518 gene, coding for an uncharacterized protein, which showed associations with social disinhibition."</data>
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;RS263781&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The genomic variant rs263781 was associated with social disinhibition risk."</data>
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;RS12646596&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Genomic variant rs12646596 showed associations with increased social disinhibition scores."</data>
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;RS3807492&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The genomic variant rs3807492 was related to risk of social disinhibition."</data>
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;TAS&quot;">
      <data key="d0">"PSYCHOSOCIAL RISK FACTOR"</data>
      <data key="d1">"TAS score, a measure of psychosocial risk factor, was positively associated with increased social disinhibition scores."</data>
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;DAS&quot;">
      <data key="d0">"PSYCHOSOCIAL RISK FACTOR"</data>
      <data key="d1">"DAS score, another psychosocial risk factor, was positively correlated with social disinhibition."</data>
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;PARENTAL EDUCATION LEVEL&quot;">
      <data key="d0">"SOCIAL DISINHIBITION DETERMINANT"</data>
      <data key="d1">"Participants whose parents had completed high school or higher showed no statistically significant difference in social disinhibition scores compared to those with less education."</data>
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;LINGUISTIC ACCULTURATION&quot;">
      <data key="d0">"SOCIAL DISINHIBITION DETERMINANT"</data>
      <data key="d1">"The overall linguistic acculturation score was found to be positively associated with increased risk of social disinhibition, leading to a higher score increase."</data>
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;NPY GENE INTERGENIC REGION&quot;">
      <data key="d0">"NON-CODING RNA INTERACTIONS"</data>
      <data key="d1">"rs16116 in the intergenic region downstream of NPY showed associations with increased social disinhibition scores."</data>
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;EIGENVALUE 1&quot;">
      <data key="d0">"PRINCIPAL COMPONENT ANALYSIS COMPONENT"</data>
      <data key="d1">"The top eigenvalue from the principal components analysis indicated significant variation in participants related to social disinhibition."</data>
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;EIGENVALUE 2&quot;">
      <data key="d0">"PRINCIPAL COMPONENT ANALYSIS COMPONENT"</data>
      <data key="d1">"The second largest eigenvalue revealed substantial contribution to differences in social disinhibition."</data>
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;EIGENVALUE 3&quot;">
      <data key="d0">"PRINCIPAL COMPONENT ANALYSIS COMPONENT"</data>
      <data key="d1">"The third largest eigenvalue showed further variation related to the social disinhibition outcome."</data>
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;SOCIAL DISINHIBITION SCORE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Social disinhibition score increased by 0.20 points (95% CI: 0.17-0.23) and 0.45 points (95% CI: 0.40-0.51), respectively."</data>
      <data key="d2">chunk-36d70bb8409856300dd77669e7c1f9ed</data>
    </node>
    <node id="&quot;GENDER AND PARENTAL EDUCATION&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"These were not significantly associated with social disinhibition score."</data>
      <data key="d2">chunk-36d70bb8409856300dd77669e7c1f9ed</data>
    </node>
    <node id="&quot;SNPS (RS1998220, RS9534511, AND RS4938056)&quot;">
      <data key="d0">"GENOMIC VARIANTS"</data>
      <data key="d1">"These SNPs had positive associations with the increased risk of social disinhibition."</data>
      <data key="d2">chunk-36d70bb8409856300dd77669e7c1f9ed</data>
    </node>
    <node id="&quot;SOCIAL DISINHIBITION&quot;">
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
      <data key="d1">"A 1-point increase in linguistic acculturation score leads to a 0.30 point increase in social disinhibition scores.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PRINCIPAL COMPONENT 3&quot;">
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
      <data key="d1">"PC3 accounted for additional variance related to social disinhibition among study participants.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INCREASED SOCIAL DISINHIBITION SCORE&quot;">
      <data key="d2">chunk-36d70bb8409856300dd77669e7c1f9ed</data>
      <data key="d1">"Three SNPs' minor alleles led to an increase in the social disinhibition score, while three others had protective effects against it.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DECREASED SOCIAL DISINHIBITION SCORE/">
      <data key="d2">chunk-36d70bb8409856300dd77669e7c1f9ed</data>
      <data key="d1">Negative Effects on Social Disinhibition"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS16116&quot; &amp; &quot;RS1003921&quot;">
      <data key="d2">chunk-36d70bb8409856300dd77669e7c1f9ed</data>
      <data key="d1">Negative Effects on Social Disinhibition"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CNR1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The CNR1 gene is based on studies by Zhang et al and National Center for Biotechnology Information."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
      <data key="d3">[{"level": 0, "cluster": 7}, {"level": 1, "cluster": 26}]</data>
    </node>
    <node id="&quot;RS2023239&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The genomic variant rs2023239, found upstream of exon 3 of the CNR1 gene, has been described as an alternative promoter."&lt;SEP&gt;"The genotypic variant rs2023239 was examined in relation to the effects of alcohol."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e&lt;SEP&gt;chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
    </node>
    <node id="&quot;POSTMORTEM HUMAN PFC&quot;">
      <data key="d0">"SAMPLE/</data>
      <data key="d1">Disease"&lt;|"Samples from post-mortem human prefrontal cortex (PFC) were used in association studies."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;CNR1 RECEPTORS&quot;">
      <data key="d0">"MOLECULAR INTERACTION/</data>
      <data key="d1">Disease"&lt;|"CNR1 receptors modulate drug-seeking behavior, which can lead to conditions like addiction."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;ALCOHOL CUE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR/</data>
      <data key="d1">Disease"&lt;|"Exposure to alcohol cues activates neurocircuitry related to drug-seeking behavior in individuals with certain genetic variations."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;AUDIT&quot;">
      <data key="d0">"ASSESSMENT TOOL/</data>
      <data key="d1">Disease"&lt;|"The Alcohol Use Disorder Identification Test (AUDIT) measures severity of alcohol use disorders."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;ANXIETY&quot;">
      <data key="d0">"BEHAVIOR/</data>
      <data key="d1">Disease"&lt;|"Anxiety can influence behavior patterns and contribute to other health conditions."&lt;SEP&gt;Risk Factor/</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;TOBACCO USE&quot;">
      <data key="d0">"BEHAVIORS/</data>
      <data key="d1">Risk Factor"&lt;|"Tobacco use is a risk factor for many diseases, including those related to alcohol consumption."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;ALCOHOL REWARDING EFFECTS&quot;">
      <data key="d0">"BEHAVIOR/</data>
      <data key="d1">Disease"&lt;|"Certain genotypes may influence how individuals perceive rewarding effects of alcohol, potentially affecting their behavior and health."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;PROFILE OF MOOD STATES&quot;">
      <data key="d0">"ASSESSMENT TOOL/</data>
      <data key="d1">Disease"&lt;|"The Profile of Mood States (POMS) is used to assess emotional states like reward and positive affect."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;PLACEBO BEVERAGE&quot;">
      <data key="d0">"CONTROL MEASURE/</data>
      <data key="d1">Risk Factor"&lt;|"Using placebo beverages helps in determining the effects without direct influence from substances."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;ALTERNATIVE PROMOTER&quot;">
      <data key="d0">"MOLECULAR INTERACTION/</data>
      <data key="d1">CNR1 Gene"&lt;|"The rs2023239 genomic variant acts as an alternative promoter for the CNR1 gene, influencing its expression."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;CANNABINOID RECEPTOR 1/">
      <data key="d0">MOLECULAR INTERACTION/</data>
      <data key="d1">CB1 Receptor"&lt;|"Cannabinoid receptors are involved in various biological functions, and CB1 is a specific type of cannabinoid receptor."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;ALCOHOL CUE EXPOSURE/">
      <data key="d0">ENVIRONMENTAL FACTOR/</data>
      <data key="d1">Disease"/"Exposure to alcohol cues can activate neurocircuitry related to drug-seeking behavior in certain individuals, potentially leading to addictive disorders."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;ALCOHOL CONSUMPTION/">
      <data key="d0">RISK FACTOR/</data>
      <data key="d1">Disease"/"Increased alcohol consumption is linked to several health risks, including addiction."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;TOBACCO USE&quot;/&quot;BEHAVIORS/">
      <data key="d0">RISK FACTOR/</data>
      <data key="d1">Disease"/"Tobacco use is considered a risk factor contributing to multiple diseases, including addiction."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;ALCOHOL REWARDING EFFECTS/">
      <data key="d0">BEHAVIOR/</data>
      <data key="d1">Anxiety/Disease"/"Genetic variations like rs2023239 may influence how individuals perceive rewarding effects of alcohol, which can vary based on anxiety levels or predispositions to certain diseases."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;PROFILE OF MOOD STATES/">
      <data key="d0">ASSESSMENT TOOL/</data>
      <data key="d1">Risk Factor/</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;PLACEBO BEVERAGE/">
      <data key="d0">CONTROL MEASURE/</data>
      <data key="d1">Risk Factor/</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;CT GENOTYPE&quot;">
      <data key="d0">"VARIANT"</data>
      <data key="d1">"Individuals with the CT genotype were identified in the studies."</data>
      <data key="d2">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
    </node>
    <node id="&quot;TT GENOTYPE&quot;">
      <data key="d0">"VARIANT"</data>
      <data key="d1">"The TT genotype refers to individuals without rs2023239 variant present."</data>
      <data key="d2">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
    </node>
    <node id="&quot;MEDICATION: OLANZAPINE VS CYPROHEPTADINE HYDROCHLORIDE&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Medications used were olanzapine and cyproheptadine hydrochloride."</data>
      <data key="d2">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
    </node>
    <node id="&quot;GENOTYPE: TT VS CT AND CC&quot;">
      <data key="d0">"GENOTYPE"</data>
      <data key="d1">"The genotypes included were TT, CT, and CC for the study."</data>
      <data key="d2">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
    </node>
    <node id="&quot;DRINK: 1 VS 2 VS 3&quot;">
      <data key="d0">"DOSE LEVEL"</data>
      <data key="d1">"The drink levels considered were 1, 2, and 3 during the study."</data>
      <data key="d2">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
    </node>
    <node id="&quot;REWARD&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Reward was measured in relation to alcohol consumption for individuals with different genotypes."</data>
      <data key="d2">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
    </node>
    <node id="&quot;POSITIVE AFFECT&quot;">
      <data key="d0">"EMOTIONAL STATE"</data>
      <data key="d1">"Positive emotional states were observed after alcohol intake for individuals with specific genotypes."</data>
      <data key="d2">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
    </node>
    <node id="&quot;SELF-REPORTED HIGH&quot;">
      <data key="d0">"SUBJECTIVE EXPERIENCE"</data>
      <data key="d1">"Self-reported feelings of euphoria were examined in relation to different medications and drinks."</data>
      <data key="d2">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
    </node>
    <node id="&quot;ACTIVE CONTROL MEDICATION (CYPROHEPTADINE) VS OLANZAPINE&quot;">
      <data key="d0">"DRUG TYPE"</data>
      <data key="d1">"Two medications, cyproheptadine hydrochloride and olanzapine, were compared in the study."</data>
      <data key="d2">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
    </node>
    <node id="&quot;CNR1 VARIATION&quot;">
      <data key="d0">"GENETIC VARIANT"</data>
      <data key="d1">"The genetic variant CNR1 was considered for its potential interaction with olanzapine."</data>
      <data key="d2">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
    </node>
    <node id="&quot;CUE-ELICITED CRAVING&quot;">
      <data key="d0">"PSYCHOLOGICAL PROCESS"</data>
      <data key="d1">"Cravings elicited by cues were assessed in individuals treated with olanzapine and placebo."</data>
      <data key="d2">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
    </node>
    <node id="&quot;PLACEBO VS OLANZAPINE&quot;">
      <data key="d0">"TREATMENT COMPARISON"</data>
      <data key="d1">"Comparisons were made between treatment with placebo and treatment with olanzapine."</data>
      <data key="d2">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
      <data key="d3">[{"level": 0, "cluster": 8}, {"level": 1, "cluster": 29}]</data>
    </node>
    <node id="&quot;MEDICATION: OLANZAPINE&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Olanzapine was used as a medication in studies examining its effect on alcohol consumption and craving."</data>
      <data key="d2">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
    </node>
    <node id="&quot;CYPROHEPTADINE HYDROCHLORIDE&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Cyproheptadine hydrochloride served as an active control medication."</data>
      <data key="d2">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
    </node>
    <node id="&quot;CNR1 VARIATION (RS2035618)&quot;">
      <data key="d0">"GENETIC VARIANT"</data>
      <data key="d1">"The genetic variant CNR1 was also considered in studies looking at olanzapine's impact on craving."</data>
      <data key="d2">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
    </node>
    <node id="&quot;MEDICATION × GENOTYPE × CUE INTERACTION&quot;">
      <data key="d0">"STATISTICAL INTERACTION"</data>
      <data key="d1">"A statistical analysis revealed an interaction between medication, genotype and cue in relation to craving response."</data>
      <data key="d2">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
    </node>
    <node id="&quot;MEDICATION × GENOTYPE × DRINK INTERACTION&quot;">
      <data key="d0">"STATISTICAL INTERACTION"</data>
      <data key="d1">"A statistical analysis found a link between medications, genotypes and the number of drinks consumed."</data>
      <data key="d2">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
    </node>
    <node id="&quot;MEDICATION × GENOTYPE × CUE INTERACTION ON CRAVING&quot;">
      <data key="d0">"STATISTICAL ANALYSIS"</data>
      <data key="d1">"The analysis showed significant differences in craving response based on medication taken, individual's genetic profile, and presence of cues."</data>
      <data key="d2">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
    </node>
    <node id="&quot;MEDICATION × GENOTYPE × DRINK INTERACTION ON SELF-REPORTED HIGH&quot;">
      <data key="d0">"STATISTICAL INTERACTION"</data>
      <data key="d1">"A statistical analysis indicated differences in self-reported feelings of euphoria related to medications used, genotypes, and the number of drinks consumed."</data>
      <data key="d2">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
    </node>
    <node id="&quot;CB1 RECEPTOR&quot;">
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
      <data key="d1">"The rs2023239 variant influences CB1 receptor levels, affecting neurocircuitry related to drug-seeking behavior.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CB1 RECEPTOR LEVELS/">
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
      <data key="d1">Disease"&lt;|"Genetic variations in CNR1 can affect CB1 receptor levels, which are associated with addiction and other diseases.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CNR1 GENE&quot;">
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
      <data key="d1">Disease"&lt;|"Genetic variations in CNR1 can affect CB1 receptor levels, which are associated with addiction and other diseases.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ALCOHOL CUE EXPOSURE&quot;">
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
      <data key="d1">Disease"&lt;|"Exposure to alcohol cues can activate neurocircuitry that modulates drug-seeking behavior, possibly related to addictive disorders.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NEUROCIRCUITRY ACTIVATION/">
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
      <data key="d1">Disease"&lt;|"Exposure to alcohol cues can activate neurocircuitry that modulates drug-seeking behavior, possibly related to addictive disorders.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CB1 RECEPTOR REGULATION/">
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
      <data key="d1">Alcohol Use"&lt;|"The rs2023239 variant influences CB1 receptor function and its sensitivity to alcohol.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS2023239 VARIANT&quot;">
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
      <data key="d1">Alcohol Use"&lt;|"The rs2023239 variant influences CB1 receptor function and its sensitivity to alcohol.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CNR1 GENOTYPE&quot;">
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
      <data key="d1">Anxiety"&lt;|"Genetic variations in CNR1 may impact responses to alcohol, influencing anxiety levels.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS2023239 VARIANT/">
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
      <data key="d1">Anxiety/</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="CB1 RECEPTOR REGULATION/">
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
      <data key="d1">Anxiety/</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="CB1 RECEPTOR/">
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
      <data key="d1">Anxiety/</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;EXON 3/">
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
      <data key="d1">Alcohol Consumption/</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="CANNABINOID RECEPTOR REGULATION/">
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
      <data key="d1">Alcohol Consumption/</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENOMIC VARIANT/">
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
      <data key="d1">Risk Factor/</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="ALTERNATIVE PROMOTER/">
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
      <data key="d1">Risk Factor/</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MEDICATION: OLANZAPINE AND CYPROHEPTADINE HYDROCHLORIDE&quot;">
      <data key="d2">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
      <data key="d1">"The genotypic variant rs2023239 was related to the response to different medications during alcohol consumption studies.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;EXOGENOUS LIPID METABOLISM&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Involves packaging of dietary fat into chylomicrons in the small intestine, which are later transported to the bloodstream."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;ENDOGENOUS LIPID METABOLISM&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Initial step involves hydrolysis of chylomicrons by lipoprotein lipase (LPL)."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;LIPOPROTEIN LIPASE (LPL)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"An enzyme that hydrolyzes triglycerides in lipoproteins."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;LPL DEFICIENCY&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A rare autosomal recessive disorder with a prevalence of 1/1,000,000 in the United States and higher in other world regions due to a founder effect."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;HYPERTRIGLYCERIDEMIA&quot;">
      <data key="d0">"PATHOLOGICAL CONDITION"</data>
      <data key="d1">"Can be present in affected homozygotes or compound heterozygotes with LPL deficiency."&lt;SEP&gt;"Patients homozygous or compound heterozygotes of the LPL gene can present with marked hypertriglyceridemia."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63&lt;SEP&gt;chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;SIMPLE HETEROZYGOTE CARRIERS&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"Often have normal lipids, even when carrying one copy of the mutated gene."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;ERUPTIVE XANTHOMAS&quot;">
      <data key="d0">"CLINICAL SIGN"</data>
      <data key="d1">"Characterized by yellowish, papular eruptions on the skin, often seen in individuals with elevated levels of lipid metabolism-related disorders."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;ABDOMINAL PAIN&quot;">
      <data key="d0">"SYMPTOM"</data>
      <data key="d1">"One of the symptoms that can be experienced by patients with LPL deficiency or other related conditions."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;HEPATO-SPLENOMEGALY&quot;">
      <data key="d0">"ANATOMICAL ABNORMALITY"</data>
      <data key="d1">"Enlargement of liver and spleen, often observed in individuals with hypertriglyceridemia or LPL deficiency."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;LOWER GASTROINTESTINAL BLEEDING&quot;">
      <data key="d0">"COMPLICATION"</data>
      <data key="d1">"A complication that can occur due to severe hypertriglyceridemia affecting the digestive system."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;RECURRENT PANCREATITIS&quot;">
      <data key="d0">"RECURRING CONDITION"</data>
      <data key="d1">"An inflammatory condition of the pancreas, which might recur in patients with LPL deficiency or related lipid metabolism disorders."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;LIPEMIA RETINALIS&quot;">
      <data key="d0">"OCULAR ABNORMALITY"</data>
      <data key="d1">"A condition characterized by excessive blood leakage into the eye, often related to high levels of lipids in circulation."&lt;SEP&gt;"The condition where fat deposits accumulate in blood vessels supplying the retina, leading to vision problems."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63&lt;SEP&gt;chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;DIETARY FAT RESTRICTION&quot;">
      <data key="d0">"TREATMENT"</data>
      <data key="d1">"The cornerstone of treatment for patients with LPL deficiency or other lipid metabolism disorders."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;ENFAPORT LIPIL&quot;">
      <data key="d0">"FORMULA"</data>
      <data key="d1">"An infant formula with a high fat content from medium-chain triglycerides, used for treatment purposes in individuals with certain lipid metabolism disorders."&lt;SEP&gt;"Formula with a high content of medium-chain triglycerides and lower long-chain fats, used as part of the treatment regimen for affected individuals."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;LPL GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The gene responsible for encoding lipoprotein lipase (LPL), which plays a role in multiple stages of lipid metabolism."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;AUTOSOMAL RECESSIVE DISORDER&quot;">
      <data key="d0">"GENETIC CONDITION"</data>
      <data key="d1">"A disorder that requires the defective gene to be inherited from both parents in order to express clinical symptoms."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;PUERTO RICAN DESCENT&quot;">
      <data key="d0">"ETHNICITY/</data>
      <data key="d1">Population Subgroup"</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;COFFEE-GROUND EMESIS&quot;">
      <data key="d0">"SYMPTOM"/"CLINICAL SIGN"</data>
      <data key="d1">"Non-bloody, often vomited material that resembles coffee grounds, seen in patients with gastrointestinal issues or certain diseases."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;MELENA&quot;">
      <data key="d0">"GASTROINTESTINAL SYMPTOM"</data>
      <data key="d1">"Dark, tarry stool resulting from bleeding in the upper gastrointestinal tract, possibly due to severe hypertriglyceridemia."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;PAPULAR RASH&quot;">
      <data key="d0">"SKIN CONDITION"/"CLINICAL SIGN"</data>
      <data key="d1">"A rash characterized by small, red, raised lesions on the skin surface that can be a symptom of various health issues including disorders related to lipid metabolism.</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;GROSSLY LIPEMIC BLOOD&quot;">
      <data key="d0">"ANATOMICAL ABNORMALITY"</data>
      <data key="d1">"Blood with visible excess fat droplets due to high levels of lipids in circulation."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;FASTING LIPID PROFILE&quot;">
      <data key="d0">"DIAGNOSTIC TEST"</data>
      <data key="d1">"A laboratory test used to evaluate the level of different lipids (such as cholesterol and triglycerides) in the blood after an overnight fast."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;PANCREATIC LIPASE&quot;">
      <data key="d0">"ENZYME/</data>
      <data key="d1">Protein"</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;HETEROZYGOTE INDIVIDUALS&quot;">
      <data key="d0">"GENETIC STATUS"/"LIFESTYLE FACTOR"</data>
      <data key="d1">"Carriers who have one normal copy of the LPL gene and one mutated copy but do not exhibit symptoms.")</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;REFLUX&quot;">
      <data key="d0">"CLINICAL SIGN/</data>
      <data key="d1">Symptom"</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;LIPID-LOWERING DRUGS&quot;">
      <data key="d0">"MEDICAL INTERVENTION"/"THERAPY"</data>
      <data key="d1">"Pharmacological treatments aimed at reducing levels of cholesterol and triglycerides in the blood.")</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;NIACIN&quot;">
      <data key="d0">"NUTRIENT"/"VITAMIN/BIOACTIVE COMPOUND"</data>
      <data key="d1">"Often used as a dietary supplement or medication to lower triglycerides and increase HDL (good) cholesterol levels.")</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;CHOLESTYRAMINE/">
      <data key="d0">COLESTIPOL"</data>
      <data key="d1">"Drug Class/</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;ORLISTAT/">
      <data key="d0">XENICAL"</data>
      <data key="d1">"Weight Loss Drug"/"Medication"</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;GASTROINTESTINAL LIPASE&quot;">
      <data key="d0">"ENZYME/</data>
      <data key="d1">Protein"</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;PANCREATIC EXOCRINE INSUFFICIENCY&quot;">
      <data key="d0">"MEDICAL CONDITION"/"ANATOMICAL ABNORMALITY"</data>
      <data key="d1">"A disorder where the pancreas fails to produce enough digestive enzymes for proper digestion of food, often affecting fat breakdown.")</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;GASTROSTOMY/">
      <data key="d0">JEJUNOSTOMY"</data>
      <data key="d1">"Intervention/</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;P.Q240H&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The p.Q240H mutation in exon 5 of the LPL gene causes severe hypertriglyceridemia."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;LPL&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The LPL deficiency has clinical manifestations that include eruptive xanthomas, lipemia retinalis, abdominal pain, gastrointestinal hemorrhage, and pancreatitis."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;TG LEVELS&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"The damage from increased TG levels can extend to the posterior pole of retina and risk increases with higher TG levels."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;FAT RESTRICTION&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Dietary restriction is considered as a cornerstone for treating LPL deficiency."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;MCT&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Long-chain triglycerides (LCTs) are replaced with medium-chain triglycerides (MCTs) in dietary formulas for patients with LPL deficiency."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;GEMFIBROZIL&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Combination of drug therapies like gemfibrozil, omega-3 fatty acids, and orlistat can decrease TG levels when used with a fat-restricted diet."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;DGAT1 INHIBITORS&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Currently under investigation for treating LPL deficiency, DGAT1 inhibitors target the synthesis of triglycerides during dietary fat absorption."&lt;SEP&gt;"Drugs under investigation that specifically target the DGAT1 enzyme to inhibit triglyceride synthesis during fat absorption."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;GAIN-OF-FUNCTION VARIANT&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A gain-of-function variant of the LPL gene is approved in Europe for treatment of patients with LPL deficiency."&lt;SEP&gt;"A genetic variant that enhances the function of a gene product, in this case enhancing LPL activity."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;INTRAMUSCULAR INTRODUCTION&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"Introduction of a gain-of-function variant of the LPL gene through intramuscular therapy is considered but limited in duration and cost."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;DIACYLGLYCEROL O-ACYLTRANSFERASE 1 (DGAT1)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The role of DGAT1 mediates triglyceride synthesis during dietary fat absorption, an area under investigation for treatment.")("entity"</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;TRIGLYCERIDE-RICH LIPOPROTEINS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A complex consisting of triglycerides, proteins and phospholipids that transport fats through the bloodstream."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;HYPERVISCOSITY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Increased viscosity of body fluids due to high levels of triglycerides that can cause blood flow issues."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;PANCREATITIS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Inflammation of the pancreas often associated with high levels of TG and is a common issue in patients with LPL deficiency."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;GEMFIBROZIL, OMEGA-3 FATTY ACIDS, ORLISTAT&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Drugs used as part of therapy for LPL deficiency to decrease triglyceride levels when combined with dietary changes."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;INTRAMUSCULAR THERAPY&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"A medical procedure where drugs or other substances are injected into muscle tissue, as part of treatment for LPL deficiency."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;ROLE/">
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
      <data key="d1">Function"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TREATMENT FOR LPL DEFICIENCY&quot;">
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
      <data key="d1">"An effective treatment strategy to manage symptoms and complications associated with this genetic disorder.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FORMULA/">
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
      <data key="d1">Medical Intervention"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;AUTOSOMAL RECESSIVE DISORDER/">
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
      <data key="d1">"Genetic Connection"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="LPL DEFICIENCY&quot;">
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
      <data key="d1">"Genetic Connection"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MUTATION ANALYSIS/">
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
      <data key="d1">"Diagnostic Method"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="GENOMIC DNA&quot;">
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
      <data key="d1">"Diagnostic Method"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CLINICAL SIGNS/">
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
      <data key="d1">"Association between symptoms and conditions"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="PATHOLOGICAL MANIFESTATIONS&quot;">
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
      <data key="d1">"Association between symptoms and conditions"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GASTROINTESTINAL COMPLICATIONS&quot;">
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
      <data key="d1">High triglyceride levels"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;OUTCOME OF LPL DEFICIENCY/">
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
      <data key="d1">High triglyceride levels"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TOPIRAMATE&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"A drug used for treating patients during the study."</data>
      <data key="d2">chunk-0c7ab28db433187759e760725a105836</data>
      <data key="d3">[{"level": 0, "cluster": 8}, {"level": 1, "cluster": 30}]</data>
    </node>
    <node id="&quot;RS2832407&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genetic variant that influences the effects of topiramate on HDDs in European-American patients."</data>
      <data key="d2">chunk-0c7ab28db433187759e760725a105836</data>
    </node>
    <node id="&quot;HDDS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The Disease under Study, referring to the condition being treated with topiramate and placebo."</data>
      <data key="d2">chunk-0c7ab28db433187759e760725a105836</data>
    </node>
    <node id="&quot;EA PATIENTS&quot;">
      <data key="d0">"PATIENT SUBGROUP"</data>
      <data key="d1">"European-American patients included in the study."</data>
      <data key="d2">chunk-0c7ab28db433187759e760725a105836</data>
      <data key="d3">[{"level": 0, "cluster": 11}, {"level": 1, "cluster": 36}, {"level": 2, "cluster": 60}]</data>
    </node>
    <node id="&quot;A-ALLELE CARRIERS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Individuals carrying at least one copy of the A allele of rs2832407."&lt;SEP&gt;"Individuals carrying the A allele of rs2832407 that respond differently to topiramate."</data>
      <data key="d2">chunk-0c7ab28db433187759e760725a105836</data>
    </node>
    <node id="&quot;C-HOMOZYGOTES&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Individuals who are homozygous for the C allele of rs2832407."</data>
      <data key="d2">chunk-0c7ab28db433187759e760725a105836</data>
    </node>
    <node id="&quot;EFFICACY&quot;">
      <data key="d2">chunk-0c7ab28db433187759e760725a105836</data>
      <data key="d1">"The study aims to determine the effectiveness of topiramate and placebo in managing HDDs.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TOPIRAMATE EFFECT&quot;">
      <data key="d2">chunk-0c7ab28db433187759e760725a105836</data>
      <data key="d1">"The rs2832407 variant moderates the effect of topiramate on HDDs, showing a significant difference between C-homozygotes and A-allele carriers.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ADVERSE EVENTS&quot;">
      <data key="d2">chunk-0c7ab28db433187759e760725a105836&lt;SEP&gt;chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
      <data key="d1">"A-allele carriers showed a significantly higher mean severity rating for adverse events compared to those with other genotypes when taking topiramate.")&lt;SEP&gt;"Unintended negative responses or harmful effects from medical procedures or treatments.</data>
      <data key="d0">"SAFETY OUTCOME"</data>
    </node>
    <node id="&quot;EFFECT&quot;">
      <data key="d2">chunk-0c7ab28db433187759e760725a105836</data>
      <data key="d1">"C-homozygotes showed a significant reduction in HDDs when taking topiramate, with an NNT of 2.28.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PATIENT&quot;">
      <data key="d0">"PERSON"</data>
      <data key="d1">"The study involved a total of 120 eligible patients who were approached, with 90% signing consent and 89% completing the study."</data>
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
    </node>
    <node id="&quot;DATA COLLECTION&quot;">
      <data key="d0">"INFORMATION GATHERING"</data>
      <data key="d1">"Complete self-report and genetic data were collected from 88 patients who participated in the current analyses."</data>
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
    </node>
    <node id="&quot;SAMPLE ANALYSIS&quot;">
      <data key="d0">"STATISTICAL ANALYSIS"</data>
      <data key="d1">"The demographic and clinical characteristics of the sample were analyzed, with a mean age of 60 years (SD=10)."</data>
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
    </node>
    <node id="&quot;STUDY PARTICIPANTS&quot;">
      <data key="d0">"RESEARCH SUBJECTS"</data>
      <data key="d1">"Patients in the study were predominantly female (55%), white (93%), non-Hispanic (97%) and had an annual household income of at least $40,000 per year (60%)."</data>
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
    </node>
    <node id="&quot;MALIGNANCY TYPES&quot;">
      <data key="d0">"MEDICAL CONDITION"</data>
      <data key="d1">"Patients diagnosed with gastrointestinal (34%), thoracic (27%), or breast malignancies (26%); most received highly-emetogenic chemotherapy regimens (65%)."</data>
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
    </node>
    <node id="&quot;ANTI-EMETIC MEDICATIONS&quot;">
      <data key="d0">"PHARMACEUTICAL PRODUCT"</data>
      <data key="d1">"Commonly used anti-emetics included palonosetron (99%) and dexamethasone (98%). Additional medications like prochlorperazine (88%), ondansetron (46%), and fosaprepitant (34%) were also prescribed."</data>
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
    </node>
    <node id="&quot;CINV SEVERITY&quot;">
      <data key="d0">"SYMPTOM EVALUATION"</data>
      <data key="d1">"12% of patients experienced CTCAE grade 2 or above acute nausea, while 30% experienced delayed nausea. Vomiting was less frequent, with 3% experiencing it in the acute period and 11% in the delayed period."</data>
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
    </node>
    <node id="&quot;CHEMOTHERAPY REGIMEN&quot;">
      <data key="d0">"MEDICAL PROCEDURE"</data>
      <data key="d1">"Anti-emetic regimen switching occurred in 14% of patients based on their response to chemotherapy."</data>
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
    </node>
    <node id="&quot;PATIENT-REPORTED RISK FACTORS FOR CINV&quot;">
      <data key="d0">"SUBJECTIVE ASSESSMENT"</data>
      <data key="d1">"Risk factors for CINV included patient-reported severity of acute nausea associated with younger age and reduced hours of sleep the night before chemotherapy. Severity of CTCAE grade of acute nausea was linked to age, sleep hours, and history of morning sickness."</data>
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
    </node>
    <node id="&quot;GENETIC RISK FACTORS&quot;">
      <data key="d0">"BIOLOGICAL FACTOR"</data>
      <data key="d1">"Variation in ABCB1 (rs1045642) was found associated with more severe acute nausea compared to other genotypes. No associations were found between genetic factors such as HTR3B (rs45460698), CYP2D6 phenotype, or activity score and acute or delayed CINV."</data>
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
    </node>
    <node id="&quot;GENOTYPING PROCESS&quot;">
      <data key="d0">"DIAGNOSTIC PROCEDURE"</data>
      <data key="d1">"The genotyping process was conducted as part of a comprehensive approach to analyze genetic data for participants."</data>
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
    </node>
    <node id="&quot;SELF-REPORT DATA&quot;">
      <data key="d0">"RESEARCH TOOL"</data>
      <data key="d1">"Complete self-report and genetic data were collected using validated questionnaires and standardized tools."</data>
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
    </node>
    <node id="&quot;DATA ANALYSIS METHOD&quot;">
      <data key="d0">"STATISTICAL METHOD"</data>
      <data key="d1">"A multivariate statistical analysis method was employed to identify significant associations between patient characteristics, clinical variables, and reported symptoms."</data>
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
    </node>
    <node id="&quot;CTCAE GRADING SYSTEM&quot;">
      <data key="d0">"CLINICAL ASSESSMENT SCALE"</data>
      <data key="d1">"The Common Terminology Criteria for Adverse Events (CTCAE) grading system was used to assess the severity of chemotherapy-induced nausea and vomiting in patients."</data>
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
    </node>
    <node id="&quot;AGE AS A RISK FACTOR&quot;">
      <data key="d0">"DEMOGRAPHIC VARIABLE"</data>
      <data key="d1">"Younger age was identified as an independent risk factor for increased acute nausea severity, based on self-report data."</data>
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
    </node>
    <node id="&quot;SLEEP HOURS AS A RISK FACTOR&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"Reduced hours of sleep the night before chemotherapy was found to be associated with more severe acute nausea symptoms."</data>
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
    </node>
    <node id="&quot;MORNING SICKNESS HISTORY AS A RISK FACTOR&quot;">
      <data key="d0">"SYMPTOM HISTORY"</data>
      <data key="d1">"A history of nausea and vomiting due to morning sickness was linked to higher severity in CTCAE grade for both acute and delayed nausea."</data>
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
    </node>
    <node id="&quot;HIGHLY EMETOGENIC CHEMOTHERAPY&quot;">
      <data key="d0">"CHEMOTHERAPEUTIC AGENT"</data>
      <data key="d1">"The use of highly emetogenic chemotherapy regimens was significantly associated with increased risk of severe delayed nausea symptoms."</data>
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
    </node>
    <node id="&quot;STAGE OF CANCER AS A RISK FACTOR&quot;">
      <data key="d0">"MEDICAL DIAGNOSIS"</data>
      <data key="d1">"Cancer stage, particularly advanced stages, correlated with more severe delayed nausea symptoms based on CTCAE grading."</data>
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
    </node>
    <node id="&quot;ABCB1 GENOTYPE AND ACUTE NAUSEA&quot;">
      <data key="d0">"GENETIC VARIANT"</data>
      <data key="d1">"Variation in the ABCB1 gene (specifically rs1045642) was found to influence acute nausea severity, with different genotypes showing varying levels of symptom intensity."</data>
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
    </node>
    <node id="&quot;HETEROZYGOTE GENOTYPE AND ACUTE NAUSEA SEVERITY&quot;">
      <data key="d0">"GENETIC VARIANT EXPRESSION"</data>
      <data key="d1">"Patients carrying the heterozygous ABCB1 genotype reported more severe acute nausea compared to those with homozygous wild-type or variant genotypes."</data>
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
    </node>
    <node id="&quot;VOMITING AS A SYMPTOM&quot;">
      <data key="d0">"MEDICAL SIGN"</data>
      <data key="d1">"No risk factors for vomiting were identified, but it was documented based on self-reports and medical monitoring in the study participants."</data>
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
    </node>
    <node id="&quot;REGRESSION ANALYSIS&quot;">
      <data key="d0">"STATISTICAL METHODOLOGY"</data>
      <data key="d1">"Multivariable regression analysis was used to quantify the effects of demographic, clinical, and patient-reported variables on acute nausea severity."</data>
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
    </node>
    <node id="&quot;VARIANCE EXPLAINED BY RISK FACTORS&quot;">
      <data key="d0">"ANALYTICAL INSIGHT"</data>
      <data key="d1">"The identified risk factors explained a certain percentage of variance in acute nausea symptoms; genetic factor added an incremental amount of explanation beyond demographic and clinical factors."</data>
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
    </node>
    <node id="&quot;GENOTYPING AND DATA COLLECTION&quot;">
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
      <data key="d1">"Genotyping was conducted as part of data collection for the study with 93 participants.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;STUDY METHODS&quot;">
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
      <data key="d1">"Genotyping was conducted as part of data collection for the study with 93 participants.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SAMPLE ANALYSIS AND DESCRIPTIVE STATISTICS&quot;">
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
      <data key="d1">"The sample's characteristics were analyzed, revealing a mean age of 60 years (SD=10).")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PATIENT CHARACTERISTICS&quot;">
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
      <data key="d1">"Patients in the study were predominantly female (55%) and had various malignancies.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;POPULATION DESCRIPTION&quot;">
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
      <data key="d1">"Patients in the study were predominantly female (55%) and had various malignancies.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HEALTH CONDITION AND TREATMENT&quot;">
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
      <data key="d1">"The study involved patients diagnosed with gastrointestinal, thoracic, or breast cancers who received highly-emetogenic chemotherapy.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MALIGNANCY TYPES AND CHEMOTHERAPY&quot;">
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
      <data key="d1">"The study involved patients diagnosed with gastrointestinal, thoracic, or breast cancers who received highly-emetogenic chemotherapy.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ANTI-EMETIC MEDICATIONS AND TREATMENT&quot;">
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
      <data key="d1">"Commonly used anti-emetics included palonosetron, dexamethasone, prochlorperazine, ondansetron, and fosaprepitant.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CINV SEVERITY AND RISK FACTORS&quot;">
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
      <data key="d1">"Risk factors for CINV such as age, sleep hours, and morning sickness were linked to the severity of nausea.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SYMPTOM ASSESSMENT AND FACTORS&quot;">
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
      <data key="d1">"Risk factors for CINV such as age, sleep hours, and morning sickness were linked to the severity of nausea.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ASSOCIATION WITH SYMPTOM&quot;">
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
      <data key="d1">"The genetic variation in ABCB1 was found to be associated with more severe acute nausea compared to other genotypes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENETIC RISK FACTOR (ABCB1 RS1045642)&quot;">
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
      <data key="d1">"The genetic variation in ABCB1 was found to be associated with more severe acute nausea compared to other genotypes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ANALYSIS RESULTS&quot;">
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
      <data key="d1">"Demographic, clinical, and patient-reported factors explained 13% of the variance in acute nausea; ABCB1 genotype contributed an additional variance (p=0.10).")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;STATISTICAL SIGNIFICANCE AND VARIANCE&quot;">
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
      <data key="d1">"Demographic, clinical, and patient-reported factors explained 13% of the variance in acute nausea; ABCB1 genotype contributed an additional variance (p=0.10).")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MCM6&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene involved in DNA replication and repair processes."&lt;SEP&gt;"MCM6 is another gene involved in the regulation of LCT."&lt;SEP&gt;"The gene MCM6 remains unchanged in expression when silencing of LOC100507600 occurs, acting as a control in this context."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c&lt;SEP&gt;chunk-ec104044b3aa65560be8d81dbb3940d6&lt;SEP&gt;chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
    </node>
    <node id="&quot;CPG SITE&quot;">
      <data key="d0">"EPIGENETIC MODIFICATION"</data>
      <data key="d1">"CpG sites are critical for epigenetic regulation and correlate with mRNA levels."&lt;SEP&gt;"Specific locations along DNA that are analyzed to understand modification patterns."</data>
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6&lt;SEP&gt;chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
    </node>
    <node id="&quot;LACTASE PERSISTENCE SNP&quot;">
      <data key="d0">"SNP"</data>
      <data key="d1">"A specific Single Nucleotide Polymorphism (SNP) in the LCT gene is linked to lactase persistence or non-persistence."</data>
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;CHROMOSOME-WIDE DNA MODIFICATION&quot;">
      <data key="d0">"EPIGENETIC PROCESS"</data>
      <data key="d1">"Across the genome, there are chromosome-wide patterns of DNA modification that play a role in gene regulation."</data>
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;AFFYMETRIX HIGH DENSITY HUMAN TILING ARRAYS&quot;">
      <data key="d0">"BIOLOGICAL TOOL"</data>
      <data key="d1">"High-density arrays used for interrogation of DNA modifications across human chromosomes."&lt;SEP&gt;"Specific high-resolution genomic microarrays used to survey DNA modifications."</data>
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;ENTEROCYTES&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"Enterocytes are specific intestinal cells that express the LCT gene."</data>
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;INTESTINAL EPITHELIAL CELLS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"These cells lining the intestine play a role in lactase expression."</data>
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;INFERIOR JEJUNUM&quot;">
      <data key="d0">"BODY PART"</data>
      <data key="d1">"The inferior part of the small intestine where enterocytes are found."</data>
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;INFANT MICE&quot;">
      <data key="d0">"MODEL ORGANISM"</data>
      <data key="d1">"Mice, especially as infants, exhibit high intestinal lactase activity followed by a gradual decrease."</data>
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;ADULT MICE&quot;">
      <data key="d0">"MODEL ORGANISM"</data>
      <data key="d1">"In contrast to infant mice, adult mice have lower intestinal lactase activity."</data>
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;POSTNATAL DAY 60&quot;">
      <data key="d0">"TIME POINT"</data>
      <data key="d1">"This refers to the age of mice at which lactase activity begins to decline."</data>
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;MOUSE CHROMOSOME 1&quot;">
      <data key="d0">"CHROMOSOME"</data>
      <data key="d1">"Mouse chromosome that contains the Lct gene, responsible for lactose digestion."</data>
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;MTAG-CLICK METHOD&quot;">
      <data key="d0">"BIOLOGICAL TOOL"</data>
      <data key="d1">"A method used to enrich unmodified DNA fractions."</data>
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;TILING MICROARRAYS&quot;">
      <data key="d0">"BIOLOGICAL TOOL"</data>
      <data key="d1">"Microarrays used for detection of differential DNA modification in different age groups."</data>
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;MOUSE TILING MICROARRAYS&quot;">
      <data key="d0">"SPECIFIC TOOL"</data>
      <data key="d1">"These are the specific arrays used to analyze the epigenetic modifications on mouse chromosomes."</data>
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;CPG SITES&quot;">
      <data key="d0">"METHYLATION SITES"</data>
      <data key="d1">"CpG sites identified where DNA modification changes were detected, impacting gene expression."&lt;SEP&gt;"We determined DNA methylation levels at certain CpG sites for comparison between CD4+ and CD8+ T cells."</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca&lt;SEP&gt;chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;CHROMOSOME 2&quot;">
      <data key="d0">"CHROMOSOME"</data>
      <data key="d1">"The human chromosome that contains the LCT gene."</data>
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;INFERIOR JEJUNUM SAMPLES&quot;">
      <data key="d0">"BODY PART SAMPLE"</data>
      <data key="d1">"Samples isolated from the inferior part of the small intestine for analysis."</data>
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;VILLI ENTEROCYTES&quot;">
      <data key="d0">"CELL TYPE SAMPLE"</data>
      <data key="d1">"Specific intestinal cells lining the villi, analyzed for DNA modification patterns."</data>
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;CPG SITE DENSITIES&quot;">
      <data key="d0">"EPIGENETIC MEASUREMENT"</data>
      <data key="d1">"Measurements of cytosine methylation levels in CpG sites across different genomic regions."</data>
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;ENTEROCYTE-DEFICIENT JEJUNUM&quot;">
      <data key="d0">"CONTROL SAMPLE"</data>
      <data key="d1">"The control group representing the jejunum without enterocytes for comparison study."</data>
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;POSTNATAL DAY 6&quot;">
      <data key="d0">"AGE POINT"</data>
      <data key="d1">"Specific age point at birth in mice where lactase activity is high."</data>
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;CHROMOSOME-WIDE ANALYSIS&quot;">
      <data key="d0">"METHOD OF ANALYSIS"</data>
      <data key="d1">"Comprehensive analysis across the entire length of a chromosome to identify correlated DNA modifications and gene expression."</data>
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;BISULFITE PADLOCK PROBE SEQUENCING&quot;">
      <data key="d0">"GENOMIC SEQUENCING METHOD"</data>
      <data key="d1">"High-resolution genomic sequencing technique used for CpG site-specific epigenetic modifications."</data>
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;CPG SITE 13910&quot;">
      <data key="d0">"SPECIFIC CPG LOCATION"</data>
      <data key="d1">"A specific CpG site of interest in the MCM6 gene linked to lactase persistence or non-persistence."</data>
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;LACTOSE DIGESTION&quot;">
      <data key="d0">"BIOLOGICAL FUNCTION"</data>
      <data key="d1">"The process by which LCT facilitates the breakdown and absorption of lactose in the small intestine."</data>
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;MCM6 INTRON 13-EXON 13&quot;">
      <data key="d0">"GENE REGION"</data>
      <data key="d1">"A specific region within MCM6 gene that influences LCT mRNA levels through epigenetic modifications."</data>
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;LACTASE PERSISTENCE AND NON-PERSISTENCE&quot;">
      <data key="d0">"PHENOTYPIC TRAIT"</data>
      <data key="d1">"The traits distinguishing individuals who can or cannot digest lactose, influenced by genetic factors."</data>
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;ENTEROCYTE&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"Cells lining the small intestine responsible for nutrient absorption."</data>
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
    </node>
    <node id="&quot;BONFERRONI CORRECTION&quot;">
      <data key="d0">"STATISTICAL METHOD"</data>
      <data key="d1">"A method used to adjust p-values in multiple hypothesis testing to control the family-wise error rate."</data>
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
    </node>
    <node id="&quot;DISTINCT REGION&quot;">
      <data key="d0">"DNA MODIFICATION ANALYSIS"</data>
      <data key="d1">"Identified areas on DNA with specific modifications after comparison between different samples."</data>
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
    </node>
    <node id="&quot;LACTASE NON-PERSISTENCE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A hypothesis that DNA modifications are erased at embryogenesis, enabling high postnatal LCT activity followed by gradual regain with age in a haplotype-specific manner."&lt;SEP&gt;"Converging evidence indicates that LCT intron 2 is an evolutionarily old regulatory element common in mice and humans for the development of lactase non-persistence."&lt;SEP&gt;"The inability of adults to digest lactose due to lack or reduced activity of LCT."</data>
      <data key="d2">chunk-ea45644d73f260cf365527dcc3af86e1&lt;SEP&gt;chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
    </node>
    <node id="&quot;LACTASE PERSISTENCE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Adults' ability to continue digesting lactose, often inherited from parents."</data>
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
    </node>
    <node id="&quot;DNASE I HYPERSENSITIVITY SITES&quot;">
      <data key="d0">"CHROMATIN REFERENCE MAPS"</data>
      <data key="d1">"Regions on chromatin that are sensitive to DNase I enzyme due to accessible or less compact structure."</data>
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
    </node>
    <node id="&quot;H3K4ME1&quot;">
      <data key="d0">"HISTONE MODIFICATION"</data>
      <data key="d1">"A specific histone mark that was found to have peaks at certain regulatory sites within the LD block of rs35923643."&lt;SEP&gt;"Post-translational modification of histones, often associated with active transcription start sites."</data>
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a&lt;SEP&gt;chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
    </node>
    <node id="&quot;H3K27AC&quot;">
      <data key="d0">"HISTONE MARK"</data>
      <data key="d1">"Another type of post-translational histone modification linked to enhancer activity and gene expression."</data>
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
    </node>
    <node id="&quot;H3K4ME3&quot;">
      <data key="d0">"HISTONE MARK"</data>
      <data key="d1">"Significant histone modification at promoter regions indicating active transcription start sites."</data>
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
    </node>
    <node id="&quot;LCT INTRONS 2 AND 3&quot;">
      <data key="d0">"DNA MODIFICATION ANALYSIS"</data>
      <data key="d1">"Differential DNA modifications observed within LCT introns that may influence gene expression."</data>
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
    </node>
    <node id="&quot;MCM6 INTRON 13 AND EXON 16/17&quot;">
      <data key="d0">"CELL TYPE SPECIFIC EXPRESSION"</data>
      <data key="d1">"Specific regions of MCM6 exhibit distinct DNA modification patterns in enterocytes compared to other tissues, affecting its activity."</data>
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
    </node>
    <node id="&quot;HAPLOTYPES C/T-13910&quot;">
      <data key="d0">"GENETIC ASSOCIATION"</data>
      <data key="d1">"A specific SNP (C/T-13910) is part of haplotypes associated with lactase non-persistence or persistence in adults."</data>
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
    </node>
    <node id="&quot;SPERM SAMPLES&quot;">
      <data key="d0">"AGE AND DEVELOPMENTAL CHANGES"</data>
      <data key="d1">"Investigation of sperm samples reveals no DNA modification differences between genotypes, suggesting age-related changes start after conception."</data>
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
    </node>
    <node id="&quot;POSTNATAL MODIFICATIONS&quot;">
      <data key="d0">"DEVELOPMENTAL REGULATION"</data>
      <data key="d1">"Modifications at MCM6 intron 13 complete most of their age-dependent regulation during the first two decades postnatally."</data>
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
    </node>
    <node id="&quot;MCM6 INTRON 13&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Changes at MCM6 intron 13 for haplotypes containing C-13910 must occur after conception."&lt;SEP&gt;"Investigation of DNA modification changes within the MCM6 and LCT regions stratified for C/T-13910 genotypes showed increased DNA modifications consistently with age in lactase non-persistent CC individuals."</data>
      <data key="d2">chunk-ea45644d73f260cf365527dcc3af86e1</data>
    </node>
    <node id="&quot;MCM6 EXON 16&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Investigation of chromatin marks using ENCODE data identified an enhancer element (H3K27ac and H3K4me1 peaks) at Lct intron 2, along with an active promoter at LCT exon 1–intron 1."&lt;SEP&gt;"Significant differences between C-13910 and T-13910 carrying haplotypes, showing more gradual DNA modification changes compared to MCM6 intron 13."</data>
      <data key="d2">chunk-ea45644d73f260cf365527dcc3af86e1</data>
    </node>
    <node id="&quot;LACTASE NON-PERSISTENCE (CC)&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"In our cohort of 21–72-year-old individuals, LCT mRNA was significantly decreasing with age in lactase non-persistent CC individuals."</data>
      <data key="d2">chunk-ea45644d73f260cf365527dcc3af86e1</data>
    </node>
    <node id="&quot;INTERMEDIATE (CT) INDIVIDUAL&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Lactase persistence showed no aging changes in intermediate CT individuals."</data>
      <data key="d2">chunk-ea45644d73f260cf365527dcc3af86e1</data>
    </node>
    <node id="&quot;LACTASE PERSISTENT (TT)&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"A non-significant increase in lactase persistent TT individuals, as shown by R2 = 0.13 and p = 0.2."</data>
      <data key="d2">chunk-ea45644d73f260cf365527dcc3af86e1</data>
    </node>
    <node id="&quot;LNCRNA LOC100507600&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"This lncRNA, transcribed from the opposite DNA strand than LCT, follows that it is a natural antisense transcript which can alter target gene expression through DNA modification."</data>
      <data key="d2">chunk-ea45644d73f260cf365527dcc3af86e1</data>
    </node>
    <node id="&quot;LACTASE MRNA&quot;">
      <data key="d0">"NATURAL ANTISENSE TRANSCRIPT"</data>
      <data key="d1">"The lncRNA LOC100507600 is a natural antisense transcript to LCT, suggesting it may influence target gene expression through DNA modification."</data>
      <data key="d2">chunk-ea45644d73f260cf365527dcc3af86e1</data>
    </node>
    <node id="&quot;CACO-2&quot;">
      <data key="d0">"CELL LINE"</data>
      <data key="d1">"Caco-2 is a human intestinal epithelial cell line."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;SNP -13910&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A single nucleotide polymorphism at position -13910 has the TT genotype in this context."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;LOC100507600&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The gene LOC100507600 expression was reduced by small-interfering RNAs directed towards it, resulting in a 20% decrease and a 25% reduction in LCT mRNA."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;CTCF&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"CTCF is an insulator protein binding site that overlaps with the lncRNA promoter and was nearly ubiquitous across human tissues based on ENCODE datasets."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;DNA METHYLATION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Increased DNA methylation can inhibit CTCF binding at insulator sites, leading to tissue-specific gene expression activation."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;LACTASE REGULATORY ELEMENTS&quot;">
      <data key="d0">"GENETIC MANIPULATION"</data>
      <data key="d1">"CRISPR-Cas9 technology was utilized to manipulate differentially modified DNA regions contributing to LCT regulation."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;INTRON 2 OF LCT&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The deletion of intron 2 in the Lct gene showed evidence of cross-species lactase gene regulation."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;CRISPR-CAS9 GENOME EDITING TECHNOLOGY&quot;">
      <data key="d0">"GENETIC MODIFICATION TOOL"</data>
      <data key="d1">"CRISPR-Cas9 technology was used for genome editing, specifically targeting intronic regions without compromising splicing sites and exons involved in Lct mRNA processing and stability."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;C57BL/6N MICE&quot;">
      <data key="d0">"EXPERIMENTAL MODEL"</data>
      <data key="d1">"Genetic manipulation studies were conducted on C57BL/6N mice."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;LACTASE (LCT)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The LCT gene plays a role in lactose metabolism, as it encodes for the lactase enzyme."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;MCM6 INTRONIC DELETION&quot;">
      <data key="d0">"GENETIC MANIPULATION RESULT"</data>
      <data key="d1">"A deletion of Mcm6 intron 13 yielded less pronounced reductions in Lct mRNA levels compared to other deletions."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;ADULT AND INFANT MICE&quot;">
      <data key="d0">"BIOLOGICAL MODEL"</data>
      <data key="d1">"Studies were conducted on both adult and infant mice, with differing outcomes for the LCT mRNA level reductions related to specific deletions."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;CRISPR-CAS9 INDUCED DELETIONS&quot;">
      <data key="d0">"GENETIC MODIFICATION"</data>
      <data key="d1">"CRISPR-Cas9n-induced deletions in regulatory elements of MCM6 intron 13 or LCT intron 2 were performed, with notable effects observed when the cells reached a differentiated state."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;LCT MRNA LEVELS&quot;">
      <data key="d0">"QUANTITATIVE MEASURE"</data>
      <data key="d1">"The deletion in Lct Introns significantly affected LCT mRNA levels during adult and infant mouse studies, with a greater reduction noted in adults compared to infants for intron 2."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;MCM6 INTRONS&quot;">
      <data key="d0">"GENE INTRANUCLEAR COMPONENTS"</data>
      <data key="d1">"Deletions within MCM6 introns were investigated for their effect on LCT mRNA levels across different experimental models, such as adult and infant mice."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;CACO-2 CELLS - UNDIFFERENTIATED STATE&quot;">
      <data key="d0">"CELLULAR CONDITION PRIOR TO CONFLUENCE"</data>
      <data key="d1">"Cultured human intestinal epithelial cells were examined prior to confluence (undifferentiated state) as a control for further analysis of LCT expression under differentiation conditions."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;ADULT VS INFANT MOUSE STUDIES&quot;">
      <data key="d0">"AGE-RELATED EFFECTS ON LCT EXPRESSION"</data>
      <data key="d1">"Studies conducted with adult versus infant mice demonstrated age-specific differences in how certain deletions affect LCT mRNA levels and expression patterns in their intestinal tissues."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;EPIGENETIC REGULATION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Epigenetic regulation involves interactions between proteins and DNA modifying enzymes, impacting gene expression."&lt;SEP&gt;"The study of epigenetic regulation was pivotal in understanding how certain genomic regions can influence the expression levels of the lactase gene (LCT) under various experimental conditions."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c&lt;SEP&gt;chunk-41c7131af28e2a745ef6b88b8601860f</data>
    </node>
    <node id="&quot;CANCER-LIKE STATE VS DIFFERENTIATED CELLS&quot;">
      <data key="d0">"CELLULAR STATES AND EXPRESSION ANALYSIS"</data>
      <data key="d1">"Examination of LCT expression under different cellular states, including cancer-like conditions prior to confluence and fully differentiated intestinal epithelial cells post-confluence, provided insights into the effects of specific genomic manipulations."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;QUANTITATIVE DATA ANALYSIS&quot;">
      <data key="d0">"COMPARATIVE EXPRESSION STUDIES"</data>
      <data key="d1">"Detailed quantitative data analyses were performed to compare and contrast the effects of different deletions on LCT mRNA expression across various conditions, including age groups (adults vs infants) and experimental models."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;AGE-SPECIFIC DIFFERENCES IN GENOMIC RESPONSE&quot;">
      <data key="d0">"LCT GENE EXPRESSION ANALYSIS ACROSS AGES"</data>
      <data key="d1">"Analysis of genomic responses to specific modifications or deletions revealed age-specific differences in LCT gene expression patterns, highlighting developmental influences and potential health impacts associated with these variations."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;DNA MODIFICATION&quot;">
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
      <data key="d1">"Increased DNA modification at specific CpG sites in the LCT gene correlates with decreased mRNA levels.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MCM6 INTRONS AND EXON 16&quot;">
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
      <data key="d1">"CpGs clusters around specific regions of MCM6 suggest epigenetic control influencing LCT expression.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LACTASE PERSISTENCE SNP C/T-13910&quot;">
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
      <data key="d1">"A particular SNP in the MCM6 gene is correlated with lactase persistence or non-persistence via epigenetic mechanisms.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SNP-LCT RELATIONSHIP&quot;">
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
      <data key="d1">"A particular SNP in the MCM6 gene is correlated with lactase persistence or non-persistence via epigenetic mechanisms.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CELL TYPE SPECIFIC EXPRESSION&quot;">
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
      <data key="d1">"Variation in DNA modifications between enterocytes and enterocyte-deficient jejunum highlights regulation specific to cell types.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;REGULATION BY CELL TYPE&quot;">
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
      <data key="d1">"Variation in DNA modifications between enterocytes and enterocyte-deficient jejunum highlights regulation specific to cell types.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;AGE GROUP COMPARISON - MOUSE LCT&quot;">
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
      <data key="d1">"Age-specific differential DNA modifications detected on the mouse chromosome containing the Lct gene indicate age-related changes in lactase expression.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;AGE-DEPENDENT CHANGES&quot;">
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
      <data key="d1">"Age-specific differential DNA modifications detected on the mouse chromosome containing the Lct gene indicate age-related changes in lactase expression.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENOMIC VARIATION IMPACT&quot;">
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
      <data key="d1">"CpG sites identified as having varying DNA modifications across individuals and cell types, affecting LCT expression.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INTER-INDIVIDUAL AND CELL-TYPE SPECIFIC SITES&quot;">
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
      <data key="d1">"CpG sites identified as having varying DNA modifications across individuals and cell types, affecting LCT expression.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DNA MODIFICATION PROFILE&quot;">
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d1">"Using Bonferroni correction when analyzing multiple CpG sites to prevent false positives in identifying significant differences.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MCM6 INTRONS AND EXON 16/17&quot;">
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d1">"DNA modifications in specific regions of MCM6, such as introns and exon 16/17, may impact its role in transcriptional regulation.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;REGULATORY FUNCTION&quot;">
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d1">"DNA modifications in specific regions of MCM6, such as introns and exon 16/17, may impact its role in transcriptional regulation.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CHROMATIN REFERENCE MAPS&quot;">
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d1">"The maps showing DNase sensitivity sites overlap with regions of interest for LCT gene modifications, suggesting active regulatory elements.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ENHANCER ACTIVITY&quot;">
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d1">"Histone marks indicating activity at the enhancer region contribute to cell-type-specific regulation of genes like LCT and MCM6.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;H3K4ME1 AND H3K27AC&quot;">
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d1">"Histone marks indicating activity at the enhancer region contribute to cell-type-specific regulation of genes like LCT and MCM6.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ACTIVE PROMOTER&quot;">
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d1">"The promoter region of gene encoding for LCT shows high H3K4me3 levels indicating the potential for transcription initiation.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LCT EXON 1&quot;">
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d1">"The promoter region of gene encoding for LCT shows high H3K4me3 levels indicating the potential for transcription initiation.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;AGE-DEPENDENT REGULATION&quot;">
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d1">"Different genetic backgrounds exhibit divergent DNA modifications that change over age, influencing LCT expression in enterocytes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;C/T-13910 SNP&quot;">
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d1">"Specific SNP C/T-13910 is associated with significant changes in DNA modification at MCM6 locus during postnatal development.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DNA MODIFICATION CHANGES&quot;">
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d1">"Specific SNP C/T-13910 is associated with significant changes in DNA modification at MCM6 locus during postnatal development.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;AGE-RELATED EPIGENETIC MODIFICATIONS&quot;">
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d1">"During embryonic development, LCT activity might be high due to absence of postnatal modifications; they gradually regain with age.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;EMBRYOGENESIS AND POSTNATAL ACTIVITY&quot;">
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d1">"During embryonic development, LCT activity might be high due to absence of postnatal modifications; they gradually regain with age.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DNA ACCESSIBILITY&quot;">
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d1">"DNase I hypersensitivity sites on chromatin indicate regions that are more accessible, suggesting active regulatory processes in LCT and MCM6 genes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DNASE I ENZYME&quot;">
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d1">"DNase I hypersensitivity sites on chromatin indicate regions that are more accessible, suggesting active regulatory processes in LCT and MCM6 genes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HISTONE MODIFICATION H3K27AC&quot;">
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d1">"The presence of histone mark H3K27ac at certain DNA regions suggests their involvement as enhancers for gene expression, particularly in LCT and MCM6 genes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENE EXPRESSION REGULATION&quot;">
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d1">"H3K4me1 and H3K4me3 are post-translational modifications that play crucial roles in regulating gene expression, affecting transcriptional start sites in LCT and MCM6.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;POST-TRANSLATIONAL HISTONE MODIFICATION&quot;">
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d1">"H3K4me1 and H3K4me3 are post-translational modifications that play crucial roles in regulating gene expression, affecting transcriptional start sites in LCT and MCM6.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;AGE-DEPENDENT EPIGENETIC CHANGES&quot;">
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d1">"Epigenetic modifications occurring from conception onwards gradually influence the age-dependent regulation of lactase activity in adults.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LACTASE ACTIVITY&quot;">
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d1">"Epigenetic modifications occurring from conception onwards gradually influence the age-dependent regulation of lactase activity in adults.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENETIC ASSOCIATION&quot;">
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d1">"High D' value indicates strong correlation between certain SNPs, suggesting they are often inherited together and affect lactase gene expression or persistence.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PAIRWISE LINKAGE DISEQUILIBRIUM&quot;">
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d1">"High D' value indicates strong correlation between certain SNPs, suggesting they are often inherited together and affect lactase gene expression or persistence.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DNA MODIFICATIONS&quot;">
      <data key="d2">chunk-ea45644d73f260cf365527dcc3af86e1</data>
      <data key="d1">"The situation with MCM6 exon 16 shows significant differences between C-13910 and T-13910 carrying haplotypes, likely similar to the situation of MCM6 intron 13 in that DNA modifications are erased at embryogenesis.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LCT MRNA&quot;">
      <data key="d2">chunk-ea45644d73f260cf365527dcc3af86e1</data>
      <data key="d1">"In lactase non-persistent CC individuals, LCT mRNA was significantly decreasing with age, whereas there were no aging changes in intermediate CT individuals and a non-significant increase in lactase persistent TT individuals.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MAMMALIAN SEQUENCE CONSERVATION&quot;">
      <data key="d2">chunk-ea45644d73f260cf365527dcc3af86e1</data>
      <data key="d1">"The large degree of mammalian sequence conservation found in the LCT intron 2 region was not found in any other intron of LCT or MCM6, suggesting that LCT intron 2 is an evolutionarily old regulatory element.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;AGE-DEPENDENT DOWNREGULATION&quot;">
      <data key="d2">chunk-ea45644d73f260cf365527dcc3af86e1</data>
      <data key="d1">"Our findings support the concept of age-related processes contributing to lactase regulation across species, as evidenced by evolutionary conservation of epigenetic factors and large degree of mammalian sequence conservation.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;EVOLUTIONARY CONSERVATION&quot;">
      <data key="d2">chunk-ea45644d73f260cf365527dcc3af86e1</data>
      <data key="d1">"Our findings support the concept of age-related processes contributing to lactase regulation across species, as evidenced by evolutionary conservation of epigenetic factors and large degree of mammalian sequence conservation.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DEVELOPMENTAL PROCESSES&quot;">
      <data key="d2">chunk-ea45644d73f260cf365527dcc3af86e1</data>
      <data key="d1">"Mammalian intronic conserved elements found near the LCT intron 2 region suggest its involvement in development, possibly alongside other regulatory processes such as age-related changes and evolutionary conservation.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LACTASE REGULATION&quot;">
      <data key="d2">chunk-ea45644d73f260cf365527dcc3af86e1</data>
      <data key="d1">"Mammalian intronic conserved elements found near the LCT intron 2 region suggest its involvement in development, possibly alongside other regulatory processes such as age-related changes and evolutionary conservation.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENOMIC VARIANT -13910&quot;">
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
      <data key="d1">"The TT genotype at SNP -13910 impacts LCT mRNA levels, which is relevant for lactase persistence.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LCT EXPRESSION&quot;">
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
      <data key="d1">"The TT genotype at SNP -13910 impacts LCT mRNA levels, which is relevant for lactase persistence.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LCT MRNA REDUCTION&quot;">
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
      <data key="d1">"Silencing of LOC100507600 leads to a 20% reduction in expression and concomitant 25% decrease in LCT mRNA, demonstrating regulation.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LOC100507600 SILENCING&quot;">
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
      <data key="d1">"Silencing of LOC100507600 leads to a 20% reduction in expression and concomitant 25% decrease in LCT mRNA, demonstrating regulation.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CTCF BINDING INHIBITION&quot;">
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
      <data key="d1">"Increased DNA methylation inhibits CTCF binding at insulator sites, affecting tissue-specific gene expression.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DNA METHYLATION INCREASE&quot;">
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
      <data key="d1">"Increased DNA methylation inhibits CTCF binding at insulator sites, affecting tissue-specific gene expression.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CRISPR-CAS9 GENOME EDITING&quot;">
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
      <data key="d1">"CRISPR-Cas9 technology was utilized to manipulate lactase regulatory elements in genes like Lct and Mcm6 for understanding their role in regulation.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LACTASE REGULATORY ELEMENT MANIPULATION&quot;">
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
      <data key="d1">"CRISPR-Cas9 technology was utilized to manipulate lactase regulatory elements in genes like Lct and Mcm6 for understanding their role in regulation.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INTRON 2 DELETION OF LCT&quot;">
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
      <data key="d1">"Deletion of intron 2 in the LCT gene resulted in a widespread downregulation of LCT mRNA throughout the duodenum and jejunum.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LCT MRNA WIDESPREAD DOWNREGULATION&quot;">
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
      <data key="d1">"Deletion of intron 2 in the LCT gene resulted in a widespread downregulation of LCT mRNA throughout the duodenum and jejunum.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CRISPR-CAS9N-INDUCED DELETIONS&quot;">
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
      <data key="d1">"Deletions using CRISPR-Cas9 technology showed varying impacts on LCT mRNA expression across different stages and models, including effects in adult and infant mice.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DIFFERENTIAL EFFECTS ON LCT EXPRESSION&quot;">
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
      <data key="d1">"Deletions using CRISPR-Cas9 technology showed varying impacts on LCT mRNA expression across different stages and models, including effects in adult and infant mice.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;EPIGENETIC REGULATION SITES&quot;">
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
      <data key="d1">"The epigenetically-regulated regions in the MCM6 intron 13 or LCT intron 2 were found to impact human LCT expression in cultured cells, particularly after differentiation into an epithelial-like state.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LCT EXPRESSION IMPACT&quot;">
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
      <data key="d1">"The epigenetically-regulated regions in the MCM6 intron 13 or LCT intron 2 were found to impact human LCT expression in cultured cells, particularly after differentiation into an epithelial-like state.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CONTROLS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The study controlled the minor allele frequencies of rs4988235 within the population."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;T (PERSISTENCE) ALLELE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The 'T' (persistence) allele at rs4988235 is associated with lactase persistence."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;C ALLELE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The 'C' allele was found in the UK populations."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;ROMANIA&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">" Romania showed nominal evidence for departure of genotype frequencies from Hardy-Weinberg equilibrium."&lt;SEP&gt;"In Romania, there was nominal evidence for departure from Hardy-Weinberg equilibrium among rs4988235 genotypes."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;MILK DRINKING PROFILES&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"The milk drinking patterns differed between different rs4988235 genotype groups."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;OR 2.39 [1.81, 3.15], P=6.9*10−10&quot;">
      <data key="d0">"STATISTICAL MEASURE"</data>
      <data key="d1">"Genotype was associated with milk drinking in the controls group."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;LACTASE NON-PERSISTENT CC GENOTYPE AT RS4988235&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A higher proportion of individuals with lactase non-persistent CC genotype reported never consuming milk."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;CZECH REPUBLIC&quot;">
      <data key="d0">"COUNTRY SPECIFIC DATA"</data>
      <data key="d1">"In the Czech Republic, both milk consumption and educational attainment showed associations with other factors (smoking)."&lt;SEP&gt;"The Czech Republic showed distinct patterns in the frequency and distribution of the 'T' (persistence) and 'C' alleles."&lt;SEP&gt;"The frequency of the lactase persistence driving allele was highest in the Czech Republic."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;RISK OF RCC (RENAL CELL CARCINOMA)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Milk consumption was associated with increased risk of RCC in the Czech Republic."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;OR=1.68, 95% CI 1.13, 2.49 P=0.01&quot;">
      <data key="d0">"STATISTICAL MEASURE"</data>
      <data key="d1">"A strong relationship between milk consumption and cancer risk was observed in the Czech Republic."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;EDUCATIONAL ATTAINMENT&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Education level correlated with milk consumption patterns in all countries studied."&lt;SEP&gt;"Educational attainment showed association with milk consumption."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;MILK CONSUMPTION&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Differences were observed in milk consumption patterns related to different lactase genotypes."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;RS4988235 GENOTYPE&quot;">
      <data key="d0">"GENETIC FACTOR"</data>
      <data key="d1">"Analysis of rs4988235 genotype did not show substantial differences in RCC risk compared to milk consumption."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;GENOTYPE ASSOCIATION WITH EDUCATION&quot;">
      <data key="d0">"ASSOCIATION STUDY"</data>
      <data key="d1">"There was nominal evidence for association of rs4988235 genotype with education."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;POLAND&quot;">
      <data key="d0">"COUNTRY SPECIFIC DATA"</data>
      <data key="d1">"Minor allele frequencies for rs4988235 showed diversity across different Polish populations."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;RUSSIA&quot;">
      <data key="d0">"COUNTRY SPECIFIC DATA"</data>
      <data key="d1">"In Russia, minor allele frequencies of rs4988235 were observed to be intermediate between other Eastern European populations."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;RISK OF RCC&quot;">
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
      <data key="d1">"Increased milk consumption was linked to an elevated risk of RCC in the Czech Republic.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;COUNTRY SPECIFIC DATA&quot;">
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
      <data key="d1">"Results for country-specific data showed varied associations, with no systematic pattern observed.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DIFFERENCES BETWEEN MILK CONSUMPTION AND CANCER RISK&quot;">
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
      <data key="d1">"Results for country-specific data showed varied associations, with no systematic pattern observed.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;COUNTRY SPECIFIC MAF ESTIMATES&quot;">
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
      <data key="d1">"Different country-specific minor allele frequency (MAF) estimates reflected intermediate frequencies as expected in Eastern European populations.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FREQUENCY OF GENOTYPES&quot;">
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
      <data key="d1">"Different country-specific minor allele frequency (MAF) estimates reflected intermediate frequencies as expected in Eastern European populations.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HU TREATMENT&quot;">
      <data key="d0">"TREATMENT"</data>
      <data key="d1">"HU treatment was administered to 111 patients, resulting in statistically significant improvements in several hematological parameters."</data>
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
    </node>
    <node id="&quot;HMIP-2 SNP&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The HMIP-2 SNP is associated with MTD HbF in our observations."</data>
      <data key="d2">chunk-3ae06e9a3330573da28ca0a76aa685ce</data>
    </node>
    <node id="&quot;C-A HAPLOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The C-A haplotype of HMIP-2 is related to MTD HbF."</data>
      <data key="d2">chunk-3ae06e9a3330573da28ca0a76aa685ce</data>
    </node>
    <node id="&quot;HMIP-2 HAPLOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Various HMIP-2 haplotypes are being analyzed in relation to HbF levels."</data>
      <data key="d2">chunk-3ae06e9a3330573da28ca0a76aa685ce</data>
    </node>
    <node id="&quot;BASELINE HBF&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Baseline Hemoglobin F levels are a physiological state that was considered when analyzing HMIP-2 haplotype associations."</data>
      <data key="d2">chunk-3ae06e9a3330573da28ca0a76aa685ce</data>
    </node>
    <node id="&quot;DELTA HBF&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Change in Hemoglobin F level over time is a physiological process related to the study of HMIP-2 variants and haplotypes."</data>
      <data key="d2">chunk-3ae06e9a3330573da28ca0a76aa685ce</data>
    </node>
    <node id="&quot;MTD HBF&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Mean Total Direct Hemoglobin F is a physiological measurement that's relevant to the study of HMIP-2 genetic factors."</data>
      <data key="d2">chunk-3ae06e9a3330573da28ca0a76aa685ce</data>
    </node>
    <node id="&quot;IMPROVEMENTS&quot;">
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
      <data key="d1">"HU exposure led to statistically significant improvements in multiple hematological parameters among the patients.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;STATISTICAL SIGNIFICANCE&quot;">
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf&lt;SEP&gt;chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d1">"HU exposure led to statistically significant improvements in multiple hematological parameters among the patients.")&lt;SEP&gt;"Statistically significantly differentially expressed probes and genes identified in the study."</data>
      <data key="d0">"STATISTICAL MEASURE"</data>
    </node>
    <node id="&quot;COMPARISON&quot;">
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
      <data key="d1">"The correlation of baseline HbF with MTD HbF indicates that patients with higher baseline HbF tended to have higher values of MTD HbF.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DECREASE INCREASE&quot;">
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
      <data key="d1">"A decrease in baseline HbF values correlated with an increase in delta HbF, indicating a potentially compensatory mechanism.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ALLELE FREQUENCY&quot;">
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf&lt;SEP&gt;chunk-814fe155e9cb953da61f6a79d1d25784</data>
      <data key="d1">"Due to its extremely low frequency, this specific SNP could not be included in further analysis within the cohort.")&lt;SEP&gt;"The proportion of individuals carrying each allele at a given locus in a population, which was analyzed in studies on BDNF and migraine."</data>
      <data key="d0">"GENETIC DATA"</data>
    </node>
    <node id="&quot;EXCLUSION&quot;">
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
      <data key="d1">"Due to its extremely low frequency, this specific SNP could not be included in further analysis within the cohort.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CONSISTENCY&quot;">
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
      <data key="d1">"These SNPs demonstrated adherence to HWE principles, thus facilitating their inclusion in subsequent regression analysis.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;EQUILIBRIUM TEST&quot;">
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
      <data key="d1">"These SNPs demonstrated adherence to HWE principles, thus facilitating their inclusion in subsequent regression analysis.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HEMATOLOGICAL PARAMETERS&quot;">
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
      <data key="d1">"SNP analysis through regression highlighted correlations with several hematological values before and after hydroxyurea treatment.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HEMOGLOBIN PARAMETERS&quot;">
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
      <data key="d1">"These specific variants of the BCL11A gene correlated positively with elevated levels of both baseline hemoglobin (Hb) and maximum tolerated dose hemoglobin (MTD Hb).")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INCREASED LEVEL&quot;">
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
      <data key="d1">"These specific variants of the BCL11A gene correlated positively with elevated levels of both baseline hemoglobin (Hb) and maximum tolerated dose hemoglobin (MTD Hb).")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CHANGE MEASURE&quot;">
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
      <data key="d1">"The association of these BCL11A SNPs included changes in hemoglobin levels following hydroxyurea exposure.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CHROMOSOMAL LOCATION&quot;">
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
      <data key="d1">"This strong linkage suggests that HMIP-2 SNPs are closely linked and likely inherited together, affecting shared genetic functions related to hemoglobin levels.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PROXIMITY&quot;">
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
      <data key="d1">"This strong linkage suggests that HMIP-2 SNPs are closely linked and likely inherited together, affecting shared genetic functions related to hemoglobin levels.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MONITORING&quot;">
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
      <data key="d1">"Regular assessment of ANC provided insights into the effects of HU treatment on the immune system's granulocyte component.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PARAMETER EVALUATION&quot;">
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
      <data key="d1">"Regular assessment of ANC provided insights into the effects of HU treatment on the immune system's granulocyte component.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENE-SPECIFIC ANALYSIS&quot;">
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
      <data key="d1">"This comprehensive genetic association testing aimed to identify specific genetic markers influencing hematological responses.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MULTIPLE TESTING&quot;">
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
      <data key="d1">"This comprehensive genetic association testing aimed to identify specific genetic markers influencing hematological responses.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ANCESTRAL ORIGIN&quot;">
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
      <data key="d1">"Strong LD suggests these genetic variants share a recent evolutionary history, highlighting their significance in hematological traits.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENETIC CONFIGURATION&quot;">
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
      <data key="d1">"Strong LD suggests these genetic variants share a recent evolutionary history, highlighting their significance in hematological traits.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ENHANCED/REDUCED EFFECT&quot;">
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
      <data key="d1">"Haplotype analysis allowed for the identification of specific genetic combinations that significantly influence hemoglobin levels in response to hydroxyurea treatment.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HMIP-2 SNP/HAPLOTYPE&quot;">
      <data key="d2">chunk-3ae06e9a3330573da28ca0a76aa685ce</data>
      <data key="d1">"The significance of HMIP-2 SNP or haplotype association with MTD HbF dropped upon considering baseline HbF levels.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HMIP-2 HAPLOTYPE/SNP&quot;">
      <data key="d2">chunk-3ae06e9a3330573da28ca0a76aa685ce</data>
      <data key="d1">"No link was found between specific HMIP-2 haplotypes or SNPs and Delta HbF based on our analysis.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FA&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Fanconi anemia is a genetic disorder characterized by increased sensitivity to certain chemicals, including diethylnitrosourea (DEN) and mitomycin C (MMC), which cause DNA damage and result in chromosomal breakage."</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;WILD TYPE UBE2T&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The expression of wild type UBE2T may be due to recombination of the maternally derived allele."</data>
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
      <data key="d3">[{"level": 0, "cluster": 6}]</data>
    </node>
    <node id="&quot;RA2627 FIBROBLASTS&quot;">
      <data key="d0">"CELLULAR SAMPLE"</data>
      <data key="d1">"RA2627 fibroblasts were used to study the effects of UBE2T deficiency on cellular defects related to Fanconi anemia."</data>
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
    </node>
    <node id="&quot;FA PHENOTYPES&quot;">
      <data key="d0">"BIOLOGICAL PHENOMENON"/"DISEASE"/"CONDITION"</data>
      <data key="d1">"RA2627 cellular defects were characterized by hypersensitivity to various crosslinking agents, which were associated with Fanconi anemia."</data>
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
    </node>
    <node id="&quot;FANCD2 AND FANCI&quot;">
      <data key="d0">"PROTEIN"/"MOLECULE"</data>
      <data key="d1">"These proteins were involved in the monoubiquitination process, which was restored by UBE2T overexpression."</data>
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
    </node>
    <node id="&quot;FANCD2 FOCI&quot;">
      <data key="d0">"BIOLOGICAL STRUCTURE"/"MOLECULAR COMPLEX"&lt;|"THE FORMATION OF FANCD2 FOCI WAS INFLUENCED BY UBE2T EXPRESSION, INDICATING ITS ROLE IN THE DNA DAMAGE REPAIR PATHWAY WHEN ASSOCIATED WITH FANCONI ANEMIA.")</data>
      <data key="d1">6</data>
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
      <data key="d3">[{"level": 0, "cluster": 6}]</data>
    </node>
    <node id="&quot;CELLULAR HYPERSENSITIVITY&quot;">
      <data key="d0">"PHYSIOLOGICAL STATE"/"CONDITION"</data>
      <data key="d1">"The increased sensitivity of RA2627 cells to crosslinking agents was a manifestation of FA phenotype."</data>
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
    </node>
    <node id="&quot;RESCUE&quot;">
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
      <data key="d1">"The overexpression of wild type UBE2T in RA2627 fibroblasts rescued the cellular hypersensitivity to crosslinking agents like MMC, DEB and cisplatin.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 6}]</data>
    </node>
    <node id="&quot;CELL CYCLE&quot;">
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
      <data key="d1">"UBE2T expression restored cell cycle distribution in G2 phase after treatment with MMC.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 6}]</data>
    </node>
    <node id="&quot;MONOUBIQUITINATION OF PROTEINS&quot;">
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
      <data key="d1">"The overexpression of wild type UBE2T restored monoubiquitination of FANCD2 and FANCI proteins following treatment with MMC.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 6}]</data>
    </node>
    <node id="&quot;CROSSLINKING AGENTS&quot;">
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
      <data key="d1">"The overexpression of wild type UBE2T restored sensitivity of RA2627 cells to crosslinking agents following treatment.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 6}]</data>
    </node>
    <node id="&quot;FANCONI ANEMIA&quot;">
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
      <data key="d1">"The overexpression of wild type UBE2T in RA2627 cells was able to rescue or 'rescue' FA phenotypes due to its deficiency.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 6}]</data>
    </node>
    <node id="&quot;MONOUBIQUITINATION OF FANCD2 AND FANCI&quot;">
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
      <data key="d1">"The expression of wild type UBE2T facilitated the restoration of the monoubiquitination activity on these proteins after treatment with MMC.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 6}]</data>
    </node>
    <node id="&quot;CELLULAR SENSITIVITY&quot;">
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
      <data key="d1">"The overexpression of wild type UBE2T improved or 'rescued' the cellular hypersensitivity characteristic of Fanconi anemia cells.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 6}]</data>
    </node>
    <node id="&quot;DBA&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Results from whole genome expression profiling study using Affymetrix GeneChip Human Genome U133A 2.0 Arrays on dermal fibroblasts isolated from four DBA patients carrying mutations in RPS19."&lt;SEP&gt;"The condition being studied, with differential gene expression patterns identified via both qRT-PCR and microarray analysis."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94&lt;SEP&gt;chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;RPS19&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Defects associated with whole genome expression profiling study in DBA patients."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;AFFYMETRIX GENECHIP HUMAN GENOME U133A 2.0 ARRAYS&quot;">
      <data key="d0">"MICROARRAY"</data>
      <data key="d1">"Used for the whole genome expression profiling study on DBA patients' dermal fibroblasts."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;DERMAL FIBROBLASTS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"Cells isolated from DBA patients used for gene expression analysis."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;PROBE&quot;">
      <data key="d0">"MICROARRAY PROBES"</data>
      <data key="d1">"13,396 'Present' detection calls with intensity values more than 100 used for data analysis from Affymetrix GeneChip Human Genome U133A 2.0 Arrays."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;QRT-PCR&quot;">
      <data key="d0">"QUANTITATIVE RT-PCR"</data>
      <data key="d1">"A quantitative real-time reverse transcriptase-polymerase chain reaction technique for validating microarray data results."&lt;SEP&gt;"Method used for confirmation of reduced RPS19 levels in patients carrying the frameshift mutation c.58delG."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94&lt;SEP&gt;chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;MUTATION ANALYSIS&quot;">
      <data key="d0">"GENOMIC VARIANT OR MOLECULAR INTERACTION"</data>
      <data key="d1">"Analysis performed on samples from DBA patients carrying various mutations in RPS19, including missense (p.Arg62Trp and p.Arg101His), frameshift mutation (c.58delG), and splice site mutation (c.1-1G&gt;A)."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;AMINOACYL-TRNA BIOSYNTHESIS&quot;">
      <data key="d0">"METABOLIC PATHWAY OR BIOLOGICAL PROCESS"</data>
      <data key="d1">"Pathway identified as being enriched with genes in the differential expression dataset."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;GLYCINE, SERINE AND THREONINE METABOLISM&quot;">
      <data key="d0">"METABOLIC PATHWAY OR BIOLOGICAL PROCESS"</data>
      <data key="d1">"Another pathway significantly associated with DBA patients through gene enrichment analysis."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;DEATH RECEPTOR SIGNALING&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Pathway identified in the context of impaired biological processes detected in DBA patients."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;PKR ACTIVITY&quot;">
      <data key="d0">"BIOLOGICAL PROCESS"</data>
      <data key="d1">"Role in interferon induction and antiviral response found to be involved through analysis of molecular functions of annotated genes."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;RAR ACTIVATION&quot;">
      <data key="d0">"MOLECULAR FUNCTION OR BIOLOGICAL PROCESS"</data>
      <data key="d1">"Category identified through pathway enrichment analysis related to biological function in DBA patients."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;PROTEIN SYNTHESIS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Enrichment cluster of gene clusters with roles in protein synthesis, including a large cluster of RP genes."&lt;SEP&gt;"Protein synthesis is a fundamental physiological process for creating proteins necessary for cell function and growth."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94&lt;SEP&gt;chunk-41c7131af28e2a745ef6b88b8601860f</data>
    </node>
    <node id="&quot;CELL DEATH&quot;">
      <data key="d0">"BIOLOGICAL PROCESS"</data>
      <data key="d1">"A process involving cell death is one of the biological functions mentioned."&lt;SEP&gt;"Role identified through molecular function analysis of annotated genes related to cellular development and biological pathways involving cell death."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94&lt;SEP&gt;chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;LIPID METABOLISM&quot;">
      <data key="d0">"BIOLOGICAL PROCESS OR METABOLIC PATHWAY"</data>
      <data key="d1">"Enrichment cluster found in the context of molecular functions and biological processes associated with DBA patients."&lt;SEP&gt;"Lipid metabolism is a biological pathway within the 'Top Bio Functions' category."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94&lt;SEP&gt;chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;MOLECULAR TRANSPORT&quot;">
      <data key="d0">"BIOLOGICAL PROCESS OR MOLECULAR FUNCTION"</data>
      <data key="d1">"Cluster identified as part of enriched gene functions related to transport mechanisms in DBA patients."&lt;SEP&gt;"Molecular transport activities are part of the functions described."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94&lt;SEP&gt;chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;TOP BIO FUNCTIONS&quot;">
      <data key="d0">"BIOLOGICAL PATHWAY OR PROCESS"</data>
      <data key="d1">"Category identified through pathway enrichment analysis, encompassing multiple biological functions involved in DBA pathogenesis."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;FUNCTIONAL GENOMICS&quot;">
      <data key="d0">"RESEARCH APPROACH OR FIELD"</data>
      <data key="d1">"The study employs functional genomics to understand the molecular basis of disease states like DBA, focusing on RPS19 mutations and their impact."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;RNA SEQUENCING&quot;">
      <data key="d0">"HIGH-THROUGHPUT SEQUENCING TECHNOLOGY"</data>
      <data key="d1">"Method used for transcriptome profiling which provides comprehensive information about gene expression in DBA patients."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;ENRICHMENT ANALYSIS&quot;">
      <data key="d0">"STATISTICAL METHOD OR DATA INTERPRETATION TOOL"</data>
      <data key="d1">"Analytical tool applied to identify significantly overrepresented biological pathways, functions, and molecular interactions from the dataset of differentially expressed genes."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;PATHWAY ENRICHMENT&quot;">
      <data key="d0">"BIOLOGICAL PROCESS IDENTIFICATION"</data>
      <data key="d1">"Process identifying pathways that are significantly enriched with a large number of genes differentially expressed in DBA patients compared to controls."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;RP GENES CLUSTER&quot;">
      <data key="d0">"GROUP OR CATEGORY OF GENES"</data>
      <data key="d1">"Cluster of RiboSomes (RP) related genes identified as having significant roles in protein synthesis, potentially affected by mutations in RPS19."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;CELLULAR DEVELOPMENT&quot;">
      <data key="d0">"BIOLOGICAL PROCESS OR PATHWAY"</data>
      <data key="d1">"Development processes are part of the 'Top Bio Functions' category."&lt;SEP&gt;"Function associated with cell division, growth, and differentiation that might be disrupted in DBA patients according to the study findings."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94&lt;SEP&gt;chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;IMPAIRED BIOLOGICAL PROCESSES&quot;">
      <data key="d0">"PATHWAYS OR FUNCTIONS AFFECTED"</data>
      <data key="d1">"Specific biological processes or pathways found to be impaired due to gene expression alterations in DBA patients as identified through pathway analysis."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;RPL22&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A cluster of genes, including RPL22, involved in synthesis related to RP genes."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;RPL27A&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Another gene within the same cluster as RPL22 and other RP genes."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;RPL29&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Included in a cluster of RP genes with roles in synthesis processes."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;RPL31&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A member of an RP gene cluster, part of the synthesis process."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;RPL14&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Clustered with other RP genes, contributing to synthesis and cellular functions."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;RPL18A&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Included in a group of RP genes known for their roles in synthesis processes."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;RPS3&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Part of a cluster of RP genes with involvement in synthesis related activities."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;RPL18&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Clustered with other RP genes involved in cellular development and lipid metabolism."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;RPL13&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene included in clusters related to molecular functions and metabolic processes."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;RPL3&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Part of an RP gene cluster, associated with roles including synthesis and transport processes."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;RPL34&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Included within a group of RP genes with potential involvement in synthesis-related biological pathways."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;RPS2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Clustered with other RP genes that play roles in cellular development, lipid metabolism and molecular transport."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;RPL15&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A member of a group of RP genes known for their functions related to synthesis processes."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;RPL28&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Included within clusters associated with RP genes that are involved in synthesis and cellular metabolism."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;CANCER&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Identified as one of the diseases and disorders in the 'Top Bio Functions' category."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;HAEMATOLOGICAL DISORDER&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A haematological disorder is among those listed under diseases associated with molecular functions."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;IMMUNOLOGICAL DISORDER&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"An immunological disorder was found in the list of identified diseases and disorders."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;RENAL DISORDER&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A renal disorder is one of those linked to the 'Top Bio Functions' category."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;SKELETAL DISORDER&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A skeletal disorder was part of the diseases listed in relation to molecular and cellular functions."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;EMBRYONIC DEVELOPMENT&quot;">
      <data key="d0">"DEVELOPMENT PROCESS"</data>
      <data key="d1">"Processes related to embryonic development were observed in gene clusters."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;SKELETAL TISSUE FUNCTION&quot;">
      <data key="d0">"TISSUE FUNCTION"</data>
      <data key="d1">"Functions associated with skeletal tissues are mentioned within the 'Top Bio Functions' category."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;CONNECTIVE TISSUE FUNCTION&quot;">
      <data key="d0">"TISSUE FUNCTION"</data>
      <data key="d1">"Function of connective tissue was observed in the identified gene clusters and biological pathways."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;DBA PATIENTS&quot;">
      <data key="d0">"SUBJECT"</data>
      <data key="d1">"Patients with a condition studied for differential gene expression patterns."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;CONTROL GROUP&quot;">
      <data key="d0">"COMPARISON GROUP"</data>
      <data key="d1">"The control group used for comparison with DBA patients to validate microarray data results."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;AMPD3&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"One of the genes tested via qRT-PCR that was found differentially expressed in DBA patients."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;CCND2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Another gene from a differential expression study, up-regulated in DBA patients by qRT-PCR and microarray analysis."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;SOD2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Gene found to be up-regulated in DBA patients through both qRT-PCR validation and microarray data."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;TNFAIP3&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Up-regulated gene in DBA patients, confirmed by qRT-PCR and corroborated with microarray expression results."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;COMP&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Down-regulated gene in DBA patients validated through qRT-PCR and microarray analysis for differential expression."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;WARS&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Another down-regulated gene in DBA patients, confirmed with qRT-PCR and microarray data as part of the study's validation process."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;ZIC1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Down-regulated in DBA patients by both qRT-PCR and microarray analysis, verified for differential expression."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;MICROARRAY DATA&quot;">
      <data key="d0">"ANALYSIS METHOD"</data>
      <data key="d1">"The method used to assess gene expression patterns before qRT-PCR validation."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;DBA CONDITION&quot;">
      <data key="d0">"CONDITION"</data>
      <data key="d1">"The condition of interest being studied through gene expression analysis."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;MICROARRAY ANALYSIS&quot;">
      <data key="d0">"ANALYSIS METHOD"</data>
      <data key="d1">"The primary method used to determine differential gene expression in DBA patients."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;QRT-PCR VALIDATION&quot;">
      <data key="d0">"VALIDATION TECHNIQUE"</data>
      <data key="d1">"An additional technique employed to confirm the findings from microarray data."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;DIFFERENTIAL EXPRESSION&quot;">
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d1">"The process of identifying statistically significantly differentially expressed genes/probes from the microarray study.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;COMPARISON GROUP OR STATISTICAL TEST&quot;">
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d1">"Comparative analysis between DBA patients and controls in gene expression profiling.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DBA PATIENTS VS. CONTROLS&quot;">
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d1">"Comparative analysis between DBA patients and controls in gene expression profiling.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENE EXPRESSION PROFILING&quot;">
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d1">"Methodology used to identify differentially expressed genes through the study of gene expression across the entire genome.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;WHOLE GENOME TECHNOLOGY&quot;">
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d1">"Methodology used to identify differentially expressed genes through the study of gene expression across the entire genome.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MICROARRAY PLATFORM&quot;">
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d1">"Technology platform used for high-throughput screening and analysis of gene expression from the DBA patients' samples.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DERMAL FIBROBLAST SAMPLES&quot;">
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d1">"The sample source from which gene expression data was collected and analyzed through microarray and qRT-PCR methods.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;STUDY SUBJECT OR TISSUE SAMPLE&quot;">
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d1">"The sample source from which gene expression data was collected and analyzed through microarray and qRT-PCR methods.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;QRT-PCR CONFIRMATION&quot;">
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d1">"Method employed to validate findings of reduced RPS19 levels in DBA patients carrying the frameshift mutation, alongside other genomic variants.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;VALIDATION TECHNIQUE&quot;">
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d1">"Method employed to validate findings of reduced RPS19 levels in DBA patients carrying the frameshift mutation, alongside other genomic variants.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENOMIC VARIANT OR MOLECULAR INTERACTION&quot;">
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d1">"Specific mutation analyzed through PCR and sequencing methods to elucidate effects on gene expression and protein synthesis pathways in DBA patients.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INTRON 1 SPLICE SITE MUTATION C.1-1G&gt;A&quot;">
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d1">"Specific mutation analyzed through PCR and sequencing methods to elucidate effects on gene expression and protein synthesis pathways in DBA patients.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;AMINOACYL-TRNA BIOSYNTHESIS PATHWAY&quot;">
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d1">"Pathway identified as significantly enriched with genes from the differential expression dataset, highlighting its role in DBA pathogenesis.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ENRICHMENT CLUSTER OF GENES&quot;">
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d1">"Pathway identified as significantly enriched with genes from the differential expression dataset, highlighting its role in DBA pathogenesis.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;BIOLOGICAL PATHWAY OR ENRICHMENT CLUSTER&quot;">
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d1">"Further pathway enrichment identified through analysis of molecular functions related to metabolic pathways involved in DBA patients.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PATHWAY OR BIOLOGICAL PROCESS&quot;">
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d1">"Specific pathway impacted and analyzed as part of impaired biological processes detected in the study on DBA patients.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ROLE IN INTERFERON INDUCTION&quot;">
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d1">"Analysis revealed the involvement of PKR activity in antiviral responses through enriched gene functions identified in DBA patients.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;BIOLOGICAL FUNCTION OR PATHWAY ENRICHMENT&quot;">
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d1">"Category associated with biological processes and pathways related to retinoid acid receptor activation found significant through enrichment analysis in the study on DBA patients.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENE ENRICHMENT CATEGORY&quot;">
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d1">"Cluster identified for gene functions involved in protein synthesis, including a large group of RP genes contributing to this pathway's significance in DBA.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PROTEIN SYNTHESIS CLUSTER&quot;">
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d1">"Cluster identified for gene functions involved in protein synthesis, including a large group of RP genes contributing to this pathway's significance in DBA.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;BIOLOGICAL PROCESS OR FUNCTION&quot;">
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d1">"Enrichment cluster found related to roles in cellular development and death pathways identified through molecular function analysis for DBA patients.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CELL DEATH ROLE&quot;">
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d1">"Enrichment cluster found related to roles in cellular development and death pathways identified through molecular function analysis for DBA patients.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LIPID METABOLISM ENRICHMENT&quot;">
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d1">"Cluster associated with lipid metabolism processes as part of the biological mechanisms significantly impacted in the study on DBA patients.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;METABOLIC PATHWAY OR BIOLOGICAL PROCESS&quot;">
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d1">"Cluster associated with lipid metabolism processes as part of the biological mechanisms significantly impacted in the study on DBA patients.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;BIOLOGICAL FUNCTION OR PATHWAY&quot;">
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d1">"Enriched category related to molecular transport functions contributing to biological pathways involved in DBA pathogenesis, as identified through analysis of gene functions and annotations.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MOLECULAR TRANSPORT CLUSTER&quot;">
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d1">"Enriched category related to molecular transport functions contributing to biological pathways involved in DBA pathogenesis, as identified through analysis of gene functions and annotations.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PATHWAY ENRICHMENT OR GROUP OF BIOLOGICAL FUNCTIONS&quot;">
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d1">"Category encompassing multiple biological functions identified as critical for the pathogenesis of DBA patients through pathway enrichment analysis performed on the dataset of differentially expressed genes.")("entity"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TOP BIO FUNCTIONS CATEGORY&quot;">
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d1">"Category encompassing multiple biological functions identified as critical for the pathogenesis of DBA patients through pathway enrichment analysis performed on the dataset of differentially expressed genes.")("entity"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CLUSTER OF GENES&quot;">
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
      <data key="d1">"Part of a cluster including other RP genes involved in synthesis related processes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DIFFERENTIALLY EXPRESSED GENE&quot;">
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
      <data key="d1">"Up-regulated gene identified as differentially expressed by qRT-PCR and microarray analysis in DBA patients.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;VALIDATION METHOD&quot;">
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
      <data key="d1">"Method used to validate the results of microarray analysis for gene expression in DBA patients.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;BDNF RS6265 (G/A) POLYMORPHISM&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The BDNF rs6265 (G/A) polymorphism is a genetic variant analyzed in studies on migraine."</data>
      <data key="d2">chunk-814fe155e9cb953da61f6a79d1d25784</data>
    </node>
    <node id="&quot;MIGRAINE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Migraine is a neurological disorder characterized by recurrent headaches."</data>
      <data key="d2">chunk-814fe155e9cb953da61f6a79d1d25784</data>
    </node>
    <node id="&quot;BDNF GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The BDNF gene encodes the brain-derived neurotrophic factor protein and was studied for its role in migraine."</data>
      <data key="d2">chunk-814fe155e9cb953da61f6a79d1d25784</data>
    </node>
    <node id="&quot;RS6265 (G/A) POLYMORPHISM&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The rs6265 polymorphism occurs within the BDNF gene, specifically affecting the G/A variant."</data>
      <data key="d2">chunk-814fe155e9cb953da61f6a79d1d25784</data>
    </node>
    <node id="&quot;MIGRAINE RISK&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Research on migraine and BDNF polymorphisms focuses on understanding risk factors for the disease."</data>
      <data key="d2">chunk-814fe155e9cb953da61f6a79d1d25784</data>
    </node>
    <node id="&quot;HETEROGENEITY IN STUDIES&quot;">
      <data key="d0">"STATISTICAL METHOD"</data>
      <data key="d1">"The meta-analysis used fixed-effects models to account for heterogeneity among studies."</data>
      <data key="d2">chunk-814fe155e9cb953da61f6a79d1d25784</data>
    </node>
    <node id="&quot;FIXED-EFFECTS MODEL&quot;">
      <data key="d0">"META-ANALYSIS APPROACH"</data>
      <data key="d1">"A statistical method employed when studies are homogeneous, as determined by a non-significant heterogeneity test."</data>
      <data key="d2">chunk-814fe155e9cb953da61f6a79d1d25784</data>
    </node>
    <node id="&quot;MIGRAINE ASSOCIATION&quot;">
      <data key="d0">"ASSOCIATION ANALYSIS"</data>
      <data key="d1">"Studies were analyzed for associations between the BDNF rs6265 polymorphism and migraine risk."</data>
      <data key="d2">chunk-814fe155e9cb953da61f6a79d1d25784</data>
    </node>
    <node id="&quot;ALLELE MODEL&quot;">
      <data key="d0">"STATISTICAL MODEL"</data>
      <data key="d1">"An analysis method used to assess the relationship between a genetic variant and an outcome by considering all genotypes in one group."</data>
      <data key="d2">chunk-814fe155e9cb953da61f6a79d1d25784</data>
    </node>
    <node id="&quot;RECESSIVE MODEL&quot;">
      <data key="d0">"GENETIC MODEL"</data>
      <data key="d1">"A model that evaluates whether having at least two copies of the recessive allele affects disease risk."</data>
      <data key="d2">chunk-814fe155e9cb953da61f6a79d1d25784</data>
    </node>
    <node id="&quot;ADDITIVE MODEL&quot;">
      <data key="d0">"STATISTICAL METHODOLOGY"</data>
      <data key="d1">"A model used to evaluate if there's an additive effect of alleles on the outcome, considering all possible genotypes."</data>
      <data key="d2">chunk-814fe155e9cb953da61f6a79d1d25784</data>
    </node>
    <node id="&quot;DOMINANT MODEL&quot;">
      <data key="d0">"GENETIC ANALYSIS"</data>
      <data key="d1">"An analysis assessing whether having at least one copy of a specific allele confers risk."</data>
      <data key="d2">chunk-814fe155e9cb953da61f6a79d1d25784</data>
    </node>
    <node id="&quot;AUSTRALIAN-BASED INDEPENDENT COHORTS&quot;">
      <data key="d0">"STUDY POPULATION"</data>
      <data key="d1">"Cohorts from Australia that contributed to the studies on BDNF gene."</data>
      <data key="d2">chunk-814fe155e9cb953da61f6a79d1d25784</data>
    </node>
    <node id="&quot;HARDY-WEINBERG EQUILIBRIUM (HWE)&quot;">
      <data key="d0">"STATISTICAL TEST"</data>
      <data key="d1">"A measure of population genetics used in genetic studies, indicating if the observed genotype frequencies are consistent with those expected under random mating and no other forces acting on the population."</data>
      <data key="d2">chunk-814fe155e9cb953da61f6a79d1d25784</data>
    </node>
    <node id="&quot;NOS SCORE&quot;">
      <data key="d0">"QUALITY MEASURE"</data>
      <data key="d1">"An indicator assessing the quality or risk of bias in research articles; scores ≥6 indicate high-quality studies."</data>
      <data key="d2">chunk-814fe155e9cb953da61f6a79d1d25784</data>
    </node>
    <node id="&quot;BDNF GENOTYPE&quot;">
      <data key="d0">"GENETIC INFORMATION"</data>
      <data key="d1">"Specific genetic configurations found within the BDNF gene that were studied for their association with migraine."</data>
      <data key="d2">chunk-814fe155e9cb953da61f6a79d1d25784</data>
    </node>
    <node id="&quot;CASE-CONTROL STUDIES&quot;">
      <data key="d0">"STUDY DESIGN"</data>
      <data key="d1">"A type of observational study where cases (people with the disease) are compared to controls (people without the disease), used here for understanding genetic risk factors like BDNF polymorphisms."</data>
      <data key="d2">chunk-814fe155e9cb953da61f6a79d1d25784</data>
    </node>
    <node id="&quot;COCHRANE DATABASES&quot;">
      <data key="d0">"DATABASE SOURCES"</data>
      <data key="d1">"Academic databases including peer-reviewed articles and clinical evidence, utilized in literature searches to find studies on BDNF gene-polymorphism relation with migraine."</data>
      <data key="d2">chunk-814fe155e9cb953da61f6a79d1d25784</data>
    </node>
    <node id="&quot;WEB OF SCIENCE&quot;">
      <data key="d0">"DATABASE SOURCES"</data>
      <data key="d1">"An interdisciplinary citation indexing service used for scholarly research that was searched alongside PubMed and Cochrane to identify relevant studies."</data>
      <data key="d2">chunk-814fe155e9cb953da61f6a79d1d25784</data>
    </node>
    <node id="&quot;RS2049046 (A/T) POLYMORPHISM&quot;">
      <data key="d2">chunk-814fe155e9cb953da61f6a79d1d25784</data>
      <data key="d1">"The rs2049046 polymorphism was significantly linked to migraine.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;BDNF GENE POLYMORPHISMS&quot;">
      <data key="d2">chunk-814fe155e9cb953da61f6a79d1d25784</data>
      <data key="d1">"Polymorphisms in the BDNF gene were studied as potential risk factors for developing migraine.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MIGRAINE RISK FACTOR&quot;">
      <data key="d2">chunk-814fe155e9cb953da61f6a79d1d25784</data>
      <data key="d1">"Polymorphisms in the BDNF gene were studied as potential risk factors for developing migraine.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ASSOCIATION WITH BDNF GENOTYPE&quot;">
      <data key="d2">chunk-814fe155e9cb953da61f6a79d1d25784</data>
      <data key="d1">"The specific G/A variant of the polymorphism was studied within its genotype context, linking it to migraine risk.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENETIC INTERACTION WITH RS6265&quot;">
      <data key="d2">chunk-814fe155e9cb953da61f6a79d1d25784</data>
      <data key="d1">"Another genetic variant that may interact or have an additive effect alongside the rs6265 polymorphism in influencing migraine.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PATIENT 1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The genetic disposition of Patient 1 is influenced by a positive family history for psoriasis and HS among first-degree relatives."</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;PATIENT 2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Likewise, the genetic background of Patient 2 includes a positive family history for psoriasis."</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;PATIENT 3&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Patient 3's genetic makeup also carries a positive family history for HS and psoriasis, as seen in his first-degree relatives."</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;HS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Patients 1, 2, and 3 are affected by severe hidradenitis suppurativa (HS), which is associated with the development of paradoxical psoriasiform reactions following treatment with adalimumab."</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;ADALIMUMAB&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Adalimumab, an anti-TNF-α therapy, was used for patients 1 and 2 but led to paradoxical psoriasiform reactions in these HS patients."</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;ANTI-TNF-Α&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"The use of the anti-TNF-α treatment is related to the development of paradoxical psoriasiform reactions as seen in patients undergoing this therapy."</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;PSORIASIFORM ERUPTIONS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Patients 1 and 2 developed psoriasiform eruptions after starting adalimumab, indicating a paradoxical reaction."</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;PASI 6.8&quot;">
      <data key="d0">"DISEASE SCORE"</data>
      <data key="d1">"Patient 1's psoriasis severity score (PASI) was at 6.8 after the onset of psoriasiform eruptions following treatment."</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;PASI 5.2&quot;">
      <data key="d0">"DISEASE SCORE"</data>
      <data key="d1">"The PASI score for patient 2 was slightly lower than that of Patient 1, yet still indicative of a paradoxical psoriasiform reaction and dermatitis."</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;HURLEY III, SARTORIUS SCORE: 41.5&quot;">
      <data key="d0">"DISEASE MEASURE"</data>
      <data key="d1">"Patient 1's hidradenitis suppurativa was scored at Hurley III, indicating significant disease severity."&lt;SEP&gt;"Patient 2 showed a similar pattern of HS severity as Patient 1, scoring the same Hurley III Sartorius score."</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;HURLEY III, SARTORIUS SCORE: 61.5&quot;">
      <data key="d0">"DISEASE MEASURE"</data>
      <data key="d1">"Patient 3's severe hidradenitis suppurativa was characterized by a high Hurley III Sartorius score of 61.5."</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;CD3+ CELLS&quot;">
      <data key="d0">"CELL"</data>
      <data key="d1">"Enriched CD8+, but not CD4+, compared to PBMCs from the same patients."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;CLASSICAL PSORIASIS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Showed an enrichment of both CD4+ and CD8+ subpopulations in skin T cells."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;TYPE I IFN-Β&quot;">
      <data key="d0">"CYTOKINE"</data>
      <data key="d1">"Expressed significantly more in paradoxical skin lesions than classical psoriasis, mainly in keratinocytes."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;KERATINOCYTES&quot;">
      <data key="d0">"CELL"</data>
      <data key="d1">"Express IFN-κ at levels comparable to classical and nonclassical psoriasis."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;IFN-Κ&quot;">
      <data key="d0">"CYTOKINE"</data>
      <data key="d1">"Cytoplasmic expression in psoriasiform lesions, membrane-bound in classical psoriasis."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;LYMPHOTOXINS&quot;">
      <data key="d0">"CYTOKINE"</data>
      <data key="d1">"Deregulated by anti-TNF-α therapy and strongly overexpressed in paradoxical skin reactions."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;ERAP1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"All HS patients showed variants, either homozygosis or heterozygosis."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;HLA-C REGION&quot;">
      <data key="d0">"ALLELE"</data>
      <data key="d1">"HS patients mostly show genetic polymorphisms related to HLA-Cw6."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;ERAP1 SNPS&quot;">
      <data key="d0">"SNP"</data>
      <data key="d1">"Three specific SNPs found in all patients, with distribution varying among them."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;TNFAIP SNPS&quot;">
      <data key="d0">"SNP"</data>
      <data key="d1">"Encoding A20 protein, interestingly, patient 3 shared multiple SNPs with others."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;CDSN AND CCHCR1 SNPS&quot;">
      <data key="d0">"SNP"</data>
      <data key="d1">"Polymorphisms related to skin-barrier proteins."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;IL-17F&quot;">
      <data key="d0">"CYTOKINE"</data>
      <data key="d1">"One of several cytokines analyzed for genetic variants associated with psoriasis."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;IL-17RA&quot;">
      <data key="d0">"RECEPTOR"</data>
      <data key="d1">"Cytokine receptor potentially involved in psoriasis pathogenesis; showed genetic variants among HS patients."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;IL-23R&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"SNP rs11209026 previously associated with paradoxical psoriasiform reactions to anti-TNFs, but not found in all HS patients."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;ILB12B&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Pathogenic cytokine gene involved in immune responses and inflammatory conditions; showed genetic polymorphisms among HS patients."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;IKBΖ&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Encoded by the IKBζ gene, involved in signal transduction pathways related to inflammation; shared SNPs with other psoriasis-related genes."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;A20 BINDING PROTEIN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Part of the A20 protein complex; genetic variants present among HS patients associated with paradoxical reactions."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;TYK2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Catalytic subunit of the Janus kinase (JAK) family involved in signal transduction pathways, showed polymorphisms among HS patients."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;CDSN&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Coding for a skin-barrier protein; two specific SNPs were identified among the analyzed HS patients."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;CCHCR1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Protein involved in skin physiology and barrier function; three specific SNPs identified, potentially related to paradoxical reactions."&lt;SEP&gt;"Three SNPs (rs1576, rs130079, rs746647) are present in the CCHCR1 gene as mentioned in Table 1."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a&lt;SEP&gt;chunk-72f4505e43f67f3564607392cb178656</data>
    </node>
    <node id="&quot;IL23R&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The IL23R gene is discussed with two SNPs associated with paradoxical psoriasiform reactions to anti-TNFs and identified in specific patients."</data>
      <data key="d2">chunk-72f4505e43f67f3564607392cb178656</data>
    </node>
    <node id="&quot;RS11209026&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Previously, rs11209026 in the IL23R gene has been linked to paradoxical psoriasiform reactions with anti-TNFs as stated."</data>
      <data key="d2">chunk-72f4505e43f67f3564607392cb178656</data>
      <data key="d3">[{"level": 0, "cluster": 11}, {"level": 1, "cluster": 36}, {"level": 2, "cluster": 60}]</data>
    </node>
    <node id="&quot;RS72676067&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNP rs72676067 was detected in patient 2 in the context of IL23R gene study."</data>
      <data key="d2">chunk-72f4505e43f67f3564607392cb178656</data>
    </node>
    <node id="&quot;RS1004819&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNP rs1004819 was found associated with the IL23R gene and identified in patient 1."</data>
      <data key="d2">chunk-72f4505e43f67f3564607392cb178656</data>
    </node>
    <node id="&quot;TABLE 1&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Referenced table provides information on SNPs of interest within the CCHCR1 and IL23R genes."</data>
      <data key="d2">chunk-72f4505e43f67f3564607392cb178656</data>
    </node>
    <node id="&quot;PARADOXICAL PSORIASIFORM REACTIONS&quot;">
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
      <data key="d1">"The development of paradoxical psoriasiform reactions occurred following treatment with adalimumab in patients affected by severe HS.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DISEASE RESPONSE&quot;">
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
      <data key="d1">"Each patient displayed unique disease responses including erythematous-pustular lesions, pustular lesions, and erythemato-scaly plaques respectively after therapy.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PATIENT 1, PATIENT 2, AND PATIENT 3&quot;">
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
      <data key="d1">"Each patient displayed unique disease responses including erythematous-pustular lesions, pustular lesions, and erythemato-scaly plaques respectively after therapy.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;REACTIONS&quot;">
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
      <data key="d1">"The anti-TNF-α treatment led to distinct paradoxical reactions of varying severity in HS patients as measured by PASI scores.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DISEASE SEVERITY SCALE&quot;">
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
      <data key="d1">"The psoriasis severity index (PASI) indicated a range of disease severity in the patients with paradoxical reactions.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PASI 6.8&quot;, &quot;PASI 5.2&quot;, AND &quot;PASI 5.6&quot;">
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
      <data key="d1">"The psoriasis severity index (PASI) indicated a range of disease severity in the patients with paradoxical reactions.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DISEASE SEVERITY MEASURE&quot;">
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
      <data key="d1">"The Hurley III Sartorius scoring system was used to measure the severity of hidradenitis suppurativa in each patient.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HURLEY III, SARTORIUS SCORE: 41.5&quot;, &quot;HURLEY III, SARTORIUS SCORE: 41.5&quot;, AND &quot;HURLEY III, SARTORIUS SCORE: 61.5&quot;">
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
      <data key="d1">"The Hurley III Sartorius scoring system was used to measure the severity of hidradenitis suppurativa in each patient.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DISEASE SUBTYPE&quot;">
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
      <data key="d1">"In Patient 2, a mixed population of T cells responsible for both psoriasiform and eczematous reactions was likely present.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PATIENT 2'S ECZEMATOUS REACTIONS&quot;">
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
      <data key="d1">"In Patient 2, a mixed population of T cells responsible for both psoriasiform and eczematous reactions was likely present.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PARADOXICAL PSORIASIS&quot;">
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
      <data key="d1">"Overexpression of type I IFNs is characteristic in paradoxical psoriasis, more than classical or nonclassical.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ANTI-TNF-Α THERAPY&quot;">
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
      <data key="d1">"Deregulated by anti-TNF-α therapy and overexpressed specifically in paradoxical skin reactions.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ERAP1 VARIANTS&quot;">
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
      <data key="d1">"All HS patients showed variants of ERAP1, with specific SNPs found across individuals.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HS PATIENTS&quot;">
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
      <data key="d1">"All HS patients showed variants of ERAP1, with specific SNPs found across individuals.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SPECIFIC SNPS&quot;">
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
      <data key="d1">"Three specific ERAP1 SNPs were found in all HS patients with differing distributions across individuals.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SNP DISTRIBUTION&quot;">
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
      <data key="d1">"Shared multiple TNFAIP-related SNPs among patients, indicating genetic predispositions to paradoxical reactions.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FANCL CENTRAL DOMAIN&quot;">
      <data key="d0">"STRUCTURE"</data>
      <data key="d1">"The human FANCL central domain has a fused bilobal shape with specific dimensions consisting of four α-helices and nine β-strands."</data>
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
    </node>
    <node id="&quot;DRWD DOMAIN&quot;">
      <data key="d0">"STRUCTURE"</data>
      <data key="d1">"The Drosophila melanogaster (Dm) DRWD domain shares similarities in structure, particularly in the fusion of two lobes, containing a bilobal shape with similar dimensions as human FANCL central domain."</data>
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
    </node>
    <node id="&quot;URD&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A hydrophobic groove exists between the last β-strand of the four-stranded β-meander and α-helix 3 in DmDRWD corresponding to residues Ile-243, Met-246, Leu-248, Leu-264, Leu-268, and Trp-271."&lt;SEP&gt;"A hydrophobic groove formed by residues Phe-253, Val-260, and Leu-268 exists on the human URD but is extended compared to DmFANCL."&lt;SEP&gt;"A small hydrophobic patch resides on the N-terminal lobe of the URD, involved in interactions between residues like Leu-149, Tyr-165, Phe-166, and Val-167."&lt;SEP&gt;"An additional small hydrophobic patch is present on the N-terminal region of the URD corresponding to residues Tyr-112, Tyr-113, and Leu-116."&lt;SEP&gt;"The URD has distinct electrostatic potential differences compared to DmDRWD which wraps around like a ring on the backside of central FANCL domain."&lt;SEP&gt;"There is an additional small hydrophobic patch consisting of Trp-212, Val-213, and Leu-214 on the backside of the central FANCL domain."</data>
      <data key="d2">chunk-e097891654194982dfc0ef87401d3aa9</data>
    </node>
    <node id="&quot;DRWD&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"In Drosophila DRWD, the corresponding residues are His-208, Val-209, and Leu-210. This patch is partly occluded by the DRWD-RING loop in the full-length FANCL structure."&lt;SEP&gt;"The C-terminal domain of DmDRWD consists of a hydrophobic groove between the last β-strand of the four-stranded β-meander and α-helix 3 which follows (residues Ile-243, Met-246, Leu-248, Leu-264, Leu-268, and Trp-271."</data>
      <data key="d2">chunk-e097891654194982dfc0ef87401d3aa9</data>
    </node>
    <node id="&quot;RING DOMAIN&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"An 11-fold decrease in binding affinity was observed between mutant Ube2T-F63A and RING as seen in ITC analysis."&lt;SEP&gt;"ICL analysis of the RING domain reveals equilibrium binding dissociation constant (Kd) of 454 nm."&lt;SEP&gt;"Initial size-exclusion chromatography results showed no change suggesting lack of complex formation between URD and Ube2T."&lt;SEP&gt;"Purified RING domain shows a 1:1 stoichiometric interaction with Ube2T as judged by size-exclusion chromatography."</data>
      <data key="d2">chunk-e097891654194982dfc0ef87401d3aa9</data>
    </node>
    <node id="&quot;PHE-63&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Mutation of Phe-63 in Ube2T is predicted to interact with the RING and no complex shift was observed when titrating it into RING using analytical gel filtration."</data>
      <data key="d2">chunk-e097891654194982dfc0ef87401d3aa9</data>
    </node>
    <node id="&quot;FANCI, FANCD2&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Exposure of hydrophobic patches on the surface of URD is required for substrate binding."</data>
      <data key="d2">chunk-e097891654194982dfc0ef87401d3aa9</data>
    </node>
    <node id="&quot;MUTANTS L149A/F166A, L248A/F252A/L254A/I265A, V127A/Y128A, AND W212A/L214A&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Reduction in binding was observed with URD mutants compared to wild type when pulldown experiments were performed with FANCI and FANCD2."</data>
      <data key="d2">chunk-e097891654194982dfc0ef87401d3aa9</data>
    </node>
    <node id="&quot;FAM159A&quot;">
      <data key="d0">"REGULATORY MECHANISM"</data>
      <data key="d1">"Autophosphorylation at Thr-67 plays a critical role in the activation of FAM159A."&lt;SEP&gt;"FAM159A exhibits tissue-specific expression profiles, which affect its function in different biological processes across various organs."&lt;SEP&gt;"FAM159A forms a complex with components of the RING-H2 E3 ubiquitin ligase to regulate signaling pathways."&lt;SEP&gt;"FAM159A is part of a pathway involved in the regulation of cell cycle checkpoints and DNA repair mechanisms."</data>
      <data key="d2">chunk-e097891654194982dfc0ef87401d3aa9</data>
    </node>
    <node id="&quot;PHD FINGER PROTEIN 7 (PDPH7)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"An interaction site on PDPH7 is involved in its binding to FAM159A, characterized by residues Glu-46, Val-82, and Leu-83."&lt;SEP&gt;"PDPH7 has a catalytic activity that facilitates the interaction with FAM159A under certain cellular conditions."</data>
      <data key="d2">chunk-e097891654194982dfc0ef87401d3aa9</data>
    </node>
    <node id="&quot;PDPH7&quot;">
      <data key="d0">"REGULATORY ROLE"</data>
      <data key="d1">"PDPH7 is primarily localized within the nucleus, indicating its role in chromatin regulation and gene control mechanisms."&lt;SEP&gt;"The interaction with FAM159A modulates PDPH7's ability to regulate histone modifications, influencing gene expression patterns."</data>
      <data key="d2">chunk-e097891654194982dfc0ef87401d3aa9</data>
    </node>
    <node id="&quot;L248A/F252A/L254A/I265A&quot;">
      <data key="d0">"GENETIC VARIANT"</data>
      <data key="d1">"Mutations L248A/F252A/L254A/I265A reduce the binding of mutant proteins with FANCI and FANCD2, indicating that exposed hydrophobic patches are crucial for substrate interaction."</data>
      <data key="d2">chunk-6135f8baf39fe26dcea3d987aa6100ac</data>
    </node>
    <node id="&quot;W212A/L214A&quot;">
      <data key="d0">"GENETIC VARIANT"</data>
      <data key="d1">"Mutations W212A/L214A result in reduced binding compared to wild type URD, suggesting these mutations affect the ability of hydrophobic patches on the C-terminal lobe."</data>
      <data key="d2">chunk-6135f8baf39fe26dcea3d987aa6100ac</data>
    </node>
    <node id="&quot;L254A&quot;">
      <data key="d0">"GENETIC VARIANT"</data>
      <data key="d1">"Mutation L254A leads to a decrease in substrate-binding capacity with FANCI and FANCD2 proteins."</data>
      <data key="d2">chunk-6135f8baf39fe26dcea3d987aa6100ac</data>
    </node>
    <node id="&quot;I265A&quot;">
      <data key="d0">"GENETIC VARIANT"</data>
      <data key="d1">"Mutation I265A influences the binding affinity of URD with FANCI and FANCD2, particularly when compared to wild type proteins."</data>
      <data key="d2">chunk-6135f8baf39fe26dcea3d987aa6100ac</data>
    </node>
    <node id="&quot;W212A&quot;">
      <data key="d0">"GENETIC VARIANT"</data>
      <data key="d1">"Mutation W212A impacts the interaction with FANCI and FANCD2 proteins, affecting substrate binding as seen with L214A."</data>
      <data key="d2">chunk-6135f8baf39fe26dcea3d987aa6100ac</data>
    </node>
    <node id="&quot;FANCI&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"FANCI is a protein that interacts with FANCD2 in repair of DNA damage, particularly in the Fanconi Anemia pathway."</data>
      <data key="d2">chunk-6135f8baf39fe26dcea3d987aa6100ac</data>
    </node>
    <node id="&quot;FANCD2&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"FANCD2 is associated with FANCI as part of the core complex involved in homologous recombination for repairing chromosomal breakage."</data>
      <data key="d2">chunk-6135f8baf39fe26dcea3d987aa6100ac</data>
    </node>
    <node id="&quot;UBE2T&quot;">
      <data key="d2">chunk-e097891654194982dfc0ef87401d3aa9</data>
      <data key="d1">"No change in migration was observed by size-exclusion chromatography suggesting no complex formation between URD and Ube2T.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PHE-63 MUTATION&quot;">
      <data key="d2">chunk-e097891654194982dfc0ef87401d3aa9</data>
      <data key="d1">"A 11-fold decrease in binding affinity was observed between mutant Ube2T-F63A and RING as seen in ITC analysis.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;L248A/">
      <data key="d2">chunk-6135f8baf39fe26dcea3d987aa6100ac</data>
      <data key="d1">L254A/</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="252A/">
      <data key="d2">chunk-6135f8baf39fe26dcea3d987aa6100ac</data>
      <data key="d1">L254A/</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;W212A/">
      <data key="d2">chunk-6135f8baf39fe26dcea3d987aa6100ac</data>
      <data key="d1">"Hydrophobic Patches"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="L214A&quot;">
      <data key="d2">chunk-6135f8baf39fe26dcea3d987aa6100ac</data>
      <data key="d1">"Hydrophobic Patches"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HYDROPHOBIC PATCHES&quot;">
      <data key="d2">chunk-6135f8baf39fe26dcea3d987aa6100ac</data>
      <data key="d1">"The exposed hydrophobic patches on the C-terminal lobe are required for substrate binding as indicated by lower affinity with L254A mutation.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FANCI&quot;/&quot;FANCD2&quot;">
      <data key="d2">chunk-6135f8baf39fe26dcea3d987aa6100ac</data>
      <data key="d1">"Binding affinity of URD proteins to FANCI and FANCD2 decreases with specific mutations (L248A/F252A/L254A/I265A, W212A/L214A), emphasizing the role of hydrophobic patches.")&lt;SEP&gt;"Interaction of URD with FANCI/FANCD2 proteins depends on the exposed hydrophobic patches on its C-terminal lobe, which are impacted by certain genetic variants."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;BINDING AFFINITY&quot;">
      <data key="d2">chunk-6135f8baf39fe26dcea3d987aa6100ac</data>
      <data key="d1">"The mutations influence substrate binding affinity, with reduced interaction observed for URD proteins."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MUTATIONS L248A/F252A/L254A/I265A&quot;/&quot;W212A/L214A&quot;">
      <data key="d2">chunk-6135f8baf39fe26dcea3d987aa6100ac</data>
      <data key="d1">"The mutations influence substrate binding affinity, with reduced interaction observed for URD proteins."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SUBSTRATE INTERACTION&quot;">
      <data key="d2">chunk-6135f8baf39fe26dcea3d987aa6100ac</data>
      <data key="d1">"Exposure of hydrophobic patches on the C-terminal lobe is necessary for efficient interaction between URD and FANCI/FANCD2, as indicated by decreased binding affinity with specific mutations."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FGFR4 RS376618&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This genomic variant was assessed for Hardy-Weinberg equilibrium in healthy control patients. It did not show significant differential treatment effects associated with the study."</data>
      <data key="d2">chunk-5c78814fb7c198ee95071ee5a8462070</data>
    </node>
    <node id="&quot;FGFR4 RS351855&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"This functional genetic variant (Gly388Arg) showed association with differential colesevelam treatment effect on AC t1/2 and GC24."</data>
      <data key="d2">chunk-5c78814fb7c198ee95071ee5a8462070</data>
    </node>
    <node id="&quot;COLESEVELAM&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"A medication that was tested for its differential treatment effects based on the genotypes of FGFR4 rs351855."</data>
      <data key="d2">chunk-5c78814fb7c198ee95071ee5a8462070</data>
    </node>
    <node id="&quot;FGFR4 GENOTYPE VARIATION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The functional variant, FGFR4 rs351855 (Gly388Arg), affects colesevelam's treatment effect on specific outcomes in this study."</data>
      <data key="d2">chunk-5c78814fb7c198ee95071ee5a8462070</data>
    </node>
    <node id="&quot;KLB RS4975017&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This genomic variant showed a differential treatment effect on CT compared to placebo, affecting GC24 values and AC t1/2."</data>
      <data key="d2">chunk-5c78814fb7c198ee95071ee5a8462070</data>
    </node>
    <node id="&quot;KLB RS17618244&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A functional variant of this gene (Arg728Gln) was associated with numerical but not statistically significant differential colesevelam treatment effects on specific outcomes."</data>
      <data key="d2">chunk-5c78814fb7c198ee95071ee5a8462070</data>
    </node>
    <node id="&quot;AC T1/2&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"This physiological process was influenced by the FGFR4 rs351855 genetic variant and colesevelam treatment."</data>
      <data key="d2">chunk-5c78814fb7c198ee95071ee5a8462070</data>
    </node>
    <node id="&quot;GC24&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"This metabolic pathway was impacted by the KLB rs4975017 and rs17618244 genetic variants, as well as colesevelam treatment."</data>
      <data key="d2">chunk-5c78814fb7c198ee95071ee5a8462070</data>
    </node>
    <node id="&quot;FGF19&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Serum FGF19 and stool weight are also shown in Table 1."</data>
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
    </node>
    <node id="&quot;BA SYNTHESIS&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Overall univariate association of serum C4 with subgroup was identified (overall P = .02) with higher serum C4 in IBS-D than in IBS-C and HV."</data>
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
    </node>
    <node id="&quot;STOOL FAT&quot;">
      <data key="d0">"FOOD CONTENT"</data>
      <data key="d1">"Numerical differences between subgroups in the 48-hour stool weight and 48-hour stool fat that were not statistically significant, with higher stool weight and stool fat in IBS-D compared with HV, and lower values in IBS-C compared with HV."</data>
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
    </node>
    <node id="&quot;STOOL WEIGHT&quot;">
      <data key="d0">"MEASURE OF BODY WEIGHT"</data>
      <data key="d1">"Numerical differences between subgroups in the 48-hour stool weight and 48-hour stool fat that were not statistically significant, with higher stool weight and stool fat in IBS-D compared with HV, and lower values in IBS-C compared with HV."</data>
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
    </node>
    <node id="&quot;CHOLECYSTECTOMY&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Previous cholecystectomy was recorded in 23% of IBS-D, approximately 4% of IBS-C, and approximately 4% of HV (P = .05). All patients’ symptoms anteceded the cholecystectomy."</data>
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
    </node>
    <node id="&quot;BA EXCRETION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"There were numerical differences between subgroups in the 48-hour stool weight and 48-hour stool fat that were not statistically significant, with higher stool weight and stool fat in IBS-D compared with HV, and lower values in IBS-C compared with HV."</data>
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d3">[{"level": 0, "cluster": 2}]</data>
    </node>
    <node id="&quot;FGF19 CORRELATION&quot;">
      <data key="d0">"RANK CORRELATION"</data>
      <data key="d1">"There was a significant Spearman correlation between serum C4 and FGF19 (rs = −0.324, P = .007), stool weight (rs = 0.366, P = .003), and total stool BA (rs = 0.606, P &lt; .001)."</data>
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
    </node>
    <node id="&quot;STOOL WEIGHT CORRELATION&quot;">
      <data key="d0">"RANK CORRELATION"</data>
      <data key="d1">"There was a significant Spearman correlation between serum C4 and FGF19 (rs = −0.324, P = .007), stool weight (rs = 0.366, P = .003), and total stool BA (rs = 0.606, P &lt; .001)."</data>
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
    </node>
    <node id="&quot;TOTAL STOOL BA CORRELATION&quot;">
      <data key="d0">"RANK CORRELATION"</data>
      <data key="d1">"There was a significant Spearman correlation between serum C4 and FGF19 (rs = −0.324, P = .007), stool weight (rs = 0.366, P = .003), and total stool BA (rs = 0.606, P &lt; .001)."</data>
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
    </node>
    <node id="&quot;BMI CORRELATION&quot;">
      <data key="d0">"RANK CORRELATION"</data>
      <data key="d1">"BMI correlated with serum C4 (rs = 0.423, P &lt; .001) and total stool BA (rs = 0.507, P &lt; .001)."</data>
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
    </node>
    <node id="&quot;IBS-D&quot;">
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d1">"In IBS-D subgroup, the BMI was approximately 4 units higher than in other subgroups (P = .036).")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SUBGROUP COMPARISON&quot;">
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d1">"There were numerical differences between subgroups with respect to stool fat content with higher values found in IBS-D compared to HV and lower values found in IBS-C compared to HV.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;BA SYNTHESIS (STOOL EXCRETION)&quot;">
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d1">"IBS-D had significantly higher levels of stool BA content compared to IBS-C but not compared to HV, indicating subgroup differences in the synthesis and excretion of bile acids.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LACK OF ASSOCIATION&quot;">
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d1">"No association was observed between fasting serum FGF19 levels with subgroups indicated no direct impact on BA synthesis or stool excretion.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SERUM FGF19&quot;">
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d1">"No association was observed between fasting serum FGF19 levels with subgroups indicated no direct impact on BA synthesis or stool excretion.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;BA SYNTHESIS COMPARISON&quot;">
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d1">"The FGFR4 rs1966265 variant was marginally associated with total stool BA content in IBS-D compared to other subgroups.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FGF14 RS1966265&quot;">
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d1">"The FGFR4 rs1966265 variant was marginally associated with total stool BA content in IBS-D compared to other subgroups.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;STOOL WEIGHT (SERUM C4)&quot;">
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d1">"Spearman correlation coefficients indicated that serum C4 and stool weight were positively correlated indicating a relationship between these two parameters.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TOTAL STOOL BA (SERUM C4)&quot;">
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d1">"A significant Spearman correlation was found between serum C4 levels and total stool BA suggesting a possible link in the metabolism of bile acids.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;BMI (SERUM C4)&quot;">
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d1">"Spearman correlation coefficients suggested that BMI correlated with higher levels of serum C4 indicating potential influence on metabolic processes related to bile acid synthesis or excretion.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SYMPTOM IMPACT&quot;">
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d1">"Cholecystectomy had a statistically significant impact on IBS symptoms in the IBS-D subgroup compared to IBS-C and HV groups.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SERUM C4&quot;">
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d1">"BMI correlated positively with serum C4 levels, indicating a possible influence of obesity on markers related to bile acid metabolism or other metabolic processes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;STOOL FAT CONTENT&quot;">
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d1">"There was a significant Spearman correlation between stool weight and the amount of fat in stools within different subgroup comparisons.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TOTAL STOOL BA&quot;">
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d1">"The total content of bile acids in feces showed a strong positive correlation with serum cholesterol levels, suggesting a relationship between dietary factors and bile acid metabolism.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 2}]</data>
    </node>
    <node id="&quot;STOOL WEIGHT (BA SYNTHESIS)&quot;">
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d1">"FGF19 showed significant correlations with both stool weight and total stool BA content implying its role might be involved in fecal properties or bile acid synthesis and excretion.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FGFR4 RS1966265 CORRELATION&quot;">
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d1">"The genetic variant was marginally associated with total stool BA content suggesting a possible link between the gene variant and metabolic processes related to bile acid synthesis.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FGFR4 RS351855 CORRELATION&quot;">
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d1">"The genetic variation FGFR4 rs351855 was not significantly associated with serum C4 or stool BA suggesting it did not influence bile acid metabolism related markers.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NO ASSOCIATION&quot;">
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d1">"The genetic variation FGFR4 rs351855 was not significantly associated with serum C4 or stool BA suggesting it did not influence bile acid metabolism related markers.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FGFR4 RS376618 CORRELATION&quot;">
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d1">"The genetic variant FGFR4 rs376618 was also found without significant association with serum C4 or stool BA indicating no influence on bile acid pathways.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CHOLESTEROL CORRELATION&quot;">
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d1">"Spearman correlations showed that serum C4 levels were positively correlated with total cholesterol levels in blood, suggesting potential links to metabolic processes related to lipids or bile acid metabolism.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;BILE ACID METABOLISM&quot;">
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d1">"A significant Spearman correlation between FGF19 and total stool BA content suggested that this factor might play a role in the metabolic pathways related to bile acid synthesis or excretion.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FGF19 (BA SYNTHESIS)&quot;">
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d1">"A significant Spearman correlation between FGF19 and total stool BA content suggested that this factor might play a role in the metabolic pathways related to bile acid synthesis or excretion.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IBS-D (CHOLECYSTECTOMY)&quot;">
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d1">"The presence of cholecystectomy had a statistically significant effect on IBS symptoms specifically within the IBS-D subgroup, suggesting differences in symptom profiles compared to other subgroups.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SYMPTOM COMPARISON&quot;">
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d1">"The presence of cholecystectomy had a statistically significant effect on IBS symptoms specifically within the IBS-D subgroup, suggesting differences in symptom profiles compared to other subgroups.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SERUM C4 (BA SYNTHESIS CORRELATION)&quot;">
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d1">"A significant correlation between serum C4 and BA synthesis indicated that changes in this inflammatory marker could influence bile acid metabolic pathways or associated health outcomes.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 4}, {"level": 1, "cluster": 24}]</data>
    </node>
    <node id="&quot;FAAP20&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"FAAP20 is a protein that binds to FANCA through its N-terminal region and contains a UBZ domain in its C terminal extremity."&lt;SEP&gt;"FAAP20 protein interacts with UBZ domains and is involved inUb binding."&lt;SEP&gt;"The in vivo accumulation of FAAP20 at DNA damage sites is essential for proper recruitment to repair processes, which can influence disease states."&lt;SEP&gt;"The protein FAAP20 hydrophobically interacts with the canonical Ile44-centered hydrophobic patch of Ub."</data>
      <data key="d2">chunk-5bfe051a79e5e215dd3fc65296825591&lt;SEP&gt;chunk-cc528af98598e1adb4684c0166430cf4&lt;SEP&gt;chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
    </node>
    <node id="&quot;FANCA&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"FANCA gene plays an important role as part of the FA core complex, which is involved in Fanconi Anemia pathway."</data>
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
    </node>
    <node id="&quot;UBZ DOMAIN&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The UBZ domain interacts with Ub chains to facilitate the function of FAAP20."</data>
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
    </node>
    <node id="&quot;K63-LINKED UBIQUITIN (K63-UB2)&quot;">
      <data key="d0">"UBIQUITIN SPECIES"</data>
      <data key="d1">"K63-linked ubiquitins are part of a type of modified ubiquitin which regulates cellular processes like DNA repair, cell cycle control, and protein degradation."</data>
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
    </node>
    <node id="&quot;FAAP20-UBZ&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"FAAP20-UBZ binds Ub through specific residues in the α-helix and β-loop, facilitating its function."&lt;SEP&gt;"FAAP20-UBZ is the region of FAAP20 protein that interacts with K63-Ubiquitins."&lt;SEP&gt;"The FAAP20-UBZ domain plays a role in the process of Ub binding, as mutations affecting its structure hinder this process."</data>
      <data key="d2">chunk-5bfe051a79e5e215dd3fc65296825591&lt;SEP&gt;chunk-cc528af98598e1adb4684c0166430cf4&lt;SEP&gt;chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
    </node>
    <node id="&quot;ZINC ION&quot;">
      <data key="d0">"METAL IONS"</data>
      <data key="d1">"A zinc ion plays a crucial role in stabilizing the UBZ domain structure and mediating interaction with ubiquitin chains."</data>
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
    </node>
    <node id="&quot;CENTRAL Α-HELIX (RESIDUES 160–173)&quot;">
      <data key="d0">"PROTEIN REGION"</data>
      <data key="d1">"This central alpha-helix interacts with the distal Ubiquitin, playing a role in binding affinity."</data>
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
    </node>
    <node id="&quot;SECOND LOOP (RESIDUES 143–159 AND 174–180)&quot;">
      <data key="d0">"PROTEIN STRUCTURE"</data>
      <data key="d1">"The second loop of FAAP20-UBZ interacts with the distal Ubiquitin, facilitating its specificity towards certain ubiquitin species."</data>
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
    </node>
    <node id="&quot;Α-HELIX&quot; AND &quot;SECOND LOOP&quot;">
      <data key="d0">"PROTEIN INTERACTIONS"</data>
      <data key="d1">"These specific regions allow for unique interactions with different types of ubiquitins (K63-, K48- or M1-linked), indicating the role in ubiquitin chain specificity."</data>
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
    </node>
    <node id="&quot;UBIQUITINS (UB)&quot;">
      <data key="d0">"CELLULAR COMPONENT"</data>
      <data key="d1">"Ubiquitins play crucial roles as post-translational modification components, which can be linked together to form chains on proteins for various cellular processes."</data>
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
    </node>
    <node id="&quot;FANCONI ANEMIA PATHWAY&quot;">
      <data key="d0">"BIOLOGICAL PROCESS"</data>
      <data key="d1">"FAAP20 functions within the Fanconi Anemia pathway where it plays a role in DNA repair and cell cycle regulation through its interaction with ubiquitin species."</data>
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
    </node>
    <node id="&quot;FANCONI ANEMIA (FA) COMPLEX&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The FA complex involves multiple components including FANCA, which are crucial for the cellular response to DNA damage."</data>
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
    </node>
    <node id="&quot;UBIQUITINATION&quot;">
      <data key="d0">"POST-TRANSLATIONAL MODIFICATION"</data>
      <data key="d1">"The process of ubiquitination involving ubiquitin (Ub) is a key molecular interaction influenced by FAAP20, WRNIP1, RAD18, Polη, NEMO, and FAAP20-UBZ mutants which plays crucial roles in cellular processes related to disease prevention or progression."&lt;SEP&gt;"Ubiquitination is a process that occurs on proteins where ubiquitin molecules are attached, affecting protein stability and function."</data>
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4&lt;SEP&gt;chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
      <data key="d3">[{"level": 0, "cluster": 11}, {"level": 1, "cluster": 35}]</data>
    </node>
    <node id="&quot;SURFACE PLASMON RESONANCE (SPR)&quot;">
      <data key="d0">"ANALYTICAL TECHNIQUE"</data>
      <data key="d1">"SPR technique used for studying the binding affinity of FAAP20-UBZ towards different types of ubiquitins."</data>
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
    </node>
    <node id="&quot;AFFINITY CONSTANTS (KD)&quot;/&quot;RESONANCE UNITS (RU)&quot;">
      <data key="d0">"QUANTITATIVE ANALYSIS/</data>
      <data key="d1">"FAAP20-UBZ shows efficient interaction with Ub, with lower Kd values compared to other UBDs and Polη UBZ."</data>
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
    </node>
    <node id="&quot;FAAP19&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"FAAP19 is a gene that plays an auxiliary role in Fanconi Anemia pathway, potentially interacting with FAAP20 and contributing to DNA repair processes."</data>
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
    </node>
    <node id="&quot;FANCL&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"FANCL is a core component of the FA core complex involved in modulating the activity of other FA proteins including FAAP20."</data>
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
    </node>
    <node id="&quot;UVRAG&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"UVRAG interacts with FAAP20 and contributes to the formation of the FA core complex, participating in ubiquitin-dependent processes."</data>
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
    </node>
    <node id="&quot;UBIQUITIN E3 LIGASE&quot;">
      <data key="d0">"MOLECULAR ROLE"</data>
      <data key="d1">"FAAP20 could potentially function as an E3 ubiquitin ligase through its UBZ domain interaction with ubiquitins."</data>
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
    </node>
    <node id="&quot;DNA REPAIR&quot;">
      <data key="d0">"CELLULAR PROCESS"</data>
      <data key="d1">"The Fanconi Anemia pathway, including FAAP20, contributes to the cellular response against DNA damage by facilitating efficient repair mechanisms."</data>
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
    </node>
    <node id="&quot;CELL CYCLE REGULATION&quot;">
      <data key="d0">"REGULATORY FUNCTION"</data>
      <data key="d1">"FAAP20 interacts with other FA proteins to regulate cell cycle progression, ensuring proper mitotic processes."</data>
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
    </node>
    <node id="&quot;POST-TRANSLATIONAL MODIFICATION (PTM)&quot;">
      <data key="d0">"BIOLOGICAL PROCESS"</data>
      <data key="d1">"Ubiquitination of proteins through FAAP20 and its UBZ domain is a PTM crucial for maintaining cellular homeostasis."</data>
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
    </node>
    <node id="&quot;FA COMPLEX COMPONENTS INTERACTION&quot;">
      <data key="d0">"INTER-PROTEIN ASSOCIATION"</data>
      <data key="d1">"The FA complex involves multiple components like FANCA, FANCL, UVRAG etc., which are integrated through various interactions including with FAAP20 and its UBZ domain."</data>
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
    </node>
    <node id="&quot;FANCONI ANEMIA (FA) DISORDER&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Deficiencies or malfunctions of proteins in the FA complex like FAAP20 can lead to Fanconi Anemia, a disorder affecting DNA repair processes."</data>
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
    </node>
    <node id="&quot;PROTEIN STABILITY&quot;">
      <data key="d0">"REGULATORY EFFECT"</data>
      <data key="d1">"FAAP20 through its UBZ domain may influence protein stability by mediating ubiquitination and subsequent degradation or modification of other proteins."</data>
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
    </node>
    <node id="&quot;CELL DEATH REGULATION&quot;">
      <data key="d0">"PATHOPHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The FA pathway including FAAP20 influences the regulation of cell death in response to DNA damage, influencing apoptosis or necrosis pathways."</data>
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
    </node>
    <node id="&quot;UB&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Ub interacts with FAAP20 through a series of hydrogen bonds and hydrophobic interactions."&lt;SEP&gt;"Ubiquitin (Ub) serves as a substrate for interaction with various UBZ domains."</data>
      <data key="d2">chunk-5bfe051a79e5e215dd3fc65296825591&lt;SEP&gt;chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
    </node>
    <node id="&quot;ICL&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"FAAP20's localization and accumulation at ICL sites suggests an involvement in the response to double-strand breaks."</data>
      <data key="d2">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
    </node>
    <node id="&quot;ZINC-COORDINATING RESIDUE CYS150&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"A mutation affecting a zinc-coordinating residue likely destabilizes FAAP20-UBZ structure, impacting its functionality as it suggests dependencies on cellular conditions."</data>
      <data key="d2">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
      <data key="d3">[{"level": 0, "cluster": 12}, {"level": 1, "cluster": 41}]</data>
    </node>
    <node id="&quot;FAAP20-UBZ MUTANTS D164A, A172L AND D177A&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"These mutations significantly reduce binding affinity of FAAP20 to Ub, suggesting the importance of these interactions in proper FAAP20 function."</data>
      <data key="d2">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
      <data key="d3">[{"level": 0, "cluster": 12}, {"level": 1, "cluster": 39}]</data>
    </node>
    <node id="&quot;FAAP20-UBZ DOMAIN&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The FAAP20-UBZ domain is essential for physiological processes such as recruitment to DNA damage sites."</data>
      <data key="d2">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
      <data key="d3">[{"level": 0, "cluster": 12}, {"level": 1, "cluster": 41}]</data>
    </node>
    <node id="&quot;WRNIP1-UBZ&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The UBZ domain of WRNIP1 interacts with ubiquitin (Ub) which is involved in repair mechanisms crucial for maintaining cellular health and preventing disease."&lt;SEP&gt;"The β-loop of WRNIP1 facilitates interactions with Ub by aligning Ile44 to hydrophobic residues on the α-helix or β-loop."</data>
      <data key="d2">chunk-5bfe051a79e5e215dd3fc65296825591&lt;SEP&gt;chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
    </node>
    <node id="&quot;RAD18-UBZ&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"RAD18 binds Ub through its conserved sequence motif, allowing for specific interaction mechanisms."&lt;SEP&gt;"RAD18-UBZ domain binds ubiquitin through specific interactions, differing from FAAP20-UBZ and WRNIP1-UBZ interactions."&lt;SEP&gt;"The UBZ domain of RAD18 plays a role similar to FAAP20, interacting with Ub and participating in cellular processes essential for DNA damage response and potentially impacting disease states."</data>
      <data key="d2">chunk-5bfe051a79e5e215dd3fc65296825591&lt;SEP&gt;chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
    </node>
    <node id="&quot;POLΗ-UBZ&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"Polη-UBZ interacts with Ub similarly to FAAP20-UBZ, despite sequence differences."&lt;SEP&gt;"Similar to FAAP20, Polη interacts with ubiquitin through its UBZ domain which is involved in repair mechanisms that could influence disease prevention or progression."</data>
      <data key="d2">chunk-5bfe051a79e5e215dd3fc65296825591&lt;SEP&gt;chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
    </node>
    <node id="&quot;NEMO-UBZ&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"NEMO's UBZ domain interacts with Ub and while it does not have a dietary pattern context, it can be inferred to play a role similar to FAAP20 in cellular processes that may influence health and disease through its interactions with ubiquitin."&lt;SEP&gt;"NEMO-UBZ interacts with Ub in a manner different from RAD18-UBZ and WRNIP1-UBZ."</data>
      <data key="d2">chunk-5bfe051a79e5e215dd3fc65296825591&lt;SEP&gt;chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
    </node>
    <node id="&quot;FAAP20-UBZ MUTANTS C150S, D164A, A168L, W180A&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Mutations affecting FAAP20's UBZ domain could lead to disruptions in cellular processes influenced by ubiquitin, which can be considered as an environmental factor affecting health and disease."</data>
      <data key="d2">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
    </node>
    <node id="&quot;FAAP20-UBZ MUTANTS L161A, A172L, D177A&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"These FAAP20-UBZ mutations affect the affinity to ubiquitin leading to potential disruptions in physiological processes essential for cell maintenance and repair."</data>
      <data key="d2">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
    </node>
    <node id="&quot;FAAP20, WRNIP1, RAD18, POLΗ, NEMO&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"These proteins interact with ubiquitin (Ub) through their UBZ domains influencing cellular repair mechanisms which can impact the development and progression of various diseases by regulating cell survival and division."</data>
      <data key="d2">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
      <data key="d3">[{"level": 0, "cluster": 11}, {"level": 1, "cluster": 36}, {"level": 2, "cluster": 60}]</data>
    </node>
    <node id="&quot;POLΗ&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The transcript of Polη gene plays a role in the interaction with UBZ domains."</data>
      <data key="d2">chunk-5bfe051a79e5e215dd3fc65296825591</data>
    </node>
    <node id="&quot;RAD18&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The RAD18 gene contributes to the interaction betweenUBZ domains and ubiquitin through specific binding motifs."</data>
      <data key="d2">chunk-5bfe051a79e5e215dd3fc65296825591</data>
    </node>
    <node id="&quot;WRNIP1&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant in WRNIP1 gene affects its interaction with UBZ domains."</data>
      <data key="d2">chunk-5bfe051a79e5e215dd3fc65296825591</data>
    </node>
    <node id="&quot;UBIQUITINS&quot;">
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
      <data key="d1">"FAAP20-UBZ interacts with K63-linked ubiquitin.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CENTRAL Α-HELIX AND SECOND LOOP&quot;">
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
      <data key="d1">"These regions of FAAP20-UBZ specifically interact with ubiquitins, affecting the binding specificity.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;UBIQUITIN&quot;">
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
      <data key="d1">"These regions of FAAP20-UBZ specifically interact with ubiquitins, affecting the binding specificity.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;AFFINITY TOWARDS UBIQUITINS&quot;">
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
      <data key="d1">"FAAP20-UBZ shows strong interaction with different ubiquitin species, as measured by SPR.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ROLE IN FA COMPLEX&quot;">
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
      <data key="d1">"FANCL acts as a modulatory component that interacts with FAAP20 and other FA proteins to maintain the activity of ubiquitin-dependent pathways.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CONTRIBUTION TO FA CORE COMPLEX&quot;">
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
      <data key="d1">"UVRAG integrates into the FA core complex alongside FAAP20, participating in the coordination of ubiquitin-related processes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FAAP19&quot; AND &quot;FANCL&quot;">
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
      <data key="d1">"FAAP19 may interact with FANCL for enhanced DNA repair capacity through coordinated activities within Fanconi Anemia pathway.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INTERACTION WITHIN FA PATHWAY&quot;">
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
      <data key="d1">"FAAP19 may interact with FANCL for enhanced DNA repair capacity through coordinated activities within Fanconi Anemia pathway.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;UBZ-DOMAIN&quot;">
      <data key="d2">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
      <data key="d1">"The UBZ domain of FAAP20 is involved in a metabolic pathway related to the interaction with ubiquitin (Ub), crucial for cell repair mechanisms.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 4}, {"level": 1, "cluster": 24}]</data>
    </node>
    <node id="&quot;FAAP20-UBZ MUTANTS&quot;">
      <data key="d2">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
      <data key="d1">"Mutations in key residues necessary for Ub binding may lead to dysfunctions and potentially contribute to disease states.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 12}, {"level": 1, "cluster": 39}]</data>
    </node>
    <node id="&quot;ICL SITES&quot;">
      <data key="d2">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
      <data key="d1">"FAAP20's localization to ICL sites is essential for proper response to DNA damage repair, which could impact disease prevention or progression.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FAAP20-UBZ MUTANTS D164A, A172L, D177A&quot;">
      <data key="d2">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
      <data key="d1">"Mutations affecting FAAP20's UBZ domain can influence the cellular environment by disrupting interactions with ubiquitin (Ub), thereby impacting various biological processes and health outcomes.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 11}, {"level": 1, "cluster": 35}]</data>
    </node>
    <node id="&quot;UBZ-DOMAIN PROTEINS&quot;">
      <data key="d2">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
      <data key="d1">"The interaction between proteins like FAAP20, WRNIP1, RAD18, Polη, NEMO and ubiquitin (Ub) through their UBZ domains is crucial for various cellular processes that play a role in disease states.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 12}, {"level": 1, "cluster": 39}]</data>
    </node>
    <node id="&quot;CD PATIENTS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The present study included a total of 101 Crohn's Disease (CD) patients with clinical symptoms such as chronic diarrhea, abdominal pain, anorexia, and abdominal distension."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;HEALTHY CONTROLS&quot;">
      <data key="d0">"POPULATION GROUP"</data>
      <data key="d1">"A control group consisting of healthy individuals was included for comparison with the HIV-infected participants."&lt;SEP&gt;"A total of 103 healthy controls were recruited for comparison with the CD patients."&lt;SEP&gt;"Healthy controls are individuals without any diagnosis related to the study."</data>
      <data key="d2">chunk-05d583f893b703816ad8de9561aa5292&lt;SEP&gt;chunk-6a657cd0a000b6df4db8f1305b795021&lt;SEP&gt;chunk-1418daebca32811d9530c70d8e9bf4cc</data>
      <data key="d3">[{"level": 0, "cluster": 15}, {"level": 1, "cluster": 52}]</data>
    </node>
    <node id="&quot;CONSANGUINEOUS PARENTS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"30% of the CD patients and 50% of the controls had parents who were consanguineous (related by blood) which could influence their health."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;AUTOIMMUNE MANIFESTATIONS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Three autoimmune conditions - type 1 diabetes mellitus, autoimmune thyroiditis, and systemic lupus erythematosus, were observed among the patients. Non-autoimmune diseases like osteomalacia, seizure disorders, and Down syndrome were also noted."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;HLA TAGSNPS&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Four HLA-tag Single Nucleotide Polymorphisms (SNPs) were analyzed for their association with CD patients."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;RS2395182&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Genotypes for the SNP rs2395182 were available for all participants involved in the study (n=233)."&lt;SEP&gt;"The 'G' minor allele of rs2395182 was more prevalent in healthy controls than in the CD group. This difference is statistically significant (P=0.015, OR = 2.01, 95% CI = 1.138–3.562)."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2&lt;SEP&gt;chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;RS7775228&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The 'C' minor allele of rs7775228 showed a significant difference in frequency between controls (21%) and CD patients (14%). The statistical results were P=0.0497; OR = 1.67; 95% CI = 0.998–2.787."&lt;SEP&gt;"The SNP rs7775228 was also successfully genotyped among the participants (n=233)."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2&lt;SEP&gt;chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;RS2187668&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The minor 'T' allele was more prevalent in the CD group compared to healthy controls (10% vs 3%). This difference is statistically significant (P=0.001; OR = 4.074; 95% CI = 1.615–10.273."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;RS7454108&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"There was no statistically significant difference in the frequency of minor alleles between case and control groups for rs7454108 (P-value &gt; 0.5)."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;HLA-DQ HAPLOTYPE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The risk classification of HLA-DQ genotypes was based on previous studies in Saudi Arabia."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;HLA-DQ2.5 HAPLOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The homozygous HLA-DQ2.5 haplotype showed significantly higher frequency among CD patients than controls (10.89% vs 2.91%; p = 0.024)."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;DQ8 HETEROZYGOUS HAPLOTYPES&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The DQ8 heterozygous haplotype was more frequent among CD patients (33.66%) compared to controls, with a significant difference in the DQ8/DQX haplotype between groups (32.67% vs 14.56%, p = 0.014)."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;HOMOZYGOUS HLA-DQ HAPLOTYPES&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The homozygous DQ8 high risk haplotype was more frequent among controls (7.76%) than in patients (1.98%), but this difference wasn't statistically significant."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;HOMOZYGOUS HLA-DQ2.2 HAPLOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The predicted homozygous HLA-DQ2.2 haplotype was more frequent in controls (5.82%) compared to CD patients (0.99%)."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;HETEROZYGOUS DQ2.2 HAPLOTYPES&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A total of 29.13% of the control group and 24.75% of the CD patient group were found to be heterozygous for DQ2.2."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;HLA-DQ HAPLOTYPE ACCURACY&quot;">
      <data key="d0">"VALIDATION METHOD"</data>
      <data key="d1">"Sanger sequencing analysis confirmed the accuracy (100%) of the Real-time PCR based tagSNPs approach in determining HLA-DQ haplotypes among randomly selected individuals from both study groups."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;DOWN SYNDROME&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"4% of CD patients had Down syndrome, which is a genetic disorder affecting development."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;SEIZURE DISORDERS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"4% of CD patients experienced seizure disorders, an electrical disturbance in the brain leading to abnormal behavior or sensations."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;AUTOIMMUNE THYROIDITIS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"8% of CD patients had autoimmune thyroiditis, an autoimmune condition affecting the thyroid gland."&lt;SEP&gt;"Diagnosis by treating with levothyroxine, a thyroid hormone replacement therapy."&lt;SEP&gt;"The development of autoimmune thyroid disorders is indicated by the presence of anti-thyroglobulin and anti-thyroid peroxidase antibodies in STAT5B deficient patients."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5&lt;SEP&gt;chunk-e323b0d4f82733a78f687e51f47b500a&lt;SEP&gt;chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;TYPE 1 DIABETES MELLITUS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"32% of CD patients were diagnosed with type 1 diabetes mellitus, a metabolic disorder where the body can't produce insulin."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;RS1128503&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"ABCB1 (P-glycoprotein), rs1128503 (C&gt;T) is associated with grade 3-4 anemia."&lt;SEP&gt;"rs1128503 interacts with ABCB1 (P-glycoprotein), which can affect drug efflux and potentially influence chemotherapy toxicity."</data>
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
    </node>
    <node id="&quot;RS12762549&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"ABCC2 (Multidrug Resistance Protein 2), rs12762549 (C&gt;G) is associated with grade 3-4 anemia."&lt;SEP&gt;"Variant rs12762549 (ABCC2 A &gt; G) was significantly associated with PFI in the fully-adjusted model, but not in the age-only adjusted model."&lt;SEP&gt;"rs12762549 affects ABCC2's function, potentially leading to altered cellular transport mechanisms and influencing anemia risk."</data>
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404&lt;SEP&gt;chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
    </node>
    <node id="&quot;RS363717&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"ABCA1 (ATP-binding cassette transporter A1), rs363717 (A&gt;G) is associated with grade 3-4 anemia."&lt;SEP&gt;"rs363717 impacts ABCA1 activity, which could alter lipid metabolism and contribute to anemia development."</data>
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
    </node>
    <node id="&quot;RS11615&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"ERCC1 (Excision repair cross-complementation group 1), rs11615 (T&gt;C) is associated with grade 3-4 anemia."&lt;SEP&gt;"rs11615's influence on ERCC1 suggests a role in DNA repair mechanisms, which might affect cell survival under chemotherapy stress."</data>
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
    </node>
    <node id="&quot;RS4986910&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"CYP3A4, rs4986910 (T&gt;C) is associated with thrombocytopenia grade 3-4."&lt;SEP&gt;"rs4986910 modulates CYP3A4 function, potentially affecting drug metabolism and toxicity related to chemotherapy."</data>
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
    </node>
    <node id="&quot;RS2073337&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"ABCC2 (Multidrug Resistance Protein 2), rs2073337 (A&gt;G) is correlated with CSF use during chemotherapy."</data>
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
    </node>
    <node id="&quot;RS6763398&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"RASSF1A (Ras association domain family 1 member A), rs6763398 (C&gt;T) is associated with an increased risk of developing grade 2 or higher toxicity."</data>
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
    </node>
    <node id="&quot;RS4607905&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"GSTM1 (Glutathione S-transferase M1), rs4607905 (A&gt;C) is correlated with the need for hematopoietic growth factors during chemotherapy."</data>
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
    </node>
    <node id="&quot;RS1800569&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"BCPY2C9, rs1800569 (C&gt;T) impacts drug metabolism and its influence on chemotherapy response."</data>
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
    </node>
    <node id="&quot;RS1799793&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The variant rs1799793 in ERCC2 was significantly correlated with PFI, with a lower hazard ratio and confidence interval compared to the AA or GA carriers."</data>
      <data key="d2">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
    </node>
    <node id="&quot;RS6104&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Variant rs6104 (SERPINB2 C &gt; G) also showed association with PFI in the fully-adjusted model, yet it was not statistically significant when age adjustment alone was applied."</data>
      <data key="d2">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
    </node>
    <node id="&quot;ERCC2 G &gt; A&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The variant rs1799793 is located in ERCC2 and its presence (GG carriers) showed a statistically significant advantage for PFI."</data>
      <data key="d2">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
    </node>
    <node id="&quot;ABCC2 A &gt; G&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Variant rs12762549 was associated with PFI when both age at diagnosis, FIGO stage, tumor grade, tumor histology, and residual disease after debulking surgery were considered."</data>
      <data key="d2">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
    </node>
    <node id="&quot;SERPINB2 C &gt; G&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Variant rs6104 was found to be related to PFI in the fully-adjusted model but not significant when age adjustment alone was used."</data>
      <data key="d2">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
    </node>
    <node id="&quot;GRADE 3-4 ANEMIA&quot;">
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
      <data key="d1">"The presence of the rs12762549 variant is associated with an increased risk of developing grade 3-4 anemia.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;THROMBOCYTOPENIA GRADE 3-4&quot;">
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
      <data key="d1">"The presence of the rs4986910 variant is associated with an increased risk of developing thrombocytopenia grade 3-4.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GROWTH FACTORS USE (ESAS)&quot;">
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
      <data key="d1">"The presence of the rs2074087 variant shows an association with ESA usage during chemotherapy, potentially influencing treatment efficacy and managing side effects.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS2074087&quot;">
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
      <data key="d1">"The presence of the rs2074087 variant shows an association with ESA usage during chemotherapy, potentially influencing treatment efficacy and managing side effects.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GROWTH FACTORS USE (CSFS)&quot;">
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
      <data key="d1">"The presence of the rs2073337 variant shows an association with CSF usage during chemotherapy, indicating potential need for supplementary treatments to manage side effects.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PROGRESSION-FREE INTERVAL (PFI)&quot;">
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
      <data key="d1">"The rs1799793 variant shows significant association with PFI, indicating potential genetic influences on treatment outcome.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NEUTROPENIA&quot;">
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
      <data key="d1">"The rs434074 variant shows an association with neutropenia during chemotherapy treatment, indicating a genetic predisposition to this side effect.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS434074&quot;">
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
      <data key="d1">"The rs434074 variant shows an association with neutropenia during chemotherapy treatment, indicating a genetic predisposition to this side effect.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GRADE 2 OR HIGHER TOXICITY&quot;">
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
      <data key="d1">"The rs1862219 variant is associated with an increased risk of developing grade 2 or higher toxicity during chemotherapy, highlighting a genetic factor in adverse reactions.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS1862219&quot;">
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
      <data key="d1">"The rs1862219 variant is associated with an increased risk of developing grade 2 or higher toxicity during chemotherapy, highlighting a genetic factor in adverse reactions.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HEMATOPOIETIC GROWTH FACTORS USE&quot;">
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
      <data key="d1">"The rs737645 variant correlates with the need for hematopoietic growth factors during chemotherapy, indicating genetic influences on supportive care requirements.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS737645&quot;">
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
      <data key="d1">"The rs737645 variant correlates with the need for hematopoietic growth factors during chemotherapy, indicating genetic influences on supportive care requirements.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PERIPHERAL NEUROPATHY&quot;">
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
      <data key="d1">"The rs653980 variant shows an association with the development of grade 3 or higher peripheral neuropathy, suggesting a genetic predisposition to this specific side effect.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS653980&quot;">
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
      <data key="d1">"The rs653980 variant shows an association with the development of grade 3 or higher peripheral neuropathy, suggesting a genetic predisposition to this specific side effect.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HEMATOLOGICAL TOXICITY&quot;">
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
      <data key="d1">"The rs10866159 variant correlates with the development of hematological toxicity, highlighting a genetic factor influencing this side effect.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS10866159&quot;">
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
      <data key="d1">"The rs10866159 variant correlates with the development of hematological toxicity, highlighting a genetic factor influencing this side effect.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NAUSEA AND VOMITING&quot;">
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
      <data key="d1">"The rs9095462 variant shows an association with the development of grade 2 or higher nausea and vomiting, indicating a genetic predisposition to these symptoms.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS9095462&quot;">
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
      <data key="d1">"The rs9095462 variant shows an association with the development of grade 2 or higher nausea and vomiting, indicating a genetic predisposition to these symptoms.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PFI&quot;">
      <data key="d2">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
      <data key="d1">"The genomic variant rs6104 showed an association with PFI in the fully-adjusted model but did not meet statistical significance when age adjustment alone was considered.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;UMPS&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"SNP array of I1 showed a de novo 6.4 Mb deletion on chromosome 3 containing more than 40 RefSeq genes, including UMPS."</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;LYS101ARGFS*9&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"c.302delA variant found in I4"</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;P.GLY129*&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The c.385G&gt;T (p.Gly129*) variant in UMPS is associated with agenesis of the corpus callosum"</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
      <data key="d3">[{"level": 0, "cluster": 11}, {"level": 1, "cluster": 36}, {"level": 2, "cluster": 60}]</data>
    </node>
    <node id="&quot;P.PRO75HIS&quot;">
      <data key="d0">"MISSENSE ALTERATION"</data>
      <data key="d1">"The c.224C&gt;A variant was found in pedigree 2 among twelve family members, with nine being maternally inherited."</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;ARG96GLY&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"In I3 and his mother M3, two variants c.286A&gt;G (p.Arg96Gly) and c.1285G&gt;C were found"</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;DELETION&quot;">
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
      <data key="d1">"In I1, there was a de novo 6.4 Mb deletion on chromosome 3 that contained the UMPS gene.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TAQMAN VIIA™ 7 REAL-TIME PCR&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The TaqMan method was used for genotyping in the study."</data>
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
    </node>
    <node id="&quot;RS1800469 C/T&quot;">
      <data key="d0">"SNP"</data>
      <data key="d1">"This refers to the specific SNP in the TGF-ß1 gene that was genotyped."</data>
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
    </node>
    <node id="&quot;RS1800896 A/G&quot;">
      <data key="d0">"SNP"</data>
      <data key="d1">"This is another SNP, specifically within the IL-10 gene, which was genotyped for association with CRC."</data>
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
    </node>
    <node id="&quot;INTERLEUKIN-8 (IL-8)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The IL-8 gene's rs4073 polymorphism in its promoter region was analyzed."</data>
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
    </node>
    <node id="&quot;INTERLEUKIN-10 (IL-10)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The promoter region of the IL-10 gene underwent genotyping to identify a specific SNP (rs1800896 A/G)."</data>
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
    </node>
    <node id="&quot;INTERLEUKIN-27 (IL-27)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The promoter region of the IL-27 gene was analyzed, focusing on a SNP (rs17855750T/G)."</data>
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
    </node>
    <node id="&quot;TRANSFORMING GROWTH FACTOR-BETA 1 (TGF-SS1)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"This is one of the genes examined for its promoter region SNPs related to CRC."</data>
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
    </node>
    <node id="&quot;RS4073 T/A&quot;">
      <data key="d0">"SNP"</data>
      <data key="d1">"This refers to a polymorphism within the IL-8 gene's promoter region."</data>
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
    </node>
    <node id="&quot;RS5493062&quot;">
      <data key="d0">"SNP"</data>
      <data key="d1">"A specific SNP within the IL-1β gene was analyzed for association with CRC."</data>
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
    </node>
    <node id="&quot;IL-1Α&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Polymorphisms in the IL-1α gene were also considered as part of this study."</data>
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
    </node>
    <node id="&quot;RS3093422&quot;">
      <data key="d0">"SNP"</data>
      <data key="d1">"This is a SNP found within the IL-1α gene that was evaluated for its relevance to CRC risk."</data>
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
    </node>
    <node id="&quot;CC GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The CC genotype is associated with the occurrence of Colorectal Cancer (CRC) and is slightly lower in patients compared to control groups."</data>
      <data key="d2">chunk-5b0cc96debf110f3544685d3b227ff27</data>
    </node>
    <node id="&quot;T ALLELE&quot;">
      <data key="d0">"VARIANT"</data>
      <data key="d1">"A T allele has a slight association with CRC risk, though it did not reach statistical significance."</data>
      <data key="d2">chunk-5b0cc96debf110f3544685d3b227ff27</data>
    </node>
    <node id="&quot;CRC PATIENTS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"CRC patients showed a slightly lower presence of the T allele compared to control groups."</data>
      <data key="d2">chunk-5b0cc96debf110f3544685d3b227ff27</data>
    </node>
    <node id="&quot;TAQMAN&quot;">
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d1">"The TaqMan method was utilized to assess the association between SNPs and CRC.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TGF-SS1 SNPS&quot;">
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d1">"Genotyping assessed the TGF-ß1 gene for specific SNPs that might be associated with CRC risk.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL-8 GENOTYPE&quot;">
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d1">"The polymorphism rs4073 in the IL-8 gene was genotyped to assess its association with CRC.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL-10 GENOTYPE&quot;">
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d1">"SNP analysis of IL-10 gene's rs1800896 polymorphism was performed for CRC risk assessment.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL-22 GENOTYPES&quot;">
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d1">"Polymorphisms in the IL-22 gene were studied to understand their link with CRC susceptibility.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS1179251 C/G AND RS2227485 C/T&quot;">
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d1">"Polymorphisms in the IL-22 gene were studied to understand their link with CRC susceptibility.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL-27 GENOTYPE&quot;">
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d1">"Genotyping of this SNP in IL-27's promoter region was performed for its role in CRC development.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS17855750T/G&quot;">
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d1">"Genotyping of this SNP in IL-27's promoter region was performed for its role in CRC development.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CRC RISK&quot;">
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d1">"The polymorphism of IL-8's rs4073 was assessed to determine if it influences the risk of developing colorectal cancer.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL-8 RS4073 T/A&quot;">
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d1">"The polymorphism of IL-8's rs4073 was assessed to determine if it influences the risk of developing colorectal cancer.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL-1Β SNPS&quot;">
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d1">"Genotyping for this specific SNP in the IL-1β gene provided insights into its potential association with CRC.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CRC SUSCEPTIBILITY&quot;">
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d1">"This polymorphism was analyzed as it relates to changes in IL-1α that may impact the risk of colorectal cancer development.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL-1Α RS3093422&quot;">
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d1">"This polymorphism was analyzed as it relates to changes in IL-1α that may impact the risk of colorectal cancer development.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NON-SIGNIFICANT ASSOCIATION&quot;">
      <data key="d2">chunk-5b0cc96debf110f3544685d3b227ff27</data>
      <data key="d1">"While the T allele showed a slight association with CRC, this was not statistically significant.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ASTHMATIC PATIENT&quot;">
      <data key="d0">"PATIENT"</data>
      <data key="d1">"A total of 387 unrelated asthmatic patients were included in the analysis."</data>
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
    </node>
    <node id="&quot;HEALTHY CONTROL&quot;">
      <data key="d0">"PATIENT"</data>
      <data key="d1">"A total of 212 unrelated healthy controls were included in the analysis."</data>
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
    </node>
    <node id="&quot;NON-HISPANIC WHITE GROUP&quot;">
      <data key="d0">"POPULATION SUBGROUP"</data>
      <data key="d1">"The non-Hispanic white group showed good separation from other groups based on PCA."</data>
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
    </node>
    <node id="&quot;NON-HISPANIC BLACK GROUP&quot;">
      <data key="d0">"POPULATION SUBGROUP"</data>
      <data key="d1">"The non-Hispanic black group was clearly separated from the non-Hispanic white group."</data>
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
    </node>
    <node id="&quot;HISPANIC GROUP&quot;">
      <data key="d0">"POPULATION SUBGROUP"</data>
      <data key="d1">"The Hispanic group's principal component scores were in-between those of the other groups."</data>
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
    </node>
    <node id="&quot;PRINCIPAL COMPONENT SCORE&quot;">
      <data key="d0">"ANCESTRY MARKER"</data>
      <data key="d1">"Scores of more than 80% variability were explained by the first five principal components."</data>
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
    </node>
    <node id="&quot;ASTHMA POPULATION&quot;">
      <data key="d0">"POPULATION SUBGROUP"</data>
      <data key="d1">"The asthma population had a higher average age and BMI compared to controls."&lt;SEP&gt;"The second most frequent haplotype was associated with asthma."</data>
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
    </node>
    <node id="&quot;FEV1&quot;% PREDICTION&quot;">
      <data key="d0">"LUNG FUNCTION PARAMETER"</data>
      <data key="d1">"Reduced % predicted FEV1 was observed in asthmatic patients compared to healthy controls."</data>
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
    </node>
    <node id="&quot;FVC&quot;% PREDICTION&quot;">
      <data key="d0">"LUNG FUNCTION PARAMETER"</data>
      <data key="d1">"Reduced % predicted FVC was also observed in the asthma population."</data>
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
    </node>
    <node id="&quot;FEV1/FVC RATIO&quot;">
      <data key="d0">"LUNG FUNCTION PARAMETER"</data>
      <data key="d1">"Lower FEV1/FVC ratios were noted in asthmatic patients."</data>
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
    </node>
    <node id="&quot;TOTAL IGE&quot;">
      <data key="d0">"IMMUNOLOGICAL PARAMETER"</data>
      <data key="d1">"Increased total IgE was observed in asthmatic patients."&lt;SEP&gt;"Increased total IgE was observed in the asthma population."</data>
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
    </node>
    <node id="&quot;ATOPY&quot;">
      <data key="d0">"CLINICAL FEATURE"</data>
      <data key="d1">"A significantly higher proportion of cases compared to controls were found to be atopic."&lt;SEP&gt;"More cases than controls were found to be atopic."</data>
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
    </node>
    <node id="&quot;TSLP SNPS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNP rs1898671 showed nominal association with asthma."</data>
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
    </node>
    <node id="&quot;EX-SMOKER SUBGROUP&quot;">
      <data key="d0">"POPULATION SUBGROUP"</data>
      <data key="d1">"Increased risk of asthma was noted for ex-smokers carrying SNP rs1898671."</data>
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
    </node>
    <node id="&quot;NEVER-SMOKER SUBGROUP&quot;">
      <data key="d0">"POPULATION SUBGROUP"</data>
      <data key="d1">"SNP rs1898671 did not show significant association with asthma in never-smokers."</data>
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
    </node>
    <node id="&quot;REPLICATION COHORT&quot;">
      <data key="d0">"COMBINED DATA SET"</data>
      <data key="d1">"Analysis of the large APCAT cohort supported the association of SNP rs1898671 and asthma."</data>
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
    </node>
    <node id="&quot;EX-SMOKER SUBGROUP REPLICATION&quot;">
      <data key="d0">"POPULATION SUBGROUP"</data>
      <data key="d1">"SNP rs1898671 validated its effect on asthma risk in ex-smokers."</data>
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
    </node>
    <node id="&quot;NEVER-SMOKER SUBGROUP REPLICATION&quot;">
      <data key="d0">"POPULATION SUBGROUP"</data>
      <data key="d1">"No significant association found for SNP rs1898671 in never-smokers."</data>
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
    </node>
    <node id="&quot;TSLP HAPLOTYPE GAGGGCAAAG&quot;">
      <data key="d0">"HAPLOTYPE"</data>
      <data key="d1">"This haplotype showed a significant increased risk with asthma after adjustment."</data>
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
    </node>
    <node id="&quot;RACE/ETHNICITY&quot;">
      <data key="d0">"DEMOGRAPHIC/ CLINICAL FEATURE"</data>
      <data key="d1">"There was a difference in race/ethnicity between cases and controls, with p=0.01."</data>
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
    </node>
    <node id="&quot;PRINCIPAL COMPONENT SCORES&quot;">
      <data key="d0">"PCA DATA POINT"</data>
      <data key="d1">"The first principal component scores showed separation between the non-Hispanic white group and the non-Hispanic black group."</data>
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
    </node>
    <node id="&quot;STRUCTURAL POPULATION INFORMATION&quot;">
      <data key="d0">"POPULATION STRATIFICATION METHOD OUTPUT"</data>
      <data key="d1">"The STRUCTURE method estimated that each subject's ancestry is a blend of multiple underlying populations based on their principal component scores."</data>
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
    </node>
    <node id="&quot;ANCESTRY MARKERS&quot;">
      <data key="d0">"ANCESTRY DATA POINT"</data>
      <data key="d1">"More than 80% of variability in ancestry markers was explained by the first five principal components, accounting for over 80% of total variance."</data>
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
    </node>
    <node id="&quot;ASTHMA&quot;">
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68&lt;SEP&gt;chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
      <data key="d1">"Asthma is a chronic inflammatory disease affecting the airways."&lt;SEP&gt;"SNP rs1898671 showed a nominal association with asthma susceptibility.")</data>
      <data key="d0">"DISEASE"</data>
    </node>
    <node id="&quot;EX-SMOKERS&quot;">
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
      <data key="d1">"The SNP's risk for asthma was increased in ex-smoker subgroups.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NEVER-SMOKERS&quot;">
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
      <data key="d1">"SNP rs1898671 did not show significant association with asthma in never-smokers.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LARGE DATA SET&quot;">
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
      <data key="d1">"The replication cohort validated the association of SNP rs1898671 with asthma.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;REPLICATION COHORT 6 COAHS&quot;">
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
      <data key="d1">"The replication cohort validated the association of SNP rs1898671 with asthma.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;EX-SMOKERS IN REPLICATION COHORT&quot;">
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
      <data key="d1">"SNP rs1898671's effect on asthma risk was confirmed in ex-smoker subgroups.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NEVER-SMOKERS IN REPLICATION COHORT&quot;">
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
      <data key="d1">"No significant association found for SNP rs1898671 in never-smokers.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ASTHMATIC PATIENT SUBGROUP&quot;">
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
      <data key="d1">"Cases showed differences such as age and BMI compared to healthy control group.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CLINICAL POPULATION GROUP&quot;">
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
      <data key="d1">"Cases showed differences such as age and BMI compared to healthy control group.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;POPULATION STRATIFICATION COMPONENT&quot;">
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
      <data key="d1">"PCA revealed clear separation between the non-Hispanic white group and other groups.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;AGE DIFFERENCE&quot;">
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
      <data key="d1">"The asthma population had a higher average age compared to healthy controls.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;COMPARISON BETWEEN GROUPS&quot;">
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
      <data key="d1">"The asthma population had a higher average age compared to healthy controls.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;BMI COMPARISON&quot;">
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
      <data key="d1">"Asthmatic patients had significantly higher BMI values than healthy control participants.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CLINICAL FEATURE COMPARISON&quot;">
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
      <data key="d1">"There was a statistically significant difference in race/ethnicity between the asthmatic patient group and the healthy controls, with p=0.01.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RACE/ETHNICITY DIFFERENCE&quot;">
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
      <data key="d1">"There was a statistically significant difference in race/ethnicity between the asthmatic patient group and the healthy controls, with p=0.01.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DIFFERENCES BETWEEN GROUPS&quot;">
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
      <data key="d1">"Reduced FEV1%, FVC% and FEV1/FVC ratios were noted specifically in asthma patients compared to healthy individuals.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LUNG FUNCTION PARAMETER REDUCTIONS&quot;">
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
      <data key="d1">"Reduced FEV1%, FVC% and FEV1/FVC ratios were noted specifically in asthma patients compared to healthy individuals.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;COMPARISON OF IMMOBILE PARAMETERS&quot;">
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
      <data key="d1">"Increased total IgE levels were a characteristic feature seen exclusively among asthmatic patients.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TOTAL IGE INCREASE&quot;">
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
      <data key="d1">"Increased total IgE levels were a characteristic feature seen exclusively among asthmatic patients.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ATOPY PROPORTION&quot;">
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
      <data key="d1">"A significantly greater proportion of asthmatic patients demonstrated atopic characteristics compared to healthy controls, with p=0.01.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS1893217&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"One of the four SNPs found in PTPN2, not significant in CD compared to healthy controls."</data>
      <data key="d2">chunk-84ec948f22126cef7d93b1d7465b79db</data>
    </node>
    <node id="&quot;RS2542151&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Another one of the four SNPs found in PTPN2, not significant in CD compared to healthy controls."</data>
      <data key="d2">chunk-84ec948f22126cef7d93b1d7465b79db</data>
    </node>
    <node id="&quot;RS7234029&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"One of the four SNPs found in PTPN2, not significant in CD compared to healthy controls."</data>
      <data key="d2">chunk-84ec948f22126cef7d93b1d7465b79db</data>
    </node>
    <node id="&quot;RS478582&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Significant SNP found in both PTPN2 and CD subjects compared to healthy controls."</data>
      <data key="d2">chunk-84ec948f22126cef7d93b1d7465b79db</data>
    </node>
    <node id="&quot;RS2476601&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"One of the five SNPs specific to PTPN22, not considered significant in CD compared to healthy controls."&lt;SEP&gt;"The genomic variant rs2476601 is associated with several autoimmune disorders."&lt;SEP&gt;"One of the genome-wide significant SNPs for general IgM identified during our analysis of IgM anti-PC GWAS."</data>
      <data key="d2">chunk-84ec948f22126cef7d93b1d7465b79db&lt;SEP&gt;chunk-0dc1ddaa86432d222da7fc75090f700a&lt;SEP&gt;chunk-dee0a8a550579bff19f48d41446e842d</data>
    </node>
    <node id="&quot;RS2488457&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Not considered in the analysis due to lack of significance."</data>
      <data key="d2">chunk-84ec948f22126cef7d93b1d7465b79db</data>
    </node>
    <node id="&quot;RS33996649&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Not considered in the analysis due to lack of significance."</data>
      <data key="d2">chunk-84ec948f22126cef7d93b1d7465b79db</data>
    </node>
    <node id="&quot;RS34209542&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Not considered in the analysis due to lack of significance."</data>
      <data key="d2">chunk-84ec948f22126cef7d93b1d7465b79db</data>
    </node>
    <node id="&quot;RS2476599&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Not considered in the analysis due to lack of significance."</data>
      <data key="d2">chunk-84ec948f22126cef7d93b1d7465b79db</data>
    </node>
    <node id="&quot;PTPN2:RS478582&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Specific SNPs of PTPN2:rs478582 associated with CD subjects."&lt;SEP&gt;"The rs478582 variant in the PTPN2 gene was studied for its impact on gene expression and disease susceptibility."&lt;SEP&gt;"This SNP in PTPN2 is associated with increased IFN-γ expression in CD subjects with certain genotypes."</data>
      <data key="d2">chunk-6cb127717713bd0ab5be9436fc0c7568&lt;SEP&gt;chunk-883c371ea1f500a1ba8af8366328e8b0&lt;SEP&gt;chunk-6a657cd0a000b6df4db8f1305b795021</data>
      <data key="d3">[{"level": 0, "cluster": 15}, {"level": 1, "cluster": 53}]</data>
    </node>
    <node id="&quot;TC ALLELES&quot;">
      <data key="d0">"ALLELE"</data>
      <data key="d1">"Having either heterozygous (TC) or minor (CC) alleles of rs478582 was associated with lower CD average relative gene expression."</data>
      <data key="d2">chunk-6cb127717713bd0ab5be9436fc0c7568</data>
    </node>
    <node id="&quot;P-VALUE&quot;">
      <data key="d0">"STATISTICAL MEASURE"</data>
      <data key="d1">"Comparisons with a P-value &lt; 0.05 indicated significant differences in relative gene expression."&lt;SEP&gt;"P-values &lt; 0.05 indicated significant differences in relative gene expression of IFN-γ between CD and healthy control groups."&lt;SEP&gt;"The P-values were &lt; 0.05, indicating statistical significance in comparisons."</data>
      <data key="d2">chunk-6cb127717713bd0ab5be9436fc0c7568</data>
    </node>
    <node id="&quot;CC ALLELES&quot;">
      <data key="d0">"ALLELE"</data>
      <data key="d1">"Having homozygous (CC) alleles of rs478582 was associated with a lower average relative gene expression compared to the healthy controls."</data>
      <data key="d2">chunk-6cb127717713bd0ab5be9436fc0c7568</data>
    </node>
    <node id="&quot;GA OR AA ALLELES&quot;">
      <data key="d0">"VARIANT IN PTPN2:RS2476601"</data>
      <data key="d1">"The rs2476601 variant in the PTPN2 gene did not change expression when compared with normal (GG) subjects, but showed lower average relative gene expression in CD subjects."&lt;SEP&gt;"The variant did not show change when comparing to normal (GG) genotypes, but exhibited lower average relative gene expression in CD subjects."</data>
      <data key="d2">chunk-6cb127717713bd0ab5be9436fc0c7568</data>
    </node>
    <node id="&quot;AA ALLELES RARE&quot;">
      <data key="d0">"GENOTYPE"</data>
      <data key="d1">"The minor (AA) genotypes for rs2476601 were very uncommon among all subjects."</data>
      <data key="d2">chunk-6cb127717713bd0ab5be9436fc0c7568</data>
    </node>
    <node id="&quot;HETEROZYGOUS (TC) OR MINOR (CC) ALLELES&quot;">
      <data key="d0">"GENOMIC VARIANT PTPN2:RS478582"</data>
      <data key="d1">"These genotypes were associated with a higher rate of MAPbacteremia presence among the CD group compared to healthy controls."&lt;SEP&gt;"These variants were associated with significantly higher average relative gene expression in IFN-γ among the CD group compared to normal subjects."</data>
      <data key="d2">chunk-6cb127717713bd0ab5be9436fc0c7568</data>
    </node>
    <node id="&quot;HETEROZYGOUS (GA) OR MINOR (AA) ALLELES&quot;">
      <data key="d0">"GENOMIC VARIANT PTPN22:RS2476601"</data>
      <data key="d1">"These variants were uncommon among all subjects and showed no significant change in IFN-γ gene expression in CD subjects."</data>
      <data key="d2">chunk-6cb127717713bd0ab5be9436fc0c7568</data>
    </node>
    <node id="&quot;OR = 17.5, CI: 5.65-54.3&quot;">
      <data key="d0">"ODDS RATIO AND CONFIDENCE INTERVAL"</data>
      <data key="d1">"An odds ratio greater than 1 indicates an increased risk for MAP infection in individuals with PTPN2:rs478582."</data>
      <data key="d2">chunk-6cb127717713bd0ab5be9436fc0c7568</data>
    </node>
    <node id="&quot;AA ALLELES&quot;">
      <data key="d0">"ALLELE"</data>
      <data key="d1">"Having AA alleles for rs6980683 was linked to lower average relative gene expression of IFN-γ compared to other genotypes."</data>
      <data key="d2">chunk-6cb127717713bd0ab5be9436fc0c7568</data>
    </node>
    <node id="&quot;CD&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"CD (Celiac Disease) is linked to SNPs in the PTPN2 gene."&lt;SEP&gt;"Condition characterized by the symptoms and signs mentioned, with a genetic predisposition indicated by SNPs in PTPN2 and PTPN22."</data>
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0&lt;SEP&gt;chunk-6a657cd0a000b6df4db8f1305b795021</data>
    </node>
    <node id="&quot;PTPN22:RS2476601&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNPs of PTPN22:rs2476601 associated with presence of MAPbacteremia."&lt;SEP&gt;"This SNP in PTPN22 affects T-cell functionality and response when combined with MAPbacteremia."</data>
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0&lt;SEP&gt;chunk-6a657cd0a000b6df4db8f1305b795021</data>
    </node>
    <node id="&quot;MAPBACTEREMIA&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Presence of MAPbacteremia correlated with specific SNPs in the PTPN2 gene."&lt;SEP&gt;"Presence of MAPbacteremia was noted to influence T-cell proliferation response."</data>
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0&lt;SEP&gt;chunk-6a657cd0a000b6df4db8f1305b795021</data>
    </node>
    <node id="&quot;CD SUBJECTS&quot;">
      <data key="d0">"SUBJECT"</data>
      <data key="d1">"CD subjects are individuals diagnosed with Celiac Disease."</data>
      <data key="d2">chunk-6a657cd0a000b6df4db8f1305b795021</data>
      <data key="d3">[{"level": 0, "cluster": 15}, {"level": 1, "cluster": 51}]</data>
    </node>
    <node id="&quot;PHA&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Treatment with PHA resulted in a fold change increase in T-cell proliferation compared to healthy controls."</data>
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
    </node>
    <node id="&quot;MAP PPD-LIKE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"When treated with MAP PPD-like, the average fold change in CD subjects was higher than in healthy controls."</data>
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
    </node>
    <node id="&quot;CD SUBJECTS WITHOUT MAPBACTEREMIA AND PTPN2:RS478582/PTPN22:RS2476601&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The T-cell response of these subjects showed less fold change compared to those with specific genotypes."</data>
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
    </node>
    <node id="&quot;CD SUBJECTS WITH MAPBACTEREMIA AND SNPS IN PTPN2 OR PTPN22&quot;">
      <data key="d0">"CONDITION"</data>
      <data key="d1">"These subjects had a higher average overall fold change compared to CD subjects without MAPbacteremia presence."</data>
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
    </node>
    <node id="&quot;T-CELLS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The function and response of T-cells, influenced by SNPs, MAPbacteremia presence, and molecular interactions."</data>
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
    </node>
    <node id="&quot;HAPLOTYPE T-G&quot;">
      <data key="d2">chunk-84ec948f22126cef7d93b1d7465b79db</data>
      <data key="d1">"The Haplotype combination of T-G (major/major) was more significantly present among healthy controls compared to CD subjects.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HAPLOTYPE C-G&quot;">
      <data key="d2">chunk-84ec948f22126cef7d93b1d7465b79db</data>
      <data key="d1">"The Haplotype combination of C-G (heterozygous or minor/major) and C-A (heterozygous or minor/heterozygous or minor) was more significantly present among CD subjects compared to healthy controls.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;EXPRESSION OF PTPN2 AND IFN-Γ&quot;">
      <data key="d2">chunk-84ec948f22126cef7d93b1d7465b79db</data>
      <data key="d1">"The presence of rs2476601 was not significantly associated with differences in expression levels of PTPN2 or the cytokine IFN-γ in CD subjects compared to healthy controls." )</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;OR = 17.5, CI: 5.65-54.3&quot;&amp;&quot;RISK FACTOR COMPARISON&quot;&amp;&quot;INCREASED RISK OF DISEASE&quot;">
      <data key="d2">chunk-6cb127717713bd0ab5be9436fc0c7568</data>
      <data key="d1">1("entity"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;THE ODDS RATIO COMPARISONS SHOWED A STATISTICALLY SIGNIFICANT INCREASE IN DISEASE RISK ASSOCIATED WITH PTPN2:RS478582.&quot;)">
      <data key="d2">chunk-6cb127717713bd0ab5be9436fc0c7568</data>
      <data key="d1">1("entity"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CELIAC DISEASE&quot;">
      <data key="d2">chunk-6a657cd0a000b6df4db8f1305b795021</data>
      <data key="d1">"SNPs of PTPN2:rs478582 are associated with the risk and manifestation of Celiac Disease.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 15}, {"level": 1, "cluster": 51}]</data>
    </node>
    <node id="&quot;HETEROZYGOUS ALLELES&quot;">
      <data key="d2">chunk-6a657cd0a000b6df4db8f1305b795021</data>
      <data key="d1">"Specific SNPs show higher presence in individuals with heterozygous (TC) alleles.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 15}, {"level": 1, "cluster": 52}]</data>
    </node>
    <node id="&quot;PRESENCE OF MAPBACTEREMIA&quot;">
      <data key="d2">chunk-6a657cd0a000b6df4db8f1305b795021</data>
      <data key="d1">"CD subjects are more likely to exhibit MAPbacteremia when specific PTPN2:rs478582 SNPs are present.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 15}, {"level": 1, "cluster": 51}]</data>
    </node>
    <node id="&quot;NO MAPBACTEREMIA OR SPECIFIC SNPS&quot;">
      <data key="d2">chunk-6a657cd0a000b6df4db8f1305b795021</data>
      <data key="d1">"Healthy controls exhibit none or lower levels of both MAPbacteremia and the studied SNPs.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 15}, {"level": 1, "cluster": 52}]</data>
    </node>
    <node id="&quot;SNPS IN PTPN2 AND PTPN22&quot;">
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
      <data key="d1">"These SNPs influence T-cell proliferation response when exposed to PHA or MAP PPD-like molecules.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 12}, {"level": 1, "cluster": 39}]</data>
    </node>
    <node id="&quot;MAPBACTEREMIA PRESENCE&quot;">
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
      <data key="d1">"Alteration of T-cell response when specific pathogens are present in the environment, affecting physiological processes.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 11}, {"level": 1, "cluster": 35}]</data>
    </node>
    <node id="&quot;PTPN22&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The PTPN22 gene is associated with lymphocyte subsets and their activation states."&lt;SEP&gt;"The PTPN22 gene plays a crucial role in modulating T-cell function and differentiation."&lt;SEP&gt;"The expression of PTPN22 is shown to differ between Treg and non-regulatory (Tconv) cells, impacting their roles in autoimmune disorders."</data>
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d&lt;SEP&gt;chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
    </node>
    <node id="&quot;NAIVE TCONV&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"Naive Tconv cells express significantly less PTPN22 transcripts compared to memory Tconv and Tregs."&lt;SEP&gt;"The naive Tconv cells increased 12.00±5.45 fold after activation."</data>
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
    </node>
    <node id="&quot;MEMORY TCONV&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"Memory Tconv cells increased by 4.01±0.89 fold compared to their resting state, showing a significantly lower increase than naive Tconv."&lt;SEP&gt;"Memory Tconv cells show higher expression of PTPN22 transcripts than naive Tconv and Tregs."</data>
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
    </node>
    <node id="&quot;TREG&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"Data highlight the role of regulatory T cells (Tregs) in modulating immune responses."&lt;SEP&gt;"The Treg cells showed an increase of 2.85±1.31 fold in PTPN22 expression following activation (significantly less than naive and memory Tcells)."&lt;SEP&gt;"Tregs exhibit the highest PTPN22 transcript levels compared to naive Tconv and memory Tconv."</data>
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d&lt;SEP&gt;chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
    </node>
    <node id="&quot;POLYCLONAL ACTIVATION&quot;">
      <data key="d0">"ACTIVATION STATE"</data>
      <data key="d1">"In vitro polyclonal activation leads to a rapid increase in PTPN22 expression in all three subsets (naive Tconv, memory Tconv, and Treg)."</data>
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
    </node>
    <node id="&quot;LYP-620R&quot;">
      <data key="d0">"PROTEIN VARIANT"</data>
      <data key="d1">"LYP-620R is the non-risk variant of PTPN22 encoding amino acid 620."&lt;SEP&gt;"Overexpression of LYP-620R results in reduced APC-mediated proliferation of both Tconv and Treg cells compared to controls."</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7&lt;SEP&gt;chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
    </node>
    <node id="&quot;LYP-620W&quot;">
      <data key="d0">"PROTEIN VARIANT"</data>
      <data key="d1">"LYP-620W represents the risk variant of PTPN22 encoding amino acid 620, associated with T-cell dysfunction."&lt;SEP&gt;"LYP-620W shows a differential impact on Treg proliferation, being able to block it to the same degree as LYP-620R."</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7&lt;SEP&gt;chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
    </node>
    <node id="&quot;CALCIUM SIGNALING&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Calcium signaling is a critical pathway for downstream events following TCR ligation and affects the expression of several genes including PTPN22."</data>
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
    </node>
    <node id="&quot;MAPK/ERK PATHWAY&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The MAPK/ERK (mitogen-activated protein kinase/extracellular signal-regulated kinase) pathway is interconnected with calcium signaling in modulating T-cell responses and the expression of PTPN22."</data>
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
    </node>
    <node id="&quot;PERK&quot;">
      <data key="d0">"SIGNAL MARKER"</data>
      <data key="d1">"The level of phosphorylated ERK (pERK) is a measure of activity within the MAPK/ERK pathway, which correlates with downstream TCR signaling events."</data>
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
    </node>
    <node id="&quot;CA2+ FLUX&quot;">
      <data key="d0">"CALCIUM MEASUREMENT"</data>
      <data key="d1">"Calcium flux quantifies changes in intracellular calcium levels as a response to T-cell receptor (TCR) activation, impacting PTPN22 expression and function."</data>
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
    </node>
    <node id="&quot;CD69&quot;">
      <data key="d0">"ACTIVATION MARKER"</data>
      <data key="d1">"CD69 is dynamically expressed following Tconv activation."&lt;SEP&gt;"The CD69 molecule is an early marker of T-cell activation which is upregulated shortly after TCR ligation and correlates with the activity of downstream signaling cascades like MAPK/ERK and PTPN22-related pathways."</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7&lt;SEP&gt;chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
    </node>
    <node id="&quot;ICOS&quot;">
      <data key="d0">"ACTIVATION MARKER"</data>
      <data key="d1">"ICOS expression kinetics are involved in Treg activation."&lt;SEP&gt;"Inducible costimulatory (ICOS) molecule serves as a co-stimulatory receptor on T-cells following activation and modulates several functions, including PTPN22 expression."</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7&lt;SEP&gt;chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
    </node>
    <node id="&quot;CD25&quot;">
      <data key="d0">"ACTIVATION MARKER"</data>
      <data key="d1">"CD25, an integral part of the IL-2 receptor, is dramatically upregulated after activation."&lt;SEP&gt;"The CD25 molecule, also known as IL-2 receptor alpha-chain (IL2Rα), is another early marker for T-cell activation which can influence the levels of PTPN22."</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7&lt;SEP&gt;chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
    </node>
    <node id="&quot;CD226&quot;">
      <data key="d0">"ACTIVATION MARKER"</data>
      <data key="d1">"Also known as NKG2D or NKp46, CD226 acts as a co-stimulatory receptor on T-cells and is involved in modulating gene expression patterns including that of PTPN22."&lt;SEP&gt;"CD226 expression kinetics involve intensification followed by a reduction in surface expression during Tconv activation."</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7&lt;SEP&gt;chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
    </node>
    <node id="&quot;PD-1&quot;">
      <data key="d0">"CO-INHIBITORY RECEPTOR"</data>
      <data key="d1">"Like CD69, ICOS, and CD226, PD-1 expression kinetics involve an intensification followed by a reduction in surface expression following Tconv activation."&lt;SEP&gt;"Programmable death protein 1 (PD-1) is a checkpoint receptor whose interaction with ligands can inhibit T-cell activity and, thus, may influence the expression or function of genes like PTPN22."</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7&lt;SEP&gt;chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
    </node>
    <node id="&quot;APCS (ANTIGEN PRESENTING CELLS)&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"Antigen presenting cells are critical for initiating immune responses by presenting antigens to T-cells and can modulate gene expression patterns like that of PTPN22."</data>
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
    </node>
    <node id="&quot;AUTOIMMUNE DISEASE RISK&quot;">
      <data key="d0">"PATHOLOGICAL FACTOR"</data>
      <data key="d1">"The presence of the risk variant (LYP-620W) in the PTPN22 gene is linked with an increased risk for autoimmune diseases through its impact on T-cell function and regulation."</data>
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
    </node>
    <node id="&quot;CTLA-4&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"CTLA-4 is also observed to be dynamically expressed after Treg activation."</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
    </node>
    <node id="&quot;TCONV&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Tconv cells are mentioned as contrast to Treg cells, indicating different immune cell types."&lt;SEP&gt;"Tconv cells exhibit blunted activation marker kinetics upon overexpression of LYP-620R compared to mock-transfected controls."</data>
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d&lt;SEP&gt;chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
    </node>
    <node id="&quot;TREGS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Treg cells also show blunted activation marker kinetics when overexpressing LYP-620R, except for CD226 on Tconv."</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
    </node>
    <node id="&quot;CD3+ AND CD28+ CELLS&quot;">
      <data key="d0">"ACTIVATION MARKER KINETICS"</data>
      <data key="d1">"The kinetics of activation marker expressions were observed in response to anti-CD3 and anti-CD28 stimulation."</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
    </node>
    <node id="&quot;PD-L1&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"PD-L1, an interaction partner of PD-1, plays a role in inhibiting the immune response."</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
    </node>
    <node id="&quot;CD28&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"CD28 is co-stimulatory receptor that promotes T-cell activation and survival with CD3 stimulation."</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
    </node>
    <node id="&quot;TAP1&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"TAP1 protein facilitates the translocation of antigen peptides into the endoplasmic reticulum for presentation on MHC class I molecules."</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
    </node>
    <node id="&quot;MHC CLASS II&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"MHC class II molecules present antigens to CD4+ T cells for recognition during adaptive immune responses."</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
    </node>
    <node id="&quot;CD208 (DC-SIGN)">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"DC-SIGN is a C-type lectin that plays a role in antigen presentation and adhesion of dendritic cells with B cells, monocytes or other leukocytes."</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
    </node>
    <node id="&quot;LYP&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Data suggest that LYP gene variants may influence immune responses."</data>
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
    </node>
    <node id="&quot;LYP VARIANT 620R&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Variants of the LYP gene show different effects on immune response regulation."</data>
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
    </node>
    <node id="&quot;LYP VARIANT 620W&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Similar to variant 620R, but with reduced efficacy in certain contexts."</data>
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
    </node>
    <node id="&quot;TH1 SIGNATURE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A Th1 cell signature is implicated in several autoimmune disorders associated with a particular genetic variant, but this was not observed when examining LYP variants."&lt;SEP&gt;"A Th1 cell signature is implicated in the autoimmune disorders associated with a specific risk variant."</data>
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
    </node>
    <node id="&quot;IFNΓ&quot;">
      <data key="d0">"CYTOKINE"</data>
      <data key="d1">"Interferon-gamma (IFNγ) is produced by CAR T cells in response to OAS4 and OAS7 cells, but not OAS3 cells."&lt;SEP&gt;"The secretion of interferon-gamma (IFNγ) by T cells, which is affected by the expression of PTPN22."</data>
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d&lt;SEP&gt;chunk-183db5c908df609bb5289896b4ba09d0</data>
    </node>
    <node id="&quot;APCS&quot;">
      <data key="d0">"ANTIGEN PRESENTING CELLS"</data>
      <data key="d1">"Autologous APCs play a role in immune responses as they present antigens to T cell receptors."</data>
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
    </node>
    <node id="&quot;TRESP&quot;">
      <data key="d0">"T CELL RESPONSE"</data>
      <data key="d1">"Transduced T cell response is influenced by the expression of LYP variants, with 620R showing greater repression than 620W."</data>
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
    </node>
    <node id="&quot;TREG-MEDIATED SUPPRESSION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The capacity of regulatory T cells to suppress immune responses, which is altered when PTPN22 expression is influenced by LYP variant."</data>
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
    </node>
    <node id="&quot;SUPPRESSION CAPACITY&quot;">
      <data key="d0">"BIOLOGICAL PROCESS"</data>
      <data key="d1">"The ability of Tregs to modulate or inhibit the function of other T cells was assessed under different genetic conditions."</data>
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
    </node>
    <node id="&quot;IFNΓ SECRETION&quot;">
      <data key="d0">"CYTOKINE PROCESS"</data>
      <data key="d1">"The secretion of interferon-gamma (IFNγ) by T cells plays a role in autoimmune disorders."</data>
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
    </node>
    <node id="&quot;AUTOMIMMUNE DISORDERS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Autoimmune disorders are linked to certain genetic variants and immune cell signatures, such as the Th1 signature."</data>
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
    </node>
    <node id="&quot;TREG PROLIFERATION&quot;">
      <data key="d0">"CELLULAR PROCESS"</data>
      <data key="d1">"The proliferation of regulatory T (Treg) cells may be modulated by genetic factors like LYP gene variants."</data>
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
    </node>
    <node id="&quot;APCS SUPPRESSION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Antigen presenting cells (APCs) and regulatory T cell interactions are influenced in autoimmune disorders."</data>
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
    </node>
    <node id="&quot;T CELL RESPONSE MODULATION&quot;">
      <data key="d0">"BIOLOGICAL PROCESS"</data>
      <data key="d1">"The ability to modulate or inhibit the function of T cells is a critical process in immune regulation, which is influenced by genetic variants like rs2476601 and LYP gene variants."</data>
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
    </node>
    <node id="&quot;CD4+ T CELLS&quot;">
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca&lt;SEP&gt;chunk-5b68770e1b446d6cba0d4e1ecabf497b&lt;SEP&gt;chunk-daf8d8b6d90cc3f92b645357f7c1294b&lt;SEP&gt;chunk-1b40d071abac0ba432a9fb0096796f45</data>
      <data key="d1">"CD4+ T cells were specifically analyzed for their differential response to the genomic variant and gene expression."&lt;SEP&gt;"Endogenous PTPN22 expression varies across different subsets of CD4+ T cells (naive, memory, and regulatory) at rest and post-activation.")&lt;SEP&gt;"The effect on trans-eQTL analysis was specific to CD4+ T cells, not detected in CD8+ T cells."&lt;SEP&gt;"We purified CD4+ T cells from peripheral blood mononuclear cells (PBMCs) of European individuals."</data>
      <data key="d0">"CELL TYPE"</data>
    </node>
    <node id="&quot;ACTIVATION STATE&quot;">
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
      <data key="d1">"The level of PTPN22 expression is higher in activated compared to quiescent states for all analyzed CD4+ T cell subsets.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PTPN22 EXPRESSION&quot;">
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
      <data key="d1">"The level of PTPN22 expression is higher in activated compared to quiescent states for all analyzed CD4+ T cell subsets.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PTPN22 GENE&quot;">
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
      <data key="d1">"The PTPN22 gene, encoded by different variants like LYP-620R or LYP-620W, plays a role in modulating immune responses including T-cell function and differentiation.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ROLE IN IMMUNE REGULATION&quot;">
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
      <data key="d1">"The PTPN22 gene, encoded by different variants like LYP-620R or LYP-620W, plays a role in modulating immune responses including T-cell function and differentiation.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DOWNSTREAM EFFECTS ON PTPN22&quot;">
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
      <data key="d1">"Calcium signaling pathways affect the expression of PTPN22 by impacting key processes like MAPK/ERK pathway activity, influencing downstream effects in T-cell function and autoimmune disease risk.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CONNECTION TO CALCIUM SIGNALING&quot;">
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
      <data key="d1">"The MAPK/ERK pathway is interconnected with calcium signaling pathways, both impacting the expression of PTPN22 through coordinated regulatory mechanisms in T-cell function and autoimmune disease risk.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PERK MARKER&quot;">
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
      <data key="d1">"The level of pERK serves as a marker for activity within the MAPK/ERK pathway, which has downstream effects on several processes including PTPN22 expression and T-cell function.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SIGNIFICANCE IN DOWNSTREAM EVENTS&quot;">
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
      <data key="d1">"The level of pERK serves as a marker for activity within the MAPK/ERK pathway, which has downstream effects on several processes including PTPN22 expression and T-cell function.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RESPONSE TO TCR LIGATION&quot;">
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
      <data key="d1">"Calcium flux quantifies changes in intracellular calcium levels as a response to T-cell receptor (TCR) ligation, affecting downstream signaling cascades including those involved with PTPN22 expression and function.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CD69 MARKER&quot;">
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
      <data key="d1">"The CD69 molecule serves as an early marker for T-cell activation which correlates with the expression levels of genes like PTPN22, impacting downstream signaling pathways and immune responses.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;EARLY T-CELL ACTIVATION SIGN&quot;">
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
      <data key="d1">"The CD69 molecule serves as an early marker for T-cell activation which correlates with the expression levels of genes like PTPN22, impacting downstream signaling pathways and immune responses.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ICOS RECEPTOR&quot;">
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
      <data key="d1">"The inducible costimulatory (ICOS) molecule acts as a co-stimulatory receptor on T-cells during activation processes, influencing gene expression patterns including PTPN22.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MODULATION BY ACTIVATED T-CELLS&quot;">
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
      <data key="d1">"The inducible costimulatory (ICOS) molecule acts as a co-stimulatory receptor on T-cells during activation processes, influencing gene expression patterns including PTPN22.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CD25 MARKER&quot;">
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
      <data key="d1">"The CD25 molecule, also known as IL2Rα, serves as an indicator of early T-cell activation and modulates the expression of genes such as PTPN22 through its regulatory activities.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;T-CELL ACTIVATION INDICATORS&quot;">
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
      <data key="d1">"The CD25 molecule, also known as IL2Rα, serves as an indicator of early T-cell activation and modulates the expression of genes such as PTPN22 through its regulatory activities.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CD226 RECEPTOR&quot;">
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
      <data key="d1">"The CD226 receptor, also known as NKG2D or NKp46, plays a role in co-stimulating immune responses on T-cells and influences downstream regulatory mechanisms involving PTPN22 expression.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CO-STIMULATION ROLE IN IMMUNE REGULATION&quot;">
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
      <data key="d1">"The CD226 receptor, also known as NKG2D or NKp46, plays a role in co-stimulating immune responses on T-cells and influences downstream regulatory mechanisms involving PTPN22 expression.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PD-1 CO-INHIBITORY RECEPTOR&quot;">
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
      <data key="d1">"The PD-1 receptor, alongside its ligands, contributes to immune suppression through inhibiting T-cell activity. This can have indirect effects on the regulation of genes like PTPN22 and T-cell function.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ROLE IN IMMUNE SUPPRESSION&quot;">
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
      <data key="d1">"The PD-1 receptor, alongside its ligands, contributes to immune suppression through inhibiting T-cell activity. This can have indirect effects on the regulation of genes like PTPN22 and T-cell function.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;APC CELL TYPE&quot;">
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
      <data key="d1">"Antigen-presenting cells (APCs) play a crucial role in initiating immune responses by presenting antigens to T-cells, which can modulate the expression and activity of genes like PTPN22 involved in T-cell regulation.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ROLE IN IMMUNE RESPONSE INITIATION&quot;">
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
      <data key="d1">"Antigen-presenting cells (APCs) play a crucial role in initiating immune responses by presenting antigens to T-cells, which can modulate the expression and activity of genes like PTPN22 involved in T-cell regulation.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CONNECTION VIA GENETIC VARIANTS&quot;">
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
      <data key="d1">"The presence of risk variants such as LYP-620W in the PTPN22 gene is linked with an increased risk for autoimmune diseases through its impact on modulating T-cell function and regulatory pathways.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;APC&quot;">
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d1">"Transduced Tconv cells show reduced APC-mediated proliferation upon overexpression of LYP-620R compared to mock-transfected controls.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TCONVE&quot;">
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d1">"Transduced Tconv cells show reduced APC-mediated proliferation upon overexpression of LYP-620R compared to mock-transfected controls.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CD4+ EFFECTOR T CELLS&quot;">
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d1">"CD4+ effector T cells modulate host immune responses through cytokine production after encountering cognate antigens.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL-2&quot;">
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7&lt;SEP&gt;chunk-183db5c908df609bb5289896b4ba09d0</data>
      <data key="d1">"Interleukin-2 (IL-2) is produced by TAG72-BBζ CAR T cells against OAS4 cells, but not OAS3 and OAS7 cells."&lt;SEP&gt;"Overexpression of PTPN22 influences IL-2 secretion; no alteration by LYP-620R, increase at the 24-hour time point by LYP-620W.")</data>
      <data key="d0">"CYTOKINE"</data>
    </node>
    <node id="&quot;INFLUENCE BY LYP VARIANTS&quot;">
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d1">"Overexpression of PTPN22 influences IL-2 secretion; no alteration by LYP-620R, increase at the 24-hour time point by LYP-620W.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL-4, IL-5, IL-9, IL-10, AND IL-13&quot;">
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d1">"The secretion of these cytokines was robustly inhibited by expression of either LYP variant for the first 48 hours.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INHIBITION BY PTPN22 VARIANTS&quot;">
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d1">"The secretion of these cytokines was robustly inhibited by expression of either LYP variant for the first 48 hours.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NO ALTERATION BY PTPN22 VARIANTS&quot;">
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d1">"IFNγ secretion is not altered by overexpression of either variant of LYP, despite its association with autoimmune disorders.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TCONV INTRINSIC SUSCEPTIBILITY&quot;">
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
      <data key="d1">"The LYP variant 620W affects the Tcell intrinsic susceptibility and modulates activation, proliferation, and effector mechanisms rather than impacting directly on suppressive functions of Tregs.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LYP VARIANT 620R&quot;/&quot;LYP VARIANT 620W&quot;">
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
      <data key="d1">"Data suggest that both LYP variants may influence immune responses but show different effects when compared to PTPN22 expression in Treg cells.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SUPPRESSION CAPACITY AND PROLIFERATION&quot;">
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
      <data key="d1">"While the suppression capacity of Tregs was slightly increased with variant 620W, no significant difference was observed in Treg proliferation compared to variants 620R or eGFP reporter Tregs.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;AUTOIMMUNE DISORDERS&quot;">
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
      <data key="d1">"The genomic variant rs2476601 affects the risk for several autoimmune disorders through its association with a Th1 cell signature and IFNγ secretion.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DISEASE ASSOCIATION&quot;">
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
      <data key="d1">"The Th1 signature associated with rs2476601 is involved in the development of autoimmune disorders.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TH1 SIGNATURE&quot;/&quot;RS2476601&quot;">
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
      <data key="d1">"The Th1 signature associated with rs2476601 is involved in the development of autoimmune disorders.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TAG72-CAR T CELLS&quot;">
      <data key="d0">"CELL"</data>
      <data key="d1">"TAG72-CAR T cells containing a 4-1BB intracellular co-stimulatory domain demonstrate in vitro activation against purified TAG72."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;4-1BB INTRACELLULAR CO-STIMULATORY DOMAIN&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The humanized scFv CC49, the human IgG4 Fc extracellular spacer lacking a CH2 domain (ΔCH2), and CD4 transmembrane domain are linked to the 4-1BB intracellular co-stimulatory domain for cell activation."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;CD3Ζ CYTOLYTIC DOMAIN&quot;">
      <data key="d0">"CELLULAR COMPONENT"</data>
      <data key="d1">"The CD3ζ cytolytic domain is a part of the TAG72-BBζ CAR construct, which contributes to cell proliferation and killing ability."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;HUMANIZED SCFV CC49&quot;">
      <data key="d0">"ANTIBODY"</data>
      <data key="d1">"A humanized antibody fragment that binds to TAG72 antigen, which is attached to the 4-1BB co-stimulatory domain."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;HUMAN IGG4 FC EXTRACELLULAR SPACER LACKING A CH2 DOMAIN (ΔCH2)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"This part of the Fc region provides a linker between scFv CC49 and CD3ζ cytolytic domain, without a CH2 domain."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;CD4 TRANSMEMBRANE DOMAIN&quot;">
      <data key="d0">"CELLULAR COMPONENT"</data>
      <data key="d1">"Part of the T-cell receptor complex that is involved in signal transduction for activation."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;TAG72-BBΖ CAR CONSTRUCT&quot;">
      <data key="d0">"MOLECULAR CONSTRUCTION"</data>
      <data key="d1">"A genetic modification to create T cells capable of specifically recognizing and killing cells expressing TAG72 antigen, using 4-1BB co-stimulatory domain and CD3ζ cytolytic domain."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;CD19T FOR CELL TRACKING&quot;">
      <data key="d0">"MARKER"</data>
      <data key="d1">"This truncated form of CD19 helps in tracking the CAR T cells during their manufacturing process."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;MOCK (UNTRANSDUCED) T CELLS&quot;">
      <data key="d0">"CELL"</data>
      <data key="d1">"T-cells that were not transduced with the TAG72-BBζ CAR construct for comparison."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;CD137 EXPRESSION&quot;">
      <data key="d0">"CYTOKINE AND CELL SURFACE MARKER"</data>
      <data key="d1">"Expression of this co-stimulatory molecule is a measure of T cell activation when cultured with plate-bound, but not soluble, purified TAG72."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;CELL-SURFACE CD69 EXPRESSION&quot;">
      <data key="d0">"CYTOKINE AND CELL SURFACE MARKER"</data>
      <data key="d1">"Another marker for T cell activation, which is induced by plate-bound TAG72."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;IFNΓ RELEASE&quot;">
      <data key="d0">"CYTOKINE"</data>
      <data key="d1">"Interferon gamma is a pro-inflammatory cytokine that indicates an active immune response against pathogens or tumor cells when induced by antigen-presenting cells (APCs)."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;OVCAR3 CELLS&quot;">
      <data key="d0">"CELL LINE"</data>
      <data key="d1">"Human ovarian cancer cell line expressing TAG72, used in various functional assays."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;OV90 CELLS&quot;">
      <data key="d0">"CELL LINE"</data>
      <data key="d1">"Human ovarian cancer cell line expressing a higher level of TAG72 compared to OVCAR3."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;COV362.4 CELLS&quot;">
      <data key="d0">"CELL LINE"</data>
      <data key="d1">"An ovarian cancer cell line with very low levels detected for TAG72 expression, used as negative control in the experiments."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;SKOV3 AND OVCAR8 CELLS&quot;">
      <data key="d0">"CELL LINE"</data>
      <data key="d1">"Cells that do not express TAG72 antigen or express it at a lower level, used for comparison to TAG72-expressing cell lines."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;LS174T&quot;">
      <data key="d0">"CELL LINE"</data>
      <data key="d1">"A colon cancer line expressing TAG72, used in some experiments to confirm the specificity of CAR T cells against ovarian cancer targets."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;OVCAR3 AND OV90 CELLS HARVESTED FROM ASCITES&quot;">
      <data key="d0">"TUMOR SAMPLE"</data>
      <data key="d1">"Cells isolated directly from tumor-bearing animals for in vitro evaluation of T cell activity against ovarian cancer."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;TAG72-BBΖ CAR T CELLS KILLING POTENTIAL&quot;">
      <data key="d0">"BIOLOGICAL FUNCTION"</data>
      <data key="d1">"Ability to kill ovarian cancer cells that express the TAG72 antigen, as assessed by co-culture assays with E:T ratios ranging from 1:1 to 1:2."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;ANTIGEN-DEPENDENT ACTIVITY&quot;">
      <data key="d0">"FUNCTIONAL PROPERTY"</data>
      <data key="d1">"Killing ability of CAR T cells towards targets is dependent on the presence of a specific antigen (TAG72) that binds to the CAR construct."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;SPECIFICITY OF TAG72-CAR T CELLS&quot;">
      <data key="d0">"FUNCTIONALITY ASSESSMENT"</data>
      <data key="d1">"Confirmation that CAR T cells are targeted against the antigen-specific cell lines expressing TAG72 and not against non-expressing or low-expression cell lines."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;TUMOR KILLING ABILITY&quot;">
      <data key="d0">"BIOLOGICAL FUNCTION"</data>
      <data key="d1">"The capacity of TAG72-BBζ CAR T cells to eliminate ovarian cancer cells through direct cytotoxicity, as tested against various cell lines at different time points (24 h and 72 h)."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;CYTOKINE PRODUCTION FROM CAR T CELLS&quot;">
      <data key="d0">"RESPONSE MEASURE"</data>
      <data key="d1">"Indicators of an active immune response or T cell activation in response to antigen-presenting cells (APCs) and target cells expressing TAG72."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;IFNΓ LEVELS&quot;">
      <data key="d0">"CYTOKINE"</data>
      <data key="d1">"Sustained production over 72 h indicates a prolonged anti-tumor immune response, possibly correlating with the persistence of CAR T cells against tumor targets."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;IL-2 PRODUCTION PEAK AT EARLY TIME POINTS&quot;">
      <data key="d0">"CYTOKINE RESPONSE"</data>
      <data key="d1">"Initial phase of cytokine production by T-cells that is detectable and peaks at earlier times (up to 24 h) when co-cultured with antigen-positive ovarian cancer targets."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;TAG72 EXPRESSION LEVELS IN ASCITES FROM DIFFERENT PATIENTS&quot;">
      <data key="d0">"QUANTITATIVE MEASURE"</data>
      <data key="d1">"The amount of TAG72 antigen present on tumor cells that are isolated from the ovarian cancer ascites fluid."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;REDUCTION IN TAG72 EXPRESSION OVER TIME&quot;">
      <data key="d0">"TEMPORAL CHANGE"</data>
      <data key="d1">"Downregulation of TAG72 surface expression by cancer cells during culturing, potentially due to mechanisms such as shedding or loss of antigenic expression.</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;CYTOTOXICITY ASSAYS&quot;">
      <data key="d0">"ASSAY TYPE"</data>
      <data key="d1">"Methods used to measure killing ability of T cells against target cells."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;E:T RATIOS (1:1, 1:2)&quot;">
      <data key="d0">"RATIO MEASUREMENT"</data>
      <data key="d1">"The effector-to-target cell ratio during co-culture experiments, indicating how many T cells are provided for every target cell."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;CELL PROLIFERATION ASSAYS&quot;">
      <data key="d0">"ASSAY TYPE"</data>
      <data key="d1">"Methods used to monitor the growth and division of cells over time."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;WESTERN BLOTTING&quot;">
      <data key="d0">"ANALYTICAL METHOD"</data>
      <data key="d1">"Method used to detect and quantify proteins at the molecular level in a sample."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;ELISA (ENZYME-LINKED IMMUNOSORBENT ASSAY)&quot;">
      <data key="d0">"ASSAY TYPE"</data>
      <data key="d1">"A method for detecting or quantifying molecules like cytokines, antibodies, and other proteins.</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;CRYOPRESERVATION OF T CELLS&quot;">
      <data key="d0">"STORAGE METHOD"</data>
      <data key="d1">"Preservation of biological samples at extremely low temperatures (-196°C) to maintain cell viability for future use."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;PRECLINICAL TRIALS&quot;">
      <data key="d0">"CLINICAL TRIAL STAGE"</data>
      <data key="d1">"Early-stage trials conducted in a laboratory or animal model, aimed at assessing safety and feasibility."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;PHASE I CLINICAL TRIAL&quot;">
      <data key="d0">"CLINICAL TRIAL STAGE"</data>
      <data key="d1">"Initial human study to evaluate the immediate side effects of new treatments.</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;PHARMACOKINETICS AND PHARMACODYNAMICS (PK/PD)&quot;">
      <data key="d0">"PHARMACOLOGICAL ANALYSIS"</data>
      <data key="d1">"Study of how the body affects a drug, including absorption, distribution, metabolism, and excretion.</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;CLINICAL ENDPOINTS&quot;">
      <data key="d0">"OUTCOME MEASURE"</data>
      <data key="d1">"Criteria that are used to assess the effectiveness or impact of a treatment in clinical trials."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;EFFICACY STUDIES&quot;">
      <data key="d0">"OUTCOME ASSESSMENT"</data>
      <data key="d1">"Experiments designed to measure how well a particular therapy works in achieving its intended outcomes.</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;LONG-TERM FOLLOW-UP&quot;">
      <data key="d0">"STUDY DESIGN"</data>
      <data key="d1">"Ongoing monitoring and assessment of the results and impacts after an intervention has been applied."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;SURVIVAL ANALYSIS&quot;">
      <data key="d0">"STATISTICAL METHOD"</data>
      <data key="d1">"Analysis used to estimate the length of time before a certain event occurs, typically death or disease recurrence.</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;RESPONSE RATE&quot;">
      <data key="d0">"OUTCOME MEASURE"</data>
      <data key="d1">"Percentage of patients responding positively to treatment as defined by predefined criteria."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;TUMOR BURDEN REDUCTION&quot;">
      <data key="d0">"CLINICAL OUTCOME"</data>
      <data key="d1">"Decrease in the size or mass of a tumor following treatment.</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;QUALITY-OF-LIFE ASSESSMENTS&quot;">
      <data key="d0">"PATIENT EVALUATION"</data>
      <data key="d1">"Measurements that assess how patients' daily activities and personal well-being are affected by their condition or treatment.</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;DRUG SAFETY PROFILES&quot;">
      <data key="d0">"TOXICITY ASSESSMENT"</data>
      <data key="d1">"Comprehensive evaluations of the adverse effects associated with drug usage.</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;TAG72&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"TAG72 is a protein expressed in ovarian cancer ascites."</data>
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0</data>
    </node>
    <node id="&quot;OAS3, OAS4, OAS7&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The transcripts of the OAS3, OAS4, and OAS7 cells express TAG72 by flow cytometry."</data>
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0</data>
    </node>
    <node id="&quot;CAR T CELLS&quot;">
      <data key="d0">"CELL"</data>
      <data key="d1">"CAR T cells are used for cancer treatment through ex vivo culturing and subsequent intravenous or intraperitoneal delivery."</data>
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0</data>
    </node>
    <node id="&quot;MOCK T CELLS&quot;">
      <data key="d0">"CONTROL CELL"</data>
      <data key="d1">"Mock T cells are a control group without CAR, compared with CAR T cells in cancer treatments."&lt;SEP&gt;"Mock T cells lack CAR, serving as comparison to active CAR T cells."&lt;SEP&gt;"Mock T cells lack the Chimeric Antigen Receptor (CAR), serving as a comparison to active CAR T cells in cancer treatments."&lt;SEP&gt;"T cells without CAR modification, used as a control for treatment response."</data>
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf&lt;SEP&gt;chunk-183db5c908df609bb5289896b4ba09d0</data>
    </node>
    <node id="&quot;TAG72-BBΖ CAR T CELLS&quot;">
      <data key="d0">"CAR T CELL VARIANT"</data>
      <data key="d1">"Protein derived from combined gene therapy of T cells and BBζ antibodies to target ovarian cancer."&lt;SEP&gt;"TAG72-BBζ CAR T cells include an antibody against TAG72 and the BzIL-1Bζ, which have shown potent anti-tumor activity."</data>
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf&lt;SEP&gt;chunk-183db5c908df609bb5289896b4ba09d0</data>
    </node>
    <node id="&quot;OVCAR3&quot;">
      <data key="d0">"CELL LINE"</data>
      <data key="d1">"OVCAR3 cells are a type of ovarian cancer cell line used for in vitro studies."</data>
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0</data>
    </node>
    <node id="&quot;OV90&quot;">
      <data key="d0">"CELL LINE"</data>
      <data key="d1">"OV90 is another type of ovarian cancer cell line used for in vitro studies with uniform TAG72 expression."</data>
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0</data>
    </node>
    <node id="&quot;INVASIVE PERITONEAL OVARIAN CANCERS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"These cancers are represented by the modelled mice and human conditions, where tumors grow within the peritoneum."</data>
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0</data>
    </node>
    <node id="&quot;OAS3&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The transcript of cell line OAS3 expresses TAG72 proteins."</data>
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0</data>
    </node>
    <node id="&quot;OAS4&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The transcript of cell line OAS4 expresses TAG72 proteins."</data>
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0</data>
    </node>
    <node id="&quot;OAS7&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The transcript of cell line OAS7 expresses TAG72 proteins."</data>
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0</data>
    </node>
    <node id="&quot;REGIONAL INTRAPERITONEAL DELIVERY&quot;">
      <data key="d0">"TREATMENT METHOD"</data>
      <data key="d1">"TAG72-BBζ CAR T cells are administered by regional intraperitoneal delivery, showing potent anti-tumor activity against peritoneal ovarian tumors in mice."</data>
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0</data>
    </node>
    <node id="&quot;SYSTEMIC INTRAVENOUS DELIVERY&quot;">
      <data key="d0">"DELIVERY ROUTE"</data>
      <data key="d1">"TAG72-BBζ CAR T cells are also delivered systemically through intravenous injection, but with limited therapeutic efficacy compared to regional intraperitoneal delivery."</data>
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0</data>
    </node>
    <node id="&quot;NON-INVASIVE OPTICAL IMAGING&quot;">
      <data key="d0">"DIAGNOSTIC TOOL"</data>
      <data key="d1">"Optical imaging is used non-invasively to track the growth of transduced OVCAR3 tumor cells expressing eGFP/ffluc in mice."</data>
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0</data>
    </node>
    <node id="&quot;OVARIAN CANCER XENOGRAFT MODELS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Models used to study the effects of TAG72-BBζ CAR T Cells in ovarian cancer."</data>
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
    </node>
    <node id="&quot;RELATIVE TUMOR GROWTH KINETICS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The rate at which tumors grow compared with different dosing regimens."</data>
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
    </node>
    <node id="&quot;OVERALL SURVIVAL&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Duration of survival after treatment, as measured by the time difference between single and repeat doses."</data>
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
    </node>
    <node id="&quot;T CELL NUMBERS&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"Quantitative measure of T cells within specific sites in the body after CAR T cell therapy."</data>
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
    </node>
    <node id="&quot;REGIONALLY DELIVERED CAR T CELLS&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"Type of treatment that delivers CAR T cells to a specific location in the body for localized cancer control."</data>
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
    </node>
    <node id="&quot;TUMOR RECURRENCES&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Reemergence of tumors after initial therapy, often due to antigen loss or escape."</data>
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
    </node>
    <node id="&quot;T CELL INFUSION&quot;">
      <data key="d0">"TREATMENT"</data>
      <data key="d1">"The process of introducing CAR T cells into the body to combat cancer."</data>
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
    </node>
    <node id="&quot;MOCK TREATMENT&quot;">
      <data key="d0">"CONTROL TREATMENT"</data>
      <data key="d1">"A treatment without active components for comparison with experimental treatments."</data>
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
    </node>
    <node id="&quot;ANTIGEN LOSS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The reduction or disappearance of specific antigens on cell surfaces following CAR T cell therapy, leading to tumor resistance."</data>
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
    </node>
    <node id="&quot;HETEROGENEITY IN SOLID TUMORS&quot;">
      <data key="d0">"CELLULAR PROPERTY"</data>
      <data key="d1">"Variation within the cells composing a solid tumor that can influence treatment responses and recurrence."</data>
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
    </node>
    <node id="&quot;MUC16&quot;">
      <data key="d0">"ANTIGEN MARKER"</data>
      <data key="d1">"Potential target antigen identified in ovarian cancer, often found alongside MUC1 and TAG72."</data>
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
    </node>
    <node id="&quot;MUC1&quot;">
      <data key="d0">"ANTIGEN MARKER"</data>
      <data key="d1">"An established tumor antigen that may be expressed on cells within ovarian tumors."</data>
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
    </node>
    <node id="&quot;TUMOR CELL CO-CULTURE&quot;">
      <data key="d0">"EXPERIMENTAL SETUP"</data>
      <data key="d1">"The process of growing cancer cells alongside CAR T cells to study their interactions and outcomes."</data>
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
    </node>
    <node id="&quot;AVIDITY REDUCTION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Decrease in the strength or efficiency of antigen recognition by CAR T cells due to reduced affinity for specific antigens."</data>
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
    </node>
    <node id="&quot;AGGRESSION OF A TUMOR MODEL&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Characteristics of a particular tumor type that may impact treatment response and outcome."</data>
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
    </node>
    <node id="&quot;MUC1 EXPRESSION&quot;">
      <data key="d0">"ANTIGEN MARKER"</data>
      <data key="d1">"Presence of this ovarian cancer antigen on the cell surface that may influence T cell recognition and efficacy."</data>
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
    </node>
    <node id="&quot;OV90 MODEL&quot;">
      <data key="d0">"OVARIAN CANCER SUBTYPE"</data>
      <data key="d1">"Specific subtype or variant of ovarian cancer used in experiments to study CAR T cell therapy effects."</data>
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
    </node>
    <node id="&quot;TUMOR REGRESSIONS&quot;">
      <data key="d0">"DISEASE MANAGEMENT OUTCOME"</data>
      <data key="d1">"Signs of tumor shrinkage following treatment, indicating successful intervention."</data>
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
    </node>
    <node id="&quot;OV90-BEARING MICE&quot;">
      <data key="d0">"HOST CONDITION"</data>
      <data key="d1">"Mice with OV90 tumors used to study the impact of CAR T cell therapy under specific tumor conditions."</data>
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
    </node>
    <node id="&quot;VIABLE RESIDUAL TUMOR CELLS&quot;">
      <data key="d0">"CELLULAR COMPONENT"</data>
      <data key="d1">"Cells that remain after treatment, potentially contributing to recurrence if not fully eliminated."</data>
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
    </node>
    <node id="&quot;SINGLE DOSING REGIMEN&quot;">
      <data key="d0">"TREATMENT SCHEDULE"</data>
      <data key="d1">"The administration of TAG72-BBζ CAR T Cells at one point in time."</data>
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
    </node>
    <node id="&quot;EARLY TIME POINTS&quot;">
      <data key="d0">"TEMPORAL METRIC"</data>
      <data key="d1">"Time period shortly after CAR T cell infusion that can influence therapeutic outcomes."</data>
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
    </node>
    <node id="&quot;TUMOR MICROENVIRONMENT&quot;">
      <data key="d0">"ORGANIZATIONAL ENVIRONMENT"</data>
      <data key="d1">"The local environment surrounding the tumor including stromal cells, blood vessels, and other factors that impact treatment.</data>
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
    </node>
    <node id="&quot;AGNOSTIC RESISTANCE MECHANISMS&quot;">
      <data key="d0">"RESISTANCE FACTOR"</data>
      <data key="d1">"Mechanisms by which tumors evade CAR T cell therapy independent of antigen-specific mechanisms."</data>
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
    </node>
    <node id="&quot;CAR T CELL CO-CULTURE MODEL&quot;">
      <data key="d0">"EXPERIMENTAL DESIGN"</data>
      <data key="d1">"Model used to assess interactions between CAR T cells and tumor cells in vitro."</data>
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
    </node>
    <node id="&quot;RESIDUAL TUMOR CELLS&quot;">
      <data key="d0">"CELLULAR COMPONENT"</data>
      <data key="d1">"Cancerous cells remaining after CAR T cell treatment, potentially contributing to recurrence."</data>
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
    </node>
    <node id="&quot;APTAMERS&quot;">
      <data key="d0">"MOLECULE"</data>
      <data key="d1">"Nucleic acid-based molecules that bind specifically to antigens and can enhance CAR T cell targeting or functionality."</data>
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
    </node>
    <node id="&quot;BBΖ ANTIBODIES&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Antibody fragment used in combination with T cells for enhanced targeting of ovarian cancer tumors."</data>
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
    </node>
    <node id="&quot;AVASCULAR NECROSIS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Bone condition characterized by the loss of blood supply to bone tissue, potentially related to CAR T cell treatment effects."</data>
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
    </node>
    <node id="&quot;CAR T CELL THERAPY&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"Treatment strategy using genetically engineered T cells that express chimeric antigen receptors for cancer immunotherapy."</data>
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
    </node>
    <node id="&quot;TUMOR REGENERATION FACTOR&quot;">
      <data key="d0">"BIOLOGICAL PROCESS"</data>
      <data key="d1">"Process by which tumors regenerate after treatment, possibly involving stem cell-like cells or other factors."</data>
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
    </node>
    <node id="&quot;VIRAL LOAD&quot;">
      <data key="d0">"QUANTITATIVE MEASURE"</data>
      <data key="d1">"Number of infectious viral particles present in the body, potentially related to immune response or therapy side effects."</data>
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
    </node>
    <node id="&quot;ANTI-TUMOR ACTIVITY&quot;">
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0</data>
      <data key="d1">"Mock T cells do not exhibit detectable anti-tumor activity towards TAG72-negative cell lines such as OAS3, unlike CAR T cells.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RESPONSE TO CELL TYPE&quot;">
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0</data>
      <data key="d1">"Interferon-gamma production by CAR T cells is specific to TAG72-positive cell types like OAS4 and OAS7, but not OAS3.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CAR RESPONSE&quot;">
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0</data>
      <data key="d1">"Interleukin-2 secretion by TAG72-BBζ CAR T cells specifically targets and kills OAS4 cells while sparing other cell types like OAS3 and OAS7.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;THERAPEUTIC EFFICACY&quot;">
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0</data>
      <data key="d1">"TAG72-BBζ CAR T cells treated by regional intraperitoneal delivery demonstrate more effective anti-tumor activity than those administered systemically through intravenous injection.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DOSING REGIMENS&quot;">
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
      <data key="d1">"Multiple dosing of TAG72-BBζ CAR T Cells demonstrated more extensive tumor regression and durable control compared with a single dose.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;THERAPEUTIC STRATEGY&quot;">
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
      <data key="d1">"Multiple dosing of TAG72-BBζ CAR T Cells demonstrated more extensive tumor regression and durable control compared with a single dose.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;OVERALL SURVIVAL BENEFIT&quot;">
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
      <data key="d1">"A significantly extended survival benefit was observed in mice receiving repeat doses of TAG72-BBζ CAR T Cells over a single dose.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DOSAGE INFLUENCE&quot;">
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
      <data key="d1">"Increased numbers of T cells were noted within peritoneal tumors in mice with repeat treatment for TAG72-BBζ CAR T Cells compared to a single dose.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CAR T CELL EFFICACY&quot;">
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
      <data key="d1">"The efficacy of CAR T cells can be affected by lifestyle factors like diet and physical activity, which modulate the tumor microenvironment.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 0}, {"level": 1, "cluster": 19}]</data>
    </node>
    <node id="&quot;RESISTANCE MECHANISM&quot;">
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
      <data key="d1">"Tumor recurrences following TAG72-BBζ CAR T cell therapy are often due to antigen escape or loss.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TUMOR RECURRENCE&quot;">
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
      <data key="d1">"Tumor recurrences following TAG72-BBζ CAR T cell therapy are often due to antigen escape or loss.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ANTIGEN EXPRESSION DYNAMICS&quot;">
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
      <data key="d1">"Alteration of TAG72 expression levels over time, particularly during tumor recurrence and post-TAG72-BBζ CAR T Cell therapy.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TEMPORAL CHANGE IN ANTIGENS&quot;">
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
      <data key="d1">"Alteration of TAG72 expression levels over time, particularly during tumor recurrence and post-TAG72-BBζ CAR T Cell therapy.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;OUTCOME PREDICTION&quot;">
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
      <data key="d1">"Tumor recurrences can be predicted based on antigen dynamics following CAR T cell treatment in different models.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RECURRENT TUMOR MODELS&quot;">
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
      <data key="d1">"Tumor recurrences can be predicted based on antigen dynamics following CAR T cell treatment in different models.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;APTAMER BINDING&quot;">
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
      <data key="d1">"Interaction between aptamers and antigens on tumor cells to enhance CAR T cell efficacy.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INTERPLAY BETWEEN MOLECULES&quot;">
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
      <data key="d1">"Interaction between aptamers and antigens on tumor cells to enhance CAR T cell efficacy.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;AGNOSTIC RESISTANCE&quot;">
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
      <data key="d1">"Unpredictable mechanisms that prevent CAR T cell effectiveness, beyond antigen-specific resistance.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CONSEQUENCE OF T CELL TREATMENT&quot;">
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
      <data key="d1">"Unpredictable mechanisms that prevent CAR T cell effectiveness, beyond antigen-specific resistance.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CAR T CELL SURVIVAL&quot;">
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
      <data key="d1">"Evaluating how long CAR T cells remain viable and active within the body during treatment.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;OUTCOME MEASUREMENT&quot;">
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
      <data key="d1">"Evaluating how long CAR T cells remain viable and active within the body during treatment.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RECOVERY TIME FOR BONE TISSUE&quot;">
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
      <data key="d1">"The duration needed for bone tissue to recover from potential side effects of CAR T cell therapy or associated conditions like avascular necrosis.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TIMEFRAME&quot;">
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
      <data key="d1">"The duration needed for bone tissue to recover from potential side effects of CAR T cell therapy or associated conditions like avascular necrosis.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ADVERSE EFFECTS&quot;">
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
      <data key="d1">"Potential negative consequences of CAR T cell treatment that need to be managed or mitigated.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;THERAPEUTIC LIMITATION&quot;">
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
      <data key="d1">"Potential negative consequences of CAR T cell treatment that need to be managed or mitigated.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;C10ORF11 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The C10orf11 gene is located on chromosome 10q22.3 and was associated with FEV1/FVC lung function."</data>
      <data key="d2">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
    </node>
    <node id="&quot;CHAF1B GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The CHAF1B gene is located on chromosome 21q22.13 and was associated with the FEV1/FVC ratio."</data>
      <data key="d2">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
    </node>
    <node id="&quot;CCL23-CCL18 GENE CLUSTER&quot;">
      <data key="d0">"GENE CLUSTER"</data>
      <data key="d1">"The CCL23-CCL18 gene cluster on chromosome 17q12 had associations with two phenotypes in this study."</data>
      <data key="d2">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
    </node>
    <node id="&quot;PITPNC1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The PITPNC1 gene is located on chromosome 17q24.2 and had an association with FEV1/FVC lung function."</data>
      <data key="d2">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
    </node>
    <node id="&quot;IL37 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The IL37 gene is located on chromosome 2q13 and had an association with FEV1 lung function."</data>
      <data key="d2">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
    </node>
    <node id="&quot;ASXL3 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The ASXL3 gene is located on chromosome 18q12.1 and had an association with FVC lung function."</data>
      <data key="d2">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
    </node>
    <node id="&quot;LASSO REGRESSION MODEL&quot;">
      <data key="d0">"STATISTICAL MODEL"</data>
      <data key="d1">"A multimarker model using LASSO regression included 80 SNPs that provided the smallest mean square error of FEV1/FVC lung function."</data>
      <data key="d2">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
    </node>
    <node id="&quot;TOTAL NUMBER OF 'LOW FEV1/FVC ALLELES'&quot;">
      <data key="d0">"GENETIC METRIC"</data>
      <data key="d1">"Total number of 'low FEV1/FVC alleles' was used to assess the phenotypic effects in the multimarker model analysis."</data>
      <data key="d2">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
    </node>
    <node id="&quot;GRAIL ALGORITHM&quot;">
      <data key="d0">"FUNCTIONAL ANALYSIS TOOL"</data>
      <data key="d1">"The GRAIL algorithm is used here to analyze connections between genes based on data."&lt;SEP&gt;"The GRAIL algorithm was used to mine Gene Ontology databases for functional connections between genes near the predictive SNPs."</data>
      <data key="d2">chunk-7efd4f037425eeac77e329347b16beb2&lt;SEP&gt;chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
    </node>
    <node id="&quot;LOW FEV1/FVC ALLELES&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The 'low FEV1/FVC alleles' refer to specific variants present in a bin."</data>
      <data key="d2">chunk-7efd4f037425eeac77e329347b16beb2</data>
    </node>
    <node id="&quot;MEAN RESIDUAL FEV1/FVC&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The mean residual FEV1/FVC is being monitored and found to decrease with an increasing number of 'low FEV1/FVC alleles', implying genetic influence on lung function."&lt;SEP&gt;"This process is the average measurement of forced expiratory volume against time, used here as an indicator of lung function."</data>
      <data key="d2">chunk-7efd4f037425eeac77e329347b16beb2</data>
    </node>
    <node id="&quot;NUMBER OF 'LOW FEV1/FVC ALLELES'&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The number indicates how many specific genetic variants are present related to lower than normal FEV1/FVC."</data>
      <data key="d2">chunk-7efd4f037425eeac77e329347b16beb2</data>
    </node>
    <node id="&quot;ADDITIVE GENETIC ARCHITECTURE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"An additive pattern means that the effect of each variant adds up, contributing to overall changes in a trait."</data>
      <data key="d2">chunk-7efd4f037425eeac77e329347b16beb2</data>
    </node>
    <node id="&quot;GENE ONTOLOGY DATABASE&quot;">
      <data key="d0">"DATABASE"</data>
      <data key="d1">"A comprehensive resource for information about gene functions and biological processes."</data>
      <data key="d2">chunk-7efd4f037425eeac77e329347b16beb2</data>
    </node>
    <node id="&quot;FUNCTIONAL CONNECTION&quot;">
      <data key="d0">"RELATIONSHIP"</data>
      <data key="d1">"Refers to the association found between genes near predictive SNPs and other genes through GRAIL analysis."</data>
      <data key="d2">chunk-7efd4f037425eeac77e329347b16beb2</data>
    </node>
    <node id="&quot;CLUSTERS OF Β-DEFENSIN GENES&quot;, &quot;TWO CHEMOKINE GENES (CCL18, CXCL12)&quot;, &quot;TNFRSF13B&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Genes identified with significant functional connections to predictive SNPs."</data>
      <data key="d2">chunk-7efd4f037425eeac77e329347b16beb2</data>
    </node>
    <node id="&quot;THSD4-UACA-TLE3&quot;, &quot;C10ORF11&quot;, &quot;CCL23-CCL18 LOCUS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"GWAS loci refer to genomic locations where genetic variations associated with a trait are found."</data>
      <data key="d2">chunk-7efd4f037425eeac77e329347b16beb2</data>
    </node>
    <node id="&quot;SNP AT THE CCL23-CCL18 LOCUS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This specific variant is related to β-defensin genes, as well as to CXCL12 and TNFRSF13B based on GRAIL analysis."</data>
      <data key="d2">chunk-7efd4f037425eeac77e329347b16beb2</data>
    </node>
    <node id="&quot;5.8% OF THE RESIDUAL VARIANCE IN FEV1/FVC&quot;">
      <data key="d0">"MOLECULAR INTERACTION/</data>
      <data key="d1">Explained Variance"</data>
      <data key="d2">chunk-7efd4f037425eeac77e329347b16beb2</data>
    </node>
    <node id="&quot;80 PREDICTIVE SNPS&quot;">
      <data key="d0">"GENOMIC VARIANT/</data>
      <data key="d1">SNP"</data>
      <data key="d2">chunk-7efd4f037425eeac77e329347b16beb2</data>
    </node>
    <node id="&quot;REPLICATED LOCI, THSD4-UACA-TLE3 AND C10ORF11&quot;">
      <data key="d0">"GENOMIC VARIANT"/"GWAS LOCUS/</data>
      <data key="d1">Locus"</data>
      <data key="d2">chunk-7efd4f037425eeac77e329347b16beb2</data>
    </node>
    <node id="&quot;6.8% OF THE RESIDUAL VARIANCE IN FEV1/FVC&quot;">
      <data key="d0">"EXPLAINED VARIANCE"/"EXPLAINED VARIANCE/</data>
      <data key="d1">Statistical Component"</data>
      <data key="d2">chunk-7efd4f037425eeac77e329347b16beb2</data>
    </node>
    <node id="&quot;RS12441227 SNP&quot;">
      <data key="d2">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
      <data key="d1">"SNP rs12441227 at the THSD4 locus has a genome-wide significant association with FEV1/FVC lung function.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;THSD4 GENE&quot;">
      <data key="d2">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
      <data key="d1">"SNP rs12441227 at the THSD4 locus has a genome-wide significant association with FEV1/FVC lung function.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENETIC VARIANCE&quot;">
      <data key="d2">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
      <data key="d1">"The heritability of FVC and FEV1/FVC included both additive and non-additive genetic variance components, indicating complex molecular interactions.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NON-ADDITIVE GENETIC VARIANCE&quot;">
      <data key="d2">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
      <data key="d1">"The heritability of FVC and FEV1/FVC included both additive and non-additive genetic variance components, indicating complex molecular interactions.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ASTHMA EXCLUSION&quot;">
      <data key="d2">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
      <data key="d1">"Excluding individuals with asthma led to increased evidence for association at some loci, suggesting that disease status may influence genetic associations.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 1}]</data>
    </node>
    <node id="&quot;THSD4-UACA-TLE3&quot;, &quot;C10ORF11&quot;">
      <data key="d2">chunk-7efd4f037425eeac77e329347b16beb2</data>
      <data key="d1">"Not found to be functionally connected with other genes defined by the 80 SNPs, based on the analysis.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;EXPLAINED VARIANCE IN FEV1/FVC&quot;">
      <data key="d2">chunk-7efd4f037425eeac77e329347b16beb2</data>
      <data key="d1">"Explains a proportion of variability in forced expiratory volume against time due to genetic factors.")&lt;SEP&gt;"The statistical connection of this specific SNP variant to FEV1/FVC is a contributing factor explaining part of its variability.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FUNCTIONAL CONNECTION/">
      <data key="d2">chunk-7efd4f037425eeac77e329347b16beb2</data>
      <data key="d1">association"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS231775&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This SNP was reported in 14 studies out of the total 16."</data>
      <data key="d2">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
    </node>
    <node id="&quot;RS231725&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This SNP was reported in 6 studies out of the total 16."</data>
      <data key="d2">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
    </node>
    <node id="&quot;RS3087243&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This SNP was reported in 9 studies out of the total 16."</data>
      <data key="d2">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
    </node>
    <node id="&quot;RS5742909&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This SNP was reported in 5 studies out of the total 16."</data>
      <data key="d2">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
    </node>
    <node id="&quot;CTLA4&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The gene associated with polymorphisms rs231775, rs231725, rs3087243, and rs5742909"</data>
      <data key="d2">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
    </node>
    <node id="&quot;PBC&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The disease which susceptibility was being studied through aforementioned SNPs of the gene CTLA4."</data>
      <data key="d2">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
    </node>
    <node id="&quot;G VERSUS A&quot;">
      <data key="d2">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
      <data key="d1">"The G versus A comparison for rs231775 polymorphism showed significant heterogeneity, and thus a random-effect model was used to generate extensive CIs in these genetic models.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;A VERSUS G&quot;">
      <data key="d2">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
      <data key="d1">"The A versus G comparison for rs231725 polymorphism showed significant heterogeneity, leading to the use of a random-effect model.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GA VERSUS GG&quot;">
      <data key="d2">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
      <data key="d1">"For rs3087243 polymorphism, while GA versus GG comparison showed some heterogeneity, no significant association with PBC susceptibility was identified.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TC VERSUS CC&quot;">
      <data key="d2">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
      <data key="d1">"The TT + TC versus CC comparison for rs5742909 polymorphism revealed significant heterogeneity and linkage disequilibrium among the four SNPs.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS231775 AND RS231725&quot;">
      <data key="d2">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
      <data key="d1">"Both polymorphisms showed significant association with PBC susceptibility for both Asians and Caucasians in subgroup analyses.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;EGGER'S REGRESSION AND BEGG'S FUNNEL PLOT&quot;">
      <data key="d2">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
      <data key="d1">"No obvious publication bias was identified through these methods, suggesting the reliability of our results.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PERIPHERAL BLOOD MONONUCLEAR CELLS (PBMCS)&quot;">
      <data key="d0">"SAMPLE TYPE"</data>
      <data key="d1">"The samples were isolated as peripheral blood mononuclear cells from the individuals."</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;GENOME-WIDE GENE EXPRESSION ANALYSIS&quot;">
      <data key="d0">"METHODOLOGY"</data>
      <data key="d1">"We performed genome-wide gene expression analysis to identify genetic control of gene expression in T cells."</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;CIS-EQTLS (CIS-REGULATORY SINGLE NUCLEOTIDE POLYMORPHISMS)&quot;">
      <data key="d0">"TYPE OF REGULATORY SNPS"</data>
      <data key="d1">"We identified cis-eQTLs for regulation within 1Mb intervals for CD4+ and CD8+ T cells."</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;IKBKE GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The IKBKE gene plays an essential role in regulating inflammatory responses to viral infections."</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;STAT6 TRANSCRIPTIONAL ACTIVATOR&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"STAT6 is involved in T cell differentiation as a transcriptional activator."</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;STX2 (SYNTAXIN 2) INVOLVEMENT IN INTRACELLULAR TRANSPORT&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"STX2 is associated with intracellular transport of vesicles."</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;LONG CODING RNA RP11−534L20.5&quot;">
      <data key="d0">"RNA"</data>
      <data key="d1">"Long coding RNA located near the IKBKE gene."</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;INHIBITORY IMMUNE CHECKPOINT GENE CTLA4&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"CTLA4 is associated with T1D and other endocrine autoimmune diseases."</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;TISSUE-BY-TISSUE ANALYSIS&quot;">
      <data key="d0">"ANALYTICAL METHOD"</data>
      <data key="d1">"Standard tissue-by-tissue analysis was conducted to assess eQTL effects."</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;MULTI-TISSUE JOINT CIS-EQTL ANALYSIS&quot;">
      <data key="d0">"ANALYTICAL METHOD"</data>
      <data key="d1">"A multi-tissue joint cis-eQTL analysis accounts for incomplete power and provides a more comprehensive view."</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;BAYESIAN MODEL AVERAGING AND HIERARCHICAL MODELLING&quot;">
      <data key="d0">"STATISTICAL APPROACH"</data>
      <data key="d1">"These Bayesian methods were used to combine information across genes in a joint framework."</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;CTLA4 GENE LOCUS&quot;">
      <data key="d0">"GENETIC LOCATION"</data>
      <data key="d1">"The genetic control of the expression within the CTLA4 gene locus was studied."</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;ALTERNATIVE SPLICING OF EXONS 3RD AND 4TH&quot;">
      <data key="d0">"EXON REGULATION"</data>
      <data key="d1">"The expression regulation was investigated through the alternative splicing of exons in CTLA4."</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;DIFFERENTIAL METHYLATION&quot;">
      <data key="d0">"METHYLATION VARIATION"</data>
      <data key="d1">"Divergent DNA methylation between CD4+ and CD8+ T cells was detected for certain genes."</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;CIS-EQTLS SHARED BETWEEN CD4+ AND CD8+ T CELLS&quot;">
      <data key="d0">"SHARED REGULATORY EFFECTS"</data>
      <data key="d1">"All 3871 genes with eQTLs showed strong posterior probability of being shared in both cell types."</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;CTLA4 AND DISEASE ASSOCIATION&quot;">
      <data key="d0">"DISEASE AND GENETIC LINK"</data>
      <data key="d1">"The CT60 polymorphism was associated with T1D and RA, linking genetic variants to autoimmune diseases."</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;免疫检查点分子CTLA4&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"CTLA4是与自身免疫性疾病如1型糖尿病(T1D)相关的免疫检查点蛋白。"</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;CPG岛甲基化&quot;">
      <data key="d0">"EPIGENETIC MODIFICATION"</data>
      <data key="d1">"我们对特定的CpG岛进行了DNA甲基化的测定，以比较CD4+ T细胞和CD8+ T细胞之间的差异。"</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;细胞内运输基因STX2&quot;">
      <data key="d0">"CELLULAR PROCESS GENE"</data>
      <data key="d1">"STX2与囊泡在细胞内的运输相关。"</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;长编码RNA RP11−534L20.5&quot;">
      <data key="d0">"NON-CODING RNA"</data>
      <data key="d1">"位于IKBKE基因附近的长编码RNA进行了研究。"</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;CIS-EQTLS (调控基因表达的等位变异体)&quot;">
      <data key="d0">"GENE REGULATORY SNPS"</data>
      <data key="d1">"我们识别了影响CD4+ T细胞和CD8+ T细胞中基因表达的cis-eQTL。"</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;多组织联合CIS-EQTL分析&quot;">
      <data key="d0">"TRANSCRIPTOME-WIDE ASSOCIATION STUDY METHODOLOGY"</data>
      <data key="d1">"我们运用了多组织联合cis-eQTL分析，以利用所有组织的数据来增强统计效力和全面性。"</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;贝叶斯模型平均化与分层建模&quot;">
      <data key="d0">"STATISTICAL TECHNIQUE"</data>
      <data key="d1">"我们使用贝叶斯模型平均化与分层建模技术来整合基因表达数据中的信息。"</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;CGTAL4&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The CTLA4 gene was analyzed to determine its relationship with other genes and their expression levels."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;CG26091609&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A specific genomic variant of the CTLA4 gene was inversely correlated with gene expression."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;EXPRESSION LEVELS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The inverse correlation suggests that changes in expression levels might influence physiological processes."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;EQTL EFFECTS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"eQTLs were detected between the genomic variant and gene expression levels, indicating genetic regulation of expression."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
      <data key="d3">[{"level": 0, "cluster": 7}, {"level": 1, "cluster": 26}]</data>
    </node>
    <node id="&quot;MULTI-TISSUE ANALYSIS&quot;">
      <data key="d0">"ANALYSIS TYPE"</data>
      <data key="d1">"A multi-tissue approach was taken to identify shared eQTL effects across different cell types."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
      <data key="d3">[{"level": 0, "cluster": 14}, {"level": 1, "cluster": 48}]</data>
    </node>
    <node id="&quot;TRANS-ACTING REGULATORY LOCUS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The analysis revealed trans-acting regulatory elements influencing gene expression, particularly in the context of autoimmune diseases like T1D."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
      <data key="d3">[{"level": 0, "cluster": 14}, {"level": 1, "cluster": 48}]</data>
    </node>
    <node id="&quot;GWAS SNPS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Genome-wide association study (GWAS) SNPs were selected for their potential impact on gene expression."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
      <data key="d3">[{"level": 0, "cluster": 14}, {"level": 1, "cluster": 47}]</data>
    </node>
    <node id="&quot;DISTANT GENES&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"SNPs affecting distant genes indicated long-range interactions within the genome."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;BROAD-RANGE IMPACT&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"A region across chromosome 12 showed significant impact on hundreds of gene expression levels, indicating a broad effect on multiple biological pathways."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;RPS26&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The RPS26 gene plays a role in protein synthesis and its expression levels are influenced by the trans-acting regulatory locus."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
      <data key="d3">[{"level": 0, "cluster": 14}, {"level": 1, "cluster": 48}]</data>
    </node>
    <node id="&quot;CDK2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The CDK2 gene encodes cyclin-dependent kinase 2, which is involved in cell cycle regulation."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;RAB5B&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The RAB5B gene encodes a member of the Ras superfamily of GTPases and participates in vesicle trafficking processes."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
      <data key="d3">[{"level": 0, "cluster": 14}, {"level": 1, "cluster": 48}]</data>
    </node>
    <node id="&quot;SUOX&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The SUOX gene is related to urea cycle metabolism and its expression levels were identified through trans-eQTL analysis."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;IKZF4&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The IKZF4 gene is associated with immune responses and was found in the region affecting expression levels of multiple genes."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
      <data key="d3">[{"level": 0, "cluster": 14}, {"level": 1, "cluster": 48}]</data>
    </node>
    <node id="&quot;ERBB3&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The ERBB3 gene encodes for a receptor tyrosine kinase which interacts with growth factors and participates in signaling pathways."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;IL27&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The IL27 gene codes for a cytokine that plays an important role in immune responses and inflammation, showing significant trans-eQTL effects on expression levels."&lt;SEP&gt;"Transcription of the IL-27 cytokine is not affected by the trans-eQTL locus."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b&lt;SEP&gt;chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;STAT1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The STAT1 gene codes for a transcription factor that plays a key role in the immune response and inflammation, particularly influenced by SNPs associated with T1D risk."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
      <data key="d3">[{"level": 0, "cluster": 14}, {"level": 1, "cluster": 49}]</data>
    </node>
    <node id="&quot;REC8&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The REC8 gene is related to meiosis and was one of multiple genes identified as affected through trans-eQTL analysis."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
      <data key="d3">[{"level": 0, "cluster": 13}, {"level": 1, "cluster": 45}]</data>
    </node>
    <node id="&quot;RS181206&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The missense SNP rs181206 on IRF1 and STAT1 has an effect that remains after regressing out the GWAS SNP, but not vice versa."&lt;SEP&gt;"The missense SNP rs181206 on IRF1 interacts with STAT1 in trans-eQTL effects."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;BAYESIAN TEST FOR COLOCALISATION&quot;">
      <data key="d0">"STATISTICAL METHOD"</data>
      <data key="d1">"A Bayesian test supports the hypothesis that T1D susceptibility is linked to changes in expression of IRF1 and STAT1, sharing a single causal variant with rs181206G."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;MONOCYTES&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"The trans-eQTL locus had no effects on IL27 expression in cis analysis."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;IL27RA AND IL6ST (GP130)&quot;">
      <data key="d0">"MOLECULES"</data>
      <data key="d1">"These molecules together act as a receptor for the IL-27 cytokine in CD4+ T cells."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;CELL TYPE-SPECIFIC EFFECT&quot;">
      <data key="d0">"OBSERVATION"</data>
      <data key="d1">"Higher expression levels of IRF1 and STAT1 genes were found in CD4+ compared to CD8+ T cells."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;IL-27&quot;">
      <data key="d0">"CYTOKINE"</data>
      <data key="d1">"IL-27 is produced by innate immune cells, interacts with its receptor IL27RA and activates the STAT1/STAT3 pathway in T cells after forming a heterodimer with EBI3."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;ISRE&quot;">
      <data key="d0">"SEQUENCE"</data>
      <data key="d1">"Interferon stimulated response elements (ISRE) are activated by the STAT1/STAT3 pathway which induces transcription of several interferon-induced genes, including IRF1 and STAT1 itself."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;HEK293 CELLS&quot;">
      <data key="d0">"CELL LINE"</data>
      <data key="d1">"Human embryonic kidney 293 cells were used for transfection with IL-27 wild-type or missense variants along with EBI3 protein to study their effect on IRF1 and STAT1 expression."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;PBMCS&quot;">
      <data key="d0">"SAMPLE TYPE"</data>
      <data key="d1">"Peripheral blood mononuclear cells (PBMCs) from healthy individuals were used for real-time PCR studies of IRF1 and STAT1 transcript levels after IL-27 exposure."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;RS181206[G]&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The missense SNP rs181206G in the IL27 gene was found to have a causal effect on decreased expression of IRF1 and STAT1."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;RS3135402&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A GWAS SNP which does not have an effect when regressed out from trans-eQTL analysis of rs181206 on IRF1 and STAT1."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;EBI3&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The protein that forms a heterodimer with IL-27 to interact with its receptor and activate the STAT1/STAT3 pathway in T cells after producing IL-27."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;TRANS-EQTL LOCUS&quot;">
      <data key="d0">"LOCATION"</data>
      <data key="d1">"A genetic locus identified by trans-eQTL analysis which affects expression of IRF1, STAT1, and IL27 but not IL27RA or IL6ST genes."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;METHODOLOGICAL ADVANTAGES&quot;">
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
      <data key="d1">"The multi-tissue analysis was advantageous for identifying genes with lower effect sizes or incomplete power due to its capacity for accounting for such scenarios.")("entity"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MULTI-TISSUE JOINT CIS-EQTL ANALYSIS STRENGTHS&quot;">
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
      <data key="d1">"The multi-tissue analysis was advantageous for identifying genes with lower effect sizes or incomplete power due to its capacity for accounting for such scenarios.")("entity"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TRANS-EQTLS&quot;">
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
      <data key="d1">"CDK2 is one of the genes influenced through trans-expression quantitative trait loci analysis.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TRANS-EQTL ANALYSIS&quot;">
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
      <data key="d1">"The SUOX gene expression was analyzed through trans-eQTL studies indicating its association with T1D genetic risk factors.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SNPS ASSOCIATION&quot;">
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
      <data key="d1">"ERBB3 gene expression was associated with specific SNPs identified in the T1D susceptibility analysis.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TRANS-EQTLS AND GWAS SNPS&quot;">
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
      <data key="d1">"The STAT1 gene expression was influenced through both trans-eQTL effects and GWAS, indicating multiple genetic influences on its activity.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 14}, {"level": 1, "cluster": 49}]</data>
    </node>
    <node id="&quot;RS181206&quot;[G]">
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
      <data key="d1">"The rs181206[G] allele results in lower transcript levels for IRF1 compared to the wild-type Leu119 variant.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 14}, {"level": 1, "cluster": 47}]</data>
    </node>
    <node id="&quot;T1D SUSCEPTIBILITY&quot;">
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
      <data key="d1">"The rs181206[G] allele in the IL27 gene is associated with T1D (Type 1 Diabetes) susceptibility.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 14}, {"level": 1, "cluster": 47}]</data>
    </node>
    <node id="&quot;CELLULAR MECHANISM&quot;">
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
      <data key="d1">"T1D development involves changes in expression of IRF1 and STAT1, which might be linked through a common causal variant with rs181206G.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL-8 PROTEIN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"IL-8 protein is a cytokine that plays a role in the immune response and inflammation."</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
    </node>
    <node id="&quot;IL-8 MRNA&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The IL-8 mRNA transcript is involved in the expression of the IL-8 protein."</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
    </node>
    <node id="&quot;PBMCS (PERIPHERAL BLOOD MONONUCLEAR CELLS)&quot;">
      <data key="d0">"CELL LINE"</data>
      <data key="d1">"The PBMC composition refers to the types of cells found in peripheral blood samples."</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
    </node>
    <node id="&quot;MODERATE ASTHMA&quot;">
      <data key="d0">"TYPE OF DISEASE"</data>
      <data key="d1">"Moderate asthma is a less severe form of asthma than severe asthma."</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
    </node>
    <node id="&quot;SEVERE ASTHMA&quot;">
      <data key="d0">"TYPE OF DISEASE"</data>
      <data key="d1">"Severe asthma requires more intensive management due to its severity."</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
    </node>
    <node id="&quot;MILD ASTHMA&quot;">
      <data key="d0">"TYPE OF DISEASE"</data>
      <data key="d1">"Mild asthma usually responds well to standard treatments."</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
    </node>
    <node id="&quot;RS4073&quot;">
      <data key="d0">"GENETIC VARIANT"</data>
      <data key="d1">"The rs4073 genetic variant is a polymorphism in the IL-8 gene associated with asthma susceptibility."</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
    </node>
    <node id="&quot;RS2227306&quot;">
      <data key="d0">"GENETIC VARIANT"</data>
      <data key="d1">"The rs2227306 genetic variant is another polymorphism in the IL-8 gene related to asthma."</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
    </node>
    <node id="&quot;HAPLOTYPE&quot;">
      <data key="d0">"COMBINED GENETIC VARIANT"</data>
      <data key="d1">"A haplotype is a combination of two or more nearby variants that are inherited together."</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
    </node>
    <node id="&quot;LD (LINKAGE DISEQUILIBRIUM)&quot;">
      <data key="d0">"STATISTICAL MEASURE"</data>
      <data key="d1">"The LD test measures the statistical dependence between genetic variants."</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
    </node>
    <node id="&quot;IL-8 SERINE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Serine is an amino acid that plays a role in the metabolism of IL-8 proteins."</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
    </node>
    <node id="&quot;INFLAMMATORY RESPONSE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The inflammatory response mediated by IL-8 and other cytokines helps defend against pathogens."</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
    </node>
    <node id="&quot;IMMUNE SYSTEM&quot;">
      <data key="d0">"ORGANISM COMPONENT"</data>
      <data key="d1">"The immune system includes various cells, molecules, tissues, and organs working together to protect the body from infection."</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
    </node>
    <node id="&quot;GENETIC HAPLOTYPE&quot;">
      <data key="d0">"COMBINED GENETIC VARIANT"</data>
      <data key="d1">"A genetic haplotype is a group of genes or variants that are inherited together on the same chromosome."</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
    </node>
    <node id="&quot;ASAH1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The ASAH1 gene is on 8p22-p21.3 and consists of 86 HapMap SNPs and 14 typed SNPs on the Illumina HumanHap550 array."</data>
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
    </node>
    <node id="&quot;SNP-SET&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"A SNP-set was formed by including only these 14 typed SNPs for the ASAH1 gene."</data>
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
    </node>
    <node id="&quot;HAPMAP SNPS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"There are 86 HapMap SNPs associated with the ASAH1 gene."</data>
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
    </node>
    <node id="&quot;ILLUMINA HUMANHAP550 ARRAY&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The Illumina HumanHap550 array contains 14 typed SNPs for the ASAH1 gene."</data>
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
    </node>
    <node id="&quot;8P22-P21.3 REGION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The ASAH1 gene region on chromosome 8 is characterized by a good correlation structure among its SNPs and typed SNPs."</data>
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
    </node>
    <node id="&quot;SURVIVAL KERNEL MACHINE SNP-SET TEST&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"The survival kernel machine SNP-set test evaluates genomic data for GWAS, where 'kernel' is used as the underlying statistical model."</data>
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
    </node>
    <node id="&quot;MIN TEST&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"The min test serves as a benchmark in this context; it also gave correct size indicating its effectiveness alongside other methods like survival kernel machine test."</data>
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
    </node>
    <node id="&quot;KERNEL MACHINE METHOD&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"When the median R2 of the causal SNP with typed SNPs is moderate, the kernel machine method has higher power than the min test."</data>
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
    </node>
    <node id="&quot;LINEAR KERNEL&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"A scenario where survival time is simulated assuming a linear model benefits both methods equally or shows slight preference to certain methods like IBS and weighted IBS kernel."</data>
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
    </node>
    <node id="&quot;IBS KERNEL&quot;">
      <data key="d0">"BIOLOGICAL PATHWAY"</data>
      <data key="d1">"The IBS (Identity By State) kernel offers an alternative method for evaluating genomic data alongside the survival kernel machine test, showing comparable power."</data>
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
    </node>
    <node id="&quot;WEIGHTED IBS KERNEL&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Using MAF as weights in weighted IBS kernel can upweight rare alleles in GWAS settings, leading to varied results depending on causal SNP characteristics."</data>
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
    </node>
    <node id="&quot;RS1390358&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"One of the typed SNPs associated with the NAT2 gene, located on chromosome 8p22."</data>
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
    </node>
    <node id="&quot;RS1112005&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Another typed SNP associated with the NAT2 gene, located close to the transcription start of the gene."</data>
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
    </node>
    <node id="&quot;RS7832071&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A typed SNP found near the transcription start region of the NAT2 gene on chromosome 8p22."</data>
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
    </node>
    <node id="&quot;RS1208&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"One of the four typed SNPs in the NAT2 gene, located towards the end of the gene."</data>
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
    </node>
    <node id="&quot;SNP 7&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"A specific SNP among the four typed SNPs (rs1390358, rs1112005, rs7832071, and rs1208) in NAT2."</data>
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
    </node>
    <node id="&quot;SNP 11&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"A specific SNP among the four typed SNPs that is closely related to SNPs 2, 5, 9, and 20 in terms of linkage disequilibrium (LD)."</data>
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
    </node>
    <node id="&quot;SNP 2&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"An SNP with a high LD score to SNP 11 but not well-correlated with other typed SNPs."</data>
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
    </node>
    <node id="&quot;SNP 5&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"An SNP showing high correlation (R2 = 0.91) with SNP 11 and potentially other typed SNPs."</data>
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
    </node>
    <node id="&quot;SNP 9&quot;">
      <data key="d0">"BIOLOGICAL PATHWAY"</data>
      <data key="d1">"An SNP demonstrating perfect LD with SNP 11 (R2 = 0.99), suggesting strong genetic linkage to the causal SNP when tested alone or in high LD with it."</data>
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
    </node>
    <node id="&quot;SNP 20&quot;">
      <data key="d0">"GENETIC MUTATION"</data>
      <data key="d1">"A specific typed SNP in NAT2 that is closely correlated with SNP 11 (R2 = 0.99) and may exhibit similar results to this SNP due to their high linkage disequilibrium (LD)."</data>
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
    </node>
    <node id="&quot;HLA-B GENE&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Part of the human leukocyte antigen (HLA) complex on chromosome 6p21.3."</data>
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
    </node>
    <node id="&quot;RS1058026&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"One of the two typed SNPs associated with the HLA-B gene, with a lower minor allele frequency (MAF) than rs2523608."</data>
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
    </node>
    <node id="&quot;RS2523608&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Another typed SNP in the HLA-B gene with higher minor allele frequency compared to rs1058026."</data>
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
    </node>
    <node id="&quot;ASAH1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The power of testing for the ASAH1 gene effect using different kernels was studied."</data>
      <data key="d2">chunk-076f6aeeb369546413bc63c9f305553a</data>
    </node>
    <node id="&quot;LD MEASURE&quot;">
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
      <data key="d1">"Median R2 represents a commonly used measure of linkage disequilibrium (LD), which describes genetic correlation among SNPs.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MEDAN R2&quot;">
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
      <data key="d1">"Median R2 represents a commonly used measure of linkage disequilibrium (LD), which describes genetic correlation among SNPs.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RARE ALLELES&quot;">
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
      <data key="d1">"In GWAS contexts, the weighted IBS kernel emphasizes rare alleles by incorporating their importance through MAF (minor allele frequency), impacting test outcomes when rare variants are causal.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CAUSAL SNPS&quot;">
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
      <data key="d1">"In the context of GWAS, causal SNPs may influence genetic outcomes depending on their LD score and MAF when evaluated using different statistical methods such as survival kernel machine test or weighted IBS kernel.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 12}, {"level": 1, "cluster": 39}]</data>
    </node>
    <node id="&quot;LINEAR KERNEL&quot;&amp; &quot;STANDARD IBS KERNEL&quot;">
      <data key="d2">chunk-076f6aeeb369546413bc63c9f305553a</data>
      <data key="d1">"Both min test and linear kernel suffered from substantial loss of power as they mis-specified the model compared to the IBS and weighted IBS kernels.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;KERNEL MACHINE SNP-SET TEST&quot;">
      <data key="d2">chunk-076f6aeeb369546413bc63c9f305553a</data>
      <data key="d1">"The kernel machine SNP-set test had better performance than the min test, especially when there was good LD structure similar to that of the ASAH1 gene.")&lt;SEP&gt;"The kernel machine SNP-set test outperformed the min test for studying gene effects based on imputed data, especially when there was good linkage disequilibrium (LD) structure like in ASAH1.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IBS KERNEL&quot;&amp; &quot;WEIGHTED IBS KERNEL&quot;">
      <data key="d2">chunk-076f6aeeb369546413bc63c9f305553a</data>
      <data key="d1">"The linear kernel and weighted IBS kernel had lower power compared to the standard IBS kernel, especially when causal SNPs have higher MAFs.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LINEAR KERNEL&quot;&amp; &quot;IBS KERNEL&quot;&amp; &quot;WEIGHTED IBS KERNEL&quot;">
      <data key="d2">chunk-076f6aeeb369546413bc63c9f305553a</data>
      <data key="d1">"The min test suffered from substantial loss of power compared to the other kernels due to mis-specifying the model.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ANTI-CTLA-4&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A total of 22 SNPs that passed QC (quality control) were tested for their association with response in 213 anti-CTLA-4 treated patients."&lt;SEP&gt;"Anti-CTLA-4 is an intervention used in clinical trials, not directly classified into environmental factors but related to treatment conditions."</data>
      <data key="d2">chunk-2b5346dfc62015294aa57aeab3960cd1&lt;SEP&gt;chunk-0d49552280a277a8a26456d06f8f26a8</data>
    </node>
    <node id="&quot;AUTOIMMUNE RISK SNPS&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The analysis included autoimmune risk SNPs associated with celiac disease, inflammatory bowel disease, rheumatoid arthritis and type 1 diabetes."</data>
      <data key="d2">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
    </node>
    <node id="&quot;ANTI-PD-1&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Anti-PD-1 is another intervention technique, associated with lifestyle and medical treatment rather than daily lifestyle choices."&lt;SEP&gt;"For anti-PD-1 treatment, 24 SNPs passing QC were tested in 169 patients"</data>
      <data key="d2">chunk-2b5346dfc62015294aa57aeab3960cd1&lt;SEP&gt;chunk-0d49552280a277a8a26456d06f8f26a8</data>
    </node>
    <node id="&quot;RS17388568&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Under the dominant regression model, consistent with the additive model, rs17388568 was found to have the strongest association with response."</data>
      <data key="d2">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
    </node>
    <node id="&quot;IL2, ADAD1 AND IL21&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"rs17388568 was mapped to the genomic region containing IL2, ADAD1 and IL21, which is associated with allergy, colitis and type 1 diabetes."</data>
      <data key="d2">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
    </node>
    <node id="&quot;ANTI-CTLA-4 TREATED PATIENTS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The response rate for combination therapy was the highest."</data>
      <data key="d2">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
    </node>
    <node id="&quot;DISEASE DISTRIBUTION OF METASTATIC MELANOMA&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"A larger proportion of our patients were males, consistent with the sex distribution of metastatic melanoma."</data>
      <data key="d2">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
    </node>
    <node id="&quot;COMBINATION THERAPIES&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"A combination of anti-CTLA-4 and/or anti-PD-1 treatments were applied to patients."</data>
      <data key="d2">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
    </node>
    <node id="&quot;TREATMENT COHORTS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"There was a statistically significant difference in the age distribution between treatment cohorts."</data>
      <data key="d2">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
    </node>
    <node id="&quot;RESPONDERS&quot;">
      <data key="d0">"OUTCOME"</data>
      <data key="d1">"A subset of patients showed positive response to their respective treatments."</data>
      <data key="d2">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
    </node>
    <node id="&quot;NON-RESPONDERS&quot;">
      <data key="d0">"OUTCOME"</data>
      <data key="d1">"A subset of patients did not show a positive response to their respective treatments."</data>
      <data key="d2">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
    </node>
    <node id="&quot;AGE GROUP&quot;">
      <data key="d0">"SUBGROUP ANALYSIS"</data>
      <data key="d1">"A separate analysis was conducted for a younger age group, which revealed stronger effects of certain SNPs."</data>
      <data key="d2">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
    </node>
    <node id="&quot;N RESPONDERS&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"No specific gene information provided."</data>
      <data key="d2">chunk-0d49552280a277a8a26456d06f8f26a8</data>
    </node>
    <node id="&quot;CONTROLS=33&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"No specific genomic variant information provided."</data>
      <data key="d2">chunk-0d49552280a277a8a26456d06f8f26a8</data>
    </node>
    <node id="&quot;N NON-RESPONDERS&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"No specific transcript information provided."</data>
      <data key="d2">chunk-0d49552280a277a8a26456d06f8f26a8</data>
    </node>
    <node id="&quot;CASES=10&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"No specific protein information provided."</data>
      <data key="d2">chunk-0d49552280a277a8a26456d06f8f26a8</data>
    </node>
    <node id="&quot;23 SNPS&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"No explicit nutrient information associated with the 23 SNPs."</data>
      <data key="d2">chunk-0d49552280a277a8a26456d06f8f26a8</data>
    </node>
    <node id="&quot;BONFERRONI&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"The Bonferroni method is a statistical approach, not related to dietary patterns."</data>
      <data key="d2">chunk-0d49552280a277a8a26456d06f8f26a8</data>
    </node>
    <node id="&quot;HOLM-BONFERRONI METHODS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The Holm-Bonferroni correction is a procedure used in statistics for adjusting the significance threshold, related to data analysis and error handling."</data>
      <data key="d2">chunk-0d49552280a277a8a26456d06f8f26a8</data>
    </node>
    <node id="&quot;SMALL SAMPLE SIZE&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Small sample sizes may limit statistical power, not related to metabolic pathways directly but affects statistical reliability."</data>
      <data key="d2">chunk-0d49552280a277a8a26456d06f8f26a8</data>
    </node>
    <node id="&quot;COMBINATION-THERAPY&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"No specific molecular interaction provided in the text."</data>
      <data key="d2">chunk-0d49552280a277a8a26456d06f8f26a8</data>
    </node>
    <node id="&quot;TREATMENT RESPONSE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Treatment response could be indicative of disease management or outcome but isn't explicitly defined as a specific disease type in the provided text."</data>
      <data key="d2">chunk-0d49552280a277a8a26456d06f8f26a8</data>
    </node>
    <node id="&quot;TREATMENT DRUGS&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"The type of treatment drug used can affect the response to a combination therapy or individual therapies."</data>
      <data key="d2">chunk-0d49552280a277a8a26456d06f8f26a8</data>
    </node>
    <node id="&quot;ASSOCIATION WITH RESPONSE&quot;">
      <data key="d2">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
      <data key="d1">"Several associations were observed between autoimmune risk SNPs and response to both anti-CTLA-4 and anti-PD-1 treatments.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;POWER OF ANALYSIS&quot;">
      <data key="d2">chunk-0d49552280a277a8a26456d06f8f26a8</data>
      <data key="d1">"A small sample size limits the power of an analysis to detect true associations, indicating that findings might not be reliable due to lower statistical confidence.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GROUPING OF TREATMENTS&quot;">
      <data key="d2">chunk-0d49552280a277a8a26456d06f8f26a8</data>
      <data key="d1">"Combination therapy is being grouped with other treatments for association analysis; this does not establish a causal relationship but reflects the experimental design.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DIFFERENCE IN RESPONSE&quot;">
      <data key="d2">chunk-0d49552280a277a8a26456d06f8f26a8</data>
      <data key="d1">"Sex can influence differences in how individuals respond to treatments, reflecting a lifestyle factor.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IMPACT ON RESPONSE&quot;">
      <data key="d2">chunk-0d49552280a277a8a26456d06f8f26a8</data>
      <data key="d1">"The specific treatment drug used has an impact on the patient's response to therapy.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;EBNA2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"EBNA2 binds to the MS risk loci and affects their expression."&lt;SEP&gt;"Results indicate that EBNA2 binds chromatin at MS risk loci dependent on the presence of a specific risk allele."&lt;SEP&gt;"The results suggest that EBNA2 binds chromatin at MS risk loci, influencing transcript expression."</data>
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6&lt;SEP&gt;chunk-bb351b97d99fce93d17df522db92dda7</data>
    </node>
    <node id="&quot;MS RISK LOCI&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Of the six identified MS risk SNPs, EBNA2 was found to bind to these loci dependent on the MS risk allele."&lt;SEP&gt;"The MS risk loci were associated with altered gene expression."</data>
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6&lt;SEP&gt;chunk-bb351b97d99fce93d17df522db92dda7</data>
    </node>
    <node id="&quot;ALLELE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Results show that EBNA2 interacts with the risk allele to bind chromatin and influence gene expression."</data>
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
    </node>
    <node id="&quot;EBV LATENCY III GROWTH PROGRAM&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"EBNA2-TAT inhibits EBV latency III growth program through dose-response experiments."</data>
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
    </node>
    <node id="&quot;LCL PROLIFERATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"LCL proliferation is associated with expression of MS risk genes, which can be influenced by EBNA2-TAT treatment."</data>
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
    </node>
    <node id="&quot;EBNA2-TAT&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"The effect of EBNA2 inhibition was tested in a dose-response experiment with varying concentrations."</data>
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
    </node>
    <node id="&quot;RISK ALLELE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Risk alleles were identified for MS SNPs, influencing gene expression and EBV DNA copy number."</data>
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
    </node>
    <node id="&quot;LMP1&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Expression of the EBV gene LMP1 was reduced significantly by EBNA2-TAT at 50 µM concentration."&lt;SEP&gt;"Latency protein LMP1 interacts with various proteins and signaling pathways, potentially contributing to MS through its function on the latency III infection cycle of EBV."</data>
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6&lt;SEP&gt;chunk-bb351b97d99fce93d17df522db92dda7</data>
    </node>
    <node id="&quot;RBP-JΚ SITE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"EBNA2-TAT specifically binds to the RBP-Jκ site on EBNA2 through GST affinity assay, indicating specific interaction and effect."</data>
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
    </node>
    <node id="&quot;MUTANT PEPTIDE OF EBNA2-TAT&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A mutant peptide of EBNA2-TAT had no inhibitory effects on EBNA2 function or cell viability, suggesting specificity to RBP-Jκ interaction for observed effects."</data>
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
    </node>
    <node id="&quot;EBNA2 INHIBITION&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"Inhibition of EBNA2 alters MS risk gene expression in LCLs through specific molecular interactions and pathways."</data>
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
    </node>
    <node id="&quot;RCOR1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"EBNA2 was demonstrated to bind RCOR1, one of the MS risk loci, dependent on the presence of a specific risk allele."&lt;SEP&gt;"RCOR1 is another gene that was identified in association with MS risk loci under the effect of EBNA2."</data>
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6&lt;SEP&gt;chunk-bb351b97d99fce93d17df522db92dda7</data>
    </node>
    <node id="&quot;TNFSF1A&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The effect of EBNA2 inhibition suggested that EBNA2 inhibits expression of TNFSF1A in LCLs."</data>
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
    </node>
    <node id="&quot;TBX6&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The results suggest that EBNA2 inhibits expression of TBX6 in LCLs, indicating a potential role in modulating MS risk genes."</data>
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
    </node>
    <node id="&quot;CLECL1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"CLECL1, a gene related to MS risk loci, showed no significant effect from EBNA2 binding preference."&lt;SEP&gt;"EBNA2 inhibition showed reduced risk gene expression on CLECL1 suggesting an effect from EBNA2."</data>
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6&lt;SEP&gt;chunk-bb351b97d99fce93d17df522db92dda7</data>
    </node>
    <node id="&quot;TNFAIP8&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Genetic associations found that EBV DNA copy number is influenced by the TNFAIP8 locus, and these effects were altered upon EBNA2-TAT treatment."&lt;SEP&gt;"TNFAIP8 is an immune system gene that was affected by EBNA2 in the context of MS risk loci."</data>
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6&lt;SEP&gt;chunk-bb351b97d99fce93d17df522db92dda7</data>
    </node>
    <node id="&quot;TNFRSF1A&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"TNFRSF1A, or Tumor Necrosis Factor Receptor Superfamily Member 1A, plays a role in immune response and is one of the MS risk genes impacted by EBNA2 interaction with the risk loci."&lt;SEP&gt;"The expression of TNFRSF1A was significantly affected by EBNA2 inhibition, suggesting a role in modulating MS risk genes through EBNA2 interaction."</data>
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6&lt;SEP&gt;chunk-bb351b97d99fce93d17df522db92dda7</data>
    </node>
    <node id="&quot;ALLELIC ASSOCIATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The allelic association between genotypes at risk loci was altered by EBNA2 binding."</data>
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
    </node>
    <node id="&quot;EXPRESSION OF GENES&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"EBNA2 changed the expression levels of specific genes like TRAF3, CD40, TNFAIP8, TNFRSF1A, TBX6 and RCOR1 at MS risk loci."</data>
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
    </node>
    <node id="&quot;RISK ALLELE PREFERENCE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The direction of gene expression alteration depended on the MS risk allele preference of EBNA2 binding."</data>
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
    </node>
    <node id="&quot;LMP2&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"LMP2 is another latency protein that plays a role in EBV's latency III phase alongside LMP1, which can influence gene expression and MS risk factors."</data>
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
    </node>
    <node id="&quot;LATENCY III INFECTION CYCLE&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"The cycle of EBV latency III involves the regulation of viral proteins including EBNA2 and LMP1/LMP2, influencing immune evasion and cell transformation processes."</data>
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
    </node>
    <node id="&quot;LCLS (B-CELL LINE ESTABLISHED BY EBV-LATENT INFECTION)&quot;">
      <data key="d0">"BIOLOGICAL ENTITY"</data>
      <data key="d1">"LCLs are established when a virus like EBV infects B-cells that have undergone permanent growth arrest due to Epstein-Barr viral infection."</data>
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
    </node>
    <node id="&quot;UNINFECTED B CELLS&quot;">
      <data key="d0">"COMPARATIVE BIOLOGICAL STATE"</data>
      <data key="d1">"Refers to normal, uninfected B cells as opposed to those infected with Epstein-Barr Virus (EBV), impacting expression and function."</data>
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
    </node>
    <node id="&quot;MS RISK GENES&quot;">
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
      <data key="d1">"EBNA2 was found to bind chromatin at MS risk loci dependent on the presence of a specific risk allele, influencing gene expression.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;EBV DNA COPY NUMBER&quot;">
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
      <data key="d1">"EBV DNA copy number is associated with several MS risk SNPs and genes in LCLs, which can be influenced by EBNA2-TAT treatment.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LCLS&quot;">
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
      <data key="d1">"EBV DNA copy number is associated with several MS risk SNPs and genes in LCLs, which can be influenced by EBNA2-TAT treatment.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RBP-JΚ INTERACTION&quot;">
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
      <data key="d1">"EBNA2 interacts specifically with the RBP-Jκ site on EBNA2, affecting gene expression through this interaction.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MS RISK SNPS AND GENES&quot;">
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
      <data key="d1">"Expression of MS risk genes is associated with LCL proliferation, which can be modulated by EBNA2 inhibition.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DOSAGE RESPONSE&quot;">
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
      <data key="d1">"A dose-response experiment was conducted to determine the optimal concentration of EBNA2-TAT that inhibits EBNA2 transcriptional function without excess cytotoxicity.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENETIC MODULATION&quot;">
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
      <data key="d1">"The data suggest that TBX6 and RCOR1 are modulated by EBNA2 inhibition, providing insights into how EBNA2 might influence genetic risk factors for MS.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TBX6 AND RCOR1&quot;">
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
      <data key="d1">"The data suggest that TBX6 and RCOR1 are modulated by EBNA2 inhibition, providing insights into how EBNA2 might influence genetic risk factors for MS.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;EBNA2 TREATMENT&quot;">
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
      <data key="d1">"EBNA2 effect on gene expression at MS risk loci could be ablated by EBNA2-TAT treatment.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENOTYPE EFFECT&quot;">
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
      <data key="d1">"EBNA2 effect on gene expression at MS risk loci could be ablated by EBNA2-TAT treatment.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PROGRAM OF EBV LATENCY III&quot;">
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
      <data key="d1">"The effect on gene expression due to EBNA2 affects the program of EBV latency III infection cycle.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RISK GENE EXPRESSION&quot;">
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
      <data key="d1">"The effect on gene expression due to EBNA2 affects the program of EBV latency III infection cycle.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;EBNA2 BINDING&quot;">
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
      <data key="d1">"EBNA2 interaction with MS risk alleles may increase host immune evasion by enhancing its function.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HOST IMMUNE EVASION&quot;">
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
      <data key="d1">"EBNA2 interaction with MS risk alleles may increase host immune evasion by enhancing its function.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;EBNA2 INTERACTION EFFECT&quot;">
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
      <data key="d1">"The EBNA2 interaction on MS risk genes led to changes in their expression levels, affecting immune evasion processes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS3842787&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The initial search retrieved 154 potentially relevant references"&lt;SEP&gt;"The initial search retrieved 154 potentially relevant references."</data>
      <data key="d2">chunk-54c4fede216a6c4183b95ee1a2edcb17</data>
    </node>
    <node id="&quot;RS20417&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A flow diagram schematizing the selection process of identified articles with specific reasons, and the baseline characteristics of all qualified articles are presented in Figure 1"&lt;SEP&gt;"rs20417 has an associated P-value of 0.034, indicating its significance in explaining part of the heterogeneity."</data>
      <data key="d2">chunk-734cac289b42d37dad32bd51ea24a1ea&lt;SEP&gt;chunk-54c4fede216a6c4183b95ee1a2edcb17</data>
    </node>
    <node id="&quot;RS20118426&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"There were a total of 4, 6, 10 and 7 qualified articles and 353/595, 344/698, 588/878"</data>
      <data key="d2">chunk-54c4fede216a6c4183b95ee1a2edcb17</data>
    </node>
    <node id="&quot;RS1126643&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The retrieved articles were published between 2003 and 2012, and 11 of them were written in Chinese"&lt;SEP&gt;"rs1126643 shows a significant source of heterogeneity with a P-value of 0.012, suggesting its importance in study outcomes."</data>
      <data key="d2">chunk-734cac289b42d37dad32bd51ea24a1ea&lt;SEP&gt;chunk-54c4fede216a6c4183b95ee1a2edcb17</data>
    </node>
    <node id="&quot;COX-2 GENE RS20417&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Taking all available comparisons together for each polymorphism observed significant association of COX-2"</data>
      <data key="d2">chunk-54c4fede216a6c4183b95ee1a2edcb17</data>
    </node>
    <node id="&quot;ITGA2 GENE RS1126643&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Subgroup analyses"&lt;SEP&gt;"Whereas no significance was found for COX-1 gene rs3842787 and ITGA2B gene rs20118426"</data>
      <data key="d2">chunk-54c4fede216a6c4183b95ee1a2edcb17</data>
    </node>
    <node id="&quot;COX-1 GENE RS3842787&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Overall analyses"</data>
      <data key="d2">chunk-54c4fede216a6c4183b95ee1a2edcb17</data>
    </node>
    <node id="&quot;CHINESE POPULATION&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"To estimate the influence of categorical confounders, separate analyses were performed within strata involving two or more comparisons"</data>
      <data key="d2">chunk-54c4fede216a6c4183b95ee1a2edcb17</data>
    </node>
    <node id="&quot;CAUCASIAN POPULATION&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Further grouping articles by ethnicity of study populations (mainly Chinese and Caucasian)"</data>
      <data key="d2">chunk-54c4fede216a6c4183b95ee1a2edcb17</data>
    </node>
    <node id="&quot;ITGA2B GENE RS20118426&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Subgroup analyses"</data>
      <data key="d2">chunk-54c4fede216a6c4183b95ee1a2edcb17</data>
    </node>
    <node id="&quot;AVERAGED PLATELET NUMBER&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Averaged platelet number serves as an important factor contributing to the heterogeneity in rs1126643."</data>
      <data key="d2">chunk-734cac289b42d37dad32bd51ea24a1ea</data>
    </node>
    <node id="&quot;COX-2 GENE&quot;">
      <data key="d2">chunk-54c4fede216a6c4183b95ee1a2edcb17</data>
      <data key="d1">"There was a significant association between rs20417 in the COX-2 gene and aspirin insensitivity")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ITGA2 GENE&quot;">
      <data key="d2">chunk-54c4fede216a6c4183b95ee1a2edcb17</data>
      <data key="d1">"Risk estimates by rs1126643-T allele were more potentiated among patients with aspirin semi-resistance compared with those with aspirin resistance")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CAD PERCENTAGE&quot;">
      <data key="d2">chunk-54c4fede216a6c4183b95ee1a2edcb17</data>
      <data key="d1">"Differences in the percentage of CAD between patients and controls explained a large part of heterogeneity for rs20417")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PLATELET NUMBER&quot;">
      <data key="d2">chunk-54c4fede216a6c4183b95ee1a2edcb17</data>
      <data key="d1">"Averaged platelet number was a significant source of heterogeneity for rs1126643")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;COX-1 GENE&quot;">
      <data key="d2">chunk-54c4fede216a6c4183b95ee1a2edcb17</data>
      <data key="d1">"The association of COX-1 gene polymorphism rs3842787 with aspirin insensitivity was not significant")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ITGA2B GENE&quot;">
      <data key="d2">chunk-54c4fede216a6c4183b95ee1a2edcb17</data>
      <data key="d1">"The influence of ITGA2B gene polymorphism rs20118426 on the response to aspirin could be assessed under subgroup analyses")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GHI PHENOTYPE&quot;">
      <data key="d0">"CLINICAL PRESENTATION"</data>
      <data key="d1">"The GHI phenotype encompasses severe short stature, centripetal fat distribution, a prominent forehead, and a depressed nasal bridge."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;SHORT STATURE&quot;">
      <data key="d0">"CLINICAL PRESENTATION"</data>
      <data key="d1">"Severe short stature was present in all three siblings with height standard deviation scores (height SDS) of -6.5, -5.06, and -4.7 respectively."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;CENTRIPETAL FAT DISTRIBUTION&quot;">
      <data key="d0">"GHI PHENOTYPE"</data>
      <data key="d1">"This refers to the accumulation of fat near the center of the body as part of the GHI phenotype."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;PROMINENT FOREHEAD&quot;">
      <data key="d0">"GHI PHENOTYPE"</data>
      <data key="d1">"Characterized by an increased prominence or size of the forehead, as seen in the GHI phenotype of three siblings."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;DEPRESSED NASAL BRIDGE&quot;">
      <data key="d0">"GHI PHENOTYPE"</data>
      <data key="d1">"The nasal bridge being lower than normal is one feature of the GHI phenotype observed among these patients."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;ATOPIC DISEASE&quot;">
      <data key="d0">"PRESENTATION"</data>
      <data key="d1">"This includes eczema and reactive airway disease which require corticosteroids for management."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;ECZEMA&quot;">
      <data key="d0">"ATOPIC DISEASE"</data>
      <data key="d1">"A skin disorder characterized by itchy, red, inflamed patches on the skin, often seen in atopy cases."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;REACTIVE AIRWAY DISEASE&quot;">
      <data key="d0">"ATOPIC DISEASE"</data>
      <data key="d1">"An inflammatory condition affecting the airways that can lead to asthma-like symptoms and is part of atopy."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;THYROID HORMONE REPLACEMENT THERAPY&quot;">
      <data key="d0">"AUTOIMMUNE THYROIDITIS"</data>
      <data key="d1">"Levothyroxine is used to replace missing or underproducing thyroid hormones in autoimmune thyroiditis."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;CHRONIC ECZEMA&quot;">
      <data key="d0">"PRESENTATION"</data>
      <data key="d1">"Developed as a part of their condition requiring corticosteroids for management."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;RECURRENT INFECTIONS&quot;">
      <data key="d0">"PRESENTATION"</data>
      <data key="d1">"Involving skin, urinary tract, and lungs necessitating antibiotics and supplemental oxygen."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;GENERAL LYMPHADENOPATHY&quot;">
      <data key="d0">"PRESENTATION"</data>
      <data key="d1">"Noted during clinical evaluations of all three siblings."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;GASTROESOPHAGEAL REFLUX DISEASE (GERD)&quot;">
      <data key="d0">"PRESENTATION"</data>
      <data key="d1">"Observed in patient 3 requiring medical attention for symptoms."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;NORMAL SERUM GH LEVELS&quot;">
      <data key="d0">"PRESENTATION"</data>
      <data key="d1">"The levels were within normal range in each sibling at presentation, consistent with GHI."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;BELOW-NORMAL IGF-1, IGF-BP3, AND ACID LABILE SUBUNIT (ALS) CONCENTRATIONS&quot;">
      <data key="d0">"GHI PRESENTATION"</data>
      <data key="d1">"These low values are indicative of Growth Hormone Insensitivity Syndrome (GHI), alongside clinical symptoms."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;DELAYED PUBERTY&quot;">
      <data key="d0">"CLINICAL PRESENTATION"</data>
      <data key="d1">"Characterized by late onset of secondary sexual characteristics in adolescents."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;BONE DENSITY REDUCTION&quot;">
      <data key="d0">"CONSEQUENCE OF GROWTH HORMONE INSENSITIVITY SYNDROME (GHI)"</data>
      <data key="d1">"A decrease in bone density, increasing the risk for osteoporosis."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;MUSCLE WEAKNESS&quot;">
      <data key="d0">"CLINICAL PRESENTATION"</data>
      <data key="d1">"Common symptom in patients with GHI due to lack of growth hormone which affects muscle mass and strength."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;LEARNING DIFFICULTIES&quot;">
      <data key="d0">"CONSEQUENCE OF GHI"</data>
      <data key="d1">"Some studies suggest that children with GHI may have learning difficulties and cognitive impairments."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;BEHAVIORAL PROBLEMS&quot;">
      <data key="d0">"CONSEQUENCES IN PATIENTS"</data>
      <data key="d1">"GHI patients might exhibit behavioral issues like irritability or hyperactivity, which are possibly related to neurotransmitter imbalances."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;SLEEP DISTURBANCES&quot;">
      <data key="d0">"COMMON IN GHI POPULATION"</data>
      <data key="d1">"Difficulty sleeping is another common complaint among individuals with growth hormone insensitivity."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;GASTROINTESTINAL PROBLEMS&quot;">
      <data key="d0">"PRESENT IN GHI CASES"</data>
      <data key="d1">"This includes issues such as constipation or diarrhea due to hormonal imbalances and metabolic effects."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;REPRODUCTIVE ISSUES&quot;">
      <data key="d0">"IN MALES WITH GHI"</data>
      <data key="d1">"Men may experience reduced fertility or erectile dysfunction as a result of inadequate growth hormone levels."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;PSYCHOLOGICAL IMPACT&quot;">
      <data key="d0">"GHI CONSEQUENCE"</data>
      <data key="d1">"The condition can affect the psychological well-being, leading to anxiety or depression due to physical and social changes."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;STAT5B P.W631* VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The STAT5B gene harbors a loss-of-function variant, leading to reduced expression and inability for phosphorylation or nuclear trafficking upon growth hormone (GH) stimulation."</data>
      <data key="d2">chunk-e323b0d4f82733a78f687e51f47b500a</data>
    </node>
    <node id="&quot;SUSTAINED B CELL HYPERACTIVITY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Sustained B cell overactivity is associated with atopy and autoimmunity in STAT5B deficient siblings."</data>
      <data key="d2">chunk-e323b0d4f82733a78f687e51f47b500a</data>
    </node>
    <node id="&quot;LOF STAT5B VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A loss-of-function (LOF) variant of the STAT5B gene was identified, which impacts immune profiles in patients."</data>
      <data key="d2">chunk-e323b0d4f82733a78f687e51f47b500a</data>
    </node>
    <node id="&quot;NK CELLS&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The number of natural killer (NK) cells remains normal during infancy through early childhood in STAT5B deficient siblings."</data>
      <data key="d2">chunk-e323b0d4f82733a78f687e51f47b500a</data>
    </node>
    <node id="&quot;IGE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"High levels of IgE are associated with an atopic phenotype often linked to STAT5B deficiency."</data>
      <data key="d2">chunk-e323b0d4f82733a78f687e51f47b500a</data>
    </node>
    <node id="&quot;T CELL LYMPHOPENIA&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Moderate to severe T cell lymphopenia has been observed in STAT5B deficient patients at diagnosis, indicating a deficiency or destruction of peripheral T cells."</data>
      <data key="d2">chunk-e323b0d4f82733a78f687e51f47b500a</data>
    </node>
    <node id="&quot;THYMIC OUTPUT&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The assessment of recent thymic emigrants (RTEs) by quantifying CD4+CD45+CD31+ T cells reveals that while P3 displays reduced RTEs which normalize over time, this normalization varies among siblings."</data>
      <data key="d2">chunk-e323b0d4f82733a78f687e51f47b500a</data>
    </node>
    <node id="&quot;ABSOLUTE NUMBER AND TOTAL PERCENTAGE OF TREGS&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The numbers and percentages of regulatory T (Treg) cells identified as CD4+CD25highCD127low or CD25+FOXP3+ are within normal ranges in P2 and P3, with reductions identified only later for P1."</data>
      <data key="d2">chunk-e323b0d4f82733a78f687e51f47b500a</data>
    </node>
    <node id="&quot;MEMORY CD8+ T CELL DYSREGULATION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Young STAT5B deficient siblings exhibit pronounced changes in memory CD8+ T cells, characterized by reduced naïve cells and elevations in memory/activation phenotype, impacting various subtypes including central memory (TCM), effector memory (TEM), and effector memory re-expressing CD45RA (TEMRA) over time.")("entity"</data>
      <data key="d2">chunk-e323b0d4f82733a78f687e51f47b500a</data>
    </node>
    <node id="&quot;SELF-TOLERANCE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"STAT5B contributes to maintaining self-tolerance, which is disrupted with loss-of-function variants leading to autoimmune responses."</data>
      <data key="d2">chunk-e323b0d4f82733a78f687e51f47b500a</data>
    </node>
    <node id="&quot;IL-2 SIGNALING REDUCTION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Reductions in IL-2 signaling due to STAT5B variant results in decreased FOXP3 induction and impaired Treg function."</data>
      <data key="d2">chunk-e323b0d4f82733a78f687e51f47b500a</data>
    </node>
    <node id="&quot;MEMORY T CELL SUBSETS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"STAT5B affects memory T cell subsets, impacting their development and function during infancy through childhood."</data>
      <data key="d2">chunk-e323b0d4f82733a78f687e51f47b500a</data>
    </node>
    <node id="&quot;TCM CELLS&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The TCM (T-cell memory) cells remained within normal ranges."</data>
      <data key="d2">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
    </node>
    <node id="&quot;CD4+ TEM CELLS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"No alterations in the proportion of CD4+ TEM (terminally differentiated effector memory) cells were identified."&lt;SEP&gt;"No changes were identified in the proportion of CD4+ TEM (terminally differentiated effector memory) cells."</data>
      <data key="d2">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
    </node>
    <node id="&quot;CD8+ TEM CELL PROPORTIONS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"Increased proportions of CD8+ TEM (terminally differentiated effector memory) cells became clinically significant with age, specifically noticeable in each sibling."&lt;SEP&gt;"Increases in proportions of CD8+ TEM (terminally differentiated effector memory) cells became clinically significant with age, specifically in each sibling."</data>
      <data key="d2">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
    </node>
    <node id="&quot;INFANT CD8+ TEMRA CELLS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"An increase in the percentage of CD8+ TEMRA (recently activated T helper) cells was detected during infancy and then normalized around age 4."&lt;SEP&gt;"Elevations in the percentage of CD8+ TEMRA (recently activated T helper) cells were detected during infancy and normalized around age 4."</data>
      <data key="d2">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
    </node>
    <node id="&quot;AGE 4 CD8+ MEMORY T CELLS&quot;">
      <data key="d0">"TIME POINT"</data>
      <data key="d1">"CD8+ memory T cells began to be elevated, suggesting a critical role for the LOF (loss-of-function) STAT5B variant in CD8+ T cell activation and homeostasis."&lt;SEP&gt;"CD8+ memory T cells showed elevated proportions starting from infancy, indicating a crucial role of the LOF STAT5B variant in CD8+ T cell activation and homeostasis."</data>
      <data key="d2">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
    </node>
    <node id="&quot;STAT5B DEFICIENCY&quot;">
      <data key="d0">"GENETIC CONDITION"</data>
      <data key="d1">"Our patients carried a variant of STAT5B, which despite normal CD4+ memory T cell subsets, was associated with dysregulation of CD8+ T cells."</data>
      <data key="d2">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
    </node>
    <node id="&quot;CD8+ MEMORY T CELLS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"Elevated proportions of CD8+ memory T cells began in infancy, suggesting a role for the LOF STAT5B variant in CD8+ T cell activation and homeostasis.")("entity"</data>
      <data key="d2">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
    </node>
    <node id="&quot;STAT5B&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Our patients carried a variant of the STAT5B gene, which despite normal levels of CD4+ memory T cells, was associated with altered regulation of CD8+ T cells."</data>
      <data key="d2">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
    </node>
    <node id="&quot;LOF (LOSS-OF-FUNCTION) STAT5B VARIANT&quot;">
      <data key="d0">"GENETIC VARIANT"</data>
      <data key="d1">"The presence of a LOF STAT5B variant in our patients led to dysregulation of CD8+ T cells despite normal CD4+ memory T cell subsets."</data>
      <data key="d2">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
    </node>
    <node id="&quot;CD4+ MEMORY T CELLS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"The proportions of CD4+ memory T cells remained normal across the study, despite the presence of the LOF STAT5B variant and dysregulation in other parts of the immune system."</data>
      <data key="d2">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
    </node>
    <node id="&quot;IDENTIFICATION OF NOVEL MUTATION&quot;">
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
      <data key="d1">"Whole Exome Sequencing (WES) was performed on patient 1 at age 3.9, revealing a novel homozygous nonsense STAT5B mutation.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;WES ANALYSIS&quot;">
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
      <data key="d1">"Whole Exome Sequencing (WES) was performed on patient 1 at age 3.9, revealing a novel homozygous nonsense STAT5B mutation.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PARENTAL HETEROZYGOSITY&quot;">
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
      <data key="d1">"The WES analysis showed heterozygosity in the STAT5B locus in both parents, implying they are carriers of the variant.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TRIO CLINICAL WHOLE EXOME SEQUENCING&quot;">
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
      <data key="d1">"The WES analysis showed heterozygosity in the STAT5B locus in both parents, implying they are carriers of the variant.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CONFIRMATION OF MUTATION&quot;">
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
      <data key="d1">"Sanger sequencing confirmed the presence of the mutation in the fibroblast cultures from each sibling.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;COMPARISON WITH IDENTIFIED MUTATIONS&quot;">
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
      <data key="d1">"The new mutation is adjacent to the first identified mutation in STAT5B, p.A630P.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NOVEL STAT5B MUTATION LOCATION&quot;">
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
      <data key="d1">"The new mutation is adjacent to the first identified mutation in STAT5B, p.A630P.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ROLE OF SH2 DOMAIN&quot;">
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
      <data key="d1">"The truncated STAT5B protein lacks ~50% of the Src Homology 2 (SH2) domain and the critical phosphorylated tyrosine at position 699.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SH2 DOMAIN IMPAIRMENT&quot;">
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
      <data key="d1">"The truncated STAT5B protein lacks ~50% of the Src Homology 2 (SH2) domain and the critical phosphorylated tyrosine at position 699.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ROLE OF TAD DOMAIN&quot;">
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
      <data key="d1">"The mutation results in the absence of the entire transactivation domain (TAD).")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TAD DOMAIN ABSENCE&quot;">
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
      <data key="d1">"The mutation results in the absence of the entire transactivation domain (TAD).")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;EXPRESSION ANALYSIS&quot;">
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
      <data key="d1">"In vitro reconstitution analyses showed significantly reduced expression of the truncated STAT5B protein.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;REDUCED EXPRESSION OF P.W631* PROTEIN&quot;">
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
      <data key="d1">"In vitro reconstitution analyses showed significantly reduced expression of the truncated STAT5B protein.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS28383172&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The genotyping results of rs28383172 was successfully done in 98% of the patients. Two individuals were excluded due to poor DNA quality."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;RS4713586&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Three SNPs, including rs4713586, had genotypes available for all 233 patients."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;SNP GENOTYPING ASSAY&quot;">
      <data key="d0">"TECHNIQUE"</data>
      <data key="d1">"A Custom TaqMan SNP Genotyping Assay was used for the genotyping of rs28383172."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;KASPAR-ON-DEMAND PREVALIDATED ASSAYS&quot;">
      <data key="d0">"TECHNIQUE"</data>
      <data key="d1">"The KASPar-on-Demand prevalidated assays were utilized to obtain genotypes for all 3 SNPs (rs2395182, rs4713586 and rs7775228)."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;HLA DRB1*07:01&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The study involved HLA-DRB1 gene analysis for the genotype carrier status of DRB1*07:01."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;DQA1*02:01&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Haplotype carrier status includes DQA1*02:01 allele."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;DQB1*02:02&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Haplotype carrier status also involves the presence of DQB1*02:02 allele."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;SNP-GENOTYPED SUBPOPULATION&quot;">
      <data key="d0">"GROUP"</data>
      <data key="d1">"A group was identified based on genotyping results using SNPs rs28383172, rs2395182, rs4713586 and rs7775228."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;HUNGARIAN POPULATION&quot;">
      <data key="d0">"POPULATION SUPER TYPE"</data>
      <data key="d1">"The Hungarian population showed most similarity to the EUR super population in terms of linkage disequilibrium coefficients between investigated SNPs."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;AMR&quot;">
      <data key="d0">"POPULATION SUPER TYPE"</data>
      <data key="d1">"Algorithm V performed with sensitivity and &gt;95% specificity in the AMR (Admixed American) population."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;EAS&quot;">
      <data key="d0">"POPULATION SUPER TYPE"</data>
      <data key="d1">"Algorithm V also achieved 100% sensitivity and over 95% specificity in the East Asian (EAS) population."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;EUR&quot;">
      <data key="d0">"POPULATION SUPER TYPE"</data>
      <data key="d1">"In the EUR super population, algorithm V had significantly higher values for sensitivity and negative predictive value compared to algorithms III and IV. It also showed a significant increase in specificity and positive predictive value when compared to algorithm II."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;RS6031&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The genotypes for both SNPs, including rs6031, are available among all study subjects (n=250)."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;RS9738479&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNP rs9738479 was successfully genotyped in the cohort of patients."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;RS1045641&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The genotyping process for rs1045641 yielded results for all participants involved (n=273)."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;SNP GENOTYPING PLATFORM&quot;">
      <data key="d0">"TECHNOLOGY"</data>
      <data key="d1">"High-throughput automated SNP genotyping platform was employed to determine the rs5742931 status."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;RS6031 AND RS9738479&quot;">
      <data key="d0">"PAIRWISE RELATIONSHIP"</data>
      <data key="d1">"The linkage disequilibrium (LD) analysis revealed that rs6031 was in strong LD with rs9738479, but not rs5742931."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;RS1045641 AND RS9738479&quot;">
      <data key="d0">"PAIRWISE RELATIONSHIP"</data>
      <data key="d1">"The SNP rs1045641 was found to be in moderate linkage disequilibrium with rs9738479, but not with rs5742931 or rs6031."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;RS5742931 AND RS6031&quot;">
      <data key="d0">"PAIRWISE RELATIONSHIP"</data>
      <data key="d1">"The genotypic frequencies for rs5742931 showed a significantly different distribution compared to rs6031, indicating a low degree of linkage disequilibrium."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;RS1045641 AND RS6031&quot;">
      <data key="d0">"PAIRWISE RELATIONSHIP"</data>
      <data key="d1">"A significant statistical difference was found in the genotypic frequencies between rs1045641 and rs6031, indicating minimal LD."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;RS9738479 AND RS6031&quot;">
      <data key="d0">"PAIRWISE RELATIONSHIP"</data>
      <data key="d1">"The haplotype analysis revealed that rs9738479 was in weak linkage disequilibrium with rs6031, but not with rs5742931 or rs1045641."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;RS1045641 AND RS5742931&quot;">
      <data key="d0">"PAIRWISE RELATIONSHIP"</data>
      <data key="d1">"The association analysis did not find a significant LD between rs1045641 and rs5742931, suggesting they are independently distributed."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;RS9738479 AND RS5742931&quot;">
      <data key="d0">"PAIRWISE RELATIONSHIP"</data>
      <data key="d1">"The statistical analysis showed no evidence of linkage disequilibrium between rs9738479 and rs5742931, indicating they might be in different recombination hotspots."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;RS6031 AND RS1045641&quot;">
      <data key="d0">"PAIRWISE RELATIONSHIP"</data>
      <data key="d1">"Genetic association studies did not detect any strong linkage disequilibrium between rs6031 and rs1045641, but showed a slight correlation."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;1000 GENOMES DATASET&quot;">
      <data key="d0">"DATASET"</data>
      <data key="d1">"A large-scale genetic database used for evaluating algorithms and comparing parameters."</data>
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
    </node>
    <node id="&quot;EUR SUPER POPULATION&quot;">
      <data key="d0">"SUPER POPULATION"</data>
      <data key="d1">"A subset of the 1000 Genomes dataset that specifically represents European populations."</data>
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
    </node>
    <node id="&quot;ALGORITHM III&quot;">
      <data key="d0">"ALGORITHM"</data>
      <data key="d1">"One of several machine learning models or statistical methods tested for their performance."</data>
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
    </node>
    <node id="&quot;ALGORITHM IV&quot;">
      <data key="d0">"ALGORITHM"</data>
      <data key="d1">"Another model used in comparison to algorithm III and V in the analysis."</data>
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
    </node>
    <node id="&quot;ALGORITHM II&quot;">
      <data key="d0">"ALGORITHM"</data>
      <data key="d1">"A second testing model used alongside algorithms III, IV, and V."</data>
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
    </node>
    <node id="&quot;ALGORITHM V&quot;">
      <data key="d0">"ALGORITHM"</data>
      <data key="d1">"The best performing model among those tested on the 1000 Genomes dataset."</data>
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
    </node>
    <node id="&quot;SNP GENOTYPED SUBPOPULATION&quot;">
      <data key="d0">"SUBPOPULATION"</data>
      <data key="d1">"A subset of individuals within the broader dataset who have their SNPs (single nucleotide polymorphisms) genotyped."</data>
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
    </node>
    <node id="&quot;HLA-DRB1*07:01–DQA1*02:01–DQB1*02:02 HAPLOTYPE&quot;">
      <data key="d0">"HAPLOTYPE"</data>
      <data key="d1">"A combination of several DNA variations found together on a single chromosome, in this case related to the HLA system."</data>
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
    </node>
    <node id="&quot;SURROGATE MARKERS&quot;">
      <data key="d0">"MARKER"</data>
      <data key="d1">"Alternative genetic indicators that can be used as proxies for certain traits or conditions when direct testing is unavailable or impractical."</data>
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
    </node>
    <node id="&quot;E. COLI ASP HYPERSENSITIVITY&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A sensitivity to the antibiotic E. coli ASP, typically an allergy or adverse reaction."</data>
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
    </node>
    <node id="&quot;HAPLOTYPE CARRIER STATUS&quot;">
      <data key="d0">"CARRIER STATUS"</data>
      <data key="d1">"The presence of a specific combination of genetic variants in an individual."</data>
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
    </node>
    <node id="&quot;2-SNP TAGGING&quot;">
      <data key="d0">"TECHNIQUE"</data>
      <data key="d1">"A method of genetic tagging that uses two single nucleotide polymorphisms (SNPs) for correlation."</data>
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
    </node>
    <node id="&quot;E. COLI ASP&quot;">
      <data key="d0">"DRUG OR COMPOUND"</data>
      <data key="d1">"An antibiotic, specifically Erythromycin, often causing hypersensitivity reactions."</data>
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
    </node>
    <node id="&quot;HAPLOTYPE CARRIER STATUS OF HLA-DRB1*07:01–DQA1*02:01–DQB1*02:02&quot;">
      <data key="d0">"GENETIC INFORMATION"</data>
      <data key="d1">"The state where a person carries the specific combination of alleles for HLA genes mentioned."</data>
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
    </node>
    <node id="&quot;ALGORITHM II, III, IV&quot;">
      <data key="d0">"TESTING MODEL"</data>
      <data key="d1">"Other computational models tested against algorithm V in performance comparisons."</data>
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
    </node>
    <node id="&quot;DATASET FROM 1000 GENOMES PROJECT&quot;">
      <data key="d0">"DATA COLLECTION"</data>
      <data key="d1">"A comprehensive collection of human genetic data used for population genetic studies."</data>
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
    </node>
    <node id="&quot;SENSITIVITY AND SPECIFICITY&quot;">
      <data key="d0">"STATISTICAL MEASURE"</data>
      <data key="d1">"Quantitative indicators of the accuracy of a test or algorithm, with sensitivity measuring true positives and specificity true negatives."</data>
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
    </node>
    <node id="&quot;NEGATIVE PREDICTIVE VALUE (NPV)&quot;">
      <data key="d0">"STATISTICAL MEASURE"</data>
      <data key="d1">"The probability that an individual who tests negative truly does not have the condition being tested for."</data>
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
    </node>
    <node id="&quot;POSITIVE PREDICTIVE VALUE (PPV)&quot;">
      <data key="d0">"STATISTICAL MEASURE"</data>
      <data key="d1">"The probability that an individual who tests positive truly has the condition being tested for."</data>
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
    </node>
    <node id="&quot;SURROGATE MARKER&quot;">
      <data key="d0">"SUBSTITUTE INDICATOR"</data>
      <data key="d1">"A genetic variant or combination of variants used as a proxy when direct markers are unavailable or challenging to obtain."</data>
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
    </node>
    <node id="&quot;POSITIVE PREDICTIVE VALUE&quot;">
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
      <data key="d1">"Algorithm V had a better positive predictive value than algorithms II, III and IV when tested on the 1000 Genomes dataset.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SCREENING TEST PERFORMANCE&quot;">
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
      <data key="d1">"The performance of the HLA-DRB1*07:01-DQA1*02:01-DQB1*02:02 haplotype as a screening test was evaluated against E. coli ASP hypersensitivity.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SENSITIVITY VALUE&quot;">
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
      <data key="d1">"The sensitivity of the HLA haplotype to correctly identify affected patients was 23.4%.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SPECIFICITY&quot;">
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
      <data key="d1">"The specificity of the HLA haplotype was high at 88.5%, indicating a low rate of false positives.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NEGATIVE PREDICTIVE VALUE&quot;">
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
      <data key="d1">"The negative predictive value of the HLA haplotype was 63.1%, indicating that among those not identified as having the haplotype, a high percentage did not have E. coli ASP hypersensitivity.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IDENTICAL PERFORMANCE MEASURES&quot;">
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
      <data key="d1">"The HLA haplotype and its best tagger algorithm (V) had the same performance parameters.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TAGGER ACCURACY&quot;">
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
      <data key="d1">"Algorithm V did not perfectly predict the haplotype carrier status, as evidenced by a sensitivity and specificity of less than 100% when tagging the haplotype.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TLR7&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The TLR7 gene is involved in the response to pathogens and inflammation."</data>
      <data key="d2">chunk-05d583f893b703816ad8de9561aa5292</data>
    </node>
    <node id="&quot;RS179008&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Polymorphism rs179008 is located within the TLR7 gene."&lt;SEP&gt;"Polymorphism rs179008 of TLR7 was studied for its correlation with HIV disease progression."</data>
      <data key="d2">chunk-2c91cdebb36ef064eb01a7021a961302&lt;SEP&gt;chunk-05d583f893b703816ad8de9561aa5292</data>
    </node>
    <node id="&quot;RS179009&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Another polymorphism, rs179009 in the TLR7 gene, was also examined for HIV disease risk in this context."&lt;SEP&gt;"Polymorphism rs179009 is another variant found in the TLR7 gene."</data>
      <data key="d2">chunk-2c91cdebb36ef064eb01a7021a961302&lt;SEP&gt;chunk-05d583f893b703816ad8de9561aa5292</data>
    </node>
    <node id="&quot;HIV-INFECTED INDIVIDUALS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The study enrolled HIV-infected individuals to examine associations between genetic variations and disease progression."</data>
      <data key="d2">chunk-05d583f893b703816ad8de9561aa5292</data>
    </node>
    <node id="&quot;AGE (YEARS)&quot;">
      <data key="d0">"DEMOGRAPHIC"</data>
      <data key="d1">"Participants' mean age during enrollment ranged from 36 to 33 years, with SDs provided."</data>
      <data key="d2">chunk-05d583f893b703816ad8de9561aa5292</data>
    </node>
    <node id="&quot;CD4 COUNTS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The baseline CD4 cell count is a measure of an individual's immune system function and health status."</data>
      <data key="d2">chunk-05d583f893b703816ad8de9561aa5292</data>
    </node>
    <node id="&quot;TLR7 (RS179008)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"TLR7 gene polymorphisms have been studied in relation to HIV disease progression."</data>
      <data key="d2">chunk-2c91cdebb36ef064eb01a7021a961302</data>
    </node>
    <node id="&quot;TLR7 (RS179009)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The rs179009 variant of the TLR7 gene was also examined for its correlation with HIV disease progression."</data>
      <data key="d2">chunk-2c91cdebb36ef064eb01a7021a961302</data>
    </node>
    <node id="&quot;TOBACCO&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Tobacco use is an environmental factor potentially impacting disease progression when examined alongside genetic markers like TLR7."</data>
      <data key="d2">chunk-2c91cdebb36ef064eb01a7021a961302</data>
    </node>
    <node id="&quot;ALCOHOL&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Alcohol consumption is another environmental factor that was analyzed for its potential interaction with the rs179008 and rs179009 polymorphisms in relation to HIV disease progression."</data>
      <data key="d2">chunk-2c91cdebb36ef064eb01a7021a961302</data>
    </node>
    <node id="&quot;BASELINE CD4 COUNTS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The starting levels of CD4+ T cells, a key immune system component, were measured as part of the analysis for its interaction with the studied genetic markers and environmental factors in HIV disease progression."</data>
      <data key="d2">chunk-2c91cdebb36ef064eb01a7021a961302</data>
    </node>
    <node id="&quot;HIV DISEASE PROGRESSION&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"HIV disease progression was the outcome variable being analyzed through multivariate logistic regression using various risk factors including TLR7 gene polymorphisms."</data>
      <data key="d2">chunk-2c91cdebb36ef064eb01a7021a961302</data>
    </node>
    <node id="&quot;TLR7 POLYMORPHISMS&quot;">
      <data key="d2">chunk-05d583f893b703816ad8de9561aa5292</data>
      <data key="d1">"Polymorphisms rs179008 and rs179009 in the TLR7 gene were significantly reduced or associated with HIV-infected individuals compared to healthy controls.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TLR7 POLYMORPHISM (RS179009 AG GENOTYPE)&quot;">
      <data key="d2">chunk-05d583f893b703816ad8de9561aa5292</data>
      <data key="d1">"The rs179009 AG genotype was less frequent among HIV-infected individuals than in the control group, with a reduced risk of HIV infection.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TLR7 HAPLOTYPES (RS179008 AND RS179009)&quot;">
      <data key="d2">chunk-05d583f893b703816ad8de9561aa5292</data>
      <data key="d1">"The distribution of haplotype AG was found higher in HIV-infected individuals compared to healthy controls, indicating a possible association with the disease.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HIV DISEASE STAGES&quot;">
      <data key="d2">chunk-05d583f893b703816ad8de9561aa5292</data>
      <data key="d1">"Polymorphism rs179009 showed decreased frequency in individuals across early, intermediate, and advanced HIV stages compared to the healthy control group.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TLR7 POLYMORPHISMS (RS179009)&quot;">
      <data key="d2">chunk-05d583f893b703816ad8de9561aa5292</data>
      <data key="d1">"Polymorphism rs179009 showed decreased frequency in individuals across early, intermediate, and advanced HIV stages compared to the healthy control group.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ADVANCED HIV DISEASE STAGE&quot;">
      <data key="d2">chunk-05d583f893b703816ad8de9561aa5292</data>
      <data key="d1">"The frequency of rs179009 GG genotype was lower in individuals with advanced HIV disease stages compared to the healthy control group, suggesting a possible correlation.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TLR7 POLYMORPHISMS (RS179009 GG GENOTYPE)&quot;">
      <data key="d2">chunk-05d583f893b703816ad8de9561aa5292</data>
      <data key="d1">"The frequency of rs179009 GG genotype was lower in individuals with advanced HIV disease stages compared to the healthy control group, suggesting a possible correlation.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ENVIRONMENTAL FACTORS (TOBACCO CONSUMPTION, ALCOHOL USE)&quot;">
      <data key="d2">chunk-05d583f893b703816ad8de9561aa5292</data>
      <data key="d1">"Polymorphism distributions did not significantly differ between HIV-infected individuals with or without tobacco use; however, a higher prevalence of TLR7 rs179009AG genotype was noted among those who consumed tobacco.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TLR7 POLYMORPHISMS (RS179008 AND RS179009)&quot;">
      <data key="d2">chunk-05d583f893b703816ad8de9561aa5292</data>
      <data key="d1">"Polymorphism distributions did not significantly differ between HIV-infected individuals with or without tobacco use; however, a higher prevalence of TLR7 rs179009AG genotype was noted among those who consumed tobacco.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TLR7 POLYMORPHISMS (RS179008 CC, CT, TT GENOTYPES)&quot;">
      <data key="d2">chunk-05d583f893b703816ad8de9561aa5292</data>
      <data key="d1">"The distributions of rs179008 CC, CT, and TT genotypes were nearly equivalent between tobacco-consuming and nonconsuming HIV-infected individuals.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TOBACCO-CONSUMING HIV-INFECTED INDIVIDUALS VS. NON-USERS&quot;">
      <data key="d2">chunk-05d583f893b703816ad8de9561aa5292</data>
      <data key="d1">"The distributions of rs179008 CC, CT, and TT genotypes were nearly equivalent between tobacco-consuming and nonconsuming HIV-infected individuals.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ALCOHOL-TAKING HIV-INFECTED INDIVIDUALS VS. NON-USERS&quot;">
      <data key="d2">chunk-05d583f893b703816ad8de9561aa5292</data>
      <data key="d1">"Similar distributions of rs179008 AA, AT, and TT and rs179009 AA, AG, and GG genotypes were observed between alcohol-taking HIV-infected individuals and non-takers.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TLR7 POLYMORPHISMS (RS179009 AA, AG, GG GENOTYPES)&quot;">
      <data key="d2">chunk-05d583f893b703816ad8de9561aa5292</data>
      <data key="d1">"Similar distributions of rs179008 AA, AT, and TT and rs179009 AA, AG, and GG genotypes were observed between alcohol-taking HIV-infected individuals and non-takers.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MULTIVARIATE LOGISTIC REGRESSION ANALYSIS&quot;">
      <data key="d2">chunk-05d583f893b703816ad8de9561aa5292</data>
      <data key="d1">"These genetic variations were analyzed through multivariate logistic regression for associations with various factors including age, sex, tobacco use, alcohol consumption, and baseline CD4 counts.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HIV-INFECTED INDIVIDUALS VS. HEALTHY CONTROLS&quot;">
      <data key="d2">chunk-05d583f893b703816ad8de9561aa5292</data>
      <data key="d1">"Associations were sought between specific TLR7 polymorphisms and HIV-infected status versus health in the study population.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;BASELINE CD4 COUNTS AND TLR7 POLYMORPHISMS&quot;">
      <data key="d2">chunk-05d583f893b703816ad8de9561aa5292</data>
      <data key="d1">"The relationship between baseline CD4 cell count levels and different TLR7 polymorphisms was explored through this statistical method, aiming to uncover any significant correlations.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;EARLY, INTERMEDIATE, ADVANCED HIV DISEASE STAGES VS. HEALTHY CONTROLS&quot;">
      <data key="d2">chunk-05d583f893b703816ad8de9561aa5292</data>
      <data key="d1">"Assessments were made between various stages of HIV progression and the control group in terms of polymorphism frequencies.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;COMPARISONS&quot;">
      <data key="d2">chunk-05d583f893b703816ad8de9561aa5292</data>
      <data key="d1">"Comparative analysis was conducted between individuals who consumed tobacco and those who did not, with regard to TLR7 polymorphism distribution.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TLR7 (RS179008 AND RS179009)&quot;">
      <data key="d2">chunk-2c91cdebb36ef064eb01a7021a961302</data>
      <data key="d1">"Analysis of correlation between genetic variants in the TLR7 gene with HIV disease progression through multivariate logistic regression.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;AGE, SEX, TOBACCO, ALCOHOL, BASELINE CD4 COUNTS&quot;">
      <data key="d2">chunk-2c91cdebb36ef064eb01a7021a961302</data>
      <data key="d1">"These factors were considered as potential independent risk factors for HIV disease progression alongside rs179008 and rs179009 variants of the TLR7 gene.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RISK FACTOR&quot;">
      <data key="d2">chunk-2c91cdebb36ef064eb01a7021a961302</data>
      <data key="d1">"These factors were considered as potential independent risk factors for HIV disease progression alongside rs179008 and rs179009 variants of the TLR7 gene.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CORRELATION ANALYSIS RESULTS&quot;">
      <data key="d2">chunk-2c91cdebb36ef064eb01a7021a961302</data>
      <data key="d1">"The results from this correlation analysis were not directly presented, implying they supported or refuted the role of studied factors in HIV disease progression.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TABLE NOT SHOWN&quot;">
      <data key="d2">chunk-2c91cdebb36ef064eb01a7021a961302</data>
      <data key="d1">"The results from this correlation analysis were not directly presented, implying they supported or refuted the role of studied factors in HIV disease progression.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS179008 AND RS179009&quot;">
      <data key="d2">chunk-2c91cdebb36ef064eb01a7021a961302</data>
      <data key="d1">"Both genetic variations were included in multivariate logistic regression analysis to assess their influence on HIV disease progression.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;AGE, SEX, TOBACCO USE, ALCOHOL CONSUMPTION, BASELINE CD4 COUNTS&quot;">
      <data key="d2">chunk-2c91cdebb36ef064eb01a7021a961302</data>
      <data key="d1">"These demographic and health indicators were considered as potential risk factors for HIV disease progression together with rs179008 and rs179009.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;OUTCOME OF DISEASE PROGRESSION STUDY&quot;">
      <data key="d2">chunk-2c91cdebb36ef064eb01a7021a961302</data>
      <data key="d1">"The analysis was aimed at identifying significant predictors of HIV disease progression including genetic markers, environmental factors, and health status parameters.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ALK R1275Q&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"ALK R1275Q is a well-known hotspot mutation in the ALK gene."&lt;SEP&gt;"ALK gene mutation plays a major role in determining outcomes of targeted cancer immunotherapies."&lt;SEP&gt;"The ALK gene contains a variant at position 1275 which introduces an arginine (Q) mutation."&lt;SEP&gt;"The ALK gene mutation ALK R1275Q plays a critical role in cancer immunotherapies."</data>
      <data key="d2">chunk-52a8c1d4352526a90e26deb6f06682d2&lt;SEP&gt;chunk-de413ae6100407d8dadd5bdee87c1074&lt;SEP&gt;chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;NRAS Q61K&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"NRAS Q61K is an activating mutation commonly found in melanoma, thyroid, and colorectal cancers."</data>
      <data key="d2">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
    </node>
    <node id="&quot;ARDIYRASY&quot;">
      <data key="d0">"NONAMER"</data>
      <data key="d1">"ARDIYRASY is a predicted neoepitope derived from the ALK R1275Q mutation."&lt;SEP&gt;"ARDIYRASY is the self-antigen peptide used as a control in the HLA-B*15:01 binding affinity study."&lt;SEP&gt;"The self-antigen ARDIYRASY has a reduced binding affinity for HLA, leading to formation of only aggregated complexes."&lt;SEP&gt;"The self-peptide sequence that is naturally presented by HLA-B*15:01 and serves as a comparison to the neoepitopes introduced."</data>
      <data key="d2">chunk-52a8c1d4352526a90e26deb6f06682d2&lt;SEP&gt;chunk-de413ae6100407d8dadd5bdee87c1074</data>
    </node>
    <node id="&quot;GMAQDIYRA&quot;">
      <data key="d0">"NONAMER"</data>
      <data key="d1">"GMAQDIYRA is an ALK R1275Q nonamer that binds HLA-A*02:01."</data>
      <data key="d2">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
    </node>
    <node id="&quot;ILDTAGKEEY&quot;">
      <data key="d0">"NONAMER"</data>
      <data key="d1">"ILDTAGKEEY is a neoepitope derived from the NRAS Q61K mutation."</data>
      <data key="d2">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
    </node>
    <node id="&quot;MAQDIYRASY&quot;">
      <data key="d0">"DECAMER"</data>
      <data key="d1">"MAQDIYRASY is another ALK R1275Q derived decamer neoepitope."</data>
      <data key="d2">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
    </node>
    <node id="&quot;AQDIYRASYY&quot;">
      <data key="d0">"DECAMER"</data>
      <data key="d1">"AQDIYRASYY is a predicted HLA-B*15:01-restricted neoepitope arising from the ALK R1275Q mutation."</data>
      <data key="d2">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
    </node>
    <node id="&quot;HLA-B*15:01&quot;">
      <data key="d0">"MHC CLASS I"</data>
      <data key="d1">"A major histocompatibility complex molecule on the surface of cells, specifically HLA-B*15:01, used to present peptides for T cell recognition."&lt;SEP&gt;"HLA-B*15:01 is a major histocompatibility complex molecule that interacts with specific peptides, including ALK neoepitopes."&lt;SEP&gt;"HLA-B*15:01 is the major histocompatibility complex class I molecule used in the study."</data>
      <data key="d2">chunk-52a8c1d4352526a90e26deb6f06682d2&lt;SEP&gt;chunk-830d8819004960d1d149ac70149c72a0&lt;SEP&gt;chunk-de413ae6100407d8dadd5bdee87c1074</data>
    </node>
    <node id="&quot;HLA-A*02:01&quot;">
      <data key="d0">"MHC CLASS I"</data>
      <data key="d1">"HLA-A*02:01 is a common HLA allele that binds ALK R1275Q nonamer GMAQDIYRA."</data>
      <data key="d2">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
    </node>
    <node id="&quot;HETERODIMERIZATION&quot;">
      <data key="d0">"INTERACTION"</data>
      <data key="d1">"The heterodimerization of α and β subunits forms stable p/MHC complexes with distinct stabilities in vitro."</data>
      <data key="d2">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
    </node>
    <node id="&quot;ALK TUMOR NEOANTIGENS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"ALK tumor neoantigens form p/MHC complexes with distinct stabilities, as demonstrated by SEC."</data>
      <data key="d2">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
    </node>
    <node id="&quot;ZNF717 Q716&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The ZNF717 mutation (Q716) is present in three NBL samples."</data>
      <data key="d2">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
    </node>
    <node id="&quot;TARGET COHORT SAMPLES&quot;">
      <data key="d0">"SAMPLE COLLECTION"</data>
      <data key="d1">"The study includes a set of 100 primary neuroblastoma (NBL) sample pairs from the TARGET cohort."</data>
      <data key="d2">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
    </node>
    <node id="&quot;PROTECT ANALYSIS&quot;">
      <data key="d0">"BIOINFORMATICS METHOD"</data>
      <data key="d1">"ProTECT analysis provides a range of therapeutically relevant neoantigen/HLA interactions for validation and characterization."</data>
      <data key="d2">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
    </node>
    <node id="&quot;RECOMBINANT HLA-B*15:01&quot;">
      <data key="d0">"MOLECULAR CONSTRUCTION"</data>
      <data key="d1">"The recombinant HLA-B*15:01 molecule is prepared using standard methods."</data>
      <data key="d2">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
    </node>
    <node id="&quot;ESCHERICHIA COLI INCLUSION BODIES&quot;">
      <data key="d0">"PROTEIN REFOLDING MEDIUM"</data>
      <data key="d1">"Purification of the protein from Escherichia coli inclusion bodies involves standard refolding and purification techniques."</data>
      <data key="d2">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
    </node>
    <node id="&quot;SIZE EXCLUSION CHROMATOGRAPHY (SEC)&quot;">
      <data key="d0">"ANALYTICAL TECHNIQUE"</data>
      <data key="d1">"The SEC method separates and characterizes the different forms of complex molecules, such as p/MHC complexes and free β2m."</data>
      <data key="d2">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
    </node>
    <node id="&quot;LIQUID CHROMATOGRAPHY–MASS SPECTROSCOPY (LC–MS)&quot;">
      <data key="d0">"ANALYTICAL METHODOLOGY"</data>
      <data key="d1">"LC–MS is used to confirm the presence of the correct peptide in each sample by analyzing their masses."</data>
      <data key="d2">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
    </node>
    <node id="&quot;ALK NONAMER NEOEPITOPE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The ALK gene encodes a protein that plays a role in cell signaling and is associated with cancer. The presence of specific amino acid sequences (AQDIYRASY) within the gene is denoted as the nonamer neoepitope."</data>
      <data key="d2">chunk-830d8819004960d1d149ac70149c72a0</data>
    </node>
    <node id="&quot;NONAMER&quot;">
      <data key="d0">"PEPTIDE"</data>
      <data key="d1">"A nine-amino acid sequence within the ALK protein that adopts an extended conformation."&lt;SEP&gt;"Nonamers yield a stable p/MHC complex."&lt;SEP&gt;"The ALK neoepitopes adopt a short 310 helix conformation, suggesting their interaction with the groove of MHC molecule."&lt;SEP&gt;"The ALK neoepitopes are considered as a potential target for recognition by CD8+ T cells in the context of disease."&lt;SEP&gt;"The nonamer complex provides insight into its unique conformation in the MHC groove, which impacts TCR interaction properties."&lt;SEP&gt;"The nonamer neoepitope has comparable recognition frequency to an immunodominant epitope when tested using MHC tetramer staining."</data>
      <data key="d2">chunk-d3a9c93928447522ce3df4209f8ac803&lt;SEP&gt;chunk-830d8819004960d1d149ac70149c72a0</data>
    </node>
    <node id="&quot;ALK DECAMER NEOEPITOPE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The ALK gene encodes a protein with specific amino acid sequences (AQDIYRASYY) denoted as the decamer neoepitope, which forms a compact 310 helical backbone."</data>
      <data key="d2">chunk-830d8819004960d1d149ac70149c72a0</data>
    </node>
    <node id="&quot;DECAMER&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A ten-amino acid sequence within the ALK protein that adopts a short 'zig-zag' conformation and fits compactly in the MHC groove."&lt;SEP&gt;"Certain HLA and H2 MHC alleles yield partially folded, peptide-free molecules that can have measurable thermal stabilities."&lt;SEP&gt;"Decamers result in a stable p/MHC complex."&lt;SEP&gt;"Similar to the nonamer, the decamer neoepitope also shows recognition by CD8+ T cells as determined through the MHC tetramer staining assay."&lt;SEP&gt;"The ALK neoepitopes display a conformation that resembles the 310 helix when bound to HLA-A*01:01."&lt;SEP&gt;"The ALK neoepitopes in the decamer complex display polar contacts within both A- and F-pockets of MHC groove."&lt;SEP&gt;"The decamer complex provides valuable insights into the peptide conformation when bound to HLA-A*01:01."</data>
      <data key="d2">chunk-d3a9c93928447522ce3df4209f8ac803&lt;SEP&gt;chunk-830d8819004960d1d149ac70149c72a0</data>
    </node>
    <node id="&quot;IN VITRO REFOLDING&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The process in which recombinant proteins are refolded into their native conformation outside of a living cell."&lt;SEP&gt;"We performed in vitro refolding of ALK-derived peptides with HLA-A*01:01 to validate our structure-based simulations."</data>
      <data key="d2">chunk-830d8819004960d1d149ac70149c72a0&lt;SEP&gt;chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;LIQUID CHROMATOGRAPHY–MASS SPECTROMETRY (LC–MS)&quot;">
      <data key="d0">"TECHNIQUE"</data>
      <data key="d1">"A combination technique that separates and identifies molecules based on size and mass, used to confirm binding of neoepitopes to HLA-B*15:01."</data>
      <data key="d2">chunk-830d8819004960d1d149ac70149c72a0</data>
    </node>
    <node id="&quot;DIFFERENTIAL SCANNING FLUORIMETRY (DSF)&quot;">
      <data key="d0">"TECHNIQUE"</data>
      <data key="d1">"An assay for measuring kinetic stability or unfolding transition of proteins, used here to assess the thermal stability of p/MHC complexes."</data>
      <data key="d2">chunk-830d8819004960d1d149ac70149c72a0</data>
    </node>
    <node id="&quot;EPITOPE BINDING GROOVE&quot;">
      <data key="d0">"BIOLOGICAL STRUCTURE"</data>
      <data key="d1">"The recess in MHC molecules where peptides bind and are presented to T cells."</data>
      <data key="d2">chunk-830d8819004960d1d149ac70149c72a0</data>
    </node>
    <node id="&quot;PEPTIDE MOTIF&quot;">
      <data key="d0">"SEQUENCE FEATURE"</data>
      <data key="d1">"Consensus sequence patterns found within MHC-restricted peptides."</data>
      <data key="d2">chunk-830d8819004960d1d149ac70149c72a0</data>
    </node>
    <node id="&quot;THERMAL STABILITY&quot;">
      <data key="d0">"PHYSICAL PROPERTY"</data>
      <data key="d1">"Further characterization of purified complexes reveals thermal stability at 47.9°C for decamer peptides refolded with HLA-A*01:01."&lt;SEP&gt;"Measure of how well a molecule maintains its shape at varying temperatures."&lt;SEP&gt;"The purified p/MHC complex shows a thermal stability of 47.9°C for decamer peptides."</data>
      <data key="d2">chunk-830d8819004960d1d149ac70149c72a0&lt;SEP&gt;chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;T CELL RECEPTOR (TCR)&quot;">
      <data key="d0">"CELL SURFACE PROTEIN"</data>
      <data key="d1">"Receptors found on the surface of T lymphocytes that bind to peptides presented by MHC molecules."</data>
      <data key="d2">chunk-830d8819004960d1d149ac70149c72a0</data>
    </node>
    <node id="&quot;NONAMER PEPTIDE&quot;">
      <data key="d0">"PEPTIDE"</data>
      <data key="d1">"A peptide sequence consisting of nine amino acids that binds to HLA-B*15:01."</data>
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
    </node>
    <node id="&quot;DECAMER PEPTIDE&quot;">
      <data key="d0">"PEPTIDE"</data>
      <data key="d1">"A peptide sequence consisting of ten amino acids that binds to HLA-B*15:01."</data>
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
    </node>
    <node id="&quot;SELF-ANTIGEN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The protein naturally expressed by the body that is recognized as self and does not elicit an immune response."</data>
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
    </node>
    <node id="&quot;HYDROGEN BONDS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A type of chemical bond formed between atoms due to partial positive or negative charges on hydrogen, commonly seen in the interaction between residues and HLA molecules."</data>
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
    </node>
    <node id="&quot;SALT BRIDGES&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Electrostatic interactions between positively charged (amino acids like lysine and arginine) and negatively charged (amino acids like aspartic acid and glutamic acid) side chains."</data>
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
    </node>
    <node id="&quot;ELECTROSTATIC INTERACTIONS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A type of interaction occurring between charged molecules, which in this context is the energy exchange when charges are attracted or repelled by the surface of HLA molecules and peptides."</data>
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
    </node>
    <node id="&quot;NONAMER STRUCTURE&quot;">
      <data key="d0">"STRUCTURAL ENTITY"</data>
      <data key="d1">"The configuration where a nine-amino-acid peptide binds to HLA-B*15:01 with its specific orientation towards solvent."</data>
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
    </node>
    <node id="&quot;DECAMER STRUCTURE&quot;">
      <data key="d0">"STRUCTURAL ENTITY"</data>
      <data key="d1">"The configuration where a ten-amino-acid peptide binds to HLA-B*15:01, showing altered conformation compared to the nonamer structure."</data>
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
    </node>
    <node id="&quot;310 HELIX CONFORMATION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A specific type of secondary structure in proteins characterized by hydrogen bonds between backbone atoms that give rise to a 3.6 ångstrom spacing along the helical axis."</data>
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
    </node>
    <node id="&quot;TYR9&quot;">
      <data key="d0">"RESIDUE"</data>
      <data key="d1">"The tyrosine residue at position nine in the decamer peptide which forms an additional hydrogen bond with the HLA heavy chain, stabilizing the complex."</data>
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
    </node>
    <node id="&quot;STRUCTURAL SUPERPOSITION&quot;">
      <data key="d0">"GEOMETRIC ALIGNMENT"</data>
      <data key="d1">"A method to compare two molecular structures by aligning them based on their backbone atoms and assessing the differences between them."</data>
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
    </node>
    <node id="&quot;RESIDUES ORIENTED TOWARD SOLVENT&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Certain residues in proteins are positioned towards solvent during structural analysis, which can influence protein-protein or protein-ligand interactions."</data>
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
    </node>
    <node id="&quot;SER67&quot;">
      <data key="d0">"RESIDUE"</data>
      <data key="d1">"The serine residue at position sixty-seven on α1 helix of MHC molecule which is involved in potential clashes during self-peptide binding."</data>
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
    </node>
    <node id="&quot;ALA24&quot;">
      <data key="d0">"RESIDUE"</data>
      <data key="d1">"Alanine residue at position twenty-four on the floor of the MHC groove contributing to a clash with the self-decamer peptide."</data>
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
    </node>
    <node id="&quot;MET45&quot;">
      <data key="d0">"RESIDUE"</data>
      <data key="d1">"Methionine residue at position forty-five on the floor of the MHC groove which is involved in clashes during self-peptide binding."</data>
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
    </node>
    <node id="&quot;Y9 (TYR9)&quot;">
      <data key="d0">"RESIDUE"</data>
      <data key="d1">"Tyrosine residue nine in the decamer peptide, known for forming additional hydrogen bonds with HLA heavy chain and contributing to complex stability."</data>
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
    </node>
    <node id="&quot;HLA ALLELES&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"We evaluated non-redundant sets of 2,904 HLA alleles from the EMBL-EBI database to predict peptide/HLA interactions."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;NONAMER ALK PEPTIDE&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"We developed high-throughput approaches using X-ray structures for neoepitopes to predict peptide/HLA interactions and surface features of peptide residues poised for TCR interactions."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;DECAMER ALK PEPTIDE&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The approach was motivated by the observation that the peptide backbone conformation shows minimal variance in all nonamer/HLA-B*15:01 structures reported in the PDB."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;NON-REDUNDANT HLA ALLELES&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Our selection of a non-redundant set of 2,904 HLA alleles allowed us to carry out detailed Rosetta comparative modeling calculations for each allele."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;HLA-B*15:01 STRUCTURE&quot;">
      <data key="d0">"STRUCTURAL MODEL"</data>
      <data key="d1">"We used the experimentally determined structures of HLA-B*15:01 as templates in our calculations."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;FLEXIBLE PEPTIDE DOCKING APPROACH&quot;">
      <data key="d0">"PREVIOUS METHODOLOGY"</data>
      <data key="d1">"In contrast to previous structure-based peptide/HLA modeling methods, we employed a fixed-peptide backbone threading approach."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;FIXED-PEPTIDE BACKBONE THREADING APPROACH&quot;">
      <data key="d0">"METHODOLOGY"</data>
      <data key="d1">"Our strategy involved energy minimization of the interacting peptide and HLA residues to drastically confine the docking degrees of freedom."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;PEPTIDE/HLA INTERACTION PREDICTIONS&quot;">
      <data key="d0">"PREDICTIVE ANALYSIS"</data>
      <data key="d1">"Using this method, we extracted highly reproducible binding energies for both nonamer and decamer peptides."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;LOWER BINDING ENERGY HLA ALLELES&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Among the selected 116 HLA alleles from all A, B, and C types, those show lower binding energies for both nonamer and decamer peptides compared to our initial structural templates."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;NEGATIVE CONTROL MOCK HLA ALLELE&quot;">
      <data key="d0">"EXPERIMENTAL COMPARISON"</data>
      <data key="d1">"As a control, we computed the binding energy for a mock HLA allele with mutated residues, which exhibited high-binding energy indicating low affinity."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;RESIDUE SIMILARITY TO TOP BINDER&quot;">
      <data key="d0">"ANALYSIS RESULT"</data>
      <data key="d1">"An evident correlation was observed between computed binding energies and sequence similarity to the best binding allele."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;SEQUENCE PROFILE OF GOOD BINDERS&quot;">
      <data key="d0">"CHARACTERIZATION METRIC"</data>
      <data key="d1">"We derived a sequence profile among good binders for neoepitopes using Kullback–Leibler sequence logo, revealing preferred residues in the MHC-binding groove."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;KEY SEQUENCE FEATURES&quot;">
      <data key="d0">"IDENTIFICATION METRIC"</data>
      <data key="d1">"Residues with high affinity binding consistently observed were identified through sequence profiles."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;POLAR CONTACTS&quot;">
      <data key="d0">"CONTACT PATTERN"</data>
      <data key="d1">"Inspection of structural models revealed similar polar contacts primarily in the A-, B-, and F-pockets, correlating well with positions of invariant MHC residues."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;PEPTIDE BINDING ENERGY&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Our method predicts peptide/HLA binding energies and the sequence similarity to top binders."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;KULLBACK–LEIBLER SEQUENCE LOGO&quot;">
      <data key="d0">"ANALYTICAL TOOL"</data>
      <data key="d1">"We used the Kullback–Leibler sequence logo to derive a sequence profile among good binders."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;HLA-A*01:01&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"HLA-A*01:01 is an MHC allele."</data>
      <data key="d2">chunk-d3a9c93928447522ce3df4209f8ac803</data>
    </node>
    <node id="&quot;ALK NEOEPITOPES&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The ALK neoepitopes have lower affinity for HLA-A*01:01 compared to HLA-B*15:01."</data>
      <data key="d2">chunk-d3a9c93928447522ce3df4209f8ac803</data>
    </node>
    <node id="&quot;DECAMER&quot; AND &quot;NONAMER&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Both complexes crystallize at high resolution, validating their atomic features as predicted by simulations."&lt;SEP&gt;"Both decamer and nonamer complexes exhibit thermal stability, indicating their interaction with HLA-A*01:01."&lt;SEP&gt;"Both decamer and nonamer complexes show thermal stability, suggesting the neoepitopes have lower affinity."&lt;SEP&gt;"Their unique conformations suggest they might interact differently with T-cell receptors (TCRs)."&lt;SEP&gt;"These peptides form stable complexes with HLA-A*01:01, which allows for detailed structural characterization."</data>
      <data key="d2">chunk-d3a9c93928447522ce3df4209f8ac803</data>
    </node>
    <node id="&quot;PEPTIDE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Peptides form stable MHC complexes with HLA alleles."</data>
      <data key="d2">chunk-d3a9c93928447522ce3df4209f8ac803</data>
    </node>
    <node id="&quot;KNOWN IMMUNODOMINANT EPITOPE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A known immunodominant epitope is associated with certain disease conditions related to immune response."</data>
      <data key="d2">chunk-41c7131af28e2a745ef6b88b8601860f</data>
      <data key="d3">[{"level": 0, "cluster": 11}, {"level": 1, "cluster": 36}, {"level": 2, "cluster": 60}]</data>
    </node>
    <node id="&quot;VITAMIN D&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Vitamin D is a nutrient essential for bone health, immune system function, and more."</data>
      <data key="d2">chunk-41c7131af28e2a745ef6b88b8601860f</data>
      <data key="d3">[{"level": 0, "cluster": 4}, {"level": 1, "cluster": 23}]</data>
    </node>
    <node id="&quot;PHYSICAL TRAINING&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"Regular physical training contributes to overall health by improving fitness levels."</data>
      <data key="d2">chunk-41c7131af28e2a745ef6b88b8601860f</data>
      <data key="d3">[{"level": 0, "cluster": 0}, {"level": 1, "cluster": 20}]</data>
    </node>
    <node id="&quot;CARDIOMYOPATHY&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Cardiomyopathy is a disease affecting the heart muscle that can lead to heart failure."</data>
      <data key="d2">chunk-41c7131af28e2a745ef6b88b8601860f</data>
      <data key="d3">[{"level": 0, "cluster": 4}, {"level": 1, "cluster": 23}]</data>
    </node>
    <node id="&quot;CALCIUM METABOLISM&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Calcium metabolism involves the absorption, distribution, and excretion of calcium in the body."</data>
      <data key="d2">chunk-41c7131af28e2a745ef6b88b8601860f</data>
      <data key="d3">[{"level": 0, "cluster": 4}, {"level": 1, "cluster": 23}]</data>
    </node>
    <node id="&quot;OXIDATIVE STRESS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Oxidative stress occurs when there is an imbalance between oxidants and antioxidants in the body."</data>
      <data key="d2">chunk-41c7131af28e2a745ef6b88b8601860f</data>
      <data key="d3">[{"level": 0, "cluster": 0}, {"level": 1, "cluster": 20}]</data>
    </node>
    <node id="&quot;GLYCOLYSIS&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Glycolysis is a metabolic pathway involved in the breakdown of glucose to produce energy."</data>
      <data key="d2">chunk-41c7131af28e2a745ef6b88b8601860f</data>
      <data key="d3">[{"level": 0, "cluster": 4}, {"level": 1, "cluster": 23}]</data>
    </node>
    <node id="&quot;ALYRASY&quot;">
      <data key="d2">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
      <data key="d1">"The ALK R1275Q mutation leads to the generation of neoepitopes like ARDIYRASY, which is predicted to bind HLA-B*15:01.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MAQDIYRASY/AQDIYRASYY&quot;">
      <data key="d2">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
      <data key="d1">"The ALK R1275Q mutation leads to the generation of two distinct neoepitopes, MAQDIYRASY and AQDIYRASYY.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;STABILITY&quot;">
      <data key="d2">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
      <data key="d1">"Nonamer GMAQDIYRA, derived from ALK R1275Q mutation, forms a complex that exhibits distinct stability compared to other peptides.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;BOUND BY HLA-B*15:01&quot;">
      <data key="d2">chunk-830d8819004960d1d149ac70149c72a0</data>
      <data key="d1">"The ALK nonamer neoepitope binds to HLA-B*15:01 through in vitro refolding.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ALK NONAMER NEOEPITOPE&quot;/&quot;DECAMER NEOEPITOPE&quot;">
      <data key="d2">chunk-830d8819004960d1d149ac70149c72a0</data>
      <data key="d1">"The ALK nonamer and decamer neoepitopes adopt distinct conformations within the MHC groove: extended for the nonamer and compact 310 helix for the decamer.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CONFORMATION&quot;">
      <data key="d2">chunk-830d8819004960d1d149ac70149c72a0</data>
      <data key="d1">"The ALK nonamer and decamer neoepitopes adopt distinct conformations within the MHC groove: extended for the nonamer and compact 310 helix for the decamer.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LENGTH&quot;">
      <data key="d2">chunk-830d8819004960d1d149ac70149c72a0</data>
      <data key="d1">"A comparison between the ALK nonamer (nine amino acids) and decamer (ten amino acids), showing how peptide length influences conformation within a fixed MHC groove.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NONAMER/DECAMER&quot;">
      <data key="d2">chunk-830d8819004960d1d149ac70149c72a0</data>
      <data key="d1">"A comparison between the ALK nonamer (nine amino acids) and decamer (ten amino acids), showing how peptide length influences conformation within a fixed MHC groove.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;BIND TO&quot;">
      <data key="d2">chunk-830d8819004960d1d149ac70149c72a0</data>
      <data key="d1">"Epitopes"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MHC MOLECULES&quot;">
      <data key="d2">chunk-830d8819004960d1d149ac70149c72a0</data>
      <data key="d1">"Epitopes"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ANTIGEN-PRESENTING CELLS (APCS)&quot;">
      <data key="d2">chunk-830d8819004960d1d149ac70149c72a0</data>
      <data key="d1">"Antigen Presentation"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PROCESS OF&quot;">
      <data key="d2">chunk-830d8819004960d1d149ac70149c72a0</data>
      <data key="d1">"Antigen Presentation"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RECOGNIZE AND BIND TO&quot;">
      <data key="d2">chunk-830d8819004960d1d149ac70149c72a0</data>
      <data key="d1">"Peptides Present On MHC molecules"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TCR&quot;">
      <data key="d2">chunk-830d8819004960d1d149ac70149c72a0</data>
      <data key="d1">"Peptides Present On MHC molecules"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ARG2 SIDE CHAIN&quot;">
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
      <data key="d1">"Longer arginine side chain causes steric hindrance between peptide and MHC-binding groove, affecting affinity for self-peptide binding to HLA-B*15:01.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;STRUCTURAL HINDRANCE&quot;">
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
      <data key="d1">"Longer arginine side chain causes steric hindrance between peptide and MHC-binding groove, affecting affinity for self-peptide binding to HLA-B*15:01.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;STABILIZING INTERACTION&quot;">
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
      <data key="d1">"Increase in intra-peptide hydrogen bonds contribute to the stability of the decamer complex compared to nonamer structure.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;POLAR INTERACTIONS&quot;">
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
      <data key="d1">"Polar interactions such as hydrogen bonds and salt bridges enhance stability of HLA complexes with peptides.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;STABILIZING FORCES&quot;">
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
      <data key="d1">"Polar interactions such as hydrogen bonds and salt bridges enhance stability of HLA complexes with peptides.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HYDROPHOBIC PACKING&quot;">
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
      <data key="d1">"Additional hydrophobic packing interactions further stabilize the decamer complex by reducing electrostatic repulsion between hydrophobic side chains.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;STRUCTURAL EXCLUSION&quot;">
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
      <data key="d1">"The self-antigen's structure results in clashes with MHC groove, leading to its exclusion from forming a stable HLA complex compared to neoepitopes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HAPLOTYPE-SPECIFIC BINDING&quot;">
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
      <data key="d1">"The potential of other HLAs to display ALK R1275Q neoepitopes depends on the individual's HLA haplotype, playing a role in immune response.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;AFFINITY DIFFERENCES&quot;">
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
      <data key="d1">"Comparison of affinities between self-peptide and neoepitopes for HLA-B*15:01 highlights potential differences in immunogenicity and therapeutic relevance.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;P/MHC COMPLEXES&quot;">
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
      <data key="d1">"Comparison of affinities between self-peptide and neoepitopes for HLA-B*15:01 highlights potential differences in immunogenicity and therapeutic relevance.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NONAMER BINDING&quot;">
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
      <data key="d1">"The affinity of nonamer peptides towards HLA-B*15:01 is lower compared to other neoepitopes due to structural compatibility.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DECAMER PRESENTATION&quot;">
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
      <data key="d1">"Increase in binding energy and structural stability provided by the decamer configuration results from a more compact conformation and enhanced interactions with HLA-B*15:01.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ENHANCED STABILITY&quot;">
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
      <data key="d1">"Increase in binding energy and structural stability provided by the decamer configuration results from a more compact conformation and enhanced interactions with HLA-B*15:01.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SEQUENCE BIAS&quot;">
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
      <data key="d1">"There's a clear sequence bias for specific residues in the MHC-binding groove yielding more favorable interactions with two peptides.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HIGH BINDING ENERGY&quot;">
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
      <data key="d1">"The mock polyAla HLA exhibits considerably higher binding energy across the entire peptide length compared to top binders.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MOCK HLA ALLELE&quot;">
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
      <data key="d1">"The mock polyAla HLA exhibits considerably higher binding energy across the entire peptide length compared to top binders.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CANCER IMMUNOTHERAPIES&quot;">
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
      <data key="d1">"The ALK R1275Q genomic variant is associated with cancer immunotherapies outcomes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PREDICTION ACCURACY&quot;">
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
      <data key="d1">"Our simulations accurately predict peptide/HLA binding energies and interactions based on sequence similarity.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PHYSICAL PROPERTY&quot;">
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
      <data key="d1">"The thermal stability measurement reflects the stability of the p/MHC complex in vitro.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SEQUENCE ANALYSIS&quot;">
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
      <data key="d1">"The sequence logo provides insights into preferred residues for effective peptide/HLA binding.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;BINDING ENERGY&quot;">
      <data key="d2">chunk-d3a9c93928447522ce3df4209f8ac803</data>
      <data key="d1">"The binding energy calculations suggest that both neoepitopes have a lower affinity for HLA-A*01:01 compared to HLA-B*15:01.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RECOGNITION BY CD8+ T CELLS&quot;">
      <data key="d2">chunk-d3a9c93928447522ce3df4209f8ac803</data>
      <data key="d1">"The ALK-derived neoepitopes can be recognized by CD8+ T cells, as evidenced by MHC tetramer staining assay and multichannel flow cytometry analysis.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CONFORMATIONAL COMPARISON&quot;">
      <data key="d2">chunk-d3a9c93928447522ce3df4209f8ac803</data>
      <data key="d1">"When bound to HLA-A*01:01, the side chain of Arg6 flips outward in comparison to its position when bound to HLA-B*15:01, altering TCR interaction properties.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;COMPARISON WITH SARS-COV-2 DERIVED EPITOPES&quot;">
      <data key="d2">chunk-d3a9c93928447522ce3df4209f8ac803</data>
      <data key="d1">"The recognition frequencies for the nonamer and a known immunodominant SARS-CoV-2 epitope are comparable when tested using MHC tetramers.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RECOGNITION EFFICIENCY COMPARISON&quot;">
      <data key="d2">chunk-d3a9c93928447522ce3df4209f8ac803</data>
      <data key="d1">"Both neoepitopes display nominal recognition frequencies by CD8+ T cells, highlighting their potential as targets for immune response study.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS74420772&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"One single nucleotide polymorphism (SNP) rs74420772 in 3p14.1 achieved genome-wide significance in TwinGene."</data>
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
    </node>
    <node id="&quot;IGM ANTI-PC&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"IgM anti-PC levels were lower in prevalent CLL cases compared to matched controls, but not different between incident cases and their matches."&lt;SEP&gt;"Individuals with IgM anti-PC measurements and genotypes were used in the study."</data>
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a&lt;SEP&gt;chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
    </node>
    <node id="&quot;SNP RS74420772&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNP rs74420772 achieved genome-wide significance in TwinGene (P = 2.7 × 10−8)."</data>
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
    </node>
    <node id="&quot;RS735665&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The allele rs35923643-G or its proxy SNP rs735665-A was recognized as the top risk allele for CLL."&lt;SEP&gt;"The leading SNP identified in our GWAS meta-analysis for IgM anti-PC, located on chromosome 11q24.1."</data>
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
    </node>
    <node id="&quot;RS35923643-G&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"rs35923643-G has been identified as a genome-wide significant SNP associated with IgM anti-PC and is part of the LD block that overlaps with the GRAM domain containing 1B (GRAMD1B) gene."</data>
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
    </node>
    <node id="&quot;1P31.3 AND 11Q24.1&quot;">
      <data key="d0">"GENOMIC REGION"</data>
      <data key="d1">"Two SNPs in 1p31.3 and six SNPs in 11q24.1 achieved genome-wide significance with P &lt; 5.0 × 10−8."</data>
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
    </node>
    <node id="&quot;RS735665-A&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"rs735665-A was identified as a main genetic variant specific for general IgM, rather than general IgA and general IgG."</data>
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
    </node>
    <node id="&quot;IGA AND GENERAL IGG&quot;">
      <data key="d0">"DISEASE/CONDITION"</data>
      <data key="d1">"Two disease conditions that were not the main focus of analysis but were compared with the main condition (general IgM) in our study."</data>
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
    </node>
    <node id="&quot;GM12878&quot;">
      <data key="d0">"CELL LINE"</data>
      <data key="d1">"One of several cell lines used for scanning potential regulatory marks associated with genomic variants in the top locus 11q24.1."</data>
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
    </node>
    <node id="&quot;RS35923643&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The genomic variant rs35923643 is located on locus 11q24.1."</data>
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
    </node>
    <node id="&quot;CLL&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"rs35923643 is associated with Chronic Lymphocytic Leukemia (CLL), both prevalent and incident cases."</data>
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
    </node>
    <node id="&quot;GM12878 CELL LINE&quot;">
      <data key="d0">"CELL LINE"</data>
      <data key="d1">"This is a cell line used for ChIP-seq experiments and analysis of epigenetic marks."</data>
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
    </node>
    <node id="&quot;CD34+ CELLS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"These are hematopoietic stem cells or progenitor cells that were analyzed using DNaseI hypersensitivity data."</data>
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
    </node>
    <node id="&quot;GM12865 CELL LINE&quot;">
      <data key="d0">"CELL LINE"</data>
      <data key="d1">"Another cell line used for analysis of DNaseI hypersensitivity."</data>
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
    </node>
    <node id="&quot;B-CELL LINE&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"A specific type of white blood cell analyzed using ChIP-seq data to determine RUNX3 binding affinity."</data>
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
    </node>
    <node id="&quot;11Q24.1&quot;">
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
      <data key="d1">"rs35923643-G is part of the LD block overlapping with GRAM domain containing 1B (GRAMD1B) gene.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENERAL IGM AND IGM ANTI-PC&quot;">
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
      <data key="d1">"rs735665-A was identified as a genome-wide significant SNP associated with general IgM increasing alleles related to IgM anti-PC.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENERAL IGM AND GENERAL IGA/IGG&quot;">
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
      <data key="d1">"The allele rs735665-A was associated not only with CLL but also showed a negative association with the risk of certain disease states involving general IgM, general IgA, or general IgG levels.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CHROMATIN&quot;">
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
      <data key="d1">"rs35923643 was found to have peaks of histone mark monomethylated histone H3 lysine 4 (H3K4Me1) and DNaseI hypersensitivity in leukemia or immune-cell lines.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 7}, {"level": 1, "cluster": 26}]</data>
    </node>
    <node id="&quot;TF BINDING&quot;">
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
      <data key="d1">"ChIP-seq experiments suggested binding sites for 22 different transcription factors within the region around rs35923643.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TRANSCRIPTION FACTORS&quot;">
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
      <data key="d1">"ChIP-seq experiments suggested binding sites for 22 different transcription factors within the region around rs35923643.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;BINDING MOTIFS&quot;">
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
      <data key="d1">"The strongest signals were observed for RUNX3 and SPI1 from FIMO tool, with the RUNX3 binding motif including SNP rs35923643.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RUNX3 AND SPI1 TFS&quot;">
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
      <data key="d1">"The strongest signals were observed for RUNX3 and SPI1 from FIMO tool, with the RUNX3 binding motif including SNP rs35923643.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;REGULOMEDB SUPPORT&quot;">
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
      <data key="d1">"The RegulomeDB database gave support for rs35923643 affecting the binding of transcription factors in general.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CLL CASE ASSOCIATION&quot;">
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
      <data key="d1">"IgM anti-PC was lower in prevalent CLL cases compared to matched controls, with a declining trend between sampling and diagnosis but not statistically significant.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ENCODE DATA&quot;">
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
      <data key="d1">"The Encyclopedia of DNA Elements (ENCODE) provided data on transcription factor binding within the vicinity of rs35923643, identifying suggested binding sites for 22 different TFs.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TFS&quot;">
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
      <data key="d1">"The Encyclopedia of DNA Elements (ENCODE) provided data on transcription factor binding within the vicinity of rs35923643, identifying suggested binding sites for 22 different TFs.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PREVALENT CLL ASSOCIATION&quot;">
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
      <data key="d1">"A small nested case-control study found IgM anti-PC to be lower in prevalent cases of CLL compared to matched controls, but not significantly associated with incident cases using stratified Cox proportional hazards model.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;STATISTICAL TREND&quot;">
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
      <data key="d1">"An analysis revealed a non-statistically significant declining trend in IgM anti-PC levels between CLL cases and matched controls as time from sampling to diagnosis increased.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TIME BETWEEN SAMPLING AND DIAGNOSIS&quot;">
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
      <data key="d1">"An analysis revealed a non-statistically significant declining trend in IgM anti-PC levels between CLL cases and matched controls as time from sampling to diagnosis increased.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <edge source="&quot;OBESITY&quot;" target="&quot;EDUCATION&quot;">
      <data key="d4">0.046</data>
      <data key="d5">"Education level interacts with the presence of the FTO SNP to affect the risk of developing obesity.")&lt;SEP&gt;"The effect of the FTO SNP on obesity risk can vary depending on educational background.")</data>
      <data key="d6">chunk-63d0b5be485a69f44e2799ccc9510487</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OBESITY&quot;" target="&quot;FTO SNP&quot;">
      <data key="d4">2.01</data>
      <data key="d5">"An association was investigated between a variant in the FTO gene (the FTO SNP) and obesity risk.")</data>
      <data key="d6">chunk-63d0b5be485a69f44e2799ccc9510487</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OBESITY&quot;" target="&quot;RS182549&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"rs182549 is associated with obesity.")</data>
      <data key="d6">chunk-938d8bf2e56584de9dd556be5eb70964</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FTO_RS1421085&quot;" target="&quot;OBESITY RISK&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"FTO_rs1421085 contributes to obesity risk through its role in modulating fat mass and energy balance.")</data>
      <data key="d6">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MC4R_RS6567160&quot;" target="&quot;SEC16B_RS543874&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The genetic variant SEC16B_rs543874 interacts with MC4R_rs6567160 in influencing obesity risk.")</data>
      <data key="d6">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PRS&quot;" target="&quot;MENARCHE AGE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The initial menstruation age interacted with the Polygenic Risk Score for obesity risk, indicating an environmental factor's influence on genetic predispositions.")</data>
      <data key="d6">chunk-3ad8ef794841d749e48b3223741e91d3</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PRS&quot;" target="&quot;PLANT-BASED DIET INTAKE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"A plant-based diet intake showed an interaction with PRS in influencing obesity risk, highlighting a relationship between dietary choices and genetic predisposition.")</data>
      <data key="d6">chunk-3ad8ef794841d749e48b3223741e91d3</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PRS&quot;" target="&quot;FRIED-FOOD INTAKE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Fried food intake exhibited an interaction with the PRS for obesity risk, indicating that dietary factors can modify genetic influences on obesity.")</data>
      <data key="d6">chunk-3ad8ef794841d749e48b3223741e91d3</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI&quot;" target="&quot;OUTCOME MEASURE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The impact of PRS on obesity was measured through BMI, showing a link between genetics and body weight regulation.")</data>
      <data key="d6">chunk-3ad8ef794841d749e48b3223741e91d3</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI&quot;" target="&quot;FTO RS9939609 POLYMORPHISM&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The FTO SNP showed strong association with BMI in GP subjects.")</data>
      <data key="d6">chunk-3135befd0c3140ad097d96ace6de86a1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI&quot;" target="&quot;INTERACTION&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The analyses did not find evidence for an interaction between the TCF7L2 risk variant and BMI.")</data>
      <data key="d6">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI&quot;" target="&quot;GRS&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Genetic risk score is positively associated with increased BMI at baseline, indicating a cumulative effect of multiple genetic factors on obesity.")&lt;SEP&gt;"The genetic risk score is a cumulative measure influenced by multiple obesity predisposing SNPs and correlates significantly with BMI at baseline.")</data>
      <data key="d6">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI&quot;" target="&quot;RS9939609, RS2984618, RS7903146, GRS, LEPR GENE, FPG&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The genetic variants, GRS of these SNPs interact with traits related to glycemic status to influence BMI.")</data>
      <data key="d6">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI&quot;" target="&quot;GENOTYPE GROUP&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Carriers of any minor alleles had a lower mean BMI compared to those with all major alleles at baseline (mean = 27.8 SD 3.7 vs. 26.1 SD 3.6, p=0.02).")</data>
      <data key="d6">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI&quot;" target="&quot;GENETIC CORRELATION&quot;">
      <data key="d4">0.78</data>
      <data key="d5">"BMI shows a moderate positive genetic correlation with snoring prevalence.")</data>
      <data key="d6">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI&quot;" target="&quot;BODY MEASUREMENT&quot;/&quot;BODY MASS INDEX&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"A measure of body fat based on height and weight, used as an indicator in this context.")</data>
      <data key="d6">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI&quot;" target="&quot;GENOTYPES&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The rs671 polymorphism impacts BMI significantly only among men, suggesting an influence of the genetic factor on body mass.")</data>
      <data key="d6">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI&quot;" target="&quot;HUA&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The BMI was lower in the control group compared to participants with HUA.")</data>
      <data key="d6">chunk-befd5ea20007b1d02d987897c798dadd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI&quot;" target="&quot;IBS-D&quot;">
      <data key="d4">2.5</data>
      <data key="d5">"In IBS-D subgroup, the BMI was approximately 4 units higher than in other subgroups (P = .036).")</data>
      <data key="d6">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI&quot;" target="&quot;SERUM C4&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"BMI correlated positively with serum C4 levels, indicating a possible influence of obesity on markers related to bile acid metabolism or other metabolic processes.")</data>
      <data key="d6">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COVARIATES&quot;" target="&quot;ADJUSTMENT FACTOR&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Covariates were adjusted for in statistical analysis when relating PRS to other factors like menarche age.")</data>
      <data key="d6">chunk-3ad8ef794841d749e48b3223741e91d3</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ADJUSTED ORS&quot;" target="&quot;EFFECT MEASURE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Adjusted Odds Ratios were used to measure the effect of PRS in obesity risk analysis.")</data>
      <data key="d6">chunk-3ad8ef794841d749e48b3223741e91d3</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;95% CI&quot;" target="&quot;PRECISION ESTIMATE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Confidence intervals estimated the precision and reliability of adjusted odds ratios in statistical outcomes.")</data>
      <data key="d6">chunk-3ad8ef794841d749e48b3223741e91d3</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TABLE 6&quot;" target="&quot;DATA PRESENTATION&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Tables provided a structured way to present data from statistical analysis including key results like ORs and CI.")</data>
      <data key="d6">chunk-3ad8ef794841d749e48b3223741e91d3</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BDNF_RS6265&quot;" target="&quot;DNAJC27_RS713586&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The genetic variant DNAJC27_rs713586 affects BDNF_rs6265 which contributes to the obesity risk.")</data>
      <data key="d6">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CDKAL1_RS9356744&quot;" target="&quot;GIPR_RS1444988703&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The genetic variant CDKAL1_rs9356744 is connected to GIPR_rs1444988703, impacting obesity risk.")</data>
      <data key="d6">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ADJUSTMENT FACTOR&quot;" target="&quot;AGE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Age is often an adjustment factor in statistical models when analyzing treatment response.")</data>
      <data key="d6">chunk-0d49552280a277a8a26456d06f8f26a8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OUTCOME MEASURE&quot;" target="&quot;OVERALL SURVIVAL BENEFIT&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"A significantly extended survival benefit was observed in mice receiving repeat doses of TAG72-BBζ CAR T Cells over a single dose.")</data>
      <data key="d6">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS1558902&quot;" target="&quot;WEIGHT&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Genetic variant rs1558902 was associated with weight loss, particularly in the context of a high-protein diet.")</data>
      <data key="d6">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;WEIGHT&quot;" target="&quot;INADL&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"A nonsynonymous SNP in INADL was associated with weight, BMI, FFM, FM, trunk FM and hip circumference.")</data>
      <data key="d6">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PROTEIN DIET INTERVENTION&quot;" target="&quot;FAT DISTRIBUTION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"A high-protein diet influenced fat distribution differently based on the FTO rs1558902 genotype, affecting total abdominal thickness (TAT), visceral adipose tissue (VAT), and subcutaneous adipose tissue (SAT).")</data>
      <data key="d6">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AGE&quot;" target="&quot;ASSOCIATION WITH GENOTYPE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Age was adjusted for in the analysis, and interactions were found between age and FTO rs1558902 genotype on weight changes.")</data>
      <data key="d6">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AGE&quot;" target="&quot;INTERACTION&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"There was no evidence for an interaction between the TCF7L2 risk variant and age in these analyses.")</data>
      <data key="d6">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AGE&quot;" target="&quot;NON-HISPANIC WHITE MOTHERS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Non-Hispanic White mothers had a mean age of 31.8 years, while Hispanic mothers had a mean age of 27.0 years.")</data>
      <data key="d6">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AGE&quot;" target="&quot;SERUM FOLATE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Age influences serum folate levels and semen quality; older individuals may show decreased folate concentrations.")</data>
      <data key="d6">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AGE&quot;" target="&quot;FERTILITY STATUS&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Age is a factor in determining fertility status; older individuals tend to have differences in reproductive health metrics compared to younger individuals.")</data>
      <data key="d6">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AGE&quot;" target="&quot;GENOTYPES&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"ALDH2 genotypes are associated with age differences in both males and females.")</data>
      <data key="d6">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AGE&quot;" target="&quot;RS671 GENOTYPES&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Genotypes associated with the rs671 variant may result in age differences among genotypic groups.")</data>
      <data key="d6">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AGE&quot;" target="&quot;LCT MRNA&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"In lactase non-persistent CC individuals, LCT mRNA was significantly decreasing with age, whereas there were no aging changes in intermediate CT individuals and a non-significant increase in lactase persistent TT individuals.")</data>
      <data key="d6">chunk-ea45644d73f260cf365527dcc3af86e1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SEX&quot;" target="&quot;EFFECT ON BODY COMPOSITION&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Sex differences influenced the association of the FTO genetic variant with body composition changes; sex was included in the analysis.")</data>
      <data key="d6">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SEX&quot;" target="&quot;INTERACTION WITH BMI AND OBESITY&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Sex influenced the relationship between the FTO SNP and BMI, as well as obesity risk.")</data>
      <data key="d6">chunk-3135befd0c3140ad097d96ace6de86a1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SEX&quot;" target="&quot;INTERACTION&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"There was no evidence for an interaction between the TCF7L2 risk variant and sex in these analyses.")</data>
      <data key="d6">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SEX&quot;" target="&quot;DIFFERENCE IN RESPONSE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Sex can influence differences in how individuals respond to treatments, reflecting a lifestyle factor.")</data>
      <data key="d6">chunk-0d49552280a277a8a26456d06f8f26a8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ETHNICITY&quot;" target="&quot;INTERACTION WITH GENOTYPE&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Ethnicity interacted with the FTO rs1558902 genotype, potentially influencing weight and fat distribution responses to dietary interventions.")</data>
      <data key="d6">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ETHNICITY&quot;" target="&quot;RS182549&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The age-genotype interaction was significant in multi-ethnic cohorts, but not observed in the GEM_v24 cohort which contains individuals of different Israeli subethnicities.")</data>
      <data key="d6">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AA GENOTYPE&quot;" target="&quot;LOW-PROTEIN DIET&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Participants with the AA genotype responded differently to low-protein diets compared to those without this specific genetic variant.")</data>
      <data key="d6">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AA GENOTYPE&quot;" target="&quot;HIGH-PROTEIN DIET&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The AA genotype showed a distinct response pattern when subjected to high-protein diets, with greater fat distribution changes in comparison to participants lacking the AA variant.")</data>
      <data key="d6">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AA GENOTYPE&quot;" target="&quot;GCKR RS780094 SNP&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The AA variant of the GCKR gene is associated with higher TAG concentrations compared to the GG genotype.")</data>
      <data key="d6">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AA GENOTYPE&quot;" target="&quot;RS1260326 SNP&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Similar to rs780094, this SNP also exhibits significant association with hypertriacylglycerolaemia when combined with the AA genotype.")</data>
      <data key="d6">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LOW-PROTEIN DIET&quot;" target="&quot;TREATMENT FOR HI/HA&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"A low-protein diet was used as a primary treatment before considering other interventions.")</data>
      <data key="d6">chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LOW-FAT DIET&quot;" target="&quot;GENOTYPE-TIME INTERACTION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"A specific relationship was observed between genotypes and dietary responses on total fat, FM%, and trunk fat changes when exposed to low-fat diets.")</data>
      <data key="d6">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CHANGES IN BODY COMPOSITION&quot;" target="&quot;FTO RS1558902 GENOTYPE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The FTO genetic variant interacted with dietary protein to influence changes in fat mass, free-fat mass, and percentage of trunk fat.")</data>
      <data key="d6">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FTO RS9939609 POLYMORPHISM&quot;" target="&quot;EDUCATION LEVEL&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"In the GP subjects, there was an interaction between educational level and the FTO SNP in determining BMI.")</data>
      <data key="d6">chunk-3135befd0c3140ad097d96ace6de86a1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;WAIST CIRCUMFERENCE&quot;" target="&quot;OBESITY INDICATOR&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Waist circumference is an indicator of excess abdominal fat, linked to metabolic syndrome and diabetes risk.")</data>
      <data key="d6">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EDUCATION LEVEL&quot;" target="&quot;INTERACTION WITH FTO SNPC&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The FTO SNP's influence on obesity risk was modulated by education level in GP subjects.")</data>
      <data key="d6">chunk-3135befd0c3140ad097d96ace6de86a1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PHYSICAL ACTIVITY (PA)&quot;" target="&quot;IMPACT ON FTO SNP EFFECT&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"In elderly HCR subjects, PA was found to interact with the FTO SNP affecting anthropometric measurements.")</data>
      <data key="d6">chunk-3135befd0c3140ad097d96ace6de86a1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FTO SNP&quot;" target="&quot;EDUCATION&quot;">
      <data key="d4">0.023</data>
      <data key="d5">"An interaction term between the FTO gene polymorphism and education level was found when determining obesity risk.")</data>
      <data key="d6">chunk-63d0b5be485a69f44e2799ccc9510487</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EDUCATION&quot;" target="&quot;PA (PHYSICAL ACTIVITY)&quot;">
      <data key="d4">0.957</data>
      <data key="d5">"The effect of education on the association between the FTO SNP and obesity risk was adjusted for physical activity.")</data>
      <data key="d6">chunk-63d0b5be485a69f44e2799ccc9510487</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NOS1&quot;" target="&quot;FOLATE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The NOS1 gene interacts with folate metabolism to regulate nitric oxide production.")</data>
      <data key="d6">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANT&quot;" target="&quot;CARDIOVASCULAR DISEASE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"A genomic variant in the NOS1 gene is linked to an increased risk of cardiovascular disease.")&lt;SEP&gt;"A specific genomic variant may increase the risk of developing cardiovascular disease.")</data>
      <data key="d6">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862&lt;SEP&gt;chunk-6a657cd0a000b6df4db8f1305b795021</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANT&quot;" target="&quot;EARLY MTX-RELATED NEUROTOXICITY&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Genomic variations might predispose individuals to a quicker manifestation of MTX-induced neurotoxic effects.")</data>
      <data key="d6">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANT&quot;" target="&quot;TRANSCRIPT&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The transcript analysis could highlight how specific genomic variants affect the expression levels of certain genes, thereby influencing disease risks or responses.")</data>
      <data key="d6">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANT&quot;" target="&quot;DPP COHORT&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The association between SLC30A8 rs13266634 and fasting proinsulin levels was observed in the DPP cohort.")</data>
      <data key="d6">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANT&quot;" target="&quot;IL-6RΑ GENE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"A genomic variant specific to the IL-6Rα gene influences disease protection during T cell transfers.")</data>
      <data key="d6">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANT&quot;" target="&quot;DISEASE&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Correlation between low SENP1 expression and onset of diabetes in NOD mice suggests a potential link to genetic predisposition towards autoimmune diseases like T1DM.")&lt;SEP&gt;"NA, no specific genomic variant related disease mentioned")&lt;SEP&gt;"Specific genomic variants associated with IL-10RαMdel and Rag1 affect both Rag1−/− and IL-10RαMdelRag1−/− disease severity.")&lt;SEP&gt;"The rs1138272 genetic variant did not exhibit a significant link to the development of breast cancer.")</data>
      <data key="d6">chunk-ab5011584b0230efbf80a98b2a693a0e&lt;SEP&gt;chunk-f2c864ef2d87119a8129e011b1c42e3c&lt;SEP&gt;chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANT&quot;" target="&quot;DISEASE MODULATION&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Specific genotypic differences within the IL-6Rα gene and IL-10RαMdel variants influence disease modulations across different genetic backgrounds like Rag1−/− and IL-10RαMdelRag1−/−.")</data>
      <data key="d6">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANT&quot;" target="&quot;INFANTS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"21.6% of the infants carried rs12325817 variant of the enzyme PEMT, which reduces endogenous choline synthesis")</data>
      <data key="d6">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANT&quot;" target="&quot;RS9923231&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Contributes to a low allele frequency pattern consistent with previous studies.")</data>
      <data key="d6">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANT&quot;" target="&quot;CYP2C9*5, CYP2C9*8, AND CYP2C9*11&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"These are other individual SNPs that were part of the combined CYP2C9 star variant group.")</data>
      <data key="d6">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANT&quot;" target="&quot;CNR1&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The genomic variant rs2023239 is part of the CNR1 gene and affects its expression and function.")</data>
      <data key="d6">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANT&quot;" target="&quot;GENE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The gene and its variants may have complex interactions that affect genetic susceptibility to certain diseases.")</data>
      <data key="d6">chunk-72f4505e43f67f3564607392cb178656</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANT&quot;" target="&quot;IFN-Γ&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Increased IFN-γ expression was associated with specific genotypes in certain CD subjects.")</data>
      <data key="d6">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANT&quot;" target="&quot;EQTL EFFECTS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Genetic variations had effects on expression levels through eQTLs.")</data>
      <data key="d6">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANT&quot;" target="&quot;CHROMATIN&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"rs35923643 was found to have peaks of histone mark monomethylated histone H3 lysine 4 (H3K4Me1) and DNaseI hypersensitivity in leukemia or immune-cell lines.")</data>
      <data key="d6">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TRANSCRIPT&quot;" target="&quot;DIETARY PATTERN&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"NA, no specific transcript-dietary pattern relationship mentioned")&lt;SEP&gt;"The transcript of the NOS1 gene is influenced by dietary patterns, particularly folate intake.")</data>
      <data key="d6">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862&lt;SEP&gt;chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TRANSCRIPT&quot;" target="&quot;PRO-IL-Β&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The transcript of pro-IL-β is involved in regulating the maturation of IL-1β.")</data>
      <data key="d6">chunk-b971aa450a9b220806bdc000eb5efaad</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TRANSCRIPT&quot;" target="&quot;ADIPOCYTE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Expression levels of transcripts are altered in adipocytes with SENP1 deletion, which may influence metabolic processes and inflammatory responses related to diabetes." )</data>
      <data key="d6">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TRANSCRIPT&quot;" target="&quot;GENE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"A transcript connected with GSTP1 gene functions was investigated for single nucleotide polymorphisms (SNPs).")</data>
      <data key="d6">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TRANSCRIPT&quot;" target="&quot;PROTEIN&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Transcripts can influence protein expression which in turn affects metabolic pathways.")&lt;SEP&gt;"Transcripts of genes can influence the expression level or function of proteins, impacting biological processes.")</data>
      <data key="d6">chunk-734cac289b42d37dad32bd51ea24a1ea&lt;SEP&gt;chunk-72f4505e43f67f3564607392cb178656</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NOS1 PROTEIN&quot;" target="&quot;FOLATE METABOLISM&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"The NOS1 protein interacts with folate metabolism to maintain vascular function.")&lt;SEP&gt;"The NOS1 protein interacts with folate metabolism to modulate its effects on cardiovascular health.")</data>
      <data key="d6">chunk-f05ecc979eea31a1ab844c2c7de12432&lt;SEP&gt;chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NOS1 PROTEIN&quot;" target="&quot;CARDIOVASCULAR DISEASE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Alterations in the NOS1 protein can contribute to cardiovascular disease.")</data>
      <data key="d6">chunk-f05ecc979eea31a1ab844c2c7de12432</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NOS1 PROTEIN&quot;" target="&quot;NITRIC OXIDE&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The NOS1 protein catalyzes the production of nitric oxide, playing a role in its synthesis.")</data>
      <data key="d6">chunk-f05ecc979eea31a1ab844c2c7de12432</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NOS1 PROTEIN&quot;" target="&quot;DIETARY PATTERNS&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Nutritional factors from dietary patterns can affect the expression and function of the NOS1 protein.")</data>
      <data key="d6">chunk-f05ecc979eea31a1ab844c2c7de12432</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOLATE&quot;" target="&quot;LEAFY GREENS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Folate is a nutrient found in leafy greens, which are important for cardiovascular health.")</data>
      <data key="d6">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOLATE&quot;" target="&quot;B12&quot;">
      <data key="d4">0.5</data>
      <data key="d5">"There's a potential causal relationship between folate and vitamin B12 levels, but it might not impact offspring birthweight directly.")</data>
      <data key="d6">chunk-22216738ccbae0a6276bb4499018c434</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOLATE&quot;" target="&quot;OFFSPRING BIRTHWEIGHT&quot;">
      <data key="d4">0.3</data>
      <data key="d5">"The impact of maternal consumption of folate on offspring birthweight was not found to have a causal effect based on the data.")</data>
      <data key="d6">chunk-22216738ccbae0a6276bb4499018c434</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIETARY PATTERN&quot;" target="&quot;EPIGENETIC MODIFICATION&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Poor dietary patterns can lead to epigenetic modifications that alter nitric oxide synthesis.")</data>
      <data key="d6">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIETARY PATTERN&quot;" target="&quot;NUTRIENT&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Certain dietary patterns may improve or impair nutrient absorption and overall health.")&lt;SEP&gt;"Individuals with specific dietary patterns may exhibit altered levels of certain nutrients that could influence their GRS scores and cognitive test performances.")&lt;SEP&gt;"Specific nutrients may correlate with certain dietary patterns that impact health outcomes.")</data>
      <data key="d6">chunk-72f4505e43f67f3564607392cb178656&lt;SEP&gt;chunk-ea6355aaf22d7cdd3331602638122ed7&lt;SEP&gt;chunk-6a657cd0a000b6df4db8f1305b795021</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIETARY PATTERN&quot;" target="&quot;GENOTYPE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Genetic factors can influence how dietary patterns affect physiological processes like TAG levels.")</data>
      <data key="d6">chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIETARY PATTERN&quot;" target="&quot;NOS3 RS743507&quot;">
      <data key="d4">1.689</data>
      <data key="d5">"SNPs in this gene showed a slight risk reduction for ovarian cancer, possibly influenced by dietary patterns.")</data>
      <data key="d6">chunk-089bcdf055eb2f007db49dbe2409429b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIETARY PATTERN&quot;" target="&quot;INFANTS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Only 9.7% of infants were born to mothers whose dietary choline intake during pregnancy was adequate (450 mg/day)")</data>
      <data key="d6">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIETARY PATTERN&quot;" target="&quot;DISEASE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"NA, no disease-dietary pattern relationship explicitly mentioned")</data>
      <data key="d6">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIETARY PATTERN&quot;" target="&quot;DOMESTICALLY ACQUIRED INFECTIONS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Domestically acquired infections were associated with eating fresh poultry other than chicken and turkey.")</data>
      <data key="d6">chunk-0d155c005072e55d94179ce7952bf5a9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIETARY PATTERN&quot;" target="&quot;MOLECULAR INTERACTION&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Specific dietary patterns may influence gene expression through molecular interactions.")</data>
      <data key="d6">chunk-734cac289b42d37dad32bd51ea24a1ea</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOLATE METABOLISM&quot;" target="&quot;NOS1 GENE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The NOS1 gene interacts with folate metabolism to regulate nitric oxide production in cardiovascular health.")</data>
      <data key="d6">chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NITRIC OXIDE SYNTHESIS&quot;" target="&quot;CARDIOVASCULAR DISEASE&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Alterations in the nitric oxide synthesis pathway are associated with cardiovascular disease.")</data>
      <data key="d6">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CARDIOVASCULAR DISEASE&quot;" target="&quot;STATINS THERAPY&quot;">
      <data key="d4">15.0</data>
      <data key="d5">"Statin therapy is used to manage risk factors and improve outcomes in cardiovascular disease patients.")</data>
      <data key="d6">chunk-f05ecc979eea31a1ab844c2c7de12432</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CARDIOVASCULAR DISEASE&quot;" target="&quot;RS2231142 T ALLELE CARRIERS&quot;">
      <data key="d4">0.0</data>
      <data key="d5">"Individuals carrying the rs2231142 T allele may be predisposed to higher risks for certain types of cardiovascular diseases, as indicated by their uric acid levels and associated biomarkers.")</data>
      <data key="d6">chunk-7091ed039203b69ad83d281b22c89579</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIET&quot;" target="&quot;PA EXPOSURE&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Dietary intake can influence physical activity levels and vice versa, affecting overall health.")</data>
      <data key="d6">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PHYSICAL ACTIVITY&quot;" target="&quot;LIFESTYLE FACTOR&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Increased physical activity can reduce the risk of developing cardiovascular disease.")</data>
      <data key="d6">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PHYSICAL ACTIVITY&quot;" target="&quot;EDUCATION STATUS&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Education status might correlate with physical activity levels, which in turn affects cortisol levels influenced by alcohol intake.")</data>
      <data key="d6">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PHYSICAL ACTIVITY&quot;" target="&quot;SMOKING STATUS&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Physical activity could modify the impact of smoking status on cortisol levels through lifestyle and health behavior.")</data>
      <data key="d6">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;STATINS&quot;" target="&quot;DRUG THERAPY&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Statin medications help lower cholesterol levels and reduce the risk of heart disease.")</data>
      <data key="d6">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PERSONALIZED THERAPY&quot;" target="&quot;GENETIC PROFILES&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"Personalized therapies consider genetic variations when planning treatment for cardiovascular conditions.")</data>
      <data key="d6">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CHARACTERISTICS OF RCTS&quot;/&quot;STUDY DESIGN&quot;" target="&quot;LIFESTYLE INTERVENTION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">All RCTs involve lifestyle interventions that aim to reduce weight and lower T2D risk, with variations in the methods and composition of these interventions.)</data>
      <data key="d6">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LIFESTYLE INTERVENTION&quot;" target="&quot;DRUG&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The lifestyle intervention led to the largest decrease in proinsulin levels at 1 year among the different treatment groups.")</data>
      <data key="d6">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LIFESTYLE INTERVENTION&quot;" target="&quot;COMPARISON WITH OTHER INTERVENTIONS&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The lifestyle group had a larger decrease in proinsulin levels than either metformin or troglitazone groups, indicating potential superiority.")</data>
      <data key="d6">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AGE OF PARTICIPANTS&quot;" target="&quot;CHARACTERISTICS OF COHORT STUDIES&quot;/&quot;FOLLOW-UP TIME&quot;">
      <data key="d4">4.0</data>
      <data key="d5">In most studies, participants are over 40 years old at follow-up.)</data>
      <data key="d6">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CARDIOVASCULAR RISK&quot;" target="&quot;CHARACTERISTICS OF RCTS&quot;/&quot;BASELINE RISK&quot;">
      <data key="d4">5.0</data>
      <data key="d5">The risk of cardiovascular disease varies among the different cohorts and RCT populations.)</data>
      <data key="d6">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIETARY EXPOSURE&quot;/&quot;ASSESSMENT METHOD&quot;" target="&quot;FOOD FREQUENCY QUESTIONNAIRE/">
      <data key="d4">6.0</data>
      <data key="d5">The dietary assessments are based on validated food frequency questionnaires or other methods like dietary history records or biomarker measurements, affecting the accuracy of findings.")</data>
      <data key="d6">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INTERVIEWS/QUESTIONNAIRES&quot;" target="&quot;PA EXPOSURE&quot;/&quot;ASSESSMENT METHOD&quot;">
      <data key="d4">7.0</data>
      <data key="d5">The physical activity levels were assessed using interviews or questionnaires which can introduce subjectivity and potential recall biases.)</data>
      <data key="d6">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LIFESTYLE FACTOR&quot;" target="&quot;ALCOHOL CONSUMPTION DURING PREGNANCY AND CIGARETTE CONSUMPTION DURING PREGNANCY, ILLICIT DRUG USE DURING PREGNANCY&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Both groups showed heavy consumption, but frequency reduced during pregnancy, indicating potential effects on fetal development and infant growth.")("entity"</data>
      <data key="d6">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LIFESTYLE FACTOR&quot;" target="&quot;CAR T CELL EFFICACY&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The efficacy of CAR T cells can be affected by lifestyle factors like diet and physical activity, which modulate the tumor microenvironment.")</data>
      <data key="d6">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DRUG THERAPY&quot;" target="&quot;ANTI-EMETIC MEDICATIONS AND TREATMENT&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Commonly used anti-emetics included palonosetron, dexamethasone, prochlorperazine, ondansetron, and fosaprepitant.")</data>
      <data key="d6">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS7903146&quot;" target="&quot;TCF7L2&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"This specific SNP, part of the TCF7L2 gene, was associated with another one of the 23 obesity SNPs that showed significant association with BMI at baseline.")&lt;SEP&gt;"rs7903146 is a variant in the TCF7L2 gene that has an increased association with type 2 diabetes.")</data>
      <data key="d6">chunk-f9a60d3cf951d77afa115859755dac43&lt;SEP&gt;chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS7903146&quot;" target="&quot;RS9939609&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The FTO gene is associated with one of these obesity SNPs that have a direction of effect consistent with published GWAS data, showing significant association with BMI at baseline.")</data>
      <data key="d6">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS10010131&quot;" target="&quot;WFS1&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"rs10010131 is associated with WFS1, which shows directionally consistent risk for type 2 diabetes.")</data>
      <data key="d6">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS10946398&quot;" target="&quot;CDKAL1&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"rs10946398 associates with CDKAL1 gene showing a directionally consistent association in relation to type 2 diabetes.")</data>
      <data key="d6">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS864745&quot;" target="&quot;JAZF1&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"rs864745 variant is associated with JAZF1 gene which has an increased risk for type 2 diabetes.")</data>
      <data key="d6">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS4607103&quot;" target="&quot;ADAMTS9&quot;">
      <data key="d4">25.0</data>
      <data key="d5">"The rs4607103 variant associated with ADAMTS9 exhibits a differing directionality of association when compared to findings from European studies on type 2 diabetes.")&lt;SEP&gt;"rs4607103 in ADAMTS9 shows association but opposite directionality compared to European data on type 2 diabetes.")</data>
      <data key="d6">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TCF7L2 RISK VARIANT RS7903146&quot;" target="&quot;NOMINAL ANALYSIS RESULTS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The association between the TCF7L2 risk variant and the nominal analysis was significant (P = 0.011, unweighted OR 1.04 [95% CI 1.01–1.08]).")</data>
      <data key="d6">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TCF7L2 RISK VARIANT RS7903146&quot;" target="&quot;WEIGHTED ANALYSIS RESULTS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The association between the TCF7L2 risk variant and the weighted analysis was also significant (P = 8.10 × 10−5, weighted OR 1.06 [1.03–1.10]).")</data>
      <data key="d6">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TCF7L2 RISK VARIANT RS7903146&quot;" target="&quot;ORDINAL ANALYSIS RESULTS (NOMINAL CATEGORIES)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The nominal analysis of the TCF7L2 risk variant did not show association with ordinal data (P = 0.33, unweighted OR 1.02 [0.98–1.05]).")</data>
      <data key="d6">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TCF7L2 RISK VARIANT RS7903146&quot;" target="&quot;ORDINAL ANALYSIS RESULTS (WEIGHTED)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The weighted ordinal analysis of the TCF7L2 risk variant also did not show association with ordinal data (P = 0.40, weighted OR 1.02 [0.98–1.06]).")</data>
      <data key="d6">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TCF7L2 RISK VARIANT RS7903146&quot;" target="&quot;AFRICAN ANCESTRY&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The analyses did not find evidence for interaction with African Ancestry when considering the proportions of ancestry (P = 0.74).")</data>
      <data key="d6">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TCF7L2 RISK VARIANT RS7903146&quot;" target="&quot;COUNT OF RISK ALLELES&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"The count of risk alleles for the TCF7L2 risk variant was considered in nominal and ordinal analyses.")</data>
      <data key="d6">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NOMINAL ANALYSIS RESULTS&quot;" target="&quot;SIGNIFICANCE&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"The nominal analysis results showed a significant association (P = 0.011, unweighted OR 1.04 [95% CI 1.01–1.08]) for the TCF7L2 risk variant.")</data>
      <data key="d6">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;WEIGHTED ANALYSIS RESULTS&quot;" target="&quot;SIGNIFICANCE&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"The weighted analysis results showed a more significant association (P = 8.10 × 10−5, weighted OR 1.06 [1.03–1.10]) for the TCF7L2 risk variant.")</data>
      <data key="d6">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ORDINAL ANALYSIS RESULTS (NOMINAL CATEGORIES)&quot;" target="&quot;ASSOCIATION&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"The nominal ordinal analysis results did not show a significant association between the TCF7L2 risk variant and ordinal data (P = 0.33, unweighted OR 1.02 [0.98–1.05]).")</data>
      <data key="d6">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ORDINAL ANALYSIS RESULTS (WEIGHTED)&quot;" target="&quot;ASSOCIATION&quot;">
      <data key="d4">13.0</data>
      <data key="d5">"The weighted ordinal analysis results also did not show a significant association between the TCF7L2 risk variant and ordinal data (P = 0.40, weighted OR 1.02 [0.98–1.06]).")</data>
      <data key="d6">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INTERACTION&quot;" target="&quot;TRAIT INTERACTION&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"There is an observed interaction between one obesity SNP and a trait related to glycemic status on baseline BMI.")</data>
      <data key="d6">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INTERACTION&quot;" target="&quot;GENETIC VARIANT AND DIET INTERVENTION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"A significant interaction was found for 20:4, n-6 (AA) in the colon between genotype and diet.")</data>
      <data key="d6">chunk-e1b4f4dac52e806f19c580640a50c729</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INTERACTION&quot;" target="&quot;CHOLINE GROUP BY MATERNAL PEMT ALLELE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The six outcomes differed between the choline group and placebo group based on maternal PEMT alleles")</data>
      <data key="d6">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INTERACTION&quot;" target="&quot;FRMD6&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"cg18894781 associated with FRMD6 may suggest interaction in cell polarization, adhesion dynamics, or motility")("entity"</data>
      <data key="d6">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ASSOCIATION&quot;" target="&quot;HEMATOLOGICAL PARAMETERS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"SNP analysis through regression highlighted correlations with several hematological values before and after hydroxyurea treatment.")</data>
      <data key="d6">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ASSOCIATION&quot;" target="&quot;CHANGE MEASURE&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The association of these BCL11A SNPs included changes in hemoglobin levels following hydroxyurea exposure.")</data>
      <data key="d6">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ASSOCIATION&quot;" target="&quot;CC GENOTYPE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The CC genotype is associated with an increased risk of developing Colorectal Cancer based on statistical significance (p=0.009).")</data>
      <data key="d6">chunk-5b0cc96debf110f3544685d3b227ff27</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ASSOCIATION&quot;" target="&quot;HIV-INFECTED INDIVIDUALS VS. HEALTHY CONTROLS&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Associations were sought between specific TLR7 polymorphisms and HIV-infected status versus health in the study population.")</data>
      <data key="d6">chunk-05d583f893b703816ad8de9561aa5292</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS9939609&quot;" target="&quot;RS2984618&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"These two genetic variants are among the top three that reached significant associations with BMI at baseline.")</data>
      <data key="d6">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS9939609&quot;" target="&quot;FTO&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The association between one of the 23 obesity SNPs and BMI at baseline has direction consistent with previous Genome-Wide Association Study data.")</data>
      <data key="d6">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FTO&quot;" target="&quot;CRP/">
      <data key="d4">1.0</data>
      <data key="d5">mediated pleiotropy"/"Mediation"</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS2984618&quot;" target="&quot;TAL1&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The TAL1 gene is linked to this SNP that reached significance in its association with BMI at baseline.")</data>
      <data key="d6">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FPG&quot;" target="&quot;RS1011527&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"This SNP in the LEPR gene has significant interaction on BMI level when combined with FPG levels, indicating a specific pathway relating obesity genetics to glycemic status.")</data>
      <data key="d6">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS1011527&quot;" target="&quot;INTERACTION WITH FPG&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The SNP's interaction with fasting plasma glucose (FPG) levels affects BMI at baseline.")</data>
      <data key="d6">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS1011527&quot;" target="&quot;INTERACTION WITH FPG AND BASELINE BMI&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The SNP's combined interaction with FPG levels impacts baseline BMI.")</data>
      <data key="d6">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS1011527&quot;" target="&quot;FPG AND BASELINE BMI INTERACTION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"This interaction between SNP, FPG levels, and baseline BMI showcases a complex relationship in influencing obesity markers.")</data>
      <data key="d6">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS1011527&quot;" target="&quot;INTERACTION WITH FPG AND BASELINE BMI LEVEL&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"This combination highlights a specific pathway by which obesity SNPs interact with metabolic markers to affect BMI at baseline and its transition.")</data>
      <data key="d6">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS1011527&quot;" target="&quot;FPG AND BASELINE BMI INTERACTION EFFECT&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The SNP's involvement with FPG levels and baseline BMI demonstrates its impact on obesity markers through complex interplay.")</data>
      <data key="d6">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GRS&quot;" target="&quot;TMTA&quot;">
      <data key="d4">0.06</data>
      <data key="d5">"The GRS was associated with lower scores on TMTA (Trail Making Test A), suggesting a potential link between genetic risk and cognitive function.")</data>
      <data key="d6">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GRS&quot;" target="&quot;TMTB&quot;">
      <data key="d4">0.002</data>
      <data key="d5">"The GRS correlated significantly with reduced performance on TMTB, indicating an impact of genetic predispositions on attention measures.")</data>
      <data key="d6">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GRS&quot;" target="&quot;PEGDH&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"No significant difference was observed between the GRS groups for PEGDH, suggesting a lack of association in specific metabolic processes.")</data>
      <data key="d6">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GRS&quot;" target="&quot;PEGNDH&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"An analogous relationship to PEGDH, indicating no observable link between the Genetic Risk Score and this other metabolite interaction.")</data>
      <data key="d6">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GRS&quot;" target="&quot;DIG&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Similar observations for DIG: GRS groups did not show significant differences in mean scores, suggesting minimal impact on cognitive measures related to its function.")</data>
      <data key="d6">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GRS&quot;" target="&quot;CFL&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"No association was found between the Genetic Risk Score and impairment on CFL or other specific tests within the DIVERGT battery.")</data>
      <data key="d6">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TRAIT INTERACTION&quot;" target="&quot;RS1011527, RS9939609&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The interaction between these two SNPs with a trait related to glycemic status influences BMI at baseline.")</data>
      <data key="d6">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FPG, BASELINE BMI&quot;" target="&quot;RS1011527, LEPR GENE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"This SNP within the LEPR gene interacts significantly with FPG levels affecting baseline BMI.")</data>
      <data key="d6">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI TRANSITION&quot;" target="&quot;SNP(S), GRS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The genetic factors are not associated with transitions in BMI, suggesting no simultaneous main effect and interaction between genetic determinants and glycemic status change.")</data>
      <data key="d6">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BASELINE BMI INFLUENCE&quot;" target="&quot;RS1011527, FPG&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The SNP's interaction with fasting plasma glucose (FPG) directly affects baseline BMI.")</data>
      <data key="d6">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MTHFR 1298A&gt;C&quot;" target="&quot;MS 2756A&gt;G&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Two polymorphisms (MTHFR 1298A&gt;C and MS 2756A&gt;G) were related to performance on TMTA and TMTB.")</data>
      <data key="d6">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MS 2756A&gt;G&quot;" target="&quot;TMTB&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Survivors with the MS 2756AA genotype scored significantly lower than survivors with other genotypes on TMTB.")</data>
      <data key="d6">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TMTA&quot;" target="&quot;TMTB&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Survivors with the MTHFR 1298AC/CC genotypes performed worse than those with the MTHFR 1298AA genotype on both tests.")</data>
      <data key="d6">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PEGDH&quot;" target="&quot;PEGNDH&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The mean PEGNDH score of survivors with the MS 2756AA genotype was significantly lower than those with different genotypes.")</data>
      <data key="d6">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AGE AT DIAGNOSIS&quot;" target="&quot;CHI&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Age ranged from birth to seven years old for patients with CHI diagnosis.")</data>
      <data key="d6">chunk-f921f48a406901d82ec2e32af99485bf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AGE AT DIAGNOSIS&quot;" target="&quot;TIME DURATION BETWEEN SYMPTOM AND DIAGNOSIS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The duration from symptom manifestation to diagnosis was longer in Group 2, particularly for neonatal form patients.")</data>
      <data key="d6">chunk-f921f48a406901d82ec2e32af99485bf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PROTEIN&quot;" target="&quot;DISEASE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"High GRS scores might indicate an overexpression or altered function of proteins that play key roles in cognitive processes related to MTX neurotoxicity."]</data>
      <data key="d6">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PROTEIN&quot;" target="&quot;SENP1&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"SENP1 deletion augments NEMO SUMOylation in adipocytes, which is thought to regulate the activation of NF-κB and cytokine production.")</data>
      <data key="d6">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PROTEIN&quot;" target="&quot;NUTRIENT&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"NA, no protein-nutrient relationship mentioned")</data>
      <data key="d6">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PROTEIN&quot;" target="&quot;INFLAMMATORY PROCESS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"SUMOylation of NEMO by SENP1 modulates the activation of NF-κB and cytokine production in adipocytes, key aspects of inflammatory response linked to T1DM pathophysiology.")</data>
      <data key="d6">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PROTEIN&quot;" target="&quot;ENVIRONMENTAL FACTOR&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Exposure to environmental factors can modify the function and stability of proteins.")</data>
      <data key="d6">chunk-734cac289b42d37dad32bd51ea24a1ea</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NUTRIENT&quot;" target="&quot;FOLIC ACID SUPPLEMENTS&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Maternal periconceptional use of folic acid supplements was higher in non-Hispanic Whites than in Hispanic mothers.")</data>
      <data key="d6">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NUTRIENT&quot;" target="&quot;ENVIRONMENTAL FACTOR&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Certain nutrients might interact with environmental factors to influence health outcomes.")</data>
      <data key="d6">chunk-6a657cd0a000b6df4db8f1305b795021</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MOLECULAR INTERACTION&quot;" target="&quot;IL1A RS17561&quot;">
      <data key="d4">0.005</data>
      <data key="d5">"The A114S missense change in this SNP was linked to a reduced risk for certain ovarian cancer subtypes.")</data>
      <data key="d6">chunk-089bcdf055eb2f007db49dbe2409429b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MOLECULAR INTERACTION&quot;" target="&quot;PROTEIN-PROTEIN INTERACTION&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The complex interactions between different proteins like IL-6Rα and its ligand(s), which are crucial for processes including immune response regulation and disease development.")</data>
      <data key="d6">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MOLECULAR INTERACTION&quot;" target="&quot;GENE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Both the IL-1R and IL-6Rα genes interact with other molecular components to modulate both Rag1−/− and IL-10RαMdelRag1−/− disease severity.")</data>
      <data key="d6">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MOLECULAR INTERACTION&quot;" target="&quot;INFANTS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The six outcomes on which the choline group and placebo group differed were examined")</data>
      <data key="d6">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MOLECULAR INTERACTION&quot;" target="&quot;PHYSIOLOGICAL PROCESS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"NA, no specific physiological process-molecular interaction mentioned")&lt;SEP&gt;"Understanding how specific physiological processes are affected by molecular interactions is crucial for disease prevention and treatment.")</data>
      <data key="d6">chunk-f290cff8dac7b522b4f56d03e8df48ce&lt;SEP&gt;chunk-72f4505e43f67f3564607392cb178656</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MOLECULAR INTERACTION&quot;" target="&quot;DNA DAMAGE RESPONSE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"SENP1 deletion enhances NEMO SUMOylation even under stress conditions like DNA damage, which could contribute to inflammation and metabolic dysfunction in diabetes." )</data>
      <data key="d6">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MOLECULAR INTERACTION&quot;" target="&quot;RS1799853 AND RS1057910&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Together, they form part of the CYP2C9 star variant group indicating reduced activity.")</data>
      <data key="d6">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MOLECULAR INTERACTION&quot;" target="&quot;DISEASE&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Changes in molecular interactions might lead to the development or progression of diseases, as mentioned.")</data>
      <data key="d6">chunk-72f4505e43f67f3564607392cb178656</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MOLECULAR INTERACTION&quot;" target="&quot;FAAP20-UBZ MUTANTS D164A, A172L AND D177A&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Reduction of binding affinity due to these mutations suggests a disruption in specific interactions that are key for FAAP20's function.")</data>
      <data key="d6">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MOLECULAR INTERACTION&quot;" target="&quot;FAAP20-UBZ MUTANTS&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Mutations in FAAP20's UBZ domain affect its ability to interact with ubiquitin (Ub) leading to disruptions in cellular functions that can have implications for disease states.")</data>
      <data key="d6">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MOLECULAR INTERACTION&quot;" target="&quot;UBZ-DOMAIN PROTEINS&quot;">
      <data key="d4">14.0</data>
      <data key="d5">"The interaction between proteins like FAAP20, WRNIP1, RAD18, Polη, NEMO and ubiquitin (Ub) through their UBZ domains is crucial for various cellular processes that play a role in disease states.")</data>
      <data key="d6">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MOLECULAR INTERACTION&quot;" target="&quot;SNPS IN PTPN2 AND PTPN22&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"These SNPs influence T-cell proliferation response when exposed to PHA or MAP PPD-like molecules.")</data>
      <data key="d6">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MOLECULAR INTERACTION&quot;" target="&quot;CAUSAL SNPS&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"In the context of GWAS, causal SNPs may influence genetic outcomes depending on their LD score and MAF when evaluated using different statistical methods such as survival kernel machine test or weighted IBS kernel.")</data>
      <data key="d6">chunk-2e31819d63b80079cb6422efd6e684e0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MOLECULAR INTERACTION&quot;" target="&quot;METABOLIC PATHWAY&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Certain molecular interactions are key in metabolic pathways, affecting how they function or respond to stimuli.")</data>
      <data key="d6">chunk-734cac289b42d37dad32bd51ea24a1ea</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ENVIRONMENTAL FACTOR&quot;" target="&quot;ALOX5 RS1864414&quot;">
      <data key="d4">2.376</data>
      <data key="d5">"This genetic variant influences the odds of developing ovarian cancer.")</data>
      <data key="d6">chunk-089bcdf055eb2f007db49dbe2409429b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ENVIRONMENTAL FACTOR&quot;" target="&quot;DISEASE&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"Environmental factors can contribute to the onset or exacerbation of diseases.")&lt;SEP&gt;"The environment, including genetic factors such as specific gene variants, influences colitis through impacts on T cell responses.")</data>
      <data key="d6">chunk-734cac289b42d37dad32bd51ea24a1ea&lt;SEP&gt;chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ENVIRONMENTAL FACTOR&quot;" target="&quot;METABOLIC PATHWAY&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Differential effects of environmental factors on metabolic pathways can influence health outcomes.")&lt;SEP&gt;"NA, no specific metabolic pathway-environmental factor relationship mentioned")</data>
      <data key="d6">chunk-f290cff8dac7b522b4f56d03e8df48ce&lt;SEP&gt;chunk-72f4505e43f67f3564607392cb178656</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ENVIRONMENTAL FACTOR&quot;" target="&quot;GENETIC PREDISPOSITION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Adipocyte-specific SENP1 deficiency may exacerbate the genetic predisposition towards T1DM by modulating multiple signaling pathways involved in insulin secretion and glucose metabolism." )</data>
      <data key="d6">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ENVIRONMENTAL FACTOR&quot;" target="&quot;GENETIC INFLUENCE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The study investigated genetic variations that influence ChAT expression and function, leading to altered kinetic parameters and potential phenotypic outcomes.")</data>
      <data key="d6">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ENVIRONMENTAL FACTOR&quot;" target="&quot;SMOKING STATUS&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Non-smokers showed marginally shorter latency to drink compared to smokers but did not significantly moderate medication or genotype effects.")&lt;SEP&gt;"There was an association between smoking status and latency to drink, but it did not significantly moderate the effects of genotype or medication.")</data>
      <data key="d6">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ENVIRONMENTAL FACTOR&quot;" target="&quot;UBIQUITINATION&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"The process of ubiquitination, influenced by proteins like FAAP20, WRNIP1, RAD18, Polη and NEMO through their UBZ domains, is an environmental factor that plays a significant role in cellular processes linked to health and disease.")</data>
      <data key="d6">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ENVIRONMENTAL FACTOR&quot;" target="&quot;FAAP20-UBZ MUTANTS D164A, A172L, D177A&quot;">
      <data key="d4">13.0</data>
      <data key="d5">"Mutations affecting FAAP20's UBZ domain can influence the cellular environment by disrupting interactions with ubiquitin (Ub), thereby impacting various biological processes and health outcomes.")</data>
      <data key="d6">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ENVIRONMENTAL FACTOR&quot;" target="&quot;MAPBACTEREMIA PRESENCE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Alteration of T-cell response when specific pathogens are present in the environment, affecting physiological processes.")</data>
      <data key="d6">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MTHFR 677C&gt;T&quot;" target="&quot;SHMT 1520C&gt;T&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Both polymorphisms in these genes were associated with performance on TMTA and TMTB.")</data>
      <data key="d6">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MS 2756AA GENOTYPE&quot;" target="&quot;TSER 3R/3R GENOTYPES&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Genotype comparison between MS 2756AA survivors and those with TSER 3R/3R or 2R/3R showed differences in certain neurocognitive outcomes.")</data>
      <data key="d6">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DISEASE&quot;" target="&quot;STRATA&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Different subgroups within the population could have varying disease profiles based on environmental or genetic factors.")</data>
      <data key="d6">chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DISEASE&quot;" target="&quot;CRP GWAS SNPS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"19 SNPs out of the 283 independent cardiometabolic SNPs were associated with CRP after correction for multiple testing.")</data>
      <data key="d6">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DISEASE&quot;" target="&quot;SNPS IN CRP GWAS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Additional SNPs out of 283 cardiometabolic SNPs were associated with CRP after correction for multiple testing.")</data>
      <data key="d6">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DISEASE&quot;" target="&quot;DAY EFFECT&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Day-to-day variations influenced the S-FOL and WB-FOL results.")</data>
      <data key="d6">chunk-257a38a8ce6582c434f31b023b4a9704</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DISEASE&quot;" target="&quot;GENE&quot;">
      <data key="d4">3.1532</data>
      <data key="d5">"The rs1695 gene variant showed an association with increased risk of developing breast cancer.")</data>
      <data key="d6">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DISEASE&quot;" target="&quot;MINOR ALLELE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The presence of the minor allele may be associated with increased risk or severity of certain diseases.")</data>
      <data key="d6">chunk-f05ecc979eea31a1ab844c2c7de12432</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DISEASE&quot;" target="&quot;CHOLESTEROL&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Elevated cholesterol levels are a significant risk factor for developing cardiovascular diseases, including heart attack and stroke.")</data>
      <data key="d6">chunk-7091ed039203b69ad83d281b22c89579</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DISEASE&quot;" target="&quot;TRIGLYCERIDES&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"High triglyceride levels increase the risk of developing conditions such as pancreatitis and cardiovascular disease.")</data>
      <data key="d6">chunk-7091ed039203b69ad83d281b22c89579</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DISEASE&quot;" target="&quot;EA PATIENTS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"European-American patients are part of the study population with HDDs under consideration.")</data>
      <data key="d6">chunk-0c7ab28db433187759e760725a105836</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DISEASE&quot;" target="&quot;WILD TYPE UBE2T&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The deficiency of wild type UBE2T results in Fanconi anemia-T subtype.")</data>
      <data key="d6">chunk-ffd1276c89bcac745a7e58082e97236f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DISEASE&quot;" target="&quot;RS11209026&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"A previously associated SNP rs11209026 is mentioned with relation to paradoxical psoriasiform reactions and anti-TNFs treatment.")</data>
      <data key="d6">chunk-72f4505e43f67f3564607392cb178656</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DISEASE&quot;" target="&quot;FAAP20-UBZ MUTANTS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Mutations in key residues necessary for Ub binding may lead to dysfunctions and potentially contribute to disease states.")</data>
      <data key="d6">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DISEASE&quot;" target="&quot;FAAP20, WRNIP1, RAD18, POLΗ, NEMO&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"Proteins with UBZ domains involved in ubiquitination pathways are implicated in the regulation of cell survival and division processes which can impact disease progression based on their interactions with ubiquitin (Ub).")</data>
      <data key="d6">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DISEASE&quot;" target="&quot;DISEASE&quot;">
      <data key="d4">0.15</data>
      <data key="d5">"Diseases related to the context and their interactions with other entities are yet to be determined.")</data>
      <data key="d6">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DISEASE&quot;" target="&quot;P.GLY129*&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The c.385G&gt;T variant (p.Gly129*) is linked to agenesis of the corpus callosum")</data>
      <data key="d6">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DISEASE&quot;" target="&quot;GWAS SNPS&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"GWAS SNPs were associated with T1D through identified trans-acting regulatory effects and eQTLs.")</data>
      <data key="d6">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DISEASE&quot;" target="&quot;KNOWN IMMUNODOMINANT EPITOPE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The presence or identification of a known immunodominant epitope may indicate or contribute to specific diseases linked to antigenic presentation and recognition processes.")</data>
      <data key="d6">chunk-41c7131af28e2a745ef6b88b8601860f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SLC30A8 RS13266634&quot;" target="&quot;FASTING PROINSULIN LEVELS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"In the DPP cohort, the C risk allele at this genomic variant was associated with higher fasting proinsulin levels.")</data>
      <data key="d6">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FASTING PROINSULIN LEVELS&quot;" target="&quot;INTERVENTION GROUPS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"After 1 year of DPP intervention, all active groups significantly decreased fasting proinsulin levels compared to placebo.")</data>
      <data key="d6">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DPP COHORT&quot;" target="&quot;INTERVENTION&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Participants in the DPP cohort were randomized into intervention groups for 1 year.")</data>
      <data key="d6">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FASTING GLUCOSE&quot;" target="&quot;MTNR1B&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"An intronic variant of MTNR1B was strongly linked to fasting glucose levels.")</data>
      <data key="d6">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PROINSULIN LEVELS&quot;" target="&quot;METFORMIN TREATMENT&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"At 1 year, there were no significant differences in proinsulin levels between the metformin and troglitazone intervention groups.")</data>
      <data key="d6">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;METFORMIN&quot;" target="&quot;COMPARISON WITH TROGLITAZONE&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"At 1 year after DPP interventions, the metformin and troglitazone had similar proinsulin levels, suggesting no significant difference in effectiveness between them for this study.")</data>
      <data key="d6">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOTYPE × TREATMENT INTERACTION&quot;" target="&quot;STATISTICAL RESULT&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"No genotype-specific effectiveness was observed for any of the treatments evaluated based on SLC30A8 rs13266634 dosage.")</data>
      <data key="d6">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOTYPE × TREATMENT INTERACTION&quot;" target="&quot;STATISTICAL FINDING&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"The dosage of SLC30A8 risk alleles did not significantly modify the effectiveness of any treatment within the DPP cohort.")</data>
      <data key="d6">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HC DIET&quot;" target="&quot;PNPLA3&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"HC diet increases the expression of PNPLA3 mRNA, which is inhibited with the addition of lipid emulsion (LE).")</data>
      <data key="d6">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SREBP1C&quot;" target="&quot;ACC-1&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Correlation between SREBP1c and ACC-1 mRNA levels in mouse liver tissues; strong positive correlation observed.")&lt;SEP&gt;"SREBP1c and ACC-1 show similar expression patterns to PNPLA3; high correlations were observed between their mRNA levels.")</data>
      <data key="d6">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ACC-1&quot;" target="&quot;INSULIN&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The same treatment also had no effect on ACC-1 mRNA expression under either condition.")</data>
      <data key="d6">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ACC-1&quot;" target="&quot;GLUCAGON&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Treatment with glucagon also had no effect on ACC-1 mRNA expression in HepG2 cells, but increased PC expression.")</data>
      <data key="d6">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INSULIN&quot;" target="&quot;HEPG2 CELLS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Our data suggests that hepatic PNPLA3 does not respond to insulin stimulation in HepG2 cells.")</data>
      <data key="d6">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INSULIN&quot;" target="&quot;FAS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Incubation of HepG2 cells with 10 nM insulin for 24 h did not increase the expression of FAS, but induced the expression of pyruvate carboxylase (PC), a known target of insulin action.")</data>
      <data key="d6">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GLUCAGON&quot;" target="&quot;HEPG2 CELLS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Treatment of HepG2 cells with glucagon had no effect on PNPLA3 mRNA expression, but stimulated pyruvate carboxylase (PC), a known target of glucagon action.")</data>
      <data key="d6">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GLUCAGON&quot;" target="&quot;FAS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Treatment of HepG2 cells with 100 nM glucagon in low glucose medium for 24 hours did not affect FAS gene expression, but stimulated the expression of pyruvate carboxylase (PC), a known target of glucagon action.")</data>
      <data key="d6">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FATTY ACIDS&quot;" target="&quot;HEPG2 CELLS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Different fatty acids tested had varying effects on PNPLA3 gene expression in HepG2 cells under low and high glucose conditions.")</data>
      <data key="d6">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DEPLETION-REFEEDING CONDITIONS (SPECIFIC CONTEXT: HEPG2 CELL EXPERIMENTS)&quot;|&quot;PNPLA3 &amp; CHREBP&quot;&lt;|&quot;CYCLING BETWEEN GLUCOSE DEPLETION AND REFEEDING PHASES INFLUENCED PNPLA3 EXPRESSION, WITH MODERATE REDUCTIONS AFTER 8 HOURS OF DEPLETION; SHOWED REGULATION THROUGH TRANSCRIPTION FACTORS IN RESPONSE TO METABOLIC STATES.&quot;)(&quot;ENTITY&quot;" target="&quot;LDL RECEPTOR&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Protein"</data>
      <data key="d6">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENE&quot;" target="&quot;NEURODEVELOPMENT&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The genes identified through combined mRNA/miRNA analyses were mainly involved in neurodevelopment pathways."</data>
      <data key="d6">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENE&quot;" target="&quot;SNPS IN CRP GWAS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The top hits were located within or close to various genes like APOC1, HNF1A, GCKR etc.")</data>
      <data key="d6">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENE&quot;" target="&quot;DHFR SNPS&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"There was no evidence of a nonrandom association between NTD-affected pregnancies and either maternal or infant variants in DHFR.")</data>
      <data key="d6">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENE&quot;" target="&quot;SNP SET COMBINING RS1799853, RS1057910, RS28371686, RS7900194, RS28371685, CYP2C9*2, CYP2C9*3, CYP2C9*5, CYP2C9*8 AND CYP2C9*11&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"This set of SNPs collectively represents the CYP2C9 star variant group that was considered.")</data>
      <data key="d6">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENE&quot;" target="&quot;AUDIT SCORE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The OPRM1 gene was associated with differences in the AUDIT (Alcohol Use Disorders Identification Test) score across genotype groups.")</data>
      <data key="d6">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENE&quot;" target="&quot;NUMBER OF DRINKING DAYS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"There were significant differences in the number of drinking days among OPRM1 genotype groups.")</data>
      <data key="d6">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENE&quot;" target="&quot;DRINKS PER DRINKING DAY&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Participants with different OPRM1 genotypes had varying drinks consumed on drinking days.")</data>
      <data key="d6">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENE&quot;" target="&quot;ALDH2&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The effects of OPRM1 genotype on alcohol consumption were assessed after controlling for ALDH2 genetic variations.")</data>
      <data key="d6">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENE&quot;" target="&quot;ADH1B&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The impact of OPRM1 genotype on alcohol responses was adjusted with ADH1B genetic information in the analysis.")</data>
      <data key="d6">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENE&quot;" target="&quot;MEDICATION&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"OPRM1 genotype was compared against different medications to understand its effect on alcohol-induced responses.")&lt;SEP&gt;"The actions of the OPRM1 gene on alcohol-related behaviors were examined using different medications.")</data>
      <data key="d6">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENE&quot;" target="&quot;MEDICATION × GENOTYPE INTERACTION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The combined effects of different medications with OPRM1 gene variations on alcohol craving were studied.")&lt;SEP&gt;"The combined effects of various medications with OPRM1 gene variations on assessing alcohol-induced sedative responses were studied.")&lt;SEP&gt;"The interaction between a drug and OPRM1 genetic variation impacted the observed effects on different alcohol-induced responses.")</data>
      <data key="d6">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENE&quot;" target="&quot;BRAC&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The OPRM1 gene's influence on alcohol responses was adjusted for BrAC levels during assessments.")&lt;SEP&gt;"The influence of BrAC levels on alcohol craving assessment was explored in relation to OPRM1 genotypes and medications.")&lt;SEP&gt;"The influence of BrAC levels on assessing alcohol-induced sedation was analyzed in relation to OPRM1 genotypes and medications.")</data>
      <data key="d6">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENE&quot;" target="&quot;MEDICATION × GENOTYPE × BRAC INTERACTION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The combined effect of medications, OPRM1 genotypes, and BrAC in influencing alcohol-induced subjective responses was analyzed.")&lt;SEP&gt;"The complex interactions between medications, OPRM1 gene variants, and BrAC influenced evaluations related to alcohol-induced sedative responses.")&lt;SEP&gt;"The complex interactions between medications, OPRM1 gene variants, and BrAC levels influenced evaluations related to alcohol cravings.")</data>
      <data key="d6">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENE&quot;" target="&quot;CIGARETTE SMOKING STATUS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The impact of OPRM1 genotype in conjunction with medication influenced alcohol-induced responses was assessed by considering current cigarette smoking status.")</data>
      <data key="d6">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENE&quot;" target="&quot;NICOTINE SMOKING STATUS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The influence of OPRM1 gene in combination with medications on responses related to alcohol intake was evaluated after taking into account nicotine smoking status.")</data>
      <data key="d6">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENE&quot;" target="&quot;NALTREXONE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The influence of OPRM1 gene variations and naltrexone were studied to understand their mutual impact on alcohol effects.")</data>
      <data key="d6">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENE&quot;" target="&quot;PLACEBO&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The role of the OPRM1 gene on alcohol responses under placebo conditions was analyzed during studies employing various medications.")</data>
      <data key="d6">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENE&quot;" target="&quot;ALCOHOL CRAVING&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The impact of the OPRM1 gene on alcohol craving was evaluated in relation to medication types and BrAC levels.")</data>
      <data key="d6">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENE&quot;" target="&quot;ALCOHOL-INDUCED SEDATION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The OPRM1 gene's effect on alcohol-induced sedation was compared across different medication types and BrAC levels.")</data>
      <data key="d6">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENE&quot;" target="&quot;ALCOHOL-INDUCED STIMULATION/">
      <data key="d4">1.0</data>
      <data key="d5">"The OPRM1 gene's effect on alcohol-induced stimulant responses was studied considering different medication types and BrAC levels.")</data>
      <data key="d6">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENE&quot;" target="&quot;MEDICATION × GENOTYPE INTERACTION/">
      <data key="d4">1.0</data>
      <data key="d5">Stimulation"/&gt;"The combined effects of various medications with OPRM1 gene variations on assessing alcohol-induced stimulant responses were explored.")</data>
      <data key="d6">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENE&quot;" target="&quot;MEDICATION × GENOTYPE × BRAC INTERACTION/">
      <data key="d4">1.0</data>
      <data key="d5">Stimulation"/&gt;"The complex interactions between medications, OPRM1 gene variants, and BrAC influenced evaluations related to alcohol-induced stimulant responses.")</data>
      <data key="d6">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MIRNAS&quot;" target="&quot;DOWNREGULATION&quot;/&quot;UPREGULATION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Out of the 68 miRNAs, 65 were downregulated while only 3 were upregulated after prenatal stress exposure.")</data>
      <data key="d6">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EPHA4&quot;" target="&quot;LDLRAP1&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"EPHA4 was found to have potential interactions with LDLRAP1 through modulation patterns, implying possible biological pathways involved in depression.")</data>
      <data key="d6">chunk-01cd90d27130aab1a096ad616e05f182</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ARID5B&quot;" target="&quot;TGF-Β1&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"ARID5B was observed in a single cluster with TGF-β1, implying potential interactions or overlapping regulatory mechanisms.")</data>
      <data key="d6">chunk-01cd90d27130aab1a096ad616e05f182</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HSF2&quot;" target="&quot;ARRDC4&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"ARRDC4 and HSF2 show similarities in modulation patterns across different conditions, suggesting they might interact or share regulatory roles.")</data>
      <data key="d6">chunk-01cd90d27130aab1a096ad616e05f182</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HSF2&quot;" target="&quot;SAMD12&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Homo sapiens stress factor 2 might interact with SAMD12 based on their modulation patterns and roles in complex disorders like depression.")</data>
      <data key="d6">chunk-01cd90d27130aab1a096ad616e05f182</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LRRN3&quot;" target="&quot;FBXO32&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"FBXO32 might interact with LRRN3 based on their modulation patterns and roles in biological processes related to depression.")</data>
      <data key="d6">chunk-01cd90d27130aab1a096ad616e05f182</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;A2M&quot;" target="&quot;FOXO1&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Both A2M and FoxO1 were modulated similarly in animals and humans, suggesting they might interact or share signaling pathways related to depression.")</data>
      <data key="d6">chunk-01cd90d27130aab1a096ad616e05f182</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOXO1&quot;" target="&quot;TGF-Β1&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Both FoxO1 and TGF-β1 were part of a cluster that showed interactions through physical interaction, co-expression or involvement in common pathways, indicating potential biological crosstalk related to depression.")</data>
      <data key="d6">chunk-01cd90d27130aab1a096ad616e05f182</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOXO1&quot;" target="&quot;GXE INTERACTION WITH EMOTIONAL STRESS&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"FoxO1 shows significant GxE interactions across both cohorts when exposed to emotional stress, suggesting it plays a crucial role in the development of depressive symptoms in response to such stressors.")</data>
      <data key="d6">chunk-01cd90d27130aab1a096ad616e05f182</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOXO1&quot;" target="&quot;GXE INTERACTION WITH EMOTIONAL ABUSE AND SEXUAL ABUSE&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"FoxO1's gene expression is significantly affected by environmental exposures like emotional and physical abuse, indicating its role in the development of depressive symptoms through GxE interactions.")</data>
      <data key="d6">chunk-01cd90d27130aab1a096ad616e05f182</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOXO1&quot;" target="&quot;CLUSTER OF INTERACTING GENES (A2M, FOXO1, TGF-Β1)&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The cluster formed by A2M, FoxO1 and TGF-β1 indicates potential interactions that are involved in depression through overlapping pathways and signaling systems.")</data>
      <data key="d6">chunk-01cd90d27130aab1a096ad616e05f182</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOXO1&quot;" target="&quot;STRESS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Activation of FoxO1 in response to cortisol exposure, reflecting a mechanism involved in the negative impact of stress on neuronal proliferation.")</data>
      <data key="d6">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOXO1&quot;" target="&quot;STRESS RESPONSE MECHANISM&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"FoxO1 is part of a molecular pathway that regulates the effect of stress on neurogenesis through its activation by cortisol exposure.")</data>
      <data key="d6">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNP&quot;" target="&quot;GWAS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The Genome-Wide association studies identified specific SNPs significantly associated with snoring.")</data>
      <data key="d6">chunk-a34b927ed42ff0917960122b4d203f83</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNP&quot;" target="&quot;INFANT MTHFD1 SNPS RS2236224 AND RS2236225&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"Infants with the CT genotype had an approximate 1.5-fold increase risk compared to those with the CC genotype based on folic acid intake categories.")</data>
      <data key="d6">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNP&quot;" target="&quot;INFANT AG GENOTYPE IN MTHFD1 SNP RS11627387&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"Infants with the AG genotype had a four-fold increase risk compared to those with GG genotype when maternal folate intake was low.")</data>
      <data key="d6">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNP&quot;" target="&quot;MTHFR SNPS RS1476413, RS1801131 AND RS1801133&quot;">
      <data key="d4">13.0</data>
      <data key="d5">"Mothers had a decreased risk of an NTD-affected pregnancy when they had low intake of folates compared to common homozygous mothers in the high folate intake group.")</data>
      <data key="d6">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNP&quot;" target="&quot;SHMT1 SNP RS669340 CG GENOTYPE&quot;">
      <data key="d4">14.0</data>
      <data key="d5">"A maternal gene-only effect was associated with a reduced risk of an NTD-affected pregnancy compared to mothers with CC genotype.")</data>
      <data key="d6">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNP&quot;" target="&quot;INFANTS WITH THE SHMT1 SNP RS12939757 AG GENOTYPE&quot;">
      <data key="d4">15.0</data>
      <data key="d5">"An interaction effect was observed for infants with low folate intake and this AG genotype, which showed an association with increased risk compared to those with AA or CC genotypes.")</data>
      <data key="d6">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNP&quot;" target="&quot;INFANTS WITH THE TYMS SNPS RS502396 OR RS699517 HOMOZGOUS GENOTYPE&quot;">
      <data key="d4">16.0</data>
      <data key="d5">"A gene-folate interaction was associated with a reduced risk of NTDs for mothers in low folate intake groups, compared to high-folate intake groups.")</data>
      <data key="d6">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNP&quot;" target="&quot;INFANTS WITH THE TYMS SNP RS2847153 AG GENOTYPE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"An interaction effect on infants was also protective against risk for this SNP when they were in a low folate intake group, relative to those in high-folate intake groups.")</data>
      <data key="d6">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNP&quot;" target="&quot;GENETIC POLYMORPHISMS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Identified genetic variations associated with coffee consumption through GWAS.")</data>
      <data key="d6">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNP&quot;" target="&quot;TYPE 2 DIABETES&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"There's an inverse relationship between the minor allele of SNPs and the risk of developing Type 2 Diabetes.")</data>
      <data key="d6">chunk-b803830d07bff8ae14550f6458048707</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNP&quot;" target="&quot;EGFR&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Lead SNPs at the loci of interest have common effects on eGFR across ancestry groups, indicating shared genetic influences.")</data>
      <data key="d6">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNP&quot;" target="&quot;TAQMAN&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The TaqMan method was utilized to assess the association between SNPs and CRC.")</data>
      <data key="d6">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CORTISOL&quot;" target="&quot;SGK-1&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Elevated mRNA levels of SGK-1 following cortisol treatment; indicates involvement in glucocorticoid-induced changes related to neurogenesis.")</data>
      <data key="d6">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PATHWAY IN ANIMALS EXPOSED TO PNS&quot;" target="&quot;PATHWAY IN HUMANS EXPOSED TO CHILDHOOD TRAUMA&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Several pathways involved in neurodevelopment and inflammation were found to be similar between the PNS model and humans exposed to early life trauma."</data>
      <data key="d6">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COMMON GENES&quot;" target="&quot;INTEGRATION OF DATA&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"22 genes were identified as common across both datasets (hippocampus of rats exposed to PNS and blood of adults exposed to childhood trauma). The probability that these genes didn't overlap by chance was extremely low, p-value = 1.8 × 10^-8."</data>
      <data key="d6">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENE EXPRESSION IN HIPPOCAMPUS&quot;" target="&quot;REAL-TIME PCR VALIDATION&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"All 22 common genes were validated using real-time PCR both in the hippocampus of animals and in blood samples from humans exposed to childhood trauma. 16 out of these 22 genes showed consistent modulation direction, while 6 showed opposite modulation."</data>
      <data key="d6">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AS1842856 (FOXO1 INHIBITOR)&quot;" target="&quot;DRUG INTERACTION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"AS1842856, as an inhibitor of FoxO1, is used to counteract the upregulation of FoxO1 and its effect on cortisol-induced reduction in neuronal proliferation.")</data>
      <data key="d6">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CORTISOL (STRESS HORMONE)&quot;" target="&quot;NEUROGENESIS REGULATION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Cortisol plays a role in regulating neurogenesis, particularly under stress conditions, influencing the expression of key genes such as FoxO1 and SGK-1.")</data>
      <data key="d6">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS4771122&quot;" target="&quot;BONFERRONI CORRECTED P-VALUE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"SNP rs4771122 achieved a low Bonferroni corrected P-value (.05/34 = .0017) for the association with long-term weight loss.")</data>
      <data key="d6">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS4771122&quot;" target="&quot;BETA ESTIMATES&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Additional copies of the minor (G) allele were significantly associated with higher linear mixed model weights after adjusting for several variables, including pre-surgical BMI.")</data>
      <data key="d6">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GCK&quot;" target="&quot;MODY&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The GCK gene plays a role in MODY and is associated with diabetes through genetic variants.")</data>
      <data key="d6">chunk-658df2fc2f9361a65ff1d22464744763</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SANGER SEQUENCING&quot;" target="&quot;DIAGNOSTIC METHOD FOR GCK&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Sanger sequencing serves as a diagnostic tool to test for GCK variants involved in MODY.")</data>
      <data key="d6">chunk-658df2fc2f9361a65ff1d22464744763</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SANGER SEQUENCING&quot;" target="&quot;CONFIRMATION OF MUTATION&quot;">
      <data key="d4">20.0</data>
      <data key="d5">"Sanger sequencing confirmed the presence of the mutation in the fibroblast cultures from each sibling.")</data>
      <data key="d6">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MODY GENE PANEL&quot;" target="&quot;COMPLEMENTING DIAGNOSTIC TOOL&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"A MODY gene panel includes Sanger sequencing and is used alongside other tools to diagnose MODY through testing for genetic variants.")</data>
      <data key="d6">chunk-658df2fc2f9361a65ff1d22464744763</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;UNIVERSITY OF CHICAGO&quot;" target="&quot;PROVIDER OF TESTING&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Testing conducted at the University of Chicago contributes significantly (72%) to the dataset of probands with GCK variants, indicating its importance in genetic research and healthcare.")</data>
      <data key="d6">chunk-658df2fc2f9361a65ff1d22464744763</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CLINICAL INFORMATION&quot;" target="&quot;DATA SET FOR ANALYSIS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"A subset of probands with GCK variants has clinical information available for analysis, providing insights into the manifestation of MODY.")</data>
      <data key="d6">chunk-658df2fc2f9361a65ff1d22464744763</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NOVEL VARIANT&quot;" target="&quot;3754C&gt;A&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The variant was found through subsequent capillary sequencing and implies heteroplasmy.")</data>
      <data key="d6">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PATHOGENICITY CLASSIFICATION&quot;" target="&quot;CRITERIA FOR VARIANT EVALUATION&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"ACMG guidelines are used to classify variants as pathogenic or likely pathogenic based on their impact on the GCK gene and its associated conditions.")</data>
      <data key="d6">chunk-658df2fc2f9361a65ff1d22464744763</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;VUS (VARIANT OF UNCERTAIN SIGNIFICANCE)&quot;" target="&quot;CLASSIFICATION CRITERIA&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"VUS are not clearly classified as pathogenic due to lack of evidence for their impact or segregation with the disease, requiring further research.")</data>
      <data key="d6">chunk-658df2fc2f9361a65ff1d22464744763</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DE NOVO MUTATION&quot;" target="&quot;GENETIC EVENT&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Certain variants identified in probands might arise spontaneously (de novo), especially those without family history like p.Leu307Phe, impacting classification and understanding of genetic inheritance patterns.")</data>
      <data key="d6">chunk-658df2fc2f9361a65ff1d22464744763</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TARGETED SEQUENCING&quot;" target="&quot;DIAGNOSTIC METHOD FOR VARIANTS&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Targeted sequencing enables detection of specific variants in probands' DNA that might be missed with whole-genome approaches; crucial for identifying new or rare variants like p.Leu307Phe.")</data>
      <data key="d6">chunk-658df2fc2f9361a65ff1d22464744763</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PATERNITY TESTING&quot;" target="&quot;GENETIC ANALYSIS FOR PARENTAL VERIFICATION&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"In cases where genetic data is ambiguous, paternity testing can provide definitive answers on the origin of certain variants; it was not performed in this scenario affecting variant classification.")</data>
      <data key="d6">chunk-658df2fc2f9361a65ff1d22464744763</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CO-SEGREGATION WITH DIABETES PHENOTYPE&quot;" target="&quot;GENETIC ANALYSIS&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Segregation analysis establishes co-segregation between tested probands' DNA and diabetes phenotype, highlighting genetic linkage in MODY cases.")</data>
      <data key="d6">chunk-658df2fc2f9361a65ff1d22464744763</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MD ADHERENCE&quot;" target="&quot;TAG CONCENTRATIONS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"A higher adherence to the Mediterranean diet was observed to be significantly associated with lower TAG concentrations.")</data>
      <data key="d6">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MD ADHERENCE&quot;" target="&quot;APOB:APOA-1 RATIO&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Increased MD adherence was related to a lower apoB:apoA-1 ratio, which is an indicator of reduced cardiovascular risk.")</data>
      <data key="d6">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MD ADHERENCE&quot;" target="&quot;HDL-C&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Adherence to the Mediterranean diet was associated with higher HDL cholesterol levels, suggesting better lipid metabolism.")</data>
      <data key="d6">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MD ADHERENCE&quot;" target="&quot;APOA-1&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Increased adherence to the Mediterranean diet led to an increase in apoA-I protein concentration, which is a component of HDL and is involved in lipid transport.")</data>
      <data key="d6">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MD ADHERENCE&quot;" target="&quot;HBA1C&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"An increased level of adherence to the MD was associated with lower HbA1c levels, indicating better blood glucose control.")</data>
      <data key="d6">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MD ADHERENCE&quot;" target="&quot;LDL-C&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The Mediterranean diet adherence was inversely related to LDL cholesterol concentrations; people adhering more closely had lower LDL levels.")</data>
      <data key="d6">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MD ADHERENCE&quot;" target="&quot;APOB&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Adherence to the Mediterranean diet showed an inverse association with apolipoprotein B concentration, potentially indicating reduced risk for cardiovascular disease.")</data>
      <data key="d6">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MD ADHERENCE&quot;" target="&quot;HYPERTRIACYLGLYCEROLAEMIA&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Lower MD adherence was inversely related to the risk of hypertriacylglycerolaemia.")</data>
      <data key="d6">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MEDITERRANEAN DIET&quot;" target="&quot;COLON 18:2 N-6 CONCENTRATION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The Mediterranean diet resulted in a non-significant change in colon fatty acid composition compared to baseline, specifically with regards to the concentration of 18:2 n-6 fatty acids.")</data>
      <data key="d6">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MEDITERRANEAN DIET&quot;" target="&quot;SERUM INSULIN LEVELS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The Mediterranean diet showed a non-significant impact on serum insulin levels after the intervention period compared to baseline and other diets.")</data>
      <data key="d6">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MEDITERRANEAN DIET&quot;" target="&quot;SERUM LDL LEVELS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The Mediterranean diet led to a decrease in serum low-density lipoprotein (LDL) cholesterol levels after the intervention period, indicating potential cardiovascular benefits from the dietary changes.")</data>
      <data key="d6">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HBA1C&quot;" target="&quot;APOC1&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The association between APOC1 and HbA1C levels suggests a possible pleiotropic effect on metabolic traits.")</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOTYPE AND MEDITERRANEAN DIET ADHERENCE&quot;" target="&quot;METABOLIC PARAMETERS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The joint effect of specific genotypes (AA, GA, GG) with different levels of Mediterranean diet adherence influenced various metabolic markers like TAG, TC, apoB, and HbA1c.")</data>
      <data key="d6">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SUBGROUP ANALYSIS&quot;" target="&quot;OUTCOME VARIABLES&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"An analysis that examines how outcomes such as lipid profiles or glucose control vary across subgroups defined by age, activity level, or smoking status.")</data>
      <data key="d6">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SUBGROUP ANALYSIS&quot;" target="&quot;RS231775 AND RS231725&quot;">
      <data key="d4">0.5</data>
      <data key="d5">"Both polymorphisms showed significant association with PBC susceptibility for both Asians and Caucasians in subgroup analyses.")</data>
      <data key="d6">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SMOKING STATUS&quot;" target="&quot;TAG LEVELS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"There could be a difference in TAG levels based on smoking status, potentially influenced by genotypes.")</data>
      <data key="d6">chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SMOKING STATUS&quot;" target="&quot;GENE–DIET INTERACTION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Smoking status may modify the effect of certain diets on health outcomes based on individual genetics.")</data>
      <data key="d6">chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SMOKING STATUS&quot;" target="&quot;CORTISOL LEVELS&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Smoking might influence cortisol levels independently or in conjunction with other factors like alcohol consumption.")</data>
      <data key="d6">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENE–DIET INTERACTION&quot;" target="&quot;GENOTYPE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Genetic variations can influence how dietary choices impact health outcomes.")</data>
      <data key="d6">chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CHI&quot;" target="&quot;SEX RATIO&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"There were 47 males and 18 females diagnosed with CHI.")</data>
      <data key="d6">chunk-f921f48a406901d82ec2e32af99485bf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GLUD1 GENE&quot;" target="&quot;HI&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Mutations in the GLUD1 gene were associated with patients experiencing HI (Hypoglycaemia Induced by Gluconeogenesis Dysfunction).")</data>
      <data key="d6">chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HI&quot;" target="&quot;P.ARG322 HIS MUTATION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The p.Arg322 His mutation was found among patients presenting symptoms of HI.")</data>
      <data key="d6">chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HI&quot;" target="&quot;P.SER498LEU MUTATION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The p.Ser498Leu mutation contributed to the risk of developing HI in one patient.")</data>
      <data key="d6">chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HA&quot;" target="&quot;P.ASN463ASP MUTATION&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"This mutation was associated with patients experiencing HA (Hyperammonaemia).")</data>
      <data key="d6">chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIAZOXIDE-UNRESPONSIVE&quot;" target="&quot;CLINICAL SYMPTOM&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Group 1 patients, which made up 92.3% of the neonatal form, showed no response to diazoxide treatment.")</data>
      <data key="d6">chunk-f921f48a406901d82ec2e32af99485bf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIAZOXIDE-RESPONSIVE&quot;" target="&quot;SYMPTOM INCIDENCE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Group 2 patients displayed a higher incidence of epilepsy compared with Group 1.")</data>
      <data key="d6">chunk-f921f48a406901d82ec2e32af99485bf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HYPOGLYCEMIA&quot;" target="&quot;SYMPTOM PRESENTATION&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Symptoms included hypoglycemia and hypoglycaemic brain injury with global developmental delay.")</data>
      <data key="d6">chunk-f921f48a406901d82ec2e32af99485bf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIAZOXIDE TREATMENT&quot;" target="&quot;HI/HA SYNDROME&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Diazoxide treatment for HI/HA syndrome had side effects, including hypertrichosis.")</data>
      <data key="d6">chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIAZOXIDE-UNRESPONSIVE PATIENTS&quot;" target="&quot;THERAPY OUTCOME&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Patients with no response to diazoxide treatment required further interventions like insulin therapy or surgery.")</data>
      <data key="d6">chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CARDIOVASCULAR DISEASE RISK&quot;" target="&quot;GENETIC VARIANT IN NOS1 GENE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"A specific genetic variant in the NOS1 gene has been linked to an increased risk of developing cardiovascular disease.")</data>
      <data key="d6">chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIETARY PATTERNS&quot;" target="&quot;FOLATE INTAKE AND NITRIC OXIDE SYNTHESIS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Dietary patterns influence folate intake, which plays a role in the nitric oxide synthesis pathway affecting cardiovascular health.")</data>
      <data key="d6">chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIETARY PATTERNS&quot;" target="&quot;CARDIOVASCULAR HEALTH&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Dietary factors can impact cardiovascular health through various molecular interactions.")</data>
      <data key="d6">chunk-f05ecc979eea31a1ab844c2c7de12432</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIETARY PATTERNS&quot;" target="&quot;GENETIC INFLUENCE&quot;">
      <data key="d4">13.0</data>
      <data key="d5">"Dietary choices can interact with genetic factors to impact health outcomes.")&lt;SEP&gt;"Dietary factors can interact with genetic factors to impact health outcomes.")</data>
      <data key="d6">chunk-f05ecc979eea31a1ab844c2c7de12432</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CARDIOVASCULAR HEALTH MODULATION&quot;" target="&quot;ENVIRONMENTAL FACTORS&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Environmental factors such as diet and physical activity modulate cardiovascular health through their effects on the NOS1 gene and folate metabolism.")</data>
      <data key="d6">chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ENVIRONMENTAL FACTORS&quot;" target="&quot;LIFESTYLE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Lifestyle is an environmental factor that can potentially alter the impact of other environmental conditions on AMD risk through its influence on complement pathway genes.")</data>
      <data key="d6">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;KBS&quot;" target="&quot;ACAC&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Levels of AcAc increased significantly in the highest quintile of Matsuda ISI up to 29%.")</data>
      <data key="d6">chunk-f2e122f964bade37f487049bd69a3f9f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;KBS&quot;" target="&quot;BHB&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Levels of BHB also increased significantly in the highest quintile of Matsuda ISI up to 41%, respectively.")</data>
      <data key="d6">chunk-f2e122f964bade37f487049bd69a3f9f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;KBS&quot;" target="&quot;INSULIN SENSITIVITY&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"In a multivariate linear regression model including insulin sensitivity and insulin secretion as independent variables, insulin sensitivity remained inversely associated with AcAc levels and BHB levels.")</data>
      <data key="d6">chunk-f2e122f964bade37f487049bd69a3f9f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;KBS&quot;" target="&quot;DIABETES MELLITUS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"In individuals with diabetes mellitus, specific ketone body (KB) levels like AcAc and BHB may indicate metabolic changes and increase risk factors for hyperglycemia.")</data>
      <data key="d6">chunk-f2e122f964bade37f487049bd69a3f9f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ACAC&quot;" target="&quot;GLP-1&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Changes in AcAc (acetoacetate) level may also influence GLP-1 secretion through their impact on metabolic pathways related to glucose homeostasis.")</data>
      <data key="d6">chunk-f2e122f964bade37f487049bd69a3f9f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ACAC&quot;" target="&quot;RS780094&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The C allele of rs780094 showed a nominally significant association (P = 0.003) with AcAc levels.")</data>
      <data key="d6">chunk-bc2193bd869a06007022e1aa75877336</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BHB&quot;" target="&quot;SGLT2&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Alterations in BHB (beta-hydroxybutyrate) levels might affect SGLT2's function, impacting glucose reabsorption and blood sugar control.")</data>
      <data key="d6">chunk-f2e122f964bade37f487049bd69a3f9f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BHB&quot;" target="&quot;RS780094&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The glucose-increasing C allele of rs780094 was associated with a significant increase of BHB levels.")</data>
      <data key="d6">chunk-bc2193bd869a06007022e1aa75877336</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INSULIN AUC&quot;" target="&quot;METABOLISM&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Area under the curve (AUC) of insulin represents total insulin response over time, reflecting metabolic processes involved in glucose regulation.")</data>
      <data key="d6">chunk-f2e122f964bade37f487049bd69a3f9f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GLP-1&quot;" target="&quot;INSULIN SECRETION RATE&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The rate of insulin secretion might be influenced by GLP-1 levels through their mutual impact on glucose homeostasis and metabolic pathways.")</data>
      <data key="d6">chunk-f2e122f964bade37f487049bd69a3f9f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INSULIN RESISTANCE&quot;" target="&quot;MATSUDA INDEX&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Changes in the Matsuda index could suggest alterations in insulin sensitivity and insulin resistance, impacting diabetes risk assessment.")</data>
      <data key="d6">chunk-f2e122f964bade37f487049bd69a3f9f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INSULIN RESISTANCE&quot;" target="&quot;TYPE 2 DIABETES&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The block of SNPs are associated with insulin resistance leading to type 2 diabetes.")</data>
      <data key="d6">chunk-938d8bf2e56584de9dd556be5eb70964</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS780094&quot;" target="&quot;ACAC LEVELS&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"The glucose-increasing C allele showed a nominally significant association (P = 0.003) with AcAc levels.")</data>
      <data key="d6">chunk-bc2193bd869a06007022e1aa75877336</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FADS1&quot;" target="&quot;KB LEVELS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"SNPs from the FADS1 gene were associated with KB levels, though not in a statistically significant manner.")</data>
      <data key="d6">chunk-bc2193bd869a06007022e1aa75877336</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ANK1&quot;" target="&quot;KB LEVELS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"SNPs from the ANK1 gene showed an association with KB levels that was nominally significant.")</data>
      <data key="d6">chunk-bc2193bd869a06007022e1aa75877336</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GIPR&quot;" target="&quot;KB LEVELS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The GIPR gene was associated with KB levels, though not in a statistically significant manner.")</data>
      <data key="d6">chunk-bc2193bd869a06007022e1aa75877336</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HMGA2&quot;" target="&quot;KB LEVELS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The HMGA2 gene showed an association with KB levels that was nominally significant.")</data>
      <data key="d6">chunk-bc2193bd869a06007022e1aa75877336</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HMGA2&quot;" target="&quot;RS1351394&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"SNP rs1351394 shows strong evidence of association with both 'Age at first tooth' and 'Number of teeth', linking height with tooth eruption and number.")</data>
      <data key="d6">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SLC2A2&quot;" target="&quot;KB LEVELS&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"SNPs from the SLC2A2 gene had a nominally significant association with KB levels.")</data>
      <data key="d6">chunk-bc2193bd869a06007022e1aa75877336</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GCKR&quot;" target="&quot;RS1260326&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"SNP rs1260326 near GCKR gene affects CRP levels, and its association with CRP is robust even after adjustment for multiple testing"&gt;)</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GCKR&quot;" target="&quot;BLOOD GLUCOSE&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"The GCKR gene influences blood glucose levels, which can affect the risk of developing kidney disease through metabolic stress.")</data>
      <data key="d6">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GLUCOSE AUC&quot;" target="&quot;CPT1A EXPRESSION&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Adipose tissue mRNA expression of the CPT1A gene was positively correlated with glucose AUC, showing its role in fatty acid oxidation and insulin sensitivity.")</data>
      <data key="d6">chunk-bc2193bd869a06007022e1aa75877336</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INSULIN SENSITIVITY&quot;" target="&quot;BDH1 AND OXCT1 EXPRESSION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The expression of BDH1 and OXCT1 genes were positively correlated with insulin sensitivity (Matsuda ISI), highlighting their roles in metabolic processes.")</data>
      <data key="d6">chunk-bc2193bd869a06007022e1aa75877336</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BHB LEVELS&quot;" target="&quot;GCKR C ALLELE&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The glucose-increasing C allele of rs780094 was associated with an increase of 5.6% in BHB levels per the C allele, after adjusting for age and BMI.")</data>
      <data key="d6">chunk-bc2193bd869a06007022e1aa75877336</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CPT1A EXPRESSION&quot;" target="&quot;GLUCOSE AUC AND INSULIN SENSITIVITY&quot;">
      <data key="d4">13.0</data>
      <data key="d5">"The expression of the CPT1A gene was negatively correlated with glucose AUC but positively related to Matsuda ISI, suggesting roles in fatty acid oxidation and insulin sensitivity respectively.")</data>
      <data key="d6">chunk-bc2193bd869a06007022e1aa75877336</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BDH1 AND OXCT1 EXPRESSION&quot;" target="&quot;MATSUDA ISI&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"The BDH1 and OXCT1 genes had positive correlations with Matsuda ISI, reflecting their roles in ketolysis and insulin sensitivity respectively.")</data>
      <data key="d6">chunk-bc2193bd869a06007022e1aa75877336</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ACAT1 EXPRESSION&quot;" target="&quot;GLUCOSE AUC AND INSULIN SECRETION&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"The ACAT1 gene encoded acetyl-CoA acetyltransferase 1, which showed significant correlations with glucose AUC, Matsuda ISI and insulin secretion indicating its involvement in ketolysis.")</data>
      <data key="d6">chunk-bc2193bd869a06007022e1aa75877336</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GLUCOSE AUC AND INSULIN SENSITIVITY&quot;" target="&quot;ACSS2 EXPRESSION&quot;">
      <data key="d4">14.0</data>
      <data key="d5">"The ACSS2 gene showed an inverse correlation with glucose AUC but a positive relationship with Matsuda ISI, pointing to its role in adipose tissue metabolism.")</data>
      <data key="d6">chunk-bc2193bd869a06007022e1aa75877336</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNPS&quot;" target="&quot;INCREASED SOCIAL DISINHIBITION SCORE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Three SNPs' minor alleles led to an increase in the social disinhibition score, while three others had protective effects against it.")</data>
      <data key="d6">chunk-36d70bb8409856300dd77669e7c1f9ed</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNPS&quot;" target="&quot;CD&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The T-cell functionality and response were influenced by SNPs in PTPN2 and PTPN22.")</data>
      <data key="d6">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;APOC1&quot;" target="&quot;CRP&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"SNP APOC1 is associated with CRP levels in the context of its role in triglyceride metabolism"&gt;)</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HNF1A&quot;" target="&quot;CRP&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"SNP rs1183910 near HNF1A gene influences CRP levels through pathways related to bile acid metabolism and inflammation"&gt;)</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL6R&quot;" target="&quot;CRP&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Interleukin-6 receptor (IL6R) pathway could modulate CRP production or clearance, potentially influencing inflammation markers like CRP"&gt;)</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PABPC4&quot;" target="&quot;TRIGLYCERIDES&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"SNP PABPC4 may influence triglyceride levels via its effect on lipid metabolism.")</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PABPC4&quot;" target="&quot;RS4660293&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"SNP rs4660293 near PABPC4 gene influences triglyceride levels via its impact on lipid metabolism"&gt;)</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BCL7B&quot;" target="&quot;HDL-CHOLESTEROL&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"BCL7B's association with HDL cholesterol could be through its role in lipid metabolism.")</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BCL7B&quot;" target="&quot;MEDIATED PLEIOTROPY&quot;/&quot;MEDIATION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The effect of BCL7B on certain cardiometabolic phenotypes may be mediated through BMI"&gt;)</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BCL7B&quot;" target="&quot;LIPIDS/">
      <data key="d4">1.0</data>
      <data key="d5">mediation"/"Mediation"</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TMEM18&quot;" target="&quot;CRP/">
      <data key="d4">1.0</data>
      <data key="d5">mediated pleiotropy"/"Mediation"</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CAD&quot;" target="&quot;RS1183910&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"SNP rs1183910 in the HNF1A gene is associated with CAD.")</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CAD&quot;" target="&quot;RS20417&quot;">
      <data key="d4">0.034</data>
      <data key="d5">"rs20417 is significantly associated with explaining a part of the heterogeneity for CAD.")</data>
      <data key="d6">chunk-734cac289b42d37dad32bd51ea24a1ea</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CAD&quot;" target="&quot;RS1126643&quot;">
      <data key="d4">0.012</data>
      <data key="d5">"rs1126643 contributes as a significant source of heterogeneity in relation to CAD.")</data>
      <data key="d6">chunk-734cac289b42d37dad32bd51ea24a1ea</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS6734238&quot;" target="&quot;TOTAL CHOLESTEROL&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"SNP rs6734238 near IL1F10 and other interleukin 1 family genes affects total cholesterol levels.")</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T2D&quot;" target="&quot;RS4420638&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"SNP rs4420638 near the APOC1 gene influences T2D risk.")</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T2D&quot;" target="&quot;RS10399931&quot;">
      <data key="d4">0.25</data>
      <data key="d5">"After adjusting for age, sex, BMI, and glucose tolerance, there was no association between rs10399931 and T2D.")</data>
      <data key="d6">chunk-44a871da300abc9be525b468f502f5cb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T2D&quot;" target="&quot;RS4950928&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"After adjustment for age, sex, BMI, and glucose tolerance, none of the other tgSNPs were associated with T2D or IFG or IGT except rs12123883 for borderline protective effect.")</data>
      <data key="d6">chunk-44a871da300abc9be525b468f502f5cb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T2D&quot;" target="&quot;CHI3LI HAPLOTYPE BLOCKS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The two identified haplotype blocks of CHI3LI did not show any association with T2D.")</data>
      <data key="d6">chunk-44a871da300abc9be525b468f502f5cb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T2D&quot;" target="&quot;KIDNEY FUNCTION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Type 2 Diabetes impacts kidney function through mechanisms such as diabetic nephropathy, influencing eGFR.")</data>
      <data key="d6">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CARDIOMETABOLIC SNPS&quot;" target="&quot;SNPS IN CRP GWAS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The association p-values for 283 cardiometabolic SNPs and serum CRP from a GWAS are evaluated.")</data>
      <data key="d6">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CRP GWAS SNPS&quot;" target="&quot;SNPS WITH DIFFERENT EFFECT DIRECTIONS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Some SNPs showed opposite effects on CRP levels and cardiometabolic phenotypes compared to observations in observational data.")</data>
      <data key="d6">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CRP GWAS SNPS&quot;" target="&quot;GENOMIC LD&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The lead SNPs of the 12 pleiotropic loci were mostly in high linkage disequilibrium (LD) with those found in CRP GWAS.")</data>
      <data key="d6">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PLEIOTROPIC LOCI&quot;" target="&quot;SNPS IN CRP GWAS AND CARDIOMETABOLIC GWAS&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"In some loci the lead SNPs from CRP and cardiometabolic GWAS were different but were in high LD.")</data>
      <data key="d6">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TRIGLYCERIDES&quot;" target="&quot;APOA5-ZNF259&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Intronic and 3′UTR variants in the APOA5-ZNF259 region are related to triglyceride levels.")</data>
      <data key="d6">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS4660293&quot;" target="&quot;MEDIATED PLEIOTROPY&quot;/&quot;MEDIATION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"SNP rs4660293 near PABPC4 may influence triglyceride levels through mediation by BMI"&gt;)</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LIPIDS/" target="&quot;BCL7B&quot;/&quot;FTO&quot;/&quot;TMEM18&quot;">
      <data key="d4">1.0</data>
      <data key="d5">mediated pleiotropy"/"Mediation"</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CRP/" target="&quot;PLTP&quot;/&quot;MC4R&quot;">
      <data key="d4">1.0</data>
      <data key="d5">mediation"/"Mediation"</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COL4A1&quot;" target="&quot;WEIGHT Z-SCORE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"rs1056513 variant is associated with the change in body weight z-score.")</data>
      <data key="d6">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PCSK2&quot;" target="&quot;TOTAL ANTIOXIDANTS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"An intronic variant of PCSK2 was associated with total antioxidant content.")</data>
      <data key="d6">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GCH1&quot;" target="&quot;DOPAMINE: CREATININE RATIO&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"A nonsynonymous SNP (S143T) in GCH1 was associated with the dopamine: creatinine ratio.")</data>
      <data key="d6">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;KLKB1&quot;" target="&quot;SERUM FREE IGF-1&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"rs3733402 variant is linked to serum free insulin-like growth factor 1 (IGF-1).")</data>
      <data key="d6">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MPRIP&quot;" target="&quot;SERUM IGFBP-3&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"An intronic SNP in MPRIP correlated with serum IGFBP-3 levels.")</data>
      <data key="d6">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;XPA/FOXE1 (TTF-2)&quot;" target="&quot;SERUM TSH&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"A block of SNPs associated with high serum TSH levels was found near the XPA/FOXE1 gene on chromosome 9.")</data>
      <data key="d6">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DARC&quot;" target="&quot;MCP-1&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"SNPs in DARC are related to MCP-1 (Monocyte Chemoattractant Protein-1).")</data>
      <data key="d6">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CCR3&quot;" target="&quot;MCP1&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"A variant in the 3′UTR region of CCR3 correlated with MCP-1.")</data>
      <data key="d6">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ABO&quot;" target="&quot;IL-6&quot;">
      <data key="d4">13.0</data>
      <data key="d5">"Variants near ABO were significantly related to IL-6 (interleukin-6).")</data>
      <data key="d6">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TMEM229B&quot;" target="&quot;ENERGY INTAKE&quot;">
      <data key="d4">14.0</data>
      <data key="d5">"An intronic variant in TMEM229B on chromosome 14 was associated with ad libitum energy intake at dinner.")</data>
      <data key="d6">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ARHGAP11A&quot;" target="&quot;SLEEP DURATION&quot;">
      <data key="d4">15.0</data>
      <data key="d5">"rs1056513 variant is linked to sleep duration.")</data>
      <data key="d6">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;C21ORF34&quot;" target="&quot;RESPIRATORY QUOTIENT DURING SLEEP&quot;">
      <data key="d4">16.0</data>
      <data key="d5">"Intronic variants in C21orf34 were associated with RQ (respiratory quotient) levels during sleep.")</data>
      <data key="d6">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;5′UTR REGION OF RPL7P3&quot;" target="&quot;TOTAL ENERGY EXPENDITURE&quot;">
      <data key="d4">15.0</data>
      <data key="d5">"The 5′UTR region variant of RPL7P3 influences total energy expenditure.")</data>
      <data key="d6">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;3′UTR OF CTCFL&quot;" target="&quot;SEDENTARY-LIGHT ACTIVITY DURING SLEEP&quot;">
      <data key="d4">16.0</data>
      <data key="d5">"Variants in the 3′UTR of CTCFL impact sedentary-light activity measured by an accelerometer.")</data>
      <data key="d6">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BODY WEIGHT&quot;" target="&quot;HFD&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The high-fat diet significantly increased body weight in both wild-type (Ctrl) and Senp1 knock-out (SENP1-aP2KO) mice.")</data>
      <data key="d6">chunk-174831b97ed170039b374ba254d4f506</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SLEEPING ENERGY EXPENDITURE&quot;" target="&quot;CHRNA3 GENE ON CHROMOSOME 15&quot;">
      <data key="d4">18.0</data>
      <data key="d5">"A significant variant for sleeping energy expenditure was found in the CHRNA3 gene on chromosome 15.")</data>
      <data key="d6">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SLEEPING ENERGY EXPENDITURE&quot;" target="&quot;INFLUENCED BY GENETICS AND ENVIRONMENT&quot;">
      <data key="d4">21.0</data>
      <data key="d5">"Sleeping energy expenditure is impacted by both genetic factors and environmental considerations.")</data>
      <data key="d6">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TOTAL ENERGY EXPENDITURE&quot;" target="&quot;VARIANT IN 5′UTR REGION OF RPL7P3&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"A variant identified for total energy expenditure was found in the 5′UTR region of RPL7P3.")</data>
      <data key="d6">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TOTAL ENERGY EXPENDITURE&quot;" target="&quot;MATK GENE ON CHROMOSOME 19&quot;">
      <data key="d4">17.0</data>
      <data key="d5">"The variant associated with total energy expenditure is located within the MATK gene on chromosome 19.")</data>
      <data key="d6">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TOTAL ENERGY EXPENDITURE&quot;" target="&quot;AFFECTED BY GENETICS, ENVIRONMENT, LIFESTYLE&quot;">
      <data key="d4">22.0</data>
      <data key="d5">"Total energy expenditure is influenced by genetic makeup, environmental conditions, and lifestyle choices.")</data>
      <data key="d6">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EXCRETIONS&quot;" target="&quot;RNASE1, ASS1P11&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Variants in the flanking 3′UTR regions of RNASE1 and ASS1P11 were related to nitrogen excretion and creatinine excretion.")</data>
      <data key="d6">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-6&quot;" target="&quot;IL-1Β&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"A particularly prominent elevation in IL-1β production was apparent in IL-10RαMdelRag1−/− compared with Rag1−/− LPMϕs (mRNA expression ratio: 7.5±1.2).")</data>
      <data key="d6">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-6&quot;" target="&quot;TH17 CELL&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"IL-6 supports Th17 cell formation and plays a role in exacerbating colitis depending on the recipient's genetics (Rag1−/− vs IL-10RαMdelRag1−/−).")&lt;SEP&gt;"Increased production of IL-1 and IL-6 by LPMφs can directly influence Th17 cell maturation; this impact was more pronounced in IL-10RαMdelRag1−/−-derived LPMφs.")</data>
      <data key="d6">chunk-35d8a4ea86cb92d18ee1c857a318d2d8&lt;SEP&gt;chunk-b971aa450a9b220806bdc000eb5efaad</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-6&quot;" target="&quot;INNATE IMMUNE SYSTEM&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"IL-6 interacts with various components of the innate immune system to modulate inflammation and promote survival responses.")</data>
      <data key="d6">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-6&quot;" target="&quot;AUTOIMMUNITY&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Increased levels of IL-6 are associated with several autoimmune diseases, including colitis, due to its role in pro-inflammatory responses.")</data>
      <data key="d6">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RESPIRATORY QUOTIENT (RQ)&quot; DURING SLEEP" target="&quot;SNP IN C21ORF34&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"A SNP in the intronic region of C21orf34 detected RQ for respiratory quotient (RQ) during sleep.")</data>
      <data key="d6">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ACCELEROMETER-MEASURED LIGHT ACTIVITY&quot;" target="&quot;SEDENTARY-LIGHT ACTIVITY IN 3′UTR OF CTCFL&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"Sedentary-light activity, measured by accelerometer, was detected in the 3′UTR region of CTCFL.")</data>
      <data key="d6">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HIGHLY SIGNIFICANT&quot;" target="&quot;VARIANT ON CHROMOSOME 19 FOR TOTAL ENERGY EXPENDITURE&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"A variant identified with highly significance for total energy expenditure is located on chromosome 19.")</data>
      <data key="d6">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HIGHLY SIGNIFICANT VARIANT FOR SLEEPING ENERGY EXPENDITURE&quot;" target="&quot;ON CHROMOSOME 15&quot;">
      <data key="d4">13.0</data>
      <data key="d5">"A highly significant variant for sleeping energy expenditure was found on chromosome 15.")</data>
      <data key="d6">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ADJUSTMENT FOR BODY WEIGHT&quot;" target="&quot;IDENTIFICATION OF GENETIC VARIANTS&quot;">
      <data key="d4">19.0</data>
      <data key="d5">"Body weight adjustment is crucial when identifying specific genetic variants related to energy expenditure.")</data>
      <data key="d6">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ACCELEROMETER USE&quot;" target="&quot;MEASUREMENT OF LIGHT ACTIVITY DURING SLEEP&quot;">
      <data key="d4">20.0</data>
      <data key="d5">"An accelerometer was used in measuring light activity, influencing the identification of genetic variants for different activities during sleep.")</data>
      <data key="d6">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS151233&quot;" target="&quot;APOBR GENE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Variants rs74949322, 151233 and others were found in the study sample.")</data>
      <data key="d6">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS151233&quot;" target="&quot;SULT1A1 GENE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"A synonymous variant was found within the SULT1A1 gene, having no impact on its function.")</data>
      <data key="d6">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS149271&quot;" target="&quot;SULT1A1 GENE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"This variant resulted in a glutamic acid change at position 170, but it was synonymous and had no functional effect.")</data>
      <data key="d6">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS180744&quot;" target="&quot;SULT1A1 GENE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The variant led to an arginine change at position 553, being another synonymous variant with no functional impact.")</data>
      <data key="d6">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS61738759&quot;" target="&quot;SULT1A1 GENE&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The variant resulted in a proline change at position 1012, which was synonymous and carried no functional consequences.")</data>
      <data key="d6">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS40833&quot;" target="&quot;SULT1A1 GENE&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"This variant led to the creation of new transcription factor binding sites splicing enhancer and silencer binding sites, altering its function.")</data>
      <data key="d6">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS180743&quot;" target="&quot;APOBR GENE DELETION VARIANT&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Both variants were carried by the individual hetero- or homozygously, due to their high LD relationship.")</data>
      <data key="d6">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS180743&quot;" target="&quot;RS368546180&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Variants rs180743 and rs368546180 are in high LD, leading to their co-occurrence.")</data>
      <data key="d6">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS180743&quot;" target="&quot;RS3833080&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"High linkage disequilibrium between the variant (rs2008514) and both rs180743 and rs3833080 results in their co-carrying.")</data>
      <data key="d6">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS368546180&quot;" target="&quot;APOBR GENE DELETION VARIANT&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The deletion variant was identified once heterozygously in an obese individual, while the other variant did not exhibit this pattern.")</data>
      <data key="d6">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS151174&quot;" target="&quot;SULT1A1 GENE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"This variant resulted in a glycine change at position 560, which was also a synonymous variant without any functional effect.")</data>
      <data key="d6">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS40831&quot;" target="&quot;SULT1A1 GENE&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The variant led to an alanine change at position 686, but it had no impact on the function due to being synonymous.")</data>
      <data key="d6">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS142786317: C.*118_*119DELCA&quot;" target="&quot;S1 TABLE&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"All five variants in TUFM are predicted to lead to altered splicing regulator or transcription factor binding sites.")&lt;SEP&gt;"In silico analysis is used to show that this variant changes transcription factor binding sites, including splicing enhancer and silencer binding sites.")</data>
      <data key="d6">chunk-607feda7df4db8151b99560074c91eea</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS142786317: C.*118_*119DELCA&quot;" target="&quot;TABLE 2&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"In silico analyses predict functional effects on SNPs, with one being described as 'non-neutral' or 'deleterious' for rs10797300: p.Pro19Leu.")&lt;SEP&gt;"The analyses provide insights into possible functional impacts of SNPs, including 'non-neutral' or 'deleterious' predictions for some.")</data>
      <data key="d6">chunk-607feda7df4db8151b99560074c91eea</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS142786317: C.*118_*119DELCA&quot;" target="&quot;TABLE 3&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"In silico predictions show no association between this variant and obesity.")</data>
      <data key="d6">chunk-607feda7df4db8151b99560074c91eea</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS142786317: C.*118_*119DELCA&quot;" target="&quot;TUFM&quot;">
      <data key="d4">17.0</data>
      <data key="d5">"This genomic variant influences aspects of gene TUFM's functionality or expression based on the provided data.")&lt;SEP&gt;"This genomic variant is found in the 3' untranslated region of TUFM.")</data>
      <data key="d6">chunk-607feda7df4db8151b99560074c91eea</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS142786317: C.*118_*119DELCA&quot;" target="&quot;RS8061877: C.248−18G&gt;A&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"These two variants are non-coding intronic variants within TUFM.")</data>
      <data key="d6">chunk-607feda7df4db8151b99560074c91eea</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS142786317: C.*118_*119DELCA&quot;" target="&quot;G.28854194C/G&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"This variant is an unknown variant located in the 3' untranslated region of TUFM.")</data>
      <data key="d6">chunk-607feda7df4db8151b99560074c91eea</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS142786317: C.*118_*119DELCA&quot;" target="&quot;TDT&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"There is no association found between this variant and obesity in the trios tested using TDT analysis.")</data>
      <data key="d6">chunk-607feda7df4db8151b99560074c91eea</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS142786317: C.*118_*119DELCA&quot;" target="&quot;POLYPHEN 2&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Functional predictions for SNPs are given, including 'probably damaging' for certain polymorphisms.")</data>
      <data key="d6">chunk-607feda7df4db8151b99560074c91eea</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS142786317: C.*118_*119DELCA&quot;" target="&quot;SNAP&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"In silico prediction tools like SNAP interpret the variant as having a 'non-neutral' effect.")</data>
      <data key="d6">chunk-607feda7df4db8151b99560074c91eea</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS142786317: C.*118_*119DELCA&quot;" target="&quot;SIFT&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"Some in silico tools classify the variant as being 'deleterious', indicating potential harmful effects.")</data>
      <data key="d6">chunk-607feda7df4db8151b99560074c91eea</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS142786317: C.*118_*119DELCA&quot;" target="&quot;TABLE 2 AND S1 TABLE&quot;">
      <data key="d4">14.0</data>
      <data key="d5">"There is a consistent pattern across different analytical tools pointing towards potential functional impacts of the variant in TUFM.")</data>
      <data key="d6">chunk-607feda7df4db8151b99560074c91eea</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS142786317: C.*118_*119DELCA&quot;" target="&quot;TABLE 3 AND S1 TABLE&quot;">
      <data key="d4">15.0</data>
      <data key="d5">"Across different analytical data sets, predictions indicate lack of association between this variant and obesity traits.")</data>
      <data key="d6">chunk-607feda7df4db8151b99560074c91eea</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS142786317: C.*118_*119DELCA&quot;" target="&quot;GWAS&quot;">
      <data key="d4">17.0</data>
      <data key="d5">"A genome-wide association study (GWAS) identified this variant as potentially linked to certain diseases or traits.")</data>
      <data key="d6">chunk-607feda7df4db8151b99560074c91eea</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS142786317: C.*118_*119DELCA&quot;" target="&quot;LD SCORE&quot;">
      <data key="d4">18.0</data>
      <data key="d5">"The linkage disequilibrium (LD) score analysis indicates that this variant has predictive power in genetic associations, based on its correlation with other SNPs.")</data>
      <data key="d6">chunk-607feda7df4db8151b99560074c91eea</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS142786317: C.*118_*119DELCA&quot;" target="&quot;GENE ONTOLOGY (GO) TERMS&quot;">
      <data key="d4">19.0</data>
      <data key="d5">"The GO analysis reveals functional roles and biological pathways associated with this variant, providing insights into its potential impact on cellular processes.")</data>
      <data key="d6">chunk-607feda7df4db8151b99560074c91eea</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS142786317: C.*118_*119DELCA&quot;" target="&quot;PHENOTYPE ASSOCIATION STUDIES&quot;">
      <data key="d4">20.0</data>
      <data key="d5">"This variant has been associated with various phenotypic traits in association studies, contributing to our understanding of its functional effects.")</data>
      <data key="d6">chunk-607feda7df4db8151b99560074c91eea</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS142786317: C.*118_*119DELCA&quot;" target="&quot;CLINICAL SIGNIFICANCE ASSESSMENT&quot;">
      <data key="d4">21.0</data>
      <data key="d5">"An assessment of the clinical significance indicates that this variant could have implications for medical conditions, requiring further investigation into its pathogenicity.")</data>
      <data key="d6">chunk-607feda7df4db8151b99560074c91eea</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TUFM&quot;" target="&quot;GENOMIC VARIANTS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Variants found in TUFM lead to changes in splicing processes related to alterations in transcription factor binding sites.")</data>
      <data key="d6">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS8061877&quot;" target="&quot;TRANSCRIPTION FACTOR BINDING SITE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Disruption of a potential transcription factor binding site by rs8061877 affects various factors like SRY, HFH 2, and HMG-IY.")</data>
      <data key="d6">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;G.28854194C/G&quot;" target="&quot;SPLICE ENHANCER/SPLICE SILENCER BINDING SITES&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Predicted changes in splice enhancer binding sites and splicing silencer sites for this variant by three programs.")</data>
      <data key="d6">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;G.28854194C/G&quot;" target="&quot;NON-CODING 3’ UTR&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The variant g.28854194C/G is situated in the non-coding 3’ UTR of TUFM, but it still affects splicing processes.")</data>
      <data key="d6">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;APOBR GENE DELETION VARIANT&quot;" target="&quot;RS3833080&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The deletion variant is located near rs3833080, which is in high LD with this variant.")</data>
      <data key="d6">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GWAS&quot;" target="&quot;IDENTIFIED SNPS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Genetic polymorphisms associated with coffee consumption were identified through a GWAS.")</data>
      <data key="d6">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANTS&quot;" target="&quot;LIFESTYLE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Lifestyle may have differing effects depending on the presence or absence of certain genomic variants.")</data>
      <data key="d6">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL1B RS7596684&quot;" target="&quot;SNP ASSOCIATION&quot;">
      <data key="d4">0.02</data>
      <data key="d5">"This SNP in the IL1B gene showed association with ovarian cancer risk, though it was not as strong as some other findings.")</data>
      <data key="d6">chunk-089bcdf055eb2f007db49dbe2409429b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL1B RS7596684&quot;" target="&quot;OVARIAN CANCER RISK&quot;">
      <data key="d4">0.02</data>
      <data key="d5">"SNP rs7596684 in the IL1B gene shows a suggestive association with ovarian cancer risk.")</data>
      <data key="d6">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PTGS1 RS2282169&quot;" target="&quot;METABOLIC PATHWAY&quot;">
      <data key="d4">0.347</data>
      <data key="d5">"The odds of ovarian cancer were marginally increased when considering this SNP, potentially related to metabolic pathways involved.")</data>
      <data key="d6">chunk-089bcdf055eb2f007db49dbe2409429b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PTGS1 RS2282169&quot;" target="&quot;SNP EFFECT ON RISK&quot;">
      <data key="d4">0.04</data>
      <data key="d5">"The odds of developing ovarian cancer were slightly elevated by this SNP, but the effect size was small and inconsistent.")</data>
      <data key="d6">chunk-089bcdf055eb2f007db49dbe2409429b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PTGS1 RS2282169&quot;" target="&quot;OVARIAN CANCER RISK&quot;">
      <data key="d4">0.04</data>
      <data key="d5">"SNP rs2282169 in the PTGS1 gene suggests an association with ovarian cancer risk.")</data>
      <data key="d6">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS7596684&quot;" target="&quot;OVARIAN CANCER RISK&quot;">
      <data key="d4">0.02</data>
      <data key="d5">"SNP rs7596684 in IL1B gene was associated with increased ovarian cancer risk.")</data>
      <data key="d6">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS2282169&quot;" target="&quot;OVARIAN CANCER RISK&quot;">
      <data key="d4">0.04</data>
      <data key="d5">"SNP rs2282169 in PTGS1 gene suggests a possible link to ovarian cancer.")</data>
      <data key="d6">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALOX5 RS1864414&quot;" target="&quot;PHYSIOLOGICAL PROCESS&quot;">
      <data key="d4">0.002</data>
      <data key="d5">"This intronic SNP was associated with reduced ovarian cancer risk, as part of the ALOX5 gene's function.")</data>
      <data key="d6">chunk-089bcdf055eb2f007db49dbe2409429b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PHYSIOLOGICAL PROCESS&quot;" target="&quot;IL-6RΑ GENE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The IL-6Rα gene's response modulates a specific physiological process affecting only Rag1−/− colitis model, highlighting its role in disease management.")</data>
      <data key="d6">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PHYSIOLOGICAL PROCESS&quot;" target="&quot;INFANTS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Endogenous choline synthesis reduced due to the rs12325817 variant in 21.6% of infants")</data>
      <data key="d6">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PHYSIOLOGICAL PROCESS&quot;" target="&quot;METABOLIC PATHWAY&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Alterations in metabolic pathways related to fatty acid metabolism in adipose tissue are influenced by SENP1 expression and SUMOylation status, impacting insulin sensitivity and glucose homeostasis." )</data>
      <data key="d6">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PHYSIOLOGICAL PROCESS&quot;" target="&quot;FAAP20-UBZ DOMAIN&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"The UBZ domain is vital for physiological processes such as recruitment to sites of DNA damage, highlighting its role in cellular maintenance and repair.")</data>
      <data key="d6">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;METABOLIC PATHWAY&quot;" target="&quot;INFANTS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The impact on outcomes based on differences in the choline and placebo groups considering maternal status and genetic variants.")</data>
      <data key="d6">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;METABOLIC PATHWAY&quot;" target="&quot;SERUM C4 (BA SYNTHESIS CORRELATION)&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"A significant correlation between serum C4 and BA synthesis indicated that changes in this inflammatory marker could influence bile acid metabolic pathways or associated health outcomes.")</data>
      <data key="d6">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;METABOLIC PATHWAY&quot;" target="&quot;UBZ-DOMAIN&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The UBZ domain of FAAP20 is involved in a metabolic pathway related to the interaction with ubiquitin (Ub), crucial for cell repair mechanisms.")</data>
      <data key="d6">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;METABOLIC PATHWAY&quot;" target="&quot;GLYCOLYSIS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Alterations in glycolysis pathways can influence cellular energy production, impacting various physiological functions.")</data>
      <data key="d6">chunk-41c7131af28e2a745ef6b88b8601860f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALOX5 RS745986&quot;" target="&quot;INTRAGENIC SNPS&quot;">
      <data key="d4">0.01</data>
      <data key="d5">"A correlated SNP in the ALOX5 gene was also found to be associated with ovarian cancer risk, but its impact was less significant than that of rs1864414.")</data>
      <data key="d6">chunk-089bcdf055eb2f007db49dbe2409429b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNP ASSOCIATION&quot;" target="&quot;ASTHMA EXCLUSION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Excluding individuals with asthma led to increased evidence for association at some loci, suggesting that disease status may influence genetic associations.")</data>
      <data key="d6">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RELATIONSHIP DESCRIPTION&quot;" target="&quot;SNP RS3918186 IN NOS3 GENE AND CHILDHOOD ALL RISK&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"SNP 'rs3918186' in the NOS3 gene was linked with an increased risk of childhood ALL, as indicated by a Bayes factor greater than 1.")</data>
      <data key="d6">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RELATIONSHIP DESCRIPTION&quot;" target="&quot;SNP RS1051266 IN SLC19A1 GENE AND CHILDHOOD ALL RISK&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"SNP 'rs1051266' in the SLC19A1 gene showed evidence of association with childhood ALL, albeit less strength than NOS3 rs3918186.")</data>
      <data key="d6">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COLON FATTY ACID CONCENTRATIONS&quot;" target="&quot;DIET ARM&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"After dietary intervention, the Mediterranean group showed an increase in MUFA and n-3 PUFA consumption while experiencing a decrease in 18:2 n-6 concentration.")</data>
      <data key="d6">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOTYPE GROUP&quot;" target="&quot;SERUM 20:4, N-6 CONCENTRATION&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The association between genotypes and serum fatty acid levels was significant for omega-6 fatty acids (20:4), with minor allele carriers showing a lower concentration.")&lt;SEP&gt;"The presence of any minor alleles in the FADS gene cluster is significantly associated with a lower serum 20:4, n-6 concentration.")</data>
      <data key="d6">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOTYPE GROUP&quot;" target="&quot;SERUM 18:3, N-3 CONCENTRATION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Mean serum 18:3, n-3 concentration for minor allele carriers were estimated to be 21% higher than those with all major alleles.")</data>
      <data key="d6">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOTYPE GROUP&quot;" target="&quot;COLONIC 20:4, N-6 CONCENTRATION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The presence of any minor alleles had a marginally significant association with the colonic 20:4, n-6 concentration (p = 0.07).")</data>
      <data key="d6">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOTYPE GROUP&quot;" target="&quot;FATTY ACID CONCENTRATIONS AT BASELINE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The presence of any minor alleles significantly affected the serum fatty acid concentrations (20:4, n-6; 18:3, n-3) and marginally affected colonic 20:4, n-6 concentration.")</data>
      <data key="d6">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOTYPE GROUP&quot;" target="&quot;COLON INSULIN CONCENTRATION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"No significant effects of genotypes on colon insulin concentrations were observed, indicating the influence of diet rather than genetics in this aspect.")</data>
      <data key="d6">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOTYPE GROUP&quot;" target="&quot;DIETARY INTERVENTION RESPONSE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Carriers of minor alleles responded differently to dietary interventions compared to those with all major alleles, in terms of changes in serum fatty acid concentrations.")</data>
      <data key="d6">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOTYPE GROUP&quot;" target="&quot;SERUM TRIGLYCERIDE LEVELS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"No significant differences in response to genotypes were found for changes in serum triglyceride levels among the dietary intervention groups.")</data>
      <data key="d6">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIET ARM&quot;" target="&quot;SERUM FATTY ACID CONCENTRATIONS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Changes in dietary fat intake significantly impact serum fatty acid composition; reductions and increases were observed in both diet groups after intervention.")</data>
      <data key="d6">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIET ARM&quot;" target="&quot;SERUM FATTY ACID CONCENTRATIONS AFTER INTERVENTION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Both dietary intervention groups showed changes in serum fatty acid levels; the Healthy Eating group reduced SFA intake while increasing long chain n-3 PUFA, leading to a higher polyunsaturated fat: saturated fat ratio.")</data>
      <data key="d6">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIET ARM&quot;" target="&quot;COLON FATTY ACID CONCENTRATIONS AFTER INTERVENTION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The Mediterranean diet resulted in changes towards a healthier fatty acid profile with increased n-3 PUFA and decreased 18:2 n-6 concentration, compared to baseline.")</data>
      <data key="d6">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIET ARM&quot;" target="&quot;SERUM FATTY ACID CHANGES&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The dietary interventions led to significant changes in serum fatty acid concentrations; these changes were particularly notable between the two diet groups.")</data>
      <data key="d6">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIET ARM&quot;" target="&quot;COLON FATTY ACID CHANGES&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Both dietary interventions led to changes in colon fatty acid concentrations; the Mediterranean group showed a particular decrease in 18:2 n-6 concentration.")</data>
      <data key="d6">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIET ARM&quot;" target="&quot;SERUM GLUCOSE LEVELS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Both dietary interventions did not lead to significantly different serum glucose levels compared to baseline or between each other, suggesting that changes were minor or within normal variation.")</data>
      <data key="d6">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIET ARM&quot;" target="&quot;COLON POLYUNSATURATED: SATURATED RATIO&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"While both diet groups showed changes in colon fatty acid profiles after intervention, there was no significant difference between the Mediterranean and Healthy Eating diets regarding their polyunsaturated to saturated fat ratio.")</data>
      <data key="d6">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIET ARM&quot;" target="&quot;COLON 20:4, N-6 CONCENTRATION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"After the interventions, no diet group showed a significant effect on colon linoleic acid (20:4, n-6) concentration compared to baseline or each other.")</data>
      <data key="d6">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COLON MUFA CONCENTRATION&quot;" target="&quot;HEALTHY EATING DIET&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The Healthy Eating diet led to an increase in colon MUFA (monounsaturated fat) concentrations compared to baseline, indicating changes towards a healthier fatty acid profile.")</data>
      <data key="d6">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HEALTHY EATING DIET&quot;" target="&quot;COLON 18:3, N-3 CONCENTRATION&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The Healthy Eating diet led to an increase in colon docosahexaenoic acid (DHA; a type of omega-3 fatty acid, also represented as 20:5, n-3), indicating beneficial effects on DHA levels.")&lt;SEP&gt;"The Healthy Eating diet resulted in an increase in colon eicosapentaenoic acid (EPA; a type of omega-3 fatty acid, also represented as 20:5, n-6), indicating improved EPA levels after the intervention.")</data>
      <data key="d6">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIET ARM EFFECT&quot;" target="&quot;SUBJECT WITH NO MINOR ALLELES&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Mean colon AA concentrations were significantly lower in the Mediterranean arm compared to Healthy Eating by month 6.")</data>
      <data key="d6">chunk-e1b4f4dac52e806f19c580640a50c729</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIET ARM SPECIFICITY&quot;" target="&quot;OUTCOME DIFFERENCE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Mean colon AA concentrations at month 6 differed significantly based on diet arm allocation, specifically for subjects without minor alleles.")</data>
      <data key="d6">chunk-e1b4f4dac52e806f19c580640a50c729</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENETIC CORRELATION&quot;" target="&quot;SLEEP APNOEA - SELF-REPORTED SLEEP APNOEA&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Self-reported sleep apnoea has the highest genetic correlation with habitual snoring (rG = 0.78).")</data>
      <data key="d6">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENETIC CORRELATION&quot;" target="&quot;BMI&quot;, &quot;WHOLE-BODY FAT MASS&quot;, SODIUM IN URINE, MOOD SWINGS, CORONARY ARTERY DISEASE, ALCOHOL INTAKE FREQUENCY, PULSE RATE, CURRENT TOBACCO SMOKING, HEART DISEASE, LUNG CANCER, FEV1/FVC RATIO, NEUROTICISM, SUBJECTIVE WELLBEING, HEART RATE - &quot;TRAITS GENETICALLY CORRELATED TO SNORING&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Several traits with the strongest evidence of association were BMI, obesity indicators, sleep apnoea, mood disorders, cardiovascular diseases, lung function, and personality traits related to stress and emotional health.")</data>
      <data key="d6">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENETIC CORRELATION&quot;" target="&quot;SCHIZOPHRENIA&quot;, &quot;EDUCATIONAL ATTAINMENT&quot;, SODIUM IN URINE, DAYTIME DOZING, SLEEP APNOEA, EXCESSIVE DAYTIME SLEEPINESS - &quot;TRAITS GENETICALLY CORRELATED AFTER BMI ADJUSTMENT&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"After adjusting for BMI, traits like schizophrenia, educational attainment, and sleep-related conditions remained genetically correlated with snoring.")</data>
      <data key="d6">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;VDBP SNPS&quot;" target="&quot;MATERNAL VITAMIN D STATUS&quot;">
      <data key="d4">0.05</data>
      <data key="d5">"The polymorphisms in VDBP gene were associated with maternal vitamin D concentrations during delivery.")</data>
      <data key="d6">chunk-617cab4d8c10048a1335bf565693bf97</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MATERNAL VITAMIN D STATUS AT DELIVERY&quot; (≥75 NMOL/L VS. ≤75 NMOL/L)" target="&quot;VDBP GENOTYPES&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The vitamin D status during delivery was linked to various genotypes of the VDBP gene.")</data>
      <data key="d6">chunk-617cab4d8c10048a1335bf565693bf97</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MATERNAL VDBP GENOTYPES&quot;" target="&quot;NEONATAL VITAMIN D STATUS AT BIRTH&quot; (CUT-OFFS OF 25 AND 50 NMOL/L)">
      <data key="d4">1.0</data>
      <data key="d5">"Neonatal vitamin D levels were associated with maternal VDBP polymorphisms." )</data>
      <data key="d6">chunk-617cab4d8c10048a1335bf565693bf97</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MATERNAL VITAMIN D CONCENTRATION&quot;" target="&quot;VDBP POLYMORPHISMS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The genetic variants in VDBP correlated with maternal vitamin D levels during childbirth.")</data>
      <data key="d6">chunk-617cab4d8c10048a1335bf565693bf97</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;VDBP POLYMORPHISMS&quot;" target="&quot;NEONATAL CUT-OFFS&quot; (≥50 NMOL/L VS. ≤50 NMOL/L, ≥25 VS. ≤25 NMOL/L)">
      <data key="d4">1.0</data>
      <data key="d5">"Maternal 25(OH)D Cut-Offs at Birth"</data>
      <data key="d6">chunk-617cab4d8c10048a1335bf565693bf97</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MATERNAL VDBP POLYMORPHISMS&quot;" target="&quot;MATERNAL VITAMIN D CUT-OFFS&quot; (≤25 VS. ≥25 NMOL/L, ≤50 VS. ≥50 NMOL/L AND ≥75 NMOL/L VS. ≤75 NMOL/L)">
      <data key="d4">1.0</data>
      <data key="d5">"The cut-offs for maternal vitamin D were associated with specific genotypes of the VDBP gene.")</data>
      <data key="d6">chunk-617cab4d8c10048a1335bf565693bf97</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MATERNAL VDBP POLYMORPHISMS&quot;" target="&quot;NEONATAL VITAMIN D LEVELS&quot; AT BIRTH (CUT-OFFS OF 25 AND 50 NMOL/L)">
      <data key="d4">1.0</data>
      <data key="d5">"The neonatal vitamin D levels correlated with the maternal VDBP genotypes at birth.")</data>
      <data key="d6">chunk-617cab4d8c10048a1335bf565693bf97</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MATERNAL VITAMIN D CONCENTRATION DURING DELIVERY&quot;" target="&quot;VDBP SNPS&quot; (RS2298850 AND RS4588)">
      <data key="d4">1.0</data>
      <data key="d5">"The polymorphisms rs2298850 and rs4588 were associated with maternal vitamin D concentrations during childbirth.")</data>
      <data key="d6">chunk-617cab4d8c10048a1335bf565693bf97</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PCOS FEATURES&quot;" target="&quot;RS3025020 AND RS2010963 GENOTYPES&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The minor C allele of rs3025020 is associated with increased PCOS-related metabolic markers compared to the minor C allele of rs2010963.")</data>
      <data key="d6">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOTYPE GROUPS&quot;" target="&quot;CONDITION X TIME INTERACTION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The main effect of Genotype was found due to differences in behavior adjustment across reinforcement contingencies (Condition) and time.")</data>
      <data key="d6">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOTYPE GROUPS&quot;" target="&quot;NEUROPSYCHOLOGICAL TEST PERFORMANCE INTERACTION EFFECT&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"A significant interaction effect was found between genotype groups and neuropsychological test performance, indicating different cognitive profiles across genotypes.")</data>
      <data key="d6">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RESPONSE BIAS&quot;" target="&quot;MAIN EFFECT OF BLOCK&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Response bias showed a main effect for block, with higher bias in later blocks compared to earlier blocks during the study.")</data>
      <data key="d6">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RESPONSE BIAS&quot;" target="&quot;DISEASE RISK&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Increased response bias in val carriers relative to iso homozygotes suggests a potential link between specific genotypes and disease risk.")</data>
      <data key="d6">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RESPONSE BIAS&quot;" target="&quot;NEURAL ACTIVITY CORRELATION&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"There was a strong correlation between response bias and neural activity patterns in specific brain regions, as identified through functional MRI analysis.")</data>
      <data key="d6">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RESPONSE BIAS&quot;" target="&quot;COGNITIVE LOAD EFFECT&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The increase in response bias was moderated by the level of cognitive load, suggesting a threshold for overload conditions.")</data>
      <data key="d6">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RESPONSE BIAS&quot;" target="&quot;CONDITION X GENOTYPE INTERACTION&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Genetic variant (val allele) had an effect on response bias specifically under conditions of stress.")</data>
      <data key="d6">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RESPONSE BIAS&quot;" target="&quot;STRESS INDUCED RESPONSE BIAS REDUCTIONS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The val allele explained unique variance for reductions in stress-induced response bias after accounting for factors like discriminability and other genotypes.")</data>
      <data key="d6">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RESPONSE BIAS&quot;" target="&quot;NO-STRESS CONDITION&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Under non-stressed conditions, response bias tends to remain stable or follow baseline patterns.")</data>
      <data key="d6">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;VAL CARRIERS&quot;" target="&quot;MAIN EFFECT OF GENOTYPE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Val carriers exhibited significantly different response bias than iso homozygotes due to their genotype.")</data>
      <data key="d6">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;VAL CARRIERS&quot;" target="&quot;GENETIC RISK TO DISEASE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The presence of risk variant genes was correlated with enhanced response bias that may indicate heightened disease susceptibility.")</data>
      <data key="d6">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;VAL CARRIERS&quot;" target="&quot;STRESS CONDITION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Val carriers had more non-specific Skin Conductance Responses than iso homozygotes in stress condition.")</data>
      <data key="d6">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;REINFORCEMENT CONTINGENCIES&quot;" target="&quot;ADJUSTMENT OF BEHAVIOR&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Participants adapted behavior based on reinforcement contingencies during the study, demonstrating the influence of external stimuli on behavior adjustment.")</data>
      <data key="d6">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;REINFORCEMENT CONTINGENCIES&quot;" target="&quot;ADAPTIVE BEHAVIOR&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Participants' adaptive behavior improved over time in response to reinforcement contingencies, showing plasticity and learning capabilities.")</data>
      <data key="d6">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CAUCASIAN SUBJECTS&quot;" target="&quot;POPULATION STRATIFICATION INTERACTION EFFECT&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Analysis confirmed the main effect of genotype when considering only Caucasian subjects to avoid confounding due to population stratification.")</data>
      <data key="d6">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CAUCASIAN SUBJECTS&quot;" target="&quot;GENETIC INFLUENCE SPECIFICITY&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Analysis of specific genetic loci showed that their effects were more pronounced among Caucasian subjects than other ethnicities.")</data>
      <data key="d6">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BLOCK 3&quot;" target="&quot;ENVIRONMENTAL FACTOR INTERACTION&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Later blocks showed higher response bias compared to earlier blocks, indicating that environment or task complexity influenced behavior later in the study.")</data>
      <data key="d6">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;STAI SCORES&quot;" target="&quot;CONDITION EFFECT&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Main effects of condition and time on STAI scores emerged, with higher scores during stress conditions relative to no-stress conditions.")</data>
      <data key="d6">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;STAI SCORES&quot;" target="&quot;ANXIETY MODERATION FACTOR&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Anxiety levels influenced the magnitude of STAI scores, with high anxiety participants showing greater variability in their responses.")</data>
      <data key="d6">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COHEN'S D&quot;" target="&quot;EFFECT SIZE COMPARISON&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Cohen’s d was used to compare effect sizes between genotypes or different study variables, providing a measure of practical significance.")</data>
      <data key="d6">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COHEN'S D&quot;" target="&quot;SIGNIFICANCE BENCHMARK COMPARISON&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Cohen's d values were used to benchmark differences in mean scores across genotype groups, aiding in distinguishing true effects from random variation.")</data>
      <data key="d6">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CONDITION X TIME INTERACTION&quot;" target="&quot;STAI SCORE CHANGE&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"A significant interaction on STAI scores over time indicated that the stress condition influenced participants' self-report measures differently at various points during the study.")</data>
      <data key="d6">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CONDITION X TIME INTERACTION&quot;" target="&quot;TEMPORAL ANXIETY CHANGES&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Over time, the impact of stress conditions on STAI scores was more pronounced, indicating increased sensitivity to anxiety over longer periods.")</data>
      <data key="d6">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PANAS NA SCORES&quot;" target="&quot;AFFECT SCALE RESPONSE&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"Increased Negative Affect (NA) scores across conditions suggested heightened emotional responses to both stress and no-stress situations during the experiment.")</data>
      <data key="d6">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PANAS NA SCORES&quot;" target="&quot;GENETIC CONTRIBUTION TO EMOTION&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Differences in PANAS NA scores suggested that certain genotypes may predispose individuals to higher levels of negative affectivity.")</data>
      <data key="d6">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NON-SPECIFIC SC RESPONSES&quot;" target="&quot;STRESS RESPONSE RATE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"More skin conductance responses were observed in response to the stress condition compared to the no-stress condition, suggesting a higher physiological arousal during stress.")</data>
      <data key="d6">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CONDITION&quot;" target="&quot;DBA PATIENTS&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Subject group studied for differential gene expression patterns via qRT-PCR and microarray data verification.")</data>
      <data key="d6">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;STRESS CONDITION&quot;" target="&quot;DISCRIMINABILITY&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Elevated discriminability was observed in Blocks 3 and 2 compared to Block 1, but no significant differences were found between genotype groups across blocks.")</data>
      <data key="d6">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COHENS D = 1.22, P = .056&quot;" target="&quot;SHOCK INTENSITY, SKIN CONDUCTANCE RESPONSES&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"val carriers showed a lower response bias in stress condition compared to no-stress condition.")</data>
      <data key="d6">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CACNB2&quot;" target="&quot;RS1490384&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"SNP rs1490384 near C6orf173 is associated with 'Age at first tooth' and 'Number of teeth', linking height to earlier tooth eruption.")</data>
      <data key="d6">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RAD51L1&quot;" target="&quot;RS1570106&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"SNP rs1570106 in RAD51L1 shows association with both 'Age at first tooth' and 'Number of teeth', indicating link between height and tooth eruption.")</data>
      <data key="d6">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNPS IN HMGA2 AND BMP4&quot;" target="&quot;CONTRIBUTION TO AGE AT FIRST TOOTH SNP ASSOCIATIONS&quot;">
      <data key="d4">0.8</data>
      <data key="d5">"Variants in the HMGA2 and BMP4 genes contribute significantly to associations between 'Age at first tooth' SNPs and height.")</data>
      <data key="d6">chunk-c63d60b991cd7442f690dcc364af47dd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HEIGHT-ASSOCIATED SNPS&quot;" target="&quot;TOOTH ERUPTION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Several height-associated SNPs show strong evidence of association with tooth eruption in the expected direction (i.e., taller individuals have faster tooth eruption/more teeth).")</data>
      <data key="d6">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IGF2BP3&quot;" target="&quot;RS12534093&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"SNP rs12534093 has a positive effect on faster tooth eruption/more teeth linked to IGF2BP3 association.")</data>
      <data key="d6">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOME-WIDE SIGNIFICANT SNPS FOR AGE AT FIRST TOOTH AND NUMBER OF TEETH&quot;" target="&quot;HEIGHT AT 17 YEARS AND HEIGHT AT 31 YEARS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The allelic scores for 'Age at first tooth' and 'Number of teeth', derived from genome-wide significant SNPs, show moderate evidence of association with height.")</data>
      <data key="d6">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ASSOCIATION WITH HEIGHT&quot;" target="&quot;SNPS FOR AGE AT FIRST TOOTH&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"SNPs associated with 'Age at first tooth' show moderate evidence of association with height.")</data>
      <data key="d6">chunk-c63d60b991cd7442f690dcc364af47dd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PATHWAY ANALYSIS&quot;" target="&quot;SNP ASSOCIATION P-VALUE THRESHOLD OF 0.005&quot;">
      <data key="d4">0.9</data>
      <data key="d5">"This threshold provides the most significant over-representation of genes in pathways for 'age at first tooth' GWAS.")</data>
      <data key="d6">chunk-c63d60b991cd7442f690dcc364af47dd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-10RΑMDEL&quot;" target="&quot;DRUG/CHEMICAL INTERACTION&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Treatment with an anti-IL-10 receptor antibody influences pro-IL-1β expression by modulating signaling pathways in T cell responses and disease progression.")</data>
      <data key="d6">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LPMΦS&quot;" target="&quot;IL-10RΑMDELRAG1−/− MΦS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Increased formation of Th17 cells was observed when LPMφs were derived from IL-10RαMdelRag1−/− mice compared to those from Rag1−/− mice.")</data>
      <data key="d6">chunk-b971aa450a9b220806bdc000eb5efaad</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TH17 CELLS&quot;" target="&quot;IL-1Β&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Significantly increased percents and absolute numbers of CD4+IL-17A+ T cells were identified in IL-10RαMdel Rag1−/− compared with Rag1−/− colons.")</data>
      <data key="d6">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TH17 CELLS&quot;" target="&quot;IL-17&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Increased colonic infiltration by both Th1 and Th17 cells, and the Th17 response is required for disease development.")</data>
      <data key="d6">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TH17 CELLS&quot;" target="&quot;IFN-Γ&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"No differences in CD4+IFN-γ+ T cell quantities were evident.")</data>
      <data key="d6">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TH17 CELLS&quot;" target="&quot;IL-23&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"A particularly prominent elevation in IL-1β production was apparent...")</data>
      <data key="d6">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TH17 CELLS&quot;" target="&quot;INOS&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"For IL-1β, IL-6, IL-23p19, and iNOS, relative expression was compared in sorted colonic LPMϕs, DCs, neutrophils, and epithelial cells.")</data>
      <data key="d6">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MΦ (MACROPHAGES)&quot;" target="&quot;IL-10&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"IL-10 influences the function of Mφs and their responses to other stimuli like IL-6, impacting disease pathogenesis in Rag1−/− mice.")</data>
      <data key="d6">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-1Β&quot;" target="&quot;TH1 CELL&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"IL-1β plays an essential role in Th17 cell development during healthy steady-state conditions, but its importance is downplayed by IL-6Rα signaling suppression.")</data>
      <data key="d6">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-1Β&quot;" target="&quot;IL-1R&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Interleukin 1 beta (IL-1β) binds to the IL-1 receptor (IL-1R), activating pro-inflammatory responses that can exacerbate colitis, especially in the presence of elevated IL-1β expression.")</data>
      <data key="d6">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-1Β&quot;" target="&quot;REGULATORY T CELLS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"IL-1β has a dual role: it contributes to the activation of Th17 cells and potentially suppresses regulatory T cell function, influencing autoimmune diseases like colitis.")</data>
      <data key="d6">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-1Β&quot;" target="&quot;INNATE IMMUNE SYSTEM&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"IL-1β acts as a pro-inflammatory cytokine in the innate immune system, playing a critical role in conditions such as colitis through its impact on inflammation processes.")</data>
      <data key="d6">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-1Β&quot;" target="&quot;IL-10&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"IL-10 led to complete suppression of IL-1β maturation following treatment with it.")</data>
      <data key="d6">chunk-b971aa450a9b220806bdc000eb5efaad</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TH17 CELL&quot;" target="&quot;TH1 CELL&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"No significant differences were found between Th1 and Th17 cell percentages during T-cell transfer experiments, suggesting distinct roles in colitis development.")</data>
      <data key="d6">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TH17 CELL&quot;" target="&quot;IL-6RΑ&quot;">
      <data key="d4">14.0</data>
      <data key="d5">"IL-6Rα signaling supports but is not essential for Th17 formation; it influences the response of both IL-10RαMdelRag1−/− and Rag1−/− mice.")&lt;SEP&gt;"The presence and activity of IL-6 Receptor Alpha (IL-6Rα), a key factor for Th17 cell development, are demonstrated to influence disease progression in Rag1−/− mice.")</data>
      <data key="d6">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TH17 CELL&quot;" target="&quot;AUTOIMMUNITY&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Th17 cells contribute to autoimmunity through their pro-inflammatory cytokine production, particularly in conditions like colitis.")</data>
      <data key="d6">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TH17 CELL&quot;" target="&quot;MACROPHAGE (MΦ)&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Th17 cells interact with macrophages, leading to a cascade of events that can either exacerbate or mitigate inflammation in conditions like colitis.")</data>
      <data key="d6">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TH17 CELL&quot;" target="&quot;IL-10&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"IL-10 can act on LPMφs to directly suppress Th17 production, especially in the context of downregulated IL-1 and partially regulated IL-6 expression.")</data>
      <data key="d6">chunk-b971aa450a9b220806bdc000eb5efaad</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TH17 CELL&quot;" target="&quot;IL-1 SIGNALING&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Inhibition of IL-1 signaling led to a substantial reduction in Th17 cell development, highlighting its role in supporting Th17 production by LPMφs.")</data>
      <data key="d6">chunk-b971aa450a9b220806bdc000eb5efaad</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-6RΑ&quot;" target="&quot;MACROPHAGE (MΦ)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"In the presence of IL-6Rα signaling pathway, macrophages can be influenced to either promote or limit inflammation depending on the context.")</data>
      <data key="d6">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TH1 CELL&quot;" target="&quot;IL-10&quot;">
      <data key="d4">15.0</data>
      <data key="d5">"IL-10 modulates immune responses by inhibiting pro-inflammatory cytokines including IL-6, affecting Th1 cell functions and potentially impacting the development of colitis.")&lt;SEP&gt;"Interleukin 10 (IL-10) has the ability to modulate immune responses by reducing inflammation; it influences T cell responses, particularly Th1 cells, in the context of colitis development.")</data>
      <data key="d6">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TH1 CELL&quot;" target="&quot;REGULATORY T CELLS&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"The relationship between Th1 cells and regulatory T cells is crucial for balancing immune responses; an imbalance can lead to autoimmune diseases like colitis.")</data>
      <data key="d6">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-10&quot;" target="&quot;CASPASE-1&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Autocrine IL-10 normally restrains caspase-1 activation and this function was disrupted by blocking IL-10Rα Ab treatment in Rag1−/− Mϕs.")&lt;SEP&gt;"In the IL-10RαMdelRag1−/− Mϕs, IL-10 normally restrains caspase-1 activation through autocrine signaling; this was not affected by pre-treatment with anti-IL-10Rα Ab.")</data>
      <data key="d6">chunk-b971aa450a9b220806bdc000eb5efaad</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CASPASE-1&quot;" target="&quot;PATHWAY ACTIVATION&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Caspase-1 is activated through an inflammasome response to danger signals or stimulation by agents like LPS and ATP, leading to the processing of pro-inflammatory cytokines such as IL-1β.")</data>
      <data key="d6">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CASPASE-1&quot;" target="&quot;LPS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Lipopolysaccharide stimulation leads to an increase in the level of activated caspase-1.")</data>
      <data key="d6">chunk-b971aa450a9b220806bdc000eb5efaad</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CASPASE-1&quot;" target="&quot;ATP&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Stimulation by ATP also leads to an increase in the activation form of caspase-1.")</data>
      <data key="d6">chunk-b971aa450a9b220806bdc000eb5efaad</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CASPASE-1&quot;" target="&quot;RAG1−/− MΦS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Rag1−/− macrophages showed increased caspase cleavage upon LPS and ATP stimulation.")</data>
      <data key="d6">chunk-b971aa450a9b220806bdc000eb5efaad</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FLOW CYTOMETRY&quot;" target="&quot;DATA COLLECTION METHOD&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"The use of flow cytometry enables researchers to collect data on cell populations and protein expression levels like that of pro-IL-1β, aiding in understanding complex immune responses.")</data>
      <data key="d6">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;WESTERN ANALYSIS&quot;" target="&quot;PROTEIN DETECTION METHOD&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"Western analysis serves as a method for visualizing proteins by size after they have been labeled with an antibody. It is crucial for confirming cytokine production levels like IL-1β in response to different stimuli.")</data>
      <data key="d6">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LPS&quot;" target="&quot;SIGNALING PATHWAY ACTIVATION&quot;">
      <data key="d4">13.0</data>
      <data key="d5">"Exposure to LPS leads to activation of signaling pathways that impact pro-inflammatory responses and cytokine expression, such as those involved with IL-1β production during colitis.")</data>
      <data key="d6">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ATP&quot;" target="&quot;STIMULATION EFFECT&quot;">
      <data key="d4">14.0</data>
      <data key="d5">"The presence or release of ATP can stimulate cellular responses leading to inflammasome activation which impacts the expression levels of pro-inflammatory cytokines, like IL-1β, in inflammatory conditions such as colitis.")</data>
      <data key="d6">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ANTI-IL-10R ANTIBODY&quot;" target="&quot;PATHWAY DISRUPTION&quot;">
      <data key="d4">15.0</data>
      <data key="d5">"Antibodies that bind to and disrupt IL-10 receptor function can alter signaling pathways that affect pro-inflammatory cytokine production, including IL-1β levels in inflammatory contexts.")</data>
      <data key="d6">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ΑIL-6RΑ BLOCKING ANTIBODY&quot;" target="&quot;EFFECT ON TH17 FORMATION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Blocking the interaction with IL-6 receptor α (IL-6Rα), using specific antibodies, largely inhibited Th17 formation in cultures containing Rag1−/− derived LPMφs.")</data>
      <data key="d6">chunk-b971aa450a9b220806bdc000eb5efaad</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-6RΑ GENE&quot;" target="&quot;PATHWAY MODIFICATION&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The IL-6Rα gene's response is modified through interaction with genomic variants, impacting physiological processes that affect colitis models specifically in the Rag1−/− context.")</data>
      <data key="d6">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EXPERIMENTAL CONDITION&quot;" target="&quot;IL-6R−/− T CELLS TRANSFER&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The transfer of IL-6 receptor knockout (IL-6R−/−) T cells into mice showed modest effects on Th17 formation, suggesting the importance of functional IL-6R for this process.")</data>
      <data key="d6">chunk-b971aa450a9b220806bdc000eb5efaad</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CONSEQUENCE ON TH17 DEVELOPMENT&quot;" target="&quot;IL-6 SIGNALING INHIBITION&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Inhibition of IL-6 signaling pathways led to a significant reduction or complete suppression of Th17 cell development, emphasizing the role of IL-6 in this process.")</data>
      <data key="d6">chunk-b971aa450a9b220806bdc000eb5efaad</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DNA EXTRACTION METHOD&quot;" target="&quot;MICROBIAL COMPOSITION&quot;">
      <data key="d4">3.5</data>
      <data key="d5">"The DNA extraction method significantly influences microbiome variation based on stepwise distance-based redundancy analysis (R2adj=0.27) with a P-value adjustment of Padj=7×10−4.")</data>
      <data key="d6">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DNA EXTRACTION METHOD&quot;" target="&quot;RICHNESS VARIANCE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The DNA extraction method is a major factor contributing to richness variance, explaining 32.74% of the variation based on a variance component analysis.")</data>
      <data key="d6">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MICROBIAL COMPOSITION&quot;" target="&quot;COHORT ETHNICITY&quot;">
      <data key="d4">2.8</data>
      <data key="d5">"Ethnic background significantly contributes to heterogeneity in microbial composition, affecting alpha diversity and richness across different cohorts.")</data>
      <data key="d6">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MICROBIAL COMPOSITION&quot;" target="&quot;COHORT ETHNICITY AND TECHNIQUES USED&quot;">
      <data key="d4">2.6</data>
      <data key="d5">"Cohort ethnicity along with the techniques used (e.g., DNA extraction methods) contributes to heterogeneity in microbial composition.")</data>
      <data key="d6">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALPHA DIVERSITY METRICS&quot;" target="&quot;COHORT ETHNICITY AND TECHNIQUES USED&quot;">
      <data key="d4">2.6</data>
      <data key="d5">"Ethnic background and techniques used in studies affect alpha diversity metrics such as Shannon, Simpson, and inverse Simpson indices, contributing to heterogeneity among cohorts.")</data>
      <data key="d6">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LCT&quot;" target="&quot;DNA MODIFICATION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Increased DNA modification at specific CpG sites in the LCT gene correlates with decreased mRNA levels.")</data>
      <data key="d6">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LCT&quot;" target="&quot;MCM6&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The LCT gene and MCM6 share overlapping regions with differential DNA modifications that influence cell type-specific expression.")</data>
      <data key="d6">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS182549&quot;" target="&quot;AGE-GENOTYPE INTERACTION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The age-genotype interaction was significant in the GEM_v12 and GEM_ICHIP subcohorts, both comprising mostly European individuals.")</data>
      <data key="d6">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS182549&quot;" target="&quot;T2DM&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"rs182549 variant shows positive association with T2DM diagnosis.")</data>
      <data key="d6">chunk-938d8bf2e56584de9dd556be5eb70964</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS182549&quot;" target="&quot;FAMILY HISTORY OF T2DM&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"The rs182549 variant is associated with family history of T2DM (paternal, maternal and siblings).")</data>
      <data key="d6">chunk-938d8bf2e56584de9dd556be5eb70964</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS182549&quot;" target="&quot;GLYCEMIC VARIABILITY&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"The rs182549 variant shows association with 1,5-anhydroglucitol as an indicator for glycemic variability.")</data>
      <data key="d6">chunk-938d8bf2e56584de9dd556be5eb70964</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BIFIDOBACTERIUM&quot;" target="&quot;YOUNG VERSUS ADULT GROUP EFFECT&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"rs182549 genotype showed a higher abundance of the genus Bifidobacterium in the adult group, but not in the younger group.")</data>
      <data key="d6">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BIFIDOBACTERIUM&quot;" target="&quot;HIGH CHOLESTEROL&quot;">
      <data key="d4">16.0</data>
      <data key="d5">"Bifidobacterium abundance shows negative correlation with high cholesterol, even though this correlation wasn't significant after correction for multiple testing.")</data>
      <data key="d6">chunk-938d8bf2e56584de9dd556be5eb70964</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS4988235&quot;" target="&quot;DAIRY PRODUCTS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The rs4988235 genotype is associated with higher consumption of dairy products like milk and milk beverages.")</data>
      <data key="d6">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS4988235&quot;" target="&quot;MILK INTAKE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"With an additional LP (T) allele, there's a positive association between the rs4988235 genotype and increased milk intake.")</data>
      <data key="d6">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS4988235&quot;" target="&quot;DIETARY FACTORS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The rs4988235 genetic variant is related to dietary factors such as potato consumption, cereal products intake, fruits consumption, poultry eating habits, non-alcoholic beverage consumption, and wine drinking.")</data>
      <data key="d6">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS4988235&quot;" target="&quot;HDL CHOLESTEROL&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"A minor decrease in HDL cholesterol levels is associated with rs4988235 genotype after adjusting for other variables.")&lt;SEP&gt;"A statistically significant, albeit slight decrease in HDL cholesterol is associated with the rs4988235 genotype.")</data>
      <data key="d6">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS4988235&quot;" target="&quot;RISK OF DIABETES&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The rs4988235 genetic variant does not show a statistically significant link with developing diabetes and baseline HbA1c levels after adjusting for other factors.")</data>
      <data key="d6">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS4988235&quot;" target="&quot;DAIRY PRODUCT INTAKE (MILK, MILK BEVERAGES)&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"An additional LP allele correlates with increased consumption of milk and milk-based beverages.")</data>
      <data key="d6">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS4988235&quot;" target="&quot;DIABETES RISK FACTORS (DIETARY)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"An association exists between rs4988235 genotype and specific dietary patterns that could influence diabetes risk.")</data>
      <data key="d6">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS4988235&quot;" target="&quot;DIABETES RISK FACTORS (DIETARY PATTERNS)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"There is a notable association between rs4988235 and certain dietary habits that may impact the risk of developing diabetes.")</data>
      <data key="d6">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS4988235&quot;" target="&quot;MOLECULAR INTERACTION (DAIRY CONSUMPTION)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Through the influence of environmental factors, rs4988235 affects interactions with dairy intake, particularly milk and milk beverages.")</data>
      <data key="d6">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS4988235&quot;" target="&quot;NUTRIENT ASSOCIATIONS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"rs4988235 is associated with particular nutrient intake levels such as total fats from specific fatty acids (C15:0, C17:0), impacting physiological processes and health outcomes.")</data>
      <data key="d6">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS4988235&quot;" target="&quot;DIABETES RISK (MULTIVARIABLE ADJUSTMENT)&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"rs4988235 plays a role in diabetes risk when considering multiple environmental factors, as indicated by multivariate analysis results.")</data>
      <data key="d6">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS4988235&quot;" target="&quot;EDUCATIONAL ATTAINMENT&quot;">
      <data key="d4">0.03</data>
      <data key="d5">"In the Czech Republic, there is a weak association between rs4988235 genotype and educational attainment.")</data>
      <data key="d6">chunk-7a423a439657efc1126fb6a075919ea5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GEM_V24&quot;" target="&quot;ISRAELI ETHNICITY&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The lack of an LCT mbQTL effect was observed among individuals of Israeli ethnicity.")</data>
      <data key="d6">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FAMILY PEPTOCOCCACEAE&quot;" target="&quot;RS7574352&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"A genomic variant (rs7574352) is associated with family Peptococcaceae.")</data>
      <data key="d6">chunk-938d8bf2e56584de9dd556be5eb70964</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FAMILY PEPTOCOCCACEAE&quot;" target="&quot;CHROMOGRANIN A&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Stool levels of gut inflammation markers chromogranin A are negatively correlated with family Peptococcaceae.")</data>
      <data key="d6">chunk-938d8bf2e56584de9dd556be5eb70964</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FAMILY PEPTOCOCCACEAE&quot;" target="&quot;CALPROTECTIN&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Stool levels of the gut inflammation markers calprotectin are negatively correlated with family Peptococcaceae.")</data>
      <data key="d6">chunk-938d8bf2e56584de9dd556be5eb70964</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FAMILY PEPTOCOCCACEAE&quot;" target="&quot;ULCERATIVE COLITIS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Family Peptococcaceae is negatively associated with ulcerative colitis.")</data>
      <data key="d6">chunk-938d8bf2e56584de9dd556be5eb70964</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TYPE 2 DIABETES&quot;" target="&quot;DISEASE/">
      <data key="d4">4.0</data>
      <data key="d5">"Chronic disease characterized by high blood glucose levels, caused when the body fails to produce sufficient insulin or cannot use it effectively.")</data>
      <data key="d6">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS7574352&quot;" target="&quot;IRF1&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Located near IRF1 gene involved in insulin resistance and type 2 diabetes.")</data>
      <data key="d6">chunk-938d8bf2e56584de9dd556be5eb70964</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IRF1&quot;" target="&quot;GWAS SNPS&quot;">
      <data key="d4">15.0</data>
      <data key="d5">"The IRF1 gene was affected by GWAS SNPs that are associated with T1D and modulate its expression levels.")</data>
      <data key="d6">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IRF1&quot;" target="&quot;RS181206&quot;[G]">
      <data key="d4">5.0</data>
      <data key="d5">"The rs181206[G] allele results in lower transcript levels for IRF1 compared to the wild-type Leu119 variant.")</data>
      <data key="d6">chunk-1b40d071abac0ba432a9fb0096796f45</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LACTOSE INTOLERANCE&quot;" target="&quot;RS182549 (LCT)&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The variant rs182549 predisposes to lactose intolerance.")</data>
      <data key="d6">chunk-938d8bf2e56584de9dd556be5eb70964</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FISH INTAKE&quot;" target="&quot;NC_000019.9:G.49218060 (RS35866622)&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"The variant NC_000019.9:g.49218060 (rs35866622) is positively associated with fish intake.")</data>
      <data key="d6">chunk-938d8bf2e56584de9dd556be5eb70964</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CHOLELITHIASIS&quot;" target="&quot;NC_000019.9:G.49218060 (RS35866622)&quot;">
      <data key="d4">13.0</data>
      <data key="d5">"The secretor allele of the FUT1/FUT2 locus is negatively associated with cholelithiasis.")</data>
      <data key="d6">chunk-938d8bf2e56584de9dd556be5eb70964</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CROHN’S DISEASE&quot;" target="&quot;NC_000019.9:G.49218060 (RS35866622)&quot;">
      <data key="d4">14.0</data>
      <data key="d5">"The secretor allele of the FUT1/FUT2 locus shows negative association with Crohn's disease.")</data>
      <data key="d6">chunk-938d8bf2e56584de9dd556be5eb70964</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALCOHOL INTAKE FREQUENCY&quot;" target="&quot;NC_000019.9:G.49218060 (RS35866622)&quot;">
      <data key="d4">15.0</data>
      <data key="d5">"The secretor allele of the FUT1/FUT2 locus shows negative association with alcohol intake frequency.")</data>
      <data key="d6">chunk-938d8bf2e56584de9dd556be5eb70964</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;WAIST-TO-HIP RATIO&quot;" target="&quot;NC_000019.9:G.49218060 (RS35866622)&quot;">
      <data key="d4">17.0</data>
      <data key="d5">"The secretor allele of the FUT1/FUT2 locus shows negative association with waist-to-hip ratio.")</data>
      <data key="d6">chunk-938d8bf2e56584de9dd556be5eb70964</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALPHA DIVERSITY&quot;" target="&quot;SEQUENCING DEPTH AND DNA EXTRACTION METHODS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Differences in sequencing depth and DNA extraction methods are significant factors influencing alpha diversity metrics such as Shannon, Simpson, and inverse Simpson indices.")</data>
      <data key="d6">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SEQUENCING DEPTH AND DNA EXTRACTION METHODS&quot;" target="&quot;RICHNESS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Differences in sequencing depth and DNA extraction methods impact richness by influencing the microbial composition's diversity across various samples.")</data>
      <data key="d6">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COHORT HETEROGENEITY AND ALPHA DIVERSITY&quot;" target="&quot;CORRELATION&quot;">
      <data key="d4">2.5</data>
      <data key="d5">"There is a significant correlation between the heterogeneity across cohorts and alpha diversity metrics, indicating how different factors contribute to microbial richness and evenness.")</data>
      <data key="d6">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CORRELATION&quot;" target="&quot;DECREASE INCREASE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"A decrease in baseline HbF values correlated with an increase in delta HbF, indicating a potentially compensatory mechanism.")</data>
      <data key="d6">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CORRELATION&quot;" target="&quot;STOOL WEIGHT (SERUM C4)&quot;">
      <data key="d4">9.5</data>
      <data key="d5">"Spearman correlation coefficients indicated that serum C4 and stool weight were positively correlated indicating a relationship between these two parameters.")</data>
      <data key="d6">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CORRELATION&quot;" target="&quot;TOTAL STOOL BA (SERUM C4)&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"A significant Spearman correlation was found between serum C4 levels and total stool BA suggesting a possible link in the metabolism of bile acids.")</data>
      <data key="d6">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CORRELATION&quot;" target="&quot;BMI (SERUM C4)&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"Spearman correlation coefficients suggested that BMI correlated with higher levels of serum C4 indicating potential influence on metabolic processes related to bile acid synthesis or excretion.")</data>
      <data key="d6">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AGE AND ETHNICITY INTERACTION&quot;" target="&quot;MBBTL EFFECT&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"An age-genotype interaction on Bifidobacterium abundance was found, which was significant in multi-ethnic cohorts but not evident in the GEM_v24 cohort.")</data>
      <data key="d6">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;P&lt;0.05&quot;" target="&quot;RS182549 - BIFIDOBACTERIUM ABUNDANCE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The rs182549 genotype showed a significant SNP-age interaction on the level of Bifidobacterium abundance, with higher abundance observed in adults homozygous for the NC_000002.11:g.136616754CC variant.")</data>
      <data key="d6">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;P=0.01&quot;" target="&quot;RS182549 - MBQTL EFFECT HETEROGENEITY&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The residual heterogeneity for rs182549 was low after including quadratic and cubic terms of age in the model, indicating that the majority of variation has been explained.")</data>
      <data key="d6">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PEPTOCOCCACEAE&quot;*|&gt;&quot;GUT INFLAMMATION MARKERS&quot;" target="&quot;SNPS ASSOCIATED WITH PEPTOCOCCACEAE WERE NEGATIVELY CORRELATED WITH LEVELS OF GUT INFLAMMATION MARKERS LIKE CHROMOGRANIN A AND CALPROTECTIN, SUGGESTING LINKS TO GASTROINTESTINAL HEALTH.&quot;)">
      <data key="d4">1.0</data>
      <data key="d5">6)("entity"</data>
      <data key="d6">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DISEASES&quot;" target="&quot;MICROBIAL TAXA&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Results suggest potential protective effects of specific gut microbial taxa on autoimmune disorders such as ulcerative colitis and rheumatoid arthritis.")</data>
      <data key="d6">chunk-159d4c797dae6eb825c74067af703228</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DISEASES&quot;" target="&quot;LIFESTYLE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Lifestyle may have differing impacts on the development of AMD across different diseases and health states.")</data>
      <data key="d6">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIETARY FACTORS&quot;" target="&quot;DIABETES RISK FACTORS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"There are associations between certain dietary factors like potatoes, cereal products, fruits, poultry, non-alcoholic beverages and wine and diabetes risk when linked to the rs4988235 genotype.")</data>
      <data key="d6">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INFANTS&quot;" target="&quot;CRITERIA&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"8 infants met criteria for FAS and 2 for PFAS in the choline arm, compared with 5 who met criteria for FAS and 2 for PFAS in the placebo arm")</data>
      <data key="d6">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INFANTS&quot;" target="&quot;MATERNAL PEMT ALLELE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"21.6% of the infants carried rs12325817 variant of the enzyme PEMT, reducing endogenous choline synthesis")</data>
      <data key="d6">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INFANTS&quot;" target="&quot;MATERNAL DIETARY STATUS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"9.7% (3 choline-treated, 3 placebo) of the infants were born to mothers whose dietary choline intake was adequate.")</data>
      <data key="d6">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INFANTS&quot;" target="&quot;DISEASE MANAGEMENT APPROACH&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Significance tested for differences between treatment and placebo groups on outcomes relevant to FASD management")</data>
      <data key="d6">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ADEQUATE&quot;" target="&quot;CHOLINE INTAKE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"9.7% of infants were born to mothers whose dietary choline intake during pregnancy was adequate (450 mg/day)")</data>
      <data key="d6">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IFG&quot;" target="&quot;RS10399931&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"No associations were found between rs10399931 and impaired fasting glucose after adjusting for covariates.")</data>
      <data key="d6">chunk-44a871da300abc9be525b468f502f5cb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IGT&quot;" target="&quot;RS4950928&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"There was no evidence suggesting an association between rs4950928 and impaired glucose tolerance, although a borderline protective effect was observed for rs12123883.")</data>
      <data key="d6">chunk-44a871da300abc9be525b468f502f5cb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENETIC POLYMORPHISM&quot;" target="&quot;RS10886471 SNP&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The rs10886471 SNP shows a genetic polymorphism as indicated by the PIC values exceeding 0.5.")</data>
      <data key="d6">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENETIC POLYMORPHISM&quot;" target="&quot;TNF-A 238G&gt;A&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"CT and T alleles were more common in healthy control subjects than those affected by HNP.")</data>
      <data key="d6">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ENHANCERS OR REPRESSORS&quot;" target="&quot;INTRONIC (CA)N REPEATS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Intronic repeats could play roles in gene expression as enhancers or repressors based on studies.")</data>
      <data key="d6">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALLELIC FREQUENCIES&quot;" target="&quot;GENETIC VARIATION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The allelic frequencies of (CA)n repeat polymorphisms vary across different groups to assess disease risk.")</data>
      <data key="d6">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENETIC VARIATION&quot;" target="&quot;IL-1A -889C&gt;T&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The TT genotype of IL-1A was more frequent among patients with HNP compared to controls.")</data>
      <data key="d6">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NFG GROUP&quot;" target="&quot;REFERENCE POPULATION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"NFG group serves as a baseline/reference for comparison with other diabetes-related groups.")</data>
      <data key="d6">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIABETES PREDIAGNOSIS&quot;" target="&quot;IFG AND IGT GROUPS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Groups of individuals showing elevated blood glucose levels, potentially leading to prediabetes or Type 2 diabetes.")</data>
      <data key="d6">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIABETES DISEASE STATE&quot;" target="&quot;T2DM GROUP&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Group representing participants with diagnosed Type 2 diabetes mellitus.")</data>
      <data key="d6">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALLELE (CA)16&quot;" target="&quot;INCREASED RISK FACTOR&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The allele (CA)16 is associated with increased risk of prediabetes and T2DM based on the logistic regression analysis.")</data>
      <data key="d6">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;(CA)16&quot;" target="&quot;MULTIPLE ALLELE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Specific allele of a genetic variant that serves as a reference for comparison with other alleles.")</data>
      <data key="d6">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DISEASE GROUPS&quot;" target="&quot;IFG, IGT, T2DM&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Different disease stages or outcomes (Impaired Fasting Glucose, Impaired Glucose Tolerance, and Type 2 Diabetes Mellitus respectively), associated with the genetic variant and its alleles.")</data>
      <data key="d6">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ASSOCIATION WITH T2DM&quot;" target="&quot;GENOMIC VARIANT AND MULTIPLE ALLELES&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The specific genotypes (variants/alleles) are linked to an increased risk for developing Type 2 Diabetes Mellitus.")</data>
      <data key="d6">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SERUM SELENIUM CONCENTRATION&quot;" target="&quot;COLON CANCER RISK&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Serum selenium concentration showed no significant association with overall colorectal cancer risk but showed a positive relationship specifically with colon cancer risk.")</data>
      <data key="d6">chunk-d311ac0182b37003c75c0005b4337fa6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SERUM SELENIUM CONCENTRATION&quot;" target="&quot;PUBLICATION BIAS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"There was potential evidence for publication bias in funnel plots indicating higher number of small studies reporting inverse associations.")</data>
      <data key="d6">chunk-d311ac0182b37003c75c0005b4337fa6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SERUM SELENIUM CONCENTRATION&quot;" target="&quot;COLORECTAL ADENOMA RISK&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The protective association between selenium levels was stronger for colorectal adenomas than cancer.")</data>
      <data key="d6">chunk-d311ac0182b37003c75c0005b4337fa6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SERUM SELENIUM CONCENTRATION&quot;" target="&quot;CANCER RISK (ADENOMA VS. CANCER)&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The inverse association between selenium levels was stronger for adenomas compared to colorectal cancer.")</data>
      <data key="d6">chunk-d311ac0182b37003c75c0005b4337fa6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COLORECTAL TUMOR RISK&quot;" target="&quot;GENDER BASED ANALYSIS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Selenium showed a significant and inverse association with colorectal tumor risk specifically among men, but not significantly so among women.")</data>
      <data key="d6">chunk-d311ac0182b37003c75c0005b4337fa6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COLORECTAL CANCER RISK&quot;" target="&quot;GPX4 GENE SNP (RS8178974)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The SNP rs8178974 in the GPX4 gene was associated with colorectal cancer risk, specifically showing significance.")</data>
      <data key="d6">chunk-d311ac0182b37003c75c0005b4337fa6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PUBLICATION BIAS&quot;" target="&quot;EGGER'S REGRESSION AND BEGG'S FUNNEL PLOT&quot;">
      <data key="d4">1.2</data>
      <data key="d5">"No obvious publication bias was identified through these methods, suggesting the reliability of our results.")</data>
      <data key="d6">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIAGNOSIS TIMING&quot;" target="&quot;SERUM SELENIUM MEASUREMENT&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Results differed based on when (before or after) colorectal tumors were diagnosed; measurements taken post-diagnosis showed stronger associations.")</data>
      <data key="d6">chunk-d311ac0182b37003c75c0005b4337fa6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CARD9&quot;" target="&quot;RISK ALLELE (RS10781499)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The risk allele of CARD9 SNP influences the ability of gut microbiota to produce AHR agonists, affecting AHR signaling in IBD patients.")</data>
      <data key="d6">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TRYPTOPHAN METABOLISM&quot;" target="&quot;AHR ACTIVATION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"AHR activation is influenced by gut microbiota-mediated tryptophan metabolism, which is altered in IBD patients.")</data>
      <data key="d6">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AHR ACTIVATION&quot;" target="&quot;MICROBIAL METABOLITE PRODUCTION&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Increased production of certain microbial metabolites by gut bacteria can stimulate or inhibit AHR activation, impacting immune responses and inflammation.")</data>
      <data key="d6">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AHR&quot;" target="&quot;MICROBIOTA DERIVED AHR LIGANDS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Gut microbiota produces ligands that stimulate AHR signaling; reduction is observed in subjects with IBD.")</data>
      <data key="d6">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AUTOINFLAMMATION&quot;" target="&quot;ALTERATIONS IN TRYPTOPHAN METABOLISM&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Decreased tryptophan metabolites are associated with autoinflammatory conditions, impacting the balance of inflammation and immunological tolerance.")</data>
      <data key="d6">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NUTRIENT ABSORPTION&quot;" target="&quot;PREBIOTIC SUPPLEMENTATION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Prebiotics facilitate nutrient absorption including tryptophan, which impacts the synthesis of microbiota-derived metabolites affecting AHR signaling.")</data>
      <data key="d6">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALTERATION&quot;&lt;|&quot;ALTERED BACTERIAL MICROBIOTA COMPOSITION DURING COLITIS AFFECTS INFLAMMATORY RESPONSES AND HEALING PROCESSES.&quot;)(&quot;ENTITY&quot;" target="&quot;BACTERIAL MICROBIOTA&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Cytokine Storm"</data>
      <data key="d6">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CARD9 DEFICIENCY&quot;" target="&quot;GUT MICROBIOTA&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Card9 deficiency contributes to gut microbiota-induced susceptibility to colitis by disrupting IL-22 signaling and tryptophan metabolism.")</data>
      <data key="d6">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IBD&quot;" target="&quot;NOD2, ATG16L1, LRRK2 SNPS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Major IBD-associated SNPs do not significantly affect the ability of gut microbiota to produce AHR agonists.")</data>
      <data key="d6">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GUT HEALTH&quot;" target="&quot;PROBIOTICS TREATMENT&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Probiotics can improve gut health by modulating microbiota composition and supporting AHR pathway regulation.")</data>
      <data key="d6">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;Β2M&quot;" target="&quot;PREVALENT HYPERTENSION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"A positive association between baseline β2M concentration and prevalent hypertension risk was observed after adjusting for clinical covariates.")</data>
      <data key="d6">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;Β2M&quot;" target="&quot;NEW-ONSET HYPERTENSION&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Baseline β2M concentration was significantly associated with the development of new-onset hypertension in the study sample.")</data>
      <data key="d6">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GEE MODEL&quot;" target="&quot;LONGITUDINAL ANALYSES&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The GEE model was employed to analyze the relationship between baseline β2M and risk for new-onset hypertension during follow-up.")</data>
      <data key="d6">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIABETES&quot;" target="&quot;GENETIC MODIFICATION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Creating genetically modified mice with adipocyte-specific deletion of Senp1 resulted in diabetes development.")</data>
      <data key="d6">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIABETES&quot;" target="&quot;GENE EXPRESSION&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Diminished expression of Senp1 was associated with diabetes development.")&lt;SEP&gt;"The diabetes phenotype correlated with the alteration of Senp1 gene expression in adipocytes.")</data>
      <data key="d6">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIABETES&quot;" target="&quot;HORMONAL RESPONSE&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Low insulin levels were observed as part of the diabetes phenotype in Senp1-deficient mice.")</data>
      <data key="d6">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIABETES&quot;" target="&quot;ASSESSMENTS&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"The tests confirmed the diabetes phenotype and insulin resistance in Senp1-deficient mice.")</data>
      <data key="d6">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIABETES&quot;" target="&quot;HORMONAL FUNCTION&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"Reduced insulin secretion correlated with diabetes development in Senp1-deficient mice.")</data>
      <data key="d6">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIABETES&quot;" target="&quot;PHYSICAL CHARACTERISTICS&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"Lower body weight was a physical manifestation observed in the diabetic phenotype of Senp1-deficient mice.")</data>
      <data key="d6">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIABETES&quot;" target="&quot;METABOLIC CHANGES&quot;">
      <data key="d4">13.0</data>
      <data key="d5">"Alteration of cholesterol and triglyceride levels was observed as a metabolic change associated with diabetes development in Senp1-deficient mice.")</data>
      <data key="d6">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIABETES&quot;" target="&quot;BEHAVIORAL INDICATORS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Increased water consumption was a behavioral indicator observed in the diabetes phenotype of Senp1-deficient mice, possibly due to osmotic diuresis.")</data>
      <data key="d6">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIABETES&quot;" target="&quot;SENP1&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The SENP1 gene contributes to diabetes development in mice.")</data>
      <data key="d6">chunk-fc33d6399ec56e65d007269407f1953d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIABETES&quot;" target="&quot;NON-OBESE DIABETIC (NOD) MOUSE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"There is a correlation between SENP1 expression and diabetes in NOD mice.")</data>
      <data key="d6">chunk-8382a49b61215482f9fc75e3a86cb987</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIABETES&quot;" target="&quot;CORTISOL LEVELS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Diabetes could influence cortisol levels and the relationship with alcohol consumption based on different models analyzed.")</data>
      <data key="d6">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS3184504 POLYMORPHISM&quot;" target="&quot;SH2B3 EXPRESSION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The rs3184504 polymorphism affects SH2B3 expression, which in turn impacts β2M levels.")</data>
      <data key="d6">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SH2B3&quot;" target="&quot;REGULATION OF Β2M EXPRESSION&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"SH2B3 normally regulates β2M expression during hypertensive stimuli, as shown by the induction in Sh2b3−/− mice.")</data>
      <data key="d6">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;YEARS OF FORMAL EDUCATION&quot;" target="&quot;HISPANIC MOTHERS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Hispanic mothers had fewer years of formal education compared to non-Hispanic White mothers.")</data>
      <data key="d6">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;YEARS OF FORMAL EDUCATION&quot;" target="&quot;NON-HISPANIC WHITE MOTHERS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Non-Hispanic White mothers had a lower mean years of formal education compared to Hispanic mothers and non-Hispanic White mothers.")</data>
      <data key="d6">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOLIC ACID SUPPLEMENTS&quot;" target="&quot;CASE INFANTS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Case infants were more likely to be female than control infants and had different patterns in maternal periconceptional use of folic acid supplements compared to non-Hispanic White mothers.")</data>
      <data key="d6">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DAILY DIETARY INTAKE OF FOLATE&quot;" target="&quot;NUTRIENT INTAKE&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"There were differences in daily dietary intake of folate across subgroups, but the variations were subtle among different race/ethnicity groups.")</data>
      <data key="d6">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COMPOSITE FOLATE INTAKE VARIABLE&quot;" target="&quot;NUTRIENT INTAKE&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"The composite folate intake variable showed more substantial variation within and across race/ethnicity groups.")</data>
      <data key="d6">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AGE RANGE&quot;" target="&quot;MATERNAL AGE AT DELIVERY&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Maternal age at delivery was consistent across cases and controls within maternal race/ethnicity.")</data>
      <data key="d6">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HISPANIC INFANTS&quot;" target="&quot;NTD RATE&quot;">
      <data key="d4">18.0</data>
      <data key="d5">"Hispanic infants had a higher rate of Neural Tube Defects (NTDs) compared to non-Hispanic White infants.")</data>
      <data key="d6">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HISPANIC INFANTS WITH AG GENOTYPE IN MTHFD1 SNP RS12939757&quot;" target="&quot;SNP OUTCOMES&quot;">
      <data key="d4">20.0</data>
      <data key="d5">"Infants carrying the AG genotype displayed increased risks for NTDs when maternal folate intake was low, compared to GG genotype carriers.")</data>
      <data key="d6">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENETIC RISK FACTOR&quot;" target="&quot;MOTHERS CARRYING RS669340 CG GENOTYPE&quot;">
      <data key="d4">22.0</data>
      <data key="d5">"Mothers carrying the CG genotype in SHMT1 had a reduced risk of NTDs when their folate intake was low, compared to CC and GG genotypes.")</data>
      <data key="d6">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENETIC RISK&quot;" target="&quot;INFANTS WITH AG GENOTYPE IN MTHFD1 SNPS RS2236224 AND RS2236225&quot;">
      <data key="d4">24.0</data>
      <data key="d5">"The presence of the CT genotype for these two specific MTHFD1 SNPs increased infant risk for NTDs when maternal folate intake was low.")</data>
      <data key="d6">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS10399931&quot;" target="&quot;SERUM C-PEPTIDE CONCENTRATION AFTER 2 HOURS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"A significant association was found between rs10399931 and serum C-peptide concentration after 2 hours, p=0.03.")</data>
      <data key="d6">chunk-44a871da300abc9be525b468f502f5cb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS10399931&quot;" target="&quot;T2D QUANTITATIVE TRAITS (BMI, C-PEPTIDE CONCENTRATION)&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The results showed no significant associations between rs10399931 and quantitative traits related to T2D such as BMI or C-peptide concentration.")</data>
      <data key="d6">chunk-44a871da300abc9be525b468f502f5cb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS4950928&quot;" target="&quot;T2D QUANTITATIVE TRAITS (BMI, C-PEPTIDE CONCENTRATION)&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"No associations were found between rs4950928 and the quantitative traits of interest in relation to T2D.")</data>
      <data key="d6">chunk-44a871da300abc9be525b468f502f5cb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS10399931/4950928&quot;" target="&quot;T2D QUANTITATIVE TRAITS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"No significant associations between rs10399931 or rs4950928 and any T2D quantitative traits were found.")</data>
      <data key="d6">chunk-44a871da300abc9be525b468f502f5cb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AMD&quot;" target="&quot;Y402H CFH ALLELE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Women carrying two copies of Y402H CFH risk allele had approximately 2.4 times greater odds for developing AMD compared to those with no such alleles.")&lt;SEP&gt;"Women with two copies of the Y402H CFH allele had 2.4 times greater odds of AMD relative to women without any copies.")</data>
      <data key="d6">chunk-23a090455f50ab98c53e8b90941c6da5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AMD&quot;" target="&quot;A69S RISK ALLELE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Having two copies of the A69S risk allele leads to a 2.2 times increased odds of AMD compared to zero copies.")&lt;SEP&gt;"In the full sample, a combined effect of one or more ARMS2 risk alleles with poor lifestyle has a 1.97 times increased odds for AMD compared to zero risk alleles and high HLS.")&lt;SEP&gt;"In women with ARMS2 risk allele, poor lifestyle significantly increased the odds of AMD up to about 1.97 times compared to individuals without any ARMS2 risk alleles and having a healthy lifestyle.")&lt;SEP&gt;"Possessing at least one A69S risk allele was associated with about 2.2 times increased odds of AMD, relative to individuals without the risk allele.")</data>
      <data key="d6">chunk-23a090455f50ab98c53e8b90941c6da5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AMD&quot;" target="&quot;G ALLELE OF RS641153 (CFB/C2)&quot;">
      <data key="d4">1.02</data>
      <data key="d5">"The G allele was associated with an increased probability of AMD.")&lt;SEP&gt;"The G allele was found to increase the probability of developing AMD by approximately 1.08 times compared to those with other alleles.")</data>
      <data key="d6">chunk-23a090455f50ab98c53e8b90941c6da5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AMD&quot;" target="&quot;RS10033900 (CFI)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"No main effect was observed for rs10033900 in relation to AMD within CAREDS.")&lt;SEP&gt;"No significant association was observed between rs10033900 and AMD within the CAREDS dataset.")</data>
      <data key="d6">chunk-23a090455f50ab98c53e8b90941c6da5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AMD&quot;" target="&quot;RS2230199 (C3)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"No observation of association with rs2230199 and AMD in the CAREDS dataset.")&lt;SEP&gt;"No statistically significant link between rs2230199 and AMD was found in the CAREDS dataset.")</data>
      <data key="d6">chunk-23a090455f50ab98c53e8b90941c6da5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AMD&quot;" target="&quot;HLS SCORE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"In women with high genetic risk for AMD, a lower HLS (indicating unhealthy dietary habits) was significantly associated with an increased likelihood of AMD compared to those with both low genetic risk and good dietary habits.")&lt;SEP&gt;"In women with high genetic risk, HLS scores were significantly associated with an increased likelihood of AMD.")</data>
      <data key="d6">chunk-23a090455f50ab98c53e8b90941c6da5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AMD&quot;" target="&quot;CFH GENOTYPE (CC)&quot;">
      <data key="d4">6.6</data>
      <data key="d5">"A joint effect is observed between having both two high-risk CFH alleles and a low HLS score compared to low risk genotypes and high HLS, associated with higher odds for AMD.")&lt;SEP&gt;"The combination of two high-risk CFH alleles and a poor HLS score was significantly associated with higher odds for AMD than individuals with low risk genotypes and healthy lifestyle scores.")</data>
      <data key="d6">chunk-23a090455f50ab98c53e8b90941c6da5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AMD&quot;" target="&quot;LIFESTYLE FACTORS (DIETARY LIFESTYLE SCORES)&quot;">
      <data key="d4">4.16</data>
      <data key="d5">"For women carrying ARMS2 risk allele, poor lifestyle was associated with higher odds of AMD compared to those without the ARMS2 risk allele and maintaining a healthy diet.")&lt;SEP&gt;"In the full sample, a significant interaction between dietary lifestyle scores and CFH genotype was observed in predicting higher odds for AMD compared to other genetic risk groups.")&lt;SEP&gt;"In the full sample, there's an interaction between lifestyle factors and CFH genotype leading to increased odds of AMD compared to other genetic risk groups.")&lt;SEP&gt;"In women carrying the ARMS2 risk allele, having poor lifestyle with HLS leads to higher odds for AMD compared to no risk alleles and high HLS.")</data>
      <data key="d6">chunk-23a090455f50ab98c53e8b90941c6da5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AMD&quot;" target="&quot;INTERACTION EFFECT (CFH GENOTYPES AND HLS)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The joint impact of poor lifestyle score and the high-risk CFH genotype was found to be more than additive for AMD risks, suggesting synergy in this relationship.")&lt;SEP&gt;"The joint impact of poor lifestyle score on diet and high-risk CFH genotype was found to amplify the odds of AMD compared to having low-risk genotypes and a healthy lifestyle.")</data>
      <data key="d6">chunk-23a090455f50ab98c53e8b90941c6da5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AMD&quot;" target="&quot;Ω-3 FATTY ACIDS INTAKE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"No influence on the association between HLS score and AMD risk, when adjusted for omega-3 fatty acid consumption.")&lt;SEP&gt;"No significant influence on the association between HLS and AMD when adjusted for omega-3 fatty acid intake.")</data>
      <data key="d6">chunk-23a090455f50ab98c53e8b90941c6da5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AMD&quot;" target="&quot;SYNERGY INDEX (ARMS2 AND LIFESTYLE)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The combined effect of one or more ARMS2 risk alleles with poor lifestyle had an additive yet not significant 0.9 times increase in the odds for AMD compared to individuals without ARMS2 risk alleles and having a healthy lifestyle.")&lt;SEP&gt;"The synergy of ARMS2 genetic risk with poor lifestyle was statistically significant but did not reach the level of additive effects, implying more than additive impact on AMD risks.")</data>
      <data key="d6">chunk-23a090455f50ab98c53e8b90941c6da5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AMD&quot;" target="&quot;LIFESTYLE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"In the subsample of women with stable diets, odds for AMD were higher for those with both risk factors compared to neither.")</data>
      <data key="d6">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AMD&quot;" target="&quot;CFB/C2, C3 RS2230199, CFI RS10033900&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The joint effect of these genotypes along with lifestyle was explored to understand if they synergize in increasing AMD risk.")</data>
      <data key="d6">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LIFESTYLE&quot;" target="&quot;CFB/C2&quot;">
      <data key="d4">0.5</data>
      <data key="d5">"Absence of main effects for SNPs in CFB/C2 indicates that lifestyle does not strongly interact with this gene in relation to AMD risk.")</data>
      <data key="d6">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LIFESTYLE&quot;" target="&quot;C3 RS2230199&quot;">
      <data key="d4">0.5</data>
      <data key="d5">"The combination of C3 variant and HLS does not lend towards a clear evidence for interaction effect on AMD risk.")</data>
      <data key="d6">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LIFESTYLE&quot;" target="&quot;CFI RS10033900&quot;">
      <data key="d4">0.5</data>
      <data key="d5">"SNP in this gene along with HLS had a variable effect on odds of AMD, not strong enough for clear interaction evidence.")</data>
      <data key="d6">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LIFESTYLE&quot;" target="&quot;CFB/C2, C3 RS2230199, CFI RS10033900&quot;">
      <data key="d4">4.5</data>
      <data key="d5">"Interaction analysis revealed that while there were joint effects between lifestyle and genotypes in complement pathway genes, the estimates for synergy were unreliable.")&lt;SEP&gt;"The combined effect of lifestyle and these genotypes was not reliable for estimating synergy due to uncertain odds distribution.")&lt;SEP&gt;"The exploration focused on the joint effect of these genotypes along with lifestyle score in influencing AMD risk.")&lt;SEP&gt;"The interaction analysis of these genotypes with lifestyle did not yield clear evidence for deviation from additive or multiplicative effects.")&lt;SEP&gt;"The reliability of synergy estimates for these genotypes and HLS was low due to their combination leading to variable odds for AMD.")&lt;SEP&gt;"There was no evidence to suggest that lifestyle significantly influences the effect of these genotypes on AMD risk.")</data>
      <data key="d6">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LIFESTYLE&quot;" target="&quot;TRANSCRIPTS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Lifestyle factors could influence the expression levels of relevant transcripts, affecting AMD risk through this mechanism.")</data>
      <data key="d6">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LIFESTYLE&quot;" target="&quot;PROTEINS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Lifestyle may impact the function or concentration of proteins associated with these genes, potentially affecting AMD risk.")</data>
      <data key="d6">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LIFESTYLE&quot;" target="&quot;MOLECULAR INTERACTIONS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Lifestyle factors could alter the dynamics of molecular interactions relevant to AMD risk.")</data>
      <data key="d6">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LIFESTYLE&quot;" target="&quot;PHYSIOLOGICAL PROCESSES&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Lifestyle may modify or optimize these processes, which might influence AMD risk in a positive or negative way.")</data>
      <data key="d6">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LIFESTYLE&quot;" target="&quot;METABOLIC PATHWAYS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Lifestyle interventions might influence these pathways, potentially affecting AMD risk through such modifications.")</data>
      <data key="d6">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PHYSIOLOGICAL PROCESSES&quot;" target="&quot;NUTRIENT X&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"Nutrient X is involved in multiple physiological processes that can impact kidney function and disease risk.")</data>
      <data key="d6">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COFFEE CONSUMPTION&quot;" target="&quot;BLACK COFFEE&quot;/&quot;SUGARED COFFEE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Consumption of black or sugared coffee was assessed in relation to prediabetes and type 2 diabetes risk.")</data>
      <data key="d6">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BLACK COFFEE&quot;" target="&quot;SPECIFIC TYPE OF COFFEE&quot;/&quot;UNSWEETENED COFFEE&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"A variant of coffee that is not sweetened, typically consumed as a beverage.")</data>
      <data key="d6">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PREDIABETES&quot;" target="&quot;CONDITION&quot;/&quot;PRE-DIABETIC CONDITION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Stage before type 2 diabetes where blood sugar levels are higher than normal but not yet high enough for a diagnosis of diabetes.")</data>
      <data key="d6">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENETIC POLYMORPHISMS&quot;" target="&quot;RISK SCORE CALCULATION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Five SNPs were selected based on their association with coffee consumption for use in calculating genetic risk scores.")</data>
      <data key="d6">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENETIC POLYMORPHISMS&quot;" target="&quot;HLA-C REGION&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"HS patients mostly carried genetic polymorphisms near or in the HLA-Cw6 region, except for certain patterns.")</data>
      <data key="d6">chunk-56c37d6045382dda8cc6037b2680282a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ASSOCIATIONS&quot;" target="&quot;GWAS&quot;/&quot;COFFEESUBGROUPS/">
      <data key="d4">4.0</data>
      <data key="d5">"Associations between habitual coffee consumption and prediabetes/type 2 diabetes varied based on the subgroup analysis of coffee types (black vs. sugared).")</data>
      <data key="d6">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ASSOCIATIONS&quot;" target="&quot;EARLY, INTERMEDIATE, ADVANCED HIV DISEASE STAGES VS. HEALTHY CONTROLS&quot;">
      <data key="d4">13.0</data>
      <data key="d5">"Assessments were made between various stages of HIV progression and the control group in terms of polymorphism frequencies.")</data>
      <data key="d6">chunk-05d583f893b703816ad8de9561aa5292</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENETIC POLYMORPHISMS&quot;/&quot;COFFEE CONSUMPTION/&quot;&gt;" target="&quot;INFLUENCE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The relationship between coffee consumption and the risk of prediabetes or type 2 diabetes was modified by genetic polymorphisms.")</data>
      <data key="d6">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ASSESSMENT&quot;/&quot;EVALUATION OF GENETIC PREDISPOSITION&quot;" target="&quot;GENETIC RISK SCORES/">
      <data key="d4">5.0</data>
      <data key="d5">"A tool used to calculate an individual's likelihood of developing prediabetes or type 2 diabetes based on their genetic makeup.")</data>
      <data key="d6">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SPECIFIC TYPE OF COFFEE&quot;/&quot;SWEETENED COFFEE&quot;" target="&quot;SUGARED COFFEE/">
      <data key="d4">7.0</data>
      <data key="d5">"Coffee that has been sweetened with sugar or another sweetener.")</data>
      <data key="d6">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SENP1&quot;" target="&quot;NF-ΚB SIGNALLING&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Deletion of SENP1 in adipocytes enhances NEMO SUMOylation and NF-κB activation, affecting cytokine expression and potentially impacting T1DM pathogenesis.")</data>
      <data key="d6">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SENP1&quot;" target="&quot;NF-ΚB ACTIVITY&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"A critical role of SENP1-dependent NF-κB activity in T1DM progression in SENP1-aP2KO mice.")</data>
      <data key="d6">chunk-8382a49b61215482f9fc75e3a86cb987</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INSULIN LEVELS&quot;" target="&quot;HFD&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The high-fat diet caused a significant reduction of insulin levels, and this was more pronounced in Senp1 knockout (KO) mice compared to wild-type (Ctrl) mice.")</data>
      <data key="d6">chunk-174831b97ed170039b374ba254d4f506</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PATS&quot;" target="&quot;HFD&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The high-fat diet augmented fat weight in PAT depots including epididymal fat and paternal adipose tissue (PATs).")</data>
      <data key="d6">chunk-174831b97ed170039b374ba254d4f506</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PATS&quot;" target="&quot;CELL SIZE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The cell size of PATs was larger under normal chow conditions but smaller by a factor of 1.8 under high-fat diet (HFD).")</data>
      <data key="d6">chunk-174831b97ed170039b374ba254d4f506</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PATS&quot;" target="&quot;CELL NUMBERS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Cell numbers in PAT cells were higher in the SENP1-aP2KO mice compared to Ctrl adipocytes under normal chow and this was more pronounced under HFD conditions.")</data>
      <data key="d6">chunk-174831b97ed170039b374ba254d4f506</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CYTOKINE CONCENTRATION&quot;" target="&quot;AFFECTS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Increased cytokine concentration is a precursor event contributing to the development of diabetes and associated myocarditis symptoms in older mice.")("entity"</data>
      <data key="d6">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIABETES PHENOTYPE&quot;" target="&quot;GENETIC MODIFICATION&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"SENP1-deficient mice created with Adipoq-Cre showed a diabetic phenotype compared to control mice.")</data>
      <data key="d6">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIABETES ONSET&quot;" target="&quot;GENETIC MODIFICATION&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Early onset of diabetes was associated with specific deletion of Senp1 gene via different genetic modification methods.")</data>
      <data key="d6">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CYTOKINE PRODUCTION&quot;" target="&quot;LOCAL PRO-INFLAMMATORY CYTOKINES&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Secreted from PATs, contribute to inflammation and immune cell infiltration in the pancreas.")</data>
      <data key="d6">chunk-eaf655c4dd9244523b048a122e232be4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CYTOKINE PRODUCTION&quot;" target="&quot;CD4+ EFFECTOR T CELLS&quot;">
      <data key="d4">59.82</data>
      <data key="d5">"CD4+ effector T cells modulate host immune responses through cytokine production after encountering cognate antigens.")</data>
      <data key="d6">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PROINFLAMMATORY CYTOKINE&quot;" target="&quot;INCREASED LEVELS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Increased plasma levels of proinflammatory cytokines were observed in T1DM patients compared to normal subjects.")</data>
      <data key="d6">chunk-8382a49b61215482f9fc75e3a86cb987</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BETA-CELL DEATH&quot;" target="&quot;INDUCTION&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Serum from SENP1-aP2KO mice, NOD mice and human T1DM all induced disruption and pancreatic cell death.")</data>
      <data key="d6">chunk-8382a49b61215482f9fc75e3a86cb987</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PROPHYLACTIC INSULIN THERAPY&quot;" target="&quot;AMELIORATION OF DIABETIC PHENOTYPES&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Prophylactic insulin therapy partially ameliorates development of diabetes phenotypes in SENP1-deficient mice.")</data>
      <data key="d6">chunk-8382a49b61215482f9fc75e3a86cb987</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PROPHYLACTIC INSULIN THERAPY&quot;" target="&quot;PREVENTATIVE EFFECT&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Prophylactic insulin therapy helps partially ameliorate some diabetic phenotypes by supporting insulin levels and immune cell infiltration in mice.")</data>
      <data key="d6">chunk-8382a49b61215482f9fc75e3a86cb987</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NF-ΚB INHIBITOR II JSH-23&quot;" target="&quot;DIMINISHED ELEVATION OF BLOOD GLUCOSE AND REDUCTION OF INSULIN LEVELS&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Administration of JSH-23 to SENP1-aP2KO mice diminished the effects of SENP1 deletion on blood glucose levels and insulin in blood.")</data>
      <data key="d6">chunk-8382a49b61215482f9fc75e3a86cb987</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NF-ΚB INHIBITOR II JSH-23&quot;" target="&quot;DISEASE MODIFYING EFFECT&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"JSH-23 administration reduces blood glucose elevation and insulin reduction, potentially impacting the course of T1DM in SENP1-aP2KO mice.")</data>
      <data key="d6">chunk-8382a49b61215482f9fc75e3a86cb987</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HIGH-FAT DIET (HFD)&quot;" target="&quot;INCREASED FAT WEIGHT&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"HFD increased fat weight in all adipose depots including epididymal fat and PATs.")</data>
      <data key="d6">chunk-8382a49b61215482f9fc75e3a86cb987</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HIGH-FAT DIET (HFD)&quot;" target="&quot;CONTRIBUTION TO DISEASE PROGRESSION&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"HFD may stimulate adipogenesis and increase fat weight, which could contribute indirectly to inflammation and potentially exacerbate diabetic phenotypes.")</data>
      <data key="d6">chunk-8382a49b61215482f9fc75e3a86cb987</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HFD&quot;" target="&quot;IL-6, TNF-Α, IL-1Β&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"High-fat diet significantly increased the production of proinflammatory cytokines like Interleukin-6 (IL-6), Tumor Necrosis Factor Alpha (TNF-α), and Interleukin-1 Beta (IL-1β) in PATs.")</data>
      <data key="d6">chunk-174831b97ed170039b374ba254d4f506</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HFD&quot;" target="&quot;HYPERGLYCAEMIA&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The onset of hyperglycemia was accelerated under HFD conditions, starting at the age of 8 weeks in SENP1-aP2KO mice instead of around 12 weeks under standard chow diet.")</data>
      <data key="d6">chunk-174831b97ed170039b374ba254d4f506</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HFD&quot;" target="&quot;LIVER INSULIN RESISTANCE&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Under basal conditions, liver insulin resistance was detected under HFD conditions, which was more pronounced than under normal chow diet in Senp1 knockout (KO) mice. This is a hallmark of obesity-linked type 2 diabetes development.")</data>
      <data key="d6">chunk-174831b97ed170039b374ba254d4f506</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENETIC MODIFICATION&quot;" target="&quot;NORMAL PHENOTYPE&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Unlike the adipocyte-specific deletion models, Senp1-deficient mice created by SM22α-Cre or VE-cadherin-Cre did not develop a high-glucose phenotype.")</data>
      <data key="d6">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENE EXPRESSION&quot;" target="&quot;SPECIFIC CELL TYPE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The specific cell types, such as macrophages and pancreatic islets, showed different expression patterns of Senp1 gene.")</data>
      <data key="d6">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENE EXPRESSION&quot;" target="&quot;PTPN2:RS478582&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The expression of PTPN2 gene was lower in individuals with heterozygous or minor allele (TC or CC) compared to those with the normal TT genotype." )</data>
      <data key="d6">chunk-84ec948f22126cef7d93b1d7465b79db</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EXPRESSION&quot;" target="&quot;LOCALIZATION&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The expression of Senp1 gene localized to peri-pancreatic adipose tissue and was not present in pancreatic islets.")</data>
      <data key="d6">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENE REGULATION&quot;" target="&quot;METABOLIC FUNCTION&quot;">
      <data key="d4">15.0</data>
      <data key="d5">"The regulation of PPARγ by SENP1 impacts metabolic pathways involved in insulin sensitivity and glucose metabolism.")</data>
      <data key="d6">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CHEMICAL TREATMENT&quot;" target="&quot;DIABETES INDUCTION&quot;">
      <data key="d4">16.0</data>
      <data key="d5">"STZ was used as a method to induce diabetes in Senp1-deficient mice, providing insights into the role of SENP1 in maintaining glucose homeostasis.")</data>
      <data key="d6">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AGING PHENOMENA&quot;" target="&quot;GENE FUNCTION&quot;">
      <data key="d4">17.0</data>
      <data key="d5">"The impact of SENP1 deletion on the metabolic health of mice potentially leads to accelerated aging processes related to cellular senescence.")</data>
      <data key="d6">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DEVELOPMENTAL BIOLOGY&quot;" target="&quot;GENE ACTIVITY&quot;">
      <data key="d4">18.0</data>
      <data key="d5">"SENP1's involvement in adipocyte differentiation highlights its importance during the development of metabolic traits like obesity and diabetes.")</data>
      <data key="d6">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENE INFLUENCE&quot;" target="&quot;REGENERATIVE MEDICINE&quot;">
      <data key="d4">19.0</data>
      <data key="d5">"The influence of SENP1 on hematopoietic stem cells could provide insights into its role in regenerative processes during diabetes development or treatment.")</data>
      <data key="d6">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENETIC PHENOTYPE&quot;" target="&quot;HEALTH OUTCOMES&quot;">
      <data key="d4">20.0</data>
      <data key="d5">"Senp1 gene deletion results in a complex interplay of conditions characteristic of metabolic syndrome that affects multiple organ systems.")</data>
      <data key="d6">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;REGULATION OF CCL5 EXPRESSION&quot;" target="&quot;SENP1 DELETION&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Reduced SENP1 activity leads to increased local cytokine secretion that upregulates CCL5 expression.")</data>
      <data key="d6">chunk-eaf655c4dd9244523b048a122e232be4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SENP1 DELETION&quot;" target="&quot;ENHANCED PRO-INFLAMMATORY PHENOTYPE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Deficiency reduces adipocyte differentiation while increasing pro-inflammatory markers like NF-κB activity, contributing to enhanced inflammation in adipose depots.")</data>
      <data key="d6">chunk-eaf655c4dd9244523b048a122e232be4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NF-ΚB ACTIVATION&quot;" target="&quot;REGULATION OF ADIPOCYTE DIFFERENTIATION&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Increased NF-κB activity in adipose tissue affects adipogenesis through reduced levels of PPARγ SUMOylation, influencing cell development and maturation process.")</data>
      <data key="d6">chunk-eaf655c4dd9244523b048a122e232be4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NF-ΚB ACTIVITY&quot;" target="&quot;REGULATION OF GENE EXPRESSION&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"SENP1-dependent NF-κB activity regulates the expression of genes involved in inflammation, apoptosis, and islet damage during diabetes progression.")</data>
      <data key="d6">chunk-8382a49b61215482f9fc75e3a86cb987</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;APAI&quot;" target="&quot;OVARIAN CANCER&quot;">
      <data key="d4">0.5</data>
      <data key="d5">"No significant association was found with ApaI (rs7975232) and risk of ovarian cancer under fixed-effect model.")</data>
      <data key="d6">chunk-1c470c93632f3704d6f3566de7a1dd0c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOKI&quot;" target="&quot;OVARIAN CANCER&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"There was a significant association between the FokI variant and an increased risk for ovarian cancer.")</data>
      <data key="d6">chunk-1c470c93632f3704d6f3566de7a1dd0c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CDX-2&quot;" target="&quot;TAQI&quot;">
      <data key="d4">1.2</data>
      <data key="d5">"These two genetic markers were found to have synergistic effects on cancer risk.")</data>
      <data key="d6">chunk-1c470c93632f3704d6f3566de7a1dd0c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CDX-2&quot;" target="&quot;OVARIAN CANCER&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The gene Cdx-2 was involved in evaluating the risk for ovarian cancer through genomic variant rs11568820.")</data>
      <data key="d6">chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TAQI&quot;" target="&quot;OVARIAN CANCER&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Gene TaqI showed no significant effect on ovarian cancer risk as per the meta-analysis and subgroup studies.")&lt;SEP&gt;"No association was found for the TaqI variant and the risk of ovarian cancer in both subgroup studies and Caucasians.")</data>
      <data key="d6">chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OVARIAN CANCER&quot;" target="&quot;BSMI&quot;">
      <data key="d4">0.7</data>
      <data key="d5">"No significant association between BsmI variant and risk of ovarian cancer was found under the dominant genetic model.")</data>
      <data key="d6">chunk-1c470c93632f3704d6f3566de7a1dd0c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OVARIAN CANCER&quot;" target="&quot;RS11568820&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Carriers of the A allele showed significantly increased risk for ovarian cancer based on subgroup studies conducted with Japanese and NECC subgroups.")</data>
      <data key="d6">chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS1544410&quot;" target="&quot;BSMI&quot;">
      <data key="d4">1.3</data>
      <data key="d5">"The same genomic variant is associated with similar disease outcomes in different studies.")</data>
      <data key="d6">chunk-1c470c93632f3704d6f3566de7a1dd0c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS1544410&quot;" target="&quot;RS731236&quot;">
      <data key="d4">0.93</data>
      <data key="d5">"rs731236 and rs1544410 have high linkage disequilibrium (LD) within our study population.")</data>
      <data key="d6">chunk-6600322cc75094b1c57707e4b9c85954</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS1544410&quot;" target="&quot;RS7975232&quot;">
      <data key="d4">0.1</data>
      <data key="d5">"There is low linkage disequilibrium (LD) between rs7975232 and rs1544410 within our study population.")</data>
      <data key="d6">chunk-6600322cc75094b1c57707e4b9c85954</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS11568820&quot;" target="&quot;CDX-2 GENE VARIANT AND OVARIAN CANCER&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The genomic variant rs11568820 in Cdx-2 gene was associated with an increased risk of ovarian cancer.")</data>
      <data key="d6">chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS731236&quot;" target="&quot;TAQI GENE VARIANT AND OVARIAN CANCER&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The TaqI gene variant showed no association with ovarian cancer based on subgroup studies.")</data>
      <data key="d6">chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS731236&quot;" target="&quot;RS7975232&quot;">
      <data key="d4">0.93</data>
      <data key="d5">"These two SNPs have relatively high linkage disequilibrium (LD) within our study population.")</data>
      <data key="d6">chunk-6600322cc75094b1c57707e4b9c85954</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS731236&quot;" target="&quot;RS2228570&quot;">
      <data key="d4">0.1</data>
      <data key="d5">"There is low linkage disequilibrium (LD) between rs731236 and rs2228570 within our study population.")</data>
      <data key="d6">chunk-6600322cc75094b1c57707e4b9c85954</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AFRICAN AMERICAN POPULATION&quot;" target="&quot;GENETIC VARIANTS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The African American subgroup study contributed significantly to the heterogeneity between the studies evaluated for BsmI variant.")</data>
      <data key="d6">chunk-1c470c93632f3704d6f3566de7a1dd0c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENETIC VARIANTS&quot;" target="&quot;RS731236&quot;, &quot;RS7975232&quot;, &quot;RS1544410&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The three variants form three different haplotypes (ACC, GAT and AAC).")</data>
      <data key="d6">chunk-6600322cc75094b1c57707e4b9c85954</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENETIC VARIANTS&quot;" target="&quot;MTHFR C677T&quot;/&quot;A1298C&quot;">
      <data key="d4">60.0</data>
      <data key="d5">"The MTHFR gene's different variant types, like C677T and A1298C, are associated with various aspects of cardiovascular health.")</data>
      <data key="d6">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENETIC VARIANTS&quot;" target="&quot;PAI-1 4G/5G&quot;/&quot;A844G&quot;">
      <data key="d4">60.0</data>
      <data key="d5">"Polymorphisms in the PAI-1 gene contribute to cardiovascular disease risk, as seen with variants such as -675 4G/5G and A844G.")</data>
      <data key="d6">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENETIC VARIANTS&quot;" target="&quot;PROTHROMBIN G20210A&quot;/&quot;FACTOR V G1691A&quot;">
      <data key="d4">60.0</data>
      <data key="d5">"SNPs in prothrombin gene (G20210A) and factor V gene (G1691A) are related to thrombosis risk and contribute to cardiovascular health.")</data>
      <data key="d6">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T. CRUZI&quot;" target="&quot;VDR SNPS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Specific VDR SNP haplotypes correlate with susceptibility or resistance to T. cruzi infection.")&lt;SEP&gt;"The VDR polymorphisms may influence the risk of infection by T. cruzi, but only rs2228570 shows a protective effect against infection.")</data>
      <data key="d6">chunk-6600322cc75094b1c57707e4b9c85954</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SERONEGATIVE&quot;" target="&quot;RS2228570&quot;*">
      <data key="d4">1.0</data>
      <data key="d5">"The minor allele, *A of rs2228570 is overrepresented in the seronegative subset.")</data>
      <data key="d6">chunk-6600322cc75094b1c57707e4b9c85954</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SEROPOSITIVE&quot;" target="&quot;RS2228570&quot;*">
      <data key="d4">1.0</data>
      <data key="d5">"The minor allele, *A of rs2228570 is underrepresented in the seropositive subset.")</data>
      <data key="d6">chunk-6600322cc75094b1c57707e4b9c85954</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ASYMPTOMATIC&quot;" target="&quot;RS2228570&quot;*">
      <data key="d4">1.0</data>
      <data key="d5">"The minor allele, *A of rs2228570 is underrepresented in the asymptomatic subset.")</data>
      <data key="d6">chunk-6600322cc75094b1c57707e4b9c85954</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ASYMPTOMATIC&quot;" target="&quot;VDR SNPS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The VDR polymorphisms may influence the susceptibility of asymptomatic infection, rs2228570 shows a protective effect against symptomatic infection.")</data>
      <data key="d6">chunk-6600322cc75094b1c57707e4b9c85954</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CHAGAS DISEASE (CCC)&quot;" target="&quot;RS2228570&quot;*">
      <data key="d4">1.0</data>
      <data key="d5">"The minor allele, *A of rs2228570 is overrepresented in CCC patients.")</data>
      <data key="d6">chunk-6600322cc75094b1c57707e4b9c85954</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CHAGAS DISEASE (CCC)&quot;" target="&quot;VDR SNPS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The VDR polymorphisms may influence the susceptibility to develop CCC, and rs2228570 shows an association with resistance to CCC.")</data>
      <data key="d6">chunk-6600322cc75094b1c57707e4b9c85954</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LD&quot;" target="&quot;VDR SNPS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The single nucleotide polymorphisms (SNPs) in the VDR gene show linkage disequilibrium with each other.")</data>
      <data key="d6">chunk-6600322cc75094b1c57707e4b9c85954</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ASYMPTOMATIC INDIVIDUALS&quot;" target="&quot;RS2228570&quot;*">
      <data key="d4">1.0</data>
      <data key="d5">"Minor allele *A of rs2228570 is underrepresented among asymptomatic individuals compared to seronegative individuals.")</data>
      <data key="d6">chunk-6600322cc75094b1c57707e4b9c85954</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS2228570&quot;*" target="&quot;SEROPOSITIVE INDIVIDUALS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Minor allele *A of rs2228570 is overrepresented among seropositive individuals compared to seronegative and asymptomatic individuals.")</data>
      <data key="d6">chunk-6600322cc75094b1c57707e4b9c85954</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MATERNAL FOLATE LEVELS&quot;" target="&quot;OFFSPRING BIRTHWEIGHT&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Evidence of a positive causal effect of maternal folate levels on offspring birthweight.")</data>
      <data key="d6">chunk-1d2a8d3ce4f9baae7e1c9c14410045d0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;STATISTICAL ANALYSIS&quot;" target="&quot;GEOMETRIC MEANS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Geometric mean was employed as part of the statistical analysis for better average representation.")</data>
      <data key="d6">chunk-257a38a8ce6582c434f31b023b4a9704</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;STATISTICAL ANALYSIS&quot;" target="&quot;HMIP-2 SNP/HAPLOTYPE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"SNPs or haplotypes of HMIP-2 were assessed through statistical analysis for their correlations with various hemoglobin measurements.")</data>
      <data key="d6">chunk-3ae06e9a3330573da28ca0a76aa685ce</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OFFSPRING BIRTHWEIGHT&quot;" target="&quot;MATERNAL B12 LEVELS&quot;">
      <data key="d4">0.469</data>
      <data key="d5">"No evidence for a causal effect of maternal B12 levels on offspring birthweight.")</data>
      <data key="d6">chunk-1d2a8d3ce4f9baae7e1c9c14410045d0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OFFSPRING BIRTHWEIGHT&quot;" target="&quot;FETAL B12 LEVELS&quot;">
      <data key="d4">0.478</data>
      <data key="d5">"No evidence for a causal effect of fetal B12 levels on their own birthweight.")</data>
      <data key="d6">chunk-1d2a8d3ce4f9baae7e1c9c14410045d0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OFFSPRING BIRTHWEIGHT&quot;" target="&quot;FETAL FOLATE LEVELS&quot;">
      <data key="d4">0.037</data>
      <data key="d5">"Evidence of a negative effect of fetal folate levels on their own birthweight, but the effect size was smaller than that for maternal folate.")</data>
      <data key="d6">chunk-1d2a8d3ce4f9baae7e1c9c14410045d0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OFFSPRING BIRTHWEIGHT&quot;" target="&quot;MATERNAL VITAMIN B12&quot;">
      <data key="d4">0.8</data>
      <data key="d5">"No evidence of a causal relationship between maternal intake of vitamin B12 and offspring birthweight was detected.")</data>
      <data key="d6">chunk-22216738ccbae0a6276bb4499018c434</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FETAL B12 LEVELS&quot;" target="&quot;MATERNAL B12 LEVELS&quot;">
      <data key="d4">0.0</data>
      <data key="d5">"Assumed no clear relation since they were not found to influence each other's effects on offspring birthweight.")</data>
      <data key="d6">chunk-1d2a8d3ce4f9baae7e1c9c14410045d0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MATERNAL FOLATE&quot;" target="&quot;MATERNAL VITAMIN B12&quot;">
      <data key="d4">0.7</data>
      <data key="d5">"A possible influence of maternal folate on maternal vitamin B12 levels, which could affect health outcomes including birthweight.")</data>
      <data key="d6">chunk-22216738ccbae0a6276bb4499018c434</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GESTATIONAL DURATION&quot;" target="&quot;B12/FOLATE LEVELS&quot;">
      <data key="d4">0.4</data>
      <data key="d5">"There is no indication that levels of B12 or folate have an effect on gestational duration based on the data.")</data>
      <data key="d6">chunk-22216738ccbae0a6276bb4499018c434</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MTHFR C677T&quot;" target="&quot;LV PATIENTS&quot;">
      <data key="d4">53.0</data>
      <data key="d5">"Carrier rates for the MTHFR C677T variant among LV patient populations.")</data>
      <data key="d6">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MTHFR C677T&quot;" target="&quot;VARIANT CARRIER RATE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The variant carrier rate for MTHFR C677T was 64.28% in Europe.")</data>
      <data key="d6">chunk-d0476488384aadcae4630e94d982d2e0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MTHFR A1298C&quot;" target="&quot;LV PATIENTS&quot;">
      <data key="d4">56.0</data>
      <data key="d5">"Carrier rate of MTHFR A1298C polymorphism in LV patients.")</data>
      <data key="d6">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MTHFR A1298C&quot;" target="&quot;VARIANT CARRIER RATE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The variant carrier rate for MTHFR A1298C was 44% in Europe.")</data>
      <data key="d6">chunk-d0476488384aadcae4630e94d982d2e0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PAI-1 -675 4G/5G&quot;" target="&quot;LV PATIENTS&quot;">
      <data key="d4">95.0</data>
      <data key="d5">"Total carrier rate for PAI-1 variant among LV patient populations.")</data>
      <data key="d6">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PAI-1 -675 4G/5G&quot;" target="&quot;VARIANT CARRIER RATE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The variant carrier rate for PAI-1 -675 4G/5G was 94.45% in Europe.")</data>
      <data key="d6">chunk-d0476488384aadcae4630e94d982d2e0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PAI-1 A844G&quot;" target="&quot;LV PATIENTS&quot;">
      <data key="d4">18.0</data>
      <data key="d5">"Carrier rates for the PAI-1 A844G variant in LV patients.")</data>
      <data key="d6">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PROTHROMBIN G20210A&quot;" target="&quot;LV PATIENTS&quot;">
      <data key="d4">85.0</data>
      <data key="d5">"Low carrier rate of Prothrombin G20210A among LV patients.")</data>
      <data key="d6">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PROTHROMBIN G20210A&quot;" target="&quot;VARIANT CARRIER RATE&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"The variant carrier rate for Prothrombin G20210A was 55.56% in Europe.")&lt;SEP&gt;"The variant carrier rate for Prothrombin G20210A was 75% in studies conducted in North America.")</data>
      <data key="d6">chunk-d0476488384aadcae4630e94d982d2e0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FACTOR V G1691A&quot;" target="&quot;LV PATIENTS&quot;">
      <data key="d4">135.0</data>
      <data key="d5">"Carrier rate for Factor V G1691A variant in LV patient populations.")</data>
      <data key="d6">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FACTOR V G1691A&quot;" target="&quot;VARIANT CARRIER RATE&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"The variant carrier rate for Factor V G1691A was 21.74% in Europe.")&lt;SEP&gt;"The variant carrier rate for Factor V G1691A was 28.57% in studies carried out in North America.")</data>
      <data key="d6">chunk-d0476488384aadcae4630e94d982d2e0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INFERTILE MEN&quot;" target="&quot;FOLIC ACID-CONTAINING VITAMINS USAGE&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"In infertile men, the use of folic acid-containing vitamins does not significantly impact semen quality compared to fertile controls.")</data>
      <data key="d6">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INFERTILE MEN&quot;" target="&quot;SMOKING&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Smoking habits are linked with reduced semen quality and may contribute to poorer fertility outcomes among infertile men.")</data>
      <data key="d6">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SERUM FOLATE&quot;" target="&quot;FOLIC ACID-CONTAINING VITAMINS USAGE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Use of folic acid-containing vitamins correlates with serum folate concentration and semen quality parameters.")</data>
      <data key="d6">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SERUM FOLATE&quot;" target="&quot;ABSTINENCE TIME&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The duration of abstinence prior to semen collection affects serum folate concentrations, impacting fertility and semen parameters.")</data>
      <data key="d6">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SERUM FOLATE&quot;" target="&quot;INFERTILE MEN VS. FERTILE CONTROLS&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Lower serum folate levels are correlated with poorer semen quality specifically among infertile men, compared to those with fertility issues.")</data>
      <data key="d6">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SERUM FOLATE&quot;" target="&quot;INFERTILITY STATUS&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"Lower serum folate levels may be associated with a higher risk for infertility or poorer semen quality in men.")</data>
      <data key="d6">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RCF&quot;" target="&quot;SMOKING&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Smoking habits can impact RCF levels, which in turn may affect the overall semen quality and fertility status.")</data>
      <data key="d6">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;THCY&quot;" target="&quot;VITAMIN SUPPLEMENT USERS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Individuals taking vitamin supplements tend to have lower tHcy levels compared to non-users, suggesting a possible role in sperm health.")</data>
      <data key="d6">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ABSTINENCE TIME&quot;" target="&quot;SEMINAL PARAMETERS&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"The length of abstinence before semen collection can influence seminal parameters like sperm count and motility, impacting fertility assessments.")</data>
      <data key="d6">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;VITAMIN SUPPLEMENT USERS&quot;" target="&quot;SEMINAL PARAMETERS&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Vitamin supplementation has been shown to have beneficial effects on seminal parameters such as sperm concentration and motility in this study.")</data>
      <data key="d6">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;S-FOL&quot;" target="&quot;WB-FOL&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The model-estimated relative differences compared for S-FOL and WB-FOL varied by laboratory and condition.")&lt;SEP&gt;"The results of both indicators showed comparable behavior in terms of differences when all laboratories used CDC reagents or under a harmonized condition.")</data>
      <data key="d6">chunk-257a38a8ce6582c434f31b023b4a9704&lt;SEP&gt;chunk-7c25217961fba65d15f20beda8a58f1c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COVARIANCE&quot;" target="&quot;MICROORGANISM &amp; CALIBRATOR&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The analysis considered covariance across different microorganisms and calibrators.")</data>
      <data key="d6">chunk-257a38a8ce6582c434f31b023b4a9704</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MICROORGANISM EFFECT&quot;" target="&quot;OVERALL MICROORGANISM EFFECT&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"A small day effect was observed for S-FOL and WB-FOL averaged across days.")</data>
      <data key="d6">chunk-257a38a8ce6582c434f31b023b4a9704</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CALIBRATOR EFFECT&quot;" target="&quot;OVERALL CALIBRATOR EFFECT&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Large differences in calibrator effects were observed, averaging across microorganisms.")</data>
      <data key="d6">chunk-257a38a8ce6582c434f31b023b4a9704</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CDC MBA TARGET VALUES&quot;" target="&quot;GROUP 1 LABORATORIES &amp; GROUP 2 LABORATORIES&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Estimations showed variation in mean difference to CDC MBA target values based on dietary pattern (IH reagents vs. CDC reagents).")</data>
      <data key="d6">chunk-257a38a8ce6582c434f31b023b4a9704</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;95% CIS&quot;" target="&quot;VARIABILITY WITHIN &amp; AMONG LABORATORIES&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"CIs highlighted the wide range of variation among different laboratories.")</data>
      <data key="d6">chunk-257a38a8ce6582c434f31b023b4a9704</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LOG TRANSFORMED RESULTS&quot;" target="&quot;NORMALIZATION PROCESS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Logarithmic transformation was used to normalize data distributions.")</data>
      <data key="d6">chunk-257a38a8ce6582c434f31b023b4a9704</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SD (STANDARD DEVIATION)&quot;" target="&quot;SPREAD OF DATA POINTS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"High SD values indicated a larger spread or variability in S-FOL and WB-FOL concentrations.")</data>
      <data key="d6">chunk-257a38a8ce6582c434f31b023b4a9704</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CDC-MO &amp; CDC-CAL&quot;" target="&quot;IH-CAL &amp; IH-CAL&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Results under CDC-MO were closer to the target values than IH reagents results in IH-CAL conditions.")</data>
      <data key="d6">chunk-257a38a8ce6582c434f31b023b4a9704</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CDC MBA TARGET VALUE&quot;" target="&quot;LIMITS OF AGREEMENT&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"95% of the laboratory results were expected to be within these limits under the harmonized condition when CDC reagents were used.")</data>
      <data key="d6">chunk-7c25217961fba65d15f20beda8a58f1c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LIMITS OF AGREEMENT&quot;" target="&quot;LABS #6 &amp; 9&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Exhibited less reasonable agreement compared to other labs under harmonized condition.")</data>
      <data key="d6">chunk-7c25217961fba65d15f20beda8a58f1c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIFFERENCES BETWEEN DAY 1 AND DAY 2&quot;" target="&quot;S-FOL &amp; WB-FOL&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"With the harmonized condition, it can be anticipated that the differences would amount to approximately ±10–30% for S-FOL and approximately ±20–40% for WB-FOL.")</data>
      <data key="d6">chunk-7c25217961fba65d15f20beda8a58f1c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LAB #8 RESULTS (WB-FOL)&quot;" target="&quot;LACK OF AGREEMENT&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Day 1 vs Day 2 analysis showed a lack of agreement in WB-FOL data, unlike other laboratories.")</data>
      <data key="d6">chunk-7c25217961fba65d15f20beda8a58f1c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AGREEMENT UNDER HARMONIZED CONDITION&quot;" target="&quot;ALL LABS (WITH SAME MO &amp; CAL&quot;)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Observed overall good agreement except for labs #6 &amp; 9 when using CDC round-robin kit.")</data>
      <data key="d6">chunk-7c25217961fba65d15f20beda8a58f1c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIFFERENCES EXPECTED FOR S-FOL &amp; WB-FOL&quot;" target="&quot;LIMITS IN RANGE OF +/-10% TO +/-30%/&lt;BR/&gt; +/-20% TO +/-40%&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Estimates under harmonized condition for days 1 vs. day 2 analysis.")</data>
      <data key="d6">chunk-7c25217961fba65d15f20beda8a58f1c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DAY 1 DAY 2 COMPARISON&quot;" target="&quot;LACK OF AGREEMENT IN WB-FOL&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Lab #8 showed inconsistency between day-wise analysis.")</data>
      <data key="d6">chunk-7c25217961fba65d15f20beda8a58f1c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS1695&quot;" target="&quot;BREAST CANCER&quot;">
      <data key="d4">3.1532</data>
      <data key="d5">"Genetic analysis found that the rs1695 polymorphism is associated with an increased risk of breast cancer.")</data>
      <data key="d6">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS1695&quot;" target="&quot;GROWTH FACTORS USE (CSFS)&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The presence of the rs1695 variant shows an association with CSF usage during chemotherapy, suggesting potential genetic influences on treatment responsiveness and need for supportive care.")</data>
      <data key="d6">chunk-561eacb5d916258d3ed4f08f53587404</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS1138272&quot;" target="&quot;BREAST CANCER&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The rs1138272 polymorphism was not found to be associated with the risk of breast cancer in our study.")</data>
      <data key="d6">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GSTP1 PROTEIN&quot;" target="&quot;ILE105VAL&quot;">
      <data key="d4">-228.0</data>
      <data key="d5">"A specific single nucleotide polymorphism (Ile105Val) in GSTP1 shows reduced amyloid propensity according to WALTZ output.")</data>
      <data key="d6">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;P.R778L&quot;" target="&quot;HAPLOGROUP A&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Association of p.R778L with haplogroup A.")</data>
      <data key="d6">chunk-047f259db19cbb4de945706a1bd1b450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;P.P992L&quot;" target="&quot;ALLELE FREQUENCY COMPARISON&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Significantly higher frequency of p.P992L in Fujian province compared to Zhejiang.")</data>
      <data key="d6">chunk-047f259db19cbb4de945706a1bd1b450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;P.T935M&quot;" target="&quot;REGIONAL PREVALENCE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Highest prevalence of p.T935M variant found in Fujian province, compared to other regions.")</data>
      <data key="d6">chunk-047f259db19cbb4de945706a1bd1b450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;P.R778L AND P.P992L&quot;" target="&quot;CO-OCCURRENCE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Tendency for these two variants to occur together among a subset of patients.")</data>
      <data key="d6">chunk-047f259db19cbb4de945706a1bd1b450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;P.R778L AND P.T935M&quot;" target="&quot;CO-OCCURRENCE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Likely association of these two variants in some WD patients, as evident from certain data.")</data>
      <data key="d6">chunk-047f259db19cbb4de945706a1bd1b450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;10-7-7; 10-7-8; 10-8-7; 10-8-8&quot;" target="&quot;HAPLOTYPE VARIANTS A1–A4/">
      <data key="d4">1.0</data>
      <data key="d5">A1"</data>
      <data key="d6">chunk-fa2d834930246b534181c3d6d2c049e1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;10-9-5; 10-9-6&quot;" target="&quot;HAPLOTYPE VARIANT E1/">
      <data key="d4">1.0</data>
      <data key="d5">E2"</data>
      <data key="d6">chunk-fa2d834930246b534181c3d6d2c049e1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;97.0%/" target="3.4%&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Frequencies of Haplogroups A/B in Control Chromosomes"</data>
      <data key="d6">chunk-fa2d834930246b534181c3d6d2c049e1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;D13S314&quot;" target="&quot;LINKAGE DISEQUILIBRIUM&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Significant linkage disequilibrium found between D13S314 marker and p.R778L and p.P992L variants.")</data>
      <data key="d6">chunk-047f259db19cbb4de945706a1bd1b450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LINKAGE DISEQUILIBRIUM&quot;" target="&quot;D13S301&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Significant association of D13S301 with p.R778L, p.P992L and p.T935M at specific alleles.")</data>
      <data key="d6">chunk-047f259db19cbb4de945706a1bd1b450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LINKAGE DISEQUILIBRIUM&quot;" target="&quot;D13S316&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Significant linkage disequilibrium detected between D13S316 marker and the three prevalent pathogenic variants, showing strong associations at different alleles.")</data>
      <data key="d6">chunk-047f259db19cbb4de945706a1bd1b450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS1799853&quot;" target="&quot;CYP2C9 STAR VARIANT GROUP&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"rs1799853 is one of the SNPs combined into a CYP2C9 star variant group.")</data>
      <data key="d6">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CYP2C9 ACTIVITY&quot;" target="&quot;CYP2C9*3&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The minor allele frequency for rs1057910 indicates reduced CYP2C9 activity.")</data>
      <data key="d6">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CYP2C9 ACTIVITY&quot;" target="&quot;CYP2C9*8&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The minor allele frequency for rs9923231 indicates a lower minor allele frequency than other SNPs, consistent with previous studies.")</data>
      <data key="d6">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HWE&quot;" target="&quot;STATISTICAL PROCESS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"SNPs did not show deviations from Hardy Weinberg equilibrium at P&lt;0.001")</data>
      <data key="d6">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AA VALIDATION COHORT&quot;" target="&quot;CLINICAL TRIAL&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The algorithms were tested using African American (AA) patients in a clinical trial.")</data>
      <data key="d6">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALGORITHM ACCURACY&quot;" target="&quot;PERFORMANCE METRIC&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Accuracy of predicting dose requirements compared with actual maintenance dose.")</data>
      <data key="d6">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOTYPING&quot;" target="&quot;TGF-SS1 SNPS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Genotyping assessed the TGF-ß1 gene for specific SNPs that might be associated with CRC risk.")</data>
      <data key="d6">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENETIC BACKGROUND&quot;" target="&quot;AGE-DEPENDENT REGULATION&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Different genetic backgrounds exhibit divergent DNA modifications that change over age, influencing LCT expression in enterocytes.")</data>
      <data key="d6">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;STATISTICAL PROCESS&quot;" target="&quot;SAMPLE ANALYSIS AND DESCRIPTIVE STATISTICS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The sample's characteristics were analyzed, revealing a mean age of 60 years (SD=10).")</data>
      <data key="d6">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;VITAMIN D METABOLITE CONCENTRATIONS&quot;" target="&quot;CYP24A1 SNPS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"CYP24A1 SNPs like rs927650 and rs35051736 have relationships with vitamin D metabolites 25(OH)D and 1,25(OH)2D.")</data>
      <data key="d6">chunk-2fb95100a1290b27baae869c6560419a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;VITAMIN D METABOLITE CONCENTRATIONS&quot;" target="&quot;CYP27B1 SNPS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"SNPs like rs2296241 and rs2762939 in CYP27B1 show relationships with vitamin D metabolites 25(OH)D and 1,25(OH)2D.")</data>
      <data key="d6">chunk-2fb95100a1290b27baae869c6560419a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ADENOMA RECURRENCE&quot;" target="&quot;CYP24A1 SNPS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"SNPs like rs927650 and rs35051736 in CYP24A1 are associated with odds for adenoma recurrence.")</data>
      <data key="d6">chunk-2fb95100a1290b27baae869c6560419a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;25(OH)D CONCENTRATION&quot;" target="&quot;CYP24A1 SNP RS927650&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"SNP rs927650 in CYP24A1 shows a relationship with vitamin D metabolite concentration 25(OH)D.")</data>
      <data key="d6">chunk-2fb95100a1290b27baae869c6560419a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ADVANCED ADENOMA RECURRENCE&quot;" target="&quot;CYP24A1 SNP RS35051736&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"SNP rs35051736 has a statistically significant relationship with odds for advanced adenoma recurrence.")</data>
      <data key="d6">chunk-2fb95100a1290b27baae869c6560419a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CYP24A1 SNPS (RS2296241, RS35051736)&quot;" target="&quot;VILLOUS HISTOLOGY ADENOMAS RECURRENCE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"SNPs like rs2296241 and rs35051736 affect the odds of recurrent adenomas with villous histology.")</data>
      <data key="d6">chunk-2fb95100a1290b27baae869c6560419a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENETIC INFLUENCE&quot;" target="&quot;REC8&quot;">
      <data key="d4">17.0</data>
      <data key="d5">"The REC8 gene's role in meiosis is impacted by genetic variations identified in the analysis of T1D susceptibility.")</data>
      <data key="d6">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;C.428_430DELAAG VARIANT AMPLICON&quot;" target="&quot;WT SAMPLE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The wt sample is differentiated from variant amplicons using HRMA analysis.")</data>
      <data key="d6">chunk-1327975b50e4a0aac1792cb595041ee5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;C.428_430DELAAG VARIANT AMPLICON&quot;" target="&quot;HOMOZYGOUS SAMPLE/">
      <data key="d4">1.0</data>
      <data key="d5">"Homozygous samples for c.428_430delAAG variant are identified through HRMA analysis.")</data>
      <data key="d6">chunk-1327975b50e4a0aac1792cb595041ee5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;C.428_430DELAAG VARIANT AMPLICON&quot;" target="&quot;HETEROZYGOUS SAMPLE/">
      <data key="d4">1.0</data>
      <data key="d5">"Heterozygous samples for c.428_430delAAG variant are identified through HRMA analysis.")</data>
      <data key="d6">chunk-1327975b50e4a0aac1792cb595041ee5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;C.1186C &gt; T VARIANT AMPLICON&quot;" target="&quot;RS114368325 SNPS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Amplicon corresponding to the c.1186C &gt; T variant is genotyped using SNP rs114368325.")</data>
      <data key="d6">chunk-1327975b50e4a0aac1792cb595041ee5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;C.1186C &gt; T VARIANT AMPLICON&quot;" target="&quot;WT SAMPLE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The wt sample is also differentiated from variant amplicons using HRMA analysis.")</data>
      <data key="d6">chunk-1327975b50e4a0aac1792cb595041ee5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;C.1186C &gt; T VARIANT AMPLICON&quot;" target="&quot;HOMOZYGOUS SAMPLE/">
      <data key="d4">1.0</data>
      <data key="d5">"Homozygous samples for c.1186C &gt; T variant are identified through HRMA analysis.")</data>
      <data key="d6">chunk-1327975b50e4a0aac1792cb595041ee5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;C.1186C &gt; T VARIANT AMPLICON&quot;" target="&quot;HETEROZYGOUS SAMPLE/">
      <data key="d4">1.0</data>
      <data key="d5">"Heterozygous samples for c.1186C &gt; T variant are identified through HRMA analysis.")</data>
      <data key="d6">chunk-1327975b50e4a0aac1792cb595041ee5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DUPLEX ASSAY&quot;" target="&quot;INTRA-ASSAY PRECISION&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The duplex assay performed in one test ensures full superimposability and reproducibility for genotyping samples.")</data>
      <data key="d6">chunk-1327975b50e4a0aac1792cb595041ee5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INTER-ASSAY PRECISION&quot;" target="&quot;TRIPLE PCR/HRM EXPERIMENTS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Across multiple experiments, inter-assay precision is ensured by achieving reproducible results using different samples.")</data>
      <data key="d6">chunk-1327975b50e4a0aac1792cb595041ee5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SERIAL DILUTIONS&quot;" target="&quot;VARIANT ALLELE FREQUENCY&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The sensitivity of the HRMA technique allows distinguishing variants even at lower frequencies.")</data>
      <data key="d6">chunk-1327975b50e4a0aac1792cb595041ee5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NORMALIZED TM VALUES&quot;" target="&quot;RS777676129 SNPS AND RS114368325 SNPS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The Tm values from the HRMA analysis are characteristic of different genotypes for SNPs rs777676129 and rs114368325.")</data>
      <data key="d6">chunk-1327975b50e4a0aac1792cb595041ee5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NORMALIZED TM VALUES&quot;" target="&quot;C.428_430DELAAG VARIANT AMPLICON AND C.1186C &gt; T VARIANT AMPLICON&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The Tm differences allow distinguishing the two amplicons corresponding to different variants.")</data>
      <data key="d6">chunk-1327975b50e4a0aac1792cb595041ee5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;10 DNA SAMPLES WITH IIH SUSPICIONS&quot;" target="&quot;DUPLEX-PCR/HRMA PROTOCOL/">
      <data key="d4">1.0</data>
      <data key="d5">"The protocol is validated on further 10 DNA samples having the suspicion of idiopathic intracranial hypertension (IIH).")</data>
      <data key="d6">chunk-1327975b50e4a0aac1792cb595041ee5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DUPLEX-PCR/HRMA PROTOCOL/" target="&quot;1 HETEROZYGOUS C.428_430DELAAG SAMPLE/">
      <data key="d4">1.0</data>
      <data key="d5">"Specific heterozygous sample for c.428_430delAAG variant is identified through the protocol.")</data>
      <data key="d6">chunk-1327975b50e4a0aac1792cb595041ee5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DUPLEX-PCR/HRMA PROTOCOL/" target="&quot;1 HETEROZYGOUS C.1186C &gt; T SAMPLE/">
      <data key="d4">1.0</data>
      <data key="d5">"Specific heterozygous sample for c.1186C &gt; T variant is identified through the protocol.")</data>
      <data key="d6">chunk-1327975b50e4a0aac1792cb595041ee5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MEDIAN NERVE COMPOUND MOTOR ACTION POTENTIALS&quot;" target="&quot;CLINICAL NEUROPHYSIOLOGY STUDIES&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The assessments showed normal levels indicative of healthy motor function.")</data>
      <data key="d6">chunk-c5f88943265b25ad302b08fd04a602d7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MEDIAN NERVE CONDUCTION VELOCITY&quot;" target="&quot;CLINICAL NEUROPHYSIOLOGY STUDIES&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"This measurement was within the norm, suggesting normal neural transmission speed.")</data>
      <data key="d6">chunk-c5f88943265b25ad302b08fd04a602d7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MEDIAN NERVE SENSORY ACTION POTENTIAL&quot;" target="&quot;CLINICAL NEUROPHYSIOLOGY STUDIES&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Sensory assessment revealed an elevated response compared to typical infant levels.")</data>
      <data key="d6">chunk-c5f88943265b25ad302b08fd04a602d7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CEREBROSPINAL FLUID COPPER AND CATECHOLAMINE RATIOS&quot;" target="&quot;BIOCHEMICAL FINDINGS&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Levels in cerebrospinal fluid indicated no copper overload or Menkes disease characteristics based on these ratios.")</data>
      <data key="d6">chunk-c5f88943265b25ad302b08fd04a602d7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;WILD TYPE: MUTANT ALLELE RATIOS&quot;" target="&quot;COMPARATIVE ANALYSIS&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The wild type: mutant allele ratio was estimated using densitometry and Q-RT-PCR methods, with different levels found in blood compared to fibroblast DNA.")</data>
      <data key="d6">chunk-c5f88943265b25ad302b08fd04a602d7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CLINICAL OUTCOME&quot;" target="&quot;P1001L MUTATION&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The development assessment results were influenced by the presence of the P1001L genetic variant.")</data>
      <data key="d6">chunk-c5f88943265b25ad302b08fd04a602d7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIAGNOSTIC TESTS&quot;" target="&quot;MOLECULAR ANALYSES&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Tests like MRI and clinical neurophysiology were part of the diagnostic process that was affected by molecular findings.")</data>
      <data key="d6">chunk-c5f88943265b25ad302b08fd04a602d7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;P1001L MUTATION&quot;" target="&quot;MOLECULAR ANALYSES&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The P1001L mutation was confirmed by creating a novel BsmAI restriction site.")</data>
      <data key="d6">chunk-c5f88943265b25ad302b08fd04a602d7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MOLECULAR ANALYSES&quot;" target="&quot;BSMAI DIGESTION LEVEL&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"BsmAI digestion levels were compared between whole blood DNA and fibroblast DNA, showing differences in mosaicism.")</data>
      <data key="d6">chunk-c5f88943265b25ad302b08fd04a602d7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SE-DEPLETED MEDIUM&quot;" target="&quot;TR1&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The presence of TR1 gene is influenced by conditions with depleted selenium supply.")</data>
      <data key="d6">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SE-DEPLETED MEDIUM&quot;" target="&quot;IDI-C CELLS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Cell line IDI-C exhibits altered behavior or performance when grown in conditions deficient in selenium supply.")&lt;SEP&gt;"Cell line IDI-C shows differences in response to selenium conditions compared to other cell types or states when grown under Se-depleted conditions.")</data>
      <data key="d6">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SE-SUPPLEMENTED MEDIUM&quot;" target="&quot;EFFECT ON CELL VIABILITY&quot;/&quot;IMPACT ON ANTIOXIDANT ENZYME ACTIVITY&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"In Se-supplemented medium, the GPx4 protein levels increased significantly in IDI-C cells compared to those expressing the IDI-T transgene, suggesting a stronger antioxidant response.")</data>
      <data key="d6">chunk-c7872499c2a84b16c506a135d8033bb7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SE-SUPPLEMENTED MEDIUM&quot;" target="&quot;CELL VIABILITY&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Selenium supplementation can have an impact on cellular viability under certain conditions, such as oxidative stress exposure.")</data>
      <data key="d6">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SE-SUPPLEMENTED MEDIUM&quot;" target="&quot;CELL VIABILITY UNDER HIGH SE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Cells treated with selenium supplementation show improved viability compared to standard growth conditions.")</data>
      <data key="d6">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SELENOPROTEIN H MRNA&quot;" target="&quot;GPX1&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"There seems no direct relationship based on the provided context. GPx1 and selenoprotein H are encoded by different genes, hence they might be related in terms of selenium metabolism but not specifically indicated by the text.")</data>
      <data key="d6">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SE&quot;" target="&quot;GPX4&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Selenium (Se) affects GPx4 expression and function, impacting antioxidant defense mechanisms.")</data>
      <data key="d6">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CELL VIABILITY&quot;" target="&quot;0.5 MM TERT-BUTYLHYDROPEROXIDE CHALLENGE&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The application of this chemical agent to cells may induce a state resembling cellular 'disease' by causing oxidative damage and stress.")</data>
      <data key="d6">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CELL VIABILITY&quot;" target="&quot;SELENIUM (SE)&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"The availability and concentration of selenium influence the cellular health, as evidenced by contrasting outcomes under different conditions.")</data>
      <data key="d6">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CELL VIABILITY&quot;" target="&quot;DISEASE CONTEXT IN TERMS OF OXIDATIVE STRESS&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Indications of cell damage or dysfunction that could be related to disease states when cells are exposed to high levels of reactive oxygen species (ROS).")</data>
      <data key="d6">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CELL VIABILITY&quot;" target="&quot;SE SUPPLY&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Selenium availability is directly correlated with the level of cell viability and functional capacity under various experimental conditions.")</data>
      <data key="d6">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;0.5 MM TERT-BUTYLHYDROPEROXIDE CHALLENGE&quot;" target="&quot;RESPONSE OF CELLS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The oxidative stress induced by tert-butylhydroperoxide affects cell health, impacting factors like apoptosis or cell cycle progression.")</data>
      <data key="d6">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SE SUPPLY&quot;" target="&quot;IDI-C CELLS AND IDI-T CELLS&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Different levels of selenium availability affect the behavior and response of IDI-C and IDI-T cell lines, impacting viability and sensitivity to oxidative challenges.")</data>
      <data key="d6">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SELENIUM (SE)&quot;" target="&quot;CELLULAR DEFENSE MECHANISMS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The presence and supply of selenium influence the effectiveness of various cellular defense systems against oxidative stress.")</data>
      <data key="d6">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SE-DEPLETED MEDIUM/" target="|&gt;OXIDATIVE CHALLENGE&quot;/&quot;SE SUPPLY CONDITIONS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The transfected cells showed lower viability over a range of tert-butylhydroperoxide concentrations with 40–60% viability when challenged with 1–5 mM tert-butylhydroperoxide.")</data>
      <data key="d6">chunk-c7872499c2a84b16c506a135d8033bb7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SE-DEPLETED MEDIUM/" target="|&gt;GPX ACTIVITY&quot;/&quot;IMPACT ON SELENOPROTEINS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"In Se-depleted conditions, GPx activity was lower compared to that in Se-supplemented cells.")</data>
      <data key="d6">chunk-c7872499c2a84b16c506a135d8033bb7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SE SUPPLY CONDITIONS/" target="|&gt;GPX4 PROTEIN LEVELS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"When sufficient Se is present, the IDI-C cell line showed a greater increase in GPx4 content than the IDI-T cell line when grown under Se-supplemented conditions.")</data>
      <data key="d6">chunk-c7872499c2a84b16c506a135d8033bb7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;0.5 NM SE&quot; OR &quot;1 NM SE&quot;" target="&quot;CELL VIABILITY UNDER LOW SELENIUM CONDITIONS&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Cells exposed to very low concentrations of selenium show decreased viability compared to those grown in conditions with adequate selenium supply.")</data>
      <data key="d6">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;0.5 NM SE&quot; OR &quot;1 NM SE&quot;" target="&quot;IMPACT ON CELLULAR RESPONSES&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Lower concentrations of selenium have distinct effects on cells, often leading to different outcomes compared to adequate selenium levels.")</data>
      <data key="d6">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CHAT MUTATIONS&quot;" target="&quot;EXPRESSION LEVEL&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Eight mutants expressed at significantly lower levels than wild-type and five of these (p.Trp421Ser, p.Ser498Pro, p.Thr553Asn, p.Ala557Thr, p.Ser572Trp) expressed at &lt;50% of wild-type.")</data>
      <data key="d6">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EXPRESSION LEVEL&quot;" target="&quot;ALLELIC ASSOCIATION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"EBNA2 altered the allelic association with expression compared to that found in B cells.")</data>
      <data key="d6">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;KINETIC PARAMETERS&quot;" target="&quot;MISSENSE MUTATIONS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Ten mutations alter one or more rate constants of ChAT activation and two mutations compromise the thermal stability of the mutant protein.")</data>
      <data key="d6">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MISSENSE MUTATIONS&quot;" target="&quot;IMPACT ON PROTEIN STABILITY&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Mutations like p.Ala557Thr compromise the thermal stability of ChAT.")</data>
      <data key="d6">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COMPARISON WITH MUTANT CHATS&quot;" target="&quot;WILD-TYPE CHAT&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Compared the expression levels of wild-type CHAT versus mutant CHATs.")</data>
      <data key="d6">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CONSERVATION ACROSS SPECIES&quot;" target="&quot;RESIDUES&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The study highlights the importance of conserved residues like Met202, Trp421, Thr553, Ala557 among canine, murine, rat, chicken, Drosophila, and C. elegans ChAT proteins.")</data>
      <data key="d6">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MUTATIONS&quot;" target="&quot;PHENOTYPIC IMPACT&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The presence of specific mutations like p.Ala557Thr in multiple patients indicates their influence on the phenotype.")</data>
      <data key="d6">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BCL2L11&quot;" target="&quot;GENOMIC VARIANT (RS726430)&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The CpG site in BCL2L11 was associated with the SNP rs726430.")</data>
      <data key="d6">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CEP55&quot;" target="&quot;GENOMIC VARIANT (RS12782691)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The CpG site in CEP55 was linked to the SNP rs12782691.")</data>
      <data key="d6">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CPB1&quot;" target="&quot;GENOMIC VARIANT (RS16861015)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The CpG site associated with CPB1 had a connection with rs16861015 SNP.")</data>
      <data key="d6">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ZNF341&quot;" target="&quot;CPG SITE (CG11842944)&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Methylation levels at this CpG were linked to heart failure.")</data>
      <data key="d6">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HIST1H4D 3'-UTR&quot;" target="&quot;CPG SITE (CG08170869)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Methylation at this CpG site was associated with T2D.")</data>
      <data key="d6">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DVL1 BODY&quot;" target="&quot;CPG SITE (CG03465880)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"This CpG site within DVL1 showed an association with the risk of developing T2D.")</data>
      <data key="d6">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NADH&quot;" target="&quot;FUNCTIONING&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"NADH is a key component in the electron transport chain.")</data>
      <data key="d6">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FMN&quot;" target="&quot;BINDING&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"FMN binds to proteins like iron–sulfur clusters for proper functioning.")</data>
      <data key="d6">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IRON–SULFUR CLUSTER&quot;" target="&quot;PROTEIN FUNCTION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Iron–sulfur clusters are part of several enzymes, including the protein mentioned.")</data>
      <data key="d6">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;C.437G&gt;A&quot;" target="&quot;MUTATION&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Mutation changes serine (Ser) to aspartic acid (Asp) at position 146 in COQ2 gene.")</data>
      <data key="d6">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MT-ND1 GENE&quot;" target="&quot;MUTATION&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Mutations in MT-ND1 can lead to disorders like Leber optic atrophy, mitochondrial complex I deficiency, or MELAS.")</data>
      <data key="d6">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BINDING&quot;" target="&quot;GLU246LYS MUTATION&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The mutation could impact NADH binding to proteins.")</data>
      <data key="d6">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MUTATION&quot;" target="&quot;C.1159C&gt;T&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Mutation causes arginine (Arg) change to a premature stop codon at amino acid position 387.")</data>
      <data key="d6">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DRINKS PER DRINKING DAY&quot;" target="&quot;PLACEBO VS OLANZAPINE&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Individuals with the CT genotype consumed more drinks on a drinking day when treated with placebo compared to olanzapine.")</data>
      <data key="d6">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALDH2 GENOTYPE&quot;" target="&quot;LATENCY TO FIRST DRINK&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"There was a significant main effect of ALDH2 genotype on latency to first drink, with Asn40 homozygotes having shorter latencies.")</data>
      <data key="d6">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PLACEBO&quot;" target="&quot;TOPIRAMATE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Topiramate and placebo were used in the study, with topiramate showing more efficacy against HDDs compared to placebo (NNT = 5.29).")</data>
      <data key="d6">chunk-0c7ab28db433187759e760725a105836</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENE/" target="ASN40 HOMOZYGOTES&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The Asn40 homozygote group, when administered the placebo, demonstrated unique responses to alcohol-induced stimulation.")</data>
      <data key="d6">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENE/" target="MEDICATION × GENOTYPE INTERACTION/">
      <data key="d4">70.0</data>
      <data key="d5">"Environmental Factors"/&gt;"Medications' combined effects with OPRM1 gene variants on alcohol-induced responses were considered when looking at external factors.")&lt;SEP&gt;"Environmental Factors"/&gt;"The combined effect of certain medications with OPRM1 gene variants played a key role in evaluating alcohol responses while considering environmental influences.")&lt;SEP&gt;"Environmental Factors"/&gt;"The combined effect of certain medications with OPRM1 gene variants significantly influenced evaluations of alcohol responses while taking into account external influences.")&lt;SEP&gt;"Environmental Factors"/&gt;"The combined impact of certain medications with OPRM1 gene variants played a key role in evaluating alcohol responses while considering environmental influences.")&lt;SEP&gt;"Environmental Factors"/&gt;"The combined influence of certain medications with OPRM1 gene variants played an important role in evaluating alcohol responses while taking into account environmental influences.")&lt;SEP&gt;"Environmental Factors"/&gt;"The combined influence of certain medications with OPRM1 gene variants significantly shaped evaluations of alcohol responses while taking into account environmental influences.")&lt;SEP&gt;"Environmental Factors"/&gt;"The combined influence of medications with OPRM1 gene variants shaped the analysis of alcohol responses when considering external factors.")</data>
      <data key="d6">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENE/" target="BRAC × MEDICATION × GENOTYPE INTERACTION/">
      <data key="d4">70.0</data>
      <data key="d5">"Environmental Factors"/&gt;"The combined effect of BrAC levels with different medications and OPRM1 gene variants influenced assessments related to alcohol responses when examining environmental influences.")&lt;SEP&gt;"Environmental Factors"/&gt;"The combined effect of differing BrAC levels with specific medications and OPRM1 gene variants significantly influenced evaluations of alcohol responses while considering environmental influences.")&lt;SEP&gt;"Environmental Factors"/&gt;"The combined effect of differing BrAC levels with specific medications and OPRM1 gene variants was crucial for assessing alcohol responses while considering environmental influences.")&lt;SEP&gt;"Environmental Factors"/&gt;"The combined effect of varying BrAC levels with specific medications and OPRM1 gene variants significantly influenced evaluations of alcohol responses while considering environmental influences.")&lt;SEP&gt;"Environmental Factors"/&gt;"The combined influence of varying BrAC levels with specific medications and OPRM1 gene variants significantly influenced evaluations of alcohol responses while considering environmental influences.")&lt;SEP&gt;"Environmental Factors"/&gt;"The combined influence of varying BrAC levels with specific medications and OPRM1 gene variants was pivotal in assessing alcohol responses while considering environmental influences.")&lt;SEP&gt;"Environmental Factors"/&gt;"The intricate relationship among BrAC levels, various medications, and OPRM1 gene variants influenced evaluations related to alcohol responses.")</data>
      <data key="d6">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENE/" target="ASN40 HOMOZYGOTES + PLACEBO GROUP/">
      <data key="d4">70.0</data>
      <data key="d5">"Stimulation"/&gt;"The Asn40 homozygote group, when receiving the placebo, showed distinct responses related to alcohol-induced stimulation compared to others.")&lt;SEP&gt;"Stimulation"/&gt;"The effect of being an Asn40 homozygote with exposure to the placebo led to differentiated responses in alcohol-induced stimulation when compared to others.")&lt;SEP&gt;"Stimulation"/&gt;"The effect of being an Asn40 homozygote, when exposed to a placebo condition, led to differentiated responses in alcohol-induced stimulation relative to others.")&lt;SEP&gt;"Stimulation"/&gt;"The effect of being an Asn40 homozygote, when exposed to a placebo condition, led to distinctive responses in alcohol-induced stimulation relative to others.")&lt;SEP&gt;"Stimulation"/&gt;"The influence of being an Asn40 homozygote, when exposed to a placebo condition, led to distinctive responses in alcohol-induced stimulation relative to others.")&lt;SEP&gt;"Stimulation"/&gt;"The influence of being an Asn40 homozygote, when in the placebo condition, led to distinctive alcohol-induced stimulation responses relative to others.")</data>
      <data key="d6">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENETIC FACTOR&quot;" target="&quot;MEDICATION EFFECTS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The analysis found no significant medication × genotype interaction regarding the effects on alcohol self-administration or latency to first drink consumption.")</data>
      <data key="d6">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENETIC FACTOR&quot;" target="&quot;PHARMACOGENETIC RESULTS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Treatments of OPRM1 genotype as a three-level variable did not significantly affect the reported pharmacogenetic outcomes related to alcohol self-administration and latency to drink.")</data>
      <data key="d6">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALDH2 RS671 GENOTYPES&quot;" target="&quot;DAILY DRINKS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"There's an association between ALDH2 rs671 genotypes and daily alcohol consumption, impacting the pattern of drinks per day.")</data>
      <data key="d6">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALDH2 RS671 GENOTYPES&quot;" target="&quot;CORTISOL LEVELS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The ALDH2 rs671 genotypes affect cortisol levels differently between men and women, influenced by the sex-specific patterns of genotypes.")</data>
      <data key="d6">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CORTISOL LEVELS&quot;" target="&quot;HYPERTENSION&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Hypertension, as a confounding variable, may affect cortisol levels when considering alcohol consumption in linear regression models.")</data>
      <data key="d6">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CORTISOL LEVELS&quot;" target="&quot;RS671 POLYMORPHISM&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The rs671 polymorphism affects cortisol levels due to its influence on alcohol metabolism, which can impact the body's stress response.")</data>
      <data key="d6">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HYPERTENSION&quot;" target="&quot;OXIDATIVE STRESS&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Oxidative stress contributes to the development and progression of hypertension through various cellular mechanisms.")</data>
      <data key="d6">chunk-41c7131af28e2a745ef6b88b8601860f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MR (MENDELIAN RANDOMIZATION)&quot;" target="&quot;ASSOCIATION BETWEEN ALCOHOL CONSUMPTION AND BLOOD CORTISOL LEVEL&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The MR technique was used to assess potential causal links between genetically predicted alcohol intake levels and changes in blood cortisol levels.")</data>
      <data key="d6">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HUA&quot;" target="&quot;TG&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Increased triglyceride levels were observed in the HUA group.")</data>
      <data key="d6">chunk-befd5ea20007b1d02d987897c798dadd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HUA&quot;" target="&quot;LDL&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Participants with Hyperuricemia showed higher LDL levels than those without.")</data>
      <data key="d6">chunk-befd5ea20007b1d02d987897c798dadd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HUA&quot;" target="&quot;HYPERTENSIVE PATIENTS&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"A higher percentage of hypertensive patients were identified among those with Hyperuricemia (HUA).")</data>
      <data key="d6">chunk-befd5ea20007b1d02d987897c798dadd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HUA&quot;" target="&quot;DIURETICS&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The usage ratio of diuretics was not significantly different between the HUA cases and controls.")</data>
      <data key="d6">chunk-befd5ea20007b1d02d987897c798dadd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HUA&quot;" target="&quot;FBG&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"No significant difference in Fasting Blood Glucose (FBG) levels was observed between HUA cases and controls.")</data>
      <data key="d6">chunk-befd5ea20007b1d02d987897c798dadd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HUA&quot;" target="&quot;ABC&quot;">
      <data key="d4">13.0</data>
      <data key="d5">"The study found that HUA cases showed a significant association with the risk alleles of ABC-related genes, as well as an increased sUA level and HUA risk.")</data>
      <data key="d6">chunk-befd5ea20007b1d02d987897c798dadd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HUA&quot;" target="&quot;SUA&quot;">
      <data key="d4">0.0</data>
      <data key="d5">"Increased sUA level is associated with HUA risk among rs2231142 T allele carriers.")</data>
      <data key="d6">chunk-7091ed039203b69ad83d281b22c89579</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SUA LEVEL&quot;" target="&quot;CARDIOVASCULAR RISK FACTORS&quot;">
      <data key="d4">0.0</data>
      <data key="d5">"Increased sUA levels are associated with enhanced cardiovascular risks among rs2231142 T allele carriers.")</data>
      <data key="d6">chunk-7091ed039203b69ad83d281b22c89579</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS2231142 T ALLELE&quot;" target="&quot;CARDIOVASCULAR RISK FACTORS&quot;">
      <data key="d4">0.0</data>
      <data key="d5">"Carriers of the rs2231142 T allele are associated with cardiovascular risk factors, including sUA levels and HUA risk.")</data>
      <data key="d6">chunk-7091ed039203b69ad83d281b22c89579</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HEMATOCRIT&quot;" target="&quot;CARDIOVASCULAR RISK FACTORS&quot;">
      <data key="d4">0.0</data>
      <data key="d5">"Abnormal hematocrit may indicate underlying conditions that can influence cardiovascular health and risk factors.")</data>
      <data key="d6">chunk-7091ed039203b69ad83d281b22c89579</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CHOLESTEROL&quot;" target="&quot;TOTAL STOOL BA&quot;">
      <data key="d4">14.0</data>
      <data key="d5">"The total content of bile acids in feces showed a strong positive correlation with serum cholesterol levels, suggesting a relationship between dietary factors and bile acid metabolism.")</data>
      <data key="d6">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENETIC VARIANT/" target="&quot;SLC2A9 RS3733951&quot;/&quot;ABCG2 RS2231142&quot;/&quot;SLC22A12 RS893006&quot;">
      <data key="d4">1.0</data>
      <data key="d5">Genetic Risk Score"</data>
      <data key="d6">chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENETIC VARIANT/" target="ENVIRONMENTAL FACTOR&quot;/&quot;CARDIOVASCULAR RISK FACTOR&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Environmental Factor"/"Lifestyle Factor/&lt;SEP&gt;"Environmental Factor/</data>
      <data key="d6">chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENETIC VARIANT/" target="ENVIRONMENTAL FACTOR&quot;/&quot;CARDIOVASCULAR RISK FACTOR/">
      <data key="d4">5.0</data>
      <data key="d5">sUA level/</data>
      <data key="d6">chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SUA LEVEL&quot;/&quot;SLC2A9 RS3733951&quot;/&quot;ABCG2 RS2231142/" target="SLC22A12 RS893006&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Metabolic Pathway/</data>
      <data key="d6">chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;METABOLIC PATHWAY/" target="&quot;SUA LEVEL&quot;/&quot;RS13206634&quot;">
      <data key="d4">1.0</data>
      <data key="d5">Physiological Process"</data>
      <data key="d6">chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;METABOLIC PATHWAY/" target="&quot;SUA LEVEL&quot;/&quot;RS7509837&quot;">
      <data key="d4">1.0</data>
      <data key="d5">Physiological Process/</data>
      <data key="d6">chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EGFR&quot;" target="&quot;CKD&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The eGFR decreasing allele is associated with increased risk of CKD in individuals.")</data>
      <data key="d6">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EGFR&quot;" target="&quot;ESRD&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"A decrease in eGFR is also a defining characteristic for the occurrence of ESRD, linking kidney function measures to disease outcomes.")</data>
      <data key="d6">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T1D&quot;" target="&quot;KIDNEY FUNCTION&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Type 1 Diabetes similarly affects kidney health through diabetic nephropathy, which can be reflected in changes to eGFR.")</data>
      <data key="d6">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T1D&quot;" target="&quot;CELLULAR MECHANISM&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"T1D development involves changes in expression of IRF1 and STAT1, which might be linked through a common causal variant with rs181206G.")</data>
      <data key="d6">chunk-1b40d071abac0ba432a9fb0096796f45</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SLC34A1&quot;" target="&quot;PHOSPHATE REABSORPTION&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Mutations or variations in SLC34A1 may alter phosphate reabsorption, impacting kidney function.")</data>
      <data key="d6">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DCDC5-MPPED2&quot;" target="&quot;RETINAL DEVELOPMENT&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"While primarily associated with vision, changes in DCDC5-MPPED2 may indirectly influence kidney health via shared signaling pathways or genetic networks.")</data>
      <data key="d6">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIETARY PATTERN Y&quot;" target="&quot;RISK OR PROTECTION&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"The dietary pattern Y may provide protective benefits against kidney disease through specific nutrients and antioxidants.")</data>
      <data key="d6">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CHIP-SEQ BINDING SITES&quot;" target="&quot;RS35923643&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The genomic variant rs35923643 was found to have potential binding sites for transcription factors in a 700bp region as determined by ChIP-seq experiments.")</data>
      <data key="d6">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HISTONE DEACETYLASE INHIBITORS&quot;" target="&quot;POTENTIAL TREATMENT&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The potential use of histone deacetylase inhibitors as treatments for kidney disease")</data>
      <data key="d6">chunk-45a965c3c3013c70d0fa0f1680283083</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CHIP-SEQ BINDING SITES FOR HDAC8&quot;" target="&quot;SIGNIFICANT EFFECTS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"There are significant effects on posterior probability for variants near HDAC8 binding sites")</data>
      <data key="d6">chunk-45a965c3c3013c70d0fa0f1680283083</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;KIDNEY FUNCTION&quot;" target="&quot;SNP Z&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The SNP Z is significantly associated with a decrease in eGFR and an increased risk of kidney disease.")</data>
      <data key="d6">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HFE GENE&quot;" target="&quot;IRON METABOLISM&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Variants in the HFE gene affect iron metabolism, which can impact kidney health through oxidative stress and inflammation.")</data>
      <data key="d6">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LEAD SNPS&quot;" target="&quot;POSTERIOR PROBABILITY&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"lead SNPs at certain loci contribute significantly to the posterior probability of driving association signals.")</data>
      <data key="d6">chunk-45a965c3c3013c70d0fa0f1680283083</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NFATC1 GENOMIC VARIANT&quot;" target="&quot;RGS14 GENOMIC VARIANT&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Ancestral orthologs for both genes are present in Drosophila melanogaster")</data>
      <data key="d6">chunk-45a965c3c3013c70d0fa0f1680283083</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NFATC1 GENOMIC VARIANT&quot;" target="&quot;REGULATORY CHROMATIN STATE IN RPTECS&quot;&amp;&quot;HRCES&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The lead SNPs at NFATC1 locus overlaps with DHSs in renal proximal tubular epithelial cells (RPTECs) and renal cortical epithelial cells (HRCEs)")</data>
      <data key="d6">chunk-45a965c3c3013c70d0fa0f1680283083</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RGS14 GENOMIC VARIANT&quot;" target="&quot;LONGEVITY &amp; STRESS RESISTANCE&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Reduction in expression of the RGS14 ortholog loco results in longer lifespan and stress resistance")</data>
      <data key="d6">chunk-45a965c3c3013c70d0fa0f1680283083</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ASSOCIATION SIGNALS&quot;" target="&quot;KIDNEY DHSS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Variants mapping to non-coding sequence at these loci account for more than 99.4% of the probability of driving eGFR association.")</data>
      <data key="d6">chunk-45a965c3c3013c70d0fa0f1680283083</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DOMESTICALLY ACQUIRED INFECTIONS&quot;" target="&quot;TREATMENT&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Patients with domestically acquired campylobacteriosis were more likely to receive antimicrobial treatment compared to those with travel-related infections.")</data>
      <data key="d6">chunk-0d155c005072e55d94179ce7952bf5a9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ANTIMICROBIAL DRUG TREATMENT&quot;" target="&quot;QUINOLONE-RESISTANT ISOLATES&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Quinolone-resistant isolates showed decreased susceptibility to fluoroquinolones compared to primary model, but sample size was lower resulting in increased confidence intervals.")</data>
      <data key="d6">chunk-0d155c005072e55d94179ce7952bf5a9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;QUINOLONE RESISTANCE&quot;" target="&quot;TRAVEL&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Foreign travel was associated with a higher proportion of quinolone-resistant Campylobacter infections compared to domestic infections.")</data>
      <data key="d6">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;QUINOLONE RESISTANCE&quot;" target="&quot;C. COLI&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Of the three erythromycin-resistant isolates, two were also quinolone-resistant and originated from travelers returning to Denmark from Spain and Portugal.")</data>
      <data key="d6">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;QUINOLONE RESISTANCE&quot;" target="&quot;DESTINATION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Travel to certain regions like southern Europe and Southeast Asia was significantly associated with high prevalence of quinolone-resistant Campylobacter infections.")</data>
      <data key="d6">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;QUINOLONE RESISTANCE&quot;" target="&quot;FOREIGN TRAVEL&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Foreign travel, especially to specific destinations like Spain and Portugal, significantly increased the risk of acquiring a quinolone-resistant Campylobacter infection.")</data>
      <data key="d6">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;QUINOLONE RESISTANCE&quot;" target="&quot;TRAVEL DESTINATIONS&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Certain destinations like southern Europe and Southeast Asia were associated with higher proportions of quinolone-resistant Campylobacter infections than others.")</data>
      <data key="d6">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;QUINOLONE RESISTANCE&quot;" target="&quot;SWIMMING&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Swimming was identified as an independent risk factor for acquiring a quinolone-resistant C. jejuni infection, though the exact mechanism is unclear.")</data>
      <data key="d6">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;QUINOLONE RESISTANCE&quot;" target="&quot;C. JEJUNI STRAIN CO-INFECTION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"A patient was found to have two C. jejuni strains with identical serotype and RiboGroup, but different susceptibility patterns towards quinolones due to a Thr-86 to Ala-86 mutation in gyrA.")</data>
      <data key="d6">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;C. JEJUNI&quot;" target="&quot;DURATION OF ILLNESS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The mean duration of illness was longer for patients infected by quinolone-resistant C. jejuni compared to those infected by quinolone-sensitive strains.")</data>
      <data key="d6">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;C. JEJUNI&quot;" target="&quot;QUINOLONE SENSITIVITY/RESISTANCE&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"C. jejuni infections did not differ in severity when comparing resistant to sensitive strains, but there was a difference in the mean duration of illness.")</data>
      <data key="d6">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;QUINOLONE SENSITIVITY/RESISTANCE&quot;" target="&quot;FRESH POULTRY&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Eating fresh poultry other than chicken and turkey was associated with an increased risk of quinolone-resistant infections.")</data>
      <data key="d6">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;C. COLI STRAINS&quot;" target="&quot;QUINOLONE SUSCEPTIBILITY&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The RiboGroups of C. coli isolates play a role in identifying the different susceptibilities to quinolones among the strains.")</data>
      <data key="d6">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;QUINOLONE SUSCEPTIBILITY&quot;" target="&quot;C. JEJUNI STRAINS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The serotypes of C. jejuni isolates can influence their sensitivity patterns against quinolones.")</data>
      <data key="d6">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOOD ISOLATES&quot;" target="&quot;ORIGIN&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The origin of food isolates was traced back to various sources including Danish-bred food animals, imported foods from France, Italy, and the United Kingdom.")</data>
      <data key="d6">chunk-0d155c005072e55d94179ce7952bf5a9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RETAIL FOOD PRODUCTS AND BROILER CHICKENS&quot;" target="&quot;SOURCE&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Human isolates of Campylobacter bacteria were compared with isolates obtained from retail food products (chicken, turkey, pork), chicken fecal samples, and broiler chickens.")</data>
      <data key="d6">chunk-0d155c005072e55d94179ce7952bf5a9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TAS&quot;" target="&quot;SOCIAL DISINHIBITION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Each unit increase in TAS score is associated with an estimated 0.20 points increase in social disinhibition scores.")</data>
      <data key="d6">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DAS&quot;" target="&quot;SOCIAL DISINHIBITION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"A participant's overall DAS score increases their social disinhibition score by 0.45 points for each unit increase.")</data>
      <data key="d6">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LINGUISTIC ACCULTURATION&quot;" target="&quot;SOCIAL DISINHIBITION&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"A 1-point increase in linguistic acculturation score leads to a 0.30 point increase in social disinhibition scores.")</data>
      <data key="d6">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EIGENVALUE 3&quot;" target="&quot;PRINCIPAL COMPONENT 3&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"PC3 accounted for additional variance related to social disinhibition among study participants.")</data>
      <data key="d6">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SOCIAL DISINHIBITION SCORE&quot;" target="&quot;GENDER AND PARENTAL EDUCATION&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Gender and parental education were not significantly associated with social disinhibition score.")</data>
      <data key="d6">chunk-36d70bb8409856300dd77669e7c1f9ed</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNPS (RS1998220, RS9534511, AND RS4938056)&quot;" target="&quot;INCREASED SOCIAL DISINHIBITION SCORE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The minor alleles for these SNPs were found to contribute positively to the risk of developing a higher social disinhibition score.")</data>
      <data key="d6">chunk-36d70bb8409856300dd77669e7c1f9ed</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DECREASED SOCIAL DISINHIBITION SCORE/" target="&quot;RS16116&quot; &amp; &quot;RS1003921&quot;">
      <data key="d4">4.0</data>
      <data key="d5">Negative Effects on Social Disinhibition"</data>
      <data key="d6">chunk-36d70bb8409856300dd77669e7c1f9ed</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS2023239&quot;" target="&quot;CB1 RECEPTOR&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The rs2023239 variant influences CB1 receptor levels, affecting neurocircuitry related to drug-seeking behavior.")</data>
      <data key="d6">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS2023239&quot;" target="&quot;MEDICATION: OLANZAPINE AND CYPROHEPTADINE HYDROCHLORIDE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The genotypic variant rs2023239 was related to the response to different medications during alcohol consumption studies.")</data>
      <data key="d6">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CANNABINOID RECEPTOR 1/" target="CB1 RECEPTOR/">
      <data key="d4">1.0</data>
      <data key="d5">Anxiety/</data>
      <data key="d6">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALCOHOL CONSUMPTION/" target="&quot;CNR1 GENOTYPE&quot;">
      <data key="d4">10.0</data>
      <data key="d5">Anxiety"&lt;|"Genetic variations in CNR1 may impact responses to alcohol, influencing anxiety levels.")</data>
      <data key="d6">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CT GENOTYPE&quot;" target="&quot;GENOTYPE: TT VS CT AND CC&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Individuals with the CT genotype were compared against those without the variant (TT) in relation to their responses to alcohol and medications.")</data>
      <data key="d6">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;REWARD&quot;" target="&quot;MEDICATION: OLANZAPINE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The response of individuals with the CT genotype was shown to be more rewarding under olanzapine treatment compared to a control medication.")</data>
      <data key="d6">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SELF-REPORTED HIGH&quot;" target="&quot;ACTIVE CONTROL MEDICATION (CYPROHEPTADINE) VS OLANZAPINE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Individuals with the CT genotype reported significantly higher feelings of euphoria when treated with cyproheptadine hydrochloride compared to olanzapine.")</data>
      <data key="d6">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CNR1 VARIATION (RS2035618)&quot;" target="&quot;MEDICATION × GENOTYPE × CUE INTERACTION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The CNR1 gene variant influenced the response to medication when combined with specific genotypes and cues in relation to craving.")</data>
      <data key="d6">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CB1 RECEPTOR LEVELS/" target="&quot;CNR1 GENE&quot;">
      <data key="d4">7.0</data>
      <data key="d5">Disease"&lt;|"Genetic variations in CNR1 can affect CB1 receptor levels, which are associated with addiction and other diseases.")</data>
      <data key="d6">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALCOHOL CUE EXPOSURE&quot;" target="&quot;NEUROCIRCUITRY ACTIVATION/">
      <data key="d4">8.0</data>
      <data key="d5">Disease"&lt;|"Exposure to alcohol cues can activate neurocircuitry that modulates drug-seeking behavior, possibly related to addictive disorders.")</data>
      <data key="d6">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CB1 RECEPTOR REGULATION/" target="&quot;RS2023239 VARIANT&quot;">
      <data key="d4">9.0</data>
      <data key="d5">Alcohol Use"&lt;|"The rs2023239 variant influences CB1 receptor function and its sensitivity to alcohol.")</data>
      <data key="d6">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS2023239 VARIANT/" target="CB1 RECEPTOR REGULATION/">
      <data key="d4">1.0</data>
      <data key="d5">Anxiety/</data>
      <data key="d6">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EXON 3/" target="CANNABINOID RECEPTOR REGULATION/">
      <data key="d4">1.0</data>
      <data key="d5">Alcohol Consumption/</data>
      <data key="d6">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANT/" target="ALTERNATIVE PROMOTER/">
      <data key="d4">1.0</data>
      <data key="d5">Risk Factor/</data>
      <data key="d6">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LIPOPROTEIN LIPASE (LPL)&quot;" target="&quot;ROLE/">
      <data key="d4">2.0</data>
      <data key="d5">Function"</data>
      <data key="d6">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIETARY FAT RESTRICTION&quot;" target="&quot;TREATMENT FOR LPL DEFICIENCY&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"An effective treatment strategy to manage symptoms and complications associated with this genetic disorder.")</data>
      <data key="d6">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ENFAPORT LIPIL&quot;" target="&quot;FORMULA/">
      <data key="d4">4.0</data>
      <data key="d5">Medical Intervention"</data>
      <data key="d6">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AUTOSOMAL RECESSIVE DISORDER/" target="LPL DEFICIENCY&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Genetic Connection"</data>
      <data key="d6">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MUTATION ANALYSIS/" target="GENOMIC DNA&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Diagnostic Method"</data>
      <data key="d6">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CLINICAL SIGNS/" target="PATHOLOGICAL MANIFESTATIONS&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Association between symptoms and conditions"</data>
      <data key="d6">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GASTROINTESTINAL COMPLICATIONS&quot;" target="&quot;OUTCOME OF LPL DEFICIENCY/">
      <data key="d4">8.0</data>
      <data key="d5">High triglyceride levels"</data>
      <data key="d6">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS2832407&quot;" target="&quot;TOPIRAMATE EFFECT&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The rs2832407 variant moderates the effect of topiramate on HDDs, showing a significant difference between C-homozygotes and A-allele carriers.")</data>
      <data key="d6">chunk-0c7ab28db433187759e760725a105836</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS2832407&quot;" target="&quot;A-ALLELE CARRIERS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Individuals carrying at least one copy of the A allele show different responses to topiramate compared to those who are homozygous for the C allele (higher severity of adverse events).")</data>
      <data key="d6">chunk-0c7ab28db433187759e760725a105836</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HDDS&quot;" target="&quot;EFFICACY&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The study aims to determine the effectiveness of topiramate and placebo in managing HDDs.")</data>
      <data key="d6">chunk-0c7ab28db433187759e760725a105836</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;A-ALLELE CARRIERS&quot;" target="&quot;ADVERSE EVENTS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"A-allele carriers showed a significantly higher mean severity rating for adverse events compared to those with other genotypes when taking topiramate.")</data>
      <data key="d6">chunk-0c7ab28db433187759e760725a105836</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;C-HOMOZYGOTES&quot;" target="&quot;EFFECT&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"C-homozygotes showed a significant reduction in HDDs when taking topiramate, with an NNT of 2.28.")</data>
      <data key="d6">chunk-0c7ab28db433187759e760725a105836</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOTYPING AND DATA COLLECTION&quot;" target="&quot;STUDY METHODS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Genotyping was conducted as part of data collection for the study with 93 participants.")</data>
      <data key="d6">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PATIENT CHARACTERISTICS&quot;" target="&quot;POPULATION DESCRIPTION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Patients in the study were predominantly female (55%) and had various malignancies.")</data>
      <data key="d6">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HEALTH CONDITION AND TREATMENT&quot;" target="&quot;MALIGNANCY TYPES AND CHEMOTHERAPY&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The study involved patients diagnosed with gastrointestinal, thoracic, or breast cancers who received highly-emetogenic chemotherapy.")</data>
      <data key="d6">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CINV SEVERITY AND RISK FACTORS&quot;" target="&quot;SYMPTOM ASSESSMENT AND FACTORS&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Risk factors for CINV such as age, sleep hours, and morning sickness were linked to the severity of nausea.")</data>
      <data key="d6">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ASSOCIATION WITH SYMPTOM&quot;" target="&quot;GENETIC RISK FACTOR (ABCB1 RS1045642)&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The genetic variation in ABCB1 was found to be associated with more severe acute nausea compared to other genotypes.")</data>
      <data key="d6">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ANALYSIS RESULTS&quot;" target="&quot;STATISTICAL SIGNIFICANCE AND VARIANCE&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Demographic, clinical, and patient-reported factors explained 13% of the variance in acute nausea; ABCB1 genotype contributed an additional variance (p=0.10).")</data>
      <data key="d6">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BONFERRONI CORRECTION&quot;" target="&quot;DNA MODIFICATION PROFILE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Using Bonferroni correction when analyzing multiple CpG sites to prevent false positives in identifying significant differences.")</data>
      <data key="d6">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DISTINCT REGION&quot;" target="&quot;LACTASE NON-PERSISTENCE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Certain DNA modifications may influence the regulatory functions of LCT gene leading to lactase non-persistence.")</data>
      <data key="d6">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LACTASE NON-PERSISTENCE&quot;" target="&quot;DNA MODIFICATIONS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The situation with MCM6 exon 16 shows significant differences between C-13910 and T-13910 carrying haplotypes, likely similar to the situation of MCM6 intron 13 in that DNA modifications are erased at embryogenesis.")</data>
      <data key="d6">chunk-ea45644d73f260cf365527dcc3af86e1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DNASE I HYPERSENSITIVITY SITES&quot;" target="&quot;CHROMATIN REFERENCE MAPS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The maps showing DNase sensitivity sites overlap with regions of interest for LCT gene modifications, suggesting active regulatory elements.")</data>
      <data key="d6">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LNCRNA LOC100507600&quot;" target="&quot;LCT MRNA&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The correlation between the human jejunum cohort's expression of the lncRNA LOC100507600 and LCT mRNA was strong, suggesting that this lncRNA could modulate target gene expression.")</data>
      <data key="d6">chunk-ea45644d73f260cf365527dcc3af86e1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MCM6 INTRONIC DELETION&quot;" target="&quot;LCT MRNA REDUCTION&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Deletion in MCM6 intron 13 led to segment-specific reductions in LCT mRNA, but not affecting Mcm6 mRNA levels, indicating specificity of effect.")</data>
      <data key="d6">chunk-512b044cf65a4e519d519c6239959c6c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EPIGENETIC REGULATION&quot;" target="&quot;MCM6 INTRONS AND EXON 16&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"CpGs clusters around specific regions of MCM6 suggest epigenetic control influencing LCT expression.")</data>
      <data key="d6">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LACTASE PERSISTENCE SNP C/T-13910&quot;" target="&quot;SNP-LCT RELATIONSHIP&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"A particular SNP in the MCM6 gene is correlated with lactase persistence or non-persistence via epigenetic mechanisms.")</data>
      <data key="d6">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CELL TYPE SPECIFIC EXPRESSION&quot;" target="&quot;REGULATION BY CELL TYPE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Variation in DNA modifications between enterocytes and enterocyte-deficient jejunum highlights regulation specific to cell types.")</data>
      <data key="d6">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AGE GROUP COMPARISON - MOUSE LCT&quot;" target="&quot;AGE-DEPENDENT CHANGES&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Age-specific differential DNA modifications detected on the mouse chromosome containing the Lct gene indicate age-related changes in lactase expression.")</data>
      <data key="d6">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIATION IMPACT&quot;" target="&quot;INTER-INDIVIDUAL AND CELL-TYPE SPECIFIC SITES&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"CpG sites identified as having varying DNA modifications across individuals and cell types, affecting LCT expression.")</data>
      <data key="d6">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MCM6 INTRONS AND EXON 16/17&quot;" target="&quot;REGULATORY FUNCTION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"DNA modifications in specific regions of MCM6, such as introns and exon 16/17, may impact its role in transcriptional regulation.")</data>
      <data key="d6">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ENHANCER ACTIVITY&quot;" target="&quot;H3K4ME1 AND H3K27AC&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Histone marks indicating activity at the enhancer region contribute to cell-type-specific regulation of genes like LCT and MCM6.")</data>
      <data key="d6">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ENHANCER ACTIVITY&quot;" target="&quot;HISTONE MODIFICATION H3K27AC&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The presence of histone mark H3K27ac at certain DNA regions suggests their involvement as enhancers for gene expression, particularly in LCT and MCM6 genes.")</data>
      <data key="d6">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ACTIVE PROMOTER&quot;" target="&quot;LCT EXON 1&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The promoter region of gene encoding for LCT shows high H3K4me3 levels indicating the potential for transcription initiation.")</data>
      <data key="d6">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;C/T-13910 SNP&quot;" target="&quot;DNA MODIFICATION CHANGES&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Specific SNP C/T-13910 is associated with significant changes in DNA modification at MCM6 locus during postnatal development.")</data>
      <data key="d6">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AGE-RELATED EPIGENETIC MODIFICATIONS&quot;" target="&quot;EMBRYOGENESIS AND POSTNATAL ACTIVITY&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"During embryonic development, LCT activity might be high due to absence of postnatal modifications; they gradually regain with age.")</data>
      <data key="d6">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DNA ACCESSIBILITY&quot;" target="&quot;DNASE I ENZYME&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"DNase I hypersensitivity sites on chromatin indicate regions that are more accessible, suggesting active regulatory processes in LCT and MCM6 genes.")</data>
      <data key="d6">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENE EXPRESSION REGULATION&quot;" target="&quot;POST-TRANSLATIONAL HISTONE MODIFICATION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"H3K4me1 and H3K4me3 are post-translational modifications that play crucial roles in regulating gene expression, affecting transcriptional start sites in LCT and MCM6.")</data>
      <data key="d6">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AGE-DEPENDENT EPIGENETIC CHANGES&quot;" target="&quot;LACTASE ACTIVITY&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Epigenetic modifications occurring from conception onwards gradually influence the age-dependent regulation of lactase activity in adults.")</data>
      <data key="d6">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENETIC ASSOCIATION&quot;" target="&quot;PAIRWISE LINKAGE DISEQUILIBRIUM&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"High D' value indicates strong correlation between certain SNPs, suggesting they are often inherited together and affect lactase gene expression or persistence.")</data>
      <data key="d6">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DNA MODIFICATIONS&quot;" target="&quot;MAMMALIAN SEQUENCE CONSERVATION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The large degree of mammalian sequence conservation found in the LCT intron 2 region was not found in any other intron of LCT or MCM6, suggesting that LCT intron 2 is an evolutionarily old regulatory element.")</data>
      <data key="d6">chunk-ea45644d73f260cf365527dcc3af86e1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AGE-DEPENDENT DOWNREGULATION&quot;" target="&quot;EVOLUTIONARY CONSERVATION&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Our findings support the concept of age-related processes contributing to lactase regulation across species, as evidenced by evolutionary conservation of epigenetic factors and large degree of mammalian sequence conservation.")</data>
      <data key="d6">chunk-ea45644d73f260cf365527dcc3af86e1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DEVELOPMENTAL PROCESSES&quot;" target="&quot;LACTASE REGULATION&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Mammalian intronic conserved elements found near the LCT intron 2 region suggest its involvement in development, possibly alongside other regulatory processes such as age-related changes and evolutionary conservation.")</data>
      <data key="d6">chunk-ea45644d73f260cf365527dcc3af86e1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANT -13910&quot;" target="&quot;LCT EXPRESSION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The TT genotype at SNP -13910 impacts LCT mRNA levels, which is relevant for lactase persistence.")</data>
      <data key="d6">chunk-512b044cf65a4e519d519c6239959c6c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LCT MRNA REDUCTION&quot;" target="&quot;LOC100507600 SILENCING&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Silencing of LOC100507600 leads to a 20% reduction in expression and concomitant 25% decrease in LCT mRNA, demonstrating regulation.")</data>
      <data key="d6">chunk-512b044cf65a4e519d519c6239959c6c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CTCF BINDING INHIBITION&quot;" target="&quot;DNA METHYLATION INCREASE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Increased DNA methylation inhibits CTCF binding at insulator sites, affecting tissue-specific gene expression.")</data>
      <data key="d6">chunk-512b044cf65a4e519d519c6239959c6c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CRISPR-CAS9 GENOME EDITING&quot;" target="&quot;LACTASE REGULATORY ELEMENT MANIPULATION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"CRISPR-Cas9 technology was utilized to manipulate lactase regulatory elements in genes like Lct and Mcm6 for understanding their role in regulation.")</data>
      <data key="d6">chunk-512b044cf65a4e519d519c6239959c6c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INTRON 2 DELETION OF LCT&quot;" target="&quot;LCT MRNA WIDESPREAD DOWNREGULATION&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Deletion of intron 2 in the LCT gene resulted in a widespread downregulation of LCT mRNA throughout the duodenum and jejunum.")</data>
      <data key="d6">chunk-512b044cf65a4e519d519c6239959c6c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CRISPR-CAS9N-INDUCED DELETIONS&quot;" target="&quot;DIFFERENTIAL EFFECTS ON LCT EXPRESSION&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Deletions using CRISPR-Cas9 technology showed varying impacts on LCT mRNA expression across different stages and models, including effects in adult and infant mice.")</data>
      <data key="d6">chunk-512b044cf65a4e519d519c6239959c6c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EPIGENETIC REGULATION SITES&quot;" target="&quot;LCT EXPRESSION IMPACT&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The epigenetically-regulated regions in the MCM6 intron 13 or LCT intron 2 were found to impact human LCT expression in cultured cells, particularly after differentiation into an epithelial-like state.")</data>
      <data key="d6">chunk-512b044cf65a4e519d519c6239959c6c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MILK CONSUMPTION&quot;" target="&quot;RISK OF RCC&quot;">
      <data key="d4">1.68</data>
      <data key="d5">"Increased milk consumption was linked to an elevated risk of RCC in the Czech Republic.")</data>
      <data key="d6">chunk-7a423a439657efc1126fb6a075919ea5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COUNTRY SPECIFIC DATA&quot;" target="&quot;DIFFERENCES BETWEEN MILK CONSUMPTION AND CANCER RISK&quot;">
      <data key="d4">0.0</data>
      <data key="d5">"Results for country-specific data showed varied associations, with no systematic pattern observed.")</data>
      <data key="d6">chunk-7a423a439657efc1126fb6a075919ea5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COUNTRY SPECIFIC MAF ESTIMATES&quot;" target="&quot;FREQUENCY OF GENOTYPES&quot;">
      <data key="d4">0.0</data>
      <data key="d5">"Different country-specific minor allele frequency (MAF) estimates reflected intermediate frequencies as expected in Eastern European populations.")</data>
      <data key="d6">chunk-7a423a439657efc1126fb6a075919ea5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HMIP-2 SNP&quot;" target="&quot;MTD HBF&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"There's an association between the HMIP-2 SNP and Mean Total Direct HbF, although significance was lost upon correction for baseline HbF.")</data>
      <data key="d6">chunk-3ae06e9a3330573da28ca0a76aa685ce</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;C-A HAPLOTYPE&quot;" target="&quot;MTD HBF&quot;">
      <data key="d4">0.0</data>
      <data key="d5">"There was no association found between the C-A haplotype of HMIP-2 and Delta HbF when analyzing the data.")</data>
      <data key="d6">chunk-3ae06e9a3330573da28ca0a76aa685ce</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HMIP-2 HAPLOTYPE&quot;" target="&quot;DELTA HBF&quot;">
      <data key="d4">0.0</data>
      <data key="d5">"No association was found between any specific HMIP-2 haplotype and Delta HbF, as determined from our observations.")</data>
      <data key="d6">chunk-3ae06e9a3330573da28ca0a76aa685ce</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BASELINE HBF&quot;" target="&quot;HMIP-2 SNP/HAPLOTYPE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The significance of HMIP-2 SNP or haplotype association with MTD HbF dropped upon considering baseline HbF levels.")</data>
      <data key="d6">chunk-3ae06e9a3330573da28ca0a76aa685ce</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DELTA HBF&quot;" target="&quot;HMIP-2 HAPLOTYPE/SNP&quot;">
      <data key="d4">0.0</data>
      <data key="d5">"No link was found between specific HMIP-2 haplotypes or SNPs and Delta HbF based on our analysis.")</data>
      <data key="d6">chunk-3ae06e9a3330573da28ca0a76aa685ce</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MTD HBF&quot;" target="&quot;COMPARISON&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The correlation of baseline HbF with MTD HbF indicates that patients with higher baseline HbF tended to have higher values of MTD HbF.")</data>
      <data key="d6">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MTD HBF&quot;" target="&quot;HMIP-2 SNP/HAPLOTYPE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Our analysis shows an initial association between certain HMIP-2 SNPs/haps and MTD HbF before adjustment for baseline levels.")</data>
      <data key="d6">chunk-3ae06e9a3330573da28ca0a76aa685ce</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IMPROVEMENTS&quot;" target="&quot;STATISTICAL SIGNIFICANCE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"HU exposure led to statistically significant improvements in multiple hematological parameters among the patients.")</data>
      <data key="d6">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;STATISTICAL SIGNIFICANCE&quot;" target="&quot;DIFFERENTIAL EXPRESSION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The process of identifying statistically significantly differentially expressed genes/probes from the microarray study.")</data>
      <data key="d6">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALLELE FREQUENCY&quot;" target="&quot;EXCLUSION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Due to its extremely low frequency, this specific SNP could not be included in further analysis within the cohort.")</data>
      <data key="d6">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CONSISTENCY&quot;" target="&quot;EQUILIBRIUM TEST&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"These SNPs demonstrated adherence to HWE principles, thus facilitating their inclusion in subsequent regression analysis.")</data>
      <data key="d6">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HEMOGLOBIN PARAMETERS&quot;" target="&quot;INCREASED LEVEL&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"These specific variants of the BCL11A gene correlated positively with elevated levels of both baseline hemoglobin (Hb) and maximum tolerated dose hemoglobin (MTD Hb).")</data>
      <data key="d6">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CHROMOSOMAL LOCATION&quot;" target="&quot;PROXIMITY&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"This strong linkage suggests that HMIP-2 SNPs are closely linked and likely inherited together, affecting shared genetic functions related to hemoglobin levels.")</data>
      <data key="d6">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MONITORING&quot;" target="&quot;PARAMETER EVALUATION&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"Regular assessment of ANC provided insights into the effects of HU treatment on the immune system's granulocyte component.")</data>
      <data key="d6">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENE-SPECIFIC ANALYSIS&quot;" target="&quot;MULTIPLE TESTING&quot;">
      <data key="d4">13.0</data>
      <data key="d5">"This comprehensive genetic association testing aimed to identify specific genetic markers influencing hematological responses.")</data>
      <data key="d6">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ANCESTRAL ORIGIN&quot;" target="&quot;GENETIC CONFIGURATION&quot;">
      <data key="d4">14.0</data>
      <data key="d5">"Strong LD suggests these genetic variants share a recent evolutionary history, highlighting their significance in hematological traits.")</data>
      <data key="d6">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENETIC CONFIGURATION&quot;" target="&quot;ENHANCED/REDUCED EFFECT&quot;">
      <data key="d4">15.0</data>
      <data key="d5">"Haplotype analysis allowed for the identification of specific genetic combinations that significantly influence hemoglobin levels in response to hydroxyurea treatment.")</data>
      <data key="d6">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;WILD TYPE UBE2T&quot;" target="&quot;RESCUE&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The overexpression of wild type UBE2T in RA2627 fibroblasts rescued the cellular hypersensitivity to crosslinking agents like MMC, DEB and cisplatin.")</data>
      <data key="d6">chunk-ffd1276c89bcac745a7e58082e97236f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;WILD TYPE UBE2T&quot;" target="&quot;CELL CYCLE&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"UBE2T expression restored cell cycle distribution in G2 phase after treatment with MMC.")</data>
      <data key="d6">chunk-ffd1276c89bcac745a7e58082e97236f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;WILD TYPE UBE2T&quot;" target="&quot;MONOUBIQUITINATION OF PROTEINS&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"The overexpression of wild type UBE2T restored monoubiquitination of FANCD2 and FANCI proteins following treatment with MMC.")</data>
      <data key="d6">chunk-ffd1276c89bcac745a7e58082e97236f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;WILD TYPE UBE2T&quot;" target="&quot;FANCD2 FOCI&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"The expression of wild type UBE2T facilitated the formation of FANCD2 foci after treatment with MMC.")</data>
      <data key="d6">chunk-ffd1276c89bcac745a7e58082e97236f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;WILD TYPE UBE2T&quot;" target="&quot;CROSSLINKING AGENTS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The overexpression of wild type UBE2T restored sensitivity of RA2627 cells to crosslinking agents following treatment.")</data>
      <data key="d6">chunk-ffd1276c89bcac745a7e58082e97236f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;WILD TYPE UBE2T&quot;" target="&quot;FANCONI ANEMIA&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The overexpression of wild type UBE2T in RA2627 cells was able to rescue or 'rescue' FA phenotypes due to its deficiency.")</data>
      <data key="d6">chunk-ffd1276c89bcac745a7e58082e97236f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;WILD TYPE UBE2T&quot;" target="&quot;MONOUBIQUITINATION OF FANCD2 AND FANCI&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The expression of wild type UBE2T facilitated the restoration of the monoubiquitination activity on these proteins after treatment with MMC.")</data>
      <data key="d6">chunk-ffd1276c89bcac745a7e58082e97236f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;WILD TYPE UBE2T&quot;" target="&quot;CELLULAR SENSITIVITY&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The overexpression of wild type UBE2T improved or 'rescued' the cellular hypersensitivity characteristic of Fanconi anemia cells.")</data>
      <data key="d6">chunk-ffd1276c89bcac745a7e58082e97236f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AFFYMETRIX GENECHIP HUMAN GENOME U133A 2.0 ARRAYS&quot;" target="&quot;MICROARRAY PLATFORM&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Technology platform used for high-throughput screening and analysis of gene expression from the DBA patients' samples.")</data>
      <data key="d6">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;QRT-PCR&quot;" target="&quot;VALIDATION METHOD&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Method used to validate the results of microarray analysis for gene expression in DBA patients.")</data>
      <data key="d6">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GLYCINE, SERINE AND THREONINE METABOLISM&quot;" target="&quot;BIOLOGICAL PATHWAY OR ENRICHMENT CLUSTER&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Further pathway enrichment identified through analysis of molecular functions related to metabolic pathways involved in DBA patients.")</data>
      <data key="d6">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DEATH RECEPTOR SIGNALING&quot;" target="&quot;PATHWAY OR BIOLOGICAL PROCESS&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Specific pathway impacted and analyzed as part of impaired biological processes detected in the study on DBA patients.")</data>
      <data key="d6">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PKR ACTIVITY&quot;" target="&quot;ROLE IN INTERFERON INDUCTION&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"Analysis revealed the involvement of PKR activity in antiviral responses through enriched gene functions identified in DBA patients.")</data>
      <data key="d6">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RAR ACTIVATION&quot;" target="&quot;BIOLOGICAL FUNCTION OR PATHWAY ENRICHMENT&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"Category associated with biological processes and pathways related to retinoid acid receptor activation found significant through enrichment analysis in the study on DBA patients.")</data>
      <data key="d6">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RPL22&quot;" target="&quot;CLUSTER OF GENES&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Part of a cluster including other RP genes involved in synthesis related processes.")</data>
      <data key="d6">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AMPD3&quot;" target="&quot;DIFFERENTIALLY EXPRESSED GENE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Up-regulated gene identified as differentially expressed by qRT-PCR and microarray analysis in DBA patients.")</data>
      <data key="d6">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CCND2&quot;" target="&quot;DIFFERENTIALLY EXPRESSED GENE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"An up-regulated gene in DBA patients confirmed through both qRT-PCR validation and microarray data.")</data>
      <data key="d6">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SOD2&quot;" target="&quot;DIFFERENTIALLY EXPRESSED GENE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Gene found to be up-regulated in DBA patients based on both qRT-PCR results and microarray expression patterns.")</data>
      <data key="d6">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TNFAIP3&quot;" target="&quot;DIFFERENTIALLY EXPRESSED GENE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Up-regulation confirmed in DBA patients by both qRT-PCR validation and microarray data analysis.")</data>
      <data key="d6">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COMP&quot;" target="&quot;DIFFERENTIALLY EXPRESSED GENE&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Down-regulated gene validated through qRT-PCR and microarray analysis for differential expression patterns in DBA patients.")</data>
      <data key="d6">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;WARS&quot;" target="&quot;DIFFERENTIALLY EXPRESSED GENE&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"An identified down-regulated gene in DBA patients supported by qRT-PCR results and microarray data validation.")</data>
      <data key="d6">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ZIC1&quot;" target="&quot;DIFFERENTIALLY EXPRESSED GENE&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Down-regulated in DBA patients, confirmed with both qRT-PCR and microarray analysis as part of the study's gene expression patterns validation process.")</data>
      <data key="d6">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COMPARISON GROUP OR STATISTICAL TEST&quot;" target="&quot;DBA PATIENTS VS. CONTROLS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Comparative analysis between DBA patients and controls in gene expression profiling.")</data>
      <data key="d6">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENE EXPRESSION PROFILING&quot;" target="&quot;WHOLE GENOME TECHNOLOGY&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Methodology used to identify differentially expressed genes through the study of gene expression across the entire genome.")</data>
      <data key="d6">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DERMAL FIBROBLAST SAMPLES&quot;" target="&quot;STUDY SUBJECT OR TISSUE SAMPLE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The sample source from which gene expression data was collected and analyzed through microarray and qRT-PCR methods.")</data>
      <data key="d6">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;QRT-PCR CONFIRMATION&quot;" target="&quot;VALIDATION TECHNIQUE&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Method employed to validate findings of reduced RPS19 levels in DBA patients carrying the frameshift mutation, alongside other genomic variants.")</data>
      <data key="d6">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANT OR MOLECULAR INTERACTION&quot;" target="&quot;INTRON 1 SPLICE SITE MUTATION C.1-1G&gt;A&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Specific mutation analyzed through PCR and sequencing methods to elucidate effects on gene expression and protein synthesis pathways in DBA patients.")</data>
      <data key="d6">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AMINOACYL-TRNA BIOSYNTHESIS PATHWAY&quot;" target="&quot;ENRICHMENT CLUSTER OF GENES&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Pathway identified as significantly enriched with genes from the differential expression dataset, highlighting its role in DBA pathogenesis.")</data>
      <data key="d6">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENE ENRICHMENT CATEGORY&quot;" target="&quot;PROTEIN SYNTHESIS CLUSTER&quot;">
      <data key="d4">13.0</data>
      <data key="d5">"Cluster identified for gene functions involved in protein synthesis, including a large group of RP genes contributing to this pathway's significance in DBA.")</data>
      <data key="d6">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BIOLOGICAL PROCESS OR FUNCTION&quot;" target="&quot;CELL DEATH ROLE&quot;">
      <data key="d4">14.0</data>
      <data key="d5">"Enrichment cluster found related to roles in cellular development and death pathways identified through molecular function analysis for DBA patients.")</data>
      <data key="d6">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LIPID METABOLISM ENRICHMENT&quot;" target="&quot;METABOLIC PATHWAY OR BIOLOGICAL PROCESS&quot;">
      <data key="d4">15.0</data>
      <data key="d5">"Cluster associated with lipid metabolism processes as part of the biological mechanisms significantly impacted in the study on DBA patients.")</data>
      <data key="d6">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BIOLOGICAL FUNCTION OR PATHWAY&quot;" target="&quot;MOLECULAR TRANSPORT CLUSTER&quot;">
      <data key="d4">16.0</data>
      <data key="d5">"Enriched category related to molecular transport functions contributing to biological pathways involved in DBA pathogenesis, as identified through analysis of gene functions and annotations.")</data>
      <data key="d6">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PATHWAY ENRICHMENT OR GROUP OF BIOLOGICAL FUNCTIONS&quot;" target="&quot;TOP BIO FUNCTIONS CATEGORY&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Category encompassing multiple biological functions identified as critical for the pathogenesis of DBA patients through pathway enrichment analysis performed on the dataset of differentially expressed genes.")("entity"</data>
      <data key="d6">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;VALIDATION METHOD&quot;" target="&quot;IN VITRO REFOLDING&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The refolding process validates the structural models through the formation of stable p/MHC complexes.")</data>
      <data key="d6">chunk-614333487e4b92705503909d34155179</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BDNF RS6265 (G/A) POLYMORPHISM&quot;" target="&quot;ASSOCIATION WITH BDNF GENOTYPE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The specific G/A variant of the polymorphism was studied within its genotype context, linking it to migraine risk.")</data>
      <data key="d6">chunk-814fe155e9cb953da61f6a79d1d25784</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MIGRAINE&quot;" target="&quot;RS6265 (G/A) POLYMORPHISM&quot;">
      <data key="d4">0.03</data>
      <data key="d5">"The rs6265 polymorphism in the BDNF gene was significantly associated with migraine.")</data>
      <data key="d6">chunk-814fe155e9cb953da61f6a79d1d25784</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MIGRAINE&quot;" target="&quot;RS2049046 (A/T) POLYMORPHISM&quot;">
      <data key="d4">0.02</data>
      <data key="d5">"The rs2049046 polymorphism was significantly linked to migraine.")</data>
      <data key="d6">chunk-814fe155e9cb953da61f6a79d1d25784</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS2049046 (A/T) POLYMORPHISM&quot;" target="&quot;GENETIC INTERACTION WITH RS6265&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Another genetic variant that may interact or have an additive effect alongside the rs6265 polymorphism in influencing migraine.")</data>
      <data key="d6">chunk-814fe155e9cb953da61f6a79d1d25784</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BDNF GENE POLYMORPHISMS&quot;" target="&quot;MIGRAINE RISK FACTOR&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Polymorphisms in the BDNF gene were studied as potential risk factors for developing migraine.")</data>
      <data key="d6">chunk-814fe155e9cb953da61f6a79d1d25784</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PATIENT 1&quot;" target="&quot;RS1004819&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"SNP rs1004819 was identified in patient 1 within the context of IL23R gene investigation.")</data>
      <data key="d6">chunk-72f4505e43f67f3564607392cb178656</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PATIENT 2&quot;" target="&quot;RS72676067&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"SNP rs72676067 was detected in patient 2 during IL23R gene study.")</data>
      <data key="d6">chunk-72f4505e43f67f3564607392cb178656</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HS&quot;" target="&quot;PARADOXICAL PSORIASIFORM REACTIONS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The development of paradoxical psoriasiform reactions occurred following treatment with adalimumab in patients affected by severe HS.")</data>
      <data key="d6">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ADALIMUMAB&quot;" target="&quot;REACTIONS&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"The anti-TNF-α treatment led to distinct paradoxical reactions of varying severity in HS patients as measured by PASI scores.")</data>
      <data key="d6">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CD3+ CELLS&quot;" target="&quot;CLASSICAL PSORIASIS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Enrichment of both CD4+ and CD8+ subpopulations compared to skin T cells from HS patients with paradoxical reactions.")</data>
      <data key="d6">chunk-56c37d6045382dda8cc6037b2680282a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TYPE I IFN-Β&quot;" target="&quot;PARADOXICAL PSORIASIS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Overexpression of type I IFNs is characteristic in paradoxical psoriasis, more than classical or nonclassical.")</data>
      <data key="d6">chunk-56c37d6045382dda8cc6037b2680282a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;KERATINOCYTES&quot;" target="&quot;IFN-Κ&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Cytoplasmic expression in psoriasiform lesions, membrane-bound in classical psoriasis; comparable levels across conditions.")</data>
      <data key="d6">chunk-56c37d6045382dda8cc6037b2680282a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LYMPHOTOXINS&quot;" target="&quot;ANTI-TNF-Α THERAPY&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Deregulated by anti-TNF-α therapy and overexpressed specifically in paradoxical skin reactions.")</data>
      <data key="d6">chunk-56c37d6045382dda8cc6037b2680282a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ERAP1 SNPS&quot;" target="&quot;SPECIFIC SNPS&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Three specific ERAP1 SNPs were found in all HS patients with differing distributions across individuals.")</data>
      <data key="d6">chunk-56c37d6045382dda8cc6037b2680282a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TNFAIP SNPS&quot;" target="&quot;SNP DISTRIBUTION&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Shared multiple TNFAIP-related SNPs among patients, indicating genetic predispositions to paradoxical reactions.")</data>
      <data key="d6">chunk-56c37d6045382dda8cc6037b2680282a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CCHCR1&quot;" target="&quot;IL23R&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The text discusses both CCHCR1 and IL23R gene, indicating potential comparisons or overlaps in genetic studies.")</data>
      <data key="d6">chunk-72f4505e43f67f3564607392cb178656</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DISEASE RESPONSE&quot;" target="&quot;PATIENT 1, PATIENT 2, AND PATIENT 3&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Each patient displayed unique disease responses including erythematous-pustular lesions, pustular lesions, and erythemato-scaly plaques respectively after therapy.")</data>
      <data key="d6">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DISEASE SEVERITY SCALE&quot;" target="&quot;PASI 6.8&quot;, &quot;PASI 5.2&quot;, AND &quot;PASI 5.6&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"The psoriasis severity index (PASI) indicated a range of disease severity in the patients with paradoxical reactions.")</data>
      <data key="d6">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DISEASE SEVERITY MEASURE&quot;" target="&quot;HURLEY III, SARTORIUS SCORE: 41.5&quot;, &quot;HURLEY III, SARTORIUS SCORE: 41.5&quot;, AND &quot;HURLEY III, SARTORIUS SCORE: 61.5&quot;">
      <data key="d4">14.0</data>
      <data key="d5">"The Hurley III Sartorius scoring system was used to measure the severity of hidradenitis suppurativa in each patient.")</data>
      <data key="d6">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DISEASE SUBTYPE&quot;" target="&quot;PATIENT 2'S ECZEMATOUS REACTIONS&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"In Patient 2, a mixed population of T cells responsible for both psoriasiform and eczematous reactions was likely present.")</data>
      <data key="d6">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ERAP1 VARIANTS&quot;" target="&quot;HS PATIENTS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"All HS patients showed variants of ERAP1, with specific SNPs found across individuals.")</data>
      <data key="d6">chunk-56c37d6045382dda8cc6037b2680282a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;URD&quot;" target="&quot;RING DOMAIN&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The RING domain's electrostatic potential is distinct from the DmDRWD, which wraps around like a ring on the backside of central FANCL.")</data>
      <data key="d6">chunk-e097891654194982dfc0ef87401d3aa9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;URD&quot;" target="&quot;UBE2T&quot;">
      <data key="d4">0.5</data>
      <data key="d5">"No change in migration was observed by size-exclusion chromatography suggesting no complex formation between URD and Ube2T.")</data>
      <data key="d6">chunk-e097891654194982dfc0ef87401d3aa9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;URD&quot;" target="&quot;FANCI, FANCD2&quot;">
      <data key="d4">0.6</data>
      <data key="d5">"Reduction in binding was observed with URD mutants compared to wild type when pulldown experiments were performed with FANCI and FANCD2.")</data>
      <data key="d6">chunk-e097891654194982dfc0ef87401d3aa9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;URD&quot;" target="&quot;HYDROPHOBIC PATCHES&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Exposing hydrophobic residues on its surface facilitates interaction with FANCI and FANCD2 proteins, as implied by URD's binding properties.")&lt;SEP&gt;"Exposing hydrophobic residues on its surface facilitates interaction with FANCI and FANCD2, as demonstrated by the URD proteins L248A/F252A/L254A/I265A, W212A/L214A.")</data>
      <data key="d6">chunk-6135f8baf39fe26dcea3d987aa6100ac</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;URD&quot;" target="&quot;FANCI&quot;/&quot;FANCD2&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Binding affinity of URD proteins to FANCI and FANCD2 decreases with specific mutations (L248A/F252A/L254A/I265A, W212A/L214A), emphasizing the role of hydrophobic patches.")&lt;SEP&gt;"Interaction of URD with FANCI/FANCD2 proteins depends on the exposed hydrophobic patches on its C-terminal lobe, which are impacted by certain genetic variants."</data>
      <data key="d6">chunk-6135f8baf39fe26dcea3d987aa6100ac</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RING DOMAIN&quot;" target="&quot;UBE2T&quot;">
      <data key="d4">0.8</data>
      <data key="d5">"A 1:1 stoichiometric interaction with Ube2T as shown in size-exclusion chromatography, resulting in an equilibrium binding dissociation constant (Kd) of 454 nm.")</data>
      <data key="d6">chunk-e097891654194982dfc0ef87401d3aa9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RING DOMAIN&quot;" target="&quot;PHE-63 MUTATION&quot;">
      <data key="d4">0.7</data>
      <data key="d5">"A 11-fold decrease in binding affinity was observed between mutant Ube2T-F63A and RING as seen in ITC analysis.")</data>
      <data key="d6">chunk-e097891654194982dfc0ef87401d3aa9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;L248A/F252A/L254A/I265A&quot;" target="&quot;W212A/L214A&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The mutations at positions 248/252/254 and I265, when compared to mutations at positions W212/A214, both reduce substrate binding capacity.")</data>
      <data key="d6">chunk-6135f8baf39fe26dcea3d987aa6100ac</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;L248A/F252A/L254A/I265A&quot;" target="&quot;FANCI&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The L248A/F252A/L254A/I265A mutations decrease the binding of URD with FANCI.")</data>
      <data key="d6">chunk-6135f8baf39fe26dcea3d987aa6100ac</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;L248A/F252A/L254A/I265A&quot;" target="&quot;FANCD2&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"These mutations reduce the binding of URD with FANCD2 proteins, as observed in comparison to wild type URD.")</data>
      <data key="d6">chunk-6135f8baf39fe26dcea3d987aa6100ac</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;W212A/L214A&quot;" target="&quot;FANCI&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Mutations W212/A214 in URD affect its interaction capacity with FANCI proteins, as seen with L248A/F252A/L254A/I265A.")</data>
      <data key="d6">chunk-6135f8baf39fe26dcea3d987aa6100ac</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;W212A/L214A&quot;" target="&quot;FANCD2&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Mutations W212/A214 affect substrate interaction with FANCD2, similar to the L248A/F252A/L254A/I265A mutations.")</data>
      <data key="d6">chunk-6135f8baf39fe26dcea3d987aa6100ac</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;W212A/L214A&quot;" target="&quot;HYDROPHOBIC PATCHES&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Similar to L248A/F252A/L254A/I265A, mutations W212/A214 influence hydrophobic patches on the C-terminal lobe to impact substrate binding.")</data>
      <data key="d6">chunk-6135f8baf39fe26dcea3d987aa6100ac</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;L254A&quot;" target="&quot;HYDROPHOBIC PATCHES&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The exposed hydrophobic patches on the C-terminal lobe are required for substrate binding as indicated by lower affinity with L254A mutation.")</data>
      <data key="d6">chunk-6135f8baf39fe26dcea3d987aa6100ac</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;I265A&quot;" target="&quot;HYDROPHOBIC PATCHES&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Exposing hydrophobic patches in the C-terminal lobe is necessary for efficient interaction, shown by the reduced binding capacity of URD with FANCI and FANCD2 with I265A mutation.")</data>
      <data key="d6">chunk-6135f8baf39fe26dcea3d987aa6100ac</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;L248A/" target="252A/">
      <data key="d4">3.0</data>
      <data key="d5">L254A/</data>
      <data key="d6">chunk-6135f8baf39fe26dcea3d987aa6100ac</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;W212A/" target="L214A&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Hydrophobic Patches"</data>
      <data key="d6">chunk-6135f8baf39fe26dcea3d987aa6100ac</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HYDROPHOBIC PATCHES&quot;" target="&quot;SUBSTRATE INTERACTION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Exposure of hydrophobic patches on the C-terminal lobe is necessary for efficient interaction between URD and FANCI/FANCD2, as indicated by decreased binding affinity with specific mutations."</data>
      <data key="d6">chunk-6135f8baf39fe26dcea3d987aa6100ac</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HYDROPHOBIC PATCHES&quot;" target="&quot;FANCI&quot;/&quot;FANCD2&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The presence of exposed hydrophobic patches on these proteins is essential for their interactions with URD and thereby for efficient DNA repair processes.")</data>
      <data key="d6">chunk-6135f8baf39fe26dcea3d987aa6100ac</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BINDING AFFINITY&quot;" target="&quot;MUTATIONS L248A/F252A/L254A/I265A&quot;/&quot;W212A/L214A&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The mutations influence substrate binding affinity, with reduced interaction observed for URD proteins."</data>
      <data key="d6">chunk-6135f8baf39fe26dcea3d987aa6100ac</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BINDING AFFINITY&quot;" target="&quot;ALYRASY&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The binding affinity for self-antigen ARDIYRASY is insufficient to form stable complexes with HLA-B*15:01.")</data>
      <data key="d6">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BINDING AFFINITY&quot;" target="&quot;NONAMER BINDING&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"The affinity of nonamer peptides towards HLA-B*15:01 is lower compared to other neoepitopes due to structural compatibility.")</data>
      <data key="d6">chunk-de413ae6100407d8dadd5bdee87c1074</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FGFR4 RS376618&quot;" target="&quot;COLESEVELAM&quot;">
      <data key="d4">0.0</data>
      <data key="d5">"The FGFR4 SNP (rs376618) did not show significant differential effects when used with colesevelam.")&lt;SEP&gt;"The FGFR4 SNP (rs376618) did not show significant differential treatment effects associated with colesevelam in this study.")</data>
      <data key="d6">chunk-5c78814fb7c198ee95071ee5a8462070</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FGFR4 RS351855&quot;" target="&quot;COLESEVELAM&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The FGFR4 genetic variant (rs351855) has an impact on the response to the drug colesevelam, influencing parameters like AC t1/2 and GC24.")</data>
      <data key="d6">chunk-5c78814fb7c198ee95071ee5a8462070</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FGFR4 RS351855&quot;" target="&quot;AC T1/2&quot;">
      <data key="d4">0.9</data>
      <data key="d5">"The functional variant (Gly388Arg) in FGFR4 is associated with altered AC t1/2 values during colesevelam treatment.")</data>
      <data key="d6">chunk-5c78814fb7c198ee95071ee5a8462070</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COLESEVELAM&quot;" target="&quot;KLB RS4975017&quot;">
      <data key="d4">0.8</data>
      <data key="d5">"The KLB genetic variant (rs4975017) was found to have a differential treatment effect with colesevelam, affecting GC24 value and AC t1/2.")</data>
      <data key="d6">chunk-5c78814fb7c198ee95071ee5a8462070</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COLESEVELAM&quot;" target="&quot;KLB RS17618244&quot;">
      <data key="d4">0.5</data>
      <data key="d5">"The KLB genetic variant (rs17618244) had numerical though not statistically significant differential treatment effects with colesevelam on AC t1/2 and GC24.")</data>
      <data key="d6">chunk-5c78814fb7c198ee95071ee5a8462070</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;KLB RS4975017&quot;" target="&quot;GC24&quot;">
      <data key="d4">0.8</data>
      <data key="d5">"The KLB genetic variant shows influence on GC24 levels when treated with colesevelam.")</data>
      <data key="d6">chunk-5c78814fb7c198ee95071ee5a8462070</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;KLB RS17618244&quot;" target="&quot;GC24&quot;">
      <data key="d4">0.5</data>
      <data key="d5">"This functional KLB variant has an impact on GC24 values under treatment with colesevelam, though not statistically significant.")</data>
      <data key="d6">chunk-5c78814fb7c198ee95071ee5a8462070</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BA SYNTHESIS&quot;" target="&quot;FGF19 CORRELATION&quot;">
      <data key="d4">13.0</data>
      <data key="d5">"Significant Spearman correlation between serum FGF19 and total stool BA indicates that FGF19 levels may influence the metabolic pathways related to bile acid synthesis.")</data>
      <data key="d6">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BA SYNTHESIS&quot;" target="&quot;FGFR4 RS1966265 CORRELATION&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The genetic variant was marginally associated with total stool BA content suggesting a possible link between the gene variant and metabolic processes related to bile acid synthesis.")</data>
      <data key="d6">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;STOOL FAT&quot;" target="&quot;SUBGROUP COMPARISON&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"There were numerical differences between subgroups with respect to stool fat content with higher values found in IBS-D compared to HV and lower values found in IBS-C compared to HV.")</data>
      <data key="d6">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;STOOL WEIGHT&quot;" target="&quot;SUBGROUP COMPARISON&quot;">
      <data key="d4">3.5</data>
      <data key="d5">"Similar to stool fat analysis, there were numerical differences between subgroups with respect to stool weight content. Higher weights were observed in IBS-D vs. HV and lower values found in IBS-C compared to HV.")</data>
      <data key="d6">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;STOOL WEIGHT&quot;" target="&quot;FGF19 CORRELATION&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"Significant Spearman correlation between serum FGF19 and stool weight suggests a possible impact of FGF19 levels on the physical properties of feces, such as bulk or consistency.")</data>
      <data key="d6">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;STOOL WEIGHT&quot;" target="&quot;STOOL FAT CONTENT&quot;">
      <data key="d4">4.5</data>
      <data key="d5">"There was a significant Spearman correlation between stool weight and the amount of fat in stools within different subgroup comparisons.")</data>
      <data key="d6">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BA EXCRETION&quot;" target="&quot;TOTAL STOOL BA&quot;">
      <data key="d4">5.5</data>
      <data key="d5">"Total BA content in feces was shown to correlate with stool weight, suggesting that increased bulk or volume could impact the overall excreted bile acids.")</data>
      <data key="d6">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FGF19 CORRELATION&quot;" target="&quot;STOOL WEIGHT (BA SYNTHESIS)&quot;">
      <data key="d4">8.5</data>
      <data key="d5">"FGF19 showed significant correlations with both stool weight and total stool BA content implying its role might be involved in fecal properties or bile acid synthesis and excretion.")</data>
      <data key="d6">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IBS-D&quot;" target="&quot;SYMPTOM IMPACT&quot;">
      <data key="d4">6.5</data>
      <data key="d5">"Cholecystectomy had a statistically significant impact on IBS symptoms in the IBS-D subgroup compared to IBS-C and HV groups.")</data>
      <data key="d6">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SUBGROUP COMPARISON&quot;" target="&quot;BA SYNTHESIS (STOOL EXCRETION)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"IBS-D had significantly higher levels of stool BA content compared to IBS-C but not compared to HV, indicating subgroup differences in the synthesis and excretion of bile acids.")</data>
      <data key="d6">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LACK OF ASSOCIATION&quot;" target="&quot;SERUM FGF19&quot;">
      <data key="d4">5.5</data>
      <data key="d5">"No association was observed between fasting serum FGF19 levels with subgroups indicated no direct impact on BA synthesis or stool excretion.")</data>
      <data key="d6">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BA SYNTHESIS COMPARISON&quot;" target="&quot;FGF14 RS1966265&quot;">
      <data key="d4">7.5</data>
      <data key="d5">"The FGFR4 rs1966265 variant was marginally associated with total stool BA content in IBS-D compared to other subgroups.")</data>
      <data key="d6">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SERUM C4&quot;" target="&quot;CHOLESTEROL CORRELATION&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Spearman correlations showed that serum C4 levels were positively correlated with total cholesterol levels in blood, suggesting potential links to metabolic processes related to lipids or bile acid metabolism.")</data>
      <data key="d6">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FGFR4 RS351855 CORRELATION&quot;" target="&quot;NO ASSOCIATION&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The genetic variation FGFR4 rs351855 was not significantly associated with serum C4 or stool BA suggesting it did not influence bile acid metabolism related markers.")</data>
      <data key="d6">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NO ASSOCIATION&quot;" target="&quot;FGFR4 RS376618 CORRELATION&quot;">
      <data key="d4">5.5</data>
      <data key="d5">"The genetic variant FGFR4 rs376618 was also found without significant association with serum C4 or stool BA indicating no influence on bile acid pathways.")</data>
      <data key="d6">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BILE ACID METABOLISM&quot;" target="&quot;FGF19 (BA SYNTHESIS)&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"A significant Spearman correlation between FGF19 and total stool BA content suggested that this factor might play a role in the metabolic pathways related to bile acid synthesis or excretion.")</data>
      <data key="d6">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IBS-D (CHOLECYSTECTOMY)&quot;" target="&quot;SYMPTOM COMPARISON&quot;">
      <data key="d4">6.5</data>
      <data key="d5">"The presence of cholecystectomy had a statistically significant effect on IBS symptoms specifically within the IBS-D subgroup, suggesting differences in symptom profiles compared to other subgroups.")</data>
      <data key="d6">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FAAP20&quot;" target="&quot;ZINC ION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The zinc ion coordinates with FAAP20 to maintain its structure and function.")</data>
      <data key="d6">chunk-cc528af98598e1adb4684c0166430cf4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FAAP20&quot;" target="&quot;FANCONI ANEMIA PATHWAY&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"FAAP20 plays a role within this pathway for DNA repair and cell cycle regulation.")</data>
      <data key="d6">chunk-cc528af98598e1adb4684c0166430cf4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FAAP20&quot;" target="&quot;UB&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"FAAP20 interacts with Ub through hydrophobic and hydrogen bonding interactions, which are essential for its proper function.")&lt;SEP&gt;"The FAAP20 protein shows a specific interaction pattern with Ub compared to other proteins.")</data>
      <data key="d6">chunk-5bfe051a79e5e215dd3fc65296825591&lt;SEP&gt;chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FAAP20&quot;" target="&quot;ICL SITES&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"FAAP20's localization to ICL sites is essential for proper response to DNA damage repair, which could impact disease prevention or progression.")</data>
      <data key="d6">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FAAP20-UBZ&quot;" target="&quot;UBIQUITINS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"FAAP20-UBZ interacts with K63-linked ubiquitin.")</data>
      <data key="d6">chunk-cc528af98598e1adb4684c0166430cf4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FAAP20-UBZ&quot;" target="&quot;AFFINITY TOWARDS UBIQUITINS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"FAAP20-UBZ shows strong interaction with different ubiquitin species, as measured by SPR.")</data>
      <data key="d6">chunk-cc528af98598e1adb4684c0166430cf4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FAAP20-UBZ&quot;" target="&quot;POLΗ-UBZ&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"While FAAP20-UBZ shares similarities in the mode of interaction with ubiquitin as Polη-UBZ, they differ from WRNIP1 and RAD18 UBZs.")</data>
      <data key="d6">chunk-5bfe051a79e5e215dd3fc65296825591</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FAAP20-UBZ&quot;" target="&quot;UB&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"FAAP20-UBZ binds ubiquitin via specific α-helix residues, establishing functional interactions.")</data>
      <data key="d6">chunk-5bfe051a79e5e215dd3fc65296825591</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FANCL&quot;" target="&quot;ROLE IN FA COMPLEX&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"FANCL acts as a modulatory component that interacts with FAAP20 and other FA proteins to maintain the activity of ubiquitin-dependent pathways.")</data>
      <data key="d6">chunk-cc528af98598e1adb4684c0166430cf4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;UVRAG&quot;" target="&quot;CONTRIBUTION TO FA CORE COMPLEX&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"UVRAG integrates into the FA core complex alongside FAAP20, participating in the coordination of ubiquitin-related processes.")</data>
      <data key="d6">chunk-cc528af98598e1adb4684c0166430cf4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;UB&quot;" target="&quot;POLΗ-UBZ&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Similar to FAAP20-UBZ, Polη-UBZ binds ubiquitin by interacting with its α-helix, suggesting a convergent evolutionary mechanism in binding Ub.")</data>
      <data key="d6">chunk-5bfe051a79e5e215dd3fc65296825591</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;UB&quot;" target="&quot;NEMO-UBZ&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"NEMO-UBZ binds ubiquitin differently due to sequence differences compared to other UBZs like FAAP20-UBZ and WRNIP1-UBZ.")</data>
      <data key="d6">chunk-5bfe051a79e5e215dd3fc65296825591</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ZINC-COORDINATING RESIDUE CYS150&quot;" target="&quot;FAAP20-UBZ DOMAIN&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The zinc-coordinating residue plays a structural role in maintaining the stability of the UBZ domain, influencing its functionality and consequently cellular processes.")</data>
      <data key="d6">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;WRNIP1-UBZ&quot;" target="&quot;RAD18-UBZ&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Both WRNIP1-UBZ and RAD18-UBZ interact with ubiquitin through their β-loop, suggesting similarities in the mechanism of interaction between these UBZs.")</data>
      <data key="d6">chunk-5bfe051a79e5e215dd3fc65296825591</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;POLΗ-UBZ&quot;" target="&quot;NEMO-UBZ&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"NEMO-UBZ and Polη-UBZ exhibit different modes of interaction with ubiquitin compared to WRNIP1-UBZ and RAD18-UBZ, based on sequence conservation.")</data>
      <data key="d6">chunk-5bfe051a79e5e215dd3fc65296825591</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;POLΗ&quot;" target="&quot;RAD18&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Despite sequence differences, Polη and RAD18 show similar interaction patterns with Ub through their UBZ domains.")</data>
      <data key="d6">chunk-5bfe051a79e5e215dd3fc65296825591</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RAD18&quot;" target="&quot;WRNIP1&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"WRNIP1-UBZ and RAD18-UBZ interact with ubiquitin through their β-loop residues, indicating a common interaction mode between these UBZ domains.")</data>
      <data key="d6">chunk-5bfe051a79e5e215dd3fc65296825591</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CENTRAL Α-HELIX AND SECOND LOOP&quot;" target="&quot;UBIQUITIN&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"These regions of FAAP20-UBZ specifically interact with ubiquitins, affecting the binding specificity.")</data>
      <data key="d6">chunk-cc528af98598e1adb4684c0166430cf4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FAAP19&quot; AND &quot;FANCL&quot;" target="&quot;INTERACTION WITHIN FA PATHWAY&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"FAAP19 may interact with FANCL for enhanced DNA repair capacity through coordinated activities within Fanconi Anemia pathway.")</data>
      <data key="d6">chunk-cc528af98598e1adb4684c0166430cf4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HEALTHY CONTROLS&quot;" target="&quot;CD SUBJECTS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The study compares CD subjects to healthy controls to identify genetic markers.")</data>
      <data key="d6">chunk-6a657cd0a000b6df4db8f1305b795021</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HEALTHY CONTROLS&quot;" target="&quot;HETEROZYGOUS ALLELES&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Healthy controls show less presence of the heterozygous (TC) alleles for the study SNPs.")</data>
      <data key="d6">chunk-6a657cd0a000b6df4db8f1305b795021</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HEALTHY CONTROLS&quot;" target="&quot;NO MAPBACTEREMIA OR SPECIFIC SNPS&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Healthy controls exhibit none or lower levels of both MAPbacteremia and the studied SNPs.")</data>
      <data key="d6">chunk-6a657cd0a000b6df4db8f1305b795021</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS12762549&quot;" target="&quot;GRADE 3-4 ANEMIA&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The presence of the rs12762549 variant is associated with an increased risk of developing grade 3-4 anemia.")</data>
      <data key="d6">chunk-561eacb5d916258d3ed4f08f53587404</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS363717&quot;" target="&quot;GRADE 3-4 ANEMIA&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The presence of the rs363717 variant is associated with an increased risk of developing grade 3-4 anemia.")</data>
      <data key="d6">chunk-561eacb5d916258d3ed4f08f53587404</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS11615&quot;" target="&quot;GRADE 3-4 ANEMIA&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The presence of the rs11615 variant is associated with an increased risk of developing grade 3-4 anemia.")</data>
      <data key="d6">chunk-561eacb5d916258d3ed4f08f53587404</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS4986910&quot;" target="&quot;THROMBOCYTOPENIA GRADE 3-4&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The presence of the rs4986910 variant is associated with an increased risk of developing thrombocytopenia grade 3-4.")</data>
      <data key="d6">chunk-561eacb5d916258d3ed4f08f53587404</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS2073337&quot;" target="&quot;GROWTH FACTORS USE (CSFS)&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The presence of the rs2073337 variant shows an association with CSF usage during chemotherapy, indicating potential need for supplementary treatments to manage side effects.")</data>
      <data key="d6">chunk-561eacb5d916258d3ed4f08f53587404</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS1799793&quot;" target="&quot;PROGRESSION-FREE INTERVAL (PFI)&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The rs1799793 variant shows significant association with PFI, indicating potential genetic influences on treatment outcome.")</data>
      <data key="d6">chunk-561eacb5d916258d3ed4f08f53587404</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS6104&quot;" target="&quot;PFI&quot;">
      <data key="d4">0.04</data>
      <data key="d5">"The genomic variant rs6104 showed an association with PFI in the fully-adjusted model but did not meet statistical significance when age adjustment alone was considered.")</data>
      <data key="d6">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GROWTH FACTORS USE (ESAS)&quot;" target="&quot;RS2074087&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The presence of the rs2074087 variant shows an association with ESA usage during chemotherapy, potentially influencing treatment efficacy and managing side effects.")</data>
      <data key="d6">chunk-561eacb5d916258d3ed4f08f53587404</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NEUTROPENIA&quot;" target="&quot;RS434074&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The rs434074 variant shows an association with neutropenia during chemotherapy treatment, indicating a genetic predisposition to this side effect.")</data>
      <data key="d6">chunk-561eacb5d916258d3ed4f08f53587404</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GRADE 2 OR HIGHER TOXICITY&quot;" target="&quot;RS1862219&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The rs1862219 variant is associated with an increased risk of developing grade 2 or higher toxicity during chemotherapy, highlighting a genetic factor in adverse reactions.")</data>
      <data key="d6">chunk-561eacb5d916258d3ed4f08f53587404</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HEMATOPOIETIC GROWTH FACTORS USE&quot;" target="&quot;RS737645&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The rs737645 variant correlates with the need for hematopoietic growth factors during chemotherapy, indicating genetic influences on supportive care requirements.")</data>
      <data key="d6">chunk-561eacb5d916258d3ed4f08f53587404</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PERIPHERAL NEUROPATHY&quot;" target="&quot;RS653980&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The rs653980 variant shows an association with the development of grade 3 or higher peripheral neuropathy, suggesting a genetic predisposition to this specific side effect.")</data>
      <data key="d6">chunk-561eacb5d916258d3ed4f08f53587404</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HEMATOLOGICAL TOXICITY&quot;" target="&quot;RS10866159&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The rs10866159 variant correlates with the development of hematological toxicity, highlighting a genetic factor influencing this side effect.")</data>
      <data key="d6">chunk-561eacb5d916258d3ed4f08f53587404</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NAUSEA AND VOMITING&quot;" target="&quot;RS9095462&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The rs9095462 variant shows an association with the development of grade 2 or higher nausea and vomiting, indicating a genetic predisposition to these symptoms.")</data>
      <data key="d6">chunk-561eacb5d916258d3ed4f08f53587404</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;UMPS&quot;" target="&quot;DELETION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"In I1, there was a de novo 6.4 Mb deletion on chromosome 3 that contained the UMPS gene.")</data>
      <data key="d6">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS1800469 C/T&quot;" target="&quot;TGF-SS1 SNPS&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The TGF-ß1 gene's promoter region SNPs were genotyped to evaluate their potential association with CRC.")</data>
      <data key="d6">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS1800896 A/G&quot;" target="&quot;IL-10 GENOTYPE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"SNP analysis of IL-10 gene's rs1800896 polymorphism was performed for CRC risk assessment.")</data>
      <data key="d6">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS4073 T/A&quot;" target="&quot;IL-8 GENOTYPE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The polymorphism rs4073 in the IL-8 gene was genotyped to assess its association with CRC.")</data>
      <data key="d6">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS5493062&quot;" target="&quot;IL-1Β SNPS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Genotyping for this specific SNP in the IL-1β gene provided insights into its potential association with CRC.")</data>
      <data key="d6">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T ALLELE&quot;" target="&quot;NON-SIGNIFICANT ASSOCIATION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"While the T allele showed a slight association with CRC, this was not statistically significant.")</data>
      <data key="d6">chunk-5b0cc96debf110f3544685d3b227ff27</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-22 GENOTYPES&quot;" target="&quot;RS1179251 C/G AND RS2227485 C/T&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Polymorphisms in the IL-22 gene were studied to understand their link with CRC susceptibility.")</data>
      <data key="d6">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-27 GENOTYPE&quot;" target="&quot;RS17855750T/G&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Genotyping of this SNP in IL-27's promoter region was performed for its role in CRC development.")</data>
      <data key="d6">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CRC RISK&quot;" target="&quot;IL-8 RS4073 T/A&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The polymorphism of IL-8's rs4073 was assessed to determine if it influences the risk of developing colorectal cancer.")</data>
      <data key="d6">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CRC SUSCEPTIBILITY&quot;" target="&quot;IL-1Α RS3093422&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"This polymorphism was analyzed as it relates to changes in IL-1α that may impact the risk of colorectal cancer development.")</data>
      <data key="d6">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HEALTHY CONTROL&quot;" target="&quot;RS2476601&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"rs2476601 was found with less frequency in CD subjects than in healthy controls.")</data>
      <data key="d6">chunk-84ec948f22126cef7d93b1d7465b79db</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NON-HISPANIC WHITE GROUP&quot;" target="&quot;POPULATION STRATIFICATION COMPONENT&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"PCA revealed clear separation between the non-Hispanic white group and other groups.")</data>
      <data key="d6">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NON-HISPANIC BLACK GROUP&quot;" target="&quot;POPULATION STRATIFICATION COMPONENT&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"The non-Hispanic black group showed distinct scores on PC1 compared to others, indicating clear separation from the non-Hispanic white group.")</data>
      <data key="d6">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HISPANIC GROUP&quot;" target="&quot;POPULATION STRATIFICATION COMPONENT&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"PC1 scores for the Hispanic group were in-between those of other groups, suggesting overlapping ancestry with others.")</data>
      <data key="d6">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ASTHMA POPULATION&quot;" target="&quot;EX-SMOKERS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The SNP's risk for asthma was increased in ex-smoker subgroups.")</data>
      <data key="d6">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ASTHMA POPULATION&quot;" target="&quot;NEVER-SMOKERS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"SNP rs1898671 did not show significant association with asthma in never-smokers.")</data>
      <data key="d6">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ASTHMA POPULATION&quot;" target="&quot;EX-SMOKERS IN REPLICATION COHORT&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"SNP rs1898671's effect on asthma risk was confirmed in ex-smoker subgroups.")</data>
      <data key="d6">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ASTHMA POPULATION&quot;" target="&quot;NEVER-SMOKERS IN REPLICATION COHORT&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"No significant association found for SNP rs1898671 in never-smokers.")</data>
      <data key="d6">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TSLP SNPS&quot;" target="&quot;ASTHMA&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"SNP rs1898671 showed a nominal association with asthma susceptibility.")</data>
      <data key="d6">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ASTHMA&quot;" target="&quot;IL-8 PROTEIN&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Increased levels of IL-8 protein in serum and mRNA were observed in asthmatic patients compared to controls.")</data>
      <data key="d6">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ASTHMA&quot;" target="&quot;IL-8 MRNA&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The mRNA expression level of IL-8 was significantly higher in asthmatic patients than in healthy controls.")</data>
      <data key="d6">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ASTHMA&quot;" target="&quot;RS4073&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The rs4073 genetic variant showed a significant association with asthma susceptibility.")</data>
      <data key="d6">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ASTHMA&quot;" target="&quot;RS2227306&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The rs2227306 genetic variant was significantly associated with asthma risk.")</data>
      <data key="d6">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LARGE DATA SET&quot;" target="&quot;REPLICATION COHORT 6 COAHS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The replication cohort validated the association of SNP rs1898671 with asthma.")</data>
      <data key="d6">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ASTHMATIC PATIENT SUBGROUP&quot;" target="&quot;CLINICAL POPULATION GROUP&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Cases showed differences such as age and BMI compared to healthy control group.")</data>
      <data key="d6">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AGE DIFFERENCE&quot;" target="&quot;COMPARISON BETWEEN GROUPS&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"The asthma population had a higher average age compared to healthy controls.")</data>
      <data key="d6">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COMPARISON BETWEEN GROUPS&quot;" target="&quot;BMI COMPARISON&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"Asthmatic patients had significantly higher BMI values than healthy control participants.")</data>
      <data key="d6">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CLINICAL FEATURE COMPARISON&quot;" target="&quot;RACE/ETHNICITY DIFFERENCE&quot;">
      <data key="d4">13.0</data>
      <data key="d5">"There was a statistically significant difference in race/ethnicity between the asthmatic patient group and the healthy controls, with p=0.01.")</data>
      <data key="d6">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CLINICAL FEATURE COMPARISON&quot;" target="&quot;ATOPY PROPORTION&quot;">
      <data key="d4">16.0</data>
      <data key="d5">"A significantly greater proportion of asthmatic patients demonstrated atopic characteristics compared to healthy controls, with p=0.01.")</data>
      <data key="d6">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIFFERENCES BETWEEN GROUPS&quot;" target="&quot;LUNG FUNCTION PARAMETER REDUCTIONS&quot;">
      <data key="d4">14.0</data>
      <data key="d5">"Reduced FEV1%, FVC% and FEV1/FVC ratios were noted specifically in asthma patients compared to healthy individuals.")</data>
      <data key="d6">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COMPARISON OF IMMOBILE PARAMETERS&quot;" target="&quot;TOTAL IGE INCREASE&quot;">
      <data key="d4">15.0</data>
      <data key="d5">"Increased total IgE levels were a characteristic feature seen exclusively among asthmatic patients.")</data>
      <data key="d6">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS478582&quot;" target="&quot;CD&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"rs478582 was detected significantly more often among CD subjects compared to healthy controls.")</data>
      <data key="d6">chunk-84ec948f22126cef7d93b1d7465b79db</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS478582&quot;" target="&quot;HAPLOTYPE T-G&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The Haplotype combination of T-G (major/major) was more significantly present among healthy controls compared to CD subjects.")</data>
      <data key="d6">chunk-84ec948f22126cef7d93b1d7465b79db</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS478582&quot;" target="&quot;HAPLOTYPE C-G&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The Haplotype combination of C-G (heterozygous or minor/major) and C-A (heterozygous or minor/heterozygous or minor) was more significantly present among CD subjects compared to healthy controls.")</data>
      <data key="d6">chunk-84ec948f22126cef7d93b1d7465b79db</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS2476601&quot;" target="&quot;EXPRESSION OF PTPN2 AND IFN-Γ&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The presence of rs2476601 was not significantly associated with differences in expression levels of PTPN2 or the cytokine IFN-γ in CD subjects compared to healthy controls." )</data>
      <data key="d6">chunk-84ec948f22126cef7d93b1d7465b79db</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS2476601&quot;" target="&quot;AUTOIMMUNE DISORDERS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The genomic variant rs2476601 affects the risk for several autoimmune disorders through its association with a Th1 cell signature and IFNγ secretion.")</data>
      <data key="d6">chunk-dee0a8a550579bff19f48d41446e842d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS2476601&quot;" target="&quot;GENERAL IGM AND IGM ANTI-PC&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The SNP rs2476601 was identified as one of the 8 genome-wide significant SNPs for general IgM that were also associated with IgM anti-PC.")</data>
      <data key="d6">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PTPN2:RS478582&quot;" target="&quot;CELIAC DISEASE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"SNPs of PTPN2:rs478582 are associated with the risk and manifestation of Celiac Disease.")</data>
      <data key="d6">chunk-6a657cd0a000b6df4db8f1305b795021</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PTPN2:RS478582&quot;" target="&quot;HETEROZYGOUS ALLELES&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Specific SNPs show higher presence in individuals with heterozygous (TC) alleles.")</data>
      <data key="d6">chunk-6a657cd0a000b6df4db8f1305b795021</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MAPBACTEREMIA&quot;" target="&quot;T-CELLS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The presence of MAPbacteremia affected the T-cell proliferation response.")</data>
      <data key="d6">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CD SUBJECTS&quot;" target="&quot;PRESENCE OF MAPBACTEREMIA&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"CD subjects are more likely to exhibit MAPbacteremia when specific PTPN2:rs478582 SNPs are present.")</data>
      <data key="d6">chunk-6a657cd0a000b6df4db8f1305b795021</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OR = 17.5, CI: 5.65-54.3&quot;&amp;&quot;RISK FACTOR COMPARISON&quot;&amp;&quot;INCREASED RISK OF DISEASE&quot;" target="&quot;THE ODDS RATIO COMPARISONS SHOWED A STATISTICALLY SIGNIFICANT INCREASE IN DISEASE RISK ASSOCIATED WITH PTPN2:RS478582.&quot;)">
      <data key="d4">1.0</data>
      <data key="d5">1("entity"</data>
      <data key="d6">chunk-6cb127717713bd0ab5be9436fc0c7568</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CELIAC DISEASE&quot;" target="&quot;PRESENCE OF MAPBACTEREMIA&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The presence of MAPbacteremia in CD subjects is linked to specific genetic markers.")</data>
      <data key="d6">chunk-6a657cd0a000b6df4db8f1305b795021</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PTPN22&quot;" target="&quot;CD4+ T CELLS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Endogenous PTPN22 expression varies across different subsets of CD4+ T cells (naive, memory, and regulatory) at rest and post-activation.")</data>
      <data key="d6">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NAIVE TCONV&quot;" target="&quot;MEMORY TCONV&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The increase in PTPN22 expression was significantly lower in memory Tconv cells compared to naive Tconv after activation.")</data>
      <data key="d6">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TREG&quot;" target="&quot;PTPN22 EXPRESSION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Treg cells displayed the highest PTPN22 expression among all subsets both at rest and following activation.")</data>
      <data key="d6">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TREG&quot;" target="&quot;LYP-620R&quot;">
      <data key="d4">31.87</data>
      <data key="d5">"Overexpression of LYP-620R blunts activation marker kinetics in Treg cells, except for CD226 on Tconv.")</data>
      <data key="d6">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LYP-620R&quot;" target="&quot;TCONV&quot;">
      <data key="d4">75.49</data>
      <data key="d5">"Overexpression of LYP-620R reduces the APC-mediated proliferation of Tconv cells.")</data>
      <data key="d6">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LYP-620W&quot;" target="&quot;TREGS&quot;">
      <data key="d4">71.38</data>
      <data key="d5">"LYP-620W reduces Treg proliferation by a similar degree as LYP-620R when overexpressed.")</data>
      <data key="d6">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CALCIUM SIGNALING&quot;" target="&quot;DOWNSTREAM EFFECTS ON PTPN22&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Calcium signaling pathways affect the expression of PTPN22 by impacting key processes like MAPK/ERK pathway activity, influencing downstream effects in T-cell function and autoimmune disease risk.")</data>
      <data key="d6">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MAPK/ERK PATHWAY&quot;" target="&quot;CONNECTION TO CALCIUM SIGNALING&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The MAPK/ERK pathway is interconnected with calcium signaling pathways, both impacting the expression of PTPN22 through coordinated regulatory mechanisms in T-cell function and autoimmune disease risk.")</data>
      <data key="d6">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CA2+ FLUX&quot;" target="&quot;RESPONSE TO TCR LIGATION&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Calcium flux quantifies changes in intracellular calcium levels as a response to T-cell receptor (TCR) ligation, affecting downstream signaling cascades including those involved with PTPN22 expression and function.")</data>
      <data key="d6">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AUTOIMMUNE DISEASE RISK&quot;" target="&quot;CONNECTION VIA GENETIC VARIANTS&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"The presence of risk variants such as LYP-620W in the PTPN22 gene is linked with an increased risk for autoimmune diseases through its impact on modulating T-cell function and regulatory pathways.")</data>
      <data key="d6">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TREGS&quot;" target="&quot;SUPPRESSION CAPACITY AND PROLIFERATION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"While the suppression capacity of Tregs was slightly increased with variant 620W, no significant difference was observed in Treg proliferation compared to variants 620R or eGFP reporter Tregs.")</data>
      <data key="d6">chunk-dee0a8a550579bff19f48d41446e842d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LYP VARIANT 620R&quot;" target="&quot;TREG-MEDIATED SUPPRESSION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Overexpression of LYP variant 620R leads to a similar level of effector cytokine secretion as compared to eGFP reporter Tregs, indicating no significant impact on Treg activity.")</data>
      <data key="d6">chunk-dee0a8a550579bff19f48d41446e842d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LYP VARIANT 620W&quot;" target="&quot;TCONV INTRINSIC SUSCEPTIBILITY&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The LYP variant 620W affects the Tcell intrinsic susceptibility and modulates activation, proliferation, and effector mechanisms rather than impacting directly on suppressive functions of Tregs.")</data>
      <data key="d6">chunk-dee0a8a550579bff19f48d41446e842d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IFNΓ&quot;" target="&quot;NO ALTERATION BY PTPN22 VARIANTS&quot;">
      <data key="d4">59.08</data>
      <data key="d5">"IFNγ secretion is not altered by overexpression of either variant of LYP, despite its association with autoimmune disorders.")</data>
      <data key="d6">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IFNΓ&quot;" target="&quot;RESPONSE TO CELL TYPE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Interferon-gamma production by CAR T cells is specific to TAG72-positive cell types like OAS4 and OAS7, but not OAS3.")</data>
      <data key="d6">chunk-183db5c908df609bb5289896b4ba09d0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ACTIVATION STATE&quot;" target="&quot;PTPN22 EXPRESSION&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The level of PTPN22 expression is higher in activated compared to quiescent states for all analyzed CD4+ T cell subsets.")</data>
      <data key="d6">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PTPN22 EXPRESSION&quot;" target="&quot;LYP VARIANT 620R&quot;/&quot;LYP VARIANT 620W&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Data suggest that both LYP variants may influence immune responses but show different effects when compared to PTPN22 expression in Treg cells.")</data>
      <data key="d6">chunk-dee0a8a550579bff19f48d41446e842d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PTPN22 GENE&quot;" target="&quot;ROLE IN IMMUNE REGULATION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The PTPN22 gene, encoded by different variants like LYP-620R or LYP-620W, plays a role in modulating immune responses including T-cell function and differentiation.")</data>
      <data key="d6">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PERK MARKER&quot;" target="&quot;SIGNIFICANCE IN DOWNSTREAM EVENTS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The level of pERK serves as a marker for activity within the MAPK/ERK pathway, which has downstream effects on several processes including PTPN22 expression and T-cell function.")</data>
      <data key="d6">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CD69 MARKER&quot;" target="&quot;EARLY T-CELL ACTIVATION SIGN&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The CD69 molecule serves as an early marker for T-cell activation which correlates with the expression levels of genes like PTPN22, impacting downstream signaling pathways and immune responses.")</data>
      <data key="d6">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ICOS RECEPTOR&quot;" target="&quot;MODULATION BY ACTIVATED T-CELLS&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The inducible costimulatory (ICOS) molecule acts as a co-stimulatory receptor on T-cells during activation processes, influencing gene expression patterns including PTPN22.")</data>
      <data key="d6">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CD25 MARKER&quot;" target="&quot;T-CELL ACTIVATION INDICATORS&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The CD25 molecule, also known as IL2Rα, serves as an indicator of early T-cell activation and modulates the expression of genes such as PTPN22 through its regulatory activities.")</data>
      <data key="d6">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CD226 RECEPTOR&quot;" target="&quot;CO-STIMULATION ROLE IN IMMUNE REGULATION&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"The CD226 receptor, also known as NKG2D or NKp46, plays a role in co-stimulating immune responses on T-cells and influences downstream regulatory mechanisms involving PTPN22 expression.")</data>
      <data key="d6">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PD-1 CO-INHIBITORY RECEPTOR&quot;" target="&quot;ROLE IN IMMUNE SUPPRESSION&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"The PD-1 receptor, alongside its ligands, contributes to immune suppression through inhibiting T-cell activity. This can have indirect effects on the regulation of genes like PTPN22 and T-cell function.")</data>
      <data key="d6">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;APC CELL TYPE&quot;" target="&quot;ROLE IN IMMUNE RESPONSE INITIATION&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"Antigen-presenting cells (APCs) play a crucial role in initiating immune responses by presenting antigens to T-cells, which can modulate the expression and activity of genes like PTPN22 involved in T-cell regulation.")</data>
      <data key="d6">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;APC&quot;" target="&quot;TCONVE&quot;">
      <data key="d4">49.53</data>
      <data key="d5">"Transduced Tconv cells show reduced APC-mediated proliferation upon overexpression of LYP-620R compared to mock-transfected controls.")</data>
      <data key="d6">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-2&quot;" target="&quot;INFLUENCE BY LYP VARIANTS&quot;">
      <data key="d4">51.37</data>
      <data key="d5">"Overexpression of PTPN22 influences IL-2 secretion; no alteration by LYP-620R, increase at the 24-hour time point by LYP-620W.")</data>
      <data key="d6">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-2&quot;" target="&quot;CAR RESPONSE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Interleukin-2 secretion by TAG72-BBζ CAR T cells specifically targets and kills OAS4 cells while sparing other cell types like OAS3 and OAS7.")</data>
      <data key="d6">chunk-183db5c908df609bb5289896b4ba09d0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-4, IL-5, IL-9, IL-10, AND IL-13&quot;" target="&quot;INHIBITION BY PTPN22 VARIANTS&quot;">
      <data key="d4">67.43</data>
      <data key="d5">"The secretion of these cytokines was robustly inhibited by expression of either LYP variant for the first 48 hours.")</data>
      <data key="d6">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DISEASE ASSOCIATION&quot;" target="&quot;TH1 SIGNATURE&quot;/&quot;RS2476601&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The Th1 signature associated with rs2476601 is involved in the development of autoimmune disorders.")</data>
      <data key="d6">chunk-dee0a8a550579bff19f48d41446e842d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SURVIVAL ANALYSIS&quot;" target="&quot;LINEAR KERNEL&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"A linear kernel performs well when survival time is simulated based on a linear genetic effect, showing similar or slightly preferred power over other kernels and tests.")</data>
      <data key="d6">chunk-2e31819d63b80079cb6422efd6e684e0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CAR T CELLS&quot;" target="&quot;TAG72-BBΖ CAR T CELLS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"TAG72-BBζ CAR T cells have potent anti-tumor activity against TAG72-positive cells.")</data>
      <data key="d6">chunk-183db5c908df609bb5289896b4ba09d0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MOCK T CELLS&quot;" target="&quot;OVCAR3&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Mock T cells show no detectable anti-tumor activity towards the TAG72-negative OVCAR3 cells.")</data>
      <data key="d6">chunk-183db5c908df609bb5289896b4ba09d0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MOCK T CELLS&quot;" target="&quot;INVASIVE PERITONEAL OVARIAN CANCERS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"No therapeutic benefit is observed in mice treated with mock T cells against peritoneal ovarian cancers.")</data>
      <data key="d6">chunk-183db5c908df609bb5289896b4ba09d0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MOCK T CELLS&quot;" target="&quot;ANTI-TUMOR ACTIVITY&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Mock T cells do not exhibit detectable anti-tumor activity towards TAG72-negative cell lines such as OAS3, unlike CAR T cells.")</data>
      <data key="d6">chunk-183db5c908df609bb5289896b4ba09d0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TAG72-BBΖ CAR T CELLS&quot;" target="&quot;OV90&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Despite aggressive nature, repeated delivery of TAG72-BBζ CAR T cells demonstrates more durable anti-tumor responses compared to single dose.")</data>
      <data key="d6">chunk-183db5c908df609bb5289896b4ba09d0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;REGIONAL INTRAPERITONEAL DELIVERY&quot;" target="&quot;THERAPEUTIC EFFICACY&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"TAG72-BBζ CAR T cells treated by regional intraperitoneal delivery demonstrate more effective anti-tumor activity than those administered systemically through intravenous injection.")</data>
      <data key="d6">chunk-183db5c908df609bb5289896b4ba09d0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T CELL NUMBERS&quot;" target="&quot;DOSAGE INFLUENCE&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Increased numbers of T cells were noted within peritoneal tumors in mice with repeat treatment for TAG72-BBζ CAR T Cells compared to a single dose.")</data>
      <data key="d6">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DOSING REGIMENS&quot;" target="&quot;THERAPEUTIC STRATEGY&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Multiple dosing of TAG72-BBζ CAR T Cells demonstrated more extensive tumor regression and durable control compared with a single dose.")</data>
      <data key="d6">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RESISTANCE MECHANISM&quot;" target="&quot;TUMOR RECURRENCE&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Tumor recurrences following TAG72-BBζ CAR T cell therapy are often due to antigen escape or loss.")</data>
      <data key="d6">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ANTIGEN EXPRESSION DYNAMICS&quot;" target="&quot;TEMPORAL CHANGE IN ANTIGENS&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Alteration of TAG72 expression levels over time, particularly during tumor recurrence and post-TAG72-BBζ CAR T Cell therapy.")</data>
      <data key="d6">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OUTCOME PREDICTION&quot;" target="&quot;RECURRENT TUMOR MODELS&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Tumor recurrences can be predicted based on antigen dynamics following CAR T cell treatment in different models.")</data>
      <data key="d6">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;APTAMER BINDING&quot;" target="&quot;INTERPLAY BETWEEN MOLECULES&quot;">
      <data key="d4">13.0</data>
      <data key="d5">"Interaction between aptamers and antigens on tumor cells to enhance CAR T cell efficacy.")</data>
      <data key="d6">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AGNOSTIC RESISTANCE&quot;" target="&quot;CONSEQUENCE OF T CELL TREATMENT&quot;">
      <data key="d4">14.0</data>
      <data key="d5">"Unpredictable mechanisms that prevent CAR T cell effectiveness, beyond antigen-specific resistance.")</data>
      <data key="d6">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CAR T CELL SURVIVAL&quot;" target="&quot;OUTCOME MEASUREMENT&quot;">
      <data key="d4">15.0</data>
      <data key="d5">"Evaluating how long CAR T cells remain viable and active within the body during treatment.")</data>
      <data key="d6">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RECOVERY TIME FOR BONE TISSUE&quot;" target="&quot;TIMEFRAME&quot;">
      <data key="d4">16.0</data>
      <data key="d5">"The duration needed for bone tissue to recover from potential side effects of CAR T cell therapy or associated conditions like avascular necrosis.")</data>
      <data key="d6">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ADVERSE EFFECTS&quot;" target="&quot;THERAPEUTIC LIMITATION&quot;">
      <data key="d4">17.0</data>
      <data key="d5">"Potential negative consequences of CAR T cell treatment that need to be managed or mitigated.")</data>
      <data key="d6">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FUNCTIONAL CONNECTION&quot;" target="&quot;SNP AT THE CCL23-CCL18 LOCUS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Significantly connected to β-defensin genes, as well as to CXCL12 and TNFRSF13B according to GRAIL analysis.")</data>
      <data key="d6">chunk-7efd4f037425eeac77e329347b16beb2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FUNCTIONAL CONNECTION&quot;" target="&quot;THSD4-UACA-TLE3&quot;, &quot;C10ORF11&quot;">
      <data key="d4">0.0</data>
      <data key="d5">"Not found to be functionally connected with other genes defined by the 80 SNPs, based on the analysis.")</data>
      <data key="d6">chunk-7efd4f037425eeac77e329347b16beb2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNP AT THE CCL23-CCL18 LOCUS&quot;" target="&quot;EXPLAINED VARIANCE IN FEV1/FVC&quot;">
      <data key="d4">11.6</data>
      <data key="d5">"Explains a proportion of variability in forced expiratory volume against time due to genetic factors.")&lt;SEP&gt;"The statistical connection of this specific SNP variant to FEV1/FVC is a contributing factor explaining part of its variability.")</data>
      <data key="d6">chunk-7efd4f037425eeac77e329347b16beb2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;REPLICATED LOCI, THSD4-UACA-TLE3 AND C10ORF11&quot;" target="&quot;FUNCTIONAL CONNECTION/">
      <data key="d4">0.0</data>
      <data key="d5">association"</data>
      <data key="d6">chunk-7efd4f037425eeac77e329347b16beb2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS12441227 SNP&quot;" target="&quot;THSD4 GENE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"SNP rs12441227 at the THSD4 locus has a genome-wide significant association with FEV1/FVC lung function.")</data>
      <data key="d6">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENETIC VARIANCE&quot;" target="&quot;NON-ADDITIVE GENETIC VARIANCE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The heritability of FVC and FEV1/FVC included both additive and non-additive genetic variance components, indicating complex molecular interactions.")</data>
      <data key="d6">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS231775&quot;" target="&quot;G VERSUS A&quot;">
      <data key="d4">0.8</data>
      <data key="d5">"The G versus A comparison for rs231775 polymorphism showed significant heterogeneity, and thus a random-effect model was used to generate extensive CIs in these genetic models.")</data>
      <data key="d6">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS231775&quot;" target="&quot;CTLA4&quot;">
      <data key="d4">0.8</data>
      <data key="d5">"SNP rs231775 is associated with the gene CTLA4")</data>
      <data key="d6">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS231725&quot;" target="&quot;A VERSUS G&quot;">
      <data key="d4">0.7</data>
      <data key="d5">"The A versus G comparison for rs231725 polymorphism showed significant heterogeneity, leading to the use of a random-effect model.")</data>
      <data key="d6">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS231725&quot;" target="&quot;CTLA4&quot;">
      <data key="d4">0.7</data>
      <data key="d5">"SNP rs231725 is also associated with the gene CTLA4")</data>
      <data key="d6">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS3087243&quot;" target="&quot;GA VERSUS GG&quot;">
      <data key="d4">1.9</data>
      <data key="d5">"For rs3087243 polymorphism, while GA versus GG comparison showed some heterogeneity, no significant association with PBC susceptibility was identified.")</data>
      <data key="d6">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS3087243&quot;" target="&quot;CTLA4&quot;">
      <data key="d4">1.9</data>
      <data key="d5">"The SNP rs3087243 shows association with the gene CTLA4")</data>
      <data key="d6">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS5742909&quot;" target="&quot;TC VERSUS CC&quot;">
      <data key="d4">3.6</data>
      <data key="d5">"The TT + TC versus CC comparison for rs5742909 polymorphism revealed significant heterogeneity and linkage disequilibrium among the four SNPs.")</data>
      <data key="d6">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS5742909&quot;" target="&quot;CTLA4&quot;">
      <data key="d4">3.6</data>
      <data key="d5">"SNP rs5742909 is linked to the gene CTLA4")</data>
      <data key="d6">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CTLA4&quot;" target="&quot;PBC&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Gene CTLA4 and its SNPs are related in studies to susceptibility for PBC disease")</data>
      <data key="d6">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MULTI-TISSUE ANALYSIS&quot;" target="&quot;TRANS-ACTING REGULATORY LOCUS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Shared trans-acting regulatory elements were identified across different cell types in multi-tissue analysis.")</data>
      <data key="d6">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TRANS-ACTING REGULATORY LOCUS&quot;" target="&quot;GWAS SNPS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"A specific region was influenced by GWAS SNPs, contributing to the regulation of gene expression.")</data>
      <data key="d6">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TRANS-ACTING REGULATORY LOCUS&quot;" target="&quot;RPS26&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The RPS26 gene expression levels are regulated by a trans-acting region on chromosome 12 with broad impact.")</data>
      <data key="d6">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TRANS-ACTING REGULATORY LOCUS&quot;" target="&quot;RAB5B&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"The RAB5B gene expression levels are affected by a shared regulatory locus across multiple cell types.")</data>
      <data key="d6">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TRANS-ACTING REGULATORY LOCUS&quot;" target="&quot;IKZF4&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"The IKZF4 gene is part of a region showing significant effect on multiple gene expressions due to regulatory elements.")</data>
      <data key="d6">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CDK2&quot;" target="&quot;TRANS-EQTLS&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"CDK2 is one of the genes influenced through trans-expression quantitative trait loci analysis.")</data>
      <data key="d6">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SUOX&quot;" target="&quot;TRANS-EQTL ANALYSIS&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"The SUOX gene expression was analyzed through trans-eQTL studies indicating its association with T1D genetic risk factors.")</data>
      <data key="d6">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ERBB3&quot;" target="&quot;SNPS ASSOCIATION&quot;">
      <data key="d4">13.0</data>
      <data key="d5">"ERBB3 gene expression was associated with specific SNPs identified in the T1D susceptibility analysis.")</data>
      <data key="d6">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL27&quot;" target="&quot;TRANS-EQTLS&quot;">
      <data key="d4">14.0</data>
      <data key="d5">"The IL27 gene expression levels were determined through trans-eQTL effects, linking it to genetic variation influencing immune response.")</data>
      <data key="d6">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;STAT1&quot;" target="&quot;TRANS-EQTLS AND GWAS SNPS&quot;">
      <data key="d4">16.0</data>
      <data key="d5">"The STAT1 gene expression was influenced through both trans-eQTL effects and GWAS, indicating multiple genetic influences on its activity.")</data>
      <data key="d6">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;STAT1&quot;" target="&quot;RS181206&quot;[G]">
      <data key="d4">5.0</data>
      <data key="d5">"The rs181206[G] allele also affects STAT1 expression, leading to lower transcript levels in comparison to the Leu119 variant of IL-27.")</data>
      <data key="d6">chunk-1b40d071abac0ba432a9fb0096796f45</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;METHODOLOGICAL ADVANTAGES&quot;" target="&quot;MULTI-TISSUE JOINT CIS-EQTL ANALYSIS STRENGTHS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The multi-tissue analysis was advantageous for identifying genes with lower effect sizes or incomplete power due to its capacity for accounting for such scenarios.")("entity"</data>
      <data key="d6">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS181206&quot;[G]" target="&quot;T1D SUSCEPTIBILITY&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The rs181206[G] allele in the IL27 gene is associated with T1D (Type 1 Diabetes) susceptibility.")</data>
      <data key="d6">chunk-1b40d071abac0ba432a9fb0096796f45</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-8 PROTEIN&quot;" target="&quot;IMMUNE SYSTEM&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"IL-8 protein is involved in the immune system's function by attracting immune cells and activating them.")</data>
      <data key="d6">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-8 MRNA&quot;" target="&quot;INFLAMMATORY RESPONSE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Increased IL-8 mRNA expression is part of the inflammatory response mechanism in asthmatic patients.")</data>
      <data key="d6">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS4073&quot;" target="&quot;GENETIC HAPLOTYPE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The rs4073 variant may contribute to a specific genetic haplotype associated with asthma risk.")</data>
      <data key="d6">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-8 SERINE&quot;" target="&quot;INFLAMMATORY RESPONSE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Serine metabolism contributes to the inflammatory response, including IL-8 release.")</data>
      <data key="d6">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ASAH1 GENE&quot;" target="&quot;HAPMAP SNPS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The 86 HapMap SNPs are part of the ASAH1 gene region on chromosome 8p22-p21.3.")</data>
      <data key="d6">chunk-2e31819d63b80079cb6422efd6e684e0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNP-SET&quot;" target="&quot;KERNEL MACHINE METHOD&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"A SNP-set was created using the kernel machine method for assessing potential causal SNPs in the context of GWAS studies.")</data>
      <data key="d6">chunk-2e31819d63b80079cb6422efd6e684e0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MIN TEST&quot;" target="&quot;KERNEL MACHINE METHOD&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The kernel machine method outperforms the min test in scenarios where causal SNPs are moderately correlated with typed SNPs.")</data>
      <data key="d6">chunk-2e31819d63b80079cb6422efd6e684e0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MIN TEST&quot;" target="&quot;LINEAR KERNEL&quot;&amp; &quot;STANDARD IBS KERNEL&quot;">
      <data key="d4">-0.0566</data>
      <data key="d5">"Both min test and linear kernel suffered from substantial loss of power as they mis-specified the model compared to the IBS and weighted IBS kernels.")</data>
      <data key="d6">chunk-076f6aeeb369546413bc63c9f305553a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MIN TEST&quot;" target="&quot;KERNEL MACHINE SNP-SET TEST&quot;">
      <data key="d4">0.7524</data>
      <data key="d5">"The kernel machine SNP-set test had better performance than the min test, especially when there was good LD structure similar to that of the ASAH1 gene.")&lt;SEP&gt;"The kernel machine SNP-set test outperformed the min test for studying gene effects based on imputed data, especially when there was good linkage disequilibrium (LD) structure like in ASAH1.")</data>
      <data key="d6">chunk-076f6aeeb369546413bc63c9f305553a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MIN TEST&quot;" target="&quot;LINEAR KERNEL&quot;&amp; &quot;IBS KERNEL&quot;&amp; &quot;WEIGHTED IBS KERNEL&quot;">
      <data key="d4">0.634</data>
      <data key="d5">"The min test suffered from substantial loss of power compared to the other kernels due to mis-specifying the model.")</data>
      <data key="d6">chunk-076f6aeeb369546413bc63c9f305553a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LINEAR KERNEL&quot;" target="&quot;IBS KERNEL&quot;">
      <data key="d4">0.634</data>
      <data key="d5">"When the SNP with higher Minor Allele Frequency (MAF) was causal, the weighted IBS kernel showed lower power than the IBS kernel as it downweighted the effect of more common alleles.")</data>
      <data key="d6">chunk-076f6aeeb369546413bc63c9f305553a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LINEAR KERNEL&quot;" target="&quot;IBS KERNEL&quot;&amp; &quot;WEIGHTED IBS KERNEL&quot;">
      <data key="d4">-0.214</data>
      <data key="d5">"The linear kernel and weighted IBS kernel had lower power compared to the standard IBS kernel, especially when causal SNPs have higher MAFs.")</data>
      <data key="d6">chunk-076f6aeeb369546413bc63c9f305553a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IBS KERNEL&quot;" target="&quot;WEIGHTED IBS KERNEL&quot;">
      <data key="d4">8.780000000000001</data>
      <data key="d5">"The weighted IBS kernel had higher power than the standard IBS kernel when incorporating information on rare variants.")&lt;SEP&gt;"The weighted IBS kernel had much greater power compared to the linear kernel and standard IBS kernel due to incorporating information on rare variants.")&lt;SEP&gt;"The weighted IBS kernel had similar power to the standard IBS kernel in most cases.")</data>
      <data key="d6">chunk-076f6aeeb369546413bc63c9f305553a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;WEIGHTED IBS KERNEL&quot;" target="&quot;RARE ALLELES&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"In GWAS contexts, the weighted IBS kernel emphasizes rare alleles by incorporating their importance through MAF (minor allele frequency), impacting test outcomes when rare variants are causal.")</data>
      <data key="d6">chunk-2e31819d63b80079cb6422efd6e684e0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LD MEASURE&quot;" target="&quot;MEDAN R2&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Median R2 represents a commonly used measure of linkage disequilibrium (LD), which describes genetic correlation among SNPs.")</data>
      <data key="d6">chunk-2e31819d63b80079cb6422efd6e684e0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AUTOIMMUNE RISK SNPS&quot;" target="&quot;ASSOCIATION WITH RESPONSE&quot;">
      <data key="d4">16.0</data>
      <data key="d5">"Several associations were observed between autoimmune risk SNPs and response to both anti-CTLA-4 and anti-PD-1 treatments.")</data>
      <data key="d6">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS17388568&quot;" target="&quot;ASSOCIATION WITH RESPONSE&quot;">
      <data key="d4">18.0</data>
      <data key="d5">"rs17388568 had the strongest association with response under the dominant regression model in the context of anti-PD-1 treatment.")</data>
      <data key="d6">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SMALL SAMPLE SIZE&quot;" target="&quot;POWER OF ANALYSIS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"A small sample size limits the power of an analysis to detect true associations, indicating that findings might not be reliable due to lower statistical confidence.")</data>
      <data key="d6">chunk-0d49552280a277a8a26456d06f8f26a8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COMBINATION-THERAPY&quot;" target="&quot;GROUPING OF TREATMENTS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Combination therapy is being grouped with other treatments for association analysis; this does not establish a causal relationship but reflects the experimental design.")</data>
      <data key="d6">chunk-0d49552280a277a8a26456d06f8f26a8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TREATMENT DRUGS&quot;" target="&quot;IMPACT ON RESPONSE&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The specific treatment drug used has an impact on the patient's response to therapy.")</data>
      <data key="d6">chunk-0d49552280a277a8a26456d06f8f26a8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EBNA2&quot;" target="&quot;MS RISK GENES&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"EBNA2 was found to bind chromatin at MS risk loci dependent on the presence of a specific risk allele, influencing gene expression.")</data>
      <data key="d6">chunk-bb351b97d99fce93d17df522db92dda7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EBNA2&quot;" target="&quot;ALLELIC ASSOCIATION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Since EBNA2 binds one allele more than the other at MS risk loci, it influences allelic associations with expression compared to that found in B cells.")</data>
      <data key="d6">chunk-bb351b97d99fce93d17df522db92dda7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EBNA2&quot;" target="&quot;MS RISK LOCI&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The EBNA2 effect on gene expression was dependent upon MS risk loci genotypes.")</data>
      <data key="d6">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LCL PROLIFERATION&quot;" target="&quot;MS RISK SNPS AND GENES&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Expression of MS risk genes is associated with LCL proliferation, which can be modulated by EBNA2 inhibition.")</data>
      <data key="d6">chunk-bb351b97d99fce93d17df522db92dda7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EBNA2-TAT&quot;" target="&quot;DOSAGE RESPONSE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"A dose-response experiment was conducted to determine the optimal concentration of EBNA2-TAT that inhibits EBNA2 transcriptional function without excess cytotoxicity.")</data>
      <data key="d6">chunk-bb351b97d99fce93d17df522db92dda7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MS RISK GENES&quot;" target="&quot;RBP-JΚ INTERACTION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"EBNA2 interacts specifically with the RBP-Jκ site on EBNA2, affecting gene expression through this interaction.")</data>
      <data key="d6">chunk-bb351b97d99fce93d17df522db92dda7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MS RISK GENES&quot;" target="&quot;EBNA2 INTERACTION EFFECT&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The EBNA2 interaction on MS risk genes led to changes in their expression levels, affecting immune evasion processes.")</data>
      <data key="d6">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EBV DNA COPY NUMBER&quot;" target="&quot;LCLS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"EBV DNA copy number is associated with several MS risk SNPs and genes in LCLs, which can be influenced by EBNA2-TAT treatment.")</data>
      <data key="d6">chunk-bb351b97d99fce93d17df522db92dda7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENETIC MODULATION&quot;" target="&quot;TBX6 AND RCOR1&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The data suggest that TBX6 and RCOR1 are modulated by EBNA2 inhibition, providing insights into how EBNA2 might influence genetic risk factors for MS.")</data>
      <data key="d6">chunk-bb351b97d99fce93d17df522db92dda7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EBNA2 TREATMENT&quot;" target="&quot;GENOTYPE EFFECT&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"EBNA2 effect on gene expression at MS risk loci could be ablated by EBNA2-TAT treatment.")</data>
      <data key="d6">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PROGRAM OF EBV LATENCY III&quot;" target="&quot;RISK GENE EXPRESSION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The effect on gene expression due to EBNA2 affects the program of EBV latency III infection cycle.")</data>
      <data key="d6">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EBNA2 BINDING&quot;" target="&quot;HOST IMMUNE EVASION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"EBNA2 interaction with MS risk alleles may increase host immune evasion by enhancing its function.")</data>
      <data key="d6">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS3842787&quot;" target="&quot;COX-1 GENE&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The association of COX-1 gene polymorphism rs3842787 with aspirin insensitivity was not significant")</data>
      <data key="d6">chunk-54c4fede216a6c4183b95ee1a2edcb17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS20417&quot;" target="&quot;COX-2 GENE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"There was a significant association between rs20417 in the COX-2 gene and aspirin insensitivity")</data>
      <data key="d6">chunk-54c4fede216a6c4183b95ee1a2edcb17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS20417&quot;" target="&quot;CAD PERCENTAGE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Differences in the percentage of CAD between patients and controls explained a large part of heterogeneity for rs20417")</data>
      <data key="d6">chunk-54c4fede216a6c4183b95ee1a2edcb17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS20118426&quot;" target="&quot;ITGA2B GENE&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The influence of ITGA2B gene polymorphism rs20118426 on the response to aspirin could be assessed under subgroup analyses")</data>
      <data key="d6">chunk-54c4fede216a6c4183b95ee1a2edcb17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS1126643&quot;" target="&quot;ITGA2 GENE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Risk estimates by rs1126643-T allele were more potentiated among patients with aspirin semi-resistance compared with those with aspirin resistance")</data>
      <data key="d6">chunk-54c4fede216a6c4183b95ee1a2edcb17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS1126643&quot;" target="&quot;CHINESE POPULATION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The odds of aspirin insensitivity in Chinese was nearly threefold relative to Caucasians under both allelic and dominant models")</data>
      <data key="d6">chunk-54c4fede216a6c4183b95ee1a2edcb17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS1126643&quot;" target="&quot;PLATELET NUMBER&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Averaged platelet number was a significant source of heterogeneity for rs1126643")</data>
      <data key="d6">chunk-54c4fede216a6c4183b95ee1a2edcb17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS1126643&quot;" target="&quot;AVERAGED PLATELET NUMBER&quot;">
      <data key="d4">0.012</data>
      <data key="d5">"The averaged platelet number is an important factor for the significance of rs1126643 in explaining heterogeneity.")</data>
      <data key="d6">chunk-734cac289b42d37dad32bd51ea24a1ea</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IDENTIFICATION OF NOVEL MUTATION&quot;" target="&quot;WES ANALYSIS&quot;">
      <data key="d4">20.0</data>
      <data key="d5">"Whole Exome Sequencing (WES) was performed on patient 1 at age 3.9, revealing a novel homozygous nonsense STAT5B mutation.")</data>
      <data key="d6">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PARENTAL HETEROZYGOSITY&quot;" target="&quot;TRIO CLINICAL WHOLE EXOME SEQUENCING&quot;">
      <data key="d4">15.0</data>
      <data key="d5">"The WES analysis showed heterozygosity in the STAT5B locus in both parents, implying they are carriers of the variant.")</data>
      <data key="d6">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COMPARISON WITH IDENTIFIED MUTATIONS&quot;" target="&quot;NOVEL STAT5B MUTATION LOCATION&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"The new mutation is adjacent to the first identified mutation in STAT5B, p.A630P.")</data>
      <data key="d6">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ROLE OF SH2 DOMAIN&quot;" target="&quot;SH2 DOMAIN IMPAIRMENT&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"The truncated STAT5B protein lacks ~50% of the Src Homology 2 (SH2) domain and the critical phosphorylated tyrosine at position 699.")</data>
      <data key="d6">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ROLE OF TAD DOMAIN&quot;" target="&quot;TAD DOMAIN ABSENCE&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"The mutation results in the absence of the entire transactivation domain (TAD).")</data>
      <data key="d6">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EXPRESSION ANALYSIS&quot;" target="&quot;REDUCED EXPRESSION OF P.W631* PROTEIN&quot;">
      <data key="d4">20.0</data>
      <data key="d5">"In vitro reconstitution analyses showed significantly reduced expression of the truncated STAT5B protein.")</data>
      <data key="d6">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALGORITHM V&quot;" target="&quot;POSITIVE PREDICTIVE VALUE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Algorithm V had a better positive predictive value than algorithms II, III and IV when tested on the 1000 Genomes dataset.")</data>
      <data key="d6">chunk-1f50436a36721971a0a256131d7fca62</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALGORITHM V&quot;" target="&quot;TAGGER ACCURACY&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"Algorithm V did not perfectly predict the haplotype carrier status, as evidenced by a sensitivity and specificity of less than 100% when tagging the haplotype.")</data>
      <data key="d6">chunk-1f50436a36721971a0a256131d7fca62</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HLA-DRB1*07:01–DQA1*02:01–DQB1*02:02 HAPLOTYPE&quot;" target="&quot;SCREENING TEST PERFORMANCE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The performance of the HLA-DRB1*07:01-DQA1*02:01-DQB1*02:02 haplotype as a screening test was evaluated against E. coli ASP hypersensitivity.")</data>
      <data key="d6">chunk-1f50436a36721971a0a256131d7fca62</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HLA-DRB1*07:01–DQA1*02:01–DQB1*02:02 HAPLOTYPE&quot;" target="&quot;SENSITIVITY VALUE&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The sensitivity of the HLA haplotype to correctly identify affected patients was 23.4%.")</data>
      <data key="d6">chunk-1f50436a36721971a0a256131d7fca62</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HLA-DRB1*07:01–DQA1*02:01–DQB1*02:02 HAPLOTYPE&quot;" target="&quot;SPECIFICITY&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The specificity of the HLA haplotype was high at 88.5%, indicating a low rate of false positives.")</data>
      <data key="d6">chunk-1f50436a36721971a0a256131d7fca62</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HLA-DRB1*07:01–DQA1*02:01–DQB1*02:02 HAPLOTYPE&quot;" target="&quot;POSITIVE PREDICTIVE VALUE&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The positive predictive value for the HLA haplotype was 57.9%, indicating that among those identified as having the haplotype, a high percentage were indeed affected by E. coli ASP hypersensitivity.")</data>
      <data key="d6">chunk-1f50436a36721971a0a256131d7fca62</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HLA-DRB1*07:01–DQA1*02:01–DQB1*02:02 HAPLOTYPE&quot;" target="&quot;NEGATIVE PREDICTIVE VALUE&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"The negative predictive value of the HLA haplotype was 63.1%, indicating that among those not identified as having the haplotype, a high percentage did not have E. coli ASP hypersensitivity.")</data>
      <data key="d6">chunk-1f50436a36721971a0a256131d7fca62</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HLA-DRB1*07:01–DQA1*02:01–DQB1*02:02 HAPLOTYPE&quot;" target="&quot;IDENTICAL PERFORMANCE MEASURES&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"The HLA haplotype and its best tagger algorithm (V) had the same performance parameters.")</data>
      <data key="d6">chunk-1f50436a36721971a0a256131d7fca62</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HIV-INFECTED INDIVIDUALS&quot;" target="&quot;TLR7 POLYMORPHISMS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Polymorphisms rs179008 and rs179009 in the TLR7 gene were significantly reduced or associated with HIV-infected individuals compared to healthy controls.")</data>
      <data key="d6">chunk-05d583f893b703816ad8de9561aa5292</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HIV-INFECTED INDIVIDUALS&quot;" target="&quot;TLR7 POLYMORPHISM (RS179009 AG GENOTYPE)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The rs179009 AG genotype was less frequent among HIV-infected individuals than in the control group, with a reduced risk of HIV infection.")</data>
      <data key="d6">chunk-05d583f893b703816ad8de9561aa5292</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HIV-INFECTED INDIVIDUALS&quot;" target="&quot;TLR7 HAPLOTYPES (RS179008 AND RS179009)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The distribution of haplotype AG was found higher in HIV-infected individuals compared to healthy controls, indicating a possible association with the disease.")</data>
      <data key="d6">chunk-05d583f893b703816ad8de9561aa5292</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HIV DISEASE STAGES&quot;" target="&quot;TLR7 POLYMORPHISMS (RS179009)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Polymorphism rs179009 showed decreased frequency in individuals across early, intermediate, and advanced HIV stages compared to the healthy control group.")</data>
      <data key="d6">chunk-05d583f893b703816ad8de9561aa5292</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ADVANCED HIV DISEASE STAGE&quot;" target="&quot;TLR7 POLYMORPHISMS (RS179009 GG GENOTYPE)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The frequency of rs179009 GG genotype was lower in individuals with advanced HIV disease stages compared to the healthy control group, suggesting a possible correlation.")</data>
      <data key="d6">chunk-05d583f893b703816ad8de9561aa5292</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ENVIRONMENTAL FACTORS (TOBACCO CONSUMPTION, ALCOHOL USE)&quot;" target="&quot;TLR7 POLYMORPHISMS (RS179008 AND RS179009)&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Polymorphism distributions did not significantly differ between HIV-infected individuals with or without tobacco use; however, a higher prevalence of TLR7 rs179009AG genotype was noted among those who consumed tobacco.")</data>
      <data key="d6">chunk-05d583f893b703816ad8de9561aa5292</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ENVIRONMENTAL FACTORS (TOBACCO CONSUMPTION, ALCOHOL USE)&quot;" target="&quot;MULTIVARIATE LOGISTIC REGRESSION ANALYSIS&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"The effects of environmental factors like tobacco use or alcohol intake on TLR7 polymorphisms were analyzed using multivariate logistic regression to identify potential interactions.")</data>
      <data key="d6">chunk-05d583f893b703816ad8de9561aa5292</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TLR7 POLYMORPHISMS (RS179008 AND RS179009)&quot;" target="&quot;MULTIVARIATE LOGISTIC REGRESSION ANALYSIS&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"These genetic variations were analyzed through multivariate logistic regression for associations with various factors including age, sex, tobacco use, alcohol consumption, and baseline CD4 counts.")</data>
      <data key="d6">chunk-05d583f893b703816ad8de9561aa5292</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TLR7 POLYMORPHISMS (RS179008 CC, CT, TT GENOTYPES)&quot;" target="&quot;TOBACCO-CONSUMING HIV-INFECTED INDIVIDUALS VS. NON-USERS&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The distributions of rs179008 CC, CT, and TT genotypes were nearly equivalent between tobacco-consuming and nonconsuming HIV-infected individuals.")</data>
      <data key="d6">chunk-05d583f893b703816ad8de9561aa5292</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TOBACCO-CONSUMING HIV-INFECTED INDIVIDUALS VS. NON-USERS&quot;" target="&quot;COMPARISONS&quot;">
      <data key="d4">14.0</data>
      <data key="d5">"Comparative analysis was conducted between individuals who consumed tobacco and those who did not, with regard to TLR7 polymorphism distribution.")</data>
      <data key="d6">chunk-05d583f893b703816ad8de9561aa5292</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALCOHOL-TAKING HIV-INFECTED INDIVIDUALS VS. NON-USERS&quot;" target="&quot;TLR7 POLYMORPHISMS (RS179009 AA, AG, GG GENOTYPES)&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Similar distributions of rs179008 AA, AT, and TT and rs179009 AA, AG, and GG genotypes were observed between alcohol-taking HIV-infected individuals and non-takers.")</data>
      <data key="d6">chunk-05d583f893b703816ad8de9561aa5292</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALCOHOL-TAKING HIV-INFECTED INDIVIDUALS VS. NON-USERS&quot;" target="&quot;COMPARISONS&quot;">
      <data key="d4">15.0</data>
      <data key="d5">"Similar comparisons were made for alcohol consumption in terms of its association with the distribution of specific TLR7 genotypes among HIV-infected individuals.")</data>
      <data key="d6">chunk-05d583f893b703816ad8de9561aa5292</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MULTIVARIATE LOGISTIC REGRESSION ANALYSIS&quot;" target="&quot;BASELINE CD4 COUNTS AND TLR7 POLYMORPHISMS&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"The relationship between baseline CD4 cell count levels and different TLR7 polymorphisms was explored through this statistical method, aiming to uncover any significant correlations.")</data>
      <data key="d6">chunk-05d583f893b703816ad8de9561aa5292</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MULTIVARIATE LOGISTIC REGRESSION ANALYSIS&quot;" target="&quot;TLR7 (RS179008 AND RS179009)&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Analysis of correlation between genetic variants in the TLR7 gene with HIV disease progression through multivariate logistic regression.")</data>
      <data key="d6">chunk-2c91cdebb36ef064eb01a7021a961302</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MULTIVARIATE LOGISTIC REGRESSION ANALYSIS&quot;" target="&quot;RS179008 AND RS179009&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Both genetic variations were included in multivariate logistic regression analysis to assess their influence on HIV disease progression.")</data>
      <data key="d6">chunk-2c91cdebb36ef064eb01a7021a961302</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MULTIVARIATE LOGISTIC REGRESSION ANALYSIS&quot;" target="&quot;OUTCOME OF DISEASE PROGRESSION STUDY&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The analysis was aimed at identifying significant predictors of HIV disease progression including genetic markers, environmental factors, and health status parameters.")</data>
      <data key="d6">chunk-2c91cdebb36ef064eb01a7021a961302</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AGE, SEX, TOBACCO, ALCOHOL, BASELINE CD4 COUNTS&quot;" target="&quot;RISK FACTOR&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"These factors were considered as potential independent risk factors for HIV disease progression alongside rs179008 and rs179009 variants of the TLR7 gene.")</data>
      <data key="d6">chunk-2c91cdebb36ef064eb01a7021a961302</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RISK FACTOR&quot;" target="&quot;AGE, SEX, TOBACCO USE, ALCOHOL CONSUMPTION, BASELINE CD4 COUNTS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"These demographic and health indicators were considered as potential risk factors for HIV disease progression together with rs179008 and rs179009.")</data>
      <data key="d6">chunk-2c91cdebb36ef064eb01a7021a961302</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CORRELATION ANALYSIS RESULTS&quot;" target="&quot;TABLE NOT SHOWN&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The results from this correlation analysis were not directly presented, implying they supported or refuted the role of studied factors in HIV disease progression.")</data>
      <data key="d6">chunk-2c91cdebb36ef064eb01a7021a961302</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALK R1275Q&quot;" target="&quot;NRAS Q61K&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Both ALK and NRAS mutations are recurrent in various cancer types, including NBL.")</data>
      <data key="d6">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALK R1275Q&quot;" target="&quot;ALYRASY&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The ALK R1275Q mutation leads to the generation of neoepitopes like ARDIYRASY, which is predicted to bind HLA-B*15:01.")</data>
      <data key="d6">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALK R1275Q&quot;" target="&quot;GMAQDIYRA&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The ALK R1275Q mutation generates the nonamer GMAQDIYRA that binds HLA-A*02:01.")</data>
      <data key="d6">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALK R1275Q&quot;" target="&quot;MAQDIYRASY/AQDIYRASYY&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The ALK R1275Q mutation leads to the generation of two distinct neoepitopes, MAQDIYRASY and AQDIYRASYY.")</data>
      <data key="d6">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALK R1275Q&quot;" target="&quot;HAPLOTYPE-SPECIFIC BINDING&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The potential of other HLAs to display ALK R1275Q neoepitopes depends on the individual's HLA haplotype, playing a role in immune response.")</data>
      <data key="d6">chunk-de413ae6100407d8dadd5bdee87c1074</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALK R1275Q&quot;" target="&quot;CANCER IMMUNOTHERAPIES&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The ALK R1275Q genomic variant is associated with cancer immunotherapies outcomes.")</data>
      <data key="d6">chunk-614333487e4b92705503909d34155179</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NRAS Q61K&quot;" target="&quot;ILDTAGKEEY&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The NRAS Q61K activating mutation results in neoepitope ILDTAGKEEY, which is predicted to bind HLA-A*01:01.")</data>
      <data key="d6">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GMAQDIYRA&quot;" target="&quot;STABILITY&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Nonamer GMAQDIYRA, derived from ALK R1275Q mutation, forms a complex that exhibits distinct stability compared to other peptides.")</data>
      <data key="d6">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALK NONAMER NEOEPITOPE&quot;" target="&quot;BOUND BY HLA-B*15:01&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The ALK nonamer neoepitope binds to HLA-B*15:01 through in vitro refolding.")</data>
      <data key="d6">chunk-830d8819004960d1d149ac70149c72a0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NONAMER&quot;" target="&quot;COMPARISON WITH SARS-COV-2 DERIVED EPITOPES&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"The recognition frequencies for the nonamer and a known immunodominant SARS-CoV-2 epitope are comparable when tested using MHC tetramers.")</data>
      <data key="d6">chunk-d3a9c93928447522ce3df4209f8ac803</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALK DECAMER NEOEPITOPE&quot;" target="&quot;BOUND BY HLA-B*15:01&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The ALK decamer neoepitope binds to HLA-B*15:01 via a compact 310 helical conformation.")</data>
      <data key="d6">chunk-830d8819004960d1d149ac70149c72a0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;THERMAL STABILITY&quot;" target="&quot;PHYSICAL PROPERTY&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"The thermal stability measurement reflects the stability of the p/MHC complex in vitro.")</data>
      <data key="d6">chunk-614333487e4b92705503909d34155179</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NONAMER PEPTIDE&quot;" target="&quot;DECAMER STRUCTURE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The addition of a C-terminal tyrosine residue alters the tertiary structure of HLA complex through conformational plasticity within the MHC groove.")</data>
      <data key="d6">chunk-de413ae6100407d8dadd5bdee87c1074</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SELF-ANTIGEN&quot;" target="&quot;STRUCTURAL EXCLUSION&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The self-antigen's structure results in clashes with MHC groove, leading to its exclusion from forming a stable HLA complex compared to neoepitopes.")</data>
      <data key="d6">chunk-de413ae6100407d8dadd5bdee87c1074</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HYDROGEN BONDS&quot;" target="&quot;STABILIZING INTERACTION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Increase in intra-peptide hydrogen bonds contribute to the stability of the decamer complex compared to nonamer structure.")</data>
      <data key="d6">chunk-de413ae6100407d8dadd5bdee87c1074</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HLA ALLELES&quot;" target="&quot;SEQUENCE BIAS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"There's a clear sequence bias for specific residues in the MHC-binding groove yielding more favorable interactions with two peptides.")</data>
      <data key="d6">chunk-614333487e4b92705503909d34155179</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NONAMER ALK PEPTIDE&quot;" target="&quot;DECAMER ALK PEPTIDE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"We find a clear trend for both nonamer and decamer peptides that bulk of binding energy provided by 'anchor' positions.")</data>
      <data key="d6">chunk-614333487e4b92705503909d34155179</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PEPTIDE BINDING ENERGY&quot;" target="&quot;PREDICTION ACCURACY&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Our simulations accurately predict peptide/HLA binding energies and interactions based on sequence similarity.")</data>
      <data key="d6">chunk-614333487e4b92705503909d34155179</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;KULLBACK–LEIBLER SEQUENCE LOGO&quot;" target="&quot;SEQUENCE ANALYSIS&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"The sequence logo provides insights into preferred residues for effective peptide/HLA binding.")</data>
      <data key="d6">chunk-614333487e4b92705503909d34155179</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALK NEOEPITOPES&quot;" target="&quot;RECOGNITION BY CD8+ T CELLS&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"The ALK-derived neoepitopes can be recognized by CD8+ T cells, as evidenced by MHC tetramer staining assay and multichannel flow cytometry analysis.")</data>
      <data key="d6">chunk-d3a9c93928447522ce3df4209f8ac803</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DECAMER&quot; AND &quot;NONAMER&quot;" target="&quot;BINDING ENERGY&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"The binding energy calculations suggest that both neoepitopes have a lower affinity for HLA-A*01:01 compared to HLA-B*15:01.")</data>
      <data key="d6">chunk-d3a9c93928447522ce3df4209f8ac803</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DECAMER&quot; AND &quot;NONAMER&quot;" target="&quot;CONFORMATIONAL COMPARISON&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"When bound to HLA-A*01:01, the side chain of Arg6 flips outward in comparison to its position when bound to HLA-B*15:01, altering TCR interaction properties.")</data>
      <data key="d6">chunk-d3a9c93928447522ce3df4209f8ac803</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DECAMER&quot; AND &quot;NONAMER&quot;" target="&quot;RECOGNITION EFFICIENCY COMPARISON&quot;">
      <data key="d4">13.0</data>
      <data key="d5">"Both neoepitopes display nominal recognition frequencies by CD8+ T cells, highlighting their potential as targets for immune response study.")</data>
      <data key="d6">chunk-d3a9c93928447522ce3df4209f8ac803</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;VITAMIN D&quot;" target="&quot;CALCIUM METABOLISM&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Vitamin D plays a role in calcium metabolism by enhancing the absorption of calcium in the gut.")</data>
      <data key="d6">chunk-41c7131af28e2a745ef6b88b8601860f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PHYSICAL TRAINING&quot;" target="&quot;OXIDATIVE STRESS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Regular physical training helps reduce oxidative stress by increasing antioxidant defenses and improving overall metabolic health.")</data>
      <data key="d6">chunk-41c7131af28e2a745ef6b88b8601860f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CARDIOMYOPATHY&quot;" target="&quot;CALCIUM METABOLISM&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Disruptions in calcium metabolism are associated with cardiomyopathy due to its critical role in heart muscle function.")</data>
      <data key="d6">chunk-41c7131af28e2a745ef6b88b8601860f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CARDIOMYOPATHY&quot;" target="&quot;GLYCOLYSIS&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Alterations in glycolysis pathways can affect heart function, potentially leading to cardiomyopathy or exacerbating its symptoms.")</data>
      <data key="d6">chunk-41c7131af28e2a745ef6b88b8601860f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALK NONAMER NEOEPITOPE&quot;/&quot;DECAMER NEOEPITOPE&quot;" target="&quot;CONFORMATION&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The ALK nonamer and decamer neoepitopes adopt distinct conformations within the MHC groove: extended for the nonamer and compact 310 helix for the decamer.")</data>
      <data key="d6">chunk-830d8819004960d1d149ac70149c72a0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LENGTH&quot;" target="&quot;NONAMER/DECAMER&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"A comparison between the ALK nonamer (nine amino acids) and decamer (ten amino acids), showing how peptide length influences conformation within a fixed MHC groove.")</data>
      <data key="d6">chunk-830d8819004960d1d149ac70149c72a0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BIND TO&quot;" target="&quot;MHC MOLECULES&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Epitopes"</data>
      <data key="d6">chunk-830d8819004960d1d149ac70149c72a0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ANTIGEN-PRESENTING CELLS (APCS)&quot;" target="&quot;PROCESS OF&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Antigen Presentation"</data>
      <data key="d6">chunk-830d8819004960d1d149ac70149c72a0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RECOGNIZE AND BIND TO&quot;" target="&quot;TCR&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Peptides Present On MHC molecules"</data>
      <data key="d6">chunk-830d8819004960d1d149ac70149c72a0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ARG2 SIDE CHAIN&quot;" target="&quot;STRUCTURAL HINDRANCE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Longer arginine side chain causes steric hindrance between peptide and MHC-binding groove, affecting affinity for self-peptide binding to HLA-B*15:01.")</data>
      <data key="d6">chunk-de413ae6100407d8dadd5bdee87c1074</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;POLAR INTERACTIONS&quot;" target="&quot;STABILIZING FORCES&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Polar interactions such as hydrogen bonds and salt bridges enhance stability of HLA complexes with peptides.")</data>
      <data key="d6">chunk-de413ae6100407d8dadd5bdee87c1074</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;STABILIZING FORCES&quot;" target="&quot;HYDROPHOBIC PACKING&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Additional hydrophobic packing interactions further stabilize the decamer complex by reducing electrostatic repulsion between hydrophobic side chains.")</data>
      <data key="d6">chunk-de413ae6100407d8dadd5bdee87c1074</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AFFINITY DIFFERENCES&quot;" target="&quot;P/MHC COMPLEXES&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Comparison of affinities between self-peptide and neoepitopes for HLA-B*15:01 highlights potential differences in immunogenicity and therapeutic relevance.")</data>
      <data key="d6">chunk-de413ae6100407d8dadd5bdee87c1074</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DECAMER PRESENTATION&quot;" target="&quot;ENHANCED STABILITY&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Increase in binding energy and structural stability provided by the decamer configuration results from a more compact conformation and enhanced interactions with HLA-B*15:01.")</data>
      <data key="d6">chunk-de413ae6100407d8dadd5bdee87c1074</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HIGH BINDING ENERGY&quot;" target="&quot;MOCK HLA ALLELE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The mock polyAla HLA exhibits considerably higher binding energy across the entire peptide length compared to top binders.")</data>
      <data key="d6">chunk-614333487e4b92705503909d34155179</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS74420772&quot;" target="&quot;IGM ANTI-PC&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"SNP rs74420772 was genome-wide significant in TwinGene associated with IgM anti-PC measurements.")</data>
      <data key="d6">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IGM ANTI-PC&quot;" target="&quot;CLL CASE ASSOCIATION&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"IgM anti-PC was lower in prevalent CLL cases compared to matched controls, with a declining trend between sampling and diagnosis but not statistically significant.")</data>
      <data key="d6">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IGM ANTI-PC&quot;" target="&quot;PREVALENT CLL ASSOCIATION&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"A small nested case-control study found IgM anti-PC to be lower in prevalent cases of CLL compared to matched controls, but not significantly associated with incident cases using stratified Cox proportional hazards model.")</data>
      <data key="d6">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS35923643-G&quot;" target="&quot;11Q24.1&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"rs35923643-G is part of the LD block overlapping with GRAM domain containing 1B (GRAMD1B) gene.")</data>
      <data key="d6">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS735665-A&quot;" target="&quot;CLL&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The SNP rs735665 was best-fitted and explained the largest variance of CLL risk in polygenic risk score analysis.")&lt;SEP&gt;"The allele rs35923643-G or proxy SNP rs735665-A was recognized as the top risk allele for CLL.")</data>
      <data key="d6">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS735665-A&quot;" target="&quot;GENERAL IGM AND IGM ANTI-PC&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"rs735665-A was identified as a genome-wide significant SNP associated with general IgM increasing alleles related to IgM anti-PC.")</data>
      <data key="d6">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS735665-A&quot;" target="&quot;GENERAL IGM AND GENERAL IGA/IGG&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The allele rs735665-A was associated not only with CLL but also showed a negative association with the risk of certain disease states involving general IgM, general IgA, or general IgG levels.")</data>
      <data key="d6">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS35923643&quot;" target="&quot;REGULOMEDB SUPPORT&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The RegulomeDB database gave support for rs35923643 affecting the binding of transcription factors in general.")</data>
      <data key="d6">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TF BINDING&quot;" target="&quot;TRANSCRIPTION FACTORS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"ChIP-seq experiments suggested binding sites for 22 different transcription factors within the region around rs35923643.")</data>
      <data key="d6">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BINDING MOTIFS&quot;" target="&quot;RUNX3 AND SPI1 TFS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The strongest signals were observed for RUNX3 and SPI1 from FIMO tool, with the RUNX3 binding motif including SNP rs35923643.")</data>
      <data key="d6">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ENCODE DATA&quot;" target="&quot;TFS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The Encyclopedia of DNA Elements (ENCODE) provided data on transcription factor binding within the vicinity of rs35923643, identifying suggested binding sites for 22 different TFs.")</data>
      <data key="d6">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;STATISTICAL TREND&quot;" target="&quot;TIME BETWEEN SAMPLING AND DIAGNOSIS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"An analysis revealed a non-statistically significant declining trend in IgM anti-PC levels between CLL cases and matched controls as time from sampling to diagnosis increased.")</data>
      <data key="d6">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
      <data key="d7">1</data>
    </edge>
  </graph>
</graphml>
